id	sid	tid	token	lemma	pos
bptjm-15	1	1	the	the	DET
bptjm-15	1	2	role	role	NOUN
bptjm-15	1	3	of	of	ADP
bptjm-15	1	4	the	the	DET
bptjm-15	1	5	gut	gut	NOUN
bptjm-15	1	6	microbiome	microbiome	NOUN
bptjm-15	1	7	in	in	ADP
bptjm-15	1	8	neuromodulation	neuromodulation	NOUN
bptjm-15	1	9	therapies	therapy	NOUN
bptjm-15	1	10	as	as	ADP
bptjm-15	1	11	a	a	DET
bptjm-15	1	12	potential	potential	ADJ
bptjm-15	1	13	treatment	treatment	NOUN
bptjm-15	1	14	adjunct	adjunct	ADJ
bptjm-15	1	15	for	for	ADP
bptjm-15	1	16	multiple	multiple	ADJ
bptjm-15	1	17	sclerosis	sclerosis	NOUN
bptjm-15	1	18	berkeley	berkeley	PROPN
bptjm-15	1	19	pharma	pharma	PROPN
bptjm-15	1	20	tech	tech	NOUN
bptjm-15	1	21	journal	journal	NOUN
bptjm-15	1	22	of	of	ADP
bptjm-15	1	23	medicine	medicine	NOUN
bptjm-15	1	24	correspondence	correspondence	NOUN
bptjm-15	1	25	:	:	PUNCT
bptjm-15	2	1	pipertonne@gmail.com	pipertonne@gmail.com	X
bptjm-15	2	2	keywords	keyword	NOUN
bptjm-15	2	3	:	:	PUNCT
bptjm-15	2	4	gut	gut	NOUN
bptjm-15	2	5	-	-	PUNCT
bptjm-15	2	6	brain	brain	NOUN
bptjm-15	2	7	axis	axis	NOUN
bptjm-15	2	8	gut	gut	NOUN
bptjm-15	2	9	microbiome	microbiome	ADJ
bptjm-15	2	10	immune	immune	ADJ
bptjm-15	2	11	system	system	NOUN
bptjm-15	2	12	multiple	multiple	ADJ
bptjm-15	2	13	sclerosis	sclerosis	NOUN
bptjm-15	2	14	neuromodulation	neuromodulation	NOUN
bptjm-15	2	15	submitted	submit	VERB
bptjm-15	2	16	june	june	PROPN
bptjm-15	2	17	28	28	NUM
bptjm-15	2	18	,	,	PUNCT
bptjm-15	2	19	2021	2021	NUM
bptjm-15	2	20	accepted	accept	VERB
bptjm-15	2	21	july	july	PROPN
bptjm-15	2	22	20	20	NUM
bptjm-15	2	23	,	,	PUNCT
bptjm-15	2	24	2021	2021	NUM
bptjm-15	2	25	published	publish	VERB
bptjm-15	2	26	december	december	PROPN
bptjm-15	2	27	17	17	NUM
bptjm-15	2	28	,	,	PUNCT
bptjm-15	2	29	2021	2021	NUM
bptjm-15	2	30	full	full	ADJ
bptjm-15	2	31	open	open	ADJ
bptjm-15	2	32	access	access	NOUN
bptjm-15	2	33	creative	creative	ADJ
bptjm-15	2	34	commons	common	NOUN
bptjm-15	2	35	attribution	attribution	NOUN
bptjm-15	2	36	license	license	VERB
bptjm-15	2	37	4.0	4.0	NUM
bptjm-15	2	38	abstract	abstract	ADJ
bptjm-15	2	39	gut	gut	NOUN
bptjm-15	2	40	microbiome	microbiome	NOUN
bptjm-15	2	41	research	research	NOUN
bptjm-15	2	42	has	have	AUX
bptjm-15	2	43	surged	surge	VERB
bptjm-15	2	44	in	in	ADP
bptjm-15	2	45	popularity	popularity	NOUN
bptjm-15	2	46	over	over	ADP
bptjm-15	2	47	the	the	DET
bptjm-15	2	48	past	past	ADJ
bptjm-15	2	49	decade	decade	NOUN
bptjm-15	2	50	.	.	PUNCT
bptjm-15	3	1	these	these	DET
bptjm-15	3	2	studies	study	NOUN
bptjm-15	3	3	have	have	AUX
bptjm-15	3	4	found	find	VERB
bptjm-15	3	5	local	local	ADJ
bptjm-15	3	6	and	and	CCONJ
bptjm-15	3	7	distal	distal	ADJ
bptjm-15	3	8	effects	effect	NOUN
bptjm-15	3	9	of	of	ADP
bptjm-15	3	10	micro	micro	ADJ
bptjm-15	3	11	organisms	organism	NOUN
bptjm-15	3	12	such	such	ADJ
bptjm-15	3	13	as	as	ADP
bptjm-15	3	14	fungi	fungus	NOUN
bptjm-15	3	15	and	and	CCONJ
bptjm-15	3	16	bacteria	bacteria	NOUN
bptjm-15	3	17	on	on	ADP
bptjm-15	3	18	human	human	ADJ
bptjm-15	3	19	physiology	physiology	NOUN
bptjm-15	3	20	,	,	PUNCT
bptjm-15	3	21	including	include	VERB
bptjm-15	3	22	the	the	DET
bptjm-15	3	23	nervous	nervous	ADJ
bptjm-15	3	24	,	,	PUNCT
bptjm-15	3	25	immune	immune	ADJ
bptjm-15	3	26	,	,	PUNCT
bptjm-15	3	27	and	and	CCONJ
bptjm-15	3	28	endocrine	endocrine	NOUN
bptjm-15	3	29	systems	system	NOUN
bptjm-15	3	30	.	.	PUNCT
bptjm-15	4	1	a	a	DET
bptjm-15	4	2	number	number	NOUN
bptjm-15	4	3	of	of	ADP
bptjm-15	4	4	studies	study	NOUN
bptjm-15	4	5	have	have	AUX
bptjm-15	4	6	demonstrated	demonstrate	VERB
bptjm-15	4	7	the	the	DET
bptjm-15	4	8	potential	potential	NOUN
bptjm-15	4	9	for	for	ADP
bptjm-15	4	10	gut	gut	NOUN
bptjm-15	4	11	microbiota	microbiota	NOUN
bptjm-15	4	12	to	to	AUX
bptjm-15	4	13	combat	combat	VERB
bptjm-15	4	14	classical	classical	ADJ
bptjm-15	4	15	diseases	disease	NOUN
bptjm-15	4	16	such	such	ADJ
bptjm-15	4	17	as	as	ADP
bptjm-15	4	18	clinical	clinical	ADJ
bptjm-15	4	19	depression	depression	NOUN
bptjm-15	4	20	and	and	CCONJ
bptjm-15	4	21	autism	autism	NOUN
bptjm-15	4	22	spectrum	spectrum	NOUN
bptjm-15	4	23	disorder	disorder	NOUN
bptjm-15	4	24	.	.	PUNCT
bptjm-15	5	1	the	the	DET
bptjm-15	5	2	impact	impact	NOUN
bptjm-15	5	3	of	of	ADP
bptjm-15	5	4	gut	gut	NOUN
bptjm-15	5	5	-	-	PUNCT
bptjm-15	5	6	produced	produce	VERB
bptjm-15	5	7	metabolites	metabolite	NOUN
bptjm-15	5	8	on	on	ADP
bptjm-15	5	9	the	the	DET
bptjm-15	5	10	secretion	secretion	NOUN
bptjm-15	5	11	of	of	ADP
bptjm-15	5	12	various	various	ADJ
bptjm-15	5	13	cytokines	cytokine	NOUN
bptjm-15	5	14	has	have	AUX
bptjm-15	5	15	presented	present	VERB
bptjm-15	5	16	a	a	DET
bptjm-15	5	17	new	new	ADV
bptjm-15	5	18	-	-	PUNCT
bptjm-15	5	19	found	find	VERB
bptjm-15	5	20	opportunity	opportunity	NOUN
bptjm-15	5	21	for	for	ADP
bptjm-15	5	22	future	future	ADJ
bptjm-15	5	23	disease	disease	NOUN
bptjm-15	5	24	therapy	therapy	NOUN
bptjm-15	5	25	through	through	ADP
bptjm-15	5	26	these	these	DET
bptjm-15	5	27	micro	micro	NOUN
bptjm-15	5	28	-	-	NOUN
bptjm-15	5	29	organisms	organism	NOUN
bptjm-15	5	30	.	.	PUNCT
bptjm-15	6	1	this	this	DET
bptjm-15	6	2	review	review	NOUN
bptjm-15	6	3	examines	examine	VERB
bptjm-15	6	4	recent	recent	ADJ
bptjm-15	6	5	evidence	evidence	NOUN
bptjm-15	6	6	for	for	ADP
bptjm-15	6	7	the	the	DET
bptjm-15	6	8	use	use	NOUN
bptjm-15	6	9	of	of	ADP
bptjm-15	6	10	gut	gut	NOUN
bptjm-15	6	11	bacteria	bacteria	NOUN
bptjm-15	6	12	in	in	ADP
bptjm-15	6	13	neurological	neurological	ADJ
bptjm-15	6	14	rehabilitation	rehabilitation	NOUN
bptjm-15	6	15	,	,	PUNCT
bptjm-15	6	16	specifically	specifically	ADV
bptjm-15	6	17	for	for	ADP
bptjm-15	6	18	multiple	multiple	ADJ
bptjm-15	6	19	sclerosis	sclerosis	NOUN
bptjm-15	6	20	(	(	PUNCT
bptjm-15	6	21	ms	ms	NOUN
bptjm-15	6	22	)	)	PUNCT
bptjm-15	6	23	patients	patient	NOUN
bptjm-15	6	24	.	.	PUNCT
bptjm-15	7	1	available	available	ADJ
bptjm-15	7	2	data	datum	NOUN
bptjm-15	7	3	has	have	AUX
bptjm-15	7	4	shown	show	VERB
bptjm-15	7	5	overwhelming	overwhelming	ADJ
bptjm-15	7	6	support	support	NOUN
bptjm-15	7	7	for	for	ADP
bptjm-15	7	8	microbiota	microbiota	NOUN
bptjm-15	7	9	-	-	PUNCT
bptjm-15	7	10	based	base	VERB
bptjm-15	7	11	ms	ms	NOUN
bptjm-15	7	12	therapy	therapy	NOUN
bptjm-15	7	13	,	,	PUNCT
bptjm-15	7	14	but	but	CCONJ
bptjm-15	7	15	the	the	DET
bptjm-15	7	16	lack	lack	NOUN
bptjm-15	7	17	of	of	ADP
bptjm-15	7	18	comprehension	comprehension	NOUN
bptjm-15	7	19	regarding	regard	VERB
bptjm-15	7	20	the	the	DET
bptjm-15	7	21	specific	specific	ADJ
bptjm-15	7	22	physiological	physiological	ADJ
bptjm-15	7	23	mechanisms	mechanism	NOUN
bptjm-15	7	24	of	of	ADP
bptjm-15	7	25	these	these	DET
bptjm-15	7	26	microbiota	microbiota	NOUN
bptjm-15	7	27	suggests	suggest	VERB
bptjm-15	7	28	that	that	SCONJ
bptjm-15	7	29	clinical	clinical	ADJ
bptjm-15	7	30	trials	trial	NOUN
bptjm-15	7	31	may	may	AUX
bptjm-15	7	32	be	be	AUX
bptjm-15	7	33	far	far	ADV
bptjm-15	7	34	off	off	ADV
bptjm-15	7	35	.	.	PUNCT
bptjm-15	8	1	furthermore	furthermore	ADV
bptjm-15	8	2	,	,	PUNCT
bptjm-15	8	3	there	there	PRON
bptjm-15	8	4	has	have	AUX
bptjm-15	8	5	been	be	AUX
bptjm-15	8	6	minimal	minimal	ADJ
bptjm-15	8	7	research	research	NOUN
bptjm-15	8	8	investigating	investigate	VERB
bptjm-15	8	9	the	the	DET
bptjm-15	8	10	consequences	consequence	NOUN
bptjm-15	8	11	of	of	ADP
bptjm-15	8	12	using	use	VERB
bptjm-15	8	13	microbiotic	microbiotic	ADJ
bptjm-15	8	14	therapy	therapy	NOUN
bptjm-15	8	15	in	in	ADP
bptjm-15	8	16	tandem	tandem	PROPN
bptjm-15	8	17	with	with	ADP
bptjm-15	8	18	current	current	ADJ
bptjm-15	8	19	therapies	therapy	NOUN
bptjm-15	8	20	such	such	ADJ
bptjm-15	8	21	as	as	ADP
bptjm-15	8	22	neurostimulation	neurostimulation	NOUN
bptjm-15	8	23	or	or	CCONJ
bptjm-15	8	24	drug	drug	NOUN
bptjm-15	8	25	therapy	therapy	NOUN
bptjm-15	8	26	.	.	PUNCT
bptjm-15	9	1	factors	factor	NOUN
bptjm-15	9	2	including	include	VERB
bptjm-15	9	3	the	the	DET
bptjm-15	9	4	mechanisms	mechanism	NOUN
bptjm-15	9	5	and	and	CCONJ
bptjm-15	9	6	restorative	restorative	ADJ
bptjm-15	9	7	capability	capability	NOUN
bptjm-15	9	8	of	of	ADP
bptjm-15	9	9	specific	specific	ADJ
bptjm-15	9	10	species	specie	NOUN
bptjm-15	9	11	of	of	ADP
bptjm-15	9	12	microbiota	microbiota	NOUN
bptjm-15	9	13	must	must	AUX
bptjm-15	9	14	be	be	AUX
bptjm-15	9	15	studied	study	VERB
bptjm-15	9	16	in	in	ADP
bptjm-15	9	17	depth	depth	NOUN
bptjm-15	9	18	in	in	ADP
bptjm-15	9	19	order	order	NOUN
bptjm-15	9	20	to	to	PART
bptjm-15	9	21	successfully	successfully	ADV
bptjm-15	9	22	manipulate	manipulate	VERB
bptjm-15	9	23	the	the	DET
bptjm-15	9	24	gut	gut	NOUN
bptjm-15	9	25	microbiome	microbiome	NOUN
bptjm-15	9	26	for	for	ADP
bptjm-15	9	27	the	the	DET
bptjm-15	9	28	treatment	treatment	NOUN
bptjm-15	9	29	of	of	ADP
bptjm-15	9	30	neurological	neurological	ADJ
bptjm-15	9	31	disorders	disorder	NOUN
bptjm-15	9	32	.	.	PUNCT
bptjm-15	10	1	the	the	DET
bptjm-15	10	2	role	role	NOUN
bptjm-15	10	3	of	of	ADP
bptjm-15	10	4	the	the	DET
bptjm-15	10	5	gut	gut	NOUN
bptjm-15	10	6	microbiome	microbiome	NOUN
bptjm-15	10	7	in	in	ADP
bptjm-15	10	8	neuromodulation	neuromodulation	NOUN
bptjm-15	10	9	therapies	therapy	NOUN
bptjm-15	10	10	as	as	ADP
bptjm-15	10	11	a	a	DET
bptjm-15	10	12	potential	potential	ADJ
bptjm-15	10	13	treatment	treatment	NOUN
bptjm-15	10	14	adjunct	adjunct	ADJ
bptjm-15	10	15	for	for	ADP
bptjm-15	10	16	multiple	multiple	ADJ
bptjm-15	10	17	sclerosis	sclerosis	NOUN
bptjm-15	10	18	by	by	ADP
bptjm-15	10	19	:	:	PUNCT
bptjm-15	10	20	piper	piper	NOUN
bptjm-15	10	21	tonne	tonne	NOUN
bptjm-15	10	22	,	,	PUNCT
bptjm-15	10	23	deondre	deondre	PROPN
bptjm-15	10	24	do	do	VERB
bptjm-15	10	25	,	,	PUNCT
bptjm-15	10	26	nabeeha	nabeeha	PROPN
bptjm-15	10	27	hasan	hasan	PROPN
bptjm-15	10	28	,	,	PUNCT
bptjm-15	10	29	sravya	sravya	NOUN
bptjm-15	10	30	gundapaneni	gundapaneni	NOUN
bptjm-15	10	31	,	,	PUNCT
bptjm-15	10	32	ariya	ariya	PROPN
bptjm-15	10	33	reddy	reddy	PROPN
bptjm-15	10	34	,	,	PUNCT
bptjm-15	10	35	saadhana	saadhana	NOUN
bptjm-15	10	36	sridharan	sridharan	ADJ
bptjm-15	10	37	,	,	PUNCT
bptjm-15	10	38	and	and	CCONJ
bptjm-15	10	39	sierra	sierra	PROPN
bptjm-15	10	40	richardson	richardson	PROPN
bptjm-15	10	41	the	the	DET
bptjm-15	10	42	axon	axon	NOUN
bptjm-15	10	43	of	of	ADP
bptjm-15	10	44	the	the	DET
bptjm-15	10	45	neuron	neuron	NOUN
bptjm-15	10	46	,	,	PUNCT
bptjm-15	10	47	pictured	picture	VERB
bptjm-15	10	48	on	on	ADP
bptjm-15	10	49	the	the	DET
bptjm-15	10	50	right	right	ADJ
bptjm-15	10	51	side	side	NOUN
bptjm-15	10	52	,	,	PUNCT
bptjm-15	10	53	begins	begin	VERB
bptjm-15	10	54	to	to	PART
bptjm-15	10	55	degrade	degrade	VERB
bptjm-15	10	56	following	follow	VERB
bptjm-15	10	57	the	the	DET
bptjm-15	10	58	onset	onset	NOUN
bptjm-15	10	59	of	of	ADP
bptjm-15	10	60	multiple	multiple	ADJ
bptjm-15	10	61	sclerosis	sclerosis	NOUN
bptjm-15	10	62	.	.	PUNCT
bptjm-15	11	1	image	image	NOUN
bptjm-15	11	2	credits	credit	NOUN
bptjm-15	11	3	:	:	PUNCT
bptjm-15	11	4	n	n	CCONJ
bptjm-15	11	5	/	/	SYM
bptjm-15	11	6	c	c	NOUN
bptjm-15	11	7	introduction	introduction	NOUN
bptjm-15	11	8	in	in	ADP
bptjm-15	11	9	recent	recent	ADJ
bptjm-15	11	10	years	year	NOUN
bptjm-15	11	11	,	,	PUNCT
bptjm-15	11	12	the	the	DET
bptjm-15	11	13	accessibility	accessibility	NOUN
bptjm-15	11	14	and	and	CCONJ
bptjm-15	11	15	prevalence	prevalence	NOUN
bptjm-15	11	16	of	of	ADP
bptjm-15	11	17	research	research	NOUN
bptjm-15	11	18	regarding	regard	VERB
bptjm-15	11	19	the	the	DET
bptjm-15	11	20	gut	gut	NOUN
bptjm-15	11	21	microbiome	microbiome	NOUN
bptjm-15	11	22	has	have	AUX
bptjm-15	11	23	increased	increase	VERB
bptjm-15	11	24	tremendously	tremendously	ADV
bptjm-15	11	25	.	.	PUNCT
bptjm-15	12	1	it	it	PRON
bptjm-15	12	2	is	be	AUX
bptjm-15	12	3	common	common	ADJ
bptjm-15	12	4	knowledge	knowledge	NOUN
bptjm-15	12	5	that	that	SCONJ
bptjm-15	12	6	the	the	DET
bptjm-15	12	7	human	human	ADJ
bptjm-15	12	8	gut	gut	NOUN
bptjm-15	12	9	plays	play	VERB
bptjm-15	12	10	an	an	DET
bptjm-15	12	11	important	important	ADJ
bptjm-15	12	12	role	role	NOUN
bptjm-15	12	13	in	in	ADP
bptjm-15	12	14	regulating	regulate	VERB
bptjm-15	12	15	health	health	NOUN
bptjm-15	12	16	.	.	PUNCT
bptjm-15	13	1	the	the	DET
bptjm-15	13	2	question	question	NOUN
bptjm-15	13	3	that	that	PRON
bptjm-15	13	4	remains	remain	VERB
bptjm-15	13	5	to	to	PART
bptjm-15	13	6	be	be	AUX
bptjm-15	13	7	asked	ask	VERB
bptjm-15	13	8	is	be	AUX
bptjm-15	13	9	,	,	PUNCT
bptjm-15	13	10	just	just	ADV
bptjm-15	13	11	how	how	SCONJ
bptjm-15	13	12	much	much	ADJ
bptjm-15	13	13	in	in	ADP
bptjm-15	13	14	�	�	NOUN
bptjm-15	13	15	uence	uence	NOUN
bptjm-15	13	16	does	do	AUX
bptjm-15	13	17	the	the	DET
bptjm-15	13	18	gut	gut	NOUN
bptjm-15	13	19	microbiome	microbiome	NOUN
bptjm-15	13	20	hold	hold	VERB
bptjm-15	13	21	?	?	PUNCT
bptjm-15	14	1	newfound	newfound	ADJ
bptjm-15	14	2	curiosity	curiosity	NOUN
bptjm-15	14	3	regarding	regard	VERB
bptjm-15	14	4	the	the	DET
bptjm-15	14	5	e	e	PROPN
bptjm-15	14	6	�	�	NOUN
bptjm-15	14	7	ects	ect	NOUN
bptjm-15	14	8	of	of	ADP
bptjm-15	14	9	manipulation	manipulation	NOUN
bptjm-15	14	10	of	of	ADP
bptjm-15	14	11	the	the	DET
bptjm-15	14	12	bacterial	bacterial	ADJ
bptjm-15	14	13	population	population	NOUN
bptjm-15	14	14	residing	reside	VERB
bptjm-15	14	15	in	in	ADP
bptjm-15	14	16	the	the	DET
bptjm-15	14	17	gut	gut	NOUN
bptjm-15	14	18	prompts	prompt	NOUN
bptjm-15	14	19	the	the	DET
bptjm-15	14	20	scienti	scienti	NOUN
bptjm-15	14	21	�	�	PROPN
bptjm-15	14	22	c	c	PROPN
bptjm-15	14	23	community	community	NOUN
bptjm-15	14	24	to	to	PART
bptjm-15	14	25	expand	expand	VERB
bptjm-15	14	26	research	research	NOUN
bptjm-15	14	27	on	on	ADP
bptjm-15	14	28	ways	way	NOUN
bptjm-15	14	29	to	to	PART
bptjm-15	14	30	harness	harness	VERB
bptjm-15	14	31	the	the	DET
bptjm-15	14	32	power	power	NOUN
bptjm-15	14	33	of	of	ADP
bptjm-15	14	34	the	the	DET
bptjm-15	14	35	gut	gut	NOUN
bptjm-15	14	36	microbiome	microbiome	NOUN
bptjm-15	14	37	.	.	PUNCT
bptjm-15	15	1	research	research	NOUN
bptjm-15	15	2	on	on	ADP
bptjm-15	15	3	the	the	DET
bptjm-15	15	4	gut	gut	NOUN
bptjm-15	15	5	microbiome	microbiome	NOUN
bptjm-15	15	6	has	have	AUX
bptjm-15	15	7	advanced	advance	VERB
bptjm-15	15	8	considerably	considerably	ADV
bptjm-15	15	9	since	since	SCONJ
bptjm-15	15	10	its	its	PRON
bptjm-15	15	11	discovery	discovery	NOUN
bptjm-15	15	12	decades	decade	NOUN
bptjm-15	15	13	ago	ago	ADV
bptjm-15	15	14	with	with	ADP
bptjm-15	15	15	the	the	DET
bptjm-15	15	16	development	development	NOUN
bptjm-15	15	17	of	of	ADP
bptjm-15	15	18	technologies	technology	NOUN
bptjm-15	15	19	such	such	ADJ
bptjm-15	15	20	as	as	ADP
bptjm-15	15	21	16s	16	NOUN
bptjm-15	15	22	rrna	rrna	NOUN
bptjm-15	15	23	sequencing	sequence	VERB
bptjm-15	15	24	to	to	PART
bptjm-15	15	25	assist	assist	VERB
bptjm-15	15	26	in	in	ADP
bptjm-15	15	27	mapping	map	VERB
bptjm-15	15	28	the	the	DET
bptjm-15	15	29	human	human	ADJ
bptjm-15	15	30	microbiome	microbiome	NOUN
bptjm-15	15	31	(	(	PUNCT
bptjm-15	15	32	choileain	choileain	NOUN
bptjm-15	15	33	,	,	PUNCT
bptjm-15	15	34	2020	2020	NUM
bptjm-15	15	35	;	;	PUNCT
bptjm-15	15	36	jangi	jangi	PROPN
bptjm-15	15	37	,	,	PUNCT
bptjm-15	15	38	2016	2016	NUM
bptjm-15	15	39	;	;	PUNCT
bptjm-15	15	40	takewaki	takewaki	PROPN
bptjm-15	15	41	,	,	PUNCT
bptjm-15	15	42	2020	2020	NUM
bptjm-15	15	43	;	;	PUNCT
bptjm-15	15	44	zuo	zuo	PROPN
bptjm-15	15	45	,	,	PUNCT
bptjm-15	15	46	2018	2018	NUM
bptjm-15	15	47	)	)	PUNCT
bptjm-15	15	48	.	.	PUNCT
bptjm-15	16	1	furthermore	furthermore	ADV
bptjm-15	16	2	,	,	PUNCT
bptjm-15	16	3	with	with	ADP
bptjm-15	16	4	advancements	advancement	NOUN
bptjm-15	16	5	in	in	ADP
bptjm-15	16	6	microbiome	microbiome	ADV
bptjm-15	16	7	-	-	PUNCT
bptjm-15	16	8	related	relate	VERB
bptjm-15	16	9	engineering	engineering	NOUN
bptjm-15	16	10	and	and	CCONJ
bptjm-15	16	11	technology	technology	NOUN
bptjm-15	16	12	,	,	PUNCT
bptjm-15	16	13	researchers	researcher	NOUN
bptjm-15	16	14	have	have	AUX
bptjm-15	16	15	come	come	VERB
bptjm-15	16	16	far	far	ADV
bptjm-15	16	17	closer	close	ADV
bptjm-15	16	18	to	to	ADP
bptjm-15	16	19	understanding	understand	VERB
bptjm-15	16	20	the	the	DET
bptjm-15	16	21	speci	speci	PROPN
bptjm-15	16	22	�	�	PROPN
bptjm-15	16	23	c	c	NOUN
bptjm-15	16	24	genes	gene	NOUN
bptjm-15	16	25	and	and	CCONJ
bptjm-15	16	26	mechanisms	mechanism	NOUN
bptjm-15	16	27	behind	behind	ADP
bptjm-15	16	28	microbial	microbial	ADJ
bptjm-15	16	29	functions	function	NOUN
bptjm-15	16	30	in	in	ADP
bptjm-15	16	31	the	the	DET
bptjm-15	16	32	gut	gut	NOUN
bptjm-15	16	33	and	and	CCONJ
bptjm-15	16	34	beyond	beyond	ADP
bptjm-15	16	35	(	(	PUNCT
bptjm-15	16	36	azad	azad	NOUN
bptjm-15	16	37	,	,	PUNCT
bptjm-15	16	38	2018	2018	NUM
bptjm-15	16	39	;	;	PUNCT
bptjm-15	16	40	cani	cani	NOUN
bptjm-15	16	41	,	,	PUNCT
bptjm-15	16	42	2018	2018	NUM
bptjm-15	16	43	)	)	PUNCT
bptjm-15	16	44	.	.	PUNCT
bptjm-15	17	1	however	however	ADV
bptjm-15	17	2	,	,	PUNCT
bptjm-15	17	3	with	with	ADP
bptjm-15	17	4	a	a	DET
bptjm-15	17	5	collective	collective	ADJ
bptjm-15	17	6	human	human	ADJ
bptjm-15	17	7	genome	genome	NOUN
bptjm-15	17	8	including	include	VERB
bptjm-15	17	9	tens	ten	NOUN
bptjm-15	17	10	of	of	ADP
bptjm-15	17	11	thousands	thousand	NOUN
bptjm-15	17	12	of	of	ADP
bptjm-15	17	13	genes	gene	NOUN
bptjm-15	17	14	,	,	PUNCT
bptjm-15	17	15	discovering	discover	VERB
bptjm-15	17	16	speci	speci	ADJ
bptjm-15	17	17	�	�	PROPN
bptjm-15	17	18	c	c	PROPN
bptjm-15	17	19	causation	causation	NOUN
bptjm-15	17	20	from	from	ADP
bptjm-15	17	21	gut	gut	NOUN
bptjm-15	17	22	-	-	PUNCT
bptjm-15	17	23	related	relate	VERB
bptjm-15	17	24	studies	study	NOUN
bptjm-15	17	25	has	have	AUX
bptjm-15	17	26	proven	prove	VERB
bptjm-15	17	27	to	to	PART
bptjm-15	17	28	be	be	AUX
bptjm-15	17	29	exceedingly	exceedingly	ADV
bptjm-15	17	30	challenging	challenging	ADJ
bptjm-15	17	31	.	.	PUNCT
bptjm-15	18	1	a	a	DET
bptjm-15	18	2	large	large	ADJ
bptjm-15	18	3	number	number	NOUN
bptjm-15	18	4	of	of	ADP
bptjm-15	18	5	papers	paper	NOUN
bptjm-15	18	6	studying	study	VERB
bptjm-15	18	7	the	the	DET
bptjm-15	18	8	human	human	ADJ
bptjm-15	18	9	microbiome	microbiome	NOUN
bptjm-15	18	10	within	within	ADP
bptjm-15	18	11	the	the	DET
bptjm-15	18	12	past	past	ADJ
bptjm-15	18	13	decade	decade	NOUN
bptjm-15	18	14	have	have	AUX
bptjm-15	18	15	covered	cover	VERB
bptjm-15	18	16	its	its	PRON
bptjm-15	18	17	immense	immense	ADJ
bptjm-15	18	18	potential	potential	NOUN
bptjm-15	18	19	to	to	PART
bptjm-15	18	20	impact	impact	VERB
bptjm-15	18	21	human	human	ADJ
bptjm-15	18	22	health	health	NOUN
bptjm-15	18	23	.	.	PUNCT
bptjm-15	19	1	however	however	ADV
bptjm-15	19	2	,	,	PUNCT
bptjm-15	19	3	none	none	NOUN
bptjm-15	19	4	have	have	AUX
bptjm-15	19	5	been	be	AUX
bptjm-15	19	6	able	able	ADJ
bptjm-15	19	7	to	to	PART
bptjm-15	19	8	specify	specify	VERB
bptjm-15	19	9	the	the	DET
bptjm-15	19	10	mechanisms	mechanism	NOUN
bptjm-15	19	11	,	,	PUNCT
bptjm-15	19	12	much	much	ADV
bptjm-15	19	13	less	less	ADJ
bptjm-15	19	14	the	the	DET
bptjm-15	19	15	genes	gene	NOUN
bptjm-15	19	16	behind	behind	ADP
bptjm-15	19	17	these	these	DET
bptjm-15	19	18	microorganisms	microorganism	NOUN
bptjm-15	19	19	,	,	PUNCT
bptjm-15	19	20	which	which	PRON
bptjm-15	19	21	mainly	mainly	ADV
bptjm-15	19	22	consist	consist	VERB
bptjm-15	19	23	of	of	ADP
bptjm-15	19	24	bacteria	bacteria	NOUN
bptjm-15	19	25	(	(	PUNCT
bptjm-15	19	26	cani	cani	NOUN
bptjm-15	19	27	,	,	PUNCT
bptjm-15	19	28	2018	2018	NUM
bptjm-15	19	29	;	;	PUNCT
bptjm-15	19	30	han	han	PROPN
bptjm-15	19	31	,	,	PUNCT
bptjm-15	19	32	2018	2018	NUM
bptjm-15	19	33	;	;	PUNCT
bptjm-15	19	34	strandwitz	strandwitz	PROPN
bptjm-15	19	35	,	,	PUNCT
bptjm-15	19	36	2018	2018	NUM
bptjm-15	19	37	)	)	PUNCT
bptjm-15	19	38	.	.	PUNCT
bptjm-15	20	1	in	in	ADP
bptjm-15	20	2	this	this	DET
bptjm-15	20	3	review	review	NOUN
bptjm-15	20	4	,	,	PUNCT
bptjm-15	20	5	recent	recent	ADJ
bptjm-15	20	6	evidence	evidence	NOUN
bptjm-15	20	7	showing	show	VERB
bptjm-15	20	8	the	the	DET
bptjm-15	20	9	impact	impact	NOUN
bptjm-15	20	10	of	of	ADP
bptjm-15	20	11	general	general	ADJ
bptjm-15	20	12	probiotics	probiotic	NOUN
bptjm-15	20	13	and	and	CCONJ
bptjm-15	20	14	speci	speci	PROPN
bptjm-15	20	15	�	�	PROPN
bptjm-15	20	16	c	c	PROPN
bptjm-15	20	17	bacterial	bacterial	ADJ
bptjm-15	20	18	implants	implant	NOUN
bptjm-15	20	19	on	on	ADP
bptjm-15	20	20	human	human	ADJ
bptjm-15	20	21	neurophysiology	neurophysiology	NOUN
bptjm-15	20	22	will	will	AUX
bptjm-15	20	23	be	be	AUX
bptjm-15	20	24	examined	examine	VERB
bptjm-15	20	25	.	.	PUNCT
bptjm-15	21	1	the	the	DET
bptjm-15	21	2	various	various	ADJ
bptjm-15	21	3	e	e	NOUN
bptjm-15	21	4	�	�	NOUN
bptjm-15	21	5	ects	ect	NOUN
bptjm-15	21	6	of	of	ADP
bptjm-15	21	7	the	the	DET
bptjm-15	21	8	gut	gut	NOUN
bptjm-15	21	9	microbiome	microbiome	NOUN
bptjm-15	21	10	on	on	ADP
bptjm-15	21	11	the	the	DET
bptjm-15	21	12	neuroimmune	neuroimmune	NOUN
bptjm-15	21	13	system	system	NOUN
bptjm-15	21	14	will	will	AUX
bptjm-15	21	15	be	be	AUX
bptjm-15	21	16	discussed	discuss	VERB
bptjm-15	21	17	along	along	ADP
bptjm-15	21	18	with	with	ADP
bptjm-15	21	19	a	a	DET
bptjm-15	21	20	scrutinization	scrutinization	NOUN
bptjm-15	21	21	of	of	ADP
bptjm-15	21	22	the	the	DET
bptjm-15	21	23	current	current	ADJ
bptjm-15	21	24	neuromodulatory	neuromodulatory	ADJ
bptjm-15	21	25	therapies	therapy	NOUN
bptjm-15	21	26	.	.	PUNCT
bptjm-15	22	1	this	this	DET
bptjm-15	22	2	paper	paper	NOUN
bptjm-15	22	3	explores	explore	VERB
bptjm-15	22	4	the	the	DET
bptjm-15	22	5	possibility	possibility	NOUN
bptjm-15	22	6	of	of	ADP
bptjm-15	22	7	using	use	VERB
bptjm-15	22	8	gut	gut	NOUN
bptjm-15	22	9	therapy	therapy	NOUN
bptjm-15	22	10	speci	speci	NOUN
bptjm-15	22	11	�	�	PROPN
bptjm-15	22	12	cally	cally	ADV
bptjm-15	22	13	for	for	ADP
bptjm-15	22	14	the	the	DET
bptjm-15	22	15	clinical	clinical	ADJ
bptjm-15	22	16	treatment	treatment	NOUN
bptjm-15	22	17	of	of	ADP
bptjm-15	22	18	multiple	multiple	ADJ
bptjm-15	22	19	sclerosis	sclerosis	NOUN
bptjm-15	22	20	(	(	PUNCT
bptjm-15	22	21	ms	ms	NOUN
bptjm-15	22	22	)	)	PUNCT
bptjm-15	22	23	patients	patient	NOUN
bptjm-15	22	24	.	.	PUNCT
bptjm-15	23	1	before	before	ADP
bptjm-15	23	2	jumping	jump	VERB
bptjm-15	23	3	into	into	ADP
bptjm-15	23	4	this	this	DET
bptjm-15	23	5	discussion	discussion	NOUN
bptjm-15	23	6	,	,	PUNCT
bptjm-15	23	7	it	it	PRON
bptjm-15	23	8	is	be	AUX
bptjm-15	23	9	imperative	imperative	ADJ
bptjm-15	23	10	to	to	PART
bptjm-15	23	11	know	know	VERB
bptjm-15	23	12	the	the	DET
bptjm-15	23	13	background	background	NOUN
bptjm-15	23	14	of	of	ADP
bptjm-15	23	15	this	this	DET
bptjm-15	23	16	disease	disease	NOUN
bptjm-15	23	17	and	and	CCONJ
bptjm-15	23	18	the	the	DET
bptjm-15	23	19	organisms	organism	NOUN
bptjm-15	23	20	that	that	PRON
bptjm-15	23	21	may	may	AUX
bptjm-15	23	22	assist	assist	VERB
bptjm-15	23	23	in	in	ADP
bptjm-15	23	24	its	its	PRON
bptjm-15	23	25	treatment	treatment	NOUN
bptjm-15	23	26	.	.	PUNCT
bptjm-15	24	1	the	the	DET
bptjm-15	24	2	gut	gut	NOUN
bptjm-15	24	3	microbiome	microbiome	NOUN
bptjm-15	24	4	the	the	DET
bptjm-15	24	5	term	term	NOUN
bptjm-15	24	6	gut	gut	NOUN
bptjm-15	24	7	microbiome	microbiome	NOUN
bptjm-15	24	8	refers	refer	VERB
bptjm-15	24	9	to	to	ADP
bptjm-15	24	10	the	the	DET
bptjm-15	24	11	trillions	trillion	NOUN
bptjm-15	24	12	of	of	ADP
bptjm-15	24	13	microbes	microbe	NOUN
bptjm-15	24	14	living	live	VERB
bptjm-15	24	15	within	within	ADP
bptjm-15	24	16	the	the	DET
bptjm-15	24	17	tract	tract	NOUN
bptjm-15	24	18	of	of	ADP
bptjm-15	24	19	humans	human	NOUN
bptjm-15	24	20	and	and	CCONJ
bptjm-15	24	21	other	other	ADJ
bptjm-15	24	22	animals	animal	NOUN
bptjm-15	24	23	.	.	PUNCT
bptjm-15	25	1	although	although	SCONJ
bptjm-15	25	2	incredibly	incredibly	ADV
bptjm-15	25	3	small	small	ADJ
bptjm-15	25	4	,	,	PUNCT
bptjm-15	25	5	the	the	DET
bptjm-15	25	6	microbes	microbe	NOUN
bptjm-15	25	7	in	in	ADP
bptjm-15	25	8	the	the	DET
bptjm-15	25	9	gut	gut	NOUN
bptjm-15	25	10	play	play	VERB
bptjm-15	25	11	a	a	DET
bptjm-15	25	12	huge	huge	ADJ
bptjm-15	25	13	role	role	NOUN
bptjm-15	25	14	in	in	ADP
bptjm-15	25	15	human	human	ADJ
bptjm-15	25	16	metabolism	metabolism	NOUN
bptjm-15	25	17	,	,	PUNCT
bptjm-15	25	18	physiology	physiology	NOUN
bptjm-15	25	19	,	,	PUNCT
bptjm-15	25	20	and	and	CCONJ
bptjm-15	25	21	immune	immune	ADJ
bptjm-15	25	22	berkeley	berkeley	PROPN
bptjm-15	25	23	pharma	pharma	PROPN
bptjm-15	25	24	tech	tech	NOUN
bptjm-15	25	25	journal	journal	NOUN
bptjm-15	25	26	of	of	ADP
bptjm-15	25	27	medicine	medicine	NOUN
bptjm-15	25	28	|	|	ADV
bptjm-15	25	29	65	65	NUM
bptjm-15	25	30	system	system	NOUN
bptjm-15	25	31	development	development	NOUN
bptjm-15	25	32	(	(	PUNCT
bptjm-15	25	33	azad	azad	NOUN
bptjm-15	25	34	,	,	PUNCT
bptjm-15	25	35	2018	2018	NUM
bptjm-15	25	36	)	)	PUNCT
bptjm-15	25	37	.	.	PUNCT
bptjm-15	26	1	the	the	DET
bptjm-15	26	2	gut	gut	NOUN
bptjm-15	26	3	microbiome	microbiome	NOUN
bptjm-15	26	4	encompasses	encompass	VERB
bptjm-15	26	5	a	a	DET
bptjm-15	26	6	large	large	ADJ
bptjm-15	26	7	scope	scope	NOUN
bptjm-15	26	8	of	of	ADP
bptjm-15	26	9	symbiotic	symbiotic	ADJ
bptjm-15	26	10	functions	function	NOUN
bptjm-15	26	11	in	in	ADP
bptjm-15	26	12	the	the	DET
bptjm-15	26	13	body	body	NOUN
bptjm-15	26	14	including	include	VERB
bptjm-15	26	15	vitamin	vitamin	NOUN
bptjm-15	26	16	synthesis	synthesis	NOUN
bptjm-15	26	17	and	and	CCONJ
bptjm-15	26	18	gi	gi	VERB
bptjm-15	26	19	hormone	hormone	NOUN
bptjm-15	26	20	release	release	NOUN
bptjm-15	26	21	,	,	PUNCT
bptjm-15	26	22	the	the	DET
bptjm-15	26	23	latter	latter	NOUN
bptjm-15	26	24	of	of	ADP
bptjm-15	26	25	which	which	PRON
bptjm-15	26	26	protects	protect	VERB
bptjm-15	26	27	the	the	DET
bptjm-15	26	28	body	body	NOUN
bptjm-15	26	29	from	from	ADP
bptjm-15	26	30	pathogen	pathogen	NOUN
bptjm-15	26	31	colonization	colonization	NOUN
bptjm-15	26	32	(	(	PUNCT
bptjm-15	26	33	collins	collin	NOUN
bptjm-15	26	34	,	,	PUNCT
bptjm-15	26	35	2012	2012	NUM
bptjm-15	26	36	)	)	PUNCT
bptjm-15	26	37	.	.	PUNCT
bptjm-15	27	1	one	one	NUM
bptjm-15	27	2	aspect	aspect	NOUN
bptjm-15	27	3	of	of	ADP
bptjm-15	27	4	this	this	DET
bptjm-15	27	5	symbiosis	symbiosis	NOUN
bptjm-15	27	6	investigated	investigate	VERB
bptjm-15	27	7	in	in	ADP
bptjm-15	27	8	this	this	DET
bptjm-15	27	9	review	review	NOUN
bptjm-15	27	10	is	be	AUX
bptjm-15	27	11	the	the	DET
bptjm-15	27	12	e	e	NOUN
bptjm-15	27	13	�	�	NOUN
bptjm-15	27	14	ects	ect	VERB
bptjm-15	27	15	on	on	ADP
bptjm-15	27	16	the	the	DET
bptjm-15	27	17	human	human	ADJ
bptjm-15	27	18	central	central	ADJ
bptjm-15	27	19	nervous	nervous	ADJ
bptjm-15	27	20	system	system	NOUN
bptjm-15	27	21	(	(	PUNCT
bptjm-15	27	22	cns	cns	NOUN
bptjm-15	27	23	)	)	PUNCT
bptjm-15	27	24	,	,	PUNCT
bptjm-15	27	25	where	where	SCONJ
bptjm-15	27	26	alterations	alteration	NOUN
bptjm-15	27	27	of	of	ADP
bptjm-15	27	28	neuronal	neuronal	ADJ
bptjm-15	27	29	signaling	signal	VERB
bptjm-15	27	30	by	by	ADP
bptjm-15	27	31	the	the	DET
bptjm-15	27	32	gut	gut	NOUN
bptjm-15	27	33	,	,	PUNCT
bptjm-15	27	34	especially	especially	ADV
bptjm-15	27	35	in	in	ADP
bptjm-15	27	36	the	the	DET
bptjm-15	27	37	brain	brain	NOUN
bptjm-15	27	38	,	,	PUNCT
bptjm-15	27	39	have	have	AUX
bptjm-15	27	40	piqued	pique	VERB
bptjm-15	27	41	scholarly	scholarly	ADJ
bptjm-15	27	42	interest	interest	NOUN
bptjm-15	27	43	.	.	PUNCT
bptjm-15	28	1	particularly	particularly	ADV
bptjm-15	28	2	,	,	PUNCT
bptjm-15	28	3	there	there	PRON
bptjm-15	28	4	has	have	AUX
bptjm-15	28	5	been	be	AUX
bptjm-15	28	6	extensive	extensive	ADJ
bptjm-15	28	7	research	research	NOUN
bptjm-15	28	8	on	on	ADP
bptjm-15	28	9	microbial	microbial	ADJ
bptjm-15	28	10	impact	impact	NOUN
bptjm-15	28	11	on	on	ADP
bptjm-15	28	12	the	the	DET
bptjm-15	28	13	gi	gi	NOUN
bptjm-15	28	14	tract	tract	NOUN
bptjm-15	28	15	,	,	PUNCT
bptjm-15	28	16	as	as	ADV
bptjm-15	28	17	well	well	ADV
bptjm-15	28	18	as	as	ADP
bptjm-15	28	19	its	its	PRON
bptjm-15	28	20	impact	impact	NOUN
bptjm-15	28	21	on	on	ADP
bptjm-15	28	22	human	human	ADJ
bptjm-15	28	23	physiology	physiology	NOUN
bptjm-15	28	24	.	.	PUNCT
bptjm-15	29	1	within	within	ADP
bptjm-15	29	2	the	the	DET
bptjm-15	29	3	past	past	ADJ
bptjm-15	29	4	decade	decade	NOUN
bptjm-15	29	5	,	,	PUNCT
bptjm-15	29	6	research	research	NOUN
bptjm-15	29	7	on	on	ADP
bptjm-15	29	8	the	the	DET
bptjm-15	29	9	gut	gut	NOUN
bptjm-15	29	10	microbiome	microbiome	NOUN
bptjm-15	29	11	has	have	AUX
bptjm-15	29	12	seen	see	VERB
bptjm-15	29	13	an	an	DET
bptjm-15	29	14	exponential	exponential	ADJ
bptjm-15	29	15	increase	increase	NOUN
bptjm-15	29	16	due	due	ADP
bptjm-15	29	17	to	to	ADP
bptjm-15	29	18	the	the	DET
bptjm-15	29	19	metagenomic	metagenomic	ADJ
bptjm-15	29	20	revolution	revolution	PROPN
bptjm-15	29	21	the	the	DET
bptjm-15	29	22	study	study	NOUN
bptjm-15	29	23	of	of	ADP
bptjm-15	29	24	genomes	genome	NOUN
bptjm-15	29	25	of	of	ADP
bptjm-15	29	26	bacterial	bacterial	ADJ
bptjm-15	29	27	species	specie	NOUN
bptjm-15	29	28	in	in	ADP
bptjm-15	29	29	a	a	DET
bptjm-15	29	30	speci	speci	ADJ
bptjm-15	29	31	�	�	PROPN
bptjm-15	29	32	c	c	PROPN
bptjm-15	29	33	environment	environment	NOUN
bptjm-15	29	34	rather	rather	ADV
bptjm-15	29	35	than	than	ADP
bptjm-15	29	36	pure	pure	ADJ
bptjm-15	29	37	laboratory	laboratory	NOUN
bptjm-15	29	38	cultures	culture	NOUN
bptjm-15	29	39	.	.	PUNCT
bptjm-15	30	1	one	one	NUM
bptjm-15	30	2	reason	reason	NOUN
bptjm-15	30	3	the	the	DET
bptjm-15	30	4	gi	gi	NOUN
bptjm-15	30	5	tract	tract	NOUN
bptjm-15	30	6	is	be	AUX
bptjm-15	30	7	an	an	DET
bptjm-15	30	8	area	area	NOUN
bptjm-15	30	9	of	of	ADP
bptjm-15	30	10	interest	interest	NOUN
bptjm-15	30	11	is	be	AUX
bptjm-15	30	12	due	due	ADJ
bptjm-15	30	13	to	to	ADP
bptjm-15	30	14	its	its	PRON
bptjm-15	30	15	key	key	ADJ
bptjm-15	30	16	role	role	NOUN
bptjm-15	30	17	in	in	ADP
bptjm-15	30	18	the	the	DET
bptjm-15	30	19	complex	complex	ADJ
bptjm-15	30	20	mechanisms	mechanism	NOUN
bptjm-15	30	21	of	of	ADP
bptjm-15	30	22	immunoregulation	immunoregulation	NOUN
bptjm-15	30	23	(	(	PUNCT
bptjm-15	30	24	joscelyn	joscelyn	NOUN
bptjm-15	30	25	,	,	PUNCT
bptjm-15	30	26	2014	2014	NUM
bptjm-15	30	27	;	;	PUNCT
bptjm-15	30	28	kirby	kirby	PROPN
bptjm-15	30	29	,	,	PUNCT
bptjm-15	30	30	2018	2018	NUM
bptjm-15	30	31	;	;	PUNCT
bptjm-15	30	32	mangalam	mangalam	PROPN
bptjm-15	30	33	,	,	PUNCT
bptjm-15	30	34	2017	2017	NUM
bptjm-15	30	35	;	;	PUNCT
bptjm-15	30	36	ochoa	ochoa	NOUN
bptjm-15	30	37	-	-	PUNCT
bptjm-15	30	38	repáraz	repáraz	NOUN
bptjm-15	30	39	,	,	PUNCT
bptjm-15	30	40	2014,2018	2014,2018	NUM
bptjm-15	30	41	;	;	PUNCT
bptjm-15	30	42	shahi	shahi	NOUN
bptjm-15	30	43	,	,	PUNCT
bptjm-15	30	44	2019	2019	NUM
bptjm-15	30	45	;	;	PUNCT
bptjm-15	30	46	velasquez	velasquez	PROPN
bptjm-15	30	47	-	-	PUNCT
bptjm-15	30	48	mano	mano	PROPN
bptjm-15	30	49	�	�	PROPN
bptjm-15	30	50	,	,	PUNCT
bptjm-15	30	51	2015	2015	NUM
bptjm-15	30	52	)	)	PUNCT
bptjm-15	30	53	.	.	PUNCT
bptjm-15	31	1	at	at	ADP
bptjm-15	31	2	�	�	PROPN
bptjm-15	31	3	rst	rst	PROPN
bptjm-15	31	4	,	,	PUNCT
bptjm-15	31	5	interest	interest	NOUN
bptjm-15	31	6	in	in	ADP
bptjm-15	31	7	the	the	DET
bptjm-15	31	8	role	role	NOUN
bptjm-15	31	9	of	of	ADP
bptjm-15	31	10	the	the	DET
bptjm-15	31	11	microbiome	microbiome	NOUN
bptjm-15	31	12	led	lead	VERB
bptjm-15	31	13	researchers	researcher	NOUN
bptjm-15	31	14	to	to	PART
bptjm-15	31	15	look	look	VERB
bptjm-15	31	16	for	for	ADP
bptjm-15	31	17	any	any	DET
bptjm-15	31	18	associations	association	NOUN
bptjm-15	31	19	regarding	regard	VERB
bptjm-15	31	20	innate	innate	ADJ
bptjm-15	31	21	and	and	CCONJ
bptjm-15	31	22	adaptive	adaptive	ADJ
bptjm-15	31	23	immunity	immunity	NOUN
bptjm-15	31	24	within	within	ADP
bptjm-15	31	25	the	the	DET
bptjm-15	31	26	human	human	ADJ
bptjm-15	31	27	body	body	NOUN
bptjm-15	31	28	.	.	PUNCT
bptjm-15	32	1	for	for	ADP
bptjm-15	32	2	example	example	NOUN
bptjm-15	32	3	,	,	PUNCT
bptjm-15	32	4	gut	gut	NOUN
bptjm-15	32	5	-	-	PUNCT
bptjm-15	32	6	associated	associate	VERB
bptjm-15	32	7	lymphoid	lymphoid	ADJ
bptjm-15	32	8	tissue	tissue	NOUN
bptjm-15	32	9	(	(	PUNCT
bptjm-15	32	10	galt	galt	PROPN
bptjm-15	32	11	)	)	PUNCT
bptjm-15	32	12	represents	represent	VERB
bptjm-15	32	13	almost	almost	ADV
bptjm-15	32	14	70	70	NUM
bptjm-15	32	15	%	%	NOUN
bptjm-15	32	16	of	of	ADP
bptjm-15	32	17	the	the	DET
bptjm-15	32	18	entire	entire	ADJ
bptjm-15	32	19	immune	immune	ADJ
bptjm-15	32	20	system	system	NOUN
bptjm-15	32	21	,	,	PUNCT
bptjm-15	32	22	and	and	CCONJ
bptjm-15	32	23	the	the	DET
bptjm-15	32	24	gi	gi	NOUN
bptjm-15	32	25	tract	tract	NOUN
bptjm-15	32	26	hosts	host	NOUN
bptjm-15	32	27	around	around	ADP
bptjm-15	32	28	80	80	NUM
bptjm-15	32	29	%	%	NOUN
bptjm-15	32	30	of	of	ADP
bptjm-15	32	31	plasma	plasma	NOUN
bptjm-15	32	32	cells	cell	NOUN
bptjm-15	32	33	,	,	PUNCT
bptjm-15	32	34	such	such	ADJ
bptjm-15	32	35	as	as	ADP
bptjm-15	32	36	immunoglobulin	immunoglobulin	NOUN
bptjm-15	32	37	a	a	PRON
bptjm-15	32	38	(	(	PUNCT
bptjm-15	32	39	iga)-bearing	iga)-beare	VERB
bptjm-15	32	40	cells	cell	NOUN
bptjm-15	32	41	(	(	PUNCT
bptjm-15	32	42	vighi	vighi	PROPN
bptjm-15	32	43	,	,	PUNCT
bptjm-15	32	44	2008	2008	NUM
bptjm-15	32	45	)	)	PUNCT
bptjm-15	32	46	.	.	PUNCT
bptjm-15	33	1	this	this	DET
bptjm-15	33	2	research	research	NOUN
bptjm-15	33	3	has	have	AUX
bptjm-15	33	4	since	since	SCONJ
bptjm-15	33	5	dramatically	dramatically	ADV
bptjm-15	33	6	expanded	expand	VERB
bptjm-15	33	7	with	with	ADP
bptjm-15	33	8	the	the	DET
bptjm-15	33	9	upsurge	upsurge	NOUN
bptjm-15	33	10	of	of	ADP
bptjm-15	33	11	discoveries	discovery	NOUN
bptjm-15	33	12	correlating	correlate	VERB
bptjm-15	33	13	bacteria	bacteria	NOUN
bptjm-15	33	14	,	,	PUNCT
bptjm-15	33	15	such	such	ADJ
bptjm-15	33	16	as	as	ADP
bptjm-15	33	17	akkermansia	akkermansia	PROPN
bptjm-15	33	18	muciniphila	muciniphila	NOUN
bptjm-15	33	19	or	or	CCONJ
bptjm-15	33	20	prevotella	prevotella	NOUN
bptjm-15	33	21	copri	copri	NOUN
bptjm-15	33	22	,	,	PUNCT
bptjm-15	33	23	with	with	ADP
bptjm-15	33	24	various	various	ADJ
bptjm-15	33	25	disease	disease	NOUN
bptjm-15	33	26	pathologies	pathology	NOUN
bptjm-15	33	27	including	include	VERB
bptjm-15	33	28	:	:	PUNCT
bptjm-15	33	29	obesity	obesity	NOUN
bptjm-15	33	30	,	,	PUNCT
bptjm-15	33	31	type	type	NOUN
bptjm-15	33	32	ii	ii	NOUN
bptjm-15	33	33	diabetes	diabetes	NOUN
bptjm-15	33	34	,	,	PUNCT
bptjm-15	33	35	and	and	CCONJ
bptjm-15	33	36	multiple	multiple	ADJ
bptjm-15	33	37	sclerosis	sclerosis	NOUN
bptjm-15	33	38	(	(	PUNCT
bptjm-15	33	39	cani	cani	PROPN
bptjm-15	33	40	,	,	PUNCT
bptjm-15	33	41	2018	2018	NUM
bptjm-15	33	42	)	)	PUNCT
bptjm-15	33	43	.	.	PUNCT
bptjm-15	34	1	for	for	ADP
bptjm-15	34	2	example	example	NOUN
bptjm-15	34	3	,	,	PUNCT
bptjm-15	34	4	researchers	researcher	NOUN
bptjm-15	34	5	now	now	ADV
bptjm-15	34	6	understand	understand	VERB
bptjm-15	34	7	that	that	SCONJ
bptjm-15	34	8	the	the	DET
bptjm-15	34	9	function	function	NOUN
bptjm-15	34	10	of	of	ADP
bptjm-15	34	11	the	the	DET
bptjm-15	34	12	overall	overall	ADJ
bptjm-15	34	13	human	human	ADJ
bptjm-15	34	14	immune	immune	ADJ
bptjm-15	34	15	system	system	NOUN
bptjm-15	34	16	is	be	AUX
bptjm-15	34	17	deeply	deeply	ADV
bptjm-15	34	18	in	in	ADP
bptjm-15	34	19	�	�	PROPN
bptjm-15	34	20	uenced	uence	VERB
bptjm-15	34	21	by	by	ADP
bptjm-15	34	22	bacteriophages	bacteriophage	NOUN
bptjm-15	34	23	,	,	PUNCT
bptjm-15	34	24	viruses	virus	NOUN
bptjm-15	34	25	that	that	PRON
bptjm-15	34	26	parasitize	parasitize	VERB
bptjm-15	34	27	bacteria	bacteria	NOUN
bptjm-15	34	28	by	by	ADP
bptjm-15	34	29	infecting	infect	VERB
bptjm-15	34	30	them	they	PRON
bptjm-15	34	31	and	and	CCONJ
bptjm-15	34	32	reproducing	reproduce	VERB
bptjm-15	34	33	inside	inside	ADP
bptjm-15	34	34	them	they	PRON
bptjm-15	34	35	.	.	PUNCT
bptjm-15	35	1	research	research	NOUN
bptjm-15	35	2	indicates	indicate	VERB
bptjm-15	35	3	that	that	SCONJ
bptjm-15	35	4	bacteriophages	bacteriophage	NOUN
bptjm-15	35	5	,	,	PUNCT
bptjm-15	35	6	such	such	ADJ
bptjm-15	35	7	as	as	ADP
bptjm-15	35	8	caudovirales	caudovirale	NOUN
bptjm-15	35	9	,	,	PUNCT
bptjm-15	35	10	can	can	AUX
bptjm-15	35	11	be	be	AUX
bptjm-15	35	12	manipulated	manipulate	VERB
bptjm-15	35	13	in	in	ADP
bptjm-15	35	14	order	order	NOUN
bptjm-15	35	15	to	to	PART
bptjm-15	35	16	provide	provide	VERB
bptjm-15	35	17	relief	relief	NOUN
bptjm-15	35	18	to	to	ADP
bptjm-15	35	19	patients	patient	NOUN
bptjm-15	35	20	su	su	PROPN
bptjm-15	35	21	�	�	PROPN
bptjm-15	35	22	ering	ere	VERB
bptjm-15	35	23	from	from	ADP
bptjm-15	35	24	clostridium	clostridium	NOUN
bptjm-15	35	25	difficile	difficile	ADJ
bptjm-15	35	26	infection	infection	NOUN
bptjm-15	35	27	through	through	ADP
bptjm-15	35	28	successful	successful	ADJ
bptjm-15	35	29	fecal	fecal	ADJ
bptjm-15	35	30	microbiota	microbiota	NOUN
bptjm-15	35	31	transplantation	transplantation	NOUN
bptjm-15	35	32	.	.	PUNCT
bptjm-15	36	1	by	by	ADP
bptjm-15	36	2	administering	administer	VERB
bptjm-15	36	3	fecal	fecal	ADJ
bptjm-15	36	4	matter	matter	NOUN
bptjm-15	36	5	from	from	ADP
bptjm-15	36	6	a	a	DET
bptjm-15	36	7	donor	donor	NOUN
bptjm-15	36	8	into	into	ADP
bptjm-15	36	9	the	the	DET
bptjm-15	36	10	intestinal	intestinal	ADJ
bptjm-15	36	11	tract	tract	NOUN
bptjm-15	36	12	of	of	ADP
bptjm-15	36	13	a	a	DET
bptjm-15	36	14	recipient	recipient	NOUN
bptjm-15	36	15	,	,	PUNCT
bptjm-15	36	16	the	the	DET
bptjm-15	36	17	recipient	recipient	NOUN
bptjm-15	36	18	experiences	experience	VERB
bptjm-15	36	19	relief	relief	NOUN
bptjm-15	36	20	of	of	ADP
bptjm-15	36	21	infection	infection	NOUN
bptjm-15	36	22	symptoms	symptom	NOUN
bptjm-15	36	23	as	as	ADP
bptjm-15	36	24	a	a	DET
bptjm-15	36	25	result	result	NOUN
bptjm-15	36	26	of	of	ADP
bptjm-15	36	27	the	the	DET
bptjm-15	36	28	change	change	NOUN
bptjm-15	36	29	in	in	ADP
bptjm-15	36	30	their	their	PRON
bptjm-15	36	31	gut	gut	NOUN
bptjm-15	36	32	microbial	microbial	ADJ
bptjm-15	36	33	composition	composition	NOUN
bptjm-15	36	34	(	(	PUNCT
bptjm-15	36	35	zuo	zuo	NOUN
bptjm-15	36	36	,	,	PUNCT
bptjm-15	36	37	2018	2018	NUM
bptjm-15	36	38	)	)	PUNCT
bptjm-15	36	39	.	.	PUNCT
bptjm-15	37	1	furthermore	furthermore	ADV
bptjm-15	37	2	,	,	PUNCT
bptjm-15	37	3	with	with	ADP
bptjm-15	37	4	the	the	DET
bptjm-15	37	5	increasing	increase	VERB
bptjm-15	37	6	interest	interest	NOUN
bptjm-15	37	7	in	in	ADP
bptjm-15	37	8	elucidating	elucidate	VERB
bptjm-15	37	9	the	the	DET
bptjm-15	37	10	potential	potential	ADJ
bptjm-15	37	11	manipulation	manipulation	NOUN
bptjm-15	37	12	of	of	ADP
bptjm-15	37	13	the	the	DET
bptjm-15	37	14	gut	gut	NOUN
bptjm-15	37	15	microbiome	microbiome	NOUN
bptjm-15	37	16	,	,	PUNCT
bptjm-15	37	17	there	there	PRON
bptjm-15	37	18	has	have	AUX
bptjm-15	37	19	been	be	AUX
bptjm-15	37	20	an	an	DET
bptjm-15	37	21	increase	increase	NOUN
bptjm-15	37	22	in	in	ADP
bptjm-15	37	23	research	research	NOUN
bptjm-15	37	24	highlighting	highlight	VERB
bptjm-15	37	25	its	its	PRON
bptjm-15	37	26	connection	connection	NOUN
bptjm-15	37	27	with	with	ADP
bptjm-15	37	28	the	the	DET
bptjm-15	37	29	central	central	ADJ
bptjm-15	37	30	nervous	nervous	ADJ
bptjm-15	37	31	system	system	NOUN
bptjm-15	37	32	,	,	PUNCT
bptjm-15	37	33	and	and	CCONJ
bptjm-15	37	34	its	its	PRON
bptjm-15	37	35	role	role	NOUN
bptjm-15	37	36	in	in	ADP
bptjm-15	37	37	maintaining	maintain	VERB
bptjm-15	37	38	homeostasis	homeostasis	NOUN
bptjm-15	37	39	(	(	PUNCT
bptjm-15	37	40	ochoa	ochoa	NOUN
bptjm-15	37	41	-	-	PUNCT
bptjm-15	37	42	repáraz	repáraz	NOUN
bptjm-15	37	43	,	,	PUNCT
bptjm-15	37	44	2009	2009	NUM
bptjm-15	37	45	;	;	PUNCT
bptjm-15	37	46	wang	wang	PROPN
bptjm-15	37	47	,	,	PUNCT
bptjm-15	37	48	2014	2014	NUM
bptjm-15	37	49	;	;	PUNCT
bptjm-15	37	50	wang	wang	PROPN
bptjm-15	37	51	&	&	CCONJ
bptjm-15	37	52	kasper	kasper	PROPN
bptjm-15	37	53	,	,	PUNCT
bptjm-15	37	54	2014	2014	NUM
bptjm-15	37	55	;	;	PUNCT
bptjm-15	37	56	winter	winter	NOUN
bptjm-15	37	57	2018	2018	NUM
bptjm-15	37	58	)	)	PUNCT
bptjm-15	37	59	.	.	PUNCT
bptjm-15	38	1	however	however	ADV
bptjm-15	38	2	,	,	PUNCT
bptjm-15	38	3	although	although	SCONJ
bptjm-15	38	4	research	research	NOUN
bptjm-15	38	5	is	be	AUX
bptjm-15	38	6	extensive	extensive	ADJ
bptjm-15	38	7	,	,	PUNCT
bptjm-15	38	8	there	there	ADV
bptjm-15	38	9	berkeley	berkeley	PROPN
bptjm-15	38	10	pharma	pharma	PROPN
bptjm-15	38	11	tech	tech	NOUN
bptjm-15	38	12	journal	journal	NOUN
bptjm-15	38	13	of	of	ADP
bptjm-15	38	14	medicine	medicine	NOUN
bptjm-15	38	15	|	|	ADV
bptjm-15	38	16	66	66	NUM
bptjm-15	38	17	is	be	AUX
bptjm-15	38	18	an	an	DET
bptjm-15	38	19	inadequate	inadequate	ADJ
bptjm-15	38	20	understanding	understanding	NOUN
bptjm-15	38	21	of	of	ADP
bptjm-15	38	22	the	the	DET
bptjm-15	38	23	speci	speci	PROPN
bptjm-15	38	24	�	�	PROPN
bptjm-15	38	25	c	c	PROPN
bptjm-15	38	26	mechanisms	mechanism	NOUN
bptjm-15	38	27	of	of	ADP
bptjm-15	38	28	the	the	DET
bptjm-15	38	29	gut	gut	NOUN
bptjm-15	38	30	on	on	ADP
bptjm-15	38	31	human	human	ADJ
bptjm-15	38	32	physiology	physiology	NOUN
bptjm-15	38	33	.	.	PUNCT
bptjm-15	39	1	it	it	PRON
bptjm-15	39	2	is	be	AUX
bptjm-15	39	3	widely	widely	ADV
bptjm-15	39	4	accepted	accept	VERB
bptjm-15	39	5	that	that	SCONJ
bptjm-15	39	6	the	the	DET
bptjm-15	39	7	development	development	NOUN
bptjm-15	39	8	of	of	ADP
bptjm-15	39	9	the	the	DET
bptjm-15	39	10	gi	gi	NOUN
bptjm-15	39	11	microbiome	microbiome	NOUN
bptjm-15	39	12	begins	begin	VERB
bptjm-15	39	13	at	at	ADP
bptjm-15	39	14	birth	birth	NOUN
bptjm-15	39	15	.	.	PUNCT
bptjm-15	40	1	the	the	DET
bptjm-15	40	2	gi	gi	PROPN
bptjm-15	40	3	tract	tract	NOUN
bptjm-15	40	4	is	be	AUX
bptjm-15	40	5	rapidly	rapidly	ADV
bptjm-15	40	6	colonized	colonize	VERB
bptjm-15	40	7	after	after	ADP
bptjm-15	40	8	childbirth	childbirth	NOUN
bptjm-15	40	9	and	and	CCONJ
bptjm-15	40	10	is	be	AUX
bptjm-15	40	11	impacted	impact	VERB
bptjm-15	40	12	throughout	throughout	ADP
bptjm-15	40	13	life	life	NOUN
bptjm-15	40	14	by	by	ADP
bptjm-15	40	15	various	various	ADJ
bptjm-15	40	16	external	external	ADJ
bptjm-15	40	17	factors	factor	NOUN
bptjm-15	40	18	such	such	ADJ
bptjm-15	40	19	as	as	ADP
bptjm-15	40	20	:	:	PUNCT
bptjm-15	40	21	illness	illness	NOUN
bptjm-15	40	22	,	,	PUNCT
bptjm-15	40	23	antibiotic	antibiotic	ADJ
bptjm-15	40	24	treatment	treatment	NOUN
bptjm-15	40	25	,	,	PUNCT
bptjm-15	40	26	and	and	CCONJ
bptjm-15	40	27	changes	change	NOUN
bptjm-15	40	28	in	in	ADP
bptjm-15	40	29	diet	diet	NOUN
bptjm-15	40	30	(	(	PUNCT
bptjm-15	40	31	rodríguez	rodríguez	NOUN
bptjm-15	40	32	,	,	PUNCT
bptjm-15	40	33	2015	2015	NUM
bptjm-15	40	34	)	)	PUNCT
bptjm-15	40	35	.	.	PUNCT
bptjm-15	41	1	it	it	PRON
bptjm-15	41	2	is	be	AUX
bptjm-15	41	3	imperative	imperative	ADJ
bptjm-15	41	4	to	to	PART
bptjm-15	41	5	acknowledge	acknowledge	VERB
bptjm-15	41	6	the	the	DET
bptjm-15	41	7	consequences	consequence	NOUN
bptjm-15	41	8	of	of	ADP
bptjm-15	41	9	certain	certain	ADJ
bptjm-15	41	10	lifestyle	lifestyle	NOUN
bptjm-15	41	11	choices	choice	NOUN
bptjm-15	41	12	on	on	ADP
bptjm-15	41	13	the	the	DET
bptjm-15	41	14	gut	gut	NOUN
bptjm-15	41	15	microbiome	microbiome	NOUN
bptjm-15	41	16	,	,	PUNCT
bptjm-15	41	17	as	as	SCONJ
bptjm-15	41	18	any	any	DET
bptjm-15	41	19	shifts	shift	NOUN
bptjm-15	41	20	in	in	ADP
bptjm-15	41	21	one	one	NUM
bptjm-15	41	22	’s	’s	PART
bptjm-15	41	23	microbial	microbial	ADJ
bptjm-15	41	24	genome	genome	NOUN
bptjm-15	41	25	could	could	AUX
bptjm-15	41	26	a	a	DET
bptjm-15	41	27	�	�	NOUN
bptjm-15	41	28	ect	ect	VERB
bptjm-15	41	29	their	their	PRON
bptjm-15	41	30	entire	entire	ADJ
bptjm-15	41	31	physiology	physiology	NOUN
bptjm-15	41	32	(	(	PUNCT
bptjm-15	41	33	figure	figure	NOUN
bptjm-15	41	34	1	1	NUM
bptjm-15	41	35	)	)	PUNCT
bptjm-15	41	36	.	.	PUNCT
bptjm-15	42	1	diet	diet	PROPN
bptjm-15	42	2	is	be	AUX
bptjm-15	42	3	a	a	DET
bptjm-15	42	4	major	major	ADJ
bptjm-15	42	5	lifestyle	lifestyle	NOUN
bptjm-15	42	6	choice	choice	NOUN
bptjm-15	42	7	that	that	SCONJ
bptjm-15	42	8	in	in	ADP
bptjm-15	42	9	�	�	PROPN
bptjm-15	42	10	uences	uence	NOUN
bptjm-15	42	11	gut	gut	NOUN
bptjm-15	42	12	health	health	NOUN
bptjm-15	42	13	.	.	PUNCT
bptjm-15	43	1	both	both	DET
bptjm-15	43	2	short	short	ADJ
bptjm-15	43	3	and	and	CCONJ
bptjm-15	43	4	long	long	ADJ
bptjm-15	43	5	-	-	PUNCT
bptjm-15	43	6	term	term	NOUN
bptjm-15	43	7	alterations	alteration	NOUN
bptjm-15	43	8	in	in	ADP
bptjm-15	43	9	diet	diet	NOUN
bptjm-15	43	10	can	can	AUX
bptjm-15	43	11	impact	impact	VERB
bptjm-15	43	12	microbial	microbial	ADJ
bptjm-15	43	13	pro	pro	ADJ
bptjm-15	43	14	�	�	NOUN
bptjm-15	43	15	les	le	NOUN
bptjm-15	43	16	,	,	PUNCT
bptjm-15	43	17	and	and	CCONJ
bptjm-15	43	18	infant	infant	PROPN
bptjm-15	43	19	nutrition	nutrition	NOUN
bptjm-15	43	20	may	may	AUX
bptjm-15	43	21	have	have	VERB
bptjm-15	43	22	lifelong	lifelong	ADJ
bptjm-15	43	23	consequences	consequence	NOUN
bptjm-15	43	24	through	through	ADP
bptjm-15	43	25	microbial	microbial	ADJ
bptjm-15	43	26	modulation	modulation	NOUN
bptjm-15	43	27	of	of	ADP
bptjm-15	43	28	the	the	DET
bptjm-15	43	29	immune	immune	ADJ
bptjm-15	43	30	system	system	NOUN
bptjm-15	43	31	(	(	PUNCT
bptjm-15	43	32	harmsen	harmsen	PROPN
bptjm-15	43	33	,	,	PUNCT
bptjm-15	43	34	2000	2000	NUM
bptjm-15	43	35	)	)	PUNCT
bptjm-15	43	36	.	.	PUNCT
bptjm-15	44	1	in	in	ADP
bptjm-15	44	2	conjunction	conjunction	NOUN
bptjm-15	44	3	with	with	ADP
bptjm-15	44	4	the	the	DET
bptjm-15	44	5	prevalence	prevalence	NOUN
bptjm-15	44	6	of	of	ADP
bptjm-15	44	7	malnourishment	malnourishment	NOUN
bptjm-15	44	8	,	,	PUNCT
bptjm-15	44	9	with	with	ADP
bptjm-15	44	10	the	the	DET
bptjm-15	44	11	most	most	ADV
bptjm-15	44	12	common	common	ADJ
bptjm-15	44	13	representation	representation	NOUN
bptjm-15	44	14	being	be	AUX
bptjm-15	44	15	obesity	obesity	NOUN
bptjm-15	44	16	,	,	PUNCT
bptjm-15	44	17	diet	diet	PROPN
bptjm-15	44	18	is	be	AUX
bptjm-15	44	19	an	an	DET
bptjm-15	44	20	ever	ever	ADV
bptjm-15	44	21	-	-	PUNCT
bptjm-15	44	22	growing	grow	VERB
bptjm-15	44	23	area	area	NOUN
bptjm-15	44	24	of	of	ADP
bptjm-15	44	25	concern	concern	NOUN
bptjm-15	44	26	within	within	ADP
bptjm-15	44	27	medical	medical	ADJ
bptjm-15	44	28	research	research	NOUN
bptjm-15	44	29	(	(	PUNCT
bptjm-15	44	30	manichanh	manichanh	NOUN
bptjm-15	44	31	,	,	PUNCT
bptjm-15	44	32	2006	2006	NUM
bptjm-15	44	33	)	)	PUNCT
bptjm-15	44	34	.	.	PUNCT
bptjm-15	45	1	gut	gut	NOUN
bptjm-15	45	2	microbes	microbe	NOUN
bptjm-15	45	3	produce	produce	VERB
bptjm-15	45	4	a	a	DET
bptjm-15	45	5	large	large	ADJ
bptjm-15	45	6	number	number	NOUN
bptjm-15	45	7	of	of	ADP
bptjm-15	45	8	bioactive	bioactive	ADJ
bptjm-15	45	9	compounds	compound	NOUN
bptjm-15	45	10	that	that	PRON
bptjm-15	45	11	can	can	AUX
bptjm-15	45	12	be	be	AUX
bptjm-15	45	13	bene	bene	NOUN
bptjm-15	45	14	�	�	PROPN
bptjm-15	45	15	cial	cial	NOUN
bptjm-15	45	16	,	,	PUNCT
bptjm-15	45	17	such	such	ADJ
bptjm-15	45	18	as	as	ADP
bptjm-15	45	19	vitamins	vitamin	NOUN
bptjm-15	45	20	.	.	PUNCT
bptjm-15	46	1	bacteria	bacteria	NOUN
bptjm-15	46	2	,	,	PUNCT
bptjm-15	46	3	such	such	ADJ
bptjm-15	46	4	as	as	ADP
bptjm-15	46	5	bifidobacterium	bifidobacterium	NOUN
bptjm-15	46	6	,	,	PUNCT
bptjm-15	46	7	can	can	AUX
bptjm-15	46	8	generate	generate	VERB
bptjm-15	46	9	crucial	crucial	ADJ
bptjm-15	46	10	vitamins	vitamin	NOUN
bptjm-15	46	11	such	such	ADJ
bptjm-15	46	12	as	as	ADP
bptjm-15	46	13	:	:	PUNCT
bptjm-15	46	14	vitamin	vitamin	NOUN
bptjm-15	46	15	k	k	NOUN
bptjm-15	46	16	,	,	PUNCT
bptjm-15	46	17	b12	b12	NOUN
bptjm-15	46	18	,	,	PUNCT
bptjm-15	46	19	biotin	biotin	NOUN
bptjm-15	46	20	,	,	PUNCT
bptjm-15	46	21	folate	folate	NOUN
bptjm-15	46	22	,	,	PUNCT
bptjm-15	46	23	and	and	CCONJ
bptjm-15	46	24	thiamine	thiamine	NOUN
bptjm-15	46	25	(	(	PUNCT
bptjm-15	46	26	nicholson	nicholson	PROPN
bptjm-15	46	27	,	,	PUNCT
bptjm-15	46	28	2012	2012	NUM
bptjm-15	46	29	)	)	PUNCT
bptjm-15	46	30	.	.	PUNCT
bptjm-15	47	1	in	in	ADP
bptjm-15	47	2	addition	addition	NOUN
bptjm-15	47	3	,	,	PUNCT
bptjm-15	47	4	digestion	digestion	NOUN
bptjm-15	47	5	is	be	AUX
bptjm-15	47	6	in	in	ADP
bptjm-15	47	7	�	�	PROPN
bptjm-15	47	8	uenced	uence	VERB
bptjm-15	47	9	by	by	ADP
bptjm-15	47	10	many	many	ADJ
bptjm-15	47	11	enzymes	enzyme	NOUN
bptjm-15	47	12	produced	produce	VERB
bptjm-15	47	13	by	by	ADP
bptjm-15	47	14	microbes	microbe	NOUN
bptjm-15	47	15	.	.	PUNCT
bptjm-15	48	1	the	the	DET
bptjm-15	48	2	microbial	microbial	ADJ
bptjm-15	48	3	diversity	diversity	NOUN
bptjm-15	48	4	in	in	ADP
bptjm-15	48	5	the	the	DET
bptjm-15	48	6	human	human	ADJ
bptjm-15	48	7	gut	gut	NOUN
bptjm-15	48	8	is	be	AUX
bptjm-15	48	9	berkeley	berkeley	PROPN
bptjm-15	48	10	pharma	pharma	PROPN
bptjm-15	48	11	tech	tech	NOUN
bptjm-15	48	12	journal	journal	NOUN
bptjm-15	48	13	of	of	ADP
bptjm-15	48	14	medicine	medicine	NOUN
bptjm-15	48	15	|	|	ADV
bptjm-15	48	16	67	67	NUM
bptjm-15	48	17	figure	figure	NOUN
bptjm-15	48	18	1	1	NUM
bptjm-15	48	19	.	.	PUNCT
bptjm-15	49	1	the	the	DET
bptjm-15	49	2	gut	gut	NOUN
bptjm-15	49	3	microbiome	microbiome	NOUN
bptjm-15	49	4	plays	play	VERB
bptjm-15	49	5	an	an	DET
bptjm-15	49	6	important	important	ADJ
bptjm-15	49	7	role	role	NOUN
bptjm-15	49	8	in	in	ADP
bptjm-15	49	9	maintaining	maintain	VERB
bptjm-15	49	10	host	host	NOUN
bptjm-15	49	11	immunity	immunity	NOUN
bptjm-15	49	12	and	and	CCONJ
bptjm-15	49	13	homeostasis	homeostasis	NOUN
bptjm-15	49	14	via	via	ADP
bptjm-15	49	15	the	the	DET
bptjm-15	49	16	gut	gut	NOUN
bptjm-15	49	17	-	-	PUNCT
bptjm-15	49	18	brain	brain	NOUN
bptjm-15	49	19	axis	axis	NOUN
bptjm-15	49	20	.	.	PUNCT
bptjm-15	50	1	since	since	SCONJ
bptjm-15	50	2	the	the	DET
bptjm-15	50	3	axis	axis	NOUN
bptjm-15	50	4	is	be	AUX
bptjm-15	50	5	bidirectional	bidirectional	ADJ
bptjm-15	50	6	,	,	PUNCT
bptjm-15	50	7	factors	factor	NOUN
bptjm-15	50	8	such	such	ADJ
bptjm-15	50	9	as	as	ADP
bptjm-15	50	10	hunger	hunger	NOUN
bptjm-15	50	11	,	,	PUNCT
bptjm-15	50	12	anxiety	anxiety	NOUN
bptjm-15	50	13	,	,	PUNCT
bptjm-15	50	14	stress	stress	NOUN
bptjm-15	50	15	,	,	PUNCT
bptjm-15	50	16	and	and	CCONJ
bptjm-15	50	17	depressive	depressive	ADJ
bptjm-15	50	18	disorders	disorder	NOUN
bptjm-15	50	19	,	,	PUNCT
bptjm-15	50	20	in	in	ADP
bptjm-15	50	21	addition	addition	NOUN
bptjm-15	50	22	to	to	ADP
bptjm-15	50	23	lifestyle	lifestyle	NOUN
bptjm-15	50	24	choices	choice	NOUN
bptjm-15	50	25	such	such	ADJ
bptjm-15	50	26	as	as	ADP
bptjm-15	50	27	diet	diet	NOUN
bptjm-15	50	28	and	and	CCONJ
bptjm-15	50	29	exercise	exercise	NOUN
bptjm-15	50	30	,	,	PUNCT
bptjm-15	50	31	can	can	AUX
bptjm-15	50	32	reshape	reshape	VERB
bptjm-15	50	33	the	the	DET
bptjm-15	50	34	gut	gut	NOUN
bptjm-15	50	35	bacteria	bacteria	NOUN
bptjm-15	50	36	's	's	PART
bptjm-15	50	37	composition	composition	NOUN
bptjm-15	50	38	and	and	CCONJ
bptjm-15	50	39	exert	exert	VERB
bptjm-15	50	40	an	an	DET
bptjm-15	50	41	influence	influence	NOUN
bptjm-15	50	42	on	on	ADP
bptjm-15	50	43	immune	immune	ADJ
bptjm-15	50	44	function	function	NOUN
bptjm-15	50	45	and	and	CCONJ
bptjm-15	50	46	health	health	NOUN
bptjm-15	50	47	.	.	PUNCT
bptjm-15	51	1	attributable	attributable	ADJ
bptjm-15	51	2	to	to	ADP
bptjm-15	51	3	the	the	DET
bptjm-15	51	4	spectrum	spectrum	NOUN
bptjm-15	51	5	of	of	ADP
bptjm-15	51	6	microbial	microbial	ADJ
bptjm-15	51	7	enzymatic	enzymatic	ADJ
bptjm-15	51	8	capacity	capacity	NOUN
bptjm-15	51	9	needed	need	VERB
bptjm-15	51	10	to	to	PART
bptjm-15	51	11	degrade	degrade	VERB
bptjm-15	51	12	nutrients	nutrient	NOUN
bptjm-15	51	13	,	,	PUNCT
bptjm-15	51	14	particularly	particularly	ADV
bptjm-15	51	15	the	the	DET
bptjm-15	51	16	many	many	ADJ
bptjm-15	51	17	forms	form	NOUN
bptjm-15	51	18	of	of	ADP
bptjm-15	51	19	complex	complex	ADJ
bptjm-15	51	20	polysaccharides	polysaccharide	NOUN
bptjm-15	51	21	that	that	PRON
bptjm-15	51	22	are	be	AUX
bptjm-15	51	23	consumed	consume	VERB
bptjm-15	51	24	by	by	ADP
bptjm-15	51	25	humans	human	NOUN
bptjm-15	51	26	(	(	PUNCT
bptjm-15	51	27	cantarel	cantarel	NOUN
bptjm-15	51	28	,	,	PUNCT
bptjm-15	51	29	2012	2012	NUM
bptjm-15	51	30	)	)	PUNCT
bptjm-15	51	31	.	.	PUNCT
bptjm-15	52	1	nourishing	nourish	VERB
bptjm-15	52	2	the	the	DET
bptjm-15	52	3	body	body	NOUN
bptjm-15	52	4	properly	properly	ADV
bptjm-15	52	5	through	through	ADP
bptjm-15	52	6	a	a	DET
bptjm-15	52	7	balanced	balanced	ADJ
bptjm-15	52	8	diet	diet	NOUN
bptjm-15	52	9	is	be	AUX
bptjm-15	52	10	the	the	DET
bptjm-15	52	11	best	good	ADJ
bptjm-15	52	12	way	way	NOUN
bptjm-15	52	13	of	of	ADP
bptjm-15	52	14	maintaining	maintain	VERB
bptjm-15	52	15	a	a	DET
bptjm-15	52	16	healthy	healthy	ADJ
bptjm-15	52	17	gut	gut	NOUN
bptjm-15	52	18	microbiota	microbiota	NOUN
bptjm-15	52	19	population	population	NOUN
bptjm-15	52	20	.	.	PUNCT
bptjm-15	53	1	the	the	DET
bptjm-15	53	2	gut	gut	NOUN
bptjm-15	53	3	microbiome	microbiome	NOUN
bptjm-15	53	4	is	be	AUX
bptjm-15	53	5	a	a	DET
bptjm-15	53	6	complex	complex	ADJ
bptjm-15	53	7	ecosystem	ecosystem	NOUN
bptjm-15	53	8	that	that	PRON
bptjm-15	53	9	cycles	cycle	VERB
bptjm-15	53	10	nutrients	nutrient	NOUN
bptjm-15	53	11	between	between	ADP
bptjm-15	53	12	the	the	DET
bptjm-15	53	13	microbiota	microbiota	NOUN
bptjm-15	53	14	and	and	CCONJ
bptjm-15	53	15	their	their	PRON
bptjm-15	53	16	host	host	NOUN
bptjm-15	53	17	cells	cell	NOUN
bptjm-15	53	18	.	.	PUNCT
bptjm-15	54	1	this	this	DET
bptjm-15	54	2	cycling	cycling	NOUN
bptjm-15	54	3	of	of	ADP
bptjm-15	54	4	nutrients	nutrient	NOUN
bptjm-15	54	5	dictates	dictate	VERB
bptjm-15	54	6	the	the	DET
bptjm-15	54	7	body	body	NOUN
bptjm-15	54	8	’s	’s	PART
bptjm-15	54	9	immune	immune	ADJ
bptjm-15	54	10	response	response	NOUN
bptjm-15	54	11	to	to	ADP
bptjm-15	54	12	foreign	foreign	ADJ
bptjm-15	54	13	invaders	invader	NOUN
bptjm-15	54	14	(	(	PUNCT
bptjm-15	54	15	azad	azad	NOUN
bptjm-15	54	16	,	,	PUNCT
bptjm-15	54	17	2018	2018	NUM
bptjm-15	54	18	)	)	PUNCT
bptjm-15	54	19	.	.	PUNCT
bptjm-15	55	1	however	however	ADV
bptjm-15	55	2	,	,	PUNCT
bptjm-15	55	3	the	the	DET
bptjm-15	55	4	bidirectional	bidirectional	ADJ
bptjm-15	55	5	nature	nature	NOUN
bptjm-15	55	6	of	of	ADP
bptjm-15	55	7	this	this	DET
bptjm-15	55	8	relationship	relationship	NOUN
bptjm-15	55	9	should	should	AUX
bptjm-15	55	10	be	be	AUX
bptjm-15	55	11	noted	note	VERB
bptjm-15	55	12	.	.	PUNCT
bptjm-15	56	1	changes	change	NOUN
bptjm-15	56	2	in	in	ADP
bptjm-15	56	3	chemical	chemical	NOUN
bptjm-15	56	4	,	,	PUNCT
bptjm-15	56	5	nutritional	nutritional	NOUN
bptjm-15	56	6	,	,	PUNCT
bptjm-15	56	7	and	and	CCONJ
bptjm-15	56	8	immunological	immunological	ADJ
bptjm-15	56	9	pathways	pathway	NOUN
bptjm-15	56	10	of	of	ADP
bptjm-15	56	11	the	the	DET
bptjm-15	56	12	body	body	NOUN
bptjm-15	56	13	have	have	AUX
bptjm-15	56	14	also	also	ADV
bptjm-15	56	15	been	be	AUX
bptjm-15	56	16	shown	show	VERB
bptjm-15	56	17	to	to	ADP
bptjm-15	56	18	in	in	ADP
bptjm-15	56	19	�	�	NOUN
bptjm-15	56	20	uence	uence	NOUN
bptjm-15	56	21	the	the	DET
bptjm-15	56	22	density	density	NOUN
bptjm-15	56	23	and	and	CCONJ
bptjm-15	56	24	composition	composition	NOUN
bptjm-15	56	25	of	of	ADP
bptjm-15	56	26	the	the	DET
bptjm-15	56	27	gut	gut	NOUN
bptjm-15	56	28	microbiome	microbiome	NOUN
bptjm-15	56	29	(	(	PUNCT
bptjm-15	56	30	thursby	thursby	ADJ
bptjm-15	56	31	,	,	PUNCT
bptjm-15	56	32	2017	2017	NUM
bptjm-15	56	33	)	)	PUNCT
bptjm-15	56	34	.	.	PUNCT
bptjm-15	57	1	research	research	NOUN
bptjm-15	57	2	has	have	AUX
bptjm-15	57	3	already	already	ADV
bptjm-15	57	4	shown	show	VERB
bptjm-15	57	5	that	that	SCONJ
bptjm-15	57	6	the	the	DET
bptjm-15	57	7	gut	gut	NOUN
bptjm-15	57	8	microbiome	microbiome	NOUN
bptjm-15	57	9	is	be	AUX
bptjm-15	57	10	largely	largely	ADV
bptjm-15	57	11	dominated	dominate	VERB
bptjm-15	57	12	by	by	ADP
bptjm-15	57	13	rapidly	rapidly	ADV
bptjm-15	57	14	growing	grow	VERB
bptjm-15	57	15	probiotic	probiotic	ADJ
bptjm-15	57	16	bacteria	bacteria	NOUN
bptjm-15	57	17	because	because	SCONJ
bptjm-15	57	18	they	they	PRON
bptjm-15	57	19	have	have	VERB
bptjm-15	57	20	the	the	DET
bptjm-15	57	21	capability	capability	NOUN
bptjm-15	57	22	to	to	PART
bptjm-15	57	23	survive	survive	VERB
bptjm-15	57	24	in	in	ADP
bptjm-15	57	25	harsh	harsh	ADJ
bptjm-15	57	26	conditions	condition	NOUN
bptjm-15	57	27	.	.	PUNCT
bptjm-15	58	1	some	some	PRON
bptjm-15	58	2	of	of	ADP
bptjm-15	58	3	the	the	DET
bptjm-15	58	4	most	most	ADV
bptjm-15	58	5	common	common	ADJ
bptjm-15	58	6	genera	genera	NOUN
bptjm-15	58	7	of	of	ADP
bptjm-15	58	8	gut	gut	NOUN
bptjm-15	58	9	bacteria	bacteria	NOUN
bptjm-15	58	10	in	in	ADP
bptjm-15	58	11	adults	adult	NOUN
bptjm-15	58	12	are	be	AUX
bptjm-15	58	13	bifidobacterium	bifidobacterium	NOUN
bptjm-15	58	14	,	,	PUNCT
bptjm-15	58	15	lactobacillus	lactobacillus	NOUN
bptjm-15	58	16	,	,	PUNCT
bptjm-15	58	17	bacteroides	bacteroide	NOUN
bptjm-15	58	18	,	,	PUNCT
bptjm-15	58	19	clostridium	clostridium	NOUN
bptjm-15	58	20	,	,	PUNCT
bptjm-15	58	21	escherichia	escherichia	NOUN
bptjm-15	58	22	,	,	PUNCT
bptjm-15	58	23	streptococcus	streptococcus	NOUN
bptjm-15	58	24	,	,	PUNCT
bptjm-15	58	25	and	and	CCONJ
bptjm-15	58	26	ruminococcus	ruminococcus	NOUN
bptjm-15	58	27	(	(	PUNCT
bptjm-15	58	28	conlon	conlon	NOUN
bptjm-15	58	29	,	,	PUNCT
bptjm-15	58	30	2014	2014	NUM
bptjm-15	58	31	)	)	PUNCT
bptjm-15	58	32	.	.	PUNCT
bptjm-15	59	1	in	in	ADP
bptjm-15	59	2	order	order	NOUN
bptjm-15	59	3	to	to	PART
bptjm-15	59	4	protect	protect	VERB
bptjm-15	59	5	the	the	DET
bptjm-15	59	6	integrity	integrity	NOUN
bptjm-15	59	7	of	of	ADP
bptjm-15	59	8	the	the	DET
bptjm-15	59	9	gut	gut	NOUN
bptjm-15	59	10	,	,	PUNCT
bptjm-15	59	11	some	some	DET
bptjm-15	59	12	researchers	researcher	NOUN
bptjm-15	59	13	have	have	AUX
bptjm-15	59	14	explored	explore	VERB
bptjm-15	59	15	gut	gut	NOUN
bptjm-15	59	16	modulation	modulation	NOUN
bptjm-15	59	17	by	by	ADP
bptjm-15	59	18	probiotic	probiotic	ADJ
bptjm-15	59	19	species	specie	NOUN
bptjm-15	59	20	,	,	PUNCT
bptjm-15	59	21	which	which	PRON
bptjm-15	59	22	may	may	AUX
bptjm-15	59	23	be	be	AUX
bptjm-15	59	24	able	able	ADJ
bptjm-15	59	25	to	to	PART
bptjm-15	59	26	improve	improve	VERB
bptjm-15	59	27	and	and	CCONJ
bptjm-15	59	28	restore	restore	VERB
bptjm-15	59	29	the	the	DET
bptjm-15	59	30	gut	gut	PROPN
bptjm-15	59	31	�	�	NOUN
bptjm-15	59	32	ora	ora	PROPN
bptjm-15	59	33	if	if	SCONJ
bptjm-15	59	34	certain	certain	ADJ
bptjm-15	59	35	bacterial	bacterial	ADJ
bptjm-15	59	36	species	specie	NOUN
bptjm-15	59	37	of	of	ADP
bptjm-15	59	38	the	the	DET
bptjm-15	59	39	gut	gut	NOUN
bptjm-15	59	40	were	be	AUX
bptjm-15	59	41	ever	ever	ADV
bptjm-15	59	42	eradicated	eradicate	VERB
bptjm-15	59	43	(	(	PUNCT
bptjm-15	59	44	azad	azad	NOUN
bptjm-15	59	45	,	,	PUNCT
bptjm-15	59	46	2018	2018	NUM
bptjm-15	59	47	)	)	PUNCT
bptjm-15	59	48	.	.	PUNCT
bptjm-15	60	1	two	two	NUM
bptjm-15	60	2	crucial	crucial	ADJ
bptjm-15	60	3	microbial	microbial	ADJ
bptjm-15	60	4	strains	strain	NOUN
bptjm-15	60	5	discovered	discover	VERB
bptjm-15	60	6	for	for	ADP
bptjm-15	60	7	gut	gut	NOUN
bptjm-15	60	8	microbiome	microbiome	NOUN
bptjm-15	60	9	regulation	regulation	NOUN
bptjm-15	60	10	were	be	AUX
bptjm-15	60	11	lactobacillus	lactobacillus	NOUN
bptjm-15	60	12	and	and	CCONJ
bptjm-15	60	13	bifidobacterium	bifidobacterium	NOUN
bptjm-15	60	14	.	.	PUNCT
bptjm-15	61	1	these	these	DET
bptjm-15	61	2	quintessential	quintessential	ADJ
bptjm-15	61	3	probiotics	probiotic	NOUN
bptjm-15	61	4	are	be	AUX
bptjm-15	61	5	target	target	VERB
bptjm-15	61	6	bacterial	bacterial	ADJ
bptjm-15	61	7	groups	group	NOUN
bptjm-15	61	8	made	make	VERB
bptjm-15	61	9	from	from	ADP
bptjm-15	61	10	short	short	ADJ
bptjm-15	61	11	-	-	PUNCT
bptjm-15	61	12	chain	chain	NOUN
bptjm-15	61	13	nondigestible	nondigestible	ADJ
bptjm-15	61	14	carbohydrates	carbohydrate	NOUN
bptjm-15	61	15	(	(	PUNCT
bptjm-15	61	16	inulin	inulin	ADJ
bptjm-15	61	17	-	-	PUNCT
bptjm-15	61	18	type	type	NOUN
bptjm-15	61	19	fructans	fructan	NOUN
bptjm-15	61	20	,	,	PUNCT
bptjm-15	61	21	fructo	fructo	NOUN
bptjm-15	61	22	-	-	PUNCT
bptjm-15	61	23	oligosaccharides	oligosaccharide	NOUN
bptjm-15	61	24	[	[	X
bptjm-15	61	25	fos	fos	X
bptjm-15	61	26	]	]	X
bptjm-15	61	27	,	,	PUNCT
bptjm-15	61	28	and	and	CCONJ
bptjm-15	61	29	galacto	galacto	NOUN
bptjm-15	61	30	-	-	PUNCT
bptjm-15	61	31	oligosaccharides	oligosaccharide	NOUN
bptjm-15	61	32	[	[	X
bptjm-15	61	33	gos	gos	NOUN
bptjm-15	61	34	]	]	PUNCT
bptjm-15	61	35	)	)	PUNCT
bptjm-15	61	36	(	(	PUNCT
bptjm-15	61	37	loo	loo	NOUN
bptjm-15	61	38	,	,	PUNCT
bptjm-15	61	39	2009	2009	NUM
bptjm-15	61	40	)	)	PUNCT
bptjm-15	61	41	.	.	PUNCT
bptjm-15	62	1	as	as	SCONJ
bptjm-15	62	2	it	it	PRON
bptjm-15	62	3	stands	stand	VERB
bptjm-15	62	4	,	,	PUNCT
bptjm-15	62	5	gut	gut	NOUN
bptjm-15	62	6	regulation	regulation	NOUN
bptjm-15	62	7	is	be	AUX
bptjm-15	62	8	essential	essential	ADJ
bptjm-15	62	9	in	in	ADP
bptjm-15	62	10	isolating	isolate	VERB
bptjm-15	62	11	speci	speci	ADJ
bptjm-15	62	12	�	�	PROPN
bptjm-15	62	13	c	c	PART
bptjm-15	62	14	bacterial	bacterial	ADJ
bptjm-15	62	15	species	specie	NOUN
bptjm-15	62	16	for	for	ADP
bptjm-15	62	17	clinical	clinical	ADJ
bptjm-15	62	18	therapy	therapy	NOUN
bptjm-15	62	19	,	,	PUNCT
bptjm-15	62	20	especially	especially	ADV
bptjm-15	62	21	for	for	ADP
bptjm-15	62	22	neurological	neurological	ADJ
bptjm-15	62	23	disorders	disorder	NOUN
bptjm-15	62	24	like	like	ADP
bptjm-15	62	25	multiple	multiple	ADJ
bptjm-15	62	26	sclerosis	sclerosis	NOUN
bptjm-15	62	27	(	(	PUNCT
bptjm-15	62	28	ms	ms	NOUN
bptjm-15	62	29	)	)	PUNCT
bptjm-15	62	30	,	,	PUNCT
bptjm-15	62	31	whose	whose	DET
bptjm-15	62	32	causes	cause	NOUN
bptjm-15	62	33	are	be	AUX
bptjm-15	62	34	still	still	ADV
bptjm-15	62	35	unknown	unknown	ADJ
bptjm-15	62	36	.	.	PUNCT
bptjm-15	63	1	multiple	multiple	ADJ
bptjm-15	63	2	sclerosis	sclerosis	NOUN
bptjm-15	63	3	ms	ms	PROPN
bptjm-15	63	4	has	have	VERB
bptjm-15	63	5	cell	cell	NOUN
bptjm-15	63	6	-	-	PUNCT
bptjm-15	63	7	mediated	mediate	VERB
bptjm-15	63	8	pro	pro	ADJ
bptjm-15	63	9	-	-	ADJ
bptjm-15	63	10	in	in	ADP
bptjm-15	63	11	�	�	NOUN
bptjm-15	63	12	ammatory	ammatory	NOUN
bptjm-15	63	13	e	e	NOUN
bptjm-15	63	14	�	�	NOUN
bptjm-15	63	15	ects	ect	NOUN
bptjm-15	63	16	(	(	PUNCT
bptjm-15	63	17	also	also	ADV
bptjm-15	63	18	known	know	VERB
bptjm-15	63	19	as	as	ADP
bptjm-15	63	20	type	type	NOUN
bptjm-15	63	21	iv	iv	NUM
bptjm-15	63	22	hypersensitivities	hypersensitivity	NOUN
bptjm-15	63	23	)	)	PUNCT
bptjm-15	63	24	that	that	PRON
bptjm-15	63	25	result	result	VERB
bptjm-15	63	26	in	in	ADP
bptjm-15	63	27	demyelination	demyelination	NOUN
bptjm-15	63	28	of	of	ADP
bptjm-15	63	29	neurons	neuron	NOUN
bptjm-15	63	30	and	and	CCONJ
bptjm-15	63	31	autoimmune	autoimmune	ADJ
bptjm-15	63	32	pathogenesis	pathogenesis	NOUN
bptjm-15	63	33	of	of	ADP
bptjm-15	63	34	the	the	DET
bptjm-15	63	35	disorder	disorder	NOUN
bptjm-15	63	36	,	,	PUNCT
bptjm-15	63	37	leading	lead	VERB
bptjm-15	63	38	to	to	ADP
bptjm-15	63	39	disruptions	disruption	NOUN
bptjm-15	63	40	in	in	ADP
bptjm-15	63	41	brain	brain	NOUN
bptjm-15	63	42	-	-	PUNCT
bptjm-15	63	43	body	body	NOUN
bptjm-15	63	44	communication	communication	NOUN
bptjm-15	63	45	.	.	PUNCT
bptjm-15	64	1	in	in	ADP
bptjm-15	64	2	ms	ms	ADJ
bptjm-15	64	3	patients	patient	NOUN
bptjm-15	64	4	,	,	PUNCT
bptjm-15	64	5	autoreactive	autoreactive	ADJ
bptjm-15	64	6	t	t	PROPN
bptjm-15	64	7	and	and	CCONJ
bptjm-15	64	8	b	b	PROPN
bptjm-15	64	9	lymphocytes	lymphocyte	NOUN
bptjm-15	64	10	enter	enter	VERB
bptjm-15	64	11	the	the	DET
bptjm-15	64	12	cns	cns	NOUN
bptjm-15	64	13	,	,	PUNCT
bptjm-15	64	14	induce	induce	VERB
bptjm-15	64	15	in	in	ADP
bptjm-15	64	16	�	�	NOUN
bptjm-15	64	17	ammation	ammation	NOUN
bptjm-15	64	18	,	,	PUNCT
bptjm-15	64	19	and	and	CCONJ
bptjm-15	64	20	undermine	undermine	VERB
bptjm-15	64	21	the	the	DET
bptjm-15	64	22	blood	blood	NOUN
bptjm-15	64	23	-	-	PUNCT
bptjm-15	64	24	brain	brain	NOUN
bptjm-15	64	25	barrier	barrier	NOUN
bptjm-15	64	26	(	(	PUNCT
bptjm-15	64	27	bbb	bbb	NOUN
bptjm-15	64	28	)	)	PUNCT
bptjm-15	64	29	via	via	ADP
bptjm-15	64	30	cytokine	cytokine	ADJ
bptjm-15	64	31	secretion	secretion	NOUN
bptjm-15	64	32	(	(	PUNCT
bptjm-15	64	33	ghasemi	ghasemi	NOUN
bptjm-15	64	34	,	,	PUNCT
bptjm-15	64	35	2017	2017	NUM
bptjm-15	64	36	)	)	PUNCT
bptjm-15	64	37	.	.	PUNCT
bptjm-15	65	1	these	these	DET
bptjm-15	65	2	cytokines	cytokine	NOUN
bptjm-15	65	3	begin	begin	VERB
bptjm-15	65	4	a	a	DET
bptjm-15	65	5	signaling	signal	VERB
bptjm-15	65	6	cascade	cascade	NOUN
bptjm-15	65	7	that	that	PRON
bptjm-15	65	8	results	result	VERB
bptjm-15	65	9	in	in	ADP
bptjm-15	65	10	oligodendrocytic	oligodendrocytic	ADJ
bptjm-15	65	11	death	death	NOUN
bptjm-15	65	12	and	and	CCONJ
bptjm-15	65	13	thus	thus	ADV
bptjm-15	65	14	,	,	PUNCT
bptjm-15	65	15	the	the	DET
bptjm-15	65	16	destruction	destruction	NOUN
bptjm-15	65	17	of	of	ADP
bptjm-15	65	18	neuronal	neuronal	ADJ
bptjm-15	65	19	myelin	myelin	NOUN
bptjm-15	65	20	sheaths	sheath	NOUN
bptjm-15	65	21	in	in	ADP
bptjm-15	65	22	the	the	DET
bptjm-15	65	23	cns	cns	PROPN
bptjm-15	65	24	(	(	PUNCT
bptjm-15	65	25	ghasemi	ghasemi	NOUN
bptjm-15	65	26	,	,	PUNCT
bptjm-15	65	27	2017	2017	NUM
bptjm-15	65	28	)	)	PUNCT
bptjm-15	65	29	.	.	PUNCT
bptjm-15	66	1	the	the	DET
bptjm-15	66	2	resultant	resultant	NOUN
bptjm-15	66	3	cns	cns	PROPN
bptjm-15	66	4	lesions	lesion	NOUN
bptjm-15	66	5	disturb	disturb	VERB
bptjm-15	66	6	proper	proper	ADJ
bptjm-15	66	7	communication	communication	NOUN
bptjm-15	66	8	between	between	ADP
bptjm-15	66	9	neurons	neuron	NOUN
bptjm-15	66	10	,	,	PUNCT
bptjm-15	66	11	berkeley	berkeley	PROPN
bptjm-15	66	12	pharma	pharma	PROPN
bptjm-15	66	13	tech	tech	NOUN
bptjm-15	66	14	journal	journal	NOUN
bptjm-15	66	15	of	of	ADP
bptjm-15	66	16	medicine	medicine	NOUN
bptjm-15	66	17	|	|	ADV
bptjm-15	66	18	68	68	NUM
bptjm-15	66	19	and	and	CCONJ
bptjm-15	66	20	lead	lead	VERB
bptjm-15	66	21	to	to	ADP
bptjm-15	66	22	various	various	ADJ
bptjm-15	66	23	cortical	cortical	ADJ
bptjm-15	66	24	dysfunctions	dysfunction	NOUN
bptjm-15	66	25	within	within	ADP
bptjm-15	66	26	ms	ms	ADJ
bptjm-15	66	27	patients	patient	NOUN
bptjm-15	66	28	such	such	ADJ
bptjm-15	66	29	as	as	ADP
bptjm-15	66	30	modulations	modulation	NOUN
bptjm-15	66	31	to	to	ADP
bptjm-15	66	32	resting	rest	VERB
bptjm-15	66	33	motor	motor	NOUN
bptjm-15	66	34	threshold	threshold	NOUN
bptjm-15	66	35	,	,	PUNCT
bptjm-15	66	36	short	short	ADJ
bptjm-15	66	37	interval	interval	NOUN
bptjm-15	66	38	cortical	cortical	ADJ
bptjm-15	66	39	inhibition	inhibition	NOUN
bptjm-15	66	40	,	,	PUNCT
bptjm-15	66	41	and	and	CCONJ
bptjm-15	66	42	central	central	ADJ
bptjm-15	66	43	motor	motor	NOUN
bptjm-15	66	44	conduction	conduction	NOUN
bptjm-15	66	45	time	time	NOUN
bptjm-15	66	46	(	(	PUNCT
bptjm-15	66	47	ghasemi	ghasemi	NOUN
bptjm-15	66	48	,	,	PUNCT
bptjm-15	66	49	2017	2017	NUM
bptjm-15	66	50	)	)	PUNCT
bptjm-15	66	51	.	.	PUNCT
bptjm-15	67	1	although	although	SCONJ
bptjm-15	67	2	microbial	microbial	ADJ
bptjm-15	67	3	therapy	therapy	NOUN
bptjm-15	67	4	holds	hold	VERB
bptjm-15	67	5	promise	promise	NOUN
bptjm-15	67	6	,	,	PUNCT
bptjm-15	67	7	its	its	PRON
bptjm-15	67	8	implementation	implementation	NOUN
bptjm-15	67	9	as	as	ADP
bptjm-15	67	10	a	a	DET
bptjm-15	67	11	universal	universal	ADJ
bptjm-15	67	12	ms	ms	NOUN
bptjm-15	67	13	therapy	therapy	NOUN
bptjm-15	67	14	remains	remain	VERB
bptjm-15	67	15	far	far	ADV
bptjm-15	67	16	o	o	NOUN
bptjm-15	67	17	�	�	PROPN
bptjm-15	67	18	because	because	SCONJ
bptjm-15	67	19	of	of	ADP
bptjm-15	67	20	the	the	DET
bptjm-15	67	21	lack	lack	NOUN
bptjm-15	67	22	of	of	ADP
bptjm-15	67	23	understanding	understanding	NOUN
bptjm-15	67	24	behind	behind	ADP
bptjm-15	67	25	the	the	DET
bptjm-15	67	26	speci	speci	PROPN
bptjm-15	67	27	�	�	PROPN
bptjm-15	67	28	c	c	PROPN
bptjm-15	67	29	mechanisms	mechanism	NOUN
bptjm-15	67	30	of	of	ADP
bptjm-15	67	31	gut	gut	NOUN
bptjm-15	67	32	-	-	PUNCT
bptjm-15	67	33	brain	brain	NOUN
bptjm-15	67	34	interactions	interaction	NOUN
bptjm-15	67	35	and	and	CCONJ
bptjm-15	67	36	early	early	ADJ
bptjm-15	67	37	research	research	NOUN
bptjm-15	67	38	into	into	ADP
bptjm-15	67	39	this	this	DET
bptjm-15	67	40	�	�	PROPN
bptjm-15	67	41	eld	eld	NOUN
bptjm-15	67	42	(	(	PUNCT
bptjm-15	67	43	figure	figure	NOUN
bptjm-15	67	44	2	2	NUM
bptjm-15	67	45	)	)	PUNCT
bptjm-15	67	46	.	.	PUNCT
bptjm-15	68	1	while	while	SCONJ
bptjm-15	68	2	the	the	DET
bptjm-15	68	3	speci	speci	PROPN
bptjm-15	68	4	�	�	PROPN
bptjm-15	68	5	c	c	PROPN
bptjm-15	68	6	origin	origin	NOUN
bptjm-15	68	7	of	of	ADP
bptjm-15	68	8	ms	ms	PROPN
bptjm-15	68	9	still	still	ADV
bptjm-15	68	10	eludes	elude	VERB
bptjm-15	68	11	scientists	scientist	NOUN
bptjm-15	68	12	,	,	PUNCT
bptjm-15	68	13	most	most	ADV
bptjm-15	68	14	postulate	postulate	VERB
bptjm-15	68	15	that	that	SCONJ
bptjm-15	68	16	a	a	DET
bptjm-15	68	17	combination	combination	NOUN
bptjm-15	68	18	of	of	ADP
bptjm-15	68	19	genetic	genetic	ADJ
bptjm-15	68	20	and	and	CCONJ
bptjm-15	68	21	environmental	environmental	ADJ
bptjm-15	68	22	factors	factor	NOUN
bptjm-15	68	23	plays	play	VERB
bptjm-15	68	24	a	a	DET
bptjm-15	68	25	signi	signi	ADJ
bptjm-15	68	26	�	�	NOUN
bptjm-15	68	27	cant	cant	NOUN
bptjm-15	68	28	role	role	NOUN
bptjm-15	68	29	in	in	ADP
bptjm-15	68	30	pathogenesis	pathogenesis	NOUN
bptjm-15	68	31	.	.	PUNCT
bptjm-15	69	1	environmental	environmental	ADJ
bptjm-15	69	2	elements	element	NOUN
bptjm-15	69	3	such	such	ADJ
bptjm-15	69	4	as	as	ADP
bptjm-15	69	5	geography	geography	NOUN
bptjm-15	69	6	,	,	PUNCT
bptjm-15	69	7	vitamin	vitamin	NOUN
bptjm-15	69	8	d	d	PROPN
bptjm-15	69	9	de	de	X
bptjm-15	69	10	�	�	PROPN
bptjm-15	69	11	ciency	ciency	NOUN
bptjm-15	69	12	,	,	PUNCT
bptjm-15	69	13	obesity	obesity	NOUN
bptjm-15	69	14	,	,	PUNCT
bptjm-15	69	15	diet	diet	NOUN
bptjm-15	69	16	,	,	PUNCT
bptjm-15	69	17	smoking	smoking	NOUN
bptjm-15	69	18	,	,	PUNCT
bptjm-15	69	19	and	and	CCONJ
bptjm-15	69	20	physical	physical	ADJ
bptjm-15	69	21	or	or	CCONJ
bptjm-15	69	22	emotional	emotional	ADJ
bptjm-15	69	23	stress	stress	NOUN
bptjm-15	69	24	have	have	AUX
bptjm-15	69	25	been	be	AUX
bptjm-15	69	26	shown	show	VERB
bptjm-15	69	27	to	to	PART
bptjm-15	69	28	be	be	AUX
bptjm-15	69	29	relevant	relevant	ADJ
bptjm-15	69	30	in	in	ADP
bptjm-15	69	31	ms	ms	PROPN
bptjm-15	69	32	progression	progression	NOUN
bptjm-15	69	33	(	(	PUNCT
bptjm-15	69	34	gianfrancesco	gianfrancesco	PROPN
bptjm-15	69	35	,	,	PUNCT
bptjm-15	69	36	2016	2016	NUM
bptjm-15	69	37	;	;	PUNCT
bptjm-15	69	38	ochoa	ochoa	NOUN
bptjm-15	69	39	-	-	PUNCT
bptjm-15	69	40	repáraz	repáraz	NOUN
bptjm-15	69	41	,	,	PUNCT
bptjm-15	69	42	2014	2014	NUM
bptjm-15	69	43	;	;	PUNCT
bptjm-15	69	44	rosso	rosso	NOUN
bptjm-15	69	45	,	,	PUNCT
bptjm-15	69	46	2019	2019	NUM
bptjm-15	69	47	;	;	PUNCT
bptjm-15	69	48	sintzel	sintzel	ADJ
bptjm-15	69	49	2018	2018	NUM
bptjm-15	69	50	)	)	PUNCT
bptjm-15	69	51	.	.	PUNCT
bptjm-15	70	1	when	when	SCONJ
bptjm-15	70	2	these	these	DET
bptjm-15	70	3	factors	factor	NOUN
bptjm-15	70	4	collaborate	collaborate	VERB
bptjm-15	70	5	with	with	ADP
bptjm-15	70	6	adverse	adverse	ADJ
bptjm-15	70	7	genetics	genetic	NOUN
bptjm-15	70	8	,	,	PUNCT
bptjm-15	70	9	the	the	DET
bptjm-15	70	10	health	health	NOUN
bptjm-15	70	11	of	of	ADP
bptjm-15	70	12	ms	ms	PROPN
bptjm-15	70	13	patients	patient	NOUN
bptjm-15	70	14	can	can	AUX
bptjm-15	70	15	quickly	quickly	ADV
bptjm-15	70	16	deteriorate	deteriorate	VERB
bptjm-15	70	17	.	.	PUNCT
bptjm-15	71	1	one	one	NUM
bptjm-15	71	2	of	of	ADP
bptjm-15	71	3	the	the	DET
bptjm-15	71	4	most	most	ADV
bptjm-15	71	5	salient	salient	ADJ
bptjm-15	71	6	genetic	genetic	ADJ
bptjm-15	71	7	factors	factor	NOUN
bptjm-15	71	8	is	be	AUX
bptjm-15	71	9	sex	sex	NOUN
bptjm-15	71	10	,	,	PUNCT
bptjm-15	71	11	with	with	ADP
bptjm-15	71	12	ms	ms	ADJ
bptjm-15	71	13	diagnosis	diagnosis	NOUN
bptjm-15	71	14	showing	show	VERB
bptjm-15	71	15	an	an	DET
bptjm-15	71	16	astounding	astounding	ADJ
bptjm-15	71	17	2:1	2:1	NUM
bptjm-15	71	18	male	male	NOUN
bptjm-15	71	19	-	-	PUNCT
bptjm-15	71	20	to	to	ADP
bptjm-15	71	21	-	-	PUNCT
bptjm-15	71	22	female	female	ADJ
bptjm-15	71	23	ratio	ratio	NOUN
bptjm-15	71	24	(	(	PUNCT
bptjm-15	71	25	reynolds	reynold	NOUN
bptjm-15	71	26	,	,	PUNCT
bptjm-15	71	27	2018	2018	NUM
bptjm-15	71	28	)	)	PUNCT
bptjm-15	71	29	.	.	PUNCT
bptjm-15	72	1	women	woman	NOUN
bptjm-15	72	2	are	be	AUX
bptjm-15	72	3	also	also	ADV
bptjm-15	72	4	diagnosed	diagnose	VERB
bptjm-15	72	5	with	with	ADP
bptjm-15	72	6	an	an	DET
bptjm-15	72	7	irreversible	irreversible	ADJ
bptjm-15	72	8	disability	disability	NOUN
bptjm-15	72	9	at	at	ADP
bptjm-15	72	10	older	old	ADJ
bptjm-15	72	11	ages	age	NOUN
bptjm-15	72	12	than	than	ADP
bptjm-15	72	13	men	man	NOUN
bptjm-15	72	14	(	(	PUNCT
bptjm-15	72	15	confavreux	confavreux	PROPN
bptjm-15	72	16	,	,	PUNCT
bptjm-15	72	17	2006	2006	NUM
bptjm-15	72	18	)	)	PUNCT
bptjm-15	72	19	.	.	PUNCT
bptjm-15	73	1	another	another	DET
bptjm-15	73	2	important	important	ADJ
bptjm-15	73	3	genetic	genetic	ADJ
bptjm-15	73	4	factor	factor	NOUN
bptjm-15	73	5	is	be	AUX
bptjm-15	73	6	the	the	DET
bptjm-15	73	7	hla	hla	PROPN
bptjm-15	73	8	-	-	PUNCT
bptjm-15	73	9	drb1	drb1	PROPN
bptjm-15	73	10	*	*	NUM
bptjm-15	73	11	15	15	NUM
bptjm-15	73	12	gene	gene	NOUN
bptjm-15	73	13	haplotype	haplotype	NOUN
bptjm-15	73	14	.	.	PUNCT
bptjm-15	74	1	the	the	DET
bptjm-15	74	2	dr2	dr2	PROPN
bptjm-15	74	3	haplotype	haplotype	PROPN
bptjm-15	74	4	hla	hla	PROPN
bptjm-15	74	5	-	-	PUNCT
bptjm-15	74	6	drb1	drb1	PROPN
bptjm-15	74	7	*	*	ADJ
bptjm-15	74	8	15	15	NUM
bptjm-15	74	9	gene	gene	NOUN
bptjm-15	74	10	encodes	encode	VERB
bptjm-15	74	11	a	a	DET
bptjm-15	74	12	protein	protein	NOUN
bptjm-15	74	13	important	important	ADJ
bptjm-15	74	14	in	in	ADP
bptjm-15	74	15	t	t	NOUN
bptjm-15	74	16	-	-	PUNCT
bptjm-15	74	17	lymphocyte	lymphocyte	NOUN
bptjm-15	74	18	reactivity	reactivity	NOUN
bptjm-15	74	19	and	and	CCONJ
bptjm-15	74	20	is	be	AUX
bptjm-15	74	21	also	also	ADV
bptjm-15	74	22	associated	associate	VERB
bptjm-15	74	23	with	with	ADP
bptjm-15	74	24	ms	ms	PROPN
bptjm-15	74	25	disease	disease	NOUN
bptjm-15	74	26	progression	progression	NOUN
bptjm-15	74	27	,	,	PUNCT
bptjm-15	74	28	age	age	NOUN
bptjm-15	74	29	at	at	ADP
bptjm-15	74	30	onset	onset	NOUN
bptjm-15	74	31	,	,	PUNCT
bptjm-15	74	32	and	and	CCONJ
bptjm-15	74	33	atrophy	atrophy	NOUN
bptjm-15	74	34	of	of	ADP
bptjm-15	74	35	subcortical	subcortical	ADJ
bptjm-15	74	36	gray	gray	ADJ
bptjm-15	74	37	matter	matter	NOUN
bptjm-15	74	38	(	(	PUNCT
bptjm-15	74	39	isobe	isobe	NOUN
bptjm-15	74	40	,	,	PUNCT
bptjm-15	74	41	2016	2016	NUM
bptjm-15	74	42	)	)	PUNCT
bptjm-15	74	43	.	.	PUNCT
bptjm-15	75	1	berkeley	berkeley	PROPN
bptjm-15	75	2	pharma	pharma	PROPN
bptjm-15	75	3	tech	tech	PROPN
bptjm-15	75	4	journal	journal	NOUN
bptjm-15	75	5	of	of	ADP
bptjm-15	75	6	medicine	medicine	NOUN
bptjm-15	75	7	|	|	ADV
bptjm-15	75	8	69	69	NUM
bptjm-15	75	9	figure	figure	NOUN
bptjm-15	75	10	2	2	NUM
bptjm-15	75	11	.	.	PUNCT
bptjm-15	76	1	a	a	DET
bptjm-15	76	2	neuron	neuron	NOUN
bptjm-15	76	3	is	be	AUX
bptjm-15	76	4	made	make	VERB
bptjm-15	76	5	up	up	ADP
bptjm-15	76	6	of	of	ADP
bptjm-15	76	7	a	a	DET
bptjm-15	76	8	cell	cell	NOUN
bptjm-15	76	9	body	body	NOUN
bptjm-15	76	10	,	,	PUNCT
bptjm-15	76	11	an	an	DET
bptjm-15	76	12	axon	axon	NOUN
bptjm-15	76	13	,	,	PUNCT
bptjm-15	76	14	and	and	CCONJ
bptjm-15	76	15	dendrites	dendrite	NOUN
bptjm-15	76	16	.	.	PUNCT
bptjm-15	77	1	the	the	DET
bptjm-15	77	2	protective	protective	ADJ
bptjm-15	77	3	coating	coating	NOUN
bptjm-15	77	4	of	of	ADP
bptjm-15	77	5	the	the	DET
bptjm-15	77	6	axon	axon	NOUN
bptjm-15	77	7	,	,	PUNCT
bptjm-15	77	8	the	the	DET
bptjm-15	77	9	myelin	myelin	NOUN
bptjm-15	77	10	sheath	sheath	NOUN
bptjm-15	77	11	,	,	PUNCT
bptjm-15	77	12	are	be	AUX
bptjm-15	77	13	damaged	damage	VERB
bptjm-15	77	14	in	in	ADP
bptjm-15	77	15	patients	patient	NOUN
bptjm-15	77	16	with	with	ADP
bptjm-15	77	17	multiple	multiple	ADJ
bptjm-15	77	18	sclerosis	sclerosis	NOUN
bptjm-15	77	19	.	.	PUNCT
bptjm-15	78	1	the	the	DET
bptjm-15	78	2	immune	immune	ADJ
bptjm-15	78	3	system	system	NOUN
bptjm-15	78	4	attacks	attack	VERB
bptjm-15	78	5	the	the	DET
bptjm-15	78	6	myelin	myelin	NOUN
bptjm-15	78	7	sheath	sheath	NOUN
bptjm-15	78	8	and	and	CCONJ
bptjm-15	78	9	causes	cause	VERB
bptjm-15	78	10	injury	injury	NOUN
bptjm-15	78	11	and	and	CCONJ
bptjm-15	78	12	inflammation	inflammation	NOUN
bptjm-15	78	13	.	.	PUNCT
bptjm-15	79	1	neural	neural	ADJ
bptjm-15	79	2	deficits	deficit	NOUN
bptjm-15	79	3	ensue	ensue	VERB
bptjm-15	79	4	.	.	PUNCT
bptjm-15	80	1	types	type	NOUN
bptjm-15	80	2	of	of	ADP
bptjm-15	80	3	multiple	multiple	ADJ
bptjm-15	80	4	sclerosis	sclerosis	NOUN
bptjm-15	80	5	ms	ms	NOUN
bptjm-15	80	6	patients	patient	NOUN
bptjm-15	80	7	are	be	AUX
bptjm-15	80	8	categorized	categorize	VERB
bptjm-15	80	9	into	into	ADP
bptjm-15	80	10	four	four	NUM
bptjm-15	80	11	subtypes	subtype	NOUN
bptjm-15	80	12	including	include	VERB
bptjm-15	80	13	:	:	PUNCT
bptjm-15	80	14	relapsing	relapse	VERB
bptjm-15	80	15	-	-	PUNCT
bptjm-15	80	16	remitting	remit	VERB
bptjm-15	80	17	(	(	PUNCT
bptjm-15	80	18	rrms	rrm	NOUN
bptjm-15	80	19	)	)	PUNCT
bptjm-15	80	20	,	,	PUNCT
bptjm-15	80	21	secondary	secondary	ADJ
bptjm-15	80	22	progressive	progressive	ADJ
bptjm-15	80	23	(	(	PUNCT
bptjm-15	80	24	spms	spms	NOUN
bptjm-15	80	25	)	)	PUNCT
bptjm-15	80	26	,	,	PUNCT
bptjm-15	80	27	primary	primary	ADJ
bptjm-15	80	28	progressive	progressive	NOUN
bptjm-15	80	29	(	(	PUNCT
bptjm-15	80	30	ppms	ppm	NOUN
bptjm-15	80	31	)	)	PUNCT
bptjm-15	80	32	,	,	PUNCT
bptjm-15	80	33	and	and	CCONJ
bptjm-15	80	34	progressive	progressive	ADV
bptjm-15	80	35	-	-	PUNCT
bptjm-15	80	36	relapsing	relapse	VERB
bptjm-15	80	37	(	(	PUNCT
bptjm-15	80	38	prms	prm	NOUN
bptjm-15	80	39	)	)	PUNCT
bptjm-15	80	40	.	.	PUNCT
bptjm-15	81	1	rrms	rrm	NOUN
bptjm-15	81	2	is	be	AUX
bptjm-15	81	3	the	the	DET
bptjm-15	81	4	most	most	ADV
bptjm-15	81	5	common	common	ADJ
bptjm-15	81	6	subtype	subtype	NOUN
bptjm-15	81	7	,	,	PUNCT
bptjm-15	81	8	a	a	DET
bptjm-15	81	9	�	�	NOUN
bptjm-15	81	10	ecting	ecte	VERB
bptjm-15	81	11	approximately	approximately	ADV
bptjm-15	81	12	87	87	NUM
bptjm-15	81	13	%	%	NOUN
bptjm-15	81	14	of	of	ADP
bptjm-15	81	15	the	the	DET
bptjm-15	81	16	patient	patient	ADJ
bptjm-15	81	17	population	population	NOUN
bptjm-15	81	18	(	(	PUNCT
bptjm-15	81	19	ghasemi	ghasemi	NOUN
bptjm-15	81	20	,	,	PUNCT
bptjm-15	81	21	2017	2017	NUM
bptjm-15	81	22	)	)	PUNCT
bptjm-15	81	23	.	.	PUNCT
bptjm-15	82	1	autoimmune	autoimmune	PROPN
bptjm-15	82	2	in	in	ADP
bptjm-15	82	3	�	�	PROPN
bptjm-15	82	4	ammatory	ammatory	NOUN
bptjm-15	82	5	attacks	attack	NOUN
bptjm-15	82	6	on	on	ADP
bptjm-15	82	7	the	the	DET
bptjm-15	82	8	nervous	nervous	ADJ
bptjm-15	82	9	system	system	NOUN
bptjm-15	82	10	among	among	ADP
bptjm-15	82	11	patients	patient	NOUN
bptjm-15	82	12	of	of	ADP
bptjm-15	82	13	this	this	DET
bptjm-15	82	14	subtype	subtype	NOUN
bptjm-15	82	15	occur	occur	VERB
bptjm-15	82	16	months	month	NOUN
bptjm-15	82	17	or	or	CCONJ
bptjm-15	82	18	years	year	NOUN
bptjm-15	82	19	apart	apart	ADV
bptjm-15	82	20	followed	follow	VERB
bptjm-15	82	21	by	by	ADP
bptjm-15	82	22	a	a	DET
bptjm-15	82	23	period	period	NOUN
bptjm-15	82	24	of	of	ADP
bptjm-15	82	25	remission	remission	NOUN
bptjm-15	82	26	,	,	PUNCT
bptjm-15	82	27	leading	lead	VERB
bptjm-15	82	28	to	to	ADP
bptjm-15	82	29	a	a	DET
bptjm-15	82	30	progressive	progressive	ADJ
bptjm-15	82	31	increase	increase	NOUN
bptjm-15	82	32	in	in	ADP
bptjm-15	82	33	irreversible	irreversible	ADJ
bptjm-15	82	34	disability	disability	NOUN
bptjm-15	82	35	.	.	PUNCT
bptjm-15	83	1	this	this	DET
bptjm-15	83	2	neural	neural	ADJ
bptjm-15	83	3	damage	damage	NOUN
bptjm-15	83	4	eventually	eventually	ADV
bptjm-15	83	5	manifests	manifest	VERB
bptjm-15	83	6	as	as	ADP
bptjm-15	83	7	vision	vision	NOUN
bptjm-15	83	8	loss	loss	NOUN
bptjm-15	83	9	,	,	PUNCT
bptjm-15	83	10	muscle	muscle	NOUN
bptjm-15	83	11	weakness	weakness	NOUN
bptjm-15	83	12	,	,	PUNCT
bptjm-15	83	13	and	and	CCONJ
bptjm-15	83	14	impaired	impaired	ADJ
bptjm-15	83	15	coordination	coordination	NOUN
bptjm-15	83	16	(	(	PUNCT
bptjm-15	83	17	weiner	weiner	NOUN
bptjm-15	83	18	,	,	PUNCT
bptjm-15	83	19	2008	2008	NUM
bptjm-15	83	20	)	)	PUNCT
bptjm-15	83	21	.	.	PUNCT
bptjm-15	84	1	during	during	ADP
bptjm-15	84	2	periods	period	NOUN
bptjm-15	84	3	of	of	ADP
bptjm-15	84	4	remission	remission	NOUN
bptjm-15	84	5	,	,	PUNCT
bptjm-15	84	6	patients	patient	NOUN
bptjm-15	84	7	revert	revert	VERB
bptjm-15	84	8	to	to	ADP
bptjm-15	84	9	relatively	relatively	ADV
bptjm-15	84	10	normal	normal	ADJ
bptjm-15	84	11	neurological	neurological	ADJ
bptjm-15	84	12	activity	activity	NOUN
bptjm-15	84	13	(	(	PUNCT
bptjm-15	84	14	høglund	høglund	NOUN
bptjm-15	84	15	,	,	PUNCT
bptjm-15	84	16	2014	2014	NUM
bptjm-15	84	17	)	)	PUNCT
bptjm-15	84	18	.	.	PUNCT
bptjm-15	85	1	this	this	DET
bptjm-15	85	2	subtype	subtype	NOUN
bptjm-15	85	3	of	of	ADP
bptjm-15	85	4	ms	ms	PROPN
bptjm-15	85	5	shows	show	VERB
bptjm-15	85	6	the	the	DET
bptjm-15	85	7	greatest	great	ADJ
bptjm-15	85	8	promise	promise	NOUN
bptjm-15	85	9	of	of	ADP
bptjm-15	85	10	therapy	therapy	NOUN
bptjm-15	85	11	because	because	SCONJ
bptjm-15	85	12	intervention	intervention	NOUN
bptjm-15	85	13	is	be	AUX
bptjm-15	85	14	possible	possible	ADJ
bptjm-15	85	15	during	during	ADP
bptjm-15	85	16	remission	remission	NOUN
bptjm-15	85	17	periods	period	NOUN
bptjm-15	85	18	.	.	PUNCT
bptjm-15	86	1	unfortunately	unfortunately	ADV
bptjm-15	86	2	,	,	PUNCT
bptjm-15	86	3	within	within	ADP
bptjm-15	86	4	the	the	DET
bptjm-15	86	5	population	population	NOUN
bptjm-15	86	6	of	of	ADP
bptjm-15	86	7	rrms	rrm	NOUN
bptjm-15	86	8	patients	patient	NOUN
bptjm-15	86	9	,	,	PUNCT
bptjm-15	86	10	around	around	ADP
bptjm-15	86	11	70	70	NUM
bptjm-15	86	12	%	%	NOUN
bptjm-15	86	13	develop	develop	NOUN
bptjm-15	86	14	spms	spm	NOUN
bptjm-15	86	15	(	(	PUNCT
bptjm-15	86	16	kirby	kirby	PROPN
bptjm-15	86	17	,	,	PUNCT
bptjm-15	86	18	2018	2018	NUM
bptjm-15	86	19	)	)	PUNCT
bptjm-15	86	20	.	.	PUNCT
bptjm-15	87	1	however	however	ADV
bptjm-15	87	2	,	,	PUNCT
bptjm-15	87	3	what	what	PRON
bptjm-15	87	4	facilitates	facilitate	VERB
bptjm-15	87	5	the	the	DET
bptjm-15	87	6	progression	progression	NOUN
bptjm-15	87	7	from	from	ADP
bptjm-15	87	8	rrms	rrm	NOUN
bptjm-15	87	9	to	to	PART
bptjm-15	87	10	spms	spms	VERB
bptjm-15	87	11	remains	remain	VERB
bptjm-15	87	12	unclear	unclear	ADJ
bptjm-15	87	13	.	.	PUNCT
bptjm-15	88	1	spms	spm	NOUN
bptjm-15	88	2	is	be	AUX
bptjm-15	88	3	characterized	characterize	VERB
bptjm-15	88	4	by	by	ADP
bptjm-15	88	5	a	a	DET
bptjm-15	88	6	minimal	minimal	ADJ
bptjm-15	88	7	to	to	PART
bptjm-15	88	8	complete	complete	ADJ
bptjm-15	88	9	lack	lack	NOUN
bptjm-15	88	10	of	of	ADP
bptjm-15	88	11	relapse	relapse	NOUN
bptjm-15	88	12	activity	activity	NOUN
bptjm-15	88	13	,	,	PUNCT
bptjm-15	88	14	leading	lead	VERB
bptjm-15	88	15	to	to	ADP
bptjm-15	88	16	a	a	DET
bptjm-15	88	17	constant	constant	ADJ
bptjm-15	88	18	increase	increase	NOUN
bptjm-15	88	19	in	in	ADP
bptjm-15	88	20	irreversible	irreversible	ADJ
bptjm-15	88	21	neural	neural	ADJ
bptjm-15	88	22	damage	damage	NOUN
bptjm-15	88	23	(	(	PUNCT
bptjm-15	88	24	høglund	høglund	NOUN
bptjm-15	88	25	,	,	PUNCT
bptjm-15	88	26	2014	2014	NUM
bptjm-15	88	27	)	)	PUNCT
bptjm-15	88	28	.	.	PUNCT
bptjm-15	89	1	although	although	SCONJ
bptjm-15	89	2	the	the	DET
bptjm-15	89	3	underlying	underlying	ADJ
bptjm-15	89	4	mechanisms	mechanism	NOUN
bptjm-15	89	5	of	of	ADP
bptjm-15	89	6	the	the	DET
bptjm-15	89	7	progression	progression	NOUN
bptjm-15	89	8	from	from	ADP
bptjm-15	89	9	rrms	rrm	NOUN
bptjm-15	89	10	to	to	ADP
bptjm-15	89	11	spms	spm	NOUN
bptjm-15	89	12	are	be	AUX
bptjm-15	89	13	currently	currently	ADV
bptjm-15	89	14	unclear	unclear	ADJ
bptjm-15	89	15	,	,	PUNCT
bptjm-15	89	16	most	most	ADV
bptjm-15	89	17	likely	likely	ADJ
bptjm-15	89	18	a	a	DET
bptjm-15	89	19	combination	combination	NOUN
bptjm-15	89	20	of	of	ADP
bptjm-15	89	21	environmental	environmental	ADJ
bptjm-15	89	22	and	and	CCONJ
bptjm-15	89	23	genetic	genetic	ADJ
bptjm-15	89	24	factors	factor	NOUN
bptjm-15	89	25	,	,	PUNCT
bptjm-15	89	26	spms	spms	PROPN
bptjm-15	89	27	di	di	NOUN
bptjm-15	89	28	�	�	PROPN
bptjm-15	89	29	ers	er	NOUN
bptjm-15	89	30	from	from	ADP
bptjm-15	89	31	rrms	rrm	NOUN
bptjm-15	89	32	in	in	ADP
bptjm-15	89	33	that	that	DET
bptjm-15	89	34	demyelination	demyelination	NOUN
bptjm-15	89	35	is	be	AUX
bptjm-15	89	36	restricted	restrict	VERB
bptjm-15	89	37	to	to	ADP
bptjm-15	89	38	short	short	ADJ
bptjm-15	89	39	lengths	length	NOUN
bptjm-15	89	40	of	of	ADP
bptjm-15	89	41	disrupted	disrupt	VERB
bptjm-15	89	42	myelin	myelin	NOUN
bptjm-15	89	43	located	locate	VERB
bptjm-15	89	44	in	in	ADP
bptjm-15	89	45	aggregates	aggregate	NOUN
bptjm-15	89	46	of	of	ADP
bptjm-15	89	47	microglial	microglial	ADJ
bptjm-15	89	48	cells	cell	NOUN
bptjm-15	89	49	(	(	PUNCT
bptjm-15	89	50	prineas	prineas	ADJ
bptjm-15	89	51	,	,	PUNCT
bptjm-15	89	52	2001	2001	NUM
bptjm-15	89	53	)	)	PUNCT
bptjm-15	89	54	.	.	PUNCT
bptjm-15	90	1	patients	patient	NOUN
bptjm-15	90	2	in	in	ADP
bptjm-15	90	3	this	this	DET
bptjm-15	90	4	category	category	NOUN
bptjm-15	90	5	have	have	VERB
bptjm-15	90	6	a	a	DET
bptjm-15	90	7	mean	mean	ADJ
bptjm-15	90	8	age	age	NOUN
bptjm-15	90	9	of	of	ADP
bptjm-15	90	10	about	about	ADV
bptjm-15	90	11	44	44	NUM
bptjm-15	90	12	-	-	SYM
bptjm-15	90	13	63	63	NUM
bptjm-15	90	14	years	year	NOUN
bptjm-15	90	15	at	at	ADP
bptjm-15	90	16	spms	spm	NOUN
bptjm-15	90	17	onset	onset	VERB
bptjm-15	90	18	(	(	PUNCT
bptjm-15	90	19	confavreux	confavreux	INTJ
bptjm-15	90	20	,	,	PUNCT
bptjm-15	90	21	2006	2006	NUM
bptjm-15	90	22	)	)	PUNCT
bptjm-15	90	23	.	.	PUNCT
bptjm-15	91	1	ppms	ppm	NOUN
bptjm-15	91	2	patients	patient	NOUN
bptjm-15	91	3	see	see	VERB
bptjm-15	91	4	similar	similar	ADJ
bptjm-15	91	5	e	e	NOUN
bptjm-15	91	6	�	�	NOUN
bptjm-15	91	7	ects	ect	NOUN
bptjm-15	91	8	,	,	PUNCT
bptjm-15	91	9	but	but	CCONJ
bptjm-15	91	10	their	their	PRON
bptjm-15	91	11	pathogenesis	pathogenesis	NOUN
bptjm-15	91	12	is	be	AUX
bptjm-15	91	13	slightly	slightly	ADV
bptjm-15	91	14	di	di	NOUN
bptjm-15	91	15	�	�	PROPN
bptjm-15	91	16	erent	erent	NOUN
bptjm-15	91	17	.	.	PUNCT
bptjm-15	92	1	ppms	ppm	NOUN
bptjm-15	92	2	patients	patient	NOUN
bptjm-15	92	3	compose	compose	VERB
bptjm-15	92	4	approximately	approximately	ADV
bptjm-15	92	5	10	10	NUM
bptjm-15	92	6	-	-	SYM
bptjm-15	92	7	15	15	NUM
bptjm-15	92	8	%	%	NOUN
bptjm-15	92	9	of	of	ADP
bptjm-15	92	10	all	all	DET
bptjm-15	92	11	ms	ms	ADJ
bptjm-15	92	12	patients	patient	NOUN
bptjm-15	92	13	and	and	CCONJ
bptjm-15	92	14	tend	tend	VERB
bptjm-15	92	15	to	to	PART
bptjm-15	92	16	have	have	VERB
bptjm-15	92	17	less	less	ADJ
bptjm-15	92	18	brain	brain	NOUN
bptjm-15	92	19	atrophy	atrophy	NOUN
bptjm-15	92	20	but	but	CCONJ
bptjm-15	92	21	increased	increase	VERB
bptjm-15	92	22	spinal	spinal	ADJ
bptjm-15	92	23	cord	cord	NOUN
bptjm-15	92	24	atrophy	atrophy	NOUN
bptjm-15	92	25	(	(	PUNCT
bptjm-15	92	26	ghasemi	ghasemi	NOUN
bptjm-15	92	27	,	,	PUNCT
bptjm-15	92	28	2017	2017	NUM
bptjm-15	92	29	)	)	PUNCT
bptjm-15	92	30	.	.	PUNCT
bptjm-15	93	1	in	in	ADP
bptjm-15	93	2	ppms	ppm	NOUN
bptjm-15	93	3	,	,	PUNCT
bptjm-15	93	4	regression	regression	NOUN
bptjm-15	93	5	does	do	AUX
bptjm-15	93	6	not	not	PART
bptjm-15	93	7	occur	occur	VERB
bptjm-15	93	8	.	.	PUNCT
bptjm-15	94	1	patients	patient	NOUN
bptjm-15	94	2	instead	instead	ADV
bptjm-15	94	3	experience	experience	VERB
bptjm-15	94	4	a	a	DET
bptjm-15	94	5	steady	steady	ADJ
bptjm-15	94	6	increase	increase	NOUN
bptjm-15	94	7	in	in	ADP
bptjm-15	94	8	the	the	DET
bptjm-15	94	9	debilitating	debilitate	VERB
bptjm-15	94	10	e	e	NOUN
bptjm-15	94	11	�	�	NOUN
bptjm-15	94	12	ects	ect	NOUN
bptjm-15	94	13	of	of	ADP
bptjm-15	94	14	ms	ms	PROPN
bptjm-15	94	15	(	(	PUNCT
bptjm-15	94	16	reynolds	reynold	NOUN
bptjm-15	94	17	,	,	PUNCT
bptjm-15	94	18	2018	2018	NUM
bptjm-15	94	19	)	)	PUNCT
bptjm-15	94	20	.	.	PUNCT
bptjm-15	95	1	lastly	lastly	ADV
bptjm-15	95	2	,	,	PUNCT
bptjm-15	95	3	prms	prm	NOUN
bptjm-15	95	4	is	be	AUX
bptjm-15	95	5	the	the	DET
bptjm-15	95	6	subtype	subtype	NOUN
bptjm-15	95	7	of	of	ADP
bptjm-15	95	8	ms	ms	NOUN
bptjm-15	95	9	with	with	ADP
bptjm-15	95	10	the	the	DET
bptjm-15	95	11	fastest	fast	ADJ
bptjm-15	95	12	increase	increase	NOUN
bptjm-15	95	13	of	of	ADP
bptjm-15	95	14	disability	disability	NOUN
bptjm-15	95	15	over	over	ADP
bptjm-15	95	16	time	time	NOUN
bptjm-15	95	17	due	due	ADP
bptjm-15	95	18	to	to	ADP
bptjm-15	95	19	periodic	periodic	ADJ
bptjm-15	95	20	immune	immune	ADJ
bptjm-15	95	21	system	system	NOUN
bptjm-15	95	22	attacks	attack	NOUN
bptjm-15	95	23	along	along	ADP
bptjm-15	95	24	with	with	ADP
bptjm-15	95	25	a	a	DET
bptjm-15	95	26	steady	steady	ADJ
bptjm-15	95	27	increase	increase	NOUN
bptjm-15	95	28	in	in	ADP
bptjm-15	95	29	disability	disability	NOUN
bptjm-15	95	30	.	.	PUNCT
bptjm-15	96	1	prms	prm	NOUN
bptjm-15	96	2	is	be	AUX
bptjm-15	96	3	the	the	DET
bptjm-15	96	4	most	most	ADV
bptjm-15	96	5	devastating	devastating	ADJ
bptjm-15	96	6	subtype	subtype	NOUN
bptjm-15	96	7	,	,	PUNCT
bptjm-15	96	8	and	and	CCONJ
bptjm-15	96	9	it	it	PRON
bptjm-15	96	10	comprises	comprise	VERB
bptjm-15	96	11	approximately	approximately	ADV
bptjm-15	96	12	5	5	NUM
bptjm-15	96	13	%	%	NOUN
bptjm-15	96	14	of	of	ADP
bptjm-15	96	15	the	the	DET
bptjm-15	96	16	ms	ms	PROPN
bptjm-15	96	17	population	population	NOUN
bptjm-15	96	18	(	(	PUNCT
bptjm-15	96	19	ghasemi	ghasemi	NOUN
bptjm-15	96	20	,	,	PUNCT
bptjm-15	96	21	2017	2017	NUM
bptjm-15	96	22	)	)	PUNCT
bptjm-15	96	23	.	.	PUNCT
bptjm-15	97	1	ms	ms	NOUN
bptjm-15	97	2	symptoms	symptom	NOUN
bptjm-15	97	3	are	be	AUX
bptjm-15	97	4	similar	similar	ADJ
bptjm-15	97	5	among	among	ADP
bptjm-15	97	6	patients	patient	NOUN
bptjm-15	97	7	,	,	PUNCT
bptjm-15	97	8	with	with	ADP
bptjm-15	97	9	many	many	ADJ
bptjm-15	97	10	resulting	result	VERB
bptjm-15	97	11	from	from	ADP
bptjm-15	97	12	plaque	plaque	NOUN
bptjm-15	97	13	formation	formation	NOUN
bptjm-15	97	14	after	after	ADP
bptjm-15	97	15	demyelination	demyelination	NOUN
bptjm-15	97	16	.	.	PUNCT
bptjm-15	98	1	these	these	DET
bptjm-15	98	2	symptoms	symptom	NOUN
bptjm-15	98	3	are	be	AUX
bptjm-15	98	4	notoriously	notoriously	ADV
bptjm-15	98	5	di	di	ADJ
bptjm-15	98	6	�	�	PROPN
bptjm-15	98	7	cult	cult	NOUN
bptjm-15	98	8	for	for	ADP
bptjm-15	98	9	physicians	physician	NOUN
bptjm-15	98	10	to	to	PART
bptjm-15	98	11	predict	predict	VERB
bptjm-15	98	12	due	due	ADJ
bptjm-15	98	13	to	to	ADP
bptjm-15	98	14	di	di	NOUN
bptjm-15	98	15	�	�	PROPN
bptjm-15	98	16	ering	ere	VERB
bptjm-15	98	17	plaque	plaque	NOUN
bptjm-15	98	18	locations	location	NOUN
bptjm-15	98	19	between	between	ADP
bptjm-15	98	20	patients	patient	NOUN
bptjm-15	98	21	leading	lead	VERB
bptjm-15	98	22	to	to	ADP
bptjm-15	98	23	di	di	NOUN
bptjm-15	98	24	�	�	PROPN
bptjm-15	98	25	erent	erent	NOUN
bptjm-15	98	26	symptoms	symptom	NOUN
bptjm-15	98	27	(	(	PUNCT
bptjm-15	98	28	kister	kister	NOUN
bptjm-15	98	29	,	,	PUNCT
bptjm-15	98	30	2013	2013	NUM
bptjm-15	98	31	)	)	PUNCT
bptjm-15	98	32	.	.	PUNCT
bptjm-15	99	1	however	however	ADV
bptjm-15	99	2	,	,	PUNCT
bptjm-15	99	3	common	common	ADJ
bptjm-15	99	4	symptoms	symptom	NOUN
bptjm-15	99	5	berkeley	berkeley	PROPN
bptjm-15	99	6	pharma	pharma	PROPN
bptjm-15	99	7	tech	tech	NOUN
bptjm-15	99	8	journal	journal	NOUN
bptjm-15	99	9	of	of	ADP
bptjm-15	99	10	medicine	medicine	NOUN
bptjm-15	99	11	|	|	ADV
bptjm-15	99	12	70	70	NUM
bptjm-15	99	13	in	in	ADP
bptjm-15	99	14	those	those	PRON
bptjm-15	99	15	a	a	DET
bptjm-15	99	16	�	�	NOUN
bptjm-15	99	17	ected	ecte	VERB
bptjm-15	99	18	include	include	VERB
bptjm-15	99	19	vision	vision	NOUN
bptjm-15	99	20	loss	loss	NOUN
bptjm-15	99	21	,	,	PUNCT
bptjm-15	99	22	decreased	decrease	VERB
bptjm-15	99	23	mobility	mobility	NOUN
bptjm-15	99	24	,	,	PUNCT
bptjm-15	99	25	bowel	bowel	NOUN
bptjm-15	99	26	/	/	SYM
bptjm-15	99	27	bladder	bladder	NOUN
bptjm-15	99	28	dysfunction	dysfunction	NOUN
bptjm-15	99	29	,	,	PUNCT
bptjm-15	99	30	sensory	sensory	ADJ
bptjm-15	99	31	loss	loss	NOUN
bptjm-15	99	32	,	,	PUNCT
bptjm-15	99	33	impaired	impaired	ADJ
bptjm-15	99	34	coordination	coordination	NOUN
bptjm-15	99	35	,	,	PUNCT
bptjm-15	99	36	decreased	decrease	VERB
bptjm-15	99	37	energy	energy	NOUN
bptjm-15	99	38	,	,	PUNCT
bptjm-15	99	39	and	and	CCONJ
bptjm-15	99	40	spasticity	spasticity	NOUN
bptjm-15	99	41	(	(	PUNCT
bptjm-15	99	42	kister	kister	NOUN
bptjm-15	99	43	,	,	PUNCT
bptjm-15	99	44	2013	2013	NUM
bptjm-15	99	45	)	)	PUNCT
bptjm-15	99	46	.	.	PUNCT
bptjm-15	100	1	patients	patient	NOUN
bptjm-15	100	2	often	often	ADV
bptjm-15	100	3	experience	experience	VERB
bptjm-15	100	4	chronic	chronic	ADJ
bptjm-15	100	5	pain	pain	NOUN
bptjm-15	100	6	from	from	ADP
bptjm-15	100	7	conditions	condition	NOUN
bptjm-15	100	8	such	such	ADJ
bptjm-15	100	9	as	as	ADP
bptjm-15	100	10	trigeminal	trigeminal	ADJ
bptjm-15	100	11	neuralgia	neuralgia	NOUN
bptjm-15	100	12	(	(	PUNCT
bptjm-15	100	13	pain	pain	NOUN
bptjm-15	100	14	triggered	trigger	VERB
bptjm-15	100	15	by	by	ADP
bptjm-15	100	16	oral	oral	ADJ
bptjm-15	100	17	activity	activity	NOUN
bptjm-15	100	18	)	)	PUNCT
bptjm-15	100	19	,	,	PUNCT
bptjm-15	100	20	dysesthetic	dysesthetic	ADJ
bptjm-15	100	21	pain	pain	NOUN
bptjm-15	100	22	,	,	PUNCT
bptjm-15	100	23	back	back	NOUN
bptjm-15	100	24	pain	pain	NOUN
bptjm-15	100	25	,	,	PUNCT
bptjm-15	100	26	and	and	CCONJ
bptjm-15	100	27	painful	painful	ADJ
bptjm-15	100	28	spasms	spasm	NOUN
bptjm-15	100	29	(	(	PUNCT
bptjm-15	100	30	solaro	solaro	NOUN
bptjm-15	100	31	,	,	PUNCT
bptjm-15	100	32	2004	2004	NUM
bptjm-15	100	33	)	)	PUNCT
bptjm-15	100	34	.	.	PUNCT
bptjm-15	101	1	these	these	DET
bptjm-15	101	2	conditions	condition	NOUN
bptjm-15	101	3	are	be	AUX
bptjm-15	101	4	often	often	ADV
bptjm-15	101	5	comorbid	comorbid	ADJ
bptjm-15	101	6	with	with	ADP
bptjm-15	101	7	mental	mental	ADJ
bptjm-15	101	8	health	health	NOUN
bptjm-15	101	9	disorders	disorder	NOUN
bptjm-15	101	10	such	such	ADJ
bptjm-15	101	11	as	as	ADP
bptjm-15	101	12	depression	depression	NOUN
bptjm-15	101	13	,	,	PUNCT
bptjm-15	101	14	further	far	ADV
bptjm-15	101	15	confounding	confound	VERB
bptjm-15	101	16	diagnostic	diagnostic	ADJ
bptjm-15	101	17	e	e	NOUN
bptjm-15	101	18	�	�	NOUN
bptjm-15	101	19	orts	ort	NOUN
bptjm-15	101	20	(	(	PUNCT
bptjm-15	101	21	chwastiak	chwastiak	PROPN
bptjm-15	101	22	,	,	PUNCT
bptjm-15	101	23	2007	2007	NUM
bptjm-15	101	24	;	;	PUNCT
bptjm-15	101	25	kister	kister	NOUN
bptjm-15	101	26	,	,	PUNCT
bptjm-15	101	27	2013	2013	NUM
bptjm-15	101	28	;	;	PUNCT
bptjm-15	101	29	vattakatuchery	vattakatuchery	NOUN
bptjm-15	101	30	,	,	PUNCT
bptjm-15	101	31	2011	2011	NUM
bptjm-15	101	32	)	)	PUNCT
bptjm-15	101	33	.	.	PUNCT
bptjm-15	102	1	thus	thus	ADV
bptjm-15	102	2	,	,	PUNCT
bptjm-15	102	3	it	it	PRON
bptjm-15	102	4	is	be	AUX
bptjm-15	102	5	critical	critical	ADJ
bptjm-15	102	6	to	to	PART
bptjm-15	102	7	pinpoint	pinpoint	VERB
bptjm-15	102	8	the	the	DET
bptjm-15	102	9	speci	speci	PROPN
bptjm-15	102	10	�	�	PROPN
bptjm-15	102	11	c	c	PROPN
bptjm-15	102	12	causes	cause	NOUN
bptjm-15	102	13	of	of	ADP
bptjm-15	102	14	ms	ms	NOUN
bptjm-15	102	15	in	in	ADP
bptjm-15	102	16	order	order	NOUN
bptjm-15	102	17	to	to	PART
bptjm-15	102	18	establish	establish	VERB
bptjm-15	102	19	a	a	DET
bptjm-15	102	20	framework	framework	NOUN
bptjm-15	102	21	for	for	ADP
bptjm-15	102	22	the	the	DET
bptjm-15	102	23	development	development	NOUN
bptjm-15	102	24	of	of	ADP
bptjm-15	102	25	e	e	PROPN
bptjm-15	102	26	�	�	NOUN
bptjm-15	102	27	ective	ective	ADJ
bptjm-15	102	28	microbial	microbial	ADJ
bptjm-15	102	29	therapies	therapy	NOUN
bptjm-15	102	30	.	.	PUNCT
bptjm-15	103	1	multiple	multiple	ADJ
bptjm-15	103	2	sclerosis	sclerosis	NOUN
bptjm-15	103	3	pathogenesis	pathogenesis	NOUN
bptjm-15	103	4	it	it	PRON
bptjm-15	103	5	is	be	AUX
bptjm-15	103	6	still	still	ADV
bptjm-15	103	7	unclear	unclear	ADJ
bptjm-15	103	8	whether	whether	SCONJ
bptjm-15	103	9	an	an	DET
bptjm-15	103	10	overactive	overactive	ADJ
bptjm-15	103	11	immune	immune	ADJ
bptjm-15	103	12	system	system	NOUN
bptjm-15	103	13	and	and	CCONJ
bptjm-15	103	14	acute	acute	ADJ
bptjm-15	103	15	in	in	ADP
bptjm-15	103	16	�	�	PROPN
bptjm-15	103	17	ammation	ammation	NOUN
bptjm-15	103	18	are	be	AUX
bptjm-15	103	19	the	the	DET
bptjm-15	103	20	incipient	incipient	ADJ
bptjm-15	103	21	causes	cause	NOUN
bptjm-15	103	22	of	of	ADP
bptjm-15	103	23	ms	ms	NOUN
bptjm-15	103	24	,	,	PUNCT
bptjm-15	103	25	or	or	CCONJ
bptjm-15	103	26	if	if	SCONJ
bptjm-15	103	27	pathogenesis	pathogenesis	NOUN
bptjm-15	103	28	stems	stem	VERB
bptjm-15	103	29	from	from	ADP
bptjm-15	103	30	a	a	DET
bptjm-15	103	31	radically	radically	ADV
bptjm-15	103	32	di	di	NOUN
bptjm-15	103	33	�	�	PROPN
bptjm-15	103	34	erent	erent	NOUN
bptjm-15	103	35	cause	cause	NOUN
bptjm-15	103	36	.	.	PUNCT
bptjm-15	104	1	similarly	similarly	ADV
bptjm-15	104	2	,	,	PUNCT
bptjm-15	104	3	there	there	PRON
bptjm-15	104	4	is	be	VERB
bptjm-15	104	5	still	still	ADV
bptjm-15	104	6	ambiguity	ambiguity	NOUN
bptjm-15	104	7	regarding	regard	VERB
bptjm-15	104	8	autoreactive	autoreactive	ADJ
bptjm-15	104	9	immune	immune	ADJ
bptjm-15	104	10	cell	cell	NOUN
bptjm-15	104	11	leakage	leakage	NOUN
bptjm-15	104	12	into	into	ADP
bptjm-15	104	13	the	the	DET
bptjm-15	104	14	cns	cns	NOUN
bptjm-15	104	15	.	.	PUNCT
bptjm-15	105	1	the	the	DET
bptjm-15	105	2	current	current	ADJ
bptjm-15	105	3	literature	literature	NOUN
bptjm-15	105	4	demonstrates	demonstrate	VERB
bptjm-15	105	5	that	that	SCONJ
bptjm-15	105	6	t	t	PROPN
bptjm-15	105	7	helper	helper	NOUN
bptjm-15	105	8	(	(	PUNCT
bptjm-15	105	9	th	th	NOUN
bptjm-15	105	10	)	)	PUNCT
bptjm-15	105	11	lymphocytes	lymphocyte	NOUN
bptjm-15	105	12	and	and	CCONJ
bptjm-15	105	13	various	various	ADJ
bptjm-15	105	14	cytokines	cytokine	NOUN
bptjm-15	105	15	play	play	VERB
bptjm-15	105	16	a	a	DET
bptjm-15	105	17	primary	primary	ADJ
bptjm-15	105	18	role	role	NOUN
bptjm-15	105	19	in	in	ADP
bptjm-15	105	20	ms	ms	PROPN
bptjm-15	105	21	pathogenesis	pathogenesis	PROPN
bptjm-15	105	22	(	(	PUNCT
bptjm-15	105	23	williams	williams	PROPN
bptjm-15	105	24	,	,	PUNCT
bptjm-15	105	25	2020	2020	NUM
bptjm-15	105	26	;	;	PUNCT
bptjm-15	105	27	choileain	choileain	NOUN
bptjm-15	105	28	,	,	PUNCT
bptjm-15	105	29	2020	2020	NUM
bptjm-15	105	30	;	;	PUNCT
bptjm-15	105	31	berer	berer	ADP
bptjm-15	105	32	,	,	PUNCT
bptjm-15	105	33	2011	2011	NUM
bptjm-15	105	34	)	)	PUNCT
bptjm-15	105	35	.	.	PUNCT
bptjm-15	106	1	th17	th17	NOUN
bptjm-15	106	2	is	be	AUX
bptjm-15	106	3	the	the	DET
bptjm-15	106	4	most	most	ADV
bptjm-15	106	5	studied	study	VERB
bptjm-15	106	6	t	t	PROPN
bptjm-15	106	7	helper	helper	NOUN
bptjm-15	106	8	cell	cell	NOUN
bptjm-15	106	9	,	,	PUNCT
bptjm-15	106	10	and	and	CCONJ
bptjm-15	106	11	it	it	PRON
bptjm-15	106	12	is	be	AUX
bptjm-15	106	13	considered	consider	VERB
bptjm-15	106	14	by	by	ADP
bptjm-15	106	15	many	many	ADJ
bptjm-15	106	16	to	to	PART
bptjm-15	106	17	play	play	VERB
bptjm-15	106	18	a	a	DET
bptjm-15	106	19	large	large	ADJ
bptjm-15	106	20	role	role	NOUN
bptjm-15	106	21	in	in	ADP
bptjm-15	106	22	the	the	DET
bptjm-15	106	23	in	in	ADP
bptjm-15	106	24	�	�	PROPN
bptjm-15	106	25	ammation	ammation	NOUN
bptjm-15	106	26	observed	observe	VERB
bptjm-15	106	27	in	in	ADP
bptjm-15	106	28	ms	ms	ADJ
bptjm-15	106	29	patients	patient	NOUN
bptjm-15	106	30	.	.	PUNCT
bptjm-15	107	1	(	(	PUNCT
bptjm-15	107	2	choileáin	choileáin	ADJ
bptjm-15	107	3	,	,	PUNCT
bptjm-15	107	4	2020	2020	NUM
bptjm-15	107	5	;	;	PUNCT
bptjm-15	107	6	reynolds	reynold	NOUN
bptjm-15	107	7	,	,	PUNCT
bptjm-15	107	8	2010	2010	NUM
bptjm-15	107	9	;	;	PUNCT
bptjm-15	107	10	mangalam	mangalam	PROPN
bptjm-15	107	11	,	,	PUNCT
bptjm-15	107	12	2017	2017	NUM
bptjm-15	107	13	;	;	PUNCT
bptjm-15	107	14	tahmasebinia	tahmasebinia	PROPN
bptjm-15	107	15	,	,	PUNCT
bptjm-15	107	16	2017	2017	NUM
bptjm-15	107	17	)	)	PUNCT
bptjm-15	107	18	.	.	PUNCT
bptjm-15	108	1	many	many	ADJ
bptjm-15	108	2	studies	study	NOUN
bptjm-15	108	3	support	support	VERB
bptjm-15	108	4	the	the	DET
bptjm-15	108	5	role	role	NOUN
bptjm-15	108	6	of	of	ADP
bptjm-15	108	7	th17	th17	PROPN
bptjm-15	108	8	in	in	ADP
bptjm-15	108	9	producing	produce	VERB
bptjm-15	108	10	pro	pro	ADJ
bptjm-15	108	11	-	-	ADJ
bptjm-15	108	12	in	in	ADJ
bptjm-15	108	13	�	�	NOUN
bptjm-15	108	14	ammatory	ammatory	NOUN
bptjm-15	108	15	interleukins	interleukin	NOUN
bptjm-15	108	16	(	(	PUNCT
bptjm-15	108	17	il	il	PROPN
bptjm-15	108	18	)	)	PUNCT
bptjm-15	108	19	such	such	ADJ
bptjm-15	108	20	as	as	ADP
bptjm-15	108	21	il-17	il-17	NUM
bptjm-15	108	22	,	,	PUNCT
bptjm-15	108	23	il-17a	il-17a	PROPN
bptjm-15	108	24	,	,	PUNCT
bptjm-15	108	25	il-17f	il-17f	NOUN
bptjm-15	108	26	,	,	PUNCT
bptjm-15	108	27	il-21	il-21	NOUN
bptjm-15	108	28	,	,	PUNCT
bptjm-15	108	29	il-22	il-22	NOUN
bptjm-15	108	30	,	,	PUNCT
bptjm-15	108	31	and	and	CCONJ
bptjm-15	108	32	il-26	il-26	PUNCT
bptjm-15	108	33	(	(	PUNCT
bptjm-15	108	34	ghasemi	ghasemi	NOUN
bptjm-15	108	35	,	,	PUNCT
bptjm-15	108	36	2017	2017	NUM
bptjm-15	108	37	;	;	PUNCT
bptjm-15	108	38	xu	xu	INTJ
bptjm-15	108	39	,	,	PUNCT
bptjm-15	108	40	2020	2020	NUM
bptjm-15	108	41	;	;	PUNCT
bptjm-15	108	42	reynolds	reynold	NOUN
bptjm-15	108	43	,	,	PUNCT
bptjm-15	108	44	2010	2010	NUM
bptjm-15	108	45	)	)	PUNCT
bptjm-15	108	46	.	.	PUNCT
bptjm-15	109	1	this	this	PRON
bptjm-15	109	2	increased	increase	VERB
bptjm-15	109	3	in	in	ADP
bptjm-15	109	4	�	�	NOUN
bptjm-15	109	5	ammatory	ammatory	ADJ
bptjm-15	109	6	response	response	NOUN
bptjm-15	109	7	is	be	AUX
bptjm-15	109	8	aggravated	aggravate	VERB
bptjm-15	109	9	further	far	ADV
bptjm-15	109	10	when	when	SCONJ
bptjm-15	109	11	the	the	DET
bptjm-15	109	12	normal	normal	ADJ
bptjm-15	109	13	negative	negative	ADJ
bptjm-15	109	14	feedback	feedback	NOUN
bptjm-15	109	15	response	response	NOUN
bptjm-15	109	16	becomes	become	VERB
bptjm-15	109	17	impaired	impaired	ADJ
bptjm-15	109	18	.	.	PUNCT
bptjm-15	110	1	ms	ms	NOUN
bptjm-15	110	2	patients	patient	NOUN
bptjm-15	110	3	have	have	AUX
bptjm-15	110	4	displayed	display	VERB
bptjm-15	110	5	a	a	DET
bptjm-15	110	6	reduced	reduce	VERB
bptjm-15	110	7	ability	ability	NOUN
bptjm-15	110	8	to	to	PART
bptjm-15	110	9	produce	produce	VERB
bptjm-15	110	10	t	t	PROPN
bptjm-15	110	11	regulatory	regulatory	ADJ
bptjm-15	110	12	cells	cell	NOUN
bptjm-15	110	13	,	,	PUNCT
bptjm-15	110	14	which	which	PRON
bptjm-15	110	15	normally	normally	ADV
bptjm-15	110	16	mediate	mediate	VERB
bptjm-15	110	17	the	the	PRON
bptjm-15	110	18	in	in	ADP
bptjm-15	110	19	�	�	NOUN
bptjm-15	110	20	ammatory	ammatory	NOUN
bptjm-15	110	21	e	e	NOUN
bptjm-15	110	22	�	�	NOUN
bptjm-15	110	23	ects	ect	NOUN
bptjm-15	110	24	of	of	ADP
bptjm-15	110	25	th	th	NOUN
bptjm-15	110	26	cells	cell	NOUN
bptjm-15	110	27	that	that	PRON
bptjm-15	110	28	occur	occur	VERB
bptjm-15	110	29	as	as	ADP
bptjm-15	110	30	a	a	DET
bptjm-15	110	31	result	result	NOUN
bptjm-15	110	32	of	of	ADP
bptjm-15	110	33	leakiness	leakiness	NOUN
bptjm-15	110	34	of	of	ADP
bptjm-15	110	35	the	the	DET
bptjm-15	110	36	blood	blood	NOUN
bptjm-15	110	37	-	-	PUNCT
bptjm-15	110	38	brain	brain	NOUN
bptjm-15	110	39	barrier	barrier	NOUN
bptjm-15	110	40	(	(	PUNCT
bptjm-15	110	41	bbb	bbb	PROPN
bptjm-15	110	42	)	)	PUNCT
bptjm-15	110	43	(	(	PUNCT
bptjm-15	110	44	cekanaviciute	cekanaviciute	NOUN
bptjm-15	110	45	,	,	PUNCT
bptjm-15	110	46	2017	2017	NUM
bptjm-15	110	47	)	)	PUNCT
bptjm-15	110	48	.	.	PUNCT
bptjm-15	111	1	the	the	DET
bptjm-15	111	2	blood	blood	NOUN
bptjm-15	111	3	-	-	PUNCT
bptjm-15	111	4	brain	brain	NOUN
bptjm-15	111	5	barrier	barrier	NOUN
bptjm-15	111	6	is	be	AUX
bptjm-15	111	7	a	a	DET
bptjm-15	111	8	semipermeable	semipermeable	NOUN
bptjm-15	111	9	border	border	NOUN
bptjm-15	111	10	composed	compose	VERB
bptjm-15	111	11	of	of	ADP
bptjm-15	111	12	endothelial	endothelial	ADJ
bptjm-15	111	13	cells	cell	NOUN
bptjm-15	111	14	(	(	PUNCT
bptjm-15	111	15	ecs	ecs	PROPN
bptjm-15	111	16	)	)	PUNCT
bptjm-15	111	17	,	,	PUNCT
bptjm-15	111	18	pericytes	pericyte	NOUN
bptjm-15	111	19	,	,	PUNCT
bptjm-15	111	20	astrocytes	astrocyte	NOUN
bptjm-15	111	21	,	,	PUNCT
bptjm-15	111	22	and	and	CCONJ
bptjm-15	111	23	an	an	DET
bptjm-15	111	24	extracellular	extracellular	ADJ
bptjm-15	111	25	matrix	matrix	NOUN
bptjm-15	111	26	(	(	PUNCT
bptjm-15	111	27	abbott	abbott	PROPN
bptjm-15	111	28	,	,	PUNCT
bptjm-15	111	29	2010	2010	NUM
bptjm-15	111	30	)	)	PUNCT
bptjm-15	111	31	.	.	PUNCT
bptjm-15	112	1	recent	recent	ADJ
bptjm-15	112	2	studies	study	NOUN
bptjm-15	112	3	indicate	indicate	VERB
bptjm-15	112	4	that	that	SCONJ
bptjm-15	112	5	ms	ms	PROPN
bptjm-15	112	6	patients	patient	NOUN
bptjm-15	112	7	have	have	AUX
bptjm-15	112	8	circulating	circulate	VERB
bptjm-15	112	9	factors	factor	NOUN
bptjm-15	112	10	and	and	CCONJ
bptjm-15	112	11	the	the	DET
bptjm-15	112	12	bbb	bbb	NOUN
bptjm-15	112	13	engages	engage	VERB
bptjm-15	112	14	in	in	ADP
bptjm-15	112	15	crosstalk	crosstalk	NOUN
bptjm-15	112	16	that	that	PRON
bptjm-15	112	17	is	be	AUX
bptjm-15	112	18	mediated	mediate	VERB
bptjm-15	112	19	by	by	ADP
bptjm-15	112	20	endothelial	endothelial	ADJ
bptjm-15	112	21	cells	cell	NOUN
bptjm-15	112	22	(	(	PUNCT
bptjm-15	112	23	ecs	ec	NOUN
bptjm-15	112	24	)	)	PUNCT
bptjm-15	112	25	and	and	CCONJ
bptjm-15	112	26	adjustment	adjustment	NOUN
bptjm-15	112	27	of	of	ADP
bptjm-15	112	28	astrocytic	astrocytic	ADJ
bptjm-15	112	29	expression	expression	NOUN
bptjm-15	112	30	(	(	PUNCT
bptjm-15	112	31	williams	williams	PROPN
bptjm-15	112	32	,	,	PUNCT
bptjm-15	112	33	2020	2020	NUM
bptjm-15	112	34	;	;	PUNCT
bptjm-15	112	35	setiadi	setiadi	NOUN
bptjm-15	112	36	,	,	PUNCT
bptjm-15	112	37	2019	2019	NUM
bptjm-15	112	38	;	;	PUNCT
bptjm-15	112	39	zivadinov	zivadinov	NOUN
bptjm-15	112	40	,	,	PUNCT
bptjm-15	112	41	2016	2016	NUM
bptjm-15	112	42	)	)	PUNCT
bptjm-15	112	43	.	.	PUNCT
bptjm-15	113	1	ms	ms	PROPN
bptjm-15	113	2	patients	patient	NOUN
bptjm-15	113	3	are	be	AUX
bptjm-15	113	4	further	far	ADV
bptjm-15	113	5	characterized	characterize	VERB
bptjm-15	113	6	by	by	ADP
bptjm-15	113	7	lymphocytes	lymphocyte	NOUN
bptjm-15	113	8	berkeley	berkeley	PROPN
bptjm-15	113	9	pharma	pharma	PROPN
bptjm-15	113	10	tech	tech	NOUN
bptjm-15	113	11	journal	journal	NOUN
bptjm-15	113	12	of	of	ADP
bptjm-15	113	13	medicine	medicine	NOUN
bptjm-15	113	14	|	|	ADV
bptjm-15	113	15	71	71	NUM
bptjm-15	113	16	undermining	undermine	VERB
bptjm-15	113	17	bbb	bbb	NOUN
bptjm-15	113	18	permeability	permeability	NOUN
bptjm-15	113	19	by	by	ADP
bptjm-15	113	20	inducing	induce	VERB
bptjm-15	113	21	oxidative	oxidative	ADJ
bptjm-15	113	22	stress	stress	NOUN
bptjm-15	113	23	in	in	ADP
bptjm-15	113	24	ecs	ecs	PROPN
bptjm-15	113	25	and	and	CCONJ
bptjm-15	113	26	enhancing	enhance	VERB
bptjm-15	113	27	leukocyte	leukocyte	NOUN
bptjm-15	113	28	transmigration	transmigration	NOUN
bptjm-15	113	29	by	by	ADP
bptjm-15	113	30	producing	produce	VERB
bptjm-15	113	31	various	various	ADJ
bptjm-15	113	32	facilitative	facilitative	ADJ
bptjm-15	113	33	proteins	protein	NOUN
bptjm-15	113	34	:	:	PUNCT
bptjm-15	113	35	p	p	X
bptjm-15	113	36	-	-	PUNCT
bptjm-15	113	37	glycoprotein	glycoprotein	NOUN
bptjm-15	113	38	,	,	PUNCT
bptjm-15	113	39	intercellular	intercellular	ADJ
bptjm-15	113	40	cell	cell	NOUN
bptjm-15	113	41	adhesion	adhesion	NOUN
bptjm-15	113	42	molecule	molecule	NOUN
bptjm-15	113	43	1(icam-1	1(icam-1	NUM
bptjm-15	113	44	)	)	PUNCT
bptjm-15	113	45	,	,	PUNCT
bptjm-15	113	46	and	and	CCONJ
bptjm-15	113	47	vascular	vascular	ADJ
bptjm-15	113	48	cell	cell	NOUN
bptjm-15	113	49	adhesion	adhesion	NOUN
bptjm-15	113	50	molecule	molecule	NOUN
bptjm-15	113	51	1	1	NUM
bptjm-15	113	52	(	(	PUNCT
bptjm-15	113	53	vcam-1	vcam-1	NOUN
bptjm-15	113	54	)	)	PUNCT
bptjm-15	113	55	(	(	PUNCT
bptjm-15	113	56	sheikh	sheikh	NOUN
bptjm-15	113	57	,	,	PUNCT
bptjm-15	113	58	2020	2020	NUM
bptjm-15	113	59	)	)	PUNCT
bptjm-15	113	60	.	.	PUNCT
bptjm-15	114	1	vcam-1	vcam-1	NOUN
bptjm-15	114	2	and	and	CCONJ
bptjm-15	114	3	icam-1	icam-1	NUM
bptjm-15	114	4	expression	expression	NOUN
bptjm-15	114	5	is	be	AUX
bptjm-15	114	6	directly	directly	ADV
bptjm-15	114	7	correlated	correlate	VERB
bptjm-15	114	8	to	to	ADP
bptjm-15	114	9	levels	level	NOUN
bptjm-15	114	10	of	of	ADP
bptjm-15	114	11	il-17	il-17	NUM
bptjm-15	114	12	and	and	CCONJ
bptjm-15	114	13	tnf	tnf	PROPN
bptjm-15	114	14	-	-	PUNCT
bptjm-15	114	15	α	α	PROPN
bptjm-15	114	16	,	,	PUNCT
bptjm-15	114	17	suggesting	suggest	VERB
bptjm-15	114	18	another	another	DET
bptjm-15	114	19	mechanism	mechanism	NOUN
bptjm-15	114	20	of	of	ADP
bptjm-15	114	21	the	the	DET
bptjm-15	114	22	enhanced	enhanced	ADJ
bptjm-15	114	23	in	in	ADP
bptjm-15	114	24	�	�	PROPN
bptjm-15	114	25	ammation	ammation	NOUN
bptjm-15	114	26	seen	see	VERB
bptjm-15	114	27	in	in	ADP
bptjm-15	114	28	ms	ms	ADJ
bptjm-15	114	29	patients	patient	NOUN
bptjm-15	114	30	(	(	PUNCT
bptjm-15	114	31	gao	gao	PROPN
bptjm-15	114	32	,	,	PUNCT
bptjm-15	114	33	2017	2017	NUM
bptjm-15	114	34	)	)	PUNCT
bptjm-15	114	35	.	.	PUNCT
bptjm-15	115	1	by	by	ADP
bptjm-15	115	2	modifying	modify	VERB
bptjm-15	115	3	bbb	bbb	PROPN
bptjm-15	115	4	immuno	immuno	PROPN
bptjm-15	115	5	-	-	PUNCT
bptjm-15	115	6	tra	tra	NOUN
bptjm-15	115	7	�	�	NOUN
bptjm-15	115	8	cking	cking	ADJ
bptjm-15	115	9	,	,	PUNCT
bptjm-15	115	10	autoreactive	autoreactive	ADJ
bptjm-15	115	11	cells	cell	NOUN
bptjm-15	115	12	are	be	AUX
bptjm-15	115	13	readily	readily	ADV
bptjm-15	115	14	able	able	ADJ
bptjm-15	115	15	to	to	PART
bptjm-15	115	16	cross	cross	VERB
bptjm-15	115	17	into	into	ADP
bptjm-15	115	18	the	the	DET
bptjm-15	115	19	cns	cns	NOUN
bptjm-15	115	20	and	and	CCONJ
bptjm-15	115	21	cause	cause	VERB
bptjm-15	115	22	further	further	ADJ
bptjm-15	115	23	damage	damage	NOUN
bptjm-15	115	24	.	.	PUNCT
bptjm-15	116	1	this	this	DET
bptjm-15	116	2	leakage	leakage	NOUN
bptjm-15	116	3	of	of	ADP
bptjm-15	116	4	immune	immune	ADJ
bptjm-15	116	5	cells	cell	NOUN
bptjm-15	116	6	is	be	AUX
bptjm-15	116	7	exacerbated	exacerbate	VERB
bptjm-15	116	8	as	as	SCONJ
bptjm-15	116	9	ms	ms	PROPN
bptjm-15	116	10	lesions	lesion	NOUN
bptjm-15	116	11	begin	begin	VERB
bptjm-15	116	12	increasing	increase	VERB
bptjm-15	116	13	b	b	PRON
bptjm-15	116	14	cell	cell	NOUN
bptjm-15	116	15	transcription	transcription	NOUN
bptjm-15	116	16	ten	ten	NOUN
bptjm-15	116	17	-	-	NOUN
bptjm-15	116	18	fold	fold	VERB
bptjm-15	116	19	through	through	ADP
bptjm-15	116	20	promoting	promote	VERB
bptjm-15	116	21	the	the	DET
bptjm-15	116	22	production	production	NOUN
bptjm-15	116	23	of	of	ADP
bptjm-15	116	24	b	b	NOUN
bptjm-15	116	25	cell	cell	NOUN
bptjm-15	116	26	-	-	PUNCT
bptjm-15	116	27	activating	activate	VERB
bptjm-15	116	28	factor	factor	NOUN
bptjm-15	116	29	(	(	PUNCT
bptjm-15	116	30	baff	baff	PROPN
bptjm-15	116	31	)	)	PUNCT
bptjm-15	116	32	(	(	PUNCT
bptjm-15	116	33	krumbholz	krumbholz	NOUN
bptjm-15	116	34	,	,	PUNCT
bptjm-15	116	35	2005	2005	NUM
bptjm-15	116	36	;	;	PUNCT
bptjm-15	116	37	kannel	kannel	PROPN
bptjm-15	116	38	,	,	PUNCT
bptjm-15	116	39	2015	2015	NUM
bptjm-15	116	40	)	)	PUNCT
bptjm-15	116	41	.	.	PUNCT
bptjm-15	117	1	furthermore	furthermore	ADV
bptjm-15	117	2	,	,	PUNCT
bptjm-15	117	3	once	once	ADV
bptjm-15	117	4	pathogen	pathogen	NOUN
bptjm-15	117	5	-	-	PUNCT
bptjm-15	117	6	associated	associate	VERB
bptjm-15	117	7	molecules	molecule	NOUN
bptjm-15	117	8	bind	bind	VERB
bptjm-15	117	9	to	to	ADP
bptjm-15	117	10	toll	toll	NOUN
bptjm-15	117	11	-	-	PUNCT
bptjm-15	117	12	like	like	ADJ
bptjm-15	117	13	receptors	receptor	NOUN
bptjm-15	117	14	(	(	PUNCT
bptjm-15	117	15	tlr	tlr	PROPN
bptjm-15	117	16	)	)	PUNCT
bptjm-15	117	17	on	on	ADP
bptjm-15	117	18	these	these	DET
bptjm-15	117	19	lymphocytes	lymphocyte	NOUN
bptjm-15	117	20	,	,	PUNCT
bptjm-15	117	21	autoreactive	autoreactive	ADJ
bptjm-15	117	22	t	t	PROPN
bptjm-15	117	23	cells	cell	NOUN
bptjm-15	117	24	are	be	AUX
bptjm-15	117	25	signaled	signal	VERB
bptjm-15	117	26	to	to	PART
bptjm-15	117	27	produce	produce	VERB
bptjm-15	117	28	cytokines	cytokine	NOUN
bptjm-15	117	29	that	that	PRON
bptjm-15	117	30	induce	induce	VERB
bptjm-15	117	31	additional	additional	ADJ
bptjm-15	117	32	cell	cell	NOUN
bptjm-15	117	33	di	di	NOUN
bptjm-15	117	34	�	�	PROPN
bptjm-15	117	35	erentiation	erentiation	NOUN
bptjm-15	117	36	(	(	PUNCT
bptjm-15	117	37	reynolds	reynold	NOUN
bptjm-15	117	38	,	,	PUNCT
bptjm-15	117	39	2010	2010	NUM
bptjm-15	117	40	)	)	PUNCT
bptjm-15	117	41	.	.	PUNCT
bptjm-15	118	1	ms	ms	PROPN
bptjm-15	118	2	patients	patient	NOUN
bptjm-15	118	3	reportedly	reportedly	ADV
bptjm-15	118	4	possess	possess	VERB
bptjm-15	118	5	high	high	ADJ
bptjm-15	118	6	levels	level	NOUN
bptjm-15	118	7	of	of	ADP
bptjm-15	118	8	tlr2	tlr2	PROPN
bptjm-15	118	9	and	and	CCONJ
bptjm-15	118	10	tlr4	tlr4	NOUN
bptjm-15	118	11	among	among	ADP
bptjm-15	118	12	others	other	NOUN
bptjm-15	118	13	,	,	PUNCT
bptjm-15	118	14	with	with	ADP
bptjm-15	118	15	tlr2	tlr2	PROPN
bptjm-15	118	16	being	be	AUX
bptjm-15	118	17	associated	associate	VERB
bptjm-15	118	18	with	with	ADP
bptjm-15	118	19	the	the	DET
bptjm-15	118	20	defective	defective	ADJ
bptjm-15	118	21	remyelination	remyelination	NOUN
bptjm-15	118	22	seen	see	VERB
bptjm-15	118	23	in	in	ADP
bptjm-15	118	24	ms	ms	PROPN
bptjm-15	118	25	(	(	PUNCT
bptjm-15	118	26	hasheminia	hasheminia	PROPN
bptjm-15	118	27	,	,	PUNCT
bptjm-15	118	28	2014	2014	NUM
bptjm-15	118	29	;	;	PUNCT
bptjm-15	118	30	wasko	wasko	ADV
bptjm-15	118	31	,	,	PUNCT
bptjm-15	118	32	2020	2020	NUM
bptjm-15	118	33	)	)	PUNCT
bptjm-15	118	34	.	.	PUNCT
bptjm-15	119	1	microbial	microbial	ADJ
bptjm-15	119	2	manipulation	manipulation	NOUN
bptjm-15	119	3	of	of	ADP
bptjm-15	119	4	the	the	DET
bptjm-15	119	5	immune	immune	ADJ
bptjm-15	119	6	system	system	NOUN
bptjm-15	119	7	gives	give	VERB
bptjm-15	119	8	scientists	scientist	NOUN
bptjm-15	119	9	hope	hope	VERB
bptjm-15	119	10	for	for	ADP
bptjm-15	119	11	gut	gut	NOUN
bptjm-15	119	12	-	-	PUNCT
bptjm-15	119	13	based	base	VERB
bptjm-15	119	14	therapies	therapy	NOUN
bptjm-15	119	15	,	,	PUNCT
bptjm-15	119	16	albeit	albeit	SCONJ
bptjm-15	119	17	speci	speci	ADJ
bptjm-15	119	18	�	�	PROPN
bptjm-15	119	19	c	c	PROPN
bptjm-15	119	20	causation	causation	NOUN
bptjm-15	119	21	has	have	AUX
bptjm-15	119	22	not	not	PART
bptjm-15	119	23	been	be	AUX
bptjm-15	119	24	established	establish	VERB
bptjm-15	119	25	.	.	PUNCT
bptjm-15	120	1	current	current	ADJ
bptjm-15	120	2	treatment	treatment	NOUN
bptjm-15	120	3	options	option	NOUN
bptjm-15	120	4	for	for	ADP
bptjm-15	120	5	ms	ms	NOUN
bptjm-15	120	6	due	due	ADP
bptjm-15	120	7	to	to	ADP
bptjm-15	120	8	its	its	PRON
bptjm-15	120	9	complex	complex	ADJ
bptjm-15	120	10	neurological	neurological	ADJ
bptjm-15	120	11	pathogenesis	pathogenesis	NOUN
bptjm-15	120	12	,	,	PUNCT
bptjm-15	120	13	ms	ms	PROPN
bptjm-15	120	14	is	be	AUX
bptjm-15	120	15	currently	currently	ADV
bptjm-15	120	16	an	an	DET
bptjm-15	120	17	incurable	incurable	ADJ
bptjm-15	120	18	disease	disease	NOUN
bptjm-15	120	19	.	.	PUNCT
bptjm-15	121	1	treatment	treatment	NOUN
bptjm-15	121	2	options	option	NOUN
bptjm-15	121	3	for	for	ADP
bptjm-15	121	4	patients	patient	NOUN
bptjm-15	121	5	with	with	ADP
bptjm-15	121	6	ms	ms	PROPN
bptjm-15	121	7	are	be	AUX
bptjm-15	121	8	divided	divide	VERB
bptjm-15	121	9	into	into	ADP
bptjm-15	121	10	three	three	NUM
bptjm-15	121	11	categories	category	NOUN
bptjm-15	121	12	:	:	PUNCT
bptjm-15	121	13	acute	acute	ADJ
bptjm-15	121	14	relapse	relapse	NOUN
bptjm-15	121	15	management	management	NOUN
bptjm-15	121	16	,	,	PUNCT
bptjm-15	121	17	slowing	slow	VERB
bptjm-15	121	18	of	of	ADP
bptjm-15	121	19	disease	disease	NOUN
bptjm-15	121	20	progression	progression	NOUN
bptjm-15	121	21	,	,	PUNCT
bptjm-15	121	22	and	and	CCONJ
bptjm-15	121	23	treatment	treatment	NOUN
bptjm-15	121	24	of	of	ADP
bptjm-15	121	25	related	related	ADJ
bptjm-15	121	26	symptoms	symptom	NOUN
bptjm-15	121	27	(	(	PUNCT
bptjm-15	121	28	hart	hart	PROPN
bptjm-15	121	29	,	,	PUNCT
bptjm-15	121	30	2016	2016	NUM
bptjm-15	121	31	)	)	PUNCT
bptjm-15	121	32	.	.	PUNCT
bptjm-15	122	1	glucocorticoids	glucocorticoid	NOUN
bptjm-15	122	2	are	be	AUX
bptjm-15	122	3	the	the	DET
bptjm-15	122	4	drugs	drug	NOUN
bptjm-15	122	5	of	of	ADP
bptjm-15	122	6	choice	choice	NOUN
bptjm-15	122	7	for	for	ADP
bptjm-15	122	8	an	an	DET
bptjm-15	122	9	acute	acute	ADJ
bptjm-15	122	10	attack	attack	NOUN
bptjm-15	122	11	because	because	SCONJ
bptjm-15	122	12	they	they	PRON
bptjm-15	122	13	downregulate	downregulate	VERB
bptjm-15	122	14	molecules	molecule	NOUN
bptjm-15	122	15	associated	associate	VERB
bptjm-15	122	16	with	with	ADP
bptjm-15	122	17	in	in	ADP
bptjm-15	122	18	�	�	PROPN
bptjm-15	122	19	ammation	ammation	NOUN
bptjm-15	122	20	in	in	ADP
bptjm-15	122	21	the	the	DET
bptjm-15	122	22	body	body	NOUN
bptjm-15	122	23	,	,	PUNCT
bptjm-15	122	24	such	such	ADJ
bptjm-15	122	25	as	as	ADP
bptjm-15	122	26	cytokines	cytokine	NOUN
bptjm-15	122	27	and	and	CCONJ
bptjm-15	122	28	chemokines	chemokine	NOUN
bptjm-15	122	29	,	,	PUNCT
bptjm-15	122	30	and	and	CCONJ
bptjm-15	122	31	upregulate	upregulate	VERB
bptjm-15	122	32	anti	anti	ADJ
bptjm-15	122	33	-	-	ADJ
bptjm-15	122	34	in	in	ADP
bptjm-15	122	35	�	�	NOUN
bptjm-15	122	36	ammatory	ammatory	NOUN
bptjm-15	122	37	proteins	protein	NOUN
bptjm-15	122	38	.	.	PUNCT
bptjm-15	123	1	therapy	therapy	NOUN
bptjm-15	123	2	with	with	ADP
bptjm-15	123	3	glucocorticoids	glucocorticoid	NOUN
bptjm-15	123	4	such	such	ADJ
bptjm-15	123	5	as	as	ADP
bptjm-15	123	6	high	high	ADJ
bptjm-15	123	7	-	-	PUNCT
bptjm-15	123	8	dose	dose	NOUN
bptjm-15	123	9	methylprednisolone	methylprednisolone	NOUN
bptjm-15	123	10	should	should	AUX
bptjm-15	123	11	be	be	AUX
bptjm-15	123	12	considered	consider	VERB
bptjm-15	123	13	in	in	ADP
bptjm-15	123	14	patients	patient	NOUN
bptjm-15	123	15	whose	whose	DET
bptjm-15	123	16	relapse	relapse	NOUN
bptjm-15	123	17	is	be	AUX
bptjm-15	123	18	of	of	ADP
bptjm-15	123	19	moderate	moderate	ADJ
bptjm-15	123	20	to	to	ADP
bptjm-15	123	21	severe	severe	ADJ
bptjm-15	123	22	severity	severity	NOUN
bptjm-15	123	23	(	(	PUNCT
bptjm-15	123	24	doshi	doshi	PROPN
bptjm-15	123	25	,	,	PUNCT
bptjm-15	123	26	2016	2016	NUM
bptjm-15	123	27	)	)	PUNCT
bptjm-15	123	28	.	.	PUNCT
bptjm-15	124	1	ultimately	ultimately	ADV
bptjm-15	124	2	,	,	PUNCT
bptjm-15	124	3	glucocorticoids	glucocorticoid	NOUN
bptjm-15	124	4	are	be	AUX
bptjm-15	124	5	used	use	VERB
bptjm-15	124	6	to	to	PART
bptjm-15	124	7	shorten	shorten	VERB
bptjm-15	124	8	the	the	DET
bptjm-15	124	9	duration	duration	NOUN
bptjm-15	124	10	of	of	ADP
bptjm-15	124	11	a	a	DET
bptjm-15	124	12	relapse	relapse	NOUN
bptjm-15	124	13	or	or	CCONJ
bptjm-15	124	14	acute	acute	ADJ
bptjm-15	124	15	attack	attack	NOUN
bptjm-15	124	16	.	.	PUNCT
bptjm-15	125	1	it	it	PRON
bptjm-15	125	2	has	have	AUX
bptjm-15	125	3	become	become	VERB
bptjm-15	125	4	increasingly	increasingly	ADV
bptjm-15	125	5	important	important	ADJ
bptjm-15	125	6	to	to	PART
bptjm-15	125	7	focus	focus	VERB
bptjm-15	125	8	on	on	ADP
bptjm-15	125	9	slowing	slow	VERB
bptjm-15	125	10	disease	disease	NOUN
bptjm-15	125	11	progression	progression	NOUN
bptjm-15	125	12	in	in	ADP
bptjm-15	125	13	order	order	NOUN
bptjm-15	125	14	to	to	PART
bptjm-15	125	15	improve	improve	VERB
bptjm-15	125	16	the	the	DET
bptjm-15	125	17	quality	quality	NOUN
bptjm-15	125	18	of	of	ADP
bptjm-15	125	19	life	life	NOUN
bptjm-15	125	20	of	of	ADP
bptjm-15	125	21	ms	ms	NOUN
bptjm-15	125	22	patients	patient	NOUN
bptjm-15	125	23	.	.	PUNCT
bptjm-15	126	1	disease	disease	NOUN
bptjm-15	126	2	-	-	PUNCT
bptjm-15	126	3	modifying	modify	VERB
bptjm-15	126	4	treatments	treatment	NOUN
bptjm-15	126	5	(	(	PUNCT
bptjm-15	126	6	dmts	dmts	PROPN
bptjm-15	126	7	)	)	PUNCT
bptjm-15	126	8	have	have	AUX
bptjm-15	126	9	become	become	VERB
bptjm-15	126	10	a	a	DET
bptjm-15	126	11	key	key	ADJ
bptjm-15	126	12	component	component	NOUN
bptjm-15	126	13	of	of	ADP
bptjm-15	126	14	comprehensive	comprehensive	ADJ
bptjm-15	126	15	ms	ms	NOUN
bptjm-15	126	16	care	care	NOUN
bptjm-15	126	17	for	for	ADP
bptjm-15	126	18	this	this	DET
bptjm-15	126	19	reason	reason	NOUN
bptjm-15	126	20	(	(	PUNCT
bptjm-15	126	21	hart	hart	PROPN
bptjm-15	126	22	,	,	PUNCT
bptjm-15	126	23	2016	2016	NUM
bptjm-15	126	24	)	)	PUNCT
bptjm-15	126	25	.	.	PUNCT
bptjm-15	127	1	rrms	rrm	NOUN
bptjm-15	127	2	is	be	AUX
bptjm-15	127	3	the	the	DET
bptjm-15	127	4	most	most	ADJ
bptjm-15	127	5	berkeley	berkeley	PROPN
bptjm-15	127	6	pharma	pharma	PROPN
bptjm-15	127	7	tech	tech	NOUN
bptjm-15	127	8	journal	journal	NOUN
bptjm-15	127	9	of	of	ADP
bptjm-15	127	10	medicine	medicine	NOUN
bptjm-15	127	11	|	|	ADV
bptjm-15	127	12	72	72	NUM
bptjm-15	127	13	treatable	treatable	ADJ
bptjm-15	127	14	subtype	subtype	NOUN
bptjm-15	127	15	of	of	ADP
bptjm-15	127	16	ms	ms	PROPN
bptjm-15	127	17	.	.	PROPN
bptjm-15	127	18	drugs	drug	NOUN
bptjm-15	127	19	such	such	ADJ
bptjm-15	127	20	as	as	ADP
bptjm-15	127	21	beta	beta	NOUN
bptjm-15	127	22	-	-	PUNCT
bptjm-15	127	23	interferons	interferon	NOUN
bptjm-15	127	24	,	,	PUNCT
bptjm-15	127	25	glatiramer	glatiramer	ADJ
bptjm-15	127	26	acetate	acetate	NOUN
bptjm-15	127	27	,	,	PUNCT
bptjm-15	127	28	teri	teri	PROPN
bptjm-15	127	29	�	�	PROPN
bptjm-15	127	30	unomide	unomide	NOUN
bptjm-15	127	31	,	,	PUNCT
bptjm-15	127	32	dimethyl	dimethyl	NOUN
bptjm-15	127	33	fumarate	fumarate	NOUN
bptjm-15	127	34	,	,	PUNCT
bptjm-15	127	35	and	and	CCONJ
bptjm-15	127	36	�	�	PROPN
bptjm-15	127	37	ngolimod	ngolimod	NOUN
bptjm-15	127	38	have	have	VERB
bptjm-15	127	39	moderate	moderate	ADJ
bptjm-15	127	40	e	e	NOUN
bptjm-15	127	41	�	�	NOUN
bptjm-15	127	42	cacy	cacy	NOUN
bptjm-15	127	43	but	but	CCONJ
bptjm-15	127	44	are	be	AUX
bptjm-15	127	45	a	a	DET
bptjm-15	127	46	safer	safe	ADJ
bptjm-15	127	47	option	option	NOUN
bptjm-15	127	48	in	in	ADP
bptjm-15	127	49	patients	patient	NOUN
bptjm-15	127	50	with	with	ADP
bptjm-15	127	51	rrms	rrm	NOUN
bptjm-15	127	52	.	.	PUNCT
bptjm-15	128	1	the	the	DET
bptjm-15	128	2	human	human	ADJ
bptjm-15	128	3	body	body	NOUN
bptjm-15	128	4	already	already	ADV
bptjm-15	128	5	produces	produce	VERB
bptjm-15	128	6	beta	beta	NOUN
bptjm-15	128	7	-	-	PUNCT
bptjm-15	128	8	interferons	interferon	NOUN
bptjm-15	128	9	as	as	ADP
bptjm-15	128	10	a	a	DET
bptjm-15	128	11	natural	natural	ADJ
bptjm-15	128	12	response	response	NOUN
bptjm-15	128	13	to	to	ADP
bptjm-15	128	14	in	in	ADP
bptjm-15	128	15	�	�	PROPN
bptjm-15	128	16	ammation	ammation	NOUN
bptjm-15	128	17	.	.	PUNCT
bptjm-15	129	1	the	the	DET
bptjm-15	129	2	man	man	NOUN
bptjm-15	129	3	-	-	PUNCT
bptjm-15	129	4	made	make	VERB
bptjm-15	129	5	drug	drug	NOUN
bptjm-15	129	6	further	further	ADJ
bptjm-15	129	7	aids	aid	NOUN
bptjm-15	129	8	in	in	ADP
bptjm-15	129	9	the	the	DET
bptjm-15	129	10	downregulation	downregulation	NOUN
bptjm-15	129	11	of	of	ADP
bptjm-15	129	12	in	in	ADP
bptjm-15	129	13	�	�	PROPN
bptjm-15	129	14	ammation	ammation	NOUN
bptjm-15	129	15	and	and	CCONJ
bptjm-15	129	16	decreases	decrease	VERB
bptjm-15	129	17	the	the	DET
bptjm-15	129	18	damage	damage	NOUN
bptjm-15	129	19	to	to	ADP
bptjm-15	129	20	the	the	DET
bptjm-15	129	21	nerves	nerve	NOUN
bptjm-15	129	22	in	in	ADP
bptjm-15	129	23	the	the	DET
bptjm-15	129	24	body	body	NOUN
bptjm-15	129	25	.	.	PUNCT
bptjm-15	130	1	however	however	ADV
bptjm-15	130	2	,	,	PUNCT
bptjm-15	130	3	since	since	SCONJ
bptjm-15	130	4	other	other	ADJ
bptjm-15	130	5	dmts	dmts	NOUN
bptjm-15	130	6	can	can	AUX
bptjm-15	130	7	have	have	VERB
bptjm-15	130	8	life	life	NOUN
bptjm-15	130	9	-	-	PUNCT
bptjm-15	130	10	threatening	threaten	VERB
bptjm-15	130	11	adverse	adverse	ADJ
bptjm-15	130	12	e	e	NOUN
bptjm-15	130	13	�	�	NOUN
bptjm-15	130	14	ects	ect	NOUN
bptjm-15	130	15	,	,	PUNCT
bptjm-15	130	16	it	it	PRON
bptjm-15	130	17	is	be	AUX
bptjm-15	130	18	necessary	necessary	ADJ
bptjm-15	130	19	to	to	PART
bptjm-15	130	20	monitor	monitor	VERB
bptjm-15	130	21	clinical	clinical	ADJ
bptjm-15	130	22	conditions	condition	NOUN
bptjm-15	130	23	and	and	CCONJ
bptjm-15	130	24	conduct	conduct	VERB
bptjm-15	130	25	frequent	frequent	ADJ
bptjm-15	130	26	mri	mri	NOUN
bptjm-15	130	27	scans	scan	NOUN
bptjm-15	130	28	.	.	PUNCT
bptjm-15	131	1	alemtuzumab	alemtuzumab	NOUN
bptjm-15	131	2	and	and	CCONJ
bptjm-15	131	3	natalizumab	natalizumab	NOUN
bptjm-15	131	4	,	,	PUNCT
bptjm-15	131	5	targeted	target	VERB
bptjm-15	131	6	cancer	cancer	NOUN
bptjm-15	131	7	drugs	drug	NOUN
bptjm-15	131	8	,	,	PUNCT
bptjm-15	131	9	have	have	VERB
bptjm-15	131	10	a	a	DET
bptjm-15	131	11	higher	high	ADJ
bptjm-15	131	12	e	e	NOUN
bptjm-15	131	13	�	�	NOUN
bptjm-15	131	14	cacy	cacy	NOUN
bptjm-15	131	15	but	but	CCONJ
bptjm-15	131	16	present	present	VERB
bptjm-15	131	17	serious	serious	ADJ
bptjm-15	131	18	side	side	NOUN
bptjm-15	131	19	e	e	NOUN
bptjm-15	131	20	�	�	NOUN
bptjm-15	131	21	ects	ect	VERB
bptjm-15	131	22	such	such	ADJ
bptjm-15	131	23	as	as	ADP
bptjm-15	131	24	progressive	progressive	ADJ
bptjm-15	131	25	multifocal	multifocal	ADJ
bptjm-15	131	26	leukoencephalopathy	leukoencephalopathy	NOUN
bptjm-15	131	27	(	(	PUNCT
bptjm-15	131	28	pml	pml	PROPN
bptjm-15	131	29	)	)	PUNCT
bptjm-15	131	30	.	.	PUNCT
bptjm-15	132	1	pml	pml	PROPN
bptjm-15	132	2	,	,	PUNCT
bptjm-15	132	3	an	an	DET
bptjm-15	132	4	illness	illness	NOUN
bptjm-15	132	5	that	that	PRON
bptjm-15	132	6	leads	lead	VERB
bptjm-15	132	7	to	to	ADP
bptjm-15	132	8	brain	brain	NOUN
bptjm-15	132	9	damage	damage	NOUN
bptjm-15	132	10	,	,	PUNCT
bptjm-15	132	11	severe	severe	ADJ
bptjm-15	132	12	disabilities	disability	NOUN
bptjm-15	132	13	,	,	PUNCT
bptjm-15	132	14	and	and	CCONJ
bptjm-15	132	15	death	death	NOUN
bptjm-15	132	16	,	,	PUNCT
bptjm-15	132	17	can	can	AUX
bptjm-15	132	18	develop	develop	VERB
bptjm-15	132	19	in	in	ADP
bptjm-15	132	20	patients	patient	NOUN
bptjm-15	132	21	that	that	PRON
bptjm-15	132	22	are	be	AUX
bptjm-15	132	23	on	on	ADP
bptjm-15	132	24	natalizumab	natalizumab	NOUN
bptjm-15	132	25	treatment	treatment	NOUN
bptjm-15	132	26	for	for	ADP
bptjm-15	132	27	more	more	ADJ
bptjm-15	132	28	than	than	ADP
bptjm-15	132	29	two	two	NUM
bptjm-15	132	30	years	year	NOUN
bptjm-15	132	31	with	with	ADP
bptjm-15	132	32	a	a	DET
bptjm-15	132	33	prior	prior	ADJ
bptjm-15	132	34	history	history	NOUN
bptjm-15	132	35	of	of	ADP
bptjm-15	132	36	chemotherapy	chemotherapy	NOUN
bptjm-15	132	37	or	or	CCONJ
bptjm-15	132	38	immunosuppression	immunosuppression	NOUN
bptjm-15	132	39	(	(	PUNCT
bptjm-15	132	40	doshi	doshi	PROPN
bptjm-15	132	41	,	,	PUNCT
bptjm-15	132	42	2016	2016	NUM
bptjm-15	132	43	)	)	PUNCT
bptjm-15	132	44	(	(	PUNCT
bptjm-15	132	45	figure	figure	NOUN
bptjm-15	132	46	3	3	NUM
bptjm-15	132	47	)	)	PUNCT
bptjm-15	132	48	.	.	PUNCT
bptjm-15	133	1	it	it	PRON
bptjm-15	133	2	is	be	AUX
bptjm-15	133	3	recommended	recommend	VERB
bptjm-15	133	4	that	that	SCONJ
bptjm-15	133	5	dmts	dmts	NOUN
bptjm-15	133	6	are	be	AUX
bptjm-15	133	7	started	start	VERB
bptjm-15	133	8	as	as	ADV
bptjm-15	133	9	soon	soon	ADV
bptjm-15	133	10	as	as	ADP
bptjm-15	133	11	possible	possible	ADJ
bptjm-15	133	12	to	to	PART
bptjm-15	133	13	increase	increase	VERB
bptjm-15	133	14	the	the	DET
bptjm-15	133	15	likelihood	likelihood	NOUN
bptjm-15	133	16	of	of	ADP
bptjm-15	133	17	slowing	slow	VERB
bptjm-15	133	18	the	the	DET
bptjm-15	133	19	progression	progression	NOUN
bptjm-15	133	20	of	of	ADP
bptjm-15	133	21	the	the	DET
bptjm-15	133	22	disease	disease	NOUN
bptjm-15	133	23	before	before	ADP
bptjm-15	133	24	severe	severe	ADJ
bptjm-15	133	25	neurological	neurological	ADJ
bptjm-15	133	26	de	de	PROPN
bptjm-15	133	27	�	�	PROPN
bptjm-15	133	28	cits	cit	NOUN
bptjm-15	133	29	can	can	AUX
bptjm-15	133	30	arise	arise	VERB
bptjm-15	133	31	.	.	PUNCT
bptjm-15	134	1	unfortunately	unfortunately	ADV
bptjm-15	134	2	,	,	PUNCT
bptjm-15	134	3	there	there	PRON
bptjm-15	134	4	is	be	VERB
bptjm-15	134	5	not	not	PART
bptjm-15	134	6	enough	enough	ADJ
bptjm-15	134	7	current	current	ADJ
bptjm-15	134	8	research	research	NOUN
bptjm-15	134	9	indicating	indicate	VERB
bptjm-15	134	10	that	that	SCONJ
bptjm-15	134	11	dmts	dmts	NOUN
bptjm-15	134	12	can	can	AUX
bptjm-15	134	13	aid	aid	VERB
bptjm-15	134	14	in	in	ADP
bptjm-15	134	15	slowing	slow	VERB
bptjm-15	134	16	progressive	progressive	ADJ
bptjm-15	134	17	ms	ms	NOUN
bptjm-15	134	18	and	and	CCONJ
bptjm-15	134	19	there	there	PRON
bptjm-15	134	20	is	be	VERB
bptjm-15	134	21	still	still	ADV
bptjm-15	134	22	a	a	DET
bptjm-15	134	23	lack	lack	NOUN
bptjm-15	134	24	of	of	ADP
bptjm-15	134	25	cohesive	cohesive	ADJ
bptjm-15	134	26	understanding	understanding	NOUN
bptjm-15	134	27	about	about	ADP
bptjm-15	134	28	dmts	dmts	NOUN
bptjm-15	134	29	in	in	ADP
bptjm-15	134	30	the	the	DET
bptjm-15	134	31	research	research	NOUN
bptjm-15	134	32	community	community	NOUN
bptjm-15	134	33	.	.	PUNCT
bptjm-15	135	1	more	more	ADJ
bptjm-15	135	2	studies	study	NOUN
bptjm-15	135	3	are	be	AUX
bptjm-15	135	4	necessary	necessary	ADJ
bptjm-15	135	5	in	in	ADP
bptjm-15	135	6	order	order	NOUN
bptjm-15	135	7	to	to	PART
bptjm-15	135	8	understand	understand	VERB
bptjm-15	135	9	the	the	DET
bptjm-15	135	10	e	e	PROPN
bptjm-15	135	11	�	�	NOUN
bptjm-15	135	12	cacy	cacy	NOUN
bptjm-15	135	13	and	and	CCONJ
bptjm-15	135	14	safety	safety	NOUN
bptjm-15	135	15	of	of	ADP
bptjm-15	135	16	drugs	drug	NOUN
bptjm-15	135	17	while	while	SCONJ
bptjm-15	135	18	simultaneously	simultaneously	ADV
bptjm-15	135	19	slowing	slow	VERB
bptjm-15	135	20	the	the	DET
bptjm-15	135	21	progression	progression	NOUN
bptjm-15	135	22	of	of	ADP
bptjm-15	135	23	the	the	DET
bptjm-15	135	24	disease	disease	NOUN
bptjm-15	135	25	.	.	PUNCT
bptjm-15	136	1	berkeley	berkeley	PROPN
bptjm-15	136	2	pharma	pharma	PROPN
bptjm-15	136	3	tech	tech	PROPN
bptjm-15	136	4	journal	journal	NOUN
bptjm-15	136	5	of	of	ADP
bptjm-15	136	6	medicine	medicine	NOUN
bptjm-15	136	7	|	|	ADV
bptjm-15	136	8	73	73	NUM
bptjm-15	136	9	figure	figure	NOUN
bptjm-15	136	10	3	3	NUM
bptjm-15	136	11	.	.	PUNCT
bptjm-15	137	1	the	the	DET
bptjm-15	137	2	mechanism	mechanism	NOUN
bptjm-15	137	3	of	of	ADP
bptjm-15	137	4	action	action	NOUN
bptjm-15	137	5	of	of	ADP
bptjm-15	137	6	the	the	DET
bptjm-15	137	7	dmt	dmt	NOUN
bptjm-15	137	8	ifnβ	ifnβ	PROPN
bptjm-15	137	9	.	.	PUNCT
bptjm-15	138	1	this	this	DET
bptjm-15	138	2	drug	drug	NOUN
bptjm-15	138	3	targets	target	NOUN
bptjm-15	138	4	immune	immune	ADJ
bptjm-15	138	5	cells	cell	NOUN
bptjm-15	138	6	.	.	PUNCT
bptjm-15	139	1	it	it	PRON
bptjm-15	139	2	decreases	decrease	VERB
bptjm-15	139	3	t	t	NOUN
bptjm-15	139	4	cell	cell	NOUN
bptjm-15	139	5	activation	activation	NOUN
bptjm-15	139	6	,	,	PUNCT
bptjm-15	139	7	b	b	NOUN
bptjm-15	139	8	cell	cell	NOUN
bptjm-15	139	9	proliferation	proliferation	NOUN
bptjm-15	139	10	and	and	CCONJ
bptjm-15	139	11	promotes	promote	VERB
bptjm-15	139	12	antiinflammatory	antiinflammatory	NOUN
bptjm-15	139	13	cytokine	cytokine	NOUN
bptjm-15	139	14	production	production	NOUN
bptjm-15	139	15	.	.	PUNCT
bptjm-15	140	1	symptomatic	symptomatic	ADJ
bptjm-15	140	2	treatment	treatment	NOUN
bptjm-15	140	3	of	of	ADP
bptjm-15	140	4	ms	ms	NOUN
bptjm-15	140	5	is	be	AUX
bptjm-15	140	6	just	just	ADV
bptjm-15	140	7	as	as	ADV
bptjm-15	140	8	important	important	ADJ
bptjm-15	140	9	as	as	ADP
bptjm-15	140	10	slowing	slow	VERB
bptjm-15	140	11	the	the	DET
bptjm-15	140	12	progression	progression	NOUN
bptjm-15	140	13	of	of	ADP
bptjm-15	140	14	the	the	DET
bptjm-15	140	15	disease	disease	NOUN
bptjm-15	140	16	or	or	CCONJ
bptjm-15	140	17	treating	treat	VERB
bptjm-15	140	18	an	an	DET
bptjm-15	140	19	exacerbation	exacerbation	NOUN
bptjm-15	140	20	.	.	PUNCT
bptjm-15	141	1	patients	patient	NOUN
bptjm-15	141	2	often	often	ADV
bptjm-15	141	3	complain	complain	VERB
bptjm-15	141	4	of	of	ADP
bptjm-15	141	5	fatigue	fatigue	NOUN
bptjm-15	141	6	,	,	PUNCT
bptjm-15	141	7	depressive	depressive	ADJ
bptjm-15	141	8	symptoms	symptom	NOUN
bptjm-15	141	9	,	,	PUNCT
bptjm-15	141	10	urinary	urinary	ADJ
bptjm-15	141	11	frequency	frequency	NOUN
bptjm-15	141	12	,	,	PUNCT
bptjm-15	141	13	sexual	sexual	ADJ
bptjm-15	141	14	dysfunction	dysfunction	NOUN
bptjm-15	141	15	,	,	PUNCT
bptjm-15	141	16	constipation	constipation	NOUN
bptjm-15	141	17	,	,	PUNCT
bptjm-15	141	18	pain	pain	NOUN
bptjm-15	141	19	,	,	PUNCT
bptjm-15	141	20	ataxia	ataxia	NOUN
bptjm-15	141	21	,	,	PUNCT
bptjm-15	141	22	and	and	CCONJ
bptjm-15	141	23	more	more	ADJ
bptjm-15	141	24	(	(	PUNCT
bptjm-15	141	25	doshi	doshi	PROPN
bptjm-15	141	26	,	,	PUNCT
bptjm-15	141	27	2016	2016	NUM
bptjm-15	141	28	)	)	PUNCT
bptjm-15	141	29	.	.	PUNCT
bptjm-15	142	1	not	not	PART
bptjm-15	142	2	all	all	DET
bptjm-15	142	3	symptoms	symptom	NOUN
bptjm-15	142	4	necessarily	necessarily	ADV
bptjm-15	142	5	require	require	VERB
bptjm-15	142	6	medication	medication	NOUN
bptjm-15	142	7	.	.	PUNCT
bptjm-15	143	1	however	however	ADV
bptjm-15	143	2	,	,	PUNCT
bptjm-15	143	3	it	it	PRON
bptjm-15	143	4	is	be	AUX
bptjm-15	143	5	important	important	ADJ
bptjm-15	143	6	that	that	SCONJ
bptjm-15	143	7	physicians	physician	NOUN
bptjm-15	143	8	recognize	recognize	VERB
bptjm-15	143	9	the	the	DET
bptjm-15	143	10	heterogeneity	heterogeneity	NOUN
bptjm-15	143	11	of	of	ADP
bptjm-15	143	12	this	this	DET
bptjm-15	143	13	disease	disease	NOUN
bptjm-15	143	14	when	when	SCONJ
bptjm-15	143	15	creating	create	VERB
bptjm-15	143	16	a	a	DET
bptjm-15	143	17	treatment	treatment	NOUN
bptjm-15	143	18	plan	plan	NOUN
bptjm-15	143	19	for	for	ADP
bptjm-15	143	20	their	their	PRON
bptjm-15	143	21	patients	patient	NOUN
bptjm-15	143	22	.	.	PUNCT
bptjm-15	144	1	ms	ms	PROPN
bptjm-15	144	2	can	can	AUX
bptjm-15	144	3	largely	largely	ADV
bptjm-15	144	4	impact	impact	VERB
bptjm-15	144	5	one	one	NUM
bptjm-15	144	6	’s	’s	PART
bptjm-15	144	7	functionality	functionality	NOUN
bptjm-15	144	8	,	,	PUNCT
bptjm-15	144	9	and	and	CCONJ
bptjm-15	144	10	patients	patient	NOUN
bptjm-15	144	11	typically	typically	ADV
bptjm-15	144	12	struggle	struggle	VERB
bptjm-15	144	13	with	with	ADP
bptjm-15	144	14	adapting	adapt	VERB
bptjm-15	144	15	to	to	ADP
bptjm-15	144	16	the	the	DET
bptjm-15	144	17	changes	change	NOUN
bptjm-15	144	18	in	in	ADP
bptjm-15	144	19	their	their	PRON
bptjm-15	144	20	daily	daily	ADJ
bptjm-15	144	21	life	life	NOUN
bptjm-15	144	22	.	.	PUNCT
bptjm-15	145	1	thus	thus	ADV
bptjm-15	145	2	,	,	PUNCT
bptjm-15	145	3	patients	patient	NOUN
bptjm-15	145	4	are	be	AUX
bptjm-15	145	5	often	often	ADV
bptjm-15	145	6	recommended	recommend	VERB
bptjm-15	145	7	to	to	PART
bptjm-15	145	8	start	start	VERB
bptjm-15	145	9	cognitive	cognitive	ADJ
bptjm-15	145	10	therapy	therapy	NOUN
bptjm-15	145	11	alongside	alongside	ADP
bptjm-15	145	12	their	their	PRON
bptjm-15	145	13	medication	medication	NOUN
bptjm-15	145	14	.	.	PUNCT
bptjm-15	146	1	pain	pain	NOUN
bptjm-15	146	2	and	and	CCONJ
bptjm-15	146	3	depression	depression	NOUN
bptjm-15	146	4	are	be	AUX
bptjm-15	146	5	symptoms	symptom	NOUN
bptjm-15	146	6	that	that	PRON
bptjm-15	146	7	have	have	AUX
bptjm-15	146	8	long	long	ADV
bptjm-15	146	9	been	be	AUX
bptjm-15	146	10	overlooked	overlook	VERB
bptjm-15	146	11	in	in	ADP
bptjm-15	146	12	individuals	individual	NOUN
bptjm-15	146	13	with	with	ADP
bptjm-15	146	14	ms	ms	PROPN
bptjm-15	146	15	.	.	PROPN
bptjm-15	146	16	one	one	NUM
bptjm-15	146	17	study	study	NOUN
bptjm-15	146	18	showed	show	VERB
bptjm-15	146	19	that	that	SCONJ
bptjm-15	146	20	more	more	ADJ
bptjm-15	146	21	than	than	ADP
bptjm-15	146	22	88	88	NUM
bptjm-15	146	23	%	%	NOUN
bptjm-15	146	24	of	of	ADP
bptjm-15	146	25	people	people	NOUN
bptjm-15	146	26	with	with	ADP
bptjm-15	146	27	ms	ms	PROPN
bptjm-15	146	28	experience	experience	NOUN
bptjm-15	146	29	pain	pain	NOUN
bptjm-15	146	30	in	in	ADP
bptjm-15	146	31	more	more	ADJ
bptjm-15	146	32	than	than	ADP
bptjm-15	146	33	one	one	NUM
bptjm-15	146	34	bodily	bodily	ADJ
bptjm-15	146	35	area	area	NOUN
bptjm-15	146	36	(	(	PUNCT
bptjm-15	146	37	gromisch	gromisch	PROPN
bptjm-15	146	38	,	,	PUNCT
bptjm-15	146	39	2020	2020	NUM
bptjm-15	146	40	)	)	PUNCT
bptjm-15	146	41	.	.	PUNCT
bptjm-15	147	1	another	another	DET
bptjm-15	147	2	study	study	NOUN
bptjm-15	147	3	reported	report	VERB
bptjm-15	147	4	that	that	SCONJ
bptjm-15	147	5	22.8	22.8	NUM
bptjm-15	147	6	%	%	NOUN
bptjm-15	147	7	of	of	ADP
bptjm-15	147	8	patients	patient	NOUN
bptjm-15	147	9	with	with	ADP
bptjm-15	147	10	ms	ms	ADJ
bptjm-15	147	11	struggle	struggle	NOUN
bptjm-15	147	12	with	with	ADP
bptjm-15	147	13	lifetime	lifetime	NOUN
bptjm-15	147	14	major	major	ADJ
bptjm-15	147	15	depression	depression	NOUN
bptjm-15	147	16	(	(	PUNCT
bptjm-15	147	17	wang	wang	PROPN
bptjm-15	147	18	,	,	PUNCT
bptjm-15	147	19	2000	2000	NUM
bptjm-15	147	20	)	)	PUNCT
bptjm-15	147	21	.	.	PUNCT
bptjm-15	148	1	studies	study	NOUN
bptjm-15	148	2	have	have	AUX
bptjm-15	148	3	shown	show	VERB
bptjm-15	148	4	that	that	SCONJ
bptjm-15	148	5	using	use	VERB
bptjm-15	148	6	cognitive	cognitive	ADJ
bptjm-15	148	7	behavioral	behavioral	ADJ
bptjm-15	148	8	therapy	therapy	NOUN
bptjm-15	148	9	as	as	ADP
bptjm-15	148	10	an	an	DET
bptjm-15	148	11	adjunct	adjunct	ADJ
bptjm-15	148	12	treatment	treatment	NOUN
bptjm-15	148	13	for	for	ADP
bptjm-15	148	14	ms	ms	NOUN
bptjm-15	148	15	can	can	AUX
bptjm-15	148	16	improve	improve	VERB
bptjm-15	148	17	mental	mental	ADJ
bptjm-15	148	18	health	health	NOUN
bptjm-15	148	19	and	and	CCONJ
bptjm-15	148	20	quality	quality	NOUN
bptjm-15	148	21	of	of	ADP
bptjm-15	148	22	life	life	NOUN
bptjm-15	148	23	in	in	ADP
bptjm-15	148	24	patients	patient	NOUN
bptjm-15	148	25	(	(	PUNCT
bptjm-15	148	26	gromisch	gromisch	PROPN
bptjm-15	148	27	,	,	PUNCT
bptjm-15	148	28	2020	2020	NUM
bptjm-15	148	29	)	)	PUNCT
bptjm-15	148	30	.	.	PUNCT
bptjm-15	149	1	neurostimulation	neurostimulation	NOUN
bptjm-15	149	2	technologies	technology	NOUN
bptjm-15	149	3	are	be	AUX
bptjm-15	149	4	recent	recent	ADJ
bptjm-15	149	5	medical	medical	ADJ
bptjm-15	149	6	advancements	advancement	NOUN
bptjm-15	149	7	that	that	PRON
bptjm-15	149	8	are	be	AUX
bptjm-15	149	9	rapidly	rapidly	ADV
bptjm-15	149	10	being	be	AUX
bptjm-15	149	11	researched	research	VERB
bptjm-15	149	12	as	as	ADP
bptjm-15	149	13	potential	potential	ADJ
bptjm-15	149	14	symptomatic	symptomatic	ADJ
bptjm-15	149	15	treatment	treatment	NOUN
bptjm-15	149	16	options	option	NOUN
bptjm-15	149	17	for	for	ADP
bptjm-15	149	18	neurologic	neurologic	ADJ
bptjm-15	149	19	and	and	CCONJ
bptjm-15	149	20	psychiatric	psychiatric	ADJ
bptjm-15	149	21	disorders	disorder	NOUN
bptjm-15	149	22	.	.	PUNCT
bptjm-15	150	1	an	an	DET
bptjm-15	150	2	increased	increase	VERB
bptjm-15	150	3	understanding	understanding	NOUN
bptjm-15	150	4	of	of	ADP
bptjm-15	150	5	neural	neural	ADJ
bptjm-15	150	6	circuitry	circuitry	NOUN
bptjm-15	150	7	and	and	CCONJ
bptjm-15	150	8	neurotechnologies	neurotechnologie	NOUN
bptjm-15	150	9	has	have	AUX
bptjm-15	150	10	shown	show	VERB
bptjm-15	150	11	promising	promise	VERB
bptjm-15	150	12	therapeutic	therapeutic	ADJ
bptjm-15	150	13	results	result	NOUN
bptjm-15	150	14	in	in	ADP
bptjm-15	150	15	patients	patient	NOUN
bptjm-15	150	16	with	with	ADP
bptjm-15	150	17	neuropsychiatric	neuropsychiatric	ADJ
bptjm-15	150	18	conditions	condition	NOUN
bptjm-15	150	19	.	.	PUNCT
bptjm-15	151	1	these	these	DET
bptjm-15	151	2	therapies	therapy	NOUN
bptjm-15	151	3	include	include	VERB
bptjm-15	151	4	invasive	invasive	ADJ
bptjm-15	151	5	and	and	CCONJ
bptjm-15	151	6	noninvasive	noninvasive	ADJ
bptjm-15	151	7	approaches	approach	NOUN
bptjm-15	151	8	that	that	PRON
bptjm-15	151	9	target	target	VERB
bptjm-15	151	10	a	a	DET
bptjm-15	151	11	speci	speci	ADJ
bptjm-15	151	12	�	�	PROPN
bptjm-15	151	13	c	c	NOUN
bptjm-15	151	14	nerve	nerve	NOUN
bptjm-15	151	15	or	or	CCONJ
bptjm-15	151	16	anatomical	anatomical	ADJ
bptjm-15	151	17	region	region	NOUN
bptjm-15	151	18	in	in	ADP
bptjm-15	151	19	the	the	DET
bptjm-15	151	20	body	body	NOUN
bptjm-15	151	21	.	.	PUNCT
bptjm-15	152	1	some	some	DET
bptjm-15	152	2	examples	example	NOUN
bptjm-15	152	3	include	include	VERB
bptjm-15	152	4	brain	brain	NOUN
bptjm-15	152	5	temperature	temperature	NOUN
bptjm-15	152	6	control	control	NOUN
bptjm-15	152	7	,	,	PUNCT
bptjm-15	152	8	magnetic	magnetic	ADJ
bptjm-15	152	9	stimulation	stimulation	NOUN
bptjm-15	152	10	,	,	PUNCT
bptjm-15	152	11	deep	deep	ADJ
bptjm-15	152	12	brain	brain	NOUN
bptjm-15	152	13	stimulation	stimulation	NOUN
bptjm-15	152	14	,	,	PUNCT
bptjm-15	152	15	spinal	spinal	ADJ
bptjm-15	152	16	cord	cord	NOUN
bptjm-15	152	17	stimulation	stimulation	NOUN
bptjm-15	152	18	,	,	PUNCT
bptjm-15	152	19	and	and	CCONJ
bptjm-15	152	20	vagus	vagus	NOUN
bptjm-15	152	21	nerve	nerve	NOUN
bptjm-15	152	22	stimulation	stimulation	NOUN
bptjm-15	152	23	(	(	PUNCT
bptjm-15	152	24	edwards	edwards	PROPN
bptjm-15	152	25	,	,	PUNCT
bptjm-15	152	26	2017	2017	NUM
bptjm-15	152	27	)	)	PUNCT
bptjm-15	152	28	.	.	PUNCT
bptjm-15	153	1	research	research	NOUN
bptjm-15	153	2	has	have	AUX
bptjm-15	153	3	shown	show	VERB
bptjm-15	153	4	that	that	SCONJ
bptjm-15	153	5	gut	gut	NOUN
bptjm-15	153	6	bacteria	bacteria	NOUN
bptjm-15	153	7	communicate	communicate	VERB
bptjm-15	153	8	with	with	ADP
bptjm-15	153	9	neurons	neuron	NOUN
bptjm-15	153	10	of	of	ADP
bptjm-15	153	11	the	the	DET
bptjm-15	153	12	enteric	enteric	ADJ
bptjm-15	153	13	nervous	nervous	ADJ
bptjm-15	153	14	system	system	NOUN
bptjm-15	153	15	to	to	PART
bptjm-15	153	16	send	send	VERB
bptjm-15	153	17	signals	signal	NOUN
bptjm-15	153	18	to	to	ADP
bptjm-15	153	19	the	the	DET
bptjm-15	153	20	brain	brain	NOUN
bptjm-15	153	21	via	via	ADP
bptjm-15	153	22	the	the	DET
bptjm-15	153	23	vagus	vagus	NOUN
bptjm-15	153	24	nerve	nerve	NOUN
bptjm-15	153	25	(	(	PUNCT
bptjm-15	153	26	galland	galland	ADJ
bptjm-15	153	27	,	,	PUNCT
bptjm-15	153	28	2014	2014	NUM
bptjm-15	153	29	)	)	PUNCT
bptjm-15	153	30	.	.	PUNCT
bptjm-15	154	1	currently	currently	ADV
bptjm-15	154	2	,	,	PUNCT
bptjm-15	154	3	an	an	DET
bptjm-15	154	4	fda	fda	PROPN
bptjm-15	154	5	-	-	PUNCT
bptjm-15	154	6	approved	approve	VERB
bptjm-15	154	7	implantable	implantable	ADJ
bptjm-15	154	8	vagus	vagus	NOUN
bptjm-15	154	9	nerve	nerve	NOUN
bptjm-15	154	10	stimulator	stimulator	NOUN
bptjm-15	154	11	called	call	VERB
bptjm-15	154	12	livanova	livanova	PROPN
bptjm-15	154	13	can	can	AUX
bptjm-15	154	14	treat	treat	VERB
bptjm-15	154	15	drug	drug	NOUN
bptjm-15	154	16	-	-	PUNCT
bptjm-15	154	17	resistant	resistant	ADJ
bptjm-15	154	18	epilepsy	epilepsy	NOUN
bptjm-15	154	19	.	.	PUNCT
bptjm-15	155	1	in	in	ADP
bptjm-15	155	2	addition	addition	NOUN
bptjm-15	155	3	,	,	PUNCT
bptjm-15	155	4	vagus	vagus	ADJ
bptjm-15	155	5	nerve	nerve	NOUN
bptjm-15	155	6	stimulation	stimulation	NOUN
bptjm-15	155	7	has	have	AUX
bptjm-15	155	8	been	be	AUX
bptjm-15	155	9	used	use	VERB
bptjm-15	155	10	to	to	PART
bptjm-15	155	11	treat	treat	VERB
bptjm-15	155	12	drug	drug	NOUN
bptjm-15	155	13	-	-	PUNCT
bptjm-15	155	14	resistant	resistant	ADJ
bptjm-15	155	15	depression	depression	NOUN
bptjm-15	155	16	(	(	PUNCT
bptjm-15	155	17	edwards	edwards	PROPN
bptjm-15	155	18	,	,	PUNCT
bptjm-15	155	19	2017	2017	NUM
bptjm-15	155	20	)	)	PUNCT
bptjm-15	155	21	.	.	PUNCT
bptjm-15	156	1	researchers	researcher	NOUN
bptjm-15	156	2	at	at	ADP
bptjm-15	156	3	the	the	DET
bptjm-15	156	4	texas	texas	PROPN
bptjm-15	156	5	biomedical	biomedical	ADJ
bptjm-15	156	6	device	device	NOUN
bptjm-15	156	7	center	center	NOUN
bptjm-15	156	8	have	have	AUX
bptjm-15	156	9	developed	develop	VERB
bptjm-15	156	10	a	a	DET
bptjm-15	156	11	technology	technology	NOUN
bptjm-15	156	12	called	call	VERB
bptjm-15	156	13	the	the	DET
bptjm-15	156	14	repair	repair	NOUN
bptjm-15	156	15	system	system	NOUN
bptjm-15	156	16	that	that	PRON
bptjm-15	156	17	rewires	rewire	VERB
bptjm-15	156	18	neural	neural	ADJ
bptjm-15	156	19	circuitry	circuitry	NOUN
bptjm-15	156	20	through	through	ADP
bptjm-15	156	21	stimulation	stimulation	NOUN
bptjm-15	156	22	of	of	ADP
bptjm-15	156	23	the	the	DET
bptjm-15	156	24	vagus	vagus	NOUN
bptjm-15	156	25	nerve	nerve	NOUN
bptjm-15	156	26	,	,	PUNCT
bptjm-15	156	27	focusing	focus	VERB
bptjm-15	156	28	on	on	ADP
bptjm-15	156	29	targeted	target	VERB
bptjm-15	156	30	plasticity	plasticity	NOUN
bptjm-15	156	31	therapy	therapy	NOUN
bptjm-15	156	32	.	.	PUNCT
bptjm-15	157	1	the	the	DET
bptjm-15	157	2	�	�	PROPN
bptjm-15	157	3	rst	rst	PROPN
bptjm-15	157	4	human	human	ADJ
bptjm-15	157	5	trials	trial	NOUN
bptjm-15	157	6	involved	involve	VERB
bptjm-15	157	7	stroke	stroke	NOUN
bptjm-15	157	8	patients	patient	NOUN
bptjm-15	157	9	and	and	CCONJ
bptjm-15	157	10	focused	focus	VERB
bptjm-15	157	11	on	on	ADP
bptjm-15	157	12	improving	improve	VERB
bptjm-15	157	13	upper	upper	ADJ
bptjm-15	157	14	and	and	CCONJ
bptjm-15	157	15	lower	low	ADJ
bptjm-15	157	16	limb	limb	NOUN
bptjm-15	157	17	motor	motor	PROPN
bptjm-15	157	18	berkeley	berkeley	PROPN
bptjm-15	157	19	pharma	pharma	PROPN
bptjm-15	157	20	tech	tech	NOUN
bptjm-15	157	21	journal	journal	NOUN
bptjm-15	157	22	of	of	ADP
bptjm-15	157	23	medicine	medicine	NOUN
bptjm-15	157	24	|	|	ADV
bptjm-15	157	25	74	74	NUM
bptjm-15	157	26	de	de	PROPN
bptjm-15	157	27	�	�	PROPN
bptjm-15	157	28	cits	cit	NOUN
bptjm-15	157	29	following	follow	VERB
bptjm-15	157	30	a	a	DET
bptjm-15	157	31	brain	brain	NOUN
bptjm-15	157	32	injury	injury	NOUN
bptjm-15	157	33	or	or	CCONJ
bptjm-15	157	34	disease	disease	NOUN
bptjm-15	157	35	(	(	PUNCT
bptjm-15	157	36	darrow	darrow	PROPN
bptjm-15	157	37	,	,	PUNCT
bptjm-15	157	38	2020	2020	NUM
bptjm-15	157	39	)	)	PUNCT
bptjm-15	157	40	.	.	PUNCT
bptjm-15	158	1	symptoms	symptom	NOUN
bptjm-15	158	2	of	of	ADP
bptjm-15	158	3	ms	ms	PROPN
bptjm-15	158	4	often	often	ADV
bptjm-15	158	5	include	include	VERB
bptjm-15	158	6	muscle	muscle	NOUN
bptjm-15	158	7	weakness	weakness	NOUN
bptjm-15	158	8	and	and	CCONJ
bptjm-15	158	9	motor	motor	NOUN
bptjm-15	158	10	imbalance	imbalance	NOUN
bptjm-15	158	11	,	,	PUNCT
bptjm-15	158	12	leading	lead	VERB
bptjm-15	158	13	researchers	researcher	NOUN
bptjm-15	158	14	to	to	PART
bptjm-15	158	15	believe	believe	VERB
bptjm-15	158	16	that	that	SCONJ
bptjm-15	158	17	this	this	DET
bptjm-15	158	18	therapy	therapy	NOUN
bptjm-15	158	19	has	have	VERB
bptjm-15	158	20	the	the	DET
bptjm-15	158	21	potential	potential	NOUN
bptjm-15	158	22	to	to	PART
bptjm-15	158	23	change	change	VERB
bptjm-15	158	24	how	how	SCONJ
bptjm-15	158	25	physicians	physician	NOUN
bptjm-15	158	26	approach	approach	VERB
bptjm-15	158	27	the	the	DET
bptjm-15	158	28	treatment	treatment	NOUN
bptjm-15	158	29	of	of	ADP
bptjm-15	158	30	ms	ms	NOUN
bptjm-15	158	31	and	and	CCONJ
bptjm-15	158	32	other	other	ADJ
bptjm-15	158	33	neurological	neurological	ADJ
bptjm-15	158	34	disorders	disorder	NOUN
bptjm-15	158	35	.	.	PUNCT
bptjm-15	159	1	another	another	DET
bptjm-15	159	2	clinical	clinical	ADJ
bptjm-15	159	3	trial	trial	NOUN
bptjm-15	159	4	tested	test	VERB
bptjm-15	159	5	vagus	vagus	NOUN
bptjm-15	159	6	nerve	nerve	NOUN
bptjm-15	159	7	stimulation	stimulation	NOUN
bptjm-15	159	8	in	in	ADP
bptjm-15	159	9	three	three	NUM
bptjm-15	159	10	ms	ms	ADJ
bptjm-15	159	11	patients	patient	NOUN
bptjm-15	159	12	in	in	ADP
bptjm-15	159	13	an	an	DET
bptjm-15	159	14	e	e	NOUN
bptjm-15	159	15	�	�	NOUN
bptjm-15	159	16	ort	ort	NOUN
bptjm-15	159	17	to	to	PART
bptjm-15	159	18	reduce	reduce	VERB
bptjm-15	159	19	cerebellar	cerebellar	ADJ
bptjm-15	159	20	tremor	tremor	NOUN
bptjm-15	159	21	and	and	CCONJ
bptjm-15	159	22	dysphagia	dysphagia	NOUN
bptjm-15	159	23	.	.	PUNCT
bptjm-15	160	1	symptoms	symptom	NOUN
bptjm-15	160	2	were	be	AUX
bptjm-15	160	3	improved	improve	VERB
bptjm-15	160	4	over	over	ADP
bptjm-15	160	5	a	a	DET
bptjm-15	160	6	period	period	NOUN
bptjm-15	160	7	of	of	ADP
bptjm-15	160	8	two	two	NUM
bptjm-15	160	9	to	to	PART
bptjm-15	160	10	three	three	NUM
bptjm-15	160	11	months	month	NOUN
bptjm-15	160	12	and	and	CCONJ
bptjm-15	160	13	the	the	DET
bptjm-15	160	14	involvement	involvement	NOUN
bptjm-15	160	15	of	of	ADP
bptjm-15	160	16	the	the	DET
bptjm-15	160	17	nucleus	nucleus	PROPN
bptjm-15	160	18	tractus	tractus	PROPN
bptjm-15	160	19	solitarius	solitarius	NOUN
bptjm-15	160	20	,	,	PUNCT
bptjm-15	160	21	a	a	DET
bptjm-15	160	22	key	key	ADJ
bptjm-15	160	23	visceral	visceral	ADJ
bptjm-15	160	24	component	component	NOUN
bptjm-15	160	25	of	of	ADP
bptjm-15	160	26	the	the	DET
bptjm-15	160	27	vagus	vagus	NOUN
bptjm-15	160	28	nerve	nerve	NOUN
bptjm-15	160	29	,	,	PUNCT
bptjm-15	160	30	was	be	AUX
bptjm-15	160	31	further	far	ADV
bptjm-15	160	32	studied	study	VERB
bptjm-15	160	33	(	(	PUNCT
bptjm-15	160	34	marrasu	marrasu	ADJ
bptjm-15	160	35	,	,	PUNCT
bptjm-15	160	36	2007	2007	NUM
bptjm-15	160	37	)	)	PUNCT
bptjm-15	160	38	.	.	PUNCT
bptjm-15	161	1	to	to	ADP
bptjm-15	161	2	date	date	NOUN
bptjm-15	161	3	,	,	PUNCT
bptjm-15	161	4	the	the	DET
bptjm-15	161	5	underlying	underlying	ADJ
bptjm-15	161	6	mechanisms	mechanism	NOUN
bptjm-15	161	7	of	of	ADP
bptjm-15	161	8	neuromodulation	neuromodulation	NOUN
bptjm-15	161	9	therapies	therapy	NOUN
bptjm-15	161	10	are	be	AUX
bptjm-15	161	11	not	not	PART
bptjm-15	161	12	well	well	ADV
bptjm-15	161	13	understood	understand	VERB
bptjm-15	161	14	,	,	PUNCT
bptjm-15	161	15	which	which	PRON
bptjm-15	161	16	is	be	AUX
bptjm-15	161	17	why	why	SCONJ
bptjm-15	161	18	they	they	PRON
bptjm-15	161	19	are	be	AUX
bptjm-15	161	20	not	not	PART
bptjm-15	161	21	primary	primary	ADJ
bptjm-15	161	22	treatment	treatment	NOUN
bptjm-15	161	23	options	option	NOUN
bptjm-15	161	24	for	for	ADP
bptjm-15	161	25	most	most	ADJ
bptjm-15	161	26	neuropsychiatric	neuropsychiatric	ADJ
bptjm-15	161	27	diseases	disease	NOUN
bptjm-15	161	28	.	.	PUNCT
bptjm-15	162	1	however	however	ADV
bptjm-15	162	2	,	,	PUNCT
bptjm-15	162	3	a	a	DET
bptjm-15	162	4	better	well	ADJ
bptjm-15	162	5	understanding	understanding	NOUN
bptjm-15	162	6	of	of	ADP
bptjm-15	162	7	neural	neural	ADJ
bptjm-15	162	8	circuitry	circuitry	NOUN
bptjm-15	162	9	in	in	ADP
bptjm-15	162	10	the	the	DET
bptjm-15	162	11	human	human	ADJ
bptjm-15	162	12	body	body	NOUN
bptjm-15	162	13	has	have	AUX
bptjm-15	162	14	led	lead	VERB
bptjm-15	162	15	to	to	ADP
bptjm-15	162	16	promising	promise	VERB
bptjm-15	162	17	technological	technological	ADJ
bptjm-15	162	18	advancements	advancement	NOUN
bptjm-15	162	19	that	that	PRON
bptjm-15	162	20	may	may	AUX
bptjm-15	162	21	signi	signi	VERB
bptjm-15	162	22	�	�	PROPN
bptjm-15	162	23	cantly	cantly	ADV
bptjm-15	162	24	reduce	reduce	VERB
bptjm-15	162	25	symptoms	symptom	NOUN
bptjm-15	162	26	in	in	ADP
bptjm-15	162	27	patients	patient	NOUN
bptjm-15	162	28	su	su	PROPN
bptjm-15	162	29	�	�	PROPN
bptjm-15	162	30	ering	ere	VERB
bptjm-15	162	31	from	from	ADP
bptjm-15	162	32	various	various	ADJ
bptjm-15	162	33	neurological	neurological	ADJ
bptjm-15	162	34	conditions	condition	NOUN
bptjm-15	162	35	.	.	PUNCT
bptjm-15	163	1	microbial	microbial	ADJ
bptjm-15	163	2	links	link	NOUN
bptjm-15	163	3	to	to	ADP
bptjm-15	163	4	human	human	ADJ
bptjm-15	163	5	physiology	physiology	NOUN
bptjm-15	163	6	lactobacillus	lactobacillus	NOUN
bptjm-15	163	7	is	be	AUX
bptjm-15	163	8	a	a	DET
bptjm-15	163	9	genus	genus	NOUN
bptjm-15	163	10	of	of	ADP
bptjm-15	163	11	bene	bene	PROPN
bptjm-15	163	12	�	�	PROPN
bptjm-15	163	13	cial	cial	ADJ
bptjm-15	163	14	gut	gut	NOUN
bptjm-15	163	15	bacteria	bacteria	NOUN
bptjm-15	163	16	that	that	PRON
bptjm-15	163	17	have	have	AUX
bptjm-15	163	18	gained	gain	VERB
bptjm-15	163	19	an	an	DET
bptjm-15	163	20	increasing	increase	VERB
bptjm-15	163	21	amount	amount	NOUN
bptjm-15	163	22	of	of	ADP
bptjm-15	163	23	scholarly	scholarly	ADJ
bptjm-15	163	24	attention	attention	NOUN
bptjm-15	163	25	(	(	PUNCT
bptjm-15	163	26	esber	esber	ADJ
bptjm-15	163	27	,	,	PUNCT
bptjm-15	163	28	2020	2020	NUM
bptjm-15	163	29	;	;	PUNCT
bptjm-15	163	30	zhou	zhou	PROPN
bptjm-15	163	31	,	,	PUNCT
bptjm-15	163	32	2015	2015	NUM
bptjm-15	163	33	)	)	PUNCT
bptjm-15	163	34	.	.	PUNCT
bptjm-15	164	1	speci	speci	PROPN
bptjm-15	164	2	�	�	PROPN
bptjm-15	164	3	c	c	PROPN
bptjm-15	164	4	species	specie	NOUN
bptjm-15	164	5	of	of	ADP
bptjm-15	164	6	lactobacillus	lactobacillus	NOUN
bptjm-15	164	7	including	include	VERB
bptjm-15	164	8	l.	l.	PROPN
bptjm-15	164	9	acidophilus	acidophilus	PROPN
bptjm-15	164	10	,	,	PUNCT
bptjm-15	164	11	l.	l.	PROPN
bptjm-15	164	12	casei	casei	PROPN
bptjm-15	164	13	,	,	PUNCT
bptjm-15	164	14	l.	l.	PROPN
bptjm-15	164	15	rhamnosus	rhamnosus	PROPN
bptjm-15	164	16	,	,	PUNCT
bptjm-15	164	17	and	and	CCONJ
bptjm-15	164	18	l.	l.	PROPN
bptjm-15	164	19	helveticus	helveticus	PROPN
bptjm-15	164	20	have	have	AUX
bptjm-15	164	21	been	be	AUX
bptjm-15	164	22	linked	link	VERB
bptjm-15	164	23	to	to	ADP
bptjm-15	164	24	the	the	DET
bptjm-15	164	25	prevention	prevention	NOUN
bptjm-15	164	26	of	of	ADP
bptjm-15	164	27	disease	disease	NOUN
bptjm-15	164	28	in	in	ADP
bptjm-15	164	29	humans	human	NOUN
bptjm-15	164	30	and	and	CCONJ
bptjm-15	164	31	animals	animal	NOUN
bptjm-15	164	32	(	(	PUNCT
bptjm-15	164	33	azad	azad	NOUN
bptjm-15	164	34	,	,	PUNCT
bptjm-15	164	35	2018	2018	NUM
bptjm-15	164	36	)	)	PUNCT
bptjm-15	164	37	.	.	PUNCT
bptjm-15	165	1	lactobacillus	lactobacillus	PROPN
bptjm-15	165	2	can	can	AUX
bptjm-15	165	3	alter	alter	VERB
bptjm-15	165	4	the	the	DET
bptjm-15	165	5	population	population	NOUN
bptjm-15	165	6	of	of	ADP
bptjm-15	165	7	microorganisms	microorganism	NOUN
bptjm-15	165	8	in	in	ADP
bptjm-15	165	9	the	the	DET
bptjm-15	165	10	gut	gut	NOUN
bptjm-15	165	11	microbiome	microbiome	NOUN
bptjm-15	165	12	by	by	ADP
bptjm-15	165	13	producing	produce	VERB
bptjm-15	165	14	lactic	lactic	ADJ
bptjm-15	165	15	acid	acid	NOUN
bptjm-15	165	16	,	,	PUNCT
bptjm-15	165	17	preventing	prevent	VERB
bptjm-15	165	18	harmful	harmful	ADJ
bptjm-15	165	19	bacteria	bacteria	NOUN
bptjm-15	165	20	from	from	ADP
bptjm-15	165	21	colonizing	colonize	VERB
bptjm-15	165	22	the	the	DET
bptjm-15	165	23	intestines	intestine	NOUN
bptjm-15	165	24	.	.	PUNCT
bptjm-15	166	1	a	a	DET
bptjm-15	166	2	study	study	NOUN
bptjm-15	166	3	using	use	VERB
bptjm-15	166	4	a	a	DET
bptjm-15	166	5	mouse	mouse	NOUN
bptjm-15	166	6	model	model	NOUN
bptjm-15	166	7	of	of	ADP
bptjm-15	166	8	hyperlipidemia	hyperlipidemia	NOUN
bptjm-15	166	9	explored	explore	VERB
bptjm-15	166	10	the	the	DET
bptjm-15	166	11	impact	impact	NOUN
bptjm-15	166	12	of	of	ADP
bptjm-15	166	13	modulating	modulate	VERB
bptjm-15	166	14	the	the	DET
bptjm-15	166	15	gut	gut	NOUN
bptjm-15	166	16	microbiome	microbiome	NOUN
bptjm-15	166	17	by	by	ADP
bptjm-15	166	18	introducing	introduce	VERB
bptjm-15	166	19	probiotic	probiotic	ADJ
bptjm-15	166	20	feeding	feeding	NOUN
bptjm-15	166	21	of	of	ADP
bptjm-15	166	22	lactobacillus	lactobacillus	NOUN
bptjm-15	166	23	into	into	ADP
bptjm-15	166	24	the	the	DET
bptjm-15	166	25	mice	mouse	NOUN
bptjm-15	166	26	’s	’s	PART
bptjm-15	166	27	diet	diet	PROPN
bptjm-15	166	28	.	.	PUNCT
bptjm-15	167	1	signi	signi	PROPN
bptjm-15	167	2	�	�	PROPN
bptjm-15	167	3	cant	cant	VERB
bptjm-15	167	4	changes	change	NOUN
bptjm-15	167	5	in	in	ADP
bptjm-15	167	6	the	the	DET
bptjm-15	167	7	microbiota	microbiota	NOUN
bptjm-15	167	8	composition	composition	NOUN
bptjm-15	167	9	were	be	AUX
bptjm-15	167	10	found	find	VERB
bptjm-15	167	11	,	,	PUNCT
bptjm-15	167	12	including	include	VERB
bptjm-15	167	13	an	an	DET
bptjm-15	167	14	increased	increase	VERB
bptjm-15	167	15	abundance	abundance	NOUN
bptjm-15	167	16	of	of	ADP
bptjm-15	167	17	bacteroidetes	bacteroidete	NOUN
bptjm-15	167	18	and	and	CCONJ
bptjm-15	167	19	verrucomicrobia	verrucomicrobia	NOUN
bptjm-15	167	20	and	and	CCONJ
bptjm-15	167	21	a	a	DET
bptjm-15	167	22	reduced	reduced	ADJ
bptjm-15	167	23	ratio	ratio	NOUN
bptjm-15	167	24	of	of	ADP
bptjm-15	167	25	firmicutes	firmicute	NOUN
bptjm-15	167	26	(	(	PUNCT
bptjm-15	167	27	chen	chen	PROPN
bptjm-15	167	28	,	,	PUNCT
bptjm-15	167	29	2014	2014	NUM
bptjm-15	167	30	)	)	PUNCT
bptjm-15	167	31	.	.	PUNCT
bptjm-15	168	1	l.	l.	PROPN
bptjm-15	168	2	acidophilus	acidophilus	PROPN
bptjm-15	168	3	has	have	AUX
bptjm-15	168	4	even	even	ADV
bptjm-15	168	5	displayed	display	VERB
bptjm-15	168	6	the	the	DET
bptjm-15	168	7	ability	ability	NOUN
bptjm-15	168	8	to	to	PART
bptjm-15	168	9	maintain	maintain	VERB
bptjm-15	168	10	a	a	DET
bptjm-15	168	11	homeostatic	homeostatic	ADJ
bptjm-15	168	12	concentration	concentration	NOUN
bptjm-15	168	13	of	of	ADP
bptjm-15	168	14	in	in	ADP
bptjm-15	168	15	�	�	NOUN
bptjm-15	168	16	ammatory	ammatory	NOUN
bptjm-15	168	17	cytokines	cytokine	NOUN
bptjm-15	168	18	,	,	PUNCT
bptjm-15	168	19	th17	th17	PROPN
bptjm-15	168	20	,	,	PUNCT
bptjm-15	168	21	and	and	CCONJ
bptjm-15	168	22	regulatory	regulatory	ADJ
bptjm-15	168	23	t	t	PROPN
bptjm-15	168	24	(	(	PUNCT
bptjm-15	168	25	treg	treg	PROPN
bptjm-15	168	26	)	)	PUNCT
bptjm-15	168	27	cells	cell	NOUN
bptjm-15	168	28	(	(	PUNCT
bptjm-15	168	29	park	park	NOUN
bptjm-15	168	30	2018	2018	NUM
bptjm-15	168	31	)	)	PUNCT
bptjm-15	168	32	.	.	PUNCT
bptjm-15	169	1	furthermore	furthermore	ADV
bptjm-15	169	2	,	,	PUNCT
bptjm-15	169	3	l.	l.	PROPN
bptjm-15	169	4	acidophilus	acidophilus	PROPN
bptjm-15	169	5	suppressed	suppress	VERB
bptjm-15	169	6	proin	proin	NOUN
bptjm-15	169	7	�	�	NOUN
bptjm-15	169	8	ammatory	ammatory	NOUN
bptjm-15	169	9	cytokines	cytokine	NOUN
bptjm-15	169	10	such	such	ADJ
bptjm-15	169	11	as	as	ADP
bptjm-15	169	12	il-6	il-6	NOUN
bptjm-15	169	13	,	,	PUNCT
bptjm-15	169	14	tumor	tumor	NOUN
bptjm-15	169	15	necrosis	necrosis	NOUN
bptjm-15	169	16	factor	factor	NOUN
bptjm-15	169	17	-	-	PUNCT
bptjm-15	169	18	α	α	X
bptjm-15	169	19	(	(	PUNCT
bptjm-15	169	20	tnf	tnf	PROPN
bptjm-15	169	21	-	-	PUNCT
bptjm-15	169	22	α	α	NOUN
bptjm-15	169	23	)	)	PUNCT
bptjm-15	169	24	,	,	PUNCT
bptjm-15	169	25	and	and	CCONJ
bptjm-15	169	26	il-1β	il-1β	PROPN
bptjm-15	169	27	in	in	ADP
bptjm-15	169	28	colon	colon	NOUN
bptjm-15	169	29	tissues	tissue	NOUN
bptjm-15	169	30	.	.	PUNCT
bptjm-15	170	1	similar	similar	ADJ
bptjm-15	170	2	to	to	ADP
bptjm-15	170	3	lactobacillus	lactobacillus	NOUN
bptjm-15	170	4	,	,	PUNCT
bptjm-15	170	5	there	there	PRON
bptjm-15	170	6	has	have	AUX
bptjm-15	170	7	been	be	AUX
bptjm-15	170	8	a	a	DET
bptjm-15	170	9	research	research	NOUN
bptjm-15	170	10	focus	focus	NOUN
bptjm-15	170	11	on	on	ADP
bptjm-15	170	12	the	the	DET
bptjm-15	170	13	probiotic	probiotic	ADJ
bptjm-15	170	14	genus	genus	NOUN
bptjm-15	170	15	bifidobacterium	bifidobacterium	NOUN
bptjm-15	170	16	.	.	PUNCT
bptjm-15	171	1	bifidobacterium	bifidobacterium	NOUN
bptjm-15	171	2	assists	assist	VERB
bptjm-15	171	3	the	the	DET
bptjm-15	171	4	human	human	ADJ
bptjm-15	171	5	body	body	NOUN
bptjm-15	171	6	in	in	ADP
bptjm-15	171	7	performing	perform	VERB
bptjm-15	171	8	essential	essential	ADJ
bptjm-15	171	9	functions	function	NOUN
bptjm-15	171	10	such	such	ADJ
bptjm-15	171	11	as	as	ADP
bptjm-15	171	12	digestion	digestion	NOUN
bptjm-15	171	13	,	,	PUNCT
bptjm-15	171	14	improving	improve	VERB
bptjm-15	171	15	gastrointestinal	gastrointestinal	ADJ
bptjm-15	171	16	barrier	barrier	NOUN
bptjm-15	171	17	integrity	integrity	NOUN
bptjm-15	171	18	,	,	PUNCT
bptjm-15	171	19	preventing	prevent	VERB
bptjm-15	171	20	harmful	harmful	ADJ
bptjm-15	171	21	bacterial	bacterial	ADJ
bptjm-15	171	22	colonization	colonization	NOUN
bptjm-15	171	23	,	,	PUNCT
bptjm-15	171	24	and	and	CCONJ
bptjm-15	171	25	suppressing	suppress	VERB
bptjm-15	171	26	proin	proin	NOUN
bptjm-15	171	27	�	�	NOUN
bptjm-15	171	28	ammatory	ammatory	ADJ
bptjm-15	171	29	cytokines	cytokine	NOUN
bptjm-15	171	30	(	(	PUNCT
bptjm-15	171	31	ganz	ganz	NOUN
bptjm-15	171	32	,	,	PUNCT
bptjm-15	171	33	2002	2002	NUM
bptjm-15	171	34	)	)	PUNCT
bptjm-15	171	35	.	.	PUNCT
bptjm-15	172	1	it	it	PRON
bptjm-15	172	2	maintains	maintain	VERB
bptjm-15	172	3	immune	immune	ADJ
bptjm-15	172	4	homeostasis	homeostasis	NOUN
bptjm-15	172	5	berkeley	berkeley	PROPN
bptjm-15	172	6	pharma	pharma	PROPN
bptjm-15	172	7	tech	tech	NOUN
bptjm-15	172	8	journal	journal	NOUN
bptjm-15	172	9	of	of	ADP
bptjm-15	172	10	medicine	medicine	NOUN
bptjm-15	172	11	|	|	ADV
bptjm-15	172	12	75	75	NUM
bptjm-15	172	13	by	by	ADP
bptjm-15	172	14	altering	alter	VERB
bptjm-15	172	15	the	the	DET
bptjm-15	172	16	function	function	NOUN
bptjm-15	172	17	of	of	ADP
bptjm-15	172	18	dendritic	dendritic	ADJ
bptjm-15	172	19	cells	cell	NOUN
bptjm-15	172	20	in	in	ADP
bptjm-15	172	21	order	order	NOUN
bptjm-15	172	22	to	to	PART
bptjm-15	172	23	protect	protect	VERB
bptjm-15	172	24	against	against	ADP
bptjm-15	172	25	foreign	foreign	ADJ
bptjm-15	172	26	bacteria	bacteria	NOUN
bptjm-15	172	27	and	and	CCONJ
bptjm-15	172	28	pathogens	pathogen	NOUN
bptjm-15	172	29	(	(	PUNCT
bptjm-15	172	30	azad	azad	NOUN
bptjm-15	172	31	,	,	PUNCT
bptjm-15	172	32	2018	2018	NUM
bptjm-15	172	33	)	)	PUNCT
bptjm-15	172	34	.	.	PUNCT
bptjm-15	173	1	moreover	moreover	ADV
bptjm-15	173	2	,	,	PUNCT
bptjm-15	173	3	bi	bi	PROPN
bptjm-15	173	4	�	�	NOUN
bptjm-15	173	5	dobacteria	dobacteria	NOUN
bptjm-15	173	6	increase	increase	VERB
bptjm-15	173	7	the	the	DET
bptjm-15	173	8	proportion	proportion	NOUN
bptjm-15	173	9	of	of	ADP
bptjm-15	173	10	bene	bene	PROPN
bptjm-15	173	11	�	�	PROPN
bptjm-15	173	12	cial	cial	ADJ
bptjm-15	173	13	bacteria	bacteria	NOUN
bptjm-15	173	14	in	in	ADP
bptjm-15	173	15	the	the	DET
bptjm-15	173	16	gut	gut	NOUN
bptjm-15	173	17	microbiota	microbiota	NOUN
bptjm-15	173	18	through	through	ADP
bptjm-15	173	19	cross	cross	ADJ
bptjm-15	173	20	-	-	ADJ
bptjm-15	173	21	feeding	feeding	ADJ
bptjm-15	173	22	,	,	PUNCT
bptjm-15	173	23	allowing	allow	VERB
bptjm-15	173	24	other	other	ADJ
bptjm-15	173	25	bacteria	bacteria	NOUN
bptjm-15	173	26	to	to	PART
bptjm-15	173	27	live	live	VERB
bptjm-15	173	28	o	o	NOUN
bptjm-15	173	29	�	�	PROPN
bptjm-15	173	30	of	of	ADP
bptjm-15	173	31	their	their	PRON
bptjm-15	173	32	metabolic	metabolic	NOUN
bptjm-15	173	33	products	product	NOUN
bptjm-15	173	34	.	.	PUNCT
bptjm-15	174	1	bifidobacterium	bifidobacterium	NOUN
bptjm-15	174	2	bifidum	bifidum	NOUN
bptjm-15	174	3	has	have	AUX
bptjm-15	174	4	shown	show	VERB
bptjm-15	174	5	signi	signi	PROPN
bptjm-15	174	6	�	�	PROPN
bptjm-15	174	7	cantly	cantly	ADV
bptjm-15	174	8	increased	increase	VERB
bptjm-15	174	9	metabolic	metabolic	NOUN
bptjm-15	174	10	activity	activity	NOUN
bptjm-15	174	11	when	when	SCONJ
bptjm-15	174	12	cocultured	coculture	VERB
bptjm-15	174	13	with	with	ADP
bptjm-15	174	14	bifidobacterium	bifidobacterium	NOUN
bptjm-15	174	15	breve	breve	NOUN
bptjm-15	174	16	(	(	PUNCT
bptjm-15	174	17	turroni	turroni	NOUN
bptjm-15	174	18	,	,	PUNCT
bptjm-15	174	19	2015	2015	NUM
bptjm-15	174	20	)	)	PUNCT
bptjm-15	174	21	.	.	PUNCT
bptjm-15	175	1	this	this	DET
bptjm-15	175	2	co	co	NOUN
bptjm-15	175	3	-	-	NOUN
bptjm-15	175	4	culture	culture	NOUN
bptjm-15	175	5	of	of	ADP
bptjm-15	175	6	probiotic	probiotic	ADJ
bptjm-15	175	7	bacteria	bacteria	NOUN
bptjm-15	175	8	a	a	DET
bptjm-15	175	9	�	�	NOUN
bptjm-15	175	10	ected	ecte	VERB
bptjm-15	175	11	the	the	DET
bptjm-15	175	12	metabolic	metabolic	NOUN
bptjm-15	175	13	shift	shift	NOUN
bptjm-15	175	14	in	in	ADP
bptjm-15	175	15	the	the	DET
bptjm-15	175	16	gut	gut	NOUN
bptjm-15	175	17	microbiota	microbiota	NOUN
bptjm-15	175	18	by	by	ADP
bptjm-15	175	19	increasing	increase	VERB
bptjm-15	175	20	the	the	DET
bptjm-15	175	21	production	production	NOUN
bptjm-15	175	22	of	of	ADP
bptjm-15	175	23	short	short	ADJ
bptjm-15	175	24	-	-	PUNCT
bptjm-15	175	25	chain	chain	NOUN
bptjm-15	175	26	fatty	fatty	NOUN
bptjm-15	175	27	acids	acid	NOUN
bptjm-15	175	28	,	,	PUNCT
bptjm-15	175	29	suggesting	suggest	VERB
bptjm-15	175	30	bifidobacterium	bifidobacterium	NOUN
bptjm-15	175	31	could	could	AUX
bptjm-15	175	32	play	play	VERB
bptjm-15	175	33	a	a	DET
bptjm-15	175	34	role	role	NOUN
bptjm-15	175	35	in	in	ADP
bptjm-15	175	36	cognitive	cognitive	ADJ
bptjm-15	175	37	function	function	NOUN
bptjm-15	175	38	via	via	ADP
bptjm-15	175	39	hormonal	hormonal	ADJ
bptjm-15	175	40	signaling	signal	VERB
bptjm-15	175	41	(	(	PUNCT
bptjm-15	175	42	savignac	savignac	NOUN
bptjm-15	175	43	,	,	PUNCT
bptjm-15	175	44	2013	2013	NUM
bptjm-15	175	45	)	)	PUNCT
bptjm-15	175	46	.	.	PUNCT
bptjm-15	176	1	this	this	PRON
bptjm-15	176	2	can	can	AUX
bptjm-15	176	3	lead	lead	VERB
bptjm-15	176	4	to	to	ADP
bptjm-15	176	5	improved	improved	ADJ
bptjm-15	176	6	memory	memory	NOUN
bptjm-15	176	7	function	function	NOUN
bptjm-15	176	8	,	,	PUNCT
bptjm-15	176	9	including	include	VERB
bptjm-15	176	10	the	the	DET
bptjm-15	176	11	growth	growth	NOUN
bptjm-15	176	12	of	of	ADP
bptjm-15	176	13	brain	brain	NOUN
bptjm-15	176	14	-	-	PUNCT
bptjm-15	176	15	derived	derive	VERB
bptjm-15	176	16	neurotrophic	neurotrophic	ADJ
bptjm-15	176	17	factor	factor	NOUN
bptjm-15	176	18	(	(	PUNCT
bptjm-15	176	19	bdnf	bdnf	PROPN
bptjm-15	176	20	)	)	PUNCT
bptjm-15	176	21	and	and	CCONJ
bptjm-15	176	22	n	n	CCONJ
bptjm-15	176	23	-	-	PUNCT
bptjm-15	176	24	methyl	methyl	NOUN
bptjm-15	176	25	-	-	PUNCT
bptjm-15	176	26	d	d	NOUN
bptjm-15	176	27	-	-	PUNCT
bptjm-15	176	28	aspartate	aspartate	ADJ
bptjm-15	176	29	receptor	receptor	NOUN
bptjm-15	176	30	expression	expression	NOUN
bptjm-15	176	31	(	(	PUNCT
bptjm-15	176	32	savignac	savignac	NOUN
bptjm-15	176	33	,	,	PUNCT
bptjm-15	176	34	2013	2013	NUM
bptjm-15	176	35	)	)	PUNCT
bptjm-15	176	36	.	.	PUNCT
bptjm-15	177	1	the	the	DET
bptjm-15	177	2	prophylactic	prophylactic	ADJ
bptjm-15	177	3	role	role	NOUN
bptjm-15	177	4	of	of	ADP
bptjm-15	177	5	this	this	DET
bptjm-15	177	6	bacterial	bacterial	ADJ
bptjm-15	177	7	species	specie	NOUN
bptjm-15	177	8	among	among	ADP
bptjm-15	177	9	other	other	ADJ
bptjm-15	177	10	probiotic	probiotic	ADJ
bptjm-15	177	11	strains	strain	NOUN
bptjm-15	177	12	was	be	AUX
bptjm-15	177	13	further	far	ADV
bptjm-15	177	14	explored	explore	VERB
bptjm-15	177	15	in	in	ADP
bptjm-15	177	16	a	a	DET
bptjm-15	177	17	mouse	mouse	NOUN
bptjm-15	177	18	model	model	NOUN
bptjm-15	177	19	of	of	ADP
bptjm-15	177	20	β	β	PROPN
bptjm-15	177	21	-	-	PUNCT
bptjm-15	177	22	lactoglobulin	lactoglobulin	PROPN
bptjm-15	177	23	allergy	allergy	NOUN
bptjm-15	177	24	,	,	PUNCT
bptjm-15	177	25	�	�	PROPN
bptjm-15	177	26	nding	nde	VERB
bptjm-15	177	27	that	that	SCONJ
bptjm-15	177	28	the	the	DET
bptjm-15	177	29	administration	administration	NOUN
bptjm-15	177	30	of	of	ADP
bptjm-15	177	31	bifidobacterium	bifidobacterium	NOUN
bptjm-15	177	32	longum	longum	NOUN
bptjm-15	177	33	subsp	subsp	NOUN
bptjm-15	177	34	.	.	PUNCT
bptjm-15	178	1	infantis	infantis	PROPN
bptjm-15	178	2	(	(	PUNCT
bptjm-15	178	3	b.	b.	PROPN
bptjm-15	178	4	infantis	infantis	PROPN
bptjm-15	178	5	)	)	PUNCT
bptjm-15	178	6	la308	la308	NOUN
bptjm-15	178	7	for	for	ADP
bptjm-15	178	8	3	3	NUM
bptjm-15	178	9	 	 	SPACE
bptjm-15	178	10	weeks	week	NOUN
bptjm-15	178	11	modi	modi	PROPN
bptjm-15	178	12	�	�	PROPN
bptjm-15	178	13	ed	ed	PROPN
bptjm-15	178	14	the	the	DET
bptjm-15	178	15	composition	composition	NOUN
bptjm-15	178	16	of	of	ADP
bptjm-15	178	17	the	the	DET
bptjm-15	178	18	gut	gut	NOUN
bptjm-15	178	19	microbiota	microbiota	NOUN
bptjm-15	178	20	,	,	PUNCT
bptjm-15	178	21	signaling	signal	VERB
bptjm-15	178	22	a	a	DET
bptjm-15	178	23	connection	connection	NOUN
bptjm-15	178	24	between	between	ADP
bptjm-15	178	25	probiotics	probiotic	NOUN
bptjm-15	178	26	and	and	CCONJ
bptjm-15	178	27	the	the	DET
bptjm-15	178	28	diversity	diversity	NOUN
bptjm-15	178	29	of	of	ADP
bptjm-15	178	30	gut	gut	NOUN
bptjm-15	178	31	microbiota	microbiota	NOUN
bptjm-15	178	32	(	(	PUNCT
bptjm-15	178	33	azad	azad	NOUN
bptjm-15	178	34	,	,	PUNCT
bptjm-15	178	35	2018	2018	NUM
bptjm-15	178	36	)	)	PUNCT
bptjm-15	178	37	.	.	PUNCT
bptjm-15	179	1	there	there	PRON
bptjm-15	179	2	was	be	VERB
bptjm-15	179	3	a	a	DET
bptjm-15	179	4	signi	signi	ADJ
bptjm-15	179	5	�	�	NOUN
bptjm-15	179	6	cant	cant	NOUN
bptjm-15	179	7	change	change	NOUN
bptjm-15	179	8	in	in	ADP
bptjm-15	179	9	forkhead	forkhead	PROPN
bptjm-15	179	10	box	box	PROPN
bptjm-15	179	11	p3	p3	PROPN
bptjm-15	179	12	(	(	PUNCT
bptjm-15	179	13	foxp3	foxp3	PROPN
bptjm-15	179	14	)	)	PUNCT
bptjm-15	179	15	,	,	PUNCT
bptjm-15	179	16	transforming	transform	VERB
bptjm-15	179	17	growth	growth	NOUN
bptjm-15	179	18	factor	factor	NOUN
bptjm-15	179	19	-	-	PUNCT
bptjm-15	179	20	beta	beta	NOUN
bptjm-15	179	21	(	(	PUNCT
bptjm-15	179	22	tgf	tgf	PROPN
bptjm-15	179	23	-	-	PUNCT
bptjm-15	179	24	β	β	NOUN
bptjm-15	179	25	)	)	PUNCT
bptjm-15	179	26	,	,	PUNCT
bptjm-15	179	27	and	and	CCONJ
bptjm-15	179	28	il-10	il-10	ADP
bptjm-15	179	29	ileal	ileal	ADJ
bptjm-15	179	30	gene	gene	NOUN
bptjm-15	179	31	expression	expression	NOUN
bptjm-15	179	32	,	,	PUNCT
bptjm-15	179	33	as	as	ADV
bptjm-15	179	34	well	well	ADV
bptjm-15	179	35	as	as	ADP
bptjm-15	179	36	plasma	plasma	NOUN
bptjm-15	179	37	metabolomic	metabolomic	ADJ
bptjm-15	179	38	alterations	alteration	NOUN
bptjm-15	179	39	in	in	ADP
bptjm-15	179	40	the	the	DET
bptjm-15	179	41	tryptophan	tryptophan	NOUN
bptjm-15	179	42	(	(	PUNCT
bptjm-15	179	43	trp	trp	NOUN
bptjm-15	179	44	)	)	PUNCT
bptjm-15	179	45	pathway	pathway	NOUN
bptjm-15	179	46	.	.	PUNCT
bptjm-15	180	1	the	the	DET
bptjm-15	180	2	study	study	NOUN
bptjm-15	180	3	concluded	conclude	VERB
bptjm-15	180	4	that	that	SCONJ
bptjm-15	180	5	probiotic	probiotic	ADJ
bptjm-15	180	6	introduction	introduction	NOUN
bptjm-15	180	7	to	to	ADP
bptjm-15	180	8	the	the	DET
bptjm-15	180	9	human	human	ADJ
bptjm-15	180	10	body	body	NOUN
bptjm-15	180	11	led	lead	VERB
bptjm-15	180	12	to	to	ADP
bptjm-15	180	13	alterations	alteration	NOUN
bptjm-15	180	14	in	in	ADP
bptjm-15	180	15	immune	immune	ADJ
bptjm-15	180	16	responses	response	NOUN
bptjm-15	180	17	,	,	PUNCT
bptjm-15	180	18	tolerogenic	tolerogenic	ADJ
bptjm-15	180	19	energy	energy	NOUN
bptjm-15	180	20	induction	induction	NOUN
bptjm-15	180	21	,	,	PUNCT
bptjm-15	180	22	and	and	CCONJ
bptjm-15	180	23	anti	anti	ADJ
bptjm-15	180	24	-	-	ADJ
bptjm-15	180	25	in	in	ADP
bptjm-15	180	26	�	�	NOUN
bptjm-15	180	27	ammatory	ammatory	NOUN
bptjm-15	180	28	responses	response	NOUN
bptjm-15	180	29	(	(	PUNCT
bptjm-15	180	30	esber	esber	ADJ
bptjm-15	180	31	,	,	PUNCT
bptjm-15	180	32	2020	2020	NUM
bptjm-15	180	33	)	)	PUNCT
bptjm-15	180	34	.	.	PUNCT
bptjm-15	181	1	human	human	ADJ
bptjm-15	181	2	gut	gut	NOUN
bptjm-15	181	3	-	-	PUNCT
bptjm-15	181	4	immune	immune	ADJ
bptjm-15	181	5	interactions	interaction	NOUN
bptjm-15	181	6	the	the	DET
bptjm-15	181	7	immune	immune	ADJ
bptjm-15	181	8	system	system	NOUN
bptjm-15	181	9	plays	play	VERB
bptjm-15	181	10	a	a	DET
bptjm-15	181	11	pivotal	pivotal	ADJ
bptjm-15	181	12	role	role	NOUN
bptjm-15	181	13	as	as	ADP
bptjm-15	181	14	the	the	DET
bptjm-15	181	15	intermediary	intermediary	NOUN
bptjm-15	181	16	between	between	ADP
bptjm-15	181	17	the	the	DET
bptjm-15	181	18	gut	gut	NOUN
bptjm-15	181	19	microbiome	microbiome	NOUN
bptjm-15	181	20	and	and	CCONJ
bptjm-15	181	21	cns	cns	NOUN
bptjm-15	181	22	,	,	PUNCT
bptjm-15	181	23	especially	especially	ADV
bptjm-15	181	24	in	in	ADP
bptjm-15	181	25	the	the	DET
bptjm-15	181	26	regulation	regulation	NOUN
bptjm-15	181	27	of	of	ADP
bptjm-15	181	28	autoimmune	autoimmune	ADJ
bptjm-15	181	29	responses	response	NOUN
bptjm-15	181	30	.	.	PUNCT
bptjm-15	182	1	the	the	DET
bptjm-15	182	2	presence	presence	NOUN
bptjm-15	182	3	or	or	CCONJ
bptjm-15	182	4	absence	absence	NOUN
bptjm-15	182	5	of	of	ADP
bptjm-15	182	6	several	several	ADJ
bptjm-15	182	7	components	component	NOUN
bptjm-15	182	8	of	of	ADP
bptjm-15	182	9	the	the	DET
bptjm-15	182	10	gut	gut	NOUN
bptjm-15	182	11	microbiota	microbiota	NOUN
bptjm-15	182	12	regulates	regulate	VERB
bptjm-15	182	13	t	t	PROPN
bptjm-15	182	14	and	and	CCONJ
bptjm-15	182	15	b	b	NOUN
bptjm-15	182	16	cell	cell	NOUN
bptjm-15	182	17	activation	activation	NOUN
bptjm-15	182	18	within	within	ADP
bptjm-15	182	19	the	the	DET
bptjm-15	182	20	brain	brain	NOUN
bptjm-15	182	21	,	,	PUNCT
bptjm-15	182	22	leading	lead	VERB
bptjm-15	182	23	to	to	ADP
bptjm-15	182	24	the	the	DET
bptjm-15	182	25	enhanced	enhance	VERB
bptjm-15	182	26	in	in	ADP
bptjm-15	182	27	�	�	NOUN
bptjm-15	182	28	ammatory	ammatory	ADJ
bptjm-15	182	29	response	response	NOUN
bptjm-15	182	30	associated	associate	VERB
bptjm-15	182	31	with	with	ADP
bptjm-15	182	32	autoimmune	autoimmune	ADJ
bptjm-15	182	33	diseases	disease	NOUN
bptjm-15	182	34	like	like	SCONJ
bptjm-15	182	35	ms	ms	PROPN
bptjm-15	182	36	.	.	PROPN
bptjm-15	182	37	for	for	ADP
bptjm-15	182	38	instance	instance	NOUN
bptjm-15	182	39	,	,	PUNCT
bptjm-15	182	40	the	the	DET
bptjm-15	182	41	presence	presence	NOUN
bptjm-15	182	42	of	of	ADP
bptjm-15	182	43	gut	gut	NOUN
bptjm-15	182	44	-	-	PUNCT
bptjm-15	182	45	residing	reside	VERB
bptjm-15	182	46	bacteria	bacteria	NOUN
bptjm-15	182	47	faecalibacterium	faecalibacterium	NOUN
bptjm-15	182	48	prausnitzii	prausnitzii	NOUN
bptjm-15	182	49	caused	cause	VERB
bptjm-15	182	50	various	various	ADJ
bptjm-15	182	51	symptoms	symptom	NOUN
bptjm-15	182	52	in	in	ADP
bptjm-15	182	53	patients	patient	NOUN
bptjm-15	182	54	with	with	ADP
bptjm-15	182	55	crohn	crohn	PROPN
bptjm-15	182	56	’s	’s	PART
bptjm-15	182	57	disease	disease	NOUN
bptjm-15	182	58	,	,	PUNCT
bptjm-15	182	59	an	an	DET
bptjm-15	182	60	autoimmune	autoimmune	ADJ
bptjm-15	182	61	disease	disease	NOUN
bptjm-15	182	62	characterized	characterize	VERB
bptjm-15	182	63	by	by	ADP
bptjm-15	182	64	heightened	heighten	VERB
bptjm-15	182	65	in	in	ADP
bptjm-15	182	66	�	�	PROPN
bptjm-15	182	67	ammation	ammation	NOUN
bptjm-15	182	68	in	in	ADP
bptjm-15	182	69	the	the	DET
bptjm-15	182	70	digestive	digestive	ADJ
bptjm-15	182	71	tract	tract	NOUN
bptjm-15	182	72	(	(	PUNCT
bptjm-15	182	73	velasquez	velasquez	PROPN
bptjm-15	182	74	-	-	PUNCT
bptjm-15	182	75	mano	mano	PROPN
bptjm-15	182	76	�	�	PROPN
bptjm-15	182	77	,	,	PUNCT
bptjm-15	182	78	2015	2015	NUM
bptjm-15	182	79	)	)	PUNCT
bptjm-15	182	80	.	.	PUNCT
bptjm-15	183	1	patients	patient	NOUN
bptjm-15	183	2	who	who	PRON
bptjm-15	183	3	lacked	lack	VERB
bptjm-15	183	4	this	this	DET
bptjm-15	183	5	bacteria	bacteria	NOUN
bptjm-15	183	6	experienced	experience	VERB
bptjm-15	183	7	in	in	ADP
bptjm-15	183	8	�	�	NOUN
bptjm-15	183	9	ammatory	ammatory	ADJ
bptjm-15	183	10	bowel	bowel	NOUN
bptjm-15	183	11	syndrome	syndrome	NOUN
bptjm-15	183	12	and	and	CCONJ
bptjm-15	183	13	asthma	asthma	NOUN
bptjm-15	183	14	,	,	PUNCT
bptjm-15	183	15	while	while	SCONJ
bptjm-15	183	16	those	those	PRON
bptjm-15	183	17	possessing	possess	VERB
bptjm-15	183	18	them	they	PRON
bptjm-15	183	19	displayed	display	VERB
bptjm-15	183	20	a	a	DET
bptjm-15	183	21	negative	negative	ADJ
bptjm-15	183	22	correlation	correlation	NOUN
bptjm-15	183	23	with	with	ADP
bptjm-15	183	24	in	in	ADP
bptjm-15	183	25	�	�	PROPN
bptjm-15	183	26	ammatory	ammatory	NOUN
bptjm-15	183	27	berkeley	berkeley	PROPN
bptjm-15	183	28	pharma	pharma	PROPN
bptjm-15	183	29	tech	tech	NOUN
bptjm-15	183	30	journal	journal	NOUN
bptjm-15	183	31	of	of	ADP
bptjm-15	183	32	medicine	medicine	NOUN
bptjm-15	183	33	|	|	ADV
bptjm-15	183	34	76	76	NUM
bptjm-15	183	35	autoimmune	autoimmune	ADJ
bptjm-15	183	36	diseases	disease	NOUN
bptjm-15	183	37	(	(	PUNCT
bptjm-15	183	38	velasquez	velasquez	PROPN
bptjm-15	183	39	-	-	PUNCT
bptjm-15	183	40	mano	mano	PROPN
bptjm-15	183	41	�	�	PROPN
bptjm-15	183	42	,	,	PUNCT
bptjm-15	183	43	2015	2015	NUM
bptjm-15	183	44	)	)	PUNCT
bptjm-15	183	45	.	.	PUNCT
bptjm-15	184	1	the	the	DET
bptjm-15	184	2	potential	potential	ADJ
bptjm-15	184	3	therapeutic	therapeutic	ADJ
bptjm-15	184	4	applications	application	NOUN
bptjm-15	184	5	of	of	ADP
bptjm-15	184	6	this	this	DET
bptjm-15	184	7	bacteria	bacteria	NOUN
bptjm-15	184	8	's	's	PART
bptjm-15	184	9	anti	anti	ADJ
bptjm-15	184	10	-	-	ADJ
bptjm-15	184	11	in	in	ADP
bptjm-15	184	12	�	�	NOUN
bptjm-15	184	13	ammatory	ammatory	NOUN
bptjm-15	184	14	nature	nature	NOUN
bptjm-15	184	15	are	be	AUX
bptjm-15	184	16	currently	currently	ADV
bptjm-15	184	17	under	under	ADP
bptjm-15	184	18	research	research	NOUN
bptjm-15	184	19	for	for	ADP
bptjm-15	184	20	autoimmune	autoimmune	ADJ
bptjm-15	184	21	disorders	disorder	NOUN
bptjm-15	184	22	(	(	PUNCT
bptjm-15	184	23	figure	figure	NOUN
bptjm-15	184	24	4	4	NUM
bptjm-15	184	25	)	)	PUNCT
bptjm-15	184	26	(	(	PUNCT
bptjm-15	184	27	velasquez	velasquez	PROPN
bptjm-15	184	28	-	-	PUNCT
bptjm-15	184	29	mano	mano	PROPN
bptjm-15	184	30	�	�	PROPN
bptjm-15	184	31	,	,	PUNCT
bptjm-15	184	32	2015	2015	NUM
bptjm-15	184	33	)	)	PUNCT
bptjm-15	184	34	.	.	PUNCT
bptjm-15	185	1	human	human	ADJ
bptjm-15	185	2	-	-	PUNCT
bptjm-15	185	3	gut	gut	NOUN
bptjm-15	185	4	immune	immune	ADJ
bptjm-15	185	5	interactions	interaction	NOUN
bptjm-15	185	6	metabolites	metabolite	NOUN
bptjm-15	185	7	further	further	ADJ
bptjm-15	185	8	studies	study	NOUN
bptjm-15	185	9	on	on	ADP
bptjm-15	185	10	gut	gut	NOUN
bptjm-15	185	11	-	-	PUNCT
bptjm-15	185	12	immune	immune	ADJ
bptjm-15	185	13	interactions	interaction	NOUN
bptjm-15	185	14	have	have	AUX
bptjm-15	185	15	emphasized	emphasize	VERB
bptjm-15	185	16	modi	modi	PROPN
bptjm-15	185	17	�	�	PROPN
bptjm-15	185	18	cations	cation	NOUN
bptjm-15	185	19	to	to	PART
bptjm-15	185	20	in	in	ADP
bptjm-15	185	21	�	�	NOUN
bptjm-15	185	22	ammatory	ammatory	NOUN
bptjm-15	185	23	cytokine	cytokine	NOUN
bptjm-15	185	24	pathways	pathway	NOUN
bptjm-15	185	25	.	.	PUNCT
bptjm-15	186	1	these	these	DET
bptjm-15	186	2	interactions	interaction	NOUN
bptjm-15	186	3	vary	vary	VERB
bptjm-15	186	4	from	from	ADP
bptjm-15	186	5	cytokine	cytokine	NOUN
bptjm-15	186	6	-	-	PUNCT
bptjm-15	186	7	speci	speci	ADJ
bptjm-15	186	8	�	�	PROPN
bptjm-15	186	9	c	c	NOUN
bptjm-15	186	10	to	to	ADP
bptjm-15	186	11	stimulant	stimulant	NOUN
bptjm-15	186	12	-	-	PUNCT
bptjm-15	186	13	speci	speci	NOUN
bptjm-15	186	14	�	�	PROPN
bptjm-15	186	15	c	c	NOUN
bptjm-15	186	16	responses	response	NOUN
bptjm-15	186	17	or	or	CCONJ
bptjm-15	186	18	sometimes	sometimes	ADV
bptjm-15	186	19	,	,	PUNCT
bptjm-15	186	20	both	both	PRON
bptjm-15	186	21	concurrently	concurrently	ADV
bptjm-15	186	22	.	.	PUNCT
bptjm-15	187	1	studies	study	NOUN
bptjm-15	187	2	revealed	reveal	VERB
bptjm-15	187	3	that	that	SCONJ
bptjm-15	187	4	10	10	NUM
bptjm-15	187	5	%	%	NOUN
bptjm-15	187	6	of	of	ADP
bptjm-15	187	7	the	the	DET
bptjm-15	187	8	variability	variability	NOUN
bptjm-15	187	9	of	of	ADP
bptjm-15	187	10	cytokine	cytokine	ADJ
bptjm-15	187	11	responses	response	NOUN
bptjm-15	187	12	associated	associate	VERB
bptjm-15	187	13	with	with	ADP
bptjm-15	187	14	in	in	ADP
bptjm-15	187	15	�	�	PROPN
bptjm-15	187	16	ammation	ammation	NOUN
bptjm-15	187	17	can	can	AUX
bptjm-15	187	18	be	be	AUX
bptjm-15	187	19	accounted	account	VERB
bptjm-15	187	20	for	for	ADP
bptjm-15	187	21	by	by	ADP
bptjm-15	187	22	variations	variation	NOUN
bptjm-15	187	23	in	in	ADP
bptjm-15	187	24	the	the	DET
bptjm-15	187	25	gut	gut	NOUN
bptjm-15	187	26	microbiome	microbiome	NOUN
bptjm-15	187	27	(	(	PUNCT
bptjm-15	187	28	schirmer	schirmer	X
bptjm-15	187	29	,	,	PUNCT
bptjm-15	187	30	2016	2016	NUM
bptjm-15	187	31	)	)	PUNCT
bptjm-15	187	32	.	.	PUNCT
bptjm-15	188	1	moreover	moreover	ADV
bptjm-15	188	2	,	,	PUNCT
bptjm-15	188	3	the	the	DET
bptjm-15	188	4	interaction	interaction	NOUN
bptjm-15	188	5	between	between	ADP
bptjm-15	188	6	the	the	DET
bptjm-15	188	7	bacterial	bacterial	ADJ
bptjm-15	188	8	component	component	NOUN
bptjm-15	188	9	of	of	ADP
bptjm-15	188	10	the	the	DET
bptjm-15	188	11	gut	gut	NOUN
bptjm-15	188	12	microbiome	microbiome	ADJ
bptjm-15	188	13	and	and	CCONJ
bptjm-15	188	14	immune	immune	ADJ
bptjm-15	188	15	cells	cell	NOUN
bptjm-15	188	16	does	do	AUX
bptjm-15	188	17	not	not	PART
bptjm-15	188	18	occur	occur	VERB
bptjm-15	188	19	directly	directly	ADV
bptjm-15	188	20	,	,	PUNCT
bptjm-15	188	21	but	but	CCONJ
bptjm-15	188	22	through	through	ADP
bptjm-15	188	23	metabolites	metabolite	NOUN
bptjm-15	188	24	,	,	PUNCT
bptjm-15	188	25	small	small	ADJ
bptjm-15	188	26	molecules	molecule	NOUN
bptjm-15	188	27	referring	refer	VERB
bptjm-15	188	28	to	to	ADP
bptjm-15	188	29	the	the	DET
bptjm-15	188	30	intermediates	intermediate	NOUN
bptjm-15	188	31	or	or	CCONJ
bptjm-15	188	32	end	end	VERB
bptjm-15	188	33	products	product	NOUN
bptjm-15	188	34	of	of	ADP
bptjm-15	188	35	a	a	DET
bptjm-15	188	36	metabolic	metabolic	NOUN
bptjm-15	188	37	pathway	pathway	NOUN
bptjm-15	188	38	(	(	PUNCT
bptjm-15	188	39	wirthgen	wirthgen	PROPN
bptjm-15	188	40	,	,	PUNCT
bptjm-15	188	41	2018	2018	NUM
bptjm-15	188	42	)	)	PUNCT
bptjm-15	188	43	.	.	PUNCT
bptjm-15	189	1	one	one	NUM
bptjm-15	189	2	such	such	ADJ
bptjm-15	189	3	pathway	pathway	NOUN
bptjm-15	189	4	leads	lead	VERB
bptjm-15	189	5	to	to	ADP
bptjm-15	189	6	the	the	DET
bptjm-15	189	7	formation	formation	NOUN
bptjm-15	189	8	of	of	ADP
bptjm-15	189	9	tryptophol	tryptophol	NOUN
bptjm-15	189	10	,	,	PUNCT
bptjm-15	189	11	a	a	DET
bptjm-15	189	12	metabolite	metabolite	NOUN
bptjm-15	189	13	and	and	CCONJ
bptjm-15	189	14	common	common	ADJ
bptjm-15	189	15	inhibitor	inhibitor	NOUN
bptjm-15	189	16	of	of	ADP
bptjm-15	189	17	tnf	tnf	PROPN
bptjm-15	189	18	-	-	PUNCT
bptjm-15	189	19	α	α	PROPN
bptjm-15	189	20	.	.	PUNCT
bptjm-15	190	1	the	the	DET
bptjm-15	190	2	degradation	degradation	NOUN
bptjm-15	190	3	of	of	ADP
bptjm-15	190	4	the	the	DET
bptjm-15	190	5	essential	essential	ADJ
bptjm-15	190	6	amino	amino	NOUN
bptjm-15	190	7	acid	acid	NOUN
bptjm-15	190	8	trp	trp	PROPN
bptjm-15	190	9	to	to	ADP
bptjm-15	190	10	tryptophol	tryptophol	NOUN
bptjm-15	190	11	is	be	AUX
bptjm-15	190	12	negatively	negatively	ADV
bptjm-15	190	13	associated	associate	VERB
bptjm-15	190	14	with	with	ADP
bptjm-15	190	15	the	the	DET
bptjm-15	190	16	interferon	interferon	ADJ
bptjm-15	190	17	gamma	gamma	NOUN
bptjm-15	190	18	(	(	PUNCT
bptjm-15	190	19	ifnγ	ifnγ	NOUN
bptjm-15	190	20	)	)	PUNCT
bptjm-15	190	21	in	in	ADP
bptjm-15	190	22	�	�	NOUN
bptjm-15	190	23	ammatory	ammatory	NOUN
bptjm-15	190	24	pathway	pathway	NOUN
bptjm-15	190	25	(	(	PUNCT
bptjm-15	190	26	schirmer	schirmer	X
bptjm-15	190	27	,	,	PUNCT
bptjm-15	190	28	2016	2016	NUM
bptjm-15	190	29	)	)	PUNCT
bptjm-15	190	30	.	.	PUNCT
bptjm-15	191	1	several	several	ADJ
bptjm-15	191	2	other	other	ADJ
bptjm-15	191	3	trp	trp	ADJ
bptjm-15	191	4	-	-	PUNCT
bptjm-15	191	5	derived	derive	VERB
bptjm-15	191	6	metabolites	metabolite	NOUN
bptjm-15	191	7	,	,	PUNCT
bptjm-15	191	8	particularly	particularly	ADV
bptjm-15	191	9	the	the	DET
bptjm-15	191	10	tryp-6	tryp-6	NUM
bptjm-15	191	11	neuroactive	neuroactive	ADJ
bptjm-15	191	12	compounds	compound	NOUN
bptjm-15	191	13	kynurenine	kynurenine	NOUN
bptjm-15	191	14	,	,	PUNCT
bptjm-15	191	15	quinolinate	quinolinate	NOUN
bptjm-15	191	16	,	,	PUNCT
bptjm-15	191	17	serotonin	serotonin	VERB
bptjm-15	191	18	,	,	PUNCT
bptjm-15	191	19	indole	indole	NOUN
bptjm-15	191	20	,	,	PUNCT
bptjm-15	191	21	and	and	CCONJ
bptjm-15	191	22	indole	indole	ADJ
bptjm-15	191	23	derivatives	derivative	NOUN
bptjm-15	191	24	,	,	PUNCT
bptjm-15	191	25	may	may	AUX
bptjm-15	191	26	have	have	VERB
bptjm-15	191	27	a	a	DET
bptjm-15	191	28	critical	critical	ADJ
bptjm-15	191	29	role	role	NOUN
bptjm-15	191	30	in	in	ADP
bptjm-15	191	31	bacterial	bacterial	ADJ
bptjm-15	191	32	signaling	signal	VERB
bptjm-15	191	33	(	(	PUNCT
bptjm-15	191	34	kaur	kaur	NOUN
bptjm-15	191	35	,	,	PUNCT
bptjm-15	191	36	2019	2019	NUM
bptjm-15	191	37	)	)	PUNCT
bptjm-15	191	38	.	.	PUNCT
bptjm-15	192	1	low	low	ADJ
bptjm-15	192	2	levels	level	NOUN
bptjm-15	192	3	of	of	ADP
bptjm-15	192	4	these	these	DET
bptjm-15	192	5	compounds	compound	NOUN
bptjm-15	192	6	are	be	AUX
bptjm-15	192	7	associated	associate	VERB
bptjm-15	192	8	with	with	ADP
bptjm-15	192	9	disorders	disorder	NOUN
bptjm-15	192	10	like	like	ADP
bptjm-15	192	11	major	major	ADJ
bptjm-15	192	12	depression	depression	NOUN
bptjm-15	192	13	,	,	PUNCT
bptjm-15	192	14	autism	autism	NOUN
bptjm-15	192	15	spectrum	spectrum	NOUN
bptjm-15	192	16	disorder	disorder	NOUN
bptjm-15	192	17	,	,	PUNCT
bptjm-15	192	18	berkeley	berkeley	PROPN
bptjm-15	192	19	pharma	pharma	PROPN
bptjm-15	192	20	tech	tech	NOUN
bptjm-15	192	21	journal	journal	NOUN
bptjm-15	192	22	of	of	ADP
bptjm-15	192	23	medicine	medicine	NOUN
bptjm-15	192	24	|	|	ADV
bptjm-15	192	25	77	77	NUM
bptjm-15	192	26	figure	figure	NOUN
bptjm-15	192	27	4	4	NUM
bptjm-15	192	28	.	.	PUNCT
bptjm-15	193	1	the	the	DET
bptjm-15	193	2	presence	presence	NOUN
bptjm-15	193	3	of	of	ADP
bptjm-15	193	4	bacteria	bacteria	NOUN
bptjm-15	193	5	f.	f.	PROPN
bptjm-15	193	6	prausnitzii	prausnitzii	PROPN
bptjm-15	193	7	in	in	ADP
bptjm-15	193	8	the	the	DET
bptjm-15	193	9	gut	gut	NOUN
bptjm-15	193	10	maintains	maintain	VERB
bptjm-15	193	11	the	the	DET
bptjm-15	193	12	integrity	integrity	NOUN
bptjm-15	193	13	of	of	ADP
bptjm-15	193	14	the	the	DET
bptjm-15	193	15	epithelial	epithelial	ADJ
bptjm-15	193	16	gut	gut	NOUN
bptjm-15	193	17	lining	lining	NOUN
bptjm-15	193	18	and	and	CCONJ
bptjm-15	193	19	inhibits	inhibit	VERB
bptjm-15	193	20	the	the	DET
bptjm-15	193	21	t	t	NOUN
bptjm-15	193	22	cell	cell	NOUN
bptjm-15	193	23	inflammatory	inflammatory	ADJ
bptjm-15	193	24	response	response	NOUN
bptjm-15	193	25	.	.	PUNCT
bptjm-15	194	1	the	the	DET
bptjm-15	194	2	absence	absence	NOUN
bptjm-15	194	3	of	of	ADP
bptjm-15	194	4	this	this	DET
bptjm-15	194	5	materia	materia	NOUN
bptjm-15	194	6	creates	create	VERB
bptjm-15	194	7	leaky	leaky	ADJ
bptjm-15	194	8	cell	cell	NOUN
bptjm-15	194	9	junctions	junction	NOUN
bptjm-15	194	10	in	in	ADP
bptjm-15	194	11	the	the	DET
bptjm-15	194	12	gut	gut	NOUN
bptjm-15	194	13	lining	lining	NOUN
bptjm-15	194	14	,	,	PUNCT
bptjm-15	194	15	which	which	PRON
bptjm-15	194	16	allow	allow	VERB
bptjm-15	194	17	for	for	ADP
bptjm-15	194	18	opportunistic	opportunistic	ADJ
bptjm-15	194	19	microbes	microbe	NOUN
bptjm-15	194	20	and	and	CCONJ
bptjm-15	194	21	toxins	toxin	NOUN
bptjm-15	194	22	to	to	PART
bptjm-15	194	23	enter	enter	VERB
bptjm-15	194	24	and	and	CCONJ
bptjm-15	194	25	activate	activate	VERB
bptjm-15	194	26	the	the	DET
bptjm-15	194	27	inflammatory	inflammatory	ADJ
bptjm-15	194	28	response	response	NOUN
bptjm-15	194	29	.	.	PUNCT
bptjm-15	195	1	and	and	CCONJ
bptjm-15	195	2	parkinson	parkinson	NOUN
bptjm-15	195	3	's	's	PART
bptjm-15	195	4	disease	disease	NOUN
bptjm-15	195	5	.	.	PUNCT
bptjm-15	196	1	researchers	researcher	NOUN
bptjm-15	196	2	have	have	AUX
bptjm-15	196	3	seen	see	VERB
bptjm-15	196	4	extensive	extensive	ADJ
bptjm-15	196	5	modulation	modulation	NOUN
bptjm-15	196	6	of	of	ADP
bptjm-15	196	7	these	these	DET
bptjm-15	196	8	metabolic	metabolic	NOUN
bptjm-15	196	9	pathways	pathway	NOUN
bptjm-15	196	10	from	from	ADP
bptjm-15	196	11	several	several	ADJ
bptjm-15	196	12	genera	genera	NOUN
bptjm-15	196	13	of	of	ADP
bptjm-15	196	14	gut	gut	NOUN
bptjm-15	196	15	bacteria	bacteria	NOUN
bptjm-15	196	16	which	which	PRON
bptjm-15	196	17	break	break	VERB
bptjm-15	196	18	down	down	ADP
bptjm-15	196	19	trp	trp	PROPN
bptjm-15	196	20	like	like	ADP
bptjm-15	196	21	clostridium	clostridium	NOUN
bptjm-15	196	22	,	,	PUNCT
bptjm-15	196	23	burkholderia	burkholderia	NOUN
bptjm-15	196	24	,	,	PUNCT
bptjm-15	196	25	streptomyces	streptomyce	NOUN
bptjm-15	196	26	,	,	PUNCT
bptjm-15	196	27	pseudomonas	pseudomona	NOUN
bptjm-15	196	28	,	,	PUNCT
bptjm-15	196	29	and	and	CCONJ
bptjm-15	196	30	bacillus	bacillus	NOUN
bptjm-15	196	31	(	(	PUNCT
bptjm-15	196	32	kaur	kaur	NOUN
bptjm-15	196	33	,	,	PUNCT
bptjm-15	196	34	2019	2019	NUM
bptjm-15	196	35	)	)	PUNCT
bptjm-15	196	36	.	.	PUNCT
bptjm-15	197	1	in	in	ADP
bptjm-15	197	2	addition	addition	NOUN
bptjm-15	197	3	,	,	PUNCT
bptjm-15	197	4	it	it	PRON
bptjm-15	197	5	is	be	AUX
bptjm-15	197	6	believed	believe	VERB
bptjm-15	197	7	that	that	SCONJ
bptjm-15	197	8	gut	gut	VERB
bptjm-15	197	9	microbiota	microbiota	NOUN
bptjm-15	197	10	contribute	contribute	VERB
bptjm-15	197	11	to	to	ADP
bptjm-15	197	12	the	the	DET
bptjm-15	197	13	availability	availability	NOUN
bptjm-15	197	14	of	of	ADP
bptjm-15	197	15	trp	trp	PROPN
bptjm-15	197	16	and	and	CCONJ
bptjm-15	197	17	the	the	DET
bptjm-15	197	18	neurotransmitter	neurotransmitter	NOUN
bptjm-15	197	19	5	5	NUM
bptjm-15	197	20	-	-	PUNCT
bptjm-15	197	21	hydroxytryptamine	hydroxytryptamine	NOUN
bptjm-15	197	22	,	,	PUNCT
bptjm-15	197	23	which	which	PRON
bptjm-15	197	24	regulates	regulate	VERB
bptjm-15	197	25	neuroendocrine	neuroendocrine	NOUN
bptjm-15	197	26	signaling	signal	VERB
bptjm-15	197	27	(	(	PUNCT
bptjm-15	197	28	martin	martin	PROPN
bptjm-15	197	29	,	,	PUNCT
bptjm-15	197	30	2018	2018	NUM
bptjm-15	197	31	)	)	PUNCT
bptjm-15	197	32	.	.	PUNCT
bptjm-15	198	1	5	5	NUM
bptjm-15	198	2	-	-	PUNCT
bptjm-15	198	3	hydroxytryptamine	hydroxytryptamine	NOUN
bptjm-15	198	4	,	,	PUNCT
bptjm-15	198	5	also	also	ADV
bptjm-15	198	6	known	know	VERB
bptjm-15	198	7	as	as	ADP
bptjm-15	198	8	serotonin	serotonin	NOUN
bptjm-15	198	9	,	,	PUNCT
bptjm-15	198	10	is	be	AUX
bptjm-15	198	11	important	important	ADJ
bptjm-15	198	12	in	in	ADP
bptjm-15	198	13	combating	combat	VERB
bptjm-15	198	14	the	the	DET
bptjm-15	198	15	comorbidities	comorbiditie	NOUN
bptjm-15	198	16	that	that	PRON
bptjm-15	198	17	often	often	ADV
bptjm-15	198	18	accompany	accompany	VERB
bptjm-15	198	19	ms	ms	PROPN
bptjm-15	198	20	.	.	PROPN
bptjm-15	198	21	namely	namely	ADV
bptjm-15	198	22	,	,	PUNCT
bptjm-15	198	23	major	major	ADJ
bptjm-15	198	24	depression	depression	NOUN
bptjm-15	198	25	and	and	CCONJ
bptjm-15	198	26	anxiety	anxiety	NOUN
bptjm-15	198	27	disorder	disorder	NOUN
bptjm-15	198	28	(	(	PUNCT
bptjm-15	198	29	kelly	kelly	PROPN
bptjm-15	198	30	,	,	PUNCT
bptjm-15	198	31	2016	2016	NUM
bptjm-15	198	32	;	;	PUNCT
bptjm-15	198	33	zheng	zheng	PROPN
bptjm-15	198	34	,	,	PUNCT
bptjm-15	198	35	2016	2016	NUM
bptjm-15	198	36	;	;	PUNCT
bptjm-15	198	37	winter	winter	NOUN
bptjm-15	198	38	,	,	PUNCT
bptjm-15	198	39	2018	2018	NUM
bptjm-15	198	40	)	)	PUNCT
bptjm-15	198	41	.	.	PUNCT
bptjm-15	199	1	however	however	ADV
bptjm-15	199	2	,	,	PUNCT
bptjm-15	199	3	there	there	PRON
bptjm-15	199	4	are	be	VERB
bptjm-15	199	5	a	a	DET
bptjm-15	199	6	multitude	multitude	NOUN
bptjm-15	199	7	of	of	ADP
bptjm-15	199	8	additional	additional	ADJ
bptjm-15	199	9	disorders	disorder	NOUN
bptjm-15	199	10	that	that	PRON
bptjm-15	199	11	may	may	AUX
bptjm-15	199	12	be	be	AUX
bptjm-15	199	13	associated	associate	VERB
bptjm-15	199	14	with	with	ADP
bptjm-15	199	15	gut	gut	NOUN
bptjm-15	199	16	microbiota	microbiota	NOUN
bptjm-15	199	17	including	include	VERB
bptjm-15	199	18	obesity	obesity	NOUN
bptjm-15	199	19	,	,	PUNCT
bptjm-15	199	20	diabetes	diabetes	NOUN
bptjm-15	199	21	mellitus	mellitus	NOUN
bptjm-15	199	22	,	,	PUNCT
bptjm-15	199	23	schizophrenia	schizophrenia	NOUN
bptjm-15	199	24	,	,	PUNCT
bptjm-15	199	25	and	and	CCONJ
bptjm-15	199	26	autistic	autistic	ADJ
bptjm-15	199	27	disorders	disorder	NOUN
bptjm-15	199	28	(	(	PUNCT
bptjm-15	199	29	evrensel	evrensel	NOUN
bptjm-15	199	30	,	,	PUNCT
bptjm-15	199	31	2015	2015	NUM
bptjm-15	199	32	)	)	PUNCT
bptjm-15	199	33	.	.	PUNCT
bptjm-15	200	1	changes	change	NOUN
bptjm-15	200	2	in	in	ADP
bptjm-15	200	3	gut	gut	NOUN
bptjm-15	200	4	microbiota	microbiota	NOUN
bptjm-15	200	5	are	be	AUX
bptjm-15	200	6	relevant	relevant	ADJ
bptjm-15	200	7	to	to	ADP
bptjm-15	200	8	mood	mood	NOUN
bptjm-15	200	9	states	state	NOUN
bptjm-15	200	10	due	due	ADP
bptjm-15	200	11	to	to	ADP
bptjm-15	200	12	their	their	PRON
bptjm-15	200	13	contribution	contribution	NOUN
bptjm-15	200	14	to	to	ADP
bptjm-15	200	15	the	the	DET
bptjm-15	200	16	production	production	NOUN
bptjm-15	200	17	of	of	ADP
bptjm-15	200	18	neurotransmitters	neurotransmitter	NOUN
bptjm-15	200	19	(	(	PUNCT
bptjm-15	200	20	mittal	mittal	NOUN
bptjm-15	200	21	,	,	PUNCT
bptjm-15	200	22	2017	2017	NUM
bptjm-15	200	23	)	)	PUNCT
bptjm-15	200	24	.	.	PUNCT
bptjm-15	201	1	regulation	regulation	NOUN
bptjm-15	201	2	of	of	ADP
bptjm-15	201	3	this	this	DET
bptjm-15	201	4	pathway	pathway	NOUN
bptjm-15	201	5	appears	appear	VERB
bptjm-15	201	6	to	to	PART
bptjm-15	201	7	be	be	AUX
bptjm-15	201	8	extremely	extremely	ADV
bptjm-15	201	9	important	important	ADJ
bptjm-15	201	10	for	for	ADP
bptjm-15	201	11	the	the	DET
bptjm-15	201	12	development	development	NOUN
bptjm-15	201	13	of	of	ADP
bptjm-15	201	14	gut	gut	NOUN
bptjm-15	201	15	-	-	PUNCT
bptjm-15	201	16	based	base	VERB
bptjm-15	201	17	ms	ms	NOUN
bptjm-15	201	18	therapy	therapy	NOUN
bptjm-15	201	19	.	.	PUNCT
bptjm-15	202	1	however	however	ADV
bptjm-15	202	2	,	,	PUNCT
bptjm-15	202	3	while	while	SCONJ
bptjm-15	202	4	the	the	DET
bptjm-15	202	5	formation	formation	NOUN
bptjm-15	202	6	of	of	ADP
bptjm-15	202	7	trp	trp	PROPN
bptjm-15	202	8	metabolites	metabolite	NOUN
bptjm-15	202	9	is	be	AUX
bptjm-15	202	10	a	a	DET
bptjm-15	202	11	key	key	ADJ
bptjm-15	202	12	pathway	pathway	NOUN
bptjm-15	202	13	,	,	PUNCT
bptjm-15	202	14	there	there	PRON
bptjm-15	202	15	are	be	VERB
bptjm-15	202	16	various	various	ADJ
bptjm-15	202	17	other	other	ADJ
bptjm-15	202	18	important	important	ADJ
bptjm-15	202	19	metabolites	metabolite	NOUN
bptjm-15	202	20	that	that	PRON
bptjm-15	202	21	should	should	AUX
bptjm-15	202	22	be	be	AUX
bptjm-15	202	23	considered	consider	VERB
bptjm-15	202	24	.	.	PUNCT
bptjm-15	203	1	secondary	secondary	ADJ
bptjm-15	203	2	bile	bile	NOUN
bptjm-15	203	3	acids	acid	NOUN
bptjm-15	203	4	(	(	PUNCT
bptjm-15	203	5	2bas	2bas	NUM
bptjm-15	203	6	)	)	PUNCT
bptjm-15	203	7	are	be	AUX
bptjm-15	203	8	strongly	strongly	ADV
bptjm-15	203	9	in	in	ADP
bptjm-15	203	10	�	�	PROPN
bptjm-15	203	11	uenced	uence	VERB
bptjm-15	203	12	by	by	ADP
bptjm-15	203	13	microbial	microbial	ADJ
bptjm-15	203	14	activity	activity	NOUN
bptjm-15	203	15	and	and	CCONJ
bptjm-15	203	16	activate	activate	VERB
bptjm-15	203	17	the	the	DET
bptjm-15	203	18	intestinal	intestinal	ADJ
bptjm-15	203	19	l	l	NOUN
bptjm-15	203	20	cell	cell	NOUN
bptjm-15	203	21	’s	’s	PART
bptjm-15	203	22	surface	surface	NOUN
bptjm-15	203	23	g	g	PROPN
bptjm-15	203	24	protein	protein	NOUN
bptjm-15	203	25	-	-	PUNCT
bptjm-15	203	26	coupled	couple	VERB
bptjm-15	203	27	bile	bile	NOUN
bptjm-15	203	28	acid	acid	NOUN
bptjm-15	203	29	receptors	receptor	NOUN
bptjm-15	203	30	(	(	PUNCT
bptjm-15	203	31	martin	martin	X
bptjm-15	203	32	,	,	PUNCT
bptjm-15	203	33	2018	2018	NUM
bptjm-15	203	34	)	)	PUNCT
bptjm-15	203	35	.	.	PUNCT
bptjm-15	204	1	2bas	2bas	NUM
bptjm-15	204	2	derived	derive	VERB
bptjm-15	204	3	from	from	ADP
bptjm-15	204	4	spore	spore	ADJ
bptjm-15	204	5	-	-	PUNCT
bptjm-15	204	6	forming	form	VERB
bptjm-15	204	7	bacteria	bacteria	NOUN
bptjm-15	204	8	of	of	ADP
bptjm-15	204	9	the	the	DET
bptjm-15	204	10	gut	gut	NOUN
bptjm-15	204	11	regulate	regulate	VERB
bptjm-15	204	12	a	a	DET
bptjm-15	204	13	signi	signi	ADJ
bptjm-15	204	14	�	�	NOUN
bptjm-15	204	15	cant	cant	VERB
bptjm-15	204	16	percentage	percentage	NOUN
bptjm-15	204	17	of	of	ADP
bptjm-15	204	18	5	5	NUM
bptjm-15	204	19	-	-	PUNCT
bptjm-15	204	20	ht	ht	NOUN
bptjm-15	204	21	synthesis	synthesis	NOUN
bptjm-15	204	22	and	and	CCONJ
bptjm-15	204	23	release	release	NOUN
bptjm-15	204	24	from	from	ADP
bptjm-15	204	25	enterochroma	enterochroma	PROPN
bptjm-15	204	26	�	�	PROPN
bptjm-15	204	27	n	n	PART
bptjm-15	204	28	cells	cell	NOUN
bptjm-15	204	29	,	,	PUNCT
bptjm-15	204	30	introducing	introduce	VERB
bptjm-15	204	31	another	another	DET
bptjm-15	204	32	intriguing	intriguing	ADJ
bptjm-15	204	33	connection	connection	NOUN
bptjm-15	204	34	between	between	ADP
bptjm-15	204	35	gut	gut	NOUN
bptjm-15	204	36	metabolites	metabolite	NOUN
bptjm-15	204	37	(	(	PUNCT
bptjm-15	204	38	yano	yano	ADJ
bptjm-15	204	39	,	,	PUNCT
bptjm-15	204	40	2015	2015	NUM
bptjm-15	204	41	)	)	PUNCT
bptjm-15	204	42	.	.	PUNCT
bptjm-15	205	1	short	short	ADJ
bptjm-15	205	2	-	-	PUNCT
bptjm-15	205	3	chain	chain	NOUN
bptjm-15	205	4	fatty	fatty	NOUN
bptjm-15	205	5	acid	acid	NOUN
bptjm-15	205	6	(	(	PUNCT
bptjm-15	205	7	scfa	scfa	NOUN
bptjm-15	205	8	)	)	PUNCT
bptjm-15	205	9	synthesis	synthesis	NOUN
bptjm-15	205	10	is	be	AUX
bptjm-15	205	11	another	another	DET
bptjm-15	205	12	metabolic	metabolic	NOUN
bptjm-15	205	13	pathway	pathway	NOUN
bptjm-15	205	14	that	that	PRON
bptjm-15	205	15	is	be	AUX
bptjm-15	205	16	a	a	DET
bptjm-15	205	17	�	�	NOUN
bptjm-15	205	18	ected	ecte	VERB
bptjm-15	205	19	by	by	ADP
bptjm-15	205	20	gut	gut	NOUN
bptjm-15	205	21	bacteria	bacteria	NOUN
bptjm-15	205	22	,	,	PUNCT
bptjm-15	205	23	often	often	ADV
bptjm-15	205	24	through	through	ADP
bptjm-15	205	25	bacterial	bacterial	ADJ
bptjm-15	205	26	fermentation	fermentation	NOUN
bptjm-15	205	27	or	or	CCONJ
bptjm-15	205	28	host	host	NOUN
bptjm-15	205	29	protein	protein	NOUN
bptjm-15	205	30	glycosylation	glycosylation	NOUN
bptjm-15	205	31	.	.	PUNCT
bptjm-15	206	1	microbial	microbial	ADJ
bptjm-15	206	2	fermentation	fermentation	NOUN
bptjm-15	206	3	(	(	PUNCT
bptjm-15	206	4	primarily	primarily	ADV
bptjm-15	206	5	by	by	ADP
bptjm-15	206	6	bacteroidetes	bacteroidete	NOUN
bptjm-15	206	7	)	)	PUNCT
bptjm-15	206	8	leading	lead	VERB
bptjm-15	206	9	to	to	ADP
bptjm-15	206	10	scfa	scfa	ADJ
bptjm-15	206	11	production	production	NOUN
bptjm-15	206	12	in	in	ADP
bptjm-15	206	13	the	the	DET
bptjm-15	206	14	colon	colon	NOUN
bptjm-15	206	15	and	and	CCONJ
bptjm-15	206	16	blood	blood	NOUN
bptjm-15	206	17	is	be	AUX
bptjm-15	206	18	believed	believe	VERB
bptjm-15	206	19	to	to	PART
bptjm-15	206	20	play	play	VERB
bptjm-15	206	21	a	a	DET
bptjm-15	206	22	critical	critical	ADJ
bptjm-15	206	23	role	role	NOUN
bptjm-15	206	24	in	in	ADP
bptjm-15	206	25	immunoregulation	immunoregulation	NOUN
bptjm-15	206	26	(	(	PUNCT
bptjm-15	206	27	choileáin	choileáin	ADJ
bptjm-15	206	28	,	,	PUNCT
bptjm-15	206	29	2020	2020	NUM
bptjm-15	206	30	)	)	PUNCT
bptjm-15	206	31	.	.	PUNCT
bptjm-15	207	1	furthermore	furthermore	ADV
bptjm-15	207	2	,	,	PUNCT
bptjm-15	207	3	the	the	DET
bptjm-15	207	4	biochemical	biochemical	ADJ
bptjm-15	207	5	conversion	conversion	NOUN
bptjm-15	207	6	of	of	ADP
bptjm-15	207	7	nutrients	nutrient	NOUN
bptjm-15	207	8	into	into	ADP
bptjm-15	207	9	scfas	scfas	NOUN
bptjm-15	207	10	and	and	CCONJ
bptjm-15	207	11	other	other	ADJ
bptjm-15	207	12	amino	amino	NOUN
bptjm-15	207	13	acid	acid	NOUN
bptjm-15	207	14	-	-	PUNCT
bptjm-15	207	15	derived	derive	VERB
bptjm-15	207	16	metabolites	metabolite	NOUN
bptjm-15	207	17	like	like	ADP
bptjm-15	207	18	5	5	NUM
bptjm-15	207	19	-	-	SYM
bptjm-15	207	20	ht	ht	NOUN
bptjm-15	207	21	are	be	AUX
bptjm-15	207	22	often	often	ADV
bptjm-15	207	23	conducted	conduct	VERB
bptjm-15	207	24	by	by	ADP
bptjm-15	207	25	intestinal	intestinal	ADJ
bptjm-15	207	26	microbes	microbe	NOUN
bptjm-15	207	27	(	(	PUNCT
bptjm-15	207	28	hemarajata	hemarajata	PROPN
bptjm-15	207	29	,	,	PUNCT
bptjm-15	207	30	2013	2013	NUM
bptjm-15	207	31	)	)	PUNCT
bptjm-15	207	32	.	.	PUNCT
bptjm-15	208	1	these	these	DET
bptjm-15	208	2	peptides	peptide	NOUN
bptjm-15	208	3	function	function	VERB
bptjm-15	208	4	as	as	ADP
bptjm-15	208	5	immunomodulators	immunomodulator	NOUN
bptjm-15	208	6	through	through	ADP
bptjm-15	208	7	mechanisms	mechanism	NOUN
bptjm-15	208	8	including	include	VERB
bptjm-15	208	9	(	(	PUNCT
bptjm-15	208	10	park	park	NOUN
bptjm-15	208	11	,	,	PUNCT
bptjm-15	208	12	2019	2019	NUM
bptjm-15	208	13	):	):	PUNCT
bptjm-15	208	14	1	1	NUM
bptjm-15	208	15	.	.	X
bptjm-15	208	16	metabolic	metabolic	NOUN
bptjm-15	208	17	integration	integration	NOUN
bptjm-15	208	18	,	,	PUNCT
bptjm-15	208	19	or	or	CCONJ
bptjm-15	208	20	the	the	DET
bptjm-15	208	21	integration	integration	NOUN
bptjm-15	208	22	of	of	ADP
bptjm-15	208	23	two	two	NUM
bptjm-15	208	24	or	or	CCONJ
bptjm-15	208	25	more	more	ADJ
bptjm-15	208	26	metabolites	metabolite	NOUN
bptjm-15	208	27	2	2	NUM
bptjm-15	208	28	.	.	PUNCT
bptjm-15	208	29	microbiota	microbiota	NOUN
bptjm-15	208	30	regulation	regulation	NOUN
bptjm-15	208	31	3	3	NUM
bptjm-15	208	32	.	.	X
bptjm-15	208	33	histone	histone	NOUN
bptjm-15	208	34	deacetylase	deacetylase	PROPN
bptjm-15	208	35	(	(	PUNCT
bptjm-15	208	36	hdac	hdac	NOUN
bptjm-15	208	37	)	)	PUNCT
bptjm-15	208	38	inhibition	inhibition	NOUN
bptjm-15	208	39	,	,	PUNCT
bptjm-15	208	40	which	which	PRON
bptjm-15	208	41	is	be	AUX
bptjm-15	208	42	involved	involve	VERB
bptjm-15	208	43	in	in	ADP
bptjm-15	208	44	epigenetic	epigenetic	ADJ
bptjm-15	208	45	berkeley	berkeley	PROPN
bptjm-15	208	46	pharma	pharma	PROPN
bptjm-15	208	47	tech	tech	NOUN
bptjm-15	208	48	journal	journal	NOUN
bptjm-15	208	49	of	of	ADP
bptjm-15	208	50	medicine	medicine	NOUN
bptjm-15	208	51	|	|	ADV
bptjm-15	208	52	78	78	NUM
bptjm-15	208	53	or	or	CCONJ
bptjm-15	208	54	non	non	ADJ
bptjm-15	208	55	-	-	ADJ
bptjm-15	208	56	epigenetic	epigenetic	ADJ
bptjm-15	208	57	regulation	regulation	NOUN
bptjm-15	208	58	of	of	ADP
bptjm-15	208	59	cancer	cancer	NOUN
bptjm-15	208	60	cells	cell	NOUN
bptjm-15	208	61	4	4	NUM
bptjm-15	208	62	.	.	PUNCT
bptjm-15	209	1	g	g	NOUN
bptjm-15	209	2	-	-	PUNCT
bptjm-15	209	3	protein	protein	NOUN
bptjm-15	209	4	coupled	couple	VERB
bptjm-15	209	5	receptor	receptor	NOUN
bptjm-15	209	6	(	(	PUNCT
bptjm-15	209	7	gpcrs	gpcrs	PROPN
bptjm-15	209	8	)	)	PUNCT
bptjm-15	209	9	activation	activation	NOUN
bptjm-15	209	10	that	that	PRON
bptjm-15	209	11	plays	play	VERB
bptjm-15	209	12	a	a	DET
bptjm-15	209	13	role	role	NOUN
bptjm-15	209	14	in	in	ADP
bptjm-15	209	15	the	the	DET
bptjm-15	209	16	cellular	cellular	ADJ
bptjm-15	209	17	signal	signal	NOUN
bptjm-15	209	18	transduction	transduction	NOUN
bptjm-15	209	19	pathway	pathway	NOUN
bptjm-15	209	20	the	the	DET
bptjm-15	209	21	proin	proin	NOUN
bptjm-15	209	22	�	�	NOUN
bptjm-15	209	23	ammatory	ammatory	NOUN
bptjm-15	209	24	cytokines	cytokine	VERB
bptjm-15	209	25	tumor	tumor	NOUN
bptjm-15	209	26	necrosis	necrosis	NOUN
bptjm-15	209	27	factor	factor	NOUN
bptjm-15	209	28	-	-	PUNCT
bptjm-15	209	29	alpha	alpha	NOUN
bptjm-15	209	30	(	(	PUNCT
bptjm-15	209	31	tnf	tnf	PROPN
bptjm-15	209	32	-	-	PUNCT
bptjm-15	209	33	α	α	NOUN
bptjm-15	209	34	)	)	PUNCT
bptjm-15	209	35	and	and	CCONJ
bptjm-15	209	36	il-1β	il-1β	PROPN
bptjm-15	209	37	even	even	ADV
bptjm-15	209	38	see	see	VERB
bptjm-15	209	39	an	an	DET
bptjm-15	209	40	increased	increase	VERB
bptjm-15	209	41	level	level	NOUN
bptjm-15	209	42	after	after	ADP
bptjm-15	209	43	scfa	scfa	ADJ
bptjm-15	209	44	induction	induction	NOUN
bptjm-15	209	45	of	of	ADP
bptjm-15	209	46	the	the	DET
bptjm-15	209	47	gut	gut	NOUN
bptjm-15	209	48	-	-	PUNCT
bptjm-15	209	49	immune	immune	ADJ
bptjm-15	209	50	system	system	NOUN
bptjm-15	209	51	(	(	PUNCT
bptjm-15	209	52	galland	galland	ADJ
bptjm-15	209	53	,	,	PUNCT
bptjm-15	209	54	2014	2014	NUM
bptjm-15	209	55	)	)	PUNCT
bptjm-15	209	56	.	.	PUNCT
bptjm-15	210	1	scfas	scfas	PROPN
bptjm-15	210	2	have	have	AUX
bptjm-15	210	3	been	be	AUX
bptjm-15	210	4	shown	show	VERB
bptjm-15	210	5	to	to	PART
bptjm-15	210	6	upregulate	upregulate	VERB
bptjm-15	210	7	or	or	CCONJ
bptjm-15	210	8	downregulate	downregulate	ADJ
bptjm-15	210	9	primary	primary	ADJ
bptjm-15	210	10	immune	immune	ADJ
bptjm-15	210	11	cells	cell	NOUN
bptjm-15	210	12	such	such	ADJ
bptjm-15	210	13	as	as	ADP
bptjm-15	210	14	cd4	cd4	PROPN
bptjm-15	210	15	+	+	PROPN
bptjm-15	210	16	e	e	PROPN
bptjm-15	210	17	�	�	PROPN
bptjm-15	210	18	ector	ector	NOUN
bptjm-15	210	19	cells	cell	NOUN
bptjm-15	210	20	and	and	CCONJ
bptjm-15	210	21	il10	il10	PROPN
bptjm-15	210	22	+	+	CCONJ
bptjm-15	210	23	tregs	treg	NOUN
bptjm-15	210	24	in	in	ADP
bptjm-15	210	25	mice	mouse	NOUN
bptjm-15	210	26	with	with	ADP
bptjm-15	210	27	experimental	experimental	ADJ
bptjm-15	210	28	autoimmune	autoimmune	ADJ
bptjm-15	210	29	encephalitis	encephalitis	NOUN
bptjm-15	210	30	(	(	PUNCT
bptjm-15	210	31	eae	eae	PROPN
bptjm-15	210	32	)	)	PUNCT
bptjm-15	210	33	,	,	PUNCT
bptjm-15	210	34	a	a	DET
bptjm-15	210	35	disease	disease	NOUN
bptjm-15	210	36	with	with	ADP
bptjm-15	210	37	pathogenesis	pathogenesis	NOUN
bptjm-15	210	38	similar	similar	ADJ
bptjm-15	210	39	to	to	ADP
bptjm-15	210	40	ms	ms	PROPN
bptjm-15	210	41	(	(	PUNCT
bptjm-15	210	42	höftberger	höftberger	NOUN
bptjm-15	210	43	,	,	PUNCT
bptjm-15	210	44	2015	2015	NUM
bptjm-15	210	45	)	)	PUNCT
bptjm-15	210	46	.	.	PUNCT
bptjm-15	211	1	some	some	DET
bptjm-15	211	2	scfas	scfas	NOUN
bptjm-15	211	3	can	can	AUX
bptjm-15	211	4	contribute	contribute	VERB
bptjm-15	211	5	to	to	ADP
bptjm-15	211	6	the	the	DET
bptjm-15	211	7	anti	anti	ADJ
bptjm-15	211	8	-	-	ADJ
bptjm-15	211	9	in	in	ADP
bptjm-15	211	10	�	�	NOUN
bptjm-15	211	11	ammatory	ammatory	NOUN
bptjm-15	211	12	response	response	NOUN
bptjm-15	211	13	by	by	ADP
bptjm-15	211	14	stimulating	stimulate	VERB
bptjm-15	211	15	il-10	il-10	PRON
bptjm-15	211	16	production	production	NOUN
bptjm-15	211	17	while	while	SCONJ
bptjm-15	211	18	others	other	NOUN
bptjm-15	211	19	,	,	PUNCT
bptjm-15	211	20	for	for	ADP
bptjm-15	211	21	example	example	NOUN
bptjm-15	211	22	,	,	PUNCT
bptjm-15	211	23	the	the	DET
bptjm-15	211	24	g	g	NOUN
bptjm-15	211	25	-	-	PUNCT
bptjm-15	211	26	protein	protein	NOUN
bptjm-15	211	27	coupled	couple	VERB
bptjm-15	211	28	receptors	receptor	NOUN
bptjm-15	211	29	gpr41	gpr41	PROPN
bptjm-15	211	30	and	and	CCONJ
bptjm-15	211	31	gpr43	gpr43	NOUN
bptjm-15	211	32	,	,	PUNCT
bptjm-15	211	33	may	may	AUX
bptjm-15	211	34	initiate	initiate	VERB
bptjm-15	211	35	a	a	DET
bptjm-15	211	36	pro	pro	ADJ
bptjm-15	211	37	-	-	ADJ
bptjm-15	211	38	in	in	ADP
bptjm-15	211	39	�	�	NOUN
bptjm-15	211	40	ammatory	ammatory	NOUN
bptjm-15	211	41	response	response	NOUN
bptjm-15	211	42	.	.	PUNCT
bptjm-15	212	1	however	however	ADV
bptjm-15	212	2	,	,	PUNCT
bptjm-15	212	3	further	further	ADJ
bptjm-15	212	4	research	research	NOUN
bptjm-15	212	5	must	must	AUX
bptjm-15	212	6	occur	occur	VERB
bptjm-15	212	7	to	to	PART
bptjm-15	212	8	determine	determine	VERB
bptjm-15	212	9	the	the	DET
bptjm-15	212	10	exact	exact	ADJ
bptjm-15	212	11	relationship	relationship	NOUN
bptjm-15	212	12	between	between	ADP
bptjm-15	212	13	scfas	scfas	NOUN
bptjm-15	212	14	and	and	CCONJ
bptjm-15	212	15	related	related	ADJ
bptjm-15	212	16	immune	immune	ADJ
bptjm-15	212	17	cells	cell	NOUN
bptjm-15	212	18	,	,	PUNCT
bptjm-15	212	19	as	as	ADV
bptjm-15	212	20	well	well	ADV
bptjm-15	212	21	as	as	ADP
bptjm-15	212	22	the	the	DET
bptjm-15	212	23	pathways	pathway	NOUN
bptjm-15	212	24	through	through	ADP
bptjm-15	212	25	which	which	PRON
bptjm-15	212	26	this	this	PRON
bptjm-15	212	27	in	in	ADP
bptjm-15	212	28	�	�	PROPN
bptjm-15	212	29	ammation	ammation	NOUN
bptjm-15	212	30	occurs	occur	VERB
bptjm-15	212	31	(	(	PUNCT
bptjm-15	212	32	park	park	NOUN
bptjm-15	212	33	,	,	PUNCT
bptjm-15	212	34	2019	2019	NUM
bptjm-15	212	35	)	)	PUNCT
bptjm-15	212	36	.	.	PUNCT
bptjm-15	213	1	gut	gut	NOUN
bptjm-15	213	2	-	-	PUNCT
bptjm-15	213	3	immune	immune	ADJ
bptjm-15	213	4	interactions	interaction	NOUN
bptjm-15	213	5	proteins	protein	NOUN
bptjm-15	213	6	an	an	DET
bptjm-15	213	7	important	important	ADJ
bptjm-15	213	8	part	part	NOUN
bptjm-15	213	9	of	of	ADP
bptjm-15	213	10	gut	gut	NOUN
bptjm-15	213	11	-	-	PUNCT
bptjm-15	213	12	immune	immune	ADJ
bptjm-15	213	13	interactions	interaction	NOUN
bptjm-15	213	14	is	be	AUX
bptjm-15	213	15	the	the	DET
bptjm-15	213	16	e	e	NOUN
bptjm-15	213	17	�	�	NOUN
bptjm-15	213	18	ect	ect	VERB
bptjm-15	213	19	that	that	SCONJ
bptjm-15	213	20	they	they	PRON
bptjm-15	213	21	have	have	VERB
bptjm-15	213	22	on	on	ADP
bptjm-15	213	23	toll	toll	NOUN
bptjm-15	213	24	-	-	PUNCT
bptjm-15	213	25	like	like	ADJ
bptjm-15	213	26	receptors	receptor	NOUN
bptjm-15	213	27	(	(	PUNCT
bptjm-15	213	28	tlrs	tlrs	NOUN
bptjm-15	213	29	)	)	PUNCT
bptjm-15	213	30	.	.	PUNCT
bptjm-15	214	1	a	a	DET
bptjm-15	214	2	few	few	ADJ
bptjm-15	214	3	studies	study	NOUN
bptjm-15	214	4	have	have	AUX
bptjm-15	214	5	suggested	suggest	VERB
bptjm-15	214	6	there	there	PRON
bptjm-15	214	7	is	be	VERB
bptjm-15	214	8	a	a	DET
bptjm-15	214	9	connection	connection	NOUN
bptjm-15	214	10	between	between	ADP
bptjm-15	214	11	tlr2	tlr2	PROPN
bptjm-15	214	12	,	,	PUNCT
bptjm-15	214	13	and	and	CCONJ
bptjm-15	214	14	its	its	PRON
bptjm-15	214	15	signaling	signal	VERB
bptjm-15	214	16	pathway	pathway	NOUN
bptjm-15	214	17	,	,	PUNCT
bptjm-15	214	18	that	that	PRON
bptjm-15	214	19	ties	tie	VERB
bptjm-15	214	20	ms	ms	NOUN
bptjm-15	214	21	to	to	ADP
bptjm-15	214	22	the	the	DET
bptjm-15	214	23	microbiome	microbiome	NOUN
bptjm-15	214	24	(	(	PUNCT
bptjm-15	214	25	wang	wang	PROPN
bptjm-15	214	26	,	,	PUNCT
bptjm-15	214	27	2014	2014	NUM
bptjm-15	214	28	;	;	PUNCT
bptjm-15	214	29	wasko	wasko	ADV
bptjm-15	214	30	,	,	PUNCT
bptjm-15	214	31	2020	2020	NUM
bptjm-15	214	32	)	)	PUNCT
bptjm-15	214	33	.	.	PUNCT
bptjm-15	215	1	tlr2	tlr2	PROPN
bptjm-15	215	2	can	can	AUX
bptjm-15	215	3	be	be	AUX
bptjm-15	215	4	stimulated	stimulate	VERB
bptjm-15	215	5	by	by	ADP
bptjm-15	215	6	bacterial	bacterial	ADJ
bptjm-15	215	7	lipopeptides	lipopeptide	NOUN
bptjm-15	215	8	.	.	PUNCT
bptjm-15	216	1	in	in	ADP
bptjm-15	216	2	murine	murine	ADJ
bptjm-15	216	3	models	model	NOUN
bptjm-15	216	4	of	of	ADP
bptjm-15	216	5	ms	ms	NOUN
bptjm-15	216	6	,	,	PUNCT
bptjm-15	216	7	microbial	microbial	ADJ
bptjm-15	216	8	injections	injection	NOUN
bptjm-15	216	9	inducing	induce	VERB
bptjm-15	216	10	tlr2	tlr2	NOUN
bptjm-15	216	11	tolerance	tolerance	NOUN
bptjm-15	216	12	have	have	AUX
bptjm-15	216	13	shown	show	VERB
bptjm-15	216	14	inhibition	inhibition	NOUN
bptjm-15	216	15	of	of	ADP
bptjm-15	216	16	cns	cns	NOUN
bptjm-15	216	17	in	in	ADP
bptjm-15	216	18	�	�	PROPN
bptjm-15	216	19	ammation	ammation	NOUN
bptjm-15	216	20	while	while	SCONJ
bptjm-15	216	21	improving	improve	VERB
bptjm-15	216	22	remyelination	remyelination	NOUN
bptjm-15	216	23	(	(	PUNCT
bptjm-15	216	24	wasko	wasko	ADV
bptjm-15	216	25	,	,	PUNCT
bptjm-15	216	26	2020	2020	NUM
bptjm-15	216	27	)	)	PUNCT
bptjm-15	216	28	.	.	PUNCT
bptjm-15	217	1	another	another	DET
bptjm-15	217	2	protein	protein	NOUN
bptjm-15	217	3	,	,	PUNCT
bptjm-15	217	4	tlr4	tlr4	PROPN
bptjm-15	217	5	,	,	PUNCT
bptjm-15	217	6	has	have	AUX
bptjm-15	217	7	also	also	ADV
bptjm-15	217	8	displayed	display	VERB
bptjm-15	217	9	responses	response	NOUN
bptjm-15	217	10	to	to	ADP
bptjm-15	217	11	lipopolysaccharides	lipopolysaccharide	NOUN
bptjm-15	217	12	(	(	PUNCT
bptjm-15	217	13	lps	lps	PROPN
bptjm-15	217	14	)	)	PUNCT
bptjm-15	217	15	from	from	ADP
bptjm-15	217	16	gram	gram	NOUN
bptjm-15	217	17	-	-	PUNCT
bptjm-15	217	18	negative	negative	ADJ
bptjm-15	217	19	bacteria	bacteria	NOUN
bptjm-15	217	20	(	(	PUNCT
bptjm-15	217	21	park	park	NOUN
bptjm-15	217	22	,	,	PUNCT
bptjm-15	217	23	2009	2009	NUM
bptjm-15	217	24	)	)	PUNCT
bptjm-15	217	25	.	.	PUNCT
bptjm-15	218	1	in	in	ADP
bptjm-15	218	2	practice	practice	NOUN
bptjm-15	218	3	,	,	PUNCT
bptjm-15	218	4	lack	lack	NOUN
bptjm-15	218	5	of	of	ADP
bptjm-15	218	6	exposure	exposure	NOUN
bptjm-15	218	7	to	to	ADP
bptjm-15	218	8	lps	lps	PROPN
bptjm-15	218	9	from	from	ADP
bptjm-15	218	10	gut	gut	NOUN
bptjm-15	218	11	bacteria	bacteria	NOUN
bptjm-15	218	12	resulted	result	VERB
bptjm-15	218	13	in	in	ADP
bptjm-15	218	14	a	a	DET
bptjm-15	218	15	lack	lack	NOUN
bptjm-15	218	16	of	of	ADP
bptjm-15	218	17	tlr4	tlr4	NOUN
bptjm-15	218	18	tolerance	tolerance	NOUN
bptjm-15	218	19	,	,	PUNCT
bptjm-15	218	20	resulting	result	VERB
bptjm-15	218	21	in	in	ADP
bptjm-15	218	22	de	de	PROPN
bptjm-15	218	23	�	�	PROPN
bptjm-15	218	24	cient	cient	NOUN
bptjm-15	218	25	regulation	regulation	NOUN
bptjm-15	218	26	of	of	ADP
bptjm-15	218	27	innate	innate	ADJ
bptjm-15	218	28	immune	immune	ADJ
bptjm-15	218	29	tlr	tlr	PROPN
bptjm-15	218	30	responses	response	NOUN
bptjm-15	218	31	and	and	CCONJ
bptjm-15	218	32	enhanced	enhanced	ADJ
bptjm-15	218	33	autoimmunity	autoimmunity	NOUN
bptjm-15	218	34	(	(	PUNCT
bptjm-15	218	35	wasko	wasko	ADV
bptjm-15	218	36	,	,	PUNCT
bptjm-15	218	37	2020	2020	NUM
bptjm-15	218	38	)	)	PUNCT
bptjm-15	218	39	.	.	PUNCT
bptjm-15	219	1	gut	gut	NOUN
bptjm-15	219	2	-	-	PUNCT
bptjm-15	219	3	immune	immune	ADJ
bptjm-15	219	4	interactions	interaction	NOUN
bptjm-15	219	5	cytokines	cytokine	NOUN
bptjm-15	219	6	when	when	SCONJ
bptjm-15	219	7	researching	research	VERB
bptjm-15	219	8	the	the	DET
bptjm-15	219	9	gut	gut	NOUN
bptjm-15	219	10	-	-	PUNCT
bptjm-15	219	11	brain	brain	NOUN
bptjm-15	219	12	axis	axis	NOUN
bptjm-15	219	13	relationship	relationship	NOUN
bptjm-15	219	14	,	,	PUNCT
bptjm-15	219	15	it	it	PRON
bptjm-15	219	16	is	be	AUX
bptjm-15	219	17	important	important	ADJ
bptjm-15	219	18	to	to	PART
bptjm-15	219	19	understand	understand	VERB
bptjm-15	219	20	how	how	SCONJ
bptjm-15	219	21	each	each	DET
bptjm-15	219	22	micro	micro	NOUN
bptjm-15	219	23	or	or	CCONJ
bptjm-15	219	24	macromolecule	macromolecule	NOUN
bptjm-15	219	25	a	a	DET
bptjm-15	219	26	�	�	NOUN
bptjm-15	219	27	ects	ect	VERB
bptjm-15	219	28	both	both	DET
bptjm-15	219	29	sides	side	NOUN
bptjm-15	219	30	of	of	ADP
bptjm-15	219	31	this	this	DET
bptjm-15	219	32	a	a	DET
bptjm-15	219	33	�	�	NOUN
bptjm-15	219	34	liation	liation	NOUN
bptjm-15	219	35	.	.	PUNCT
bptjm-15	220	1	with	with	ADP
bptjm-15	220	2	the	the	DET
bptjm-15	220	3	importance	importance	NOUN
bptjm-15	220	4	of	of	ADP
bptjm-15	220	5	cytokines	cytokine	NOUN
bptjm-15	220	6	in	in	ADP
bptjm-15	220	7	the	the	DET
bptjm-15	220	8	formation	formation	NOUN
bptjm-15	220	9	of	of	ADP
bptjm-15	220	10	ms	ms	NOUN
bptjm-15	220	11	lesions	lesion	NOUN
bptjm-15	220	12	,	,	PUNCT
bptjm-15	220	13	these	these	DET
bptjm-15	220	14	proteins	protein	NOUN
bptjm-15	220	15	are	be	AUX
bptjm-15	220	16	particularly	particularly	ADV
bptjm-15	220	17	important	important	ADJ
bptjm-15	220	18	in	in	ADP
bptjm-15	220	19	understanding	understand	VERB
bptjm-15	220	20	how	how	SCONJ
bptjm-15	220	21	the	the	DET
bptjm-15	220	22	gut	gut	NOUN
bptjm-15	220	23	can	can	AUX
bptjm-15	220	24	impact	impact	VERB
bptjm-15	220	25	the	the	DET
bptjm-15	220	26	brain	brain	NOUN
bptjm-15	220	27	.	.	PUNCT
bptjm-15	221	1	numerous	numerous	ADJ
bptjm-15	221	2	studies	study	NOUN
bptjm-15	221	3	have	have	AUX
bptjm-15	221	4	found	find	VERB
bptjm-15	221	5	that	that	SCONJ
bptjm-15	221	6	dysbiosis	dysbiosis	NOUN
bptjm-15	221	7	of	of	ADP
bptjm-15	221	8	the	the	DET
bptjm-15	221	9	gut	gut	NOUN
bptjm-15	221	10	may	may	AUX
bptjm-15	221	11	induce	induce	VERB
bptjm-15	221	12	proin	proin	NOUN
bptjm-15	221	13	�	�	NOUN
bptjm-15	221	14	ammatory	ammatory	NOUN
bptjm-15	221	15	responses	response	NOUN
bptjm-15	221	16	,	,	PUNCT
bptjm-15	221	17	suggesting	suggest	VERB
bptjm-15	221	18	a	a	DET
bptjm-15	221	19	potential	potential	ADJ
bptjm-15	221	20	avenue	avenue	NOUN
bptjm-15	221	21	for	for	ADP
bptjm-15	221	22	gut	gut	NOUN
bptjm-15	221	23	-	-	PUNCT
bptjm-15	221	24	based	base	VERB
bptjm-15	221	25	ms	ms	NOUN
bptjm-15	221	26	treatment	treatment	NOUN
bptjm-15	221	27	(	(	PUNCT
bptjm-15	221	28	choileáin	choileáin	ADJ
bptjm-15	221	29	,	,	PUNCT
bptjm-15	221	30	2020	2020	NUM
bptjm-15	221	31	;	;	PUNCT
bptjm-15	221	32	galland	galland	VERB
bptjm-15	221	33	,	,	PUNCT
bptjm-15	221	34	2014	2014	NUM
bptjm-15	221	35	;	;	PUNCT
bptjm-15	221	36	berkeley	berkeley	PROPN
bptjm-15	221	37	pharma	pharma	PROPN
bptjm-15	221	38	tech	tech	NOUN
bptjm-15	221	39	journal	journal	NOUN
bptjm-15	221	40	of	of	ADP
bptjm-15	221	41	medicine	medicine	NOUN
bptjm-15	221	42	|	|	ADV
bptjm-15	221	43	79	79	NUM
bptjm-15	221	44	monteleone	monteleone	NOUN
bptjm-15	221	45	,	,	PUNCT
bptjm-15	221	46	2011	2011	NUM
bptjm-15	221	47	;	;	PUNCT
bptjm-15	221	48	martin	martin	PROPN
bptjm-15	221	49	,	,	PUNCT
bptjm-15	221	50	2018	2018	NUM
bptjm-15	221	51	;	;	PUNCT
bptjm-15	221	52	adamcyzk	adamcyzk	PROPN
bptjm-15	221	53	-	-	PUNCT
bptjm-15	221	54	sowa	sowa	NOUN
bptjm-15	221	55	,	,	PUNCT
bptjm-15	221	56	2017	2017	NUM
bptjm-15	221	57	;	;	PUNCT
bptjm-15	221	58	shahi	shahi	NOUN
bptjm-15	221	59	,	,	PUNCT
bptjm-15	221	60	2017	2017	NUM
bptjm-15	221	61	)	)	PUNCT
bptjm-15	221	62	.	.	PUNCT
bptjm-15	222	1	proin	proin	NOUN
bptjm-15	222	2	�	�	PROPN
bptjm-15	222	3	ammatory	ammatory	NOUN
bptjm-15	222	4	interleukins	interleukin	VERB
bptjm-15	222	5	such	such	ADJ
bptjm-15	222	6	as	as	ADP
bptjm-15	222	7	il-6	il-6	NUM
bptjm-15	222	8	and	and	CCONJ
bptjm-15	222	9	il-17	il-17	ADV
bptjm-15	222	10	have	have	AUX
bptjm-15	222	11	shown	show	VERB
bptjm-15	222	12	evidence	evidence	NOUN
bptjm-15	222	13	of	of	ADP
bptjm-15	222	14	being	be	AUX
bptjm-15	222	15	a	a	DET
bptjm-15	222	16	�	�	NOUN
bptjm-15	222	17	ected	ecte	VERB
bptjm-15	222	18	by	by	ADP
bptjm-15	222	19	microbial	microbial	ADJ
bptjm-15	222	20	modi	modi	PROPN
bptjm-15	222	21	�	�	NOUN
bptjm-15	222	22	cations	cation	NOUN
bptjm-15	222	23	in	in	ADP
bptjm-15	222	24	the	the	DET
bptjm-15	222	25	gut	gut	NOUN
bptjm-15	222	26	.	.	PUNCT
bptjm-15	223	1	interestingly	interestingly	ADV
bptjm-15	223	2	,	,	PUNCT
bptjm-15	223	3	mesenteric	mesenteric	ADJ
bptjm-15	223	4	lymph	lymph	NOUN
bptjm-15	223	5	nodes	node	NOUN
bptjm-15	223	6	(	(	PUNCT
bptjm-15	223	7	mln	mln	NOUN
bptjm-15	223	8	)	)	PUNCT
bptjm-15	223	9	of	of	ADP
bptjm-15	223	10	antibiotic	antibiotic	NOUN
bptjm-15	223	11	-	-	PUNCT
bptjm-15	223	12	treated	treat	VERB
bptjm-15	223	13	animals	animal	NOUN
bptjm-15	223	14	produced	produce	VERB
bptjm-15	223	15	less	less	ADJ
bptjm-15	223	16	il-6	il-6	NOUN
bptjm-15	223	17	while	while	SCONJ
bptjm-15	223	18	signi	signi	PROPN
bptjm-15	223	19	�	�	PROPN
bptjm-15	223	20	cantly	cantly	ADV
bptjm-15	223	21	increasing	increase	VERB
bptjm-15	223	22	levels	level	NOUN
bptjm-15	223	23	of	of	ADP
bptjm-15	223	24	the	the	DET
bptjm-15	223	25	anti	anti	ADJ
bptjm-15	223	26	-	-	ADJ
bptjm-15	223	27	in	in	ADP
bptjm-15	223	28	�	�	NOUN
bptjm-15	223	29	ammatory	ammatory	NOUN
bptjm-15	223	30	il-13	il-13	PUNCT
bptjm-15	223	31	and	and	CCONJ
bptjm-15	223	32	il-10	il-10	PRON
bptjm-15	223	33	compared	compare	VERB
bptjm-15	223	34	to	to	ADP
bptjm-15	223	35	controls	control	NOUN
bptjm-15	223	36	(	(	PUNCT
bptjm-15	223	37	ochoa	ochoa	NOUN
bptjm-15	223	38	-	-	PUNCT
bptjm-15	223	39	repáraz	repáraz	NOUN
bptjm-15	223	40	,	,	PUNCT
bptjm-15	223	41	2009	2009	NUM
bptjm-15	223	42	)	)	PUNCT
bptjm-15	223	43	.	.	PUNCT
bptjm-15	224	1	furthermore	furthermore	ADV
bptjm-15	224	2	,	,	PUNCT
bptjm-15	224	3	research	research	NOUN
bptjm-15	224	4	regarding	regard	VERB
bptjm-15	224	5	the	the	DET
bptjm-15	224	6	gut	gut	NOUN
bptjm-15	224	7	-	-	PUNCT
bptjm-15	224	8	brain	brain	NOUN
bptjm-15	224	9	axis	axis	NOUN
bptjm-15	224	10	has	have	AUX
bptjm-15	224	11	shown	show	VERB
bptjm-15	224	12	that	that	SCONJ
bptjm-15	224	13	arti	arti	PROPN
bptjm-15	224	14	�	�	PROPN
bptjm-15	224	15	cial	cial	ADJ
bptjm-15	224	16	activation	activation	NOUN
bptjm-15	224	17	of	of	ADP
bptjm-15	224	18	aryl	aryl	NOUN
bptjm-15	224	19	hydrocarbon	hydrocarbon	NOUN
bptjm-15	224	20	receptor	receptor	NOUN
bptjm-15	224	21	(	(	PUNCT
bptjm-15	224	22	ahr	ahr	NOUN
bptjm-15	224	23	)	)	PUNCT
bptjm-15	224	24	ligands	ligand	NOUN
bptjm-15	224	25	,	,	PUNCT
bptjm-15	224	26	a	a	DET
bptjm-15	224	27	part	part	NOUN
bptjm-15	224	28	of	of	ADP
bptjm-15	224	29	the	the	DET
bptjm-15	224	30	tryptophan	tryptophan	NOUN
bptjm-15	224	31	metabolite	metabolite	NOUN
bptjm-15	224	32	pathway	pathway	NOUN
bptjm-15	224	33	,	,	PUNCT
bptjm-15	224	34	decreased	decrease	VERB
bptjm-15	224	35	the	the	DET
bptjm-15	224	36	concentration	concentration	NOUN
bptjm-15	224	37	of	of	ADP
bptjm-15	224	38	ifn	ifn	PROPN
bptjm-15	224	39	-	-	PUNCT
bptjm-15	224	40	γ	γ	NOUN
bptjm-15	224	41	while	while	SCONJ
bptjm-15	224	42	up	up	ADV
bptjm-15	224	43	-	-	PUNCT
bptjm-15	224	44	regulating	regulate	VERB
bptjm-15	224	45	proin	proin	NOUN
bptjm-15	224	46	�	�	NOUN
bptjm-15	224	47	ammatory	ammatory	NOUN
bptjm-15	224	48	il-22	il-22	NOUN
bptjm-15	224	49	in	in	ADP
bptjm-15	224	50	the	the	DET
bptjm-15	224	51	gut	gut	NOUN
bptjm-15	224	52	of	of	ADP
bptjm-15	224	53	in	in	ADP
bptjm-15	224	54	�	�	NOUN
bptjm-15	224	55	ammatory	ammatory	ADJ
bptjm-15	224	56	bowel	bowel	NOUN
bptjm-15	224	57	disease	disease	NOUN
bptjm-15	224	58	patients	patient	NOUN
bptjm-15	224	59	(	(	PUNCT
bptjm-15	224	60	monteleone	monteleone	NOUN
bptjm-15	224	61	,	,	PUNCT
bptjm-15	224	62	2011	2011	NUM
bptjm-15	224	63	)	)	PUNCT
bptjm-15	224	64	.	.	PUNCT
bptjm-15	225	1	these	these	DET
bptjm-15	225	2	gut	gut	NOUN
bptjm-15	225	3	-	-	PUNCT
bptjm-15	225	4	based	base	VERB
bptjm-15	225	5	cytokine	cytokine	NOUN
bptjm-15	225	6	alterations	alteration	NOUN
bptjm-15	225	7	are	be	AUX
bptjm-15	225	8	only	only	ADV
bptjm-15	225	9	compounded	compound	VERB
bptjm-15	225	10	with	with	ADP
bptjm-15	225	11	the	the	DET
bptjm-15	225	12	modi	modi	PROPN
bptjm-15	225	13	�	�	PROPN
bptjm-15	225	14	cations	cation	NOUN
bptjm-15	225	15	to	to	ADP
bptjm-15	225	16	peripheral	peripheral	ADJ
bptjm-15	225	17	blood	blood	NOUN
bptjm-15	225	18	mononuclear	mononuclear	ADJ
bptjm-15	225	19	cells	cell	NOUN
bptjm-15	225	20	(	(	PUNCT
bptjm-15	225	21	pbmcs	pbmcs	NOUN
bptjm-15	225	22	)	)	PUNCT
bptjm-15	225	23	within	within	ADP
bptjm-15	225	24	the	the	DET
bptjm-15	225	25	body	body	NOUN
bptjm-15	225	26	.	.	PUNCT
bptjm-15	226	1	gut	gut	NOUN
bptjm-15	226	2	-	-	PUNCT
bptjm-15	226	3	immune	immune	ADJ
bptjm-15	226	4	interactions	interaction	NOUN
bptjm-15	226	5	-	-	PUNCT
bptjm-15	226	6	peripheral	peripheral	ADJ
bptjm-15	226	7	blood	blood	NOUN
bptjm-15	226	8	mononuclear	mononuclear	ADJ
bptjm-15	226	9	cells	cell	NOUN
bptjm-15	226	10	pbmcs	pbmc	NOUN
bptjm-15	226	11	such	such	ADJ
bptjm-15	226	12	as	as	ADP
bptjm-15	226	13	t	t	PROPN
bptjm-15	226	14	cells	cell	NOUN
bptjm-15	226	15	among	among	ADP
bptjm-15	226	16	others	other	NOUN
bptjm-15	226	17	all	all	PRON
bptjm-15	226	18	see	see	VERB
bptjm-15	226	19	concentration	concentration	NOUN
bptjm-15	226	20	adjustments	adjustment	NOUN
bptjm-15	226	21	due	due	ADP
bptjm-15	226	22	to	to	ADP
bptjm-15	226	23	the	the	DET
bptjm-15	226	24	gut	gut	NOUN
bptjm-15	226	25	.	.	PUNCT
bptjm-15	227	1	exposure	exposure	NOUN
bptjm-15	227	2	of	of	ADP
bptjm-15	227	3	healthy	healthy	ADJ
bptjm-15	227	4	pbmcs	pbmcs	NOUN
bptjm-15	227	5	to	to	ADP
bptjm-15	227	6	parabacteroides	parabacteroide	NOUN
bptjm-15	227	7	distasonis	distasonis	PROPN
bptjm-15	227	8	,	,	PUNCT
bptjm-15	227	9	a	a	DET
bptjm-15	227	10	common	common	ADJ
bptjm-15	227	11	gut	gut	NOUN
bptjm-15	227	12	bacteria	bacteria	NOUN
bptjm-15	227	13	,	,	PUNCT
bptjm-15	227	14	signi	signi	PROPN
bptjm-15	227	15	�	�	PROPN
bptjm-15	227	16	cantly	cantly	ADV
bptjm-15	227	17	increased	increase	VERB
bptjm-15	227	18	the	the	DET
bptjm-15	227	19	percentage	percentage	NOUN
bptjm-15	227	20	of	of	ADP
bptjm-15	227	21	il-10	il-10	PRON
bptjm-15	227	22	expressing	express	VERB
bptjm-15	227	23	cd4+cd25	cd4+cd25	PROPN
bptjm-15	227	24	+	+	PROPN
bptjm-15	227	25	t	t	NOUN
bptjm-15	227	26	cells	cell	NOUN
bptjm-15	227	27	and	and	CCONJ
bptjm-15	227	28	il10+foxp3	il10+foxp3	NOUN
bptjm-15	227	29	+	+	NOUN
bptjm-15	227	30	tregs	treg	NOUN
bptjm-15	227	31	within	within	ADP
bptjm-15	227	32	the	the	DET
bptjm-15	227	33	cd4+cd3	cd4+cd3	PROPN
bptjm-15	227	34	+	+	NOUN
bptjm-15	227	35	population	population	NOUN
bptjm-15	227	36	(	(	PUNCT
bptjm-15	227	37	cekanaviciute	cekanaviciute	NOUN
bptjm-15	227	38	,	,	PUNCT
bptjm-15	227	39	2017	2017	NUM
bptjm-15	227	40	)	)	PUNCT
bptjm-15	227	41	.	.	PUNCT
bptjm-15	228	1	furthermore	furthermore	ADV
bptjm-15	228	2	,	,	PUNCT
bptjm-15	228	3	treatment	treatment	NOUN
bptjm-15	228	4	of	of	ADP
bptjm-15	228	5	mice	mouse	NOUN
bptjm-15	228	6	with	with	ADP
bptjm-15	228	7	prevotella	prevotella	NOUN
bptjm-15	228	8	histicola	histicola	NOUN
bptjm-15	228	9	also	also	ADV
bptjm-15	228	10	showed	show	VERB
bptjm-15	228	11	an	an	DET
bptjm-15	228	12	increase	increase	NOUN
bptjm-15	228	13	in	in	ADP
bptjm-15	228	14	cd4+foxp3	cd4+foxp3	PUNCT
bptjm-15	228	15	+	+	ADP
bptjm-15	228	16	tregs	treg	NOUN
bptjm-15	228	17	in	in	ADP
bptjm-15	228	18	addition	addition	NOUN
bptjm-15	228	19	to	to	ADP
bptjm-15	228	20	a	a	DET
bptjm-15	228	21	decrease	decrease	NOUN
bptjm-15	228	22	in	in	ADP
bptjm-15	228	23	proin	proin	NOUN
bptjm-15	228	24	�	�	NOUN
bptjm-15	228	25	ammatory	ammatory	ADJ
bptjm-15	228	26	th1	th1	NOUN
bptjm-15	228	27	and	and	CCONJ
bptjm-15	228	28	th17	th17	PROPN
bptjm-15	228	29	immune	immune	ADJ
bptjm-15	228	30	cells	cell	NOUN
bptjm-15	228	31	(	(	PUNCT
bptjm-15	228	32	mangalam	mangalam	PROPN
bptjm-15	228	33	,	,	PUNCT
bptjm-15	228	34	2017	2017	NUM
bptjm-15	228	35	)	)	PUNCT
bptjm-15	228	36	.	.	PUNCT
bptjm-15	229	1	these	these	DET
bptjm-15	229	2	correlations	correlation	NOUN
bptjm-15	229	3	display	display	VERB
bptjm-15	229	4	bacterial	bacterial	ADJ
bptjm-15	229	5	importance	importance	NOUN
bptjm-15	229	6	in	in	ADP
bptjm-15	229	7	the	the	DET
bptjm-15	229	8	regulation	regulation	NOUN
bptjm-15	229	9	of	of	ADP
bptjm-15	229	10	cd4	cd4	PROPN
bptjm-15	229	11	+	+	PROPN
bptjm-15	229	12	and	and	CCONJ
bptjm-15	229	13	cd8	cd8	PROPN
bptjm-15	229	14	+	+	PROPN
bptjm-15	229	15	t	t	NOUN
bptjm-15	229	16	cells	cell	NOUN
bptjm-15	229	17	;	;	PUNCT
bptjm-15	229	18	which	which	PRON
bptjm-15	229	19	have	have	AUX
bptjm-15	229	20	shown	show	VERB
bptjm-15	229	21	an	an	DET
bptjm-15	229	22	increased	increase	VERB
bptjm-15	229	23	expression	expression	NOUN
bptjm-15	229	24	of	of	ADP
bptjm-15	229	25	cxcr3	cxcr3	PROPN
bptjm-15	229	26	+	+	X
bptjm-15	229	27	in	in	ADP
bptjm-15	229	28	ms	ms	ADJ
bptjm-15	229	29	patients	patient	NOUN
bptjm-15	229	30	,	,	PUNCT
bptjm-15	229	31	contributing	contribute	VERB
bptjm-15	229	32	to	to	ADP
bptjm-15	229	33	greater	great	ADJ
bptjm-15	229	34	leakage	leakage	NOUN
bptjm-15	229	35	in	in	ADP
bptjm-15	229	36	the	the	DET
bptjm-15	229	37	blood	blood	NOUN
bptjm-15	229	38	-	-	PUNCT
bptjm-15	229	39	brain	brain	NOUN
bptjm-15	229	40	barrier	barrier	NOUN
bptjm-15	229	41	(	(	PUNCT
bptjm-15	229	42	choileáin	choileáin	ADJ
bptjm-15	229	43	,	,	PUNCT
bptjm-15	229	44	2020	2020	NUM
bptjm-15	229	45	)	)	PUNCT
bptjm-15	229	46	.	.	PUNCT
bptjm-15	230	1	protection	protection	NOUN
bptjm-15	230	2	of	of	ADP
bptjm-15	230	3	this	this	DET
bptjm-15	230	4	barrier	barrier	NOUN
bptjm-15	230	5	will	will	AUX
bptjm-15	230	6	be	be	AUX
bptjm-15	230	7	crucial	crucial	ADJ
bptjm-15	230	8	in	in	ADP
bptjm-15	230	9	the	the	DET
bptjm-15	230	10	development	development	NOUN
bptjm-15	230	11	of	of	ADP
bptjm-15	230	12	gut	gut	NOUN
bptjm-15	230	13	-	-	PUNCT
bptjm-15	230	14	based	base	VERB
bptjm-15	230	15	ms	ms	NOUN
bptjm-15	230	16	therapies	therapy	NOUN
bptjm-15	230	17	in	in	ADP
bptjm-15	230	18	order	order	NOUN
bptjm-15	230	19	to	to	PART
bptjm-15	230	20	combat	combat	VERB
bptjm-15	230	21	the	the	DET
bptjm-15	230	22	reduced	reduce	VERB
bptjm-15	230	23	expression	expression	NOUN
bptjm-15	230	24	of	of	ADP
bptjm-15	230	25	regulatory	regulatory	ADJ
bptjm-15	230	26	proteins	protein	NOUN
bptjm-15	230	27	seen	see	VERB
bptjm-15	230	28	in	in	ADP
bptjm-15	230	29	rrms	rrm	NOUN
bptjm-15	230	30	patients	patient	NOUN
bptjm-15	230	31	such	such	ADJ
bptjm-15	230	32	as	as	ADP
bptjm-15	230	33	occludin	occludin	ADJ
bptjm-15	230	34	and	and	CCONJ
bptjm-15	230	35	vascular	vascular	ADJ
bptjm-15	230	36	endothelial	endothelial	NOUN
bptjm-15	230	37	cadherin	cadherin	NOUN
bptjm-15	230	38	(	(	PUNCT
bptjm-15	230	39	sheikh	sheikh	NOUN
bptjm-15	230	40	,	,	PUNCT
bptjm-15	230	41	2020	2020	NUM
bptjm-15	230	42	)	)	PUNCT
bptjm-15	230	43	.	.	PUNCT
bptjm-15	231	1	while	while	SCONJ
bptjm-15	231	2	t	t	PROPN
bptjm-15	231	3	lymphocyte	lymphocyte	NOUN
bptjm-15	231	4	regulation	regulation	NOUN
bptjm-15	231	5	is	be	AUX
bptjm-15	231	6	extremely	extremely	ADV
bptjm-15	231	7	important	important	ADJ
bptjm-15	231	8	in	in	ADP
bptjm-15	231	9	achieving	achieve	VERB
bptjm-15	231	10	this	this	DET
bptjm-15	231	11	goal	goal	NOUN
bptjm-15	231	12	,	,	PUNCT
bptjm-15	231	13	so	so	ADV
bptjm-15	231	14	are	be	AUX
bptjm-15	231	15	other	other	ADJ
bptjm-15	231	16	pmbcs	pmbc	NOUN
bptjm-15	231	17	like	like	ADP
bptjm-15	231	18	nk	nk	PROPN
bptjm-15	231	19	cells	cell	NOUN
bptjm-15	231	20	and	and	CCONJ
bptjm-15	231	21	b	b	NOUN
bptjm-15	231	22	cells	cell	NOUN
bptjm-15	231	23	,	,	PUNCT
bptjm-15	231	24	the	the	DET
bptjm-15	231	25	latter	latter	NOUN
bptjm-15	231	26	of	of	ADP
bptjm-15	231	27	which	which	PRON
bptjm-15	231	28	is	be	AUX
bptjm-15	231	29	believed	believe	VERB
bptjm-15	231	30	to	to	PART
bptjm-15	231	31	be	be	AUX
bptjm-15	231	32	involved	involve	VERB
bptjm-15	231	33	with	with	ADP
bptjm-15	231	34	ms	ms	NOUN
bptjm-15	231	35	because	because	SCONJ
bptjm-15	231	36	of	of	ADP
bptjm-15	231	37	their	their	PRON
bptjm-15	231	38	association	association	NOUN
bptjm-15	231	39	with	with	ADP
bptjm-15	231	40	immunoglobulin	immunoglobulin	NOUN
bptjm-15	231	41	presence	presence	NOUN
bptjm-15	231	42	(	(	PUNCT
bptjm-15	231	43	høglund	høglund	NOUN
bptjm-15	231	44	,	,	PUNCT
bptjm-15	231	45	2014	2014	NUM
bptjm-15	231	46	)	)	PUNCT
bptjm-15	231	47	.	.	PUNCT
bptjm-15	232	1	ms	ms	PROPN
bptjm-15	232	2	usually	usually	ADV
bptjm-15	232	3	involves	involve	VERB
bptjm-15	232	4	the	the	DET
bptjm-15	232	5	depletion	depletion	NOUN
bptjm-15	232	6	of	of	ADP
bptjm-15	232	7	b	b	NOUN
bptjm-15	232	8	cell	cell	NOUN
bptjm-15	232	9	numbers	number	NOUN
bptjm-15	232	10	and	and	CCONJ
bptjm-15	232	11	an	an	DET
bptjm-15	232	12	increase	increase	NOUN
bptjm-15	232	13	in	in	ADP
bptjm-15	232	14	t	t	NOUN
bptjm-15	232	15	lymphocytes	lymphocyte	NOUN
bptjm-15	232	16	(	(	PUNCT
bptjm-15	232	17	krumbholz	krumbholz	NOUN
bptjm-15	232	18	,	,	PUNCT
bptjm-15	232	19	2012	2012	NUM
bptjm-15	232	20	)	)	PUNCT
bptjm-15	232	21	.	.	PUNCT
bptjm-15	233	1	nk	nk	PROPN
bptjm-15	233	2	cells	cell	NOUN
bptjm-15	233	3	are	be	AUX
bptjm-15	233	4	important	important	ADJ
bptjm-15	233	5	in	in	ADP
bptjm-15	233	6	their	their	PRON
bptjm-15	233	7	role	role	NOUN
bptjm-15	233	8	of	of	ADP
bptjm-15	233	9	target	target	NOUN
bptjm-15	233	10	cell	cell	NOUN
bptjm-15	233	11	lysis	lysis	NOUN
bptjm-15	233	12	and	and	CCONJ
bptjm-15	233	13	can	can	AUX
bptjm-15	233	14	also	also	ADV
bptjm-15	233	15	be	be	AUX
bptjm-15	233	16	a	a	DET
bptjm-15	233	17	therapeutic	therapeutic	ADJ
bptjm-15	233	18	target	target	NOUN
bptjm-15	233	19	due	due	ADP
bptjm-15	233	20	to	to	ADP
bptjm-15	233	21	their	their	PRON
bptjm-15	233	22	role	role	NOUN
bptjm-15	233	23	in	in	ADP
bptjm-15	233	24	cytokine	cytokine	NOUN
bptjm-15	233	25	and	and	CCONJ
bptjm-15	233	26	chemokine	chemokine	ADJ
bptjm-15	233	27	secretion	secretion	NOUN
bptjm-15	233	28	(	(	PUNCT
bptjm-15	233	29	høglund	høglund	NOUN
bptjm-15	233	30	,	,	PUNCT
bptjm-15	233	31	2014	2014	NUM
bptjm-15	233	32	)	)	PUNCT
bptjm-15	233	33	.	.	PUNCT
bptjm-15	234	1	additionally	additionally	ADV
bptjm-15	234	2	,	,	PUNCT
bptjm-15	234	3	they	they	PRON
bptjm-15	234	4	have	have	VERB
bptjm-15	234	5	the	the	DET
bptjm-15	234	6	ability	ability	NOUN
bptjm-15	234	7	to	to	PART
bptjm-15	234	8	modify	modify	VERB
bptjm-15	234	9	or	or	CCONJ
bptjm-15	234	10	lyse	lyse	PROPN
bptjm-15	234	11	t	t	PROPN
bptjm-15	234	12	berkeley	berkeley	PROPN
bptjm-15	234	13	pharma	pharma	PROPN
bptjm-15	234	14	tech	tech	NOUN
bptjm-15	234	15	journal	journal	NOUN
bptjm-15	234	16	of	of	ADP
bptjm-15	234	17	medicine	medicine	NOUN
bptjm-15	234	18	|	|	ADP
bptjm-15	234	19	80	80	NUM
bptjm-15	234	20	cells	cell	NOUN
bptjm-15	234	21	,	,	PUNCT
bptjm-15	234	22	an	an	DET
bptjm-15	234	23	interaction	interaction	NOUN
bptjm-15	234	24	that	that	PRON
bptjm-15	234	25	can	can	AUX
bptjm-15	234	26	be	be	AUX
bptjm-15	234	27	investigated	investigate	VERB
bptjm-15	234	28	in	in	ADP
bptjm-15	234	29	the	the	DET
bptjm-15	234	30	future	future	NOUN
bptjm-15	234	31	to	to	PART
bptjm-15	234	32	improve	improve	VERB
bptjm-15	234	33	the	the	DET
bptjm-15	234	34	understanding	understanding	NOUN
bptjm-15	234	35	of	of	ADP
bptjm-15	234	36	the	the	DET
bptjm-15	234	37	dysregulation	dysregulation	NOUN
bptjm-15	234	38	of	of	ADP
bptjm-15	234	39	immune	immune	ADJ
bptjm-15	234	40	systems	system	NOUN
bptjm-15	234	41	in	in	ADP
bptjm-15	234	42	ms	ms	PROPN
bptjm-15	234	43	patients	patient	NOUN
bptjm-15	234	44	(	(	PUNCT
bptjm-15	234	45	høglund	høglund	NOUN
bptjm-15	234	46	,	,	PUNCT
bptjm-15	234	47	2014	2014	NUM
bptjm-15	234	48	)	)	PUNCT
bptjm-15	234	49	.	.	PUNCT
bptjm-15	235	1	the	the	DET
bptjm-15	235	2	gut	gut	NOUN
bptjm-15	235	3	-	-	PUNCT
bptjm-15	235	4	immune	immune	ADJ
bptjm-15	235	5	relationship	relationship	NOUN
bptjm-15	235	6	is	be	AUX
bptjm-15	235	7	a	a	DET
bptjm-15	235	8	two	two	NUM
bptjm-15	235	9	-	-	PUNCT
bptjm-15	235	10	way	way	NOUN
bptjm-15	235	11	street	street	NOUN
bptjm-15	235	12	.	.	PUNCT
bptjm-15	236	1	in	in	ADP
bptjm-15	236	2	the	the	DET
bptjm-15	236	3	future	future	NOUN
bptjm-15	236	4	,	,	PUNCT
bptjm-15	236	5	research	research	NOUN
bptjm-15	236	6	must	must	AUX
bptjm-15	236	7	take	take	VERB
bptjm-15	236	8	into	into	ADP
bptjm-15	236	9	account	account	NOUN
bptjm-15	236	10	that	that	SCONJ
bptjm-15	236	11	the	the	DET
bptjm-15	236	12	gut	gut	NOUN
bptjm-15	236	13	does	do	VERB
bptjm-15	236	14	not	not	PART
bptjm-15	236	15	a	a	DET
bptjm-15	236	16	�	�	X
bptjm-15	236	17	ect	ect	ADJ
bptjm-15	236	18	human	human	ADJ
bptjm-15	236	19	physiology	physiology	NOUN
bptjm-15	236	20	unidirectionally	unidirectionally	ADV
bptjm-15	236	21	.	.	PUNCT
bptjm-15	237	1	while	while	SCONJ
bptjm-15	237	2	the	the	DET
bptjm-15	237	3	composition	composition	NOUN
bptjm-15	237	4	of	of	ADP
bptjm-15	237	5	the	the	DET
bptjm-15	237	6	gut	gut	NOUN
bptjm-15	237	7	microbiome	microbiome	NOUN
bptjm-15	237	8	heavily	heavily	ADV
bptjm-15	237	9	in	in	ADP
bptjm-15	237	10	�	�	NOUN
bptjm-15	237	11	uences	uence	NOUN
bptjm-15	237	12	the	the	DET
bptjm-15	237	13	autoimmune	autoimmune	ADJ
bptjm-15	237	14	response	response	NOUN
bptjm-15	237	15	by	by	ADP
bptjm-15	237	16	regulating	regulate	VERB
bptjm-15	237	17	the	the	DET
bptjm-15	237	18	interactions	interaction	NOUN
bptjm-15	237	19	between	between	ADP
bptjm-15	237	20	immunoregulatory	immunoregulatory	ADJ
bptjm-15	237	21	cells	cell	NOUN
bptjm-15	237	22	and	and	CCONJ
bptjm-15	237	23	metabolites	metabolite	NOUN
bptjm-15	237	24	,	,	PUNCT
bptjm-15	237	25	the	the	DET
bptjm-15	237	26	immune	immune	ADJ
bptjm-15	237	27	system	system	NOUN
bptjm-15	237	28	is	be	AUX
bptjm-15	237	29	also	also	ADV
bptjm-15	237	30	critical	critical	ADJ
bptjm-15	237	31	in	in	ADP
bptjm-15	237	32	cultivating	cultivate	VERB
bptjm-15	237	33	healthy	healthy	ADJ
bptjm-15	237	34	bacteria	bacteria	NOUN
bptjm-15	237	35	and	and	CCONJ
bptjm-15	237	36	destroying	destroy	VERB
bptjm-15	237	37	harmful	harmful	ADJ
bptjm-15	237	38	bacteria	bacteria	NOUN
bptjm-15	237	39	in	in	ADP
bptjm-15	237	40	our	our	PRON
bptjm-15	237	41	gut	gut	NOUN
bptjm-15	237	42	(	(	PUNCT
bptjm-15	237	43	velasquez	velasquez	PROPN
bptjm-15	237	44	-	-	PUNCT
bptjm-15	237	45	mano	mano	PROPN
bptjm-15	237	46	�	�	PROPN
bptjm-15	237	47	,	,	PUNCT
bptjm-15	237	48	2015	2015	NUM
bptjm-15	237	49	)	)	PUNCT
bptjm-15	237	50	.	.	PUNCT
bptjm-15	238	1	the	the	DET
bptjm-15	238	2	key	key	ADJ
bptjm-15	238	3	players	player	NOUN
bptjm-15	238	4	in	in	ADP
bptjm-15	238	5	shaping	shape	VERB
bptjm-15	238	6	the	the	DET
bptjm-15	238	7	gut	gut	NOUN
bptjm-15	238	8	microbiome	microbiome	NOUN
bptjm-15	238	9	are	be	AUX
bptjm-15	238	10	nucleotide	nucleotide	NOUN
bptjm-15	238	11	-	-	PUNCT
bptjm-15	238	12	binding	bind	VERB
bptjm-15	238	13	and	and	CCONJ
bptjm-15	238	14	oligomerization	oligomerization	NOUN
bptjm-15	238	15	domain	domain	NOUN
bptjm-15	238	16	-	-	PUNCT
bptjm-15	238	17	like	like	ADJ
bptjm-15	238	18	receptors	receptor	NOUN
bptjm-15	238	19	(	(	PUNCT
bptjm-15	238	20	nlrs	nlrs	NOUN
bptjm-15	238	21	or	or	CCONJ
bptjm-15	238	22	nod	nod	NOUN
bptjm-15	238	23	-	-	PUNCT
bptjm-15	238	24	like	like	ADJ
bptjm-15	238	25	receptors	receptor	NOUN
bptjm-15	238	26	)	)	PUNCT
bptjm-15	238	27	.	.	PUNCT
bptjm-15	239	1	for	for	ADP
bptjm-15	239	2	instance	instance	NOUN
bptjm-15	239	3	,	,	PUNCT
bptjm-15	239	4	the	the	DET
bptjm-15	239	5	nod2	nod2	NOUN
bptjm-15	239	6	bacterial	bacterial	ADJ
bptjm-15	239	7	sensor	sensor	NOUN
bptjm-15	239	8	regulates	regulate	VERB
bptjm-15	239	9	in	in	ADP
bptjm-15	239	10	�	�	PROPN
bptjm-15	239	11	ammation	ammation	NOUN
bptjm-15	239	12	caused	cause	VERB
bptjm-15	239	13	by	by	ADP
bptjm-15	239	14	the	the	DET
bptjm-15	239	15	growth	growth	NOUN
bptjm-15	239	16	of	of	ADP
bptjm-15	239	17	the	the	DET
bptjm-15	239	18	commensal	commensal	NOUN
bptjm-15	239	19	bacteroides	bacteroide	VERB
bptjm-15	239	20	vulgatus	vulgatus	NOUN
bptjm-15	239	21	(	(	PUNCT
bptjm-15	239	22	ramanan	ramanan	NOUN
bptjm-15	239	23	,	,	PUNCT
bptjm-15	239	24	2014	2014	NUM
bptjm-15	239	25	)	)	PUNCT
bptjm-15	239	26	.	.	PUNCT
bptjm-15	240	1	this	this	DET
bptjm-15	240	2	regulation	regulation	NOUN
bptjm-15	240	3	promotes	promote	VERB
bptjm-15	240	4	epithelial	epithelial	ADJ
bptjm-15	240	5	stem	stem	NOUN
bptjm-15	240	6	cell	cell	NOUN
bptjm-15	240	7	survival	survival	NOUN
bptjm-15	240	8	and	and	CCONJ
bptjm-15	240	9	regeneration	regeneration	NOUN
bptjm-15	240	10	in	in	ADP
bptjm-15	240	11	the	the	DET
bptjm-15	240	12	gut	gut	NOUN
bptjm-15	240	13	.	.	PUNCT
bptjm-15	241	1	furthermore	furthermore	ADV
bptjm-15	241	2	,	,	PUNCT
bptjm-15	241	3	nlrs	nlrs	NOUN
bptjm-15	241	4	that	that	PRON
bptjm-15	241	5	assemble	assemble	VERB
bptjm-15	241	6	into	into	ADP
bptjm-15	241	7	multiprotein	multiprotein	ADJ
bptjm-15	241	8	complexes	complex	NOUN
bptjm-15	241	9	,	,	PUNCT
bptjm-15	241	10	known	know	VERB
bptjm-15	241	11	as	as	ADP
bptjm-15	241	12	in	in	ADP
bptjm-15	241	13	�	�	NOUN
bptjm-15	241	14	ammasomes	ammasome	NOUN
bptjm-15	241	15	,	,	PUNCT
bptjm-15	241	16	activate	activate	VERB
bptjm-15	241	17	in	in	ADP
bptjm-15	241	18	�	�	PROPN
bptjm-15	241	19	ammatory	ammatory	NOUN
bptjm-15	241	20	caspases	caspase	NOUN
bptjm-15	241	21	and	and	CCONJ
bptjm-15	241	22	regulate	regulate	VERB
bptjm-15	241	23	microbial	microbial	ADJ
bptjm-15	241	24	diversity	diversity	NOUN
bptjm-15	241	25	in	in	ADP
bptjm-15	241	26	the	the	DET
bptjm-15	241	27	gut	gut	NOUN
bptjm-15	241	28	.	.	PUNCT
bptjm-15	242	1	the	the	DET
bptjm-15	242	2	nod-	nod-	ADJ
bptjm-15	242	3	,	,	PUNCT
bptjm-15	242	4	lrr	lrr	ADJ
bptjm-15	242	5	(	(	PUNCT
bptjm-15	242	6	leucine‐rich	leucine‐rich	X
bptjm-15	242	7	repeat)and	repeat)and	PROPN
bptjm-15	242	8	pyrin	pyrin	NOUN
bptjm-15	242	9	domain	domain	NOUN
bptjm-15	242	10	-	-	PUNCT
bptjm-15	242	11	containing	contain	VERB
bptjm-15	242	12	6	6	NUM
bptjm-15	242	13	complex	complex	ADJ
bptjm-15	242	14	(	(	PUNCT
bptjm-15	242	15	nlrp6	nlrp6	ADJ
bptjm-15	242	16	)	)	PUNCT
bptjm-15	242	17	is	be	AUX
bptjm-15	242	18	a	a	DET
bptjm-15	242	19	type	type	NOUN
bptjm-15	242	20	of	of	ADP
bptjm-15	242	21	in	in	ADP
bptjm-15	242	22	�	�	PROPN
bptjm-15	242	23	ammasome	ammasome	NOUN
bptjm-15	242	24	co	co	VERB
bptjm-15	242	25	-	-	VERB
bptjm-15	242	26	modulated	modulate	VERB
bptjm-15	242	27	by	by	ADP
bptjm-15	242	28	microbiota	microbiota	NOUN
bptjm-15	242	29	-	-	PUNCT
bptjm-15	242	30	derived	derive	VERB
bptjm-15	242	31	metabolites	metabolite	NOUN
bptjm-15	242	32	that	that	PRON
bptjm-15	242	33	is	be	AUX
bptjm-15	242	34	linked	link	VERB
bptjm-15	242	35	with	with	ADP
bptjm-15	242	36	intestinal	intestinal	ADJ
bptjm-15	242	37	homeostasis	homeostasis	NOUN
bptjm-15	242	38	,	,	PUNCT
bptjm-15	242	39	intestinal	intestinal	ADJ
bptjm-15	242	40	antiviral	antiviral	ADJ
bptjm-15	242	41	innate	innate	ADJ
bptjm-15	242	42	immunity	immunity	NOUN
bptjm-15	242	43	,	,	PUNCT
bptjm-15	242	44	and	and	CCONJ
bptjm-15	242	45	the	the	DET
bptjm-15	242	46	regulation	regulation	NOUN
bptjm-15	242	47	of	of	ADP
bptjm-15	242	48	epithelial	epithelial	ADJ
bptjm-15	242	49	il-18	il-18	NOUN
bptjm-15	242	50	secretion	secretion	NOUN
bptjm-15	242	51	and	and	CCONJ
bptjm-15	242	52	amp	amp	NOUN
bptjm-15	242	53	expression	expression	NOUN
bptjm-15	242	54	pro	pro	X
bptjm-15	242	55	�	�	VERB
bptjm-15	242	56	les	les	X
bptjm-15	242	57	(	(	PUNCT
bptjm-15	242	58	zheng	zheng	PROPN
bptjm-15	242	59	,	,	PUNCT
bptjm-15	242	60	2020	2020	NUM
bptjm-15	242	61	)	)	PUNCT
bptjm-15	242	62	.	.	PUNCT
bptjm-15	243	1	to	to	PART
bptjm-15	243	2	fully	fully	ADV
bptjm-15	243	3	grasp	grasp	VERB
bptjm-15	243	4	the	the	DET
bptjm-15	243	5	intricacies	intricacy	NOUN
bptjm-15	243	6	around	around	ADP
bptjm-15	243	7	this	this	DET
bptjm-15	243	8	bidirectional	bidirectional	ADJ
bptjm-15	243	9	relationship	relationship	NOUN
bptjm-15	243	10	and	and	CCONJ
bptjm-15	243	11	the	the	DET
bptjm-15	243	12	pathways	pathway	NOUN
bptjm-15	243	13	that	that	PRON
bptjm-15	243	14	associate	associate	VERB
bptjm-15	243	15	the	the	DET
bptjm-15	243	16	two	two	NUM
bptjm-15	243	17	,	,	PUNCT
bptjm-15	243	18	researchers	researcher	NOUN
bptjm-15	243	19	continue	continue	VERB
bptjm-15	243	20	to	to	PART
bptjm-15	243	21	explore	explore	VERB
bptjm-15	243	22	this	this	DET
bptjm-15	243	23	vital	vital	ADJ
bptjm-15	243	24	frontier	frontier	NOUN
bptjm-15	243	25	.	.	PUNCT
bptjm-15	244	1	discussion	discussion	NOUN
bptjm-15	244	2	it	it	PRON
bptjm-15	244	3	is	be	AUX
bptjm-15	244	4	clear	clear	ADJ
bptjm-15	244	5	that	that	SCONJ
bptjm-15	244	6	the	the	DET
bptjm-15	244	7	gut	gut	NOUN
bptjm-15	244	8	-	-	PUNCT
bptjm-15	244	9	brain	brain	NOUN
bptjm-15	244	10	axis	axis	NOUN
bptjm-15	244	11	has	have	VERB
bptjm-15	244	12	an	an	DET
bptjm-15	244	13	impact	impact	NOUN
bptjm-15	244	14	on	on	ADP
bptjm-15	244	15	human	human	ADJ
bptjm-15	244	16	physiology	physiology	NOUN
bptjm-15	244	17	,	,	PUNCT
bptjm-15	244	18	so	so	ADV
bptjm-15	244	19	taking	take	VERB
bptjm-15	244	20	advantage	advantage	NOUN
bptjm-15	244	21	of	of	ADP
bptjm-15	244	22	this	this	DET
bptjm-15	244	23	non	non	ADJ
bptjm-15	244	24	-	-	ADJ
bptjm-15	244	25	invasive	invasive	ADJ
bptjm-15	244	26	approach	approach	NOUN
bptjm-15	244	27	will	will	AUX
bptjm-15	244	28	be	be	AUX
bptjm-15	244	29	the	the	DET
bptjm-15	244	30	crucial	crucial	ADJ
bptjm-15	244	31	next	next	ADJ
bptjm-15	244	32	step	step	NOUN
bptjm-15	244	33	to	to	ADP
bptjm-15	244	34	treating	treat	VERB
bptjm-15	244	35	and/or	and/or	CCONJ
bptjm-15	244	36	preventing	prevent	VERB
bptjm-15	244	37	ms	ms	NOUN
bptjm-15	244	38	.	.	PROPN
bptjm-15	245	1	there	there	PRON
bptjm-15	245	2	has	have	AUX
bptjm-15	245	3	been	be	AUX
bptjm-15	245	4	prior	prior	ADJ
bptjm-15	245	5	evidence	evidence	NOUN
bptjm-15	245	6	showcasing	showcase	VERB
bptjm-15	245	7	the	the	DET
bptjm-15	245	8	relevance	relevance	NOUN
bptjm-15	245	9	of	of	ADP
bptjm-15	245	10	gut	gut	NOUN
bptjm-15	245	11	microbiota	microbiota	NOUN
bptjm-15	245	12	in	in	ADP
bptjm-15	245	13	the	the	DET
bptjm-15	245	14	treatment	treatment	NOUN
bptjm-15	245	15	of	of	ADP
bptjm-15	245	16	neurological	neurological	ADJ
bptjm-15	245	17	and	and	CCONJ
bptjm-15	245	18	motor	motor	NOUN
bptjm-15	245	19	disorders	disorder	NOUN
bptjm-15	245	20	similar	similar	ADJ
bptjm-15	245	21	to	to	ADP
bptjm-15	245	22	ms	ms	NOUN
bptjm-15	245	23	including	include	VERB
bptjm-15	245	24	major	major	ADJ
bptjm-15	245	25	depression	depression	NOUN
bptjm-15	245	26	and	and	CCONJ
bptjm-15	245	27	parkinson	parkinson	NOUN
bptjm-15	245	28	’s	’s	PART
bptjm-15	245	29	disease	disease	NOUN
bptjm-15	245	30	(	(	PUNCT
bptjm-15	245	31	bremner	bremner	PROPN
bptjm-15	245	32	,	,	PUNCT
bptjm-15	245	33	2020	2020	NUM
bptjm-15	245	34	;	;	PUNCT
bptjm-15	245	35	haney	haney	PROPN
bptjm-15	245	36	,	,	PUNCT
bptjm-15	245	37	2018	2018	NUM
bptjm-15	245	38	;	;	PUNCT
bptjm-15	245	39	han	han	PROPN
bptjm-15	245	40	,	,	PUNCT
bptjm-15	245	41	2018	2018	NUM
bptjm-15	245	42	;	;	PUNCT
bptjm-15	245	43	o'reardon	o'reardon	PROPN
bptjm-15	245	44	,	,	PUNCT
bptjm-15	245	45	2006	2006	NUM
bptjm-15	245	46	;	;	PUNCT
bptjm-15	245	47	tian	tian	ADJ
bptjm-15	245	48	,	,	PUNCT
bptjm-15	245	49	2020	2020	NUM
bptjm-15	245	50	;	;	PUNCT
bptjm-15	245	51	winter	winter	NOUN
bptjm-15	245	52	,	,	PUNCT
bptjm-15	245	53	2018	2018	NUM
bptjm-15	245	54	;	;	PUNCT
bptjm-15	245	55	zhou	zhou	PROPN
bptjm-15	245	56	,	,	PUNCT
bptjm-15	245	57	2015	2015	NUM
bptjm-15	245	58	;	;	PUNCT
bptjm-15	245	59	martin	martin	PROPN
bptjm-15	245	60	,	,	PUNCT
bptjm-15	245	61	2018	2018	NUM
bptjm-15	245	62	)	)	PUNCT
bptjm-15	245	63	.	.	PUNCT
bptjm-15	246	1	yet	yet	ADV
bptjm-15	246	2	,	,	PUNCT
bptjm-15	246	3	even	even	ADV
bptjm-15	246	4	though	though	SCONJ
bptjm-15	246	5	extensive	extensive	ADJ
bptjm-15	246	6	research	research	NOUN
bptjm-15	246	7	has	have	AUX
bptjm-15	246	8	been	be	AUX
bptjm-15	246	9	conducted	conduct	VERB
bptjm-15	246	10	over	over	ADP
bptjm-15	246	11	the	the	DET
bptjm-15	246	12	past	past	ADJ
bptjm-15	246	13	decade	decade	NOUN
bptjm-15	246	14	,	,	PUNCT
bptjm-15	246	15	the	the	DET
bptjm-15	246	16	speci	speci	PROPN
bptjm-15	246	17	�	�	PROPN
bptjm-15	246	18	c	c	PROPN
bptjm-15	246	19	mechanisms	mechanism	NOUN
bptjm-15	246	20	of	of	ADP
bptjm-15	246	21	the	the	DET
bptjm-15	246	22	gut	gut	NOUN
bptjm-15	246	23	-	-	PUNCT
bptjm-15	246	24	brain	brain	NOUN
bptjm-15	246	25	axis	axis	NOUN
bptjm-15	246	26	in	in	ADP
bptjm-15	246	27	relation	relation	NOUN
bptjm-15	246	28	to	to	ADP
bptjm-15	246	29	ms	ms	PROPN
bptjm-15	246	30	have	have	VERB
bptjm-15	246	31	yet	yet	ADV
bptjm-15	246	32	to	to	PART
bptjm-15	246	33	be	be	AUX
bptjm-15	246	34	found	find	VERB
bptjm-15	246	35	.	.	PUNCT
bptjm-15	247	1	however	however	ADV
bptjm-15	247	2	,	,	PUNCT
bptjm-15	247	3	a	a	DET
bptjm-15	247	4	few	few	ADJ
bptjm-15	247	5	notable	notable	ADJ
bptjm-15	247	6	considerations	consideration	NOUN
bptjm-15	247	7	for	for	ADP
bptjm-15	247	8	these	these	DET
bptjm-15	247	9	mechanisms	mechanism	NOUN
bptjm-15	247	10	include	include	VERB
bptjm-15	247	11	(	(	PUNCT
bptjm-15	247	12	1	1	X
bptjm-15	247	13	)	)	PUNCT
bptjm-15	247	14	systemic	systemic	ADJ
bptjm-15	247	15	cytokine	cytokine	NOUN
bptjm-15	247	16	activation	activation	NOUN
bptjm-15	247	17	,	,	PUNCT
bptjm-15	247	18	(	(	PUNCT
bptjm-15	247	19	2	2	X
bptjm-15	247	20	)	)	PUNCT
bptjm-15	247	21	neurotransmitter	neurotransmitter	NOUN
bptjm-15	247	22	synthesis	synthesis	NOUN
bptjm-15	247	23	,	,	PUNCT
bptjm-15	247	24	and/or	and/or	CCONJ
bptjm-15	247	25	(	(	PUNCT
bptjm-15	247	26	3	3	NUM
bptjm-15	247	27	)	)	PUNCT
bptjm-15	247	28	neuronal	neuronal	ADJ
bptjm-15	247	29	circuitry	circuitry	NOUN
bptjm-15	247	30	alterations	alteration	NOUN
bptjm-15	247	31	(	(	PUNCT
bptjm-15	247	32	galland	galland	ADJ
bptjm-15	247	33	,	,	PUNCT
bptjm-15	247	34	2014	2014	NUM
bptjm-15	247	35	)	)	PUNCT
bptjm-15	247	36	.	.	PUNCT
bptjm-15	248	1	one	one	PRON
bptjm-15	248	2	could	could	AUX
bptjm-15	248	3	interpret	interpret	VERB
bptjm-15	248	4	this	this	PRON
bptjm-15	248	5	as	as	ADP
bptjm-15	248	6	berkeley	berkeley	PROPN
bptjm-15	248	7	pharma	pharma	PROPN
bptjm-15	248	8	tech	tech	NOUN
bptjm-15	248	9	journal	journal	NOUN
bptjm-15	248	10	of	of	ADP
bptjm-15	248	11	medicine	medicine	NOUN
bptjm-15	248	12	|	|	ADV
bptjm-15	248	13	81	81	NUM
bptjm-15	248	14	academia	academia	NOUN
bptjm-15	248	15	leaning	lean	VERB
bptjm-15	248	16	toward	toward	ADP
bptjm-15	248	17	investigations	investigation	NOUN
bptjm-15	248	18	on	on	ADP
bptjm-15	248	19	the	the	DET
bptjm-15	248	20	nervous	nervous	ADJ
bptjm-15	248	21	,	,	PUNCT
bptjm-15	248	22	immune	immune	ADJ
bptjm-15	248	23	,	,	PUNCT
bptjm-15	248	24	and	and	CCONJ
bptjm-15	248	25	endocrine	endocrine	NOUN
bptjm-15	248	26	systems	system	NOUN
bptjm-15	248	27	.	.	PUNCT
bptjm-15	249	1	researchers	researcher	NOUN
bptjm-15	249	2	of	of	ADP
bptjm-15	249	3	the	the	DET
bptjm-15	249	4	nervous	nervous	ADJ
bptjm-15	249	5	system	system	NOUN
bptjm-15	249	6	believe	believe	VERB
bptjm-15	249	7	the	the	DET
bptjm-15	249	8	vagus	vagus	NOUN
bptjm-15	249	9	nerve	nerve	NOUN
bptjm-15	249	10	,	,	PUNCT
bptjm-15	249	11	the	the	DET
bptjm-15	249	12	cranial	cranial	ADJ
bptjm-15	249	13	nerve	nerve	NOUN
bptjm-15	249	14	that	that	PRON
bptjm-15	249	15	controls	control	VERB
bptjm-15	249	16	the	the	DET
bptjm-15	249	17	signaling	signaling	NOUN
bptjm-15	249	18	between	between	ADP
bptjm-15	249	19	the	the	DET
bptjm-15	249	20	brain	brain	NOUN
bptjm-15	249	21	and	and	CCONJ
bptjm-15	249	22	gi	gi	NOUN
bptjm-15	249	23	tract	tract	NOUN
bptjm-15	249	24	,	,	PUNCT
bptjm-15	249	25	plays	play	VERB
bptjm-15	249	26	a	a	DET
bptjm-15	249	27	key	key	ADJ
bptjm-15	249	28	role	role	NOUN
bptjm-15	249	29	in	in	ADP
bptjm-15	249	30	the	the	DET
bptjm-15	249	31	interactions	interaction	NOUN
bptjm-15	249	32	of	of	ADP
bptjm-15	249	33	the	the	DET
bptjm-15	249	34	gut	gut	NOUN
bptjm-15	249	35	-	-	PUNCT
bptjm-15	249	36	brain	brain	NOUN
bptjm-15	249	37	axis	axis	NOUN
bptjm-15	249	38	(	(	PUNCT
bptjm-15	249	39	figure	figure	NOUN
bptjm-15	249	40	5	5	NUM
bptjm-15	249	41	)	)	PUNCT
bptjm-15	249	42	.	.	PUNCT
bptjm-15	250	1	one	one	NUM
bptjm-15	250	2	study	study	NOUN
bptjm-15	250	3	found	find	VERB
bptjm-15	250	4	that	that	SCONJ
bptjm-15	250	5	the	the	DET
bptjm-15	250	6	vagus	vagus	NOUN
bptjm-15	250	7	enhances	enhance	VERB
bptjm-15	250	8	neural	neural	ADJ
bptjm-15	250	9	plasticity	plasticity	NOUN
bptjm-15	250	10	(	(	PUNCT
bptjm-15	250	11	post	post	NOUN
bptjm-15	250	12	-	-	ADJ
bptjm-15	250	13	stroke	stroke	NOUN
bptjm-15	250	14	)	)	PUNCT
bptjm-15	250	15	with	with	ADP
bptjm-15	250	16	improvements	improvement	NOUN
bptjm-15	250	17	in	in	ADP
bptjm-15	250	18	both	both	CCONJ
bptjm-15	250	19	cognitive	cognitive	ADJ
bptjm-15	250	20	and	and	CCONJ
bptjm-15	250	21	motor	motor	NOUN
bptjm-15	250	22	function	function	NOUN
bptjm-15	250	23	,	,	PUNCT
bptjm-15	250	24	both	both	PRON
bptjm-15	250	25	of	of	ADP
bptjm-15	250	26	which	which	PRON
bptjm-15	250	27	are	be	AUX
bptjm-15	250	28	largely	largely	ADV
bptjm-15	250	29	diminished	diminish	VERB
bptjm-15	250	30	in	in	ADP
bptjm-15	250	31	ms	ms	ADJ
bptjm-15	250	32	patients	patient	NOUN
bptjm-15	250	33	(	(	PUNCT
bptjm-15	250	34	liu	liu	PROPN
bptjm-15	250	35	,	,	PUNCT
bptjm-15	250	36	2016	2016	NUM
bptjm-15	250	37	)	)	PUNCT
bptjm-15	250	38	.	.	PUNCT
bptjm-15	251	1	the	the	DET
bptjm-15	251	2	vagus	vagus	NOUN
bptjm-15	251	3	nerve	nerve	NOUN
bptjm-15	251	4	is	be	AUX
bptjm-15	251	5	also	also	ADV
bptjm-15	251	6	important	important	ADJ
bptjm-15	251	7	for	for	ADP
bptjm-15	251	8	neurogenesis	neurogenesis	NOUN
bptjm-15	251	9	through	through	ADP
bptjm-15	251	10	the	the	DET
bptjm-15	251	11	modulation	modulation	NOUN
bptjm-15	251	12	of	of	ADP
bptjm-15	251	13	brain	brain	NOUN
bptjm-15	251	14	-	-	PUNCT
bptjm-15	251	15	derived	derive	VERB
bptjm-15	251	16	neurotrophic	neurotrophic	ADJ
bptjm-15	251	17	factor	factor	NOUN
bptjm-15	251	18	(	(	PUNCT
bptjm-15	251	19	o’leary	o’leary	PROPN
bptjm-15	251	20	,	,	PUNCT
bptjm-15	251	21	2018	2018	NUM
bptjm-15	251	22	)	)	PUNCT
bptjm-15	251	23	.	.	PUNCT
bptjm-15	252	1	further	further	ADJ
bptjm-15	252	2	research	research	NOUN
bptjm-15	252	3	also	also	ADV
bptjm-15	252	4	correlates	correlate	VERB
bptjm-15	252	5	neuroelectrical	neuroelectrical	ADJ
bptjm-15	252	6	stimulation	stimulation	NOUN
bptjm-15	252	7	of	of	ADP
bptjm-15	252	8	the	the	DET
bptjm-15	252	9	vagus	vagus	NOUN
bptjm-15	252	10	nerve	nerve	NOUN
bptjm-15	252	11	with	with	ADP
bptjm-15	252	12	a	a	DET
bptjm-15	252	13	decrease	decrease	NOUN
bptjm-15	252	14	in	in	ADP
bptjm-15	252	15	symptoms	symptom	NOUN
bptjm-15	252	16	of	of	ADP
bptjm-15	252	17	various	various	ADJ
bptjm-15	252	18	neurological	neurological	ADJ
bptjm-15	252	19	disorders	disorder	NOUN
bptjm-15	252	20	in	in	ADP
bptjm-15	252	21	mice	mouse	NOUN
bptjm-15	252	22	(	(	PUNCT
bptjm-15	252	23	zhou	zhou	PROPN
bptjm-15	252	24	,	,	PUNCT
bptjm-15	252	25	2015	2015	NUM
bptjm-15	252	26	;	;	PUNCT
bptjm-15	252	27	haney	haney	PROPN
bptjm-15	252	28	,	,	PUNCT
bptjm-15	252	29	2018	2018	NUM
bptjm-15	252	30	)	)	PUNCT
bptjm-15	252	31	.	.	PUNCT
bptjm-15	253	1	as	as	SCONJ
bptjm-15	253	2	it	it	PRON
bptjm-15	253	3	stands	stand	VERB
bptjm-15	253	4	,	,	PUNCT
bptjm-15	253	5	gut	gut	NOUN
bptjm-15	253	6	-	-	PUNCT
bptjm-15	253	7	brain	brain	NOUN
bptjm-15	253	8	signaling	signaling	NOUN
bptjm-15	253	9	appears	appear	VERB
bptjm-15	253	10	to	to	PART
bptjm-15	253	11	be	be	AUX
bptjm-15	253	12	relatively	relatively	ADV
bptjm-15	253	13	dependent	dependent	ADJ
bptjm-15	253	14	on	on	ADP
bptjm-15	253	15	vagus	vagus	ADJ
bptjm-15	253	16	nerve	nerve	NOUN
bptjm-15	253	17	activity	activity	NOUN
bptjm-15	253	18	,	,	PUNCT
bptjm-15	253	19	but	but	CCONJ
bptjm-15	253	20	this	this	PRON
bptjm-15	253	21	may	may	AUX
bptjm-15	253	22	only	only	ADV
bptjm-15	253	23	be	be	AUX
bptjm-15	253	24	true	true	ADJ
bptjm-15	253	25	in	in	ADP
bptjm-15	253	26	certain	certain	ADJ
bptjm-15	253	27	experimental	experimental	ADJ
bptjm-15	253	28	systems	system	NOUN
bptjm-15	253	29	(	(	PUNCT
bptjm-15	253	30	bercik	bercik	ADJ
bptjm-15	253	31	,	,	PUNCT
bptjm-15	253	32	2011	2011	NUM
bptjm-15	253	33	)	)	PUNCT
bptjm-15	253	34	.	.	PUNCT
bptjm-15	254	1	impacts	impact	NOUN
bptjm-15	254	2	on	on	ADP
bptjm-15	254	3	chemical	chemical	ADJ
bptjm-15	254	4	communication	communication	NOUN
bptjm-15	254	5	in	in	ADP
bptjm-15	254	6	the	the	DET
bptjm-15	254	7	brain	brain	NOUN
bptjm-15	254	8	have	have	AUX
bptjm-15	254	9	also	also	ADV
bptjm-15	254	10	illustrated	illustrate	VERB
bptjm-15	254	11	the	the	DET
bptjm-15	254	12	value	value	NOUN
bptjm-15	254	13	of	of	ADP
bptjm-15	254	14	the	the	DET
bptjm-15	254	15	gut	gut	NOUN
bptjm-15	254	16	-	-	PUNCT
bptjm-15	254	17	brain	brain	NOUN
bptjm-15	254	18	axis	axis	NOUN
bptjm-15	254	19	in	in	ADP
bptjm-15	254	20	ms	ms	PROPN
bptjm-15	254	21	treatment	treatment	NOUN
bptjm-15	254	22	.	.	PUNCT
bptjm-15	255	1	it	it	PRON
bptjm-15	255	2	has	have	AUX
bptjm-15	255	3	been	be	AUX
bptjm-15	255	4	noted	note	VERB
bptjm-15	255	5	that	that	SCONJ
bptjm-15	255	6	more	more	ADJ
bptjm-15	255	7	than	than	ADP
bptjm-15	255	8	90	90	NUM
bptjm-15	255	9	%	%	NOUN
bptjm-15	255	10	of	of	ADP
bptjm-15	255	11	the	the	DET
bptjm-15	255	12	body	body	NOUN
bptjm-15	255	13	’s	’s	PART
bptjm-15	255	14	5	5	NUM
bptjm-15	255	15	-	-	PUNCT
bptjm-15	255	16	hydroxytryptamine	hydroxytryptamine	NOUN
bptjm-15	255	17	(	(	PUNCT
bptjm-15	255	18	5	5	NUM
bptjm-15	255	19	-	-	SYM
bptjm-15	255	20	ht	ht	NOUN
bptjm-15	255	21	)	)	PUNCT
bptjm-15	255	22	,	,	PUNCT
bptjm-15	255	23	or	or	CCONJ
bptjm-15	255	24	serotonin	serotonin	VERB
bptjm-15	255	25	,	,	PUNCT
bptjm-15	255	26	is	be	AUX
bptjm-15	255	27	produced	produce	VERB
bptjm-15	255	28	in	in	ADP
bptjm-15	255	29	the	the	DET
bptjm-15	255	30	gut	gut	NOUN
bptjm-15	255	31	(	(	PUNCT
bptjm-15	255	32	yano	yano	ADJ
bptjm-15	255	33	,	,	PUNCT
bptjm-15	255	34	2015	2015	NUM
bptjm-15	255	35	)	)	PUNCT
bptjm-15	255	36	.	.	PUNCT
bptjm-15	256	1	5	5	NUM
bptjm-15	256	2	-	-	PUNCT
bptjm-15	256	3	ht	ht	NOUN
bptjm-15	256	4	receptors	receptor	NOUN
bptjm-15	256	5	are	be	AUX
bptjm-15	256	6	critical	critical	ADJ
bptjm-15	256	7	in	in	ADP
bptjm-15	256	8	the	the	DET
bptjm-15	256	9	berkeley	berkeley	PROPN
bptjm-15	256	10	pharma	pharma	PROPN
bptjm-15	256	11	tech	tech	NOUN
bptjm-15	256	12	journal	journal	NOUN
bptjm-15	256	13	of	of	ADP
bptjm-15	256	14	medicine	medicine	NOUN
bptjm-15	256	15	|	|	ADV
bptjm-15	256	16	82	82	NUM
bptjm-15	256	17	figure	figure	NOUN
bptjm-15	256	18	5	5	NUM
bptjm-15	256	19	.	.	PUNCT
bptjm-15	257	1	the	the	DET
bptjm-15	257	2	vagus	vagus	NOUN
bptjm-15	257	3	nerve	nerve	NOUN
bptjm-15	257	4	is	be	AUX
bptjm-15	257	5	the	the	DET
bptjm-15	257	6	tenth	tenth	ADJ
bptjm-15	257	7	cranial	cranial	ADJ
bptjm-15	257	8	nerve	nerve	NOUN
bptjm-15	257	9	and	and	CCONJ
bptjm-15	257	10	extends	extend	VERB
bptjm-15	257	11	from	from	ADP
bptjm-15	257	12	the	the	DET
bptjm-15	257	13	brainstem	brainstem	NOUN
bptjm-15	257	14	through	through	ADP
bptjm-15	257	15	the	the	DET
bptjm-15	257	16	neck	neck	NOUN
bptjm-15	257	17	and	and	CCONJ
bptjm-15	257	18	the	the	DET
bptjm-15	257	19	thorax	thorax	NOUN
bptjm-15	257	20	down	down	ADP
bptjm-15	257	21	to	to	ADP
bptjm-15	257	22	the	the	DET
bptjm-15	257	23	abdomen	abdoman	NOUN
bptjm-15	257	24	.	.	PUNCT
bptjm-15	258	1	it	it	PRON
bptjm-15	258	2	carries	carry	VERB
bptjm-15	258	3	signals	signal	NOUN
bptjm-15	258	4	from	from	ADP
bptjm-15	258	5	the	the	DET
bptjm-15	258	6	digestive	digestive	ADJ
bptjm-15	258	7	system	system	NOUN
bptjm-15	258	8	and	and	CCONJ
bptjm-15	258	9	organs	organ	NOUN
bptjm-15	258	10	to	to	ADP
bptjm-15	258	11	the	the	DET
bptjm-15	258	12	brain	brain	NOUN
bptjm-15	258	13	and	and	CCONJ
bptjm-15	258	14	vice	vice	NOUN
bptjm-15	258	15	versa	versa	ADV
bptjm-15	258	16	.	.	PUNCT
bptjm-15	259	1	in	in	ADP
bptjm-15	259	2	addition	addition	NOUN
bptjm-15	259	3	,	,	PUNCT
bptjm-15	259	4	it	it	PRON
bptjm-15	259	5	modulates	modulate	VERB
bptjm-15	259	6	inflammation	inflammation	NOUN
bptjm-15	259	7	,	,	PUNCT
bptjm-15	259	8	maintains	maintain	VERB
bptjm-15	259	9	homeostasis	homeostasis	NOUN
bptjm-15	259	10	,	,	PUNCT
bptjm-15	259	11	and	and	CCONJ
bptjm-15	259	12	regulates	regulate	VERB
bptjm-15	259	13	many	many	ADJ
bptjm-15	259	14	body	body	NOUN
bptjm-15	259	15	sensations	sensation	NOUN
bptjm-15	259	16	.	.	PUNCT
bptjm-15	260	1	mediation	mediation	NOUN
bptjm-15	260	2	of	of	ADP
bptjm-15	260	3	gut	gut	NOUN
bptjm-15	260	4	-	-	PUNCT
bptjm-15	260	5	brain	brain	NOUN
bptjm-15	260	6	axis	axis	NOUN
bptjm-15	260	7	activity	activity	NOUN
bptjm-15	260	8	in	in	ADP
bptjm-15	260	9	ms	ms	ADJ
bptjm-15	260	10	patients	patient	NOUN
bptjm-15	260	11	(	(	PUNCT
bptjm-15	260	12	malinova	malinova	X
bptjm-15	260	13	,	,	PUNCT
bptjm-15	260	14	2018	2018	NUM
bptjm-15	260	15	)	)	PUNCT
bptjm-15	260	16	.	.	PUNCT
bptjm-15	261	1	gut	gut	NOUN
bptjm-15	261	2	microbiota	microbiota	NOUN
bptjm-15	261	3	have	have	AUX
bptjm-15	261	4	also	also	ADV
bptjm-15	261	5	shown	show	VERB
bptjm-15	261	6	success	success	NOUN
bptjm-15	261	7	in	in	ADP
bptjm-15	261	8	the	the	DET
bptjm-15	261	9	alteration	alteration	NOUN
bptjm-15	261	10	of	of	ADP
bptjm-15	261	11	host	host	NOUN
bptjm-15	261	12	serotonin	serotonin	NOUN
bptjm-15	261	13	levels	level	NOUN
bptjm-15	261	14	through	through	ADP
bptjm-15	261	15	the	the	DET
bptjm-15	261	16	mediation	mediation	NOUN
bptjm-15	261	17	of	of	ADP
bptjm-15	261	18	small	small	ADJ
bptjm-15	261	19	molecules	molecule	NOUN
bptjm-15	261	20	like	like	ADP
bptjm-15	261	21	scfas	scfas	NOUN
bptjm-15	261	22	or	or	CCONJ
bptjm-15	261	23	secondary	secondary	ADJ
bptjm-15	261	24	bile	bile	NOUN
bptjm-15	261	25	acids	acid	NOUN
bptjm-15	261	26	(	(	PUNCT
bptjm-15	261	27	2bas	2bas	NUM
bptjm-15	261	28	)	)	PUNCT
bptjm-15	261	29	(	(	PUNCT
bptjm-15	261	30	yano	yano	PROPN
bptjm-15	261	31	,	,	PUNCT
bptjm-15	261	32	2015	2015	NUM
bptjm-15	261	33	)	)	PUNCT
bptjm-15	261	34	.	.	PUNCT
bptjm-15	262	1	scfas	scfas	NOUN
bptjm-15	262	2	in	in	ADP
bptjm-15	262	3	particular	particular	ADJ
bptjm-15	262	4	are	be	AUX
bptjm-15	262	5	important	important	ADJ
bptjm-15	262	6	in	in	ADP
bptjm-15	262	7	mediating	mediate	VERB
bptjm-15	262	8	host	host	NOUN
bptjm-15	262	9	-	-	PUNCT
bptjm-15	262	10	microbe	microbe	NOUN
bptjm-15	262	11	communication	communication	NOUN
bptjm-15	262	12	via	via	ADP
bptjm-15	262	13	enteroendocrine	enteroendocrine	PROPN
bptjm-15	262	14	and	and	CCONJ
bptjm-15	262	15	enterochroma	enterochroma	PROPN
bptjm-15	262	16	�	�	PROPN
bptjm-15	262	17	n	n	PART
bptjm-15	262	18	cells	cell	NOUN
bptjm-15	262	19	,	,	PUNCT
bptjm-15	262	20	the	the	DET
bptjm-15	262	21	latter	latter	NOUN
bptjm-15	262	22	of	of	ADP
bptjm-15	262	23	which	which	PRON
bptjm-15	262	24	also	also	ADV
bptjm-15	262	25	play	play	VERB
bptjm-15	262	26	a	a	DET
bptjm-15	262	27	role	role	NOUN
bptjm-15	262	28	in	in	ADP
bptjm-15	262	29	tryptophan	tryptophan	NOUN
bptjm-15	262	30	metabolism	metabolism	NOUN
bptjm-15	262	31	(	(	PUNCT
bptjm-15	262	32	figure	figure	NOUN
bptjm-15	262	33	6	6	NUM
bptjm-15	262	34	)	)	PUNCT
bptjm-15	262	35	(	(	PUNCT
bptjm-15	262	36	martin	martin	PROPN
bptjm-15	262	37	,	,	PUNCT
bptjm-15	262	38	2018	2018	NUM
bptjm-15	262	39	)	)	PUNCT
bptjm-15	262	40	.	.	PUNCT
bptjm-15	263	1	although	although	SCONJ
bptjm-15	263	2	the	the	DET
bptjm-15	263	3	gut	gut	NOUN
bptjm-15	263	4	-	-	PUNCT
bptjm-15	263	5	brain	brain	NOUN
bptjm-15	263	6	axis	axis	NOUN
bptjm-15	263	7	shows	show	VERB
bptjm-15	263	8	great	great	ADJ
bptjm-15	263	9	potential	potential	NOUN
bptjm-15	263	10	for	for	ADP
bptjm-15	263	11	ms	ms	PROPN
bptjm-15	263	12	therapy	therapy	NOUN
bptjm-15	263	13	,	,	PUNCT
bptjm-15	263	14	research	research	NOUN
bptjm-15	263	15	on	on	ADP
bptjm-15	263	16	the	the	DET
bptjm-15	263	17	functions	function	NOUN
bptjm-15	263	18	of	of	ADP
bptjm-15	263	19	speci	speci	PROPN
bptjm-15	263	20	�	�	PROPN
bptjm-15	263	21	c	c	PROPN
bptjm-15	263	22	bacterial	bacterial	ADJ
bptjm-15	263	23	species	specie	NOUN
bptjm-15	263	24	on	on	ADP
bptjm-15	263	25	the	the	DET
bptjm-15	263	26	gut	gut	NOUN
bptjm-15	263	27	-	-	PUNCT
bptjm-15	263	28	brain	brain	NOUN
bptjm-15	263	29	axis	axis	NOUN
bptjm-15	263	30	is	be	AUX
bptjm-15	263	31	limited	limited	ADJ
bptjm-15	263	32	.	.	PUNCT
bptjm-15	264	1	there	there	PRON
bptjm-15	264	2	is	be	VERB
bptjm-15	264	3	signi	signi	ADJ
bptjm-15	264	4	�	�	NOUN
bptjm-15	264	5	cant	cant	VERB
bptjm-15	264	6	evidence	evidence	NOUN
bptjm-15	264	7	to	to	PART
bptjm-15	264	8	suggest	suggest	VERB
bptjm-15	264	9	that	that	SCONJ
bptjm-15	264	10	few	few	ADJ
bptjm-15	264	11	genera	genera	NOUN
bptjm-15	264	12	such	such	ADJ
bptjm-15	264	13	as	as	ADP
bptjm-15	264	14	bacteroides	bacteroide	NOUN
bptjm-15	264	15	and	and	CCONJ
bptjm-15	264	16	firmicutes	firmicute	NOUN
bptjm-15	264	17	are	be	AUX
bptjm-15	264	18	a	a	DET
bptjm-15	264	19	�	�	NOUN
bptjm-15	264	20	ected	ecte	VERB
bptjm-15	264	21	by	by	ADP
bptjm-15	264	22	mental	mental	ADJ
bptjm-15	264	23	and	and	CCONJ
bptjm-15	264	24	physiological	physiological	ADJ
bptjm-15	264	25	stress	stress	NOUN
bptjm-15	264	26	,	,	PUNCT
bptjm-15	264	27	but	but	CCONJ
bptjm-15	264	28	their	their	PRON
bptjm-15	264	29	speci	speci	PROPN
bptjm-15	264	30	�	�	PROPN
bptjm-15	264	31	c	c	PROPN
bptjm-15	264	32	e	e	NOUN
bptjm-15	264	33	�	�	PROPN
bptjm-15	264	34	ect	ect	X
bptjm-15	264	35	on	on	ADP
bptjm-15	264	36	ms	ms	PROPN
bptjm-15	264	37	pathology	pathology	NOUN
bptjm-15	264	38	is	be	AUX
bptjm-15	264	39	unclear	unclear	ADJ
bptjm-15	264	40	(	(	PUNCT
bptjm-15	264	41	tian	tian	ADJ
bptjm-15	264	42	,	,	PUNCT
bptjm-15	264	43	2020	2020	NUM
bptjm-15	264	44	;	;	PUNCT
bptjm-15	264	45	choileáin	choileáin	ADJ
bptjm-15	264	46	,	,	PUNCT
bptjm-15	264	47	2020	2020	NUM
bptjm-15	264	48	)	)	PUNCT
bptjm-15	264	49	.	.	PUNCT
bptjm-15	265	1	studying	study	VERB
bptjm-15	265	2	the	the	DET
bptjm-15	265	3	e	e	NOUN
bptjm-15	265	4	�	�	PROPN
bptjm-15	265	5	ects	ect	NOUN
bptjm-15	265	6	of	of	ADP
bptjm-15	265	7	general	general	ADJ
bptjm-15	265	8	probiotics	probiotic	NOUN
bptjm-15	265	9	versus	versus	ADP
bptjm-15	265	10	speci	speci	PROPN
bptjm-15	265	11	�	�	PROPN
bptjm-15	265	12	c	c	PROPN
bptjm-15	265	13	bacterial	bacterial	ADJ
bptjm-15	265	14	species	specie	NOUN
bptjm-15	265	15	on	on	ADP
bptjm-15	265	16	ms	ms	ADJ
bptjm-15	265	17	symptoms	symptom	NOUN
bptjm-15	265	18	is	be	AUX
bptjm-15	265	19	necessary	necessary	ADJ
bptjm-15	265	20	to	to	PART
bptjm-15	265	21	determine	determine	VERB
bptjm-15	265	22	the	the	DET
bptjm-15	265	23	direction	direction	NOUN
bptjm-15	265	24	of	of	ADP
bptjm-15	265	25	future	future	ADJ
bptjm-15	265	26	research	research	NOUN
bptjm-15	265	27	on	on	ADP
bptjm-15	265	28	ms	ms	PROPN
bptjm-15	265	29	therapy	therapy	NOUN
bptjm-15	265	30	via	via	ADP
bptjm-15	265	31	the	the	DET
bptjm-15	265	32	gut	gut	NOUN
bptjm-15	265	33	-	-	PUNCT
bptjm-15	265	34	brain	brain	NOUN
bptjm-15	265	35	axis	axis	NOUN
bptjm-15	265	36	.	.	PUNCT
bptjm-15	266	1	furthermore	furthermore	ADV
bptjm-15	266	2	,	,	PUNCT
bptjm-15	266	3	future	future	ADJ
bptjm-15	266	4	research	research	NOUN
bptjm-15	266	5	directed	direct	VERB
bptjm-15	266	6	toward	toward	ADP
bptjm-15	266	7	the	the	DET
bptjm-15	266	8	integration	integration	NOUN
bptjm-15	266	9	of	of	ADP
bptjm-15	266	10	current	current	ADJ
bptjm-15	266	11	ms	ms	NOUN
bptjm-15	266	12	therapies	therapy	NOUN
bptjm-15	266	13	and	and	CCONJ
bptjm-15	266	14	their	their	PRON
bptjm-15	266	15	e	e	NOUN
bptjm-15	266	16	�	�	NOUN
bptjm-15	266	17	ect	ect	VERB
bptjm-15	266	18	on	on	ADP
bptjm-15	266	19	the	the	DET
bptjm-15	266	20	gut	gut	NOUN
bptjm-15	266	21	-	-	PUNCT
bptjm-15	266	22	brain	brain	NOUN
bptjm-15	266	23	axis	axis	NOUN
bptjm-15	266	24	is	be	AUX
bptjm-15	266	25	needed	need	VERB
bptjm-15	266	26	.	.	PUNCT
bptjm-15	267	1	for	for	ADP
bptjm-15	267	2	example	example	NOUN
bptjm-15	267	3	,	,	PUNCT
bptjm-15	267	4	in	in	ADP
bptjm-15	267	5	regards	regard	NOUN
bptjm-15	267	6	to	to	ADP
bptjm-15	267	7	neuromodulation	neuromodulation	NOUN
bptjm-15	267	8	technology	technology	NOUN
bptjm-15	267	9	,	,	PUNCT
bptjm-15	267	10	the	the	DET
bptjm-15	267	11	development	development	NOUN
bptjm-15	267	12	of	of	ADP
bptjm-15	267	13	closed	closed	ADJ
bptjm-15	267	14	-	-	PUNCT
bptjm-15	267	15	loop	loop	NOUN
bptjm-15	267	16	adaptive	adaptive	ADJ
bptjm-15	267	17	systems	system	NOUN
bptjm-15	267	18	which	which	PRON
bptjm-15	267	19	use	use	VERB
bptjm-15	267	20	predictive	predictive	ADJ
bptjm-15	267	21	models	model	NOUN
bptjm-15	267	22	of	of	ADP
bptjm-15	267	23	neural	neural	ADJ
bptjm-15	267	24	circuitopathies	circuitopathie	NOUN
bptjm-15	267	25	to	to	PART
bptjm-15	267	26	alter	alter	VERB
bptjm-15	267	27	neurostimulation	neurostimulation	NOUN
bptjm-15	267	28	parameters	parameter	NOUN
bptjm-15	267	29	without	without	ADP
bptjm-15	267	30	clinical	clinical	ADJ
bptjm-15	267	31	supervision	supervision	NOUN
bptjm-15	267	32	is	be	AUX
bptjm-15	267	33	a	a	DET
bptjm-15	267	34	promising	promising	ADJ
bptjm-15	267	35	avenue	avenue	NOUN
bptjm-15	267	36	of	of	ADP
bptjm-15	267	37	research	research	NOUN
bptjm-15	267	38	(	(	PUNCT
bptjm-15	267	39	drew	draw	VERB
bptjm-15	267	40	,	,	PUNCT
bptjm-15	267	41	2019	2019	NUM
bptjm-15	267	42	;	;	PUNCT
bptjm-15	267	43	edwards	edwards	PROPN
bptjm-15	267	44	,	,	PUNCT
bptjm-15	267	45	2017	2017	NUM
bptjm-15	267	46	;	;	PUNCT
bptjm-15	267	47	lozano	lozano	PROPN
bptjm-15	267	48	,	,	PUNCT
bptjm-15	267	49	2019	2019	NUM
bptjm-15	267	50	)	)	PUNCT
bptjm-15	267	51	.	.	PUNCT
bptjm-15	268	1	another	another	DET
bptjm-15	268	2	promising	promising	ADJ
bptjm-15	268	3	berkeley	berkeley	PROPN
bptjm-15	268	4	pharma	pharma	PROPN
bptjm-15	268	5	tech	tech	NOUN
bptjm-15	268	6	journal	journal	NOUN
bptjm-15	268	7	of	of	ADP
bptjm-15	268	8	medicine	medicine	NOUN
bptjm-15	268	9	|	|	ADV
bptjm-15	268	10	83	83	NUM
bptjm-15	268	11	figure	figure	NOUN
bptjm-15	268	12	6	6	NUM
bptjm-15	268	13	.	.	PUNCT
bptjm-15	268	14	stimulation	stimulation	NOUN
bptjm-15	268	15	of	of	ADP
bptjm-15	268	16	the	the	DET
bptjm-15	268	17	vagus	vagus	NOUN
bptjm-15	268	18	nerve	nerve	NOUN
bptjm-15	268	19	has	have	AUX
bptjm-15	268	20	shown	show	VERB
bptjm-15	268	21	efficacy	efficacy	NOUN
bptjm-15	268	22	in	in	ADP
bptjm-15	268	23	modulating	modulate	VERB
bptjm-15	268	24	5	5	NUM
bptjm-15	268	25	-	-	PUNCT
bptjm-15	268	26	ht	ht	NOUN
bptjm-15	268	27	receptors	receptor	NOUN
bptjm-15	268	28	,	,	PUNCT
bptjm-15	268	29	scfas	scfas	NOUN
bptjm-15	268	30	,	,	PUNCT
bptjm-15	268	31	and	and	CCONJ
bptjm-15	268	32	2	2	NUM
bptjm-15	268	33	°	°	NUM
bptjm-15	268	34	bas	bas	X
bptjm-15	268	35	in	in	ADP
bptjm-15	268	36	the	the	DET
bptjm-15	268	37	gut	gut	NOUN
bptjm-15	268	38	microbiome	microbiome	NOUN
bptjm-15	268	39	.	.	PUNCT
bptjm-15	269	1	development	development	NOUN
bptjm-15	269	2	is	be	AUX
bptjm-15	269	3	the	the	DET
bptjm-15	269	4	creation	creation	NOUN
bptjm-15	269	5	of	of	ADP
bptjm-15	269	6	minimally	minimally	ADV
bptjm-15	269	7	invasive	invasive	ADJ
bptjm-15	269	8	,	,	PUNCT
bptjm-15	269	9	wireless	wireless	ADJ
bptjm-15	269	10	neuromodulation	neuromodulation	NOUN
bptjm-15	269	11	technology	technology	NOUN
bptjm-15	269	12	to	to	PART
bptjm-15	269	13	alter	alter	VERB
bptjm-15	269	14	biological	biological	ADJ
bptjm-15	269	15	parameters	parameter	NOUN
bptjm-15	269	16	in	in	ADP
bptjm-15	269	17	real	real	ADJ
bptjm-15	269	18	-	-	PUNCT
bptjm-15	269	19	time	time	NOUN
bptjm-15	269	20	(	(	PUNCT
bptjm-15	269	21	tanabe	tanabe	PROPN
bptjm-15	269	22	,	,	PUNCT
bptjm-15	269	23	2017	2017	NUM
bptjm-15	269	24	;	;	PUNCT
bptjm-15	269	25	iodice	iodice	NOUN
bptjm-15	269	26	,	,	PUNCT
bptjm-15	269	27	2017	2017	NUM
bptjm-15	269	28	)	)	PUNCT
bptjm-15	269	29	.	.	PUNCT
bptjm-15	270	1	in	in	ADP
bptjm-15	270	2	recent	recent	ADJ
bptjm-15	270	3	years	year	NOUN
bptjm-15	270	4	,	,	PUNCT
bptjm-15	270	5	there	there	PRON
bptjm-15	270	6	has	have	AUX
bptjm-15	270	7	been	be	AUX
bptjm-15	270	8	an	an	DET
bptjm-15	270	9	increase	increase	NOUN
bptjm-15	270	10	in	in	ADP
bptjm-15	270	11	clinical	clinical	ADJ
bptjm-15	270	12	trials	trial	NOUN
bptjm-15	270	13	exploring	explore	VERB
bptjm-15	270	14	the	the	DET
bptjm-15	270	15	connection	connection	NOUN
bptjm-15	270	16	between	between	ADP
bptjm-15	270	17	the	the	DET
bptjm-15	270	18	vagus	vagus	NOUN
bptjm-15	270	19	nerve	nerve	NOUN
bptjm-15	270	20	and	and	CCONJ
bptjm-15	270	21	neurological	neurological	ADJ
bptjm-15	270	22	de	de	PROPN
bptjm-15	270	23	�	�	PROPN
bptjm-15	270	24	cits	cit	NOUN
bptjm-15	270	25	.	.	PUNCT
bptjm-15	271	1	for	for	ADP
bptjm-15	271	2	example	example	NOUN
bptjm-15	271	3	,	,	PUNCT
bptjm-15	271	4	a	a	DET
bptjm-15	271	5	current	current	ADJ
bptjm-15	271	6	clinical	clinical	ADJ
bptjm-15	271	7	trial	trial	NOUN
bptjm-15	271	8	is	be	AUX
bptjm-15	271	9	exploring	explore	VERB
bptjm-15	271	10	how	how	SCONJ
bptjm-15	271	11	stimulating	stimulate	VERB
bptjm-15	271	12	the	the	DET
bptjm-15	271	13	transcutaneous	transcutaneous	ADJ
bptjm-15	271	14	vagus	vagus	NOUN
bptjm-15	271	15	nerve	nerve	NOUN
bptjm-15	271	16	could	could	AUX
bptjm-15	271	17	improve	improve	VERB
bptjm-15	271	18	cognitive	cognitive	ADJ
bptjm-15	271	19	function	function	NOUN
bptjm-15	271	20	(	(	PUNCT
bptjm-15	271	21	university	university	NOUN
bptjm-15	271	22	of	of	ADP
bptjm-15	271	23	ostrava	ostrava	PROPN
bptjm-15	271	24	,	,	PUNCT
bptjm-15	271	25	2019	2019	NUM
bptjm-15	271	26	)	)	PUNCT
bptjm-15	271	27	.	.	PUNCT
bptjm-15	272	1	the	the	DET
bptjm-15	272	2	clinical	clinical	ADJ
bptjm-15	272	3	trial	trial	NOUN
bptjm-15	272	4	is	be	AUX
bptjm-15	272	5	using	use	VERB
bptjm-15	272	6	non	non	ADJ
bptjm-15	272	7	-	-	ADJ
bptjm-15	272	8	invasive	invasive	ADJ
bptjm-15	272	9	stimulation	stimulation	NOUN
bptjm-15	272	10	provided	provide	VERB
bptjm-15	272	11	by	by	ADP
bptjm-15	272	12	a	a	DET
bptjm-15	272	13	transcutaneous	transcutaneous	ADJ
bptjm-15	272	14	electrical	electrical	ADJ
bptjm-15	272	15	nerve	nerve	NOUN
bptjm-15	272	16	stimulation	stimulation	NOUN
bptjm-15	272	17	device	device	NOUN
bptjm-15	272	18	for	for	ADP
bptjm-15	272	19	four	four	NUM
bptjm-15	272	20	hours	hour	NOUN
bptjm-15	272	21	a	a	DET
bptjm-15	272	22	day	day	NOUN
bptjm-15	272	23	at	at	ADP
bptjm-15	272	24	25hz	25hz	ADJ
bptjm-15	272	25	,	,	PUNCT
bptjm-15	272	26	250	250	NUM
bptjm-15	272	27	μs	μs	NOUN
bptjm-15	272	28	pulse	pulse	NOUN
bptjm-15	272	29	width	width	NOUN
bptjm-15	272	30	placed	place	VERB
bptjm-15	272	31	on	on	ADP
bptjm-15	272	32	the	the	DET
bptjm-15	272	33	tragus	tragus	NOUN
bptjm-15	272	34	.	.	PUNCT
bptjm-15	273	1	this	this	DET
bptjm-15	273	2	novel	novel	ADJ
bptjm-15	273	3	area	area	NOUN
bptjm-15	273	4	of	of	ADP
bptjm-15	273	5	preventive	preventive	ADJ
bptjm-15	273	6	medicine	medicine	NOUN
bptjm-15	273	7	could	could	AUX
bptjm-15	273	8	provide	provide	VERB
bptjm-15	273	9	an	an	DET
bptjm-15	273	10	interesting	interesting	ADJ
bptjm-15	273	11	perspective	perspective	NOUN
bptjm-15	273	12	on	on	ADP
bptjm-15	273	13	ms	ms	ADJ
bptjm-15	273	14	therapies	therapy	NOUN
bptjm-15	273	15	.	.	PUNCT
bptjm-15	274	1	if	if	SCONJ
bptjm-15	274	2	the	the	DET
bptjm-15	274	3	technological	technological	ADJ
bptjm-15	274	4	device	device	NOUN
bptjm-15	274	5	results	result	VERB
bptjm-15	274	6	in	in	ADP
bptjm-15	274	7	clinically	clinically	ADV
bptjm-15	274	8	signi	signi	ADJ
bptjm-15	274	9	�	�	PROPN
bptjm-15	274	10	cant	cant	NOUN
bptjm-15	274	11	applications	application	NOUN
bptjm-15	274	12	,	,	PUNCT
bptjm-15	274	13	it	it	PRON
bptjm-15	274	14	could	could	AUX
bptjm-15	274	15	improve	improve	VERB
bptjm-15	274	16	executive	executive	ADJ
bptjm-15	274	17	neurological	neurological	ADJ
bptjm-15	274	18	function	function	NOUN
bptjm-15	274	19	and	and	CCONJ
bptjm-15	274	20	potentially	potentially	ADV
bptjm-15	274	21	help	help	VERB
bptjm-15	274	22	prevent	prevent	VERB
bptjm-15	274	23	demyelination	demyelination	NOUN
bptjm-15	274	24	.	.	PUNCT
bptjm-15	275	1	conclusion	conclusion	NOUN
bptjm-15	275	2	there	there	PRON
bptjm-15	275	3	has	have	AUX
bptjm-15	275	4	been	be	AUX
bptjm-15	275	5	minimal	minimal	ADJ
bptjm-15	275	6	research	research	NOUN
bptjm-15	275	7	regarding	regard	VERB
bptjm-15	275	8	many	many	ADJ
bptjm-15	275	9	areas	area	NOUN
bptjm-15	275	10	of	of	ADP
bptjm-15	275	11	concern	concern	NOUN
bptjm-15	275	12	such	such	ADJ
bptjm-15	275	13	as	as	ADP
bptjm-15	275	14	the	the	DET
bptjm-15	275	15	e	e	NOUN
bptjm-15	275	16	�	�	NOUN
bptjm-15	275	17	ects	ect	VERB
bptjm-15	275	18	on	on	ADP
bptjm-15	275	19	the	the	DET
bptjm-15	275	20	blood	blood	NOUN
bptjm-15	275	21	-	-	PUNCT
bptjm-15	275	22	brain	brain	NOUN
bptjm-15	275	23	barrier	barrier	NOUN
bptjm-15	275	24	by	by	ADP
bptjm-15	275	25	b	b	NOUN
bptjm-15	275	26	cells	cell	NOUN
bptjm-15	275	27	,	,	PUNCT
bptjm-15	275	28	the	the	DET
bptjm-15	275	29	speci	speci	PROPN
bptjm-15	275	30	�	�	PROPN
bptjm-15	275	31	c	c	PROPN
bptjm-15	275	32	mechanisms	mechanism	NOUN
bptjm-15	275	33	of	of	ADP
bptjm-15	275	34	lymphocytes	lymphocyte	NOUN
bptjm-15	275	35	and	and	CCONJ
bptjm-15	275	36	cytokines	cytokine	NOUN
bptjm-15	275	37	on	on	ADP
bptjm-15	275	38	the	the	DET
bptjm-15	275	39	gut	gut	NOUN
bptjm-15	275	40	-	-	PUNCT
bptjm-15	275	41	brain	brain	NOUN
bptjm-15	275	42	axis	axis	NOUN
bptjm-15	275	43	,	,	PUNCT
bptjm-15	275	44	and	and	CCONJ
bptjm-15	275	45	the	the	DET
bptjm-15	275	46	association	association	NOUN
bptjm-15	275	47	between	between	ADP
bptjm-15	275	48	ms	ms	PROPN
bptjm-15	275	49	and	and	CCONJ
bptjm-15	275	50	the	the	DET
bptjm-15	275	51	microbiome	microbiome	NOUN
bptjm-15	275	52	.	.	PUNCT
bptjm-15	276	1	it	it	PRON
bptjm-15	276	2	is	be	AUX
bptjm-15	276	3	unclear	unclear	ADJ
bptjm-15	276	4	whether	whether	SCONJ
bptjm-15	276	5	or	or	CCONJ
bptjm-15	276	6	not	not	PART
bptjm-15	276	7	the	the	DET
bptjm-15	276	8	gut	gut	NOUN
bptjm-15	276	9	microbiome	microbiome	NOUN
bptjm-15	276	10	will	will	AUX
bptjm-15	276	11	become	become	VERB
bptjm-15	276	12	a	a	DET
bptjm-15	276	13	viable	viable	ADJ
bptjm-15	276	14	therapy	therapy	NOUN
bptjm-15	276	15	speci	speci	NOUN
bptjm-15	276	16	�	�	PROPN
bptjm-15	276	17	cally	cally	ADV
bptjm-15	276	18	for	for	ADP
bptjm-15	276	19	neurodegenerative	neurodegenerative	ADJ
bptjm-15	276	20	disorders	disorder	NOUN
bptjm-15	276	21	,	,	PUNCT
bptjm-15	276	22	but	but	CCONJ
bptjm-15	276	23	the	the	DET
bptjm-15	276	24	association	association	NOUN
bptjm-15	276	25	between	between	ADP
bptjm-15	276	26	human	human	ADJ
bptjm-15	276	27	physiology	physiology	NOUN
bptjm-15	276	28	and	and	CCONJ
bptjm-15	276	29	microbiota	microbiota	NOUN
bptjm-15	276	30	can	can	AUX
bptjm-15	276	31	not	not	PART
bptjm-15	276	32	be	be	AUX
bptjm-15	276	33	ignored	ignore	VERB
bptjm-15	276	34	.	.	PUNCT
bptjm-15	277	1	with	with	ADP
bptjm-15	277	2	a	a	DET
bptjm-15	277	3	greater	great	ADJ
bptjm-15	277	4	understanding	understanding	NOUN
bptjm-15	277	5	of	of	ADP
bptjm-15	277	6	symbiotic	symbiotic	ADJ
bptjm-15	277	7	human	human	ADJ
bptjm-15	277	8	-	-	PUNCT
bptjm-15	277	9	microbial	microbial	ADJ
bptjm-15	277	10	interactions	interaction	NOUN
bptjm-15	277	11	,	,	PUNCT
bptjm-15	277	12	there	there	PRON
bptjm-15	277	13	is	be	VERB
bptjm-15	277	14	no	no	DET
bptjm-15	277	15	doubt	doubt	NOUN
bptjm-15	277	16	that	that	SCONJ
bptjm-15	277	17	future	future	ADJ
bptjm-15	277	18	research	research	NOUN
bptjm-15	277	19	will	will	AUX
bptjm-15	277	20	be	be	AUX
bptjm-15	277	21	useful	useful	ADJ
bptjm-15	277	22	in	in	ADP
bptjm-15	277	23	building	build	VERB
bptjm-15	277	24	a	a	DET
bptjm-15	277	25	greater	great	ADJ
bptjm-15	277	26	comprehension	comprehension	NOUN
bptjm-15	277	27	that	that	PRON
bptjm-15	277	28	may	may	AUX
bptjm-15	277	29	result	result	VERB
bptjm-15	277	30	in	in	ADP
bptjm-15	277	31	clinically	clinically	ADV
bptjm-15	277	32	signi	signi	ADJ
bptjm-15	277	33	�	�	NOUN
bptjm-15	277	34	cant	cant	NOUN
bptjm-15	277	35	therapies	therapy	NOUN
bptjm-15	277	36	.	.	PUNCT
bptjm-15	278	1	berkeley	berkeley	PROPN
bptjm-15	278	2	pharma	pharma	PROPN
bptjm-15	278	3	tech	tech	PROPN
bptjm-15	278	4	journal	journal	NOUN
bptjm-15	278	5	of	of	ADP
bptjm-15	278	6	medicine	medicine	NOUN
bptjm-15	278	7	|	|	ADV
bptjm-15	278	8	84	84	NUM
bptjm-15	278	9	references	reference	NOUN
bptjm-15	278	10	1	1	NUM
bptjm-15	278	11	.	.	NOUN
bptjm-15	278	12	aredo	aredo	PROPN
bptjm-15	278	13	,	,	PUNCT
bptjm-15	278	14	j.	j.	PROPN
bptjm-15	278	15	v.	v.	PROPN
bptjm-15	278	16	,	,	PUNCT
bptjm-15	278	17	padda	padda	NOUN
bptjm-15	278	18	,	,	PUNCT
bptjm-15	278	19	s.	s.	PROPN
bptjm-15	278	20	k.	k.	PROPN
bptjm-15	278	21	,	,	PUNCT
bptjm-15	278	22	kunder	kunder	PROPN
bptjm-15	278	23	,	,	PUNCT
bptjm-15	278	24	c.	c.	PROPN
bptjm-15	278	25	a.	a.	PROPN
bptjm-15	278	26	,	,	PUNCT
bptjm-15	278	27	han	han	PROPN
bptjm-15	278	28	,	,	PUNCT
bptjm-15	278	29	s.	s.	PROPN
bptjm-15	278	30	s.	s.	PROPN
bptjm-15	278	31	,	,	PUNCT
bptjm-15	278	32	neal	neal	PROPN
bptjm-15	278	33	,	,	PUNCT
bptjm-15	278	34	j.	j.	PROPN
bptjm-15	278	35	w.	w.	PROPN
bptjm-15	278	36	,	,	PUNCT
bptjm-15	278	37	shrager	shrager	NOUN
bptjm-15	278	38	,	,	PUNCT
bptjm-15	278	39	j.	j.	PROPN
bptjm-15	278	40	b.	b.	PROPN
bptjm-15	278	41	,	,	PUNCT
bptjm-15	278	42	&	&	CCONJ
bptjm-15	278	43	wakelee	wakelee	PROPN
bptjm-15	278	44	,	,	PUNCT
bptjm-15	278	45	h.	h.	PROPN
bptjm-15	278	46	a.	a.	PROPN
bptjm-15	278	47	(	(	PUNCT
bptjm-15	278	48	2019	2019	NUM
bptjm-15	278	49	)	)	PUNCT
bptjm-15	278	50	.	.	PUNCT
bptjm-15	279	1	impact	impact	NOUN
bptjm-15	279	2	of	of	ADP
bptjm-15	279	3	kras	kras	PROPN
bptjm-15	279	4	mutation	mutation	NOUN
bptjm-15	279	5	subtype	subtype	NOUN
bptjm-15	279	6	and	and	CCONJ
bptjm-15	279	7	concurrent	concurrent	ADJ
bptjm-15	279	8	pathogenic	pathogenic	ADJ
bptjm-15	279	9	mutations	mutation	NOUN
bptjm-15	279	10	on	on	ADP
bptjm-15	279	11	non	non	ADJ
bptjm-15	279	12	-	-	ADJ
bptjm-15	279	13	small	small	ADJ
bptjm-15	279	14	cell	cell	NOUN
bptjm-15	279	15	lung	lung	NOUN
bptjm-15	279	16	cancer	cancer	NOUN
bptjm-15	279	17	outcomes	outcome	NOUN
bptjm-15	279	18	.	.	PUNCT
bptjm-15	280	1	lung	lung	NOUN
bptjm-15	280	2	cancer	cancer	NOUN
bptjm-15	280	3	(	(	PUNCT
bptjm-15	280	4	amsterdam	amsterdam	PROPN
bptjm-15	280	5	,	,	PUNCT
bptjm-15	280	6	netherlands	netherlands	PROPN
bptjm-15	280	7	)	)	PUNCT
bptjm-15	280	8	,	,	PUNCT
bptjm-15	280	9	133	133	NUM
bptjm-15	280	10	,	,	PUNCT
bptjm-15	280	11	144–150	144–150	NUM
bptjm-15	280	12	.	.	PUNCT
bptjm-15	281	1	https://doi.org/10.1016/j.lungcan.2019.05.015	https://doi.org/10.1016/j.lungcan.2019.05.015	NUM
bptjm-15	281	2	2	2	NUM
bptjm-15	281	3	.	.	X
bptjm-15	281	4	bardelli	bardelli	NOUN
bptjm-15	281	5	,	,	PUNCT
bptjm-15	281	6	a.	a.	NOUN
bptjm-15	281	7	,	,	PUNCT
bptjm-15	281	8	corso	corso	PROPN
bptjm-15	281	9	,	,	PUNCT
bptjm-15	281	10	s.	s.	PROPN
bptjm-15	281	11	,	,	PUNCT
bptjm-15	281	12	bertotti	bertotti	PROPN
bptjm-15	281	13	,	,	PUNCT
bptjm-15	281	14	a.	a.	PROPN
bptjm-15	281	15	,	,	PUNCT
bptjm-15	281	16	hobor	hobor	PROPN
bptjm-15	281	17	,	,	PUNCT
bptjm-15	281	18	s.	s.	PROPN
bptjm-15	281	19	,	,	PUNCT
bptjm-15	281	20	valtorta	valtorta	PROPN
bptjm-15	281	21	,	,	PUNCT
bptjm-15	281	22	e.	e.	PROPN
bptjm-15	281	23	,	,	PUNCT
bptjm-15	281	24	siravegna	siravegna	PROPN
bptjm-15	281	25	,	,	PUNCT
bptjm-15	281	26	g.	g.	PROPN
bptjm-15	281	27	,	,	PUNCT
bptjm-15	281	28	sartore	sartore	ADP
bptjm-15	281	29	bianchi	bianchi	NOUN
bptjm-15	281	30	,	,	PUNCT
bptjm-15	281	31	a.	a.	PROPN
bptjm-15	281	32	,	,	PUNCT
bptjm-15	281	33	scala	scala	PROPN
bptjm-15	281	34	,	,	PUNCT
bptjm-15	281	35	e.	e.	PROPN
bptjm-15	281	36	,	,	PUNCT
bptjm-15	281	37	cassingena	cassingena	NOUN
bptjm-15	281	38	,	,	PUNCT
bptjm-15	281	39	a.	a.	NOUN
bptjm-15	281	40	,	,	PUNCT
bptjm-15	281	41	zecchin	zecchin	PROPN
bptjm-15	281	42	,	,	PUNCT
bptjm-15	281	43	d.	d.	PROPN
bptjm-15	281	44	,	,	PUNCT
bptjm-15	281	45	apicella	apicella	NOUN
bptjm-15	281	46	,	,	PUNCT
bptjm-15	281	47	m.	m.	NOUN
bptjm-15	281	48	,	,	PUNCT
bptjm-15	281	49	migliardi	migliardi	PROPN
bptjm-15	281	50	,	,	PUNCT
bptjm-15	281	51	g.	g.	PROPN
bptjm-15	281	52	,	,	PUNCT
bptjm-15	281	53	galimi	galimi	PROPN
bptjm-15	281	54	,	,	PUNCT
bptjm-15	281	55	f.	f.	PROPN
bptjm-15	281	56	,	,	PUNCT
bptjm-15	281	57	lauricella	lauricella	PROPN
bptjm-15	281	58	,	,	PUNCT
bptjm-15	281	59	c.	c.	NOUN
bptjm-15	281	60	,	,	PUNCT
bptjm-15	281	61	zanon	zanon	NOUN
bptjm-15	281	62	,	,	PUNCT
bptjm-15	281	63	c.	c.	PROPN
bptjm-15	281	64	,	,	PUNCT
bptjm-15	281	65	perera	perera	PROPN
bptjm-15	281	66	,	,	PUNCT
bptjm-15	281	67	t.	t.	PROPN
bptjm-15	281	68	,	,	PUNCT
bptjm-15	281	69	veronese	veronese	NOUN
bptjm-15	281	70	,	,	PUNCT
bptjm-15	281	71	s.	s.	PROPN
bptjm-15	281	72	,	,	PUNCT
bptjm-15	281	73	corti	corti	PROPN
bptjm-15	281	74	,	,	PUNCT
bptjm-15	281	75	g.	g.	PROPN
bptjm-15	281	76	,	,	PUNCT
bptjm-15	281	77	amatu	amatu	PROPN
bptjm-15	281	78	,	,	PUNCT
bptjm-15	281	79	a.	a.	NOUN
bptjm-15	281	80	,	,	PUNCT
bptjm-15	281	81	gambacorta	gambacorta	NOUN
bptjm-15	281	82	,	,	PUNCT
bptjm-15	281	83	m.	m.	NOUN
bptjm-15	281	84	,	,	PUNCT
bptjm-15	281	85	…	…	PUNCT
bptjm-15	281	86	siena	siena	PROPN
bptjm-15	281	87	,	,	PUNCT
bptjm-15	281	88	s.	s.	PROPN
bptjm-15	281	89	(	(	PUNCT
bptjm-15	281	90	2013	2013	NUM
bptjm-15	281	91	)	)	PUNCT
bptjm-15	281	92	.	.	PUNCT
bptjm-15	282	1	ampli	ampli	PROPN
bptjm-15	282	2	�	�	PROPN
bptjm-15	282	3	cation	cation	NOUN
bptjm-15	282	4	of	of	ADP
bptjm-15	282	5	the	the	DET
bptjm-15	282	6	met	meet	VERB
bptjm-15	282	7	receptor	receptor	NOUN
bptjm-15	282	8	drives	drive	VERB
bptjm-15	282	9	resistance	resistance	NOUN
bptjm-15	282	10	to	to	ADP
bptjm-15	282	11	anti	anti	ADJ
bptjm-15	282	12	egfr	egfr	ADJ
bptjm-15	282	13	therapies	therapy	NOUN
bptjm-15	282	14	in	in	ADP
bptjm-15	282	15	colorectal	colorectal	ADJ
bptjm-15	282	16	cancer	cancer	NOUN
bptjm-15	282	17	.	.	PUNCT
bptjm-15	283	1	cancer	cancer	NOUN
bptjm-15	283	2	discovery	discovery	PROPN
bptjm-15	283	3	,	,	PUNCT
bptjm-15	283	4	3(6	3(6	NUM
bptjm-15	283	5	)	)	PUNCT
bptjm-15	283	6	,	,	PUNCT
bptjm-15	283	7	658–673	658–673	PROPN
bptjm-15	283	8	.	.	PUNCT
bptjm-15	284	1	https://doi.org/	https://doi.org/	PROPN
bptjm-15	284	2	10.1158/2159	10.1158/2159	NUM
bptjm-15	284	3	-	-	PUNCT
bptjm-15	284	4	8290.cd-12	8290.cd-12	NOUN
bptjm-15	284	5	-	-	PUNCT
bptjm-15	284	6	0558	0558	NUM
bptjm-15	284	7	3	3	NUM
bptjm-15	284	8	.	.	X
bptjm-15	284	9	beauchamp	beauchamp	PROPN
bptjm-15	284	10	,	,	PUNCT
bptjm-15	284	11	e.	e.	PROPN
bptjm-15	284	12	m.	m.	PROPN
bptjm-15	284	13	,	,	PUNCT
bptjm-15	284	14	woods	woods	PROPN
bptjm-15	284	15	,	,	PUNCT
bptjm-15	284	16	b.	b.	PROPN
bptjm-15	284	17	a.	a.	PROPN
bptjm-15	284	18	,	,	PUNCT
bptjm-15	284	19	dulak	dulak	NOUN
bptjm-15	284	20	,	,	PUNCT
bptjm-15	284	21	a.	a.	NOUN
bptjm-15	284	22	m.	m.	NOUN
bptjm-15	284	23	,	,	PUNCT
bptjm-15	284	24	tan	tan	PROPN
bptjm-15	284	25	,	,	PUNCT
bptjm-15	284	26	l.	l.	PROPN
bptjm-15	284	27	,	,	PUNCT
bptjm-15	284	28	xu	xu	PROPN
bptjm-15	284	29	,	,	PUNCT
bptjm-15	284	30	c.	c.	PROPN
bptjm-15	284	31	,	,	PUNCT
bptjm-15	284	32	gray	gray	ADJ
bptjm-15	284	33	,	,	PUNCT
bptjm-15	284	34	n.	n.	PROPN
bptjm-15	284	35	s.	s.	PROPN
bptjm-15	284	36	,	,	PUNCT
bptjm-15	284	37	bass	bass	NOUN
bptjm-15	284	38	,	,	PUNCT
bptjm-15	284	39	a.	a.	PROPN
bptjm-15	284	40	j.	j.	PROPN
bptjm-15	284	41	,	,	PUNCT
bptjm-15	284	42	wong	wong	PROPN
bptjm-15	284	43	,	,	PUNCT
bptjm-15	284	44	k.	k.	PROPN
bptjm-15	284	45	k.	k.	PROPN
bptjm-15	284	46	,	,	PUNCT
bptjm-15	284	47	meyerson	meyerson	PROPN
bptjm-15	284	48	,	,	PUNCT
bptjm-15	284	49	m.	m.	NOUN
bptjm-15	284	50	,	,	PUNCT
bptjm-15	284	51	&	&	CCONJ
bptjm-15	284	52	hammerman	hammerman	PROPN
bptjm-15	284	53	,	,	PUNCT
bptjm-15	284	54	p.	p.	PROPN
bptjm-15	284	55	s.	s.	PROPN
bptjm-15	284	56	(	(	PUNCT
bptjm-15	284	57	2014	2014	NUM
bptjm-15	284	58	)	)	PUNCT
bptjm-15	284	59	.	.	PUNCT
bptjm-15	285	1	acquired	acquire	VERB
bptjm-15	285	2	resistance	resistance	NOUN
bptjm-15	285	3	to	to	ADP
bptjm-15	285	4	dasatinib	dasatinib	NOUN
bptjm-15	285	5	in	in	ADP
bptjm-15	285	6	lung	lung	NOUN
bptjm-15	285	7	cancer	cancer	NOUN
bptjm-15	285	8	cell	cell	NOUN
bptjm-15	285	9	lines	line	NOUN
bptjm-15	285	10	conferred	confer	VERB
bptjm-15	285	11	by	by	ADP
bptjm-15	285	12	ddr2	ddr2	NOUN
bptjm-15	285	13	gatekeeper	gatekeeper	NOUN
bptjm-15	285	14	mutation	mutation	NOUN
bptjm-15	285	15	and	and	CCONJ
bptjm-15	285	16	nf1	nf1	NOUN
bptjm-15	285	17	loss	loss	NOUN
bptjm-15	285	18	.	.	PUNCT
bptjm-15	286	1	molecular	molecular	ADJ
bptjm-15	286	2	cancer	cancer	NOUN
bptjm-15	286	3	therapeutics	therapeutic	NOUN
bptjm-15	286	4	,	,	PUNCT
bptjm-15	286	5	13(2	13(2	NOUN
bptjm-15	286	6	)	)	PUNCT
bptjm-15	286	7	,	,	PUNCT
bptjm-15	286	8	475–482	475–482	NUM
bptjm-15	286	9	.	.	PUNCT
bptjm-15	286	10	https://doi.org/10.1158/1535-7163.mct-13-0817	https://doi.org/10.1158/1535-7163.mct-13-0817	X
bptjm-15	287	1	4	4	X
bptjm-15	287	2	.	.	X
bptjm-15	287	3	bettegowda	bettegowda	NOUN
bptjm-15	287	4	,	,	PUNCT
bptjm-15	287	5	c.	c.	PROPN
bptjm-15	287	6	,	,	PUNCT
bptjm-15	287	7	sausen	sausen	ADJ
bptjm-15	287	8	,	,	PUNCT
bptjm-15	287	9	m.	m.	NOUN
bptjm-15	287	10	,	,	PUNCT
bptjm-15	287	11	leary	leary	PROPN
bptjm-15	287	12	,	,	PUNCT
bptjm-15	287	13	r.	r.	PROPN
bptjm-15	287	14	j.	j.	PROPN
bptjm-15	287	15	,	,	PUNCT
bptjm-15	287	16	kinde	kinde	PROPN
bptjm-15	287	17	,	,	PUNCT
bptjm-15	287	18	i.	i.	PROPN
bptjm-15	287	19	,	,	PUNCT
bptjm-15	287	20	wang	wang	PROPN
bptjm-15	287	21	,	,	PUNCT
bptjm-15	287	22	y.	y.	PROPN
bptjm-15	287	23	,	,	PUNCT
bptjm-15	287	24	agrawal	agrawal	PROPN
bptjm-15	287	25	,	,	PUNCT
bptjm-15	287	26	n.	n.	NOUN
bptjm-15	287	27	,	,	PUNCT
bptjm-15	287	28	bartlett	bartlett	PROPN
bptjm-15	287	29	,	,	PUNCT
bptjm-15	287	30	b.	b.	PROPN
bptjm-15	287	31	r.	r.	PROPN
bptjm-15	287	32	,	,	PUNCT
bptjm-15	287	33	wang	wang	PROPN
bptjm-15	287	34	,	,	PUNCT
bptjm-15	287	35	h.	h.	PROPN
bptjm-15	287	36	,	,	PUNCT
bptjm-15	287	37	luber	luber	PROPN
bptjm-15	287	38	,	,	PUNCT
bptjm-15	287	39	b.	b.	PROPN
bptjm-15	287	40	,	,	PUNCT
bptjm-15	287	41	alani	alani	PROPN
bptjm-15	287	42	,	,	PUNCT
bptjm-15	287	43	r.	r.	PROPN
bptjm-15	287	44	m.	m.	PROPN
bptjm-15	287	45	,	,	PUNCT
bptjm-15	287	46	antonarakis	antonarakis	PROPN
bptjm-15	287	47	,	,	PUNCT
bptjm-15	287	48	e.	e.	PROPN
bptjm-15	287	49	s.	s.	PROPN
bptjm-15	287	50	,	,	PUNCT
bptjm-15	287	51	azad	azad	PROPN
bptjm-15	287	52	,	,	PUNCT
bptjm-15	287	53	n.	n.	PROPN
bptjm-15	287	54	s.	s.	PROPN
bptjm-15	287	55	,	,	PUNCT
bptjm-15	287	56	bardelli	bardelli	NOUN
bptjm-15	287	57	,	,	PUNCT
bptjm-15	287	58	a.	a.	NOUN
bptjm-15	287	59	,	,	PUNCT
bptjm-15	287	60	brem	brem	PROPN
bptjm-15	287	61	,	,	PUNCT
bptjm-15	287	62	h.	h.	PROPN
bptjm-15	287	63	,	,	PUNCT
bptjm-15	287	64	cameron	cameron	PROPN
bptjm-15	287	65	,	,	PUNCT
bptjm-15	287	66	j.	j.	PROPN
bptjm-15	287	67	l.	l.	PROPN
bptjm-15	287	68	,	,	PUNCT
bptjm-15	287	69	lee	lee	PROPN
bptjm-15	287	70	,	,	PUNCT
bptjm-15	287	71	c.	c.	PROPN
bptjm-15	287	72	c.	c.	PROPN
bptjm-15	287	73	,	,	PUNCT
bptjm-15	287	74	fecher	fecher	ADV
bptjm-15	287	75	,	,	PUNCT
bptjm-15	287	76	l.	l.	PROPN
bptjm-15	287	77	a.	a.	PROPN
bptjm-15	287	78	,	,	PUNCT
bptjm-15	287	79	gallia	gallia	PROPN
bptjm-15	287	80	,	,	PUNCT
bptjm-15	287	81	g.	g.	PROPN
bptjm-15	287	82	l.	l.	PROPN
bptjm-15	287	83	,	,	PUNCT
bptjm-15	287	84	gibbs	gibbs	PROPN
bptjm-15	287	85	,	,	PUNCT
bptjm-15	287	86	p.	p.	PROPN
bptjm-15	287	87	,	,	PUNCT
bptjm-15	287	88	…	…	PUNCT
bptjm-15	288	1	diaz	diaz	PROPN
bptjm-15	288	2	,	,	PUNCT
bptjm-15	288	3	l.	l.	PROPN
bptjm-15	288	4	a.	a.	PROPN
bptjm-15	288	5	(	(	PUNCT
bptjm-15	288	6	2014	2014	NUM
bptjm-15	288	7	)	)	PUNCT
bptjm-15	288	8	.	.	PUNCT
bptjm-15	289	1	detection	detection	NOUN
bptjm-15	289	2	of	of	ADP
bptjm-15	289	3	circulating	circulate	VERB
bptjm-15	289	4	tumor	tumor	NOUN
bptjm-15	289	5	dna	dna	PROPN
bptjm-15	289	6	in	in	ADP
bptjm-15	289	7	earlyand	earlyand	NOUN
bptjm-15	289	8	late	late	ADJ
bptjm-15	289	9	-	-	PUNCT
bptjm-15	289	10	stage	stage	NOUN
bptjm-15	289	11	human	human	ADJ
bptjm-15	289	12	malignancies	malignancy	NOUN
bptjm-15	289	13	.	.	PUNCT
bptjm-15	290	1	science	science	NOUN
bptjm-15	290	2	translational	translational	ADJ
bptjm-15	290	3	medicine	medicine	NOUN
bptjm-15	290	4	,	,	PUNCT
bptjm-15	290	5	6(224	6(224	NUM
bptjm-15	290	6	)	)	PUNCT
bptjm-15	290	7	,	,	PUNCT
bptjm-15	290	8	224ra24	224ra24	PROPN
bptjm-15	290	9	.	.	PUNCT
bptjm-15	291	1	https://doi.org/10.1126/	https://doi.org/10.1126/	PROPN
bptjm-15	291	2	scitranslmed.3007094	scitranslmed.3007094	PROPN
bptjm-15	291	3	5	5	NUM
bptjm-15	291	4	.	.	NOUN
bptjm-15	291	5	buderath	buderath	NOUN
bptjm-15	291	6	,	,	PUNCT
bptjm-15	292	1	p.	p.	PROPN
bptjm-15	292	2	,	,	PUNCT
bptjm-15	292	3	schwich	schwich	PROPN
bptjm-15	292	4	,	,	PUNCT
bptjm-15	292	5	e.	e.	PROPN
bptjm-15	292	6	,	,	PUNCT
bptjm-15	292	7	jensen	jensen	PROPN
bptjm-15	292	8	,	,	PUNCT
bptjm-15	292	9	c.	c.	PROPN
bptjm-15	292	10	,	,	PUNCT
bptjm-15	292	11	horn	horn	NOUN
bptjm-15	292	12	,	,	PUNCT
bptjm-15	292	13	p.	p.	NOUN
bptjm-15	292	14	a.	a.	NOUN
bptjm-15	292	15	,	,	PUNCT
bptjm-15	292	16	kimmig	kimmig	PROPN
bptjm-15	292	17	,	,	PUNCT
bptjm-15	292	18	r.	r.	PROPN
bptjm-15	292	19	,	,	PUNCT
bptjm-15	292	20	kasimir	kasimir	PROPN
bptjm-15	292	21	-	-	PROPN
bptjm-15	292	22	bauer	bauer	PROPN
bptjm-15	292	23	,	,	PUNCT
bptjm-15	292	24	s.	s.	PROPN
bptjm-15	292	25	,	,	PUNCT
bptjm-15	292	26	&	&	CCONJ
bptjm-15	292	27	rebmann	rebmann	PROPN
bptjm-15	292	28	,	,	PUNCT
bptjm-15	292	29	v.	v.	PROPN
bptjm-15	292	30	(	(	PUNCT
bptjm-15	292	31	2019	2019	NUM
bptjm-15	292	32	)	)	PUNCT
bptjm-15	292	33	.	.	PUNCT
bptjm-15	293	1	soluble	soluble	ADJ
bptjm-15	293	2	programmed	program	VERB
bptjm-15	293	3	death	death	NOUN
bptjm-15	293	4	receptor	receptor	NOUN
bptjm-15	293	5	ligands	ligand	VERB
bptjm-15	293	6	spd	spd	NOUN
bptjm-15	293	7	-	-	PUNCT
bptjm-15	293	8	l1	l1	NOUN
bptjm-15	293	9	and	and	CCONJ
bptjm-15	293	10	spd	spd	NOUN
bptjm-15	293	11	-	-	PUNCT
bptjm-15	293	12	l2	l2	NOUN
bptjm-15	293	13	as	as	ADP
bptjm-15	293	14	liquid	liquid	ADJ
bptjm-15	293	15	biopsy	biopsy	NOUN
bptjm-15	293	16	markers	marker	NOUN
bptjm-15	293	17	for	for	ADP
bptjm-15	293	18	prognosis	prognosis	NOUN
bptjm-15	293	19	and	and	CCONJ
bptjm-15	293	20	platinum	platinum	NOUN
bptjm-15	293	21	response	response	NOUN
bptjm-15	293	22	in	in	ADP
bptjm-15	293	23	epithelial	epithelial	ADJ
bptjm-15	293	24	ovarian	ovarian	ADJ
bptjm-15	293	25	cancer	cancer	NOUN
bptjm-15	293	26	.	.	PUNCT
bptjm-15	294	1	frontiers	frontier	NOUN
bptjm-15	294	2	in	in	ADP
bptjm-15	294	3	oncology	oncology	NOUN
bptjm-15	294	4	,	,	PUNCT
bptjm-15	294	5	9	9	NUM
bptjm-15	294	6	,	,	PUNCT
bptjm-15	294	7	1015	1015	NUM
bptjm-15	294	8	.	.	PUNCT
bptjm-15	295	1	https://doi.org/10.3389/fonc.2019.01015	https://doi.org/10.3389/fonc.2019.01015	PROPN
bptjm-15	295	2	6	6	NUM
bptjm-15	295	3	.	.	PUNCT
bptjm-15	295	4	camidge	camidge	NOUN
bptjm-15	295	5	,	,	PUNCT
bptjm-15	295	6	d.	d.	PROPN
bptjm-15	295	7	r.	r.	PROPN
bptjm-15	295	8	,	,	PUNCT
bptjm-15	295	9	kono	kono	PROPN
bptjm-15	295	10	,	,	PUNCT
bptjm-15	295	11	s.	s.	PROPN
bptjm-15	295	12	a.	a.	PROPN
bptjm-15	295	13	,	,	PUNCT
bptjm-15	295	14	flacco	flacco	PROPN
bptjm-15	295	15	,	,	PUNCT
bptjm-15	295	16	a.	a.	PROPN
bptjm-15	295	17	,	,	PUNCT
bptjm-15	295	18	tan	tan	PROPN
bptjm-15	295	19	,	,	PUNCT
bptjm-15	295	20	a.	a.	PROPN
bptjm-15	295	21	c.	c.	PROPN
bptjm-15	295	22	,	,	PUNCT
bptjm-15	295	23	doebele	doebele	PROPN
bptjm-15	295	24	,	,	PUNCT
bptjm-15	295	25	r.	r.	PROPN
bptjm-15	295	26	c.	c.	PROPN
bptjm-15	295	27	,	,	PUNCT
bptjm-15	295	28	zhou	zhou	PROPN
bptjm-15	295	29	,	,	PUNCT
bptjm-15	295	30	q.	q.	PROPN
bptjm-15	295	31	,	,	PUNCT
bptjm-15	295	32	crino	crino	PROPN
bptjm-15	295	33	,	,	PUNCT
bptjm-15	295	34	l.	l.	PROPN
bptjm-15	295	35	,	,	PUNCT
bptjm-15	295	36	franklin	franklin	PROPN
bptjm-15	295	37	,	,	PUNCT
bptjm-15	295	38	w.	w.	PROPN
bptjm-15	295	39	a.	a.	PROPN
bptjm-15	295	40	,	,	PUNCT
bptjm-15	295	41	&	&	CCONJ
bptjm-15	295	42	varella	varella	NOUN
bptjm-15	295	43	-	-	PUNCT
bptjm-15	295	44	garcia	garcia	PROPN
bptjm-15	295	45	,	,	PUNCT
bptjm-15	295	46	m.	m.	NOUN
bptjm-15	295	47	(	(	PUNCT
bptjm-15	295	48	2010	2010	NUM
bptjm-15	295	49	)	)	PUNCT
bptjm-15	295	50	.	.	PUNCT
bptjm-15	296	1	optimizing	optimize	VERB
bptjm-15	296	2	the	the	DET
bptjm-15	296	3	detection	detection	NOUN
bptjm-15	296	4	of	of	ADP
bptjm-15	296	5	lung	lung	NOUN
bptjm-15	296	6	cancer	cancer	NOUN
bptjm-15	296	7	patients	patient	NOUN
bptjm-15	296	8	harboring	harbor	VERB
bptjm-15	296	9	anaplastic	anaplastic	ADJ
bptjm-15	296	10	lymphoma	lymphoma	NOUN
bptjm-15	296	11	kinase	kinase	PROPN
bptjm-15	296	12	(	(	PUNCT
bptjm-15	296	13	alk	alk	PROPN
bptjm-15	296	14	)	)	PUNCT
bptjm-15	296	15	gene	gene	NOUN
bptjm-15	296	16	rearrangements	rearrangement	NOUN
bptjm-15	296	17	potentially	potentially	ADV
bptjm-15	296	18	suitable	suitable	ADJ
bptjm-15	296	19	for	for	ADP
bptjm-15	296	20	alk	alk	NOUN
bptjm-15	296	21	inhibitor	inhibitor	NOUN
bptjm-15	296	22	treatment	treatment	NOUN
bptjm-15	296	23	.	.	PUNCT
bptjm-15	297	1	clinical	clinical	ADJ
bptjm-15	297	2	cancer	cancer	NOUN
bptjm-15	297	3	research	research	NOUN
bptjm-15	297	4	:	:	PUNCT
bptjm-15	297	5	an	an	DET
bptjm-15	297	6	official	official	ADJ
bptjm-15	297	7	journal	journal	NOUN
bptjm-15	297	8	of	of	ADP
bptjm-15	297	9	the	the	DET
bptjm-15	297	10	american	american	PROPN
bptjm-15	297	11	association	association	PROPN
bptjm-15	297	12	for	for	ADP
bptjm-15	297	13	cancer	cancer	NOUN
bptjm-15	297	14	research	research	NOUN
bptjm-15	297	15	,	,	PUNCT
bptjm-15	297	16	16(22	16(22	NUM
bptjm-15	297	17	)	)	PUNCT
bptjm-15	297	18	,	,	PUNCT
bptjm-15	297	19	5581–5590	5581–5590	NUM
bptjm-15	297	20	.	.	PUNCT
bptjm-15	298	1	https://doi.org/	https://doi.org/	VERB
bptjm-15	298	2	10.1158/1078	10.1158/1078	NUM
bptjm-15	298	3	-	-	PUNCT
bptjm-15	298	4	0432.ccr-10	0432.ccr-10	NUM
bptjm-15	298	5	-	-	PUNCT
bptjm-15	298	6	0851	0851	NUM
bptjm-15	298	7	7	7	NUM
bptjm-15	298	8	.	.	PUNCT
bptjm-15	299	1	chae	chae	NOUN
bptjm-15	299	2	,	,	PUNCT
bptjm-15	299	3	y.	y.	PROPN
bptjm-15	299	4	k.	k.	PROPN
bptjm-15	299	5	,	,	PUNCT
bptjm-15	299	6	andrew	andrew	PROPN
bptjm-15	299	7	a.	a.	PROPN
bptjm-15	299	8	d.	d.	PROPN
bptjm-15	299	9	,	,	PUNCT
bptjm-15	299	10	sarika	sarika	PROPN
bptjm-15	299	11	,	,	PUNCT
bptjm-15	299	12	j.	j.	PROPN
bptjm-15	299	13	,	,	PUNCT
bptjm-15	299	14	cesar	cesar	PROPN
bptjm-15	299	15	,	,	PUNCT
bptjm-15	299	16	s.m	s.m	PROPN
bptjm-15	299	17	.	.	PROPN
bptjm-15	299	18	,	,	PUNCT
bptjm-15	299	19	lisa	lisa	PROPN
bptjm-15	299	20	,	,	PUNCT
bptjm-15	299	21	f.	f.	PROPN
bptjm-15	299	22	,	,	PUNCT
bptjm-15	299	23	nike	nike	PROPN
bptjm-15	299	24	,	,	PUNCT
bptjm-15	299	25	b.	b.	PROPN
bptjm-15	299	26	,	,	PUNCT
bptjm-15	299	27	leonidas	leonidas	PROPN
bptjm-15	299	28	,	,	PUNCT
bptjm-15	299	29	c.	c.	PROPN
bptjm-15	299	30	p.	p.	PROPN
bptjm-15	299	31	,	,	PUNCT
bptjm-15	299	32	william	william	PROPN
bptjm-15	299	33	,	,	PUNCT
bptjm-15	299	34	g.	g.	PROPN
bptjm-15	299	35	,	,	PUNCT
bptjm-15	299	36	francis	francis	PROPN
bptjm-15	299	37	j.	j.	PROPN
bptjm-15	299	38	g.	g.	PROPN
bptjm-15	299	39	,	,	PUNCT
bptjm-15	299	40	and	and	CCONJ
bptjm-15	299	41	massimo	massimo	PROPN
bptjm-15	299	42	,	,	PUNCT
bptjm-15	299	43	c.	c.	PROPN
bptjm-15	299	44	(	(	PUNCT
bptjm-15	299	45	2017	2017	NUM
bptjm-15	299	46	)	)	PUNCT
bptjm-15	299	47	.	.	PUNCT
bptjm-15	300	1	concordance	concordance	NOUN
bptjm-15	300	2	of	of	ADP
bptjm-15	300	3	genomic	genomic	ADJ
bptjm-15	300	4	alterations	alteration	NOUN
bptjm-15	300	5	by	by	ADP
bptjm-15	300	6	next	next	ADJ
bptjm-15	300	7	-	-	PUNCT
bptjm-15	300	8	generation	generation	NOUN
bptjm-15	300	9	sequencing	sequencing	NOUN
bptjm-15	300	10	in	in	ADP
bptjm-15	300	11	tumor	tumor	NOUN
bptjm-15	300	12	tissue	tissue	NOUN
bptjm-15	300	13	versus	versus	ADP
bptjm-15	300	14	circulating	circulate	VERB
bptjm-15	300	15	tumor	tumor	NOUN
bptjm-15	300	16	dna	dna	NOUN
bptjm-15	300	17	in	in	ADP
bptjm-15	300	18	breast	breast	NOUN
bptjm-15	300	19	cancer	cancer	NOUN
bptjm-15	300	20	.	.	PUNCT
bptjm-15	301	1	molecular	molecular	ADJ
bptjm-15	301	2	cancer	cancer	NOUN
bptjm-15	301	3	therapeutics	therapeutic	NOUN
bptjm-15	301	4	,	,	PUNCT
bptjm-15	301	5	16(7	16(7	NUM
bptjm-15	301	6	)	)	PUNCT
bptjm-15	301	7	,	,	PUNCT
bptjm-15	301	8	1412–1420	1412–1420	NUM
bptjm-15	301	9	.	.	PUNCT
bptjm-15	302	1	https://doi.org/10.1158/1535-7163.mct-17-0061	https://doi.org/10.1158/1535-7163.mct-17-0061	PROPN
bptjm-15	303	1	8	8	X
bptjm-15	303	2	.	.	X
bptjm-15	303	3	chian	chian	PROPN
bptjm-15	303	4	,	,	PUNCT
bptjm-15	303	5	c.	c.	PROPN
bptjm-15	303	6	f.	f.	PROPN
bptjm-15	303	7	,	,	PUNCT
bptjm-15	303	8	hwang	hwang	PROPN
bptjm-15	303	9	,	,	PUNCT
bptjm-15	303	10	y.	y.	PROPN
bptjm-15	303	11	t.	t.	PROPN
bptjm-15	303	12	,	,	PUNCT
bptjm-15	303	13	terng	terng	NOUN
bptjm-15	303	14	,	,	PUNCT
bptjm-15	303	15	h.	h.	PROPN
bptjm-15	303	16	j.	j.	PROPN
bptjm-15	303	17	,	,	PUNCT
bptjm-15	303	18	lee	lee	PROPN
bptjm-15	303	19	,	,	PUNCT
bptjm-15	303	20	s.	s.	PROPN
bptjm-15	303	21	c.	c.	PROPN
bptjm-15	303	22	,	,	PUNCT
bptjm-15	303	23	chao	chao	PROPN
bptjm-15	303	24	,	,	PUNCT
bptjm-15	303	25	t.	t.	PROPN
bptjm-15	303	26	y.	y.	PROPN
bptjm-15	303	27	,	,	PUNCT
bptjm-15	303	28	chang	chang	PROPN
bptjm-15	303	29	,	,	PUNCT
bptjm-15	303	30	h.	h.	PROPN
bptjm-15	303	31	,	,	PUNCT
bptjm-15	303	32	ho	ho	PROPN
bptjm-15	303	33	,	,	PUNCT
bptjm-15	303	34	c.	c.	PROPN
bptjm-15	303	35	l.	l.	PROPN
bptjm-15	303	36	,	,	PUNCT
bptjm-15	303	37	wu	wu	PROPN
bptjm-15	303	38	,	,	PUNCT
bptjm-15	303	39	y.	y.	PROPN
bptjm-15	303	40	y.	y.	PROPN
bptjm-15	303	41	,	,	PUNCT
bptjm-15	303	42	&	&	CCONJ
bptjm-15	303	43	perng	perng	PROPN
bptjm-15	303	44	,	,	PUNCT
bptjm-15	303	45	w.	w.	PROPN
bptjm-15	303	46	c.	c.	PROPN
bptjm-15	303	47	(	(	PUNCT
bptjm-15	303	48	2016	2016	NUM
bptjm-15	303	49	)	)	PUNCT
bptjm-15	303	50	.	.	PUNCT
bptjm-15	304	1	panels	panel	NOUN
bptjm-15	304	2	of	of	ADP
bptjm-15	304	3	tumor	tumor	NOUN
bptjm-15	304	4	-	-	PUNCT
bptjm-15	304	5	derived	derive	VERB
bptjm-15	304	6	rna	rna	NOUN
bptjm-15	304	7	markers	marker	NOUN
bptjm-15	304	8	in	in	ADP
bptjm-15	304	9	peripheral	peripheral	ADJ
bptjm-15	304	10	blood	blood	NOUN
bptjm-15	304	11	of	of	ADP
bptjm-15	304	12	patients	patient	NOUN
bptjm-15	304	13	with	with	ADP
bptjm-15	304	14	non	non	ADJ
bptjm-15	304	15	-	-	ADJ
bptjm-15	304	16	small	small	ADJ
bptjm-15	304	17	cell	cell	NOUN
bptjm-15	304	18	lung	lung	NOUN
bptjm-15	304	19	cancer	cancer	NOUN
bptjm-15	304	20	:	:	PUNCT
bptjm-15	304	21	their	their	PRON
bptjm-15	304	22	dependence	dependence	NOUN
bptjm-15	304	23	on	on	ADP
bptjm-15	304	24	age	age	NOUN
bptjm-15	304	25	,	,	PUNCT
bptjm-15	304	26	gender	gender	NOUN
bptjm-15	304	27	and	and	CCONJ
bptjm-15	304	28	clinical	clinical	ADJ
bptjm-15	304	29	stages	stage	NOUN
bptjm-15	304	30	.	.	PUNCT
bptjm-15	305	1	oncotarget	oncotarget	NOUN
bptjm-15	305	2	,	,	PUNCT
bptjm-15	305	3	7(31	7(31	NUM
bptjm-15	305	4	)	)	PUNCT
bptjm-15	305	5	,	,	PUNCT
bptjm-15	305	6	50582–50595	50582–50595	NUM
bptjm-15	305	7	.	.	NOUN
bptjm-15	305	8	https://doi.org/10.18632/oncotarget.10558	https://doi.org/10.18632/oncotarget.10558	ADJ
bptjm-15	305	9	9	9	NUM
bptjm-15	305	10	.	.	X
bptjm-15	305	11	chirshev	chirshev	PROPN
bptjm-15	305	12	,	,	PUNCT
bptjm-15	305	13	e.	e.	PROPN
bptjm-15	305	14	,	,	PUNCT
bptjm-15	305	15	oberg	oberg	PROPN
bptjm-15	305	16	,	,	PUNCT
bptjm-15	305	17	k.	k.	PROPN
bptjm-15	305	18	c.	c.	PROPN
bptjm-15	305	19	,	,	PUNCT
bptjm-15	305	20	io	io	PROPN
bptjm-15	305	21	�	�	PROPN
bptjm-15	305	22	e	e	PROPN
bptjm-15	305	23	,	,	PUNCT
bptjm-15	305	24	y.	y.	PROPN
bptjm-15	305	25	j.	j.	PROPN
bptjm-15	305	26	,	,	PUNCT
bptjm-15	305	27	&	&	CCONJ
bptjm-15	305	28	amp	amp	PROPN
bptjm-15	305	29	;	;	PUNCT
bptjm-15	305	30	unternaehrer	unternaehrer	NOUN
bptjm-15	305	31	,	,	PUNCT
bptjm-15	305	32	j.	j.	PROPN
bptjm-15	305	33	j.	j.	PROPN
bptjm-15	305	34	(	(	PUNCT
bptjm-15	305	35	2019	2019	NUM
bptjm-15	305	36	)	)	PUNCT
bptjm-15	305	37	.	.	PUNCT
bptjm-15	306	1	let	let	VERB
bptjm-15	306	2	7	7	NUM
bptjm-15	306	3	as	as	ADP
bptjm-15	306	4	biomarker	biomarker	NOUN
bptjm-15	306	5	,	,	PUNCT
bptjm-15	306	6	prognostic	prognostic	ADJ
bptjm-15	306	7	indicator	indicator	NOUN
bptjm-15	306	8	,	,	PUNCT
bptjm-15	306	9	and	and	CCONJ
bptjm-15	306	10	therapy	therapy	NOUN
bptjm-15	306	11	for	for	ADP
bptjm-15	306	12	precision	precision	NOUN
bptjm-15	306	13	medicine	medicine	NOUN
bptjm-15	306	14	in	in	ADP
bptjm-15	306	15	cancer	cancer	NOUN
bptjm-15	306	16	.	.	PUNCT
bptjm-15	307	1	clinical	clinical	ADJ
bptjm-15	307	2	and	and	CCONJ
bptjm-15	307	3	translational	translational	ADJ
bptjm-15	307	4	medicine	medicine	NOUN
bptjm-15	307	5	,	,	PUNCT
bptjm-15	307	6	8(1	8(1	NOUN
bptjm-15	307	7	)	)	PUNCT
bptjm-15	307	8	.	.	PUNCT
bptjm-15	308	1	doi:10.1186	doi:10.1186	PROPN
bptjm-15	308	2	/	/	SYM
bptjm-15	308	3	s40169	s40169	PROPN
bptjm-15	308	4	-	-	PUNCT
bptjm-15	308	5	019	019	NUM
bptjm-15	308	6	-	-	PUNCT
bptjm-15	308	7	0240	0240	NUM
bptjm-15	308	8	-	-	PUNCT
bptjm-15	308	9	y	y	PROPN
bptjm-15	308	10	10	10	NUM
bptjm-15	308	11	.	.	PUNCT
bptjm-15	309	1	christopoulos	christopoulo	NOUN
bptjm-15	309	2	,	,	PUNCT
bptjm-15	309	3	p.	p.	NOUN
bptjm-15	309	4	,	,	PUNCT
bptjm-15	309	5	kirchner	kirchner	PROPN
bptjm-15	309	6	,	,	PUNCT
bptjm-15	309	7	m.	m.	NOUN
bptjm-15	309	8	,	,	PUNCT
bptjm-15	309	9	endris	endris	PROPN
bptjm-15	309	10	,	,	PUNCT
bptjm-15	309	11	v.	v.	ADV
bptjm-15	309	12	,	,	PUNCT
bptjm-15	309	13	stenzinger	stenzinger	NOUN
bptjm-15	309	14	,	,	PUNCT
bptjm-15	309	15	a.	a.	PROPN
bptjm-15	309	16	,	,	PUNCT
bptjm-15	309	17	&	&	CCONJ
bptjm-15	309	18	thomas	thomas	PROPN
bptjm-15	309	19	,	,	PUNCT
bptjm-15	309	20	m.	m.	NOUN
bptjm-15	309	21	(	(	PUNCT
bptjm-15	309	22	2018	2018	NUM
bptjm-15	309	23	)	)	PUNCT
bptjm-15	309	24	.	.	PUNCT
bptjm-15	310	1	eml4alk	eml4alk	VERB
bptjm-15	310	2	v3	v3	PROPN
bptjm-15	310	3	,	,	PUNCT
bptjm-15	310	4	treatment	treatment	NOUN
bptjm-15	310	5	resistance	resistance	NOUN
bptjm-15	310	6	,	,	PUNCT
bptjm-15	310	7	and	and	CCONJ
bptjm-15	310	8	survival	survival	NOUN
bptjm-15	310	9	:	:	PUNCT
bptjm-15	310	10	re	re	VERB
bptjm-15	310	11	�	�	VERB
bptjm-15	310	12	ning	ne	VERB
bptjm-15	310	13	the	the	DET
bptjm-15	310	14	diagnosis	diagnosis	NOUN
bptjm-15	310	15	of	of	ADP
bptjm-15	310	16	alk+	alk+	NOUN
bptjm-15	310	17	nsclc	nsclc	NOUN
bptjm-15	310	18	.	.	PUNCT
bptjm-15	311	1	journal	journal	PROPN
bptjm-15	311	2	of	of	ADP
bptjm-15	311	3	thoracic	thoracic	NOUN
bptjm-15	311	4	disease	disease	NOUN
bptjm-15	311	5	,	,	PUNCT
bptjm-15	311	6	10(suppl	10(suppl	NOUN
bptjm-15	311	7	17	17	NUM
bptjm-15	311	8	)	)	PUNCT
bptjm-15	311	9	,	,	PUNCT
bptjm-15	311	10	s1989	s1989	NOUN
bptjm-15	311	11	–	–	PUNCT
bptjm-15	311	12	s1991	s1991	NOUN
bptjm-15	311	13	.	.	PUNCT
bptjm-15	312	1	berkeley	berkeley	PROPN
bptjm-15	312	2	pharma	pharma	PROPN
bptjm-15	312	3	tech	tech	PROPN
bptjm-15	312	4	journal	journal	NOUN
bptjm-15	312	5	of	of	ADP
bptjm-15	312	6	medicine	medicine	NOUN
bptjm-15	312	7	|	|	ADV
bptjm-15	312	8	85	85	NUM
bptjm-15	312	9	https://doi.org/10.21037/jtd.2018.05.61	https://doi.org/10.21037/jtd.2018.05.61	ADP
bptjm-15	312	10	11	11	NUM
bptjm-15	312	11	.	.	PUNCT
bptjm-15	313	1	chuang	chuang	PROPN
bptjm-15	313	2	,	,	PUNCT
bptjm-15	313	3	j.	j.	PROPN
bptjm-15	313	4	c.	c.	PROPN
bptjm-15	313	5	,	,	PUNCT
bptjm-15	313	6	henning	henning	PROPN
bptjm-15	313	7	,	,	PUNCT
bptjm-15	313	8	s.	s.	PROPN
bptjm-15	313	9	,	,	PUNCT
bptjm-15	313	10	ying	ying	PROPN
bptjm-15	313	11	,	,	PUNCT
bptjm-15	313	12	l.	l.	PROPN
bptjm-15	313	13	,	,	PUNCT
bptjm-15	313	14	millie	millie	PROPN
bptjm-15	313	15	,	,	PUNCT
bptjm-15	313	16	d.	d.	PROPN
bptjm-15	313	17	,	,	PUNCT
bptjm-15	313	18	jane	jane	PROPN
bptjm-15	313	19	,	,	PUNCT
bptjm-15	313	20	h.	h.	PROPN
bptjm-15	313	21	,	,	PUNCT
bptjm-15	313	22	maximilian	maximilian	PROPN
bptjm-15	313	23	,	,	PUNCT
bptjm-15	313	24	d.	d.	PROPN
bptjm-15	313	25	,	,	PUNCT
bptjm-15	313	26	heather	heather	PROPN
bptjm-15	313	27	,	,	PUNCT
bptjm-15	313	28	a.	a.	PROPN
bptjm-15	313	29	w.	w.	PROPN
bptjm-15	313	30	and	and	CCONJ
bptjm-15	313	31	joel	joel	PROPN
bptjm-15	313	32	,	,	PUNCT
bptjm-15	313	33	w.	w.	PROPN
bptjm-15	313	34	n.	n.	PROPN
bptjm-15	313	35	(	(	PUNCT
bptjm-15	313	36	2017	2017	NUM
bptjm-15	313	37	)	)	PUNCT
bptjm-15	313	38	.	.	PUNCT
bptjm-15	314	1	erbb2	erbb2	PROPN
bptjm-15	314	2	-	-	PUNCT
bptjm-15	314	3	mutated	mutate	VERB
bptjm-15	314	4	metastatic	metastatic	ADJ
bptjm-15	314	5	non	non	ADJ
bptjm-15	314	6	–	–	ADJ
bptjm-15	314	7	small	small	ADJ
bptjm-15	314	8	cell	cell	NOUN
bptjm-15	314	9	lung	lung	NOUN
bptjm-15	314	10	cancer	cancer	NOUN
bptjm-15	314	11	:	:	PUNCT
bptjm-15	314	12	response	response	NOUN
bptjm-15	314	13	and	and	CCONJ
bptjm-15	314	14	resistance	resistance	NOUN
bptjm-15	314	15	to	to	ADP
bptjm-15	314	16	targeted	target	VERB
bptjm-15	314	17	therapies	therapy	NOUN
bptjm-15	314	18	.	.	PUNCT
bptjm-15	315	1	journal	journal	PROPN
bptjm-15	315	2	of	of	ADP
bptjm-15	315	3	thoracic	thoracic	NOUN
bptjm-15	315	4	oncology	oncology	NOUN
bptjm-15	315	5	,	,	PUNCT
bptjm-15	315	6	12(5	12(5	NUM
bptjm-15	315	7	)	)	PUNCT
bptjm-15	315	8	,	,	PUNCT
bptjm-15	315	9	833–842	833–842	NUM
bptjm-15	315	10	.	.	PUNCT
bptjm-15	316	1	https://doi.org/10.1016/j.jtho.2017.01.023	https://doi.org/10.1016/j.jtho.2017.01.023	PROPN
bptjm-15	316	2	.	.	PROPN
bptjm-15	317	1	12	12	NUM
bptjm-15	317	2	.	.	PUNCT
bptjm-15	317	3	cui	cui	PROPN
bptjm-15	317	4	,	,	PUNCT
bptjm-15	317	5	e.	e.	PROPN
bptjm-15	317	6	h.	h.	PROPN
bptjm-15	317	7	,	,	PUNCT
bptjm-15	317	8	li	li	PROPN
bptjm-15	317	9	,	,	PUNCT
bptjm-15	317	10	h.	h.	PROPN
bptjm-15	317	11	j.	j.	PROPN
bptjm-15	317	12	,	,	PUNCT
bptjm-15	317	13	hua	hua	PROPN
bptjm-15	317	14	,	,	PUNCT
bptjm-15	317	15	f.	f.	PROPN
bptjm-15	317	16	,	,	PUNCT
bptjm-15	317	17	wang	wang	PROPN
bptjm-15	317	18	,	,	PUNCT
bptjm-15	317	19	b.	b.	PROPN
bptjm-15	317	20	,	,	PUNCT
bptjm-15	317	21	mao	mao	PROPN
bptjm-15	317	22	,	,	PUNCT
bptjm-15	317	23	w.	w.	PROPN
bptjm-15	317	24	,	,	PUNCT
bptjm-15	317	25	feng	feng	PROPN
bptjm-15	317	26	,	,	PUNCT
bptjm-15	317	27	x.	x.	PROPN
bptjm-15	317	28	r.	r.	PROPN
bptjm-15	317	29	,	,	PUNCT
bptjm-15	317	30	et	et	PROPN
bptjm-15	317	31	al	al	PROPN
bptjm-15	317	32	.	.	PROPN
bptjm-15	317	33	(	(	PUNCT
bptjm-15	317	34	2013	2013	NUM
bptjm-15	317	35	)	)	PUNCT
bptjm-15	317	36	.	.	PUNCT
bptjm-15	318	1	serum	serum	PROPN
bptjm-15	318	2	microrna	microrna	PROPN
bptjm-15	318	3	125b	125b	PROPN
bptjm-15	318	4	as	as	ADP
bptjm-15	318	5	a	a	DET
bptjm-15	318	6	diagnostic	diagnostic	ADJ
bptjm-15	318	7	or	or	CCONJ
bptjm-15	318	8	prognostic	prognostic	ADJ
bptjm-15	318	9	biomarker	biomarker	NOUN
bptjm-15	318	10	for	for	ADP
bptjm-15	318	11	advanced	advanced	ADJ
bptjm-15	318	12	nsclc	nsclc	NOUN
bptjm-15	318	13	patients	patient	NOUN
bptjm-15	318	14	receiving	receive	VERB
bptjm-15	318	15	cisplatin	cisplatin	NOUN
bptjm-15	318	16	-	-	PUNCT
bptjm-15	318	17	based	base	VERB
bptjm-15	318	18	chemotherapy	chemotherapy	NOUN
bptjm-15	318	19	.	.	PUNCT
bptjm-15	319	1	acta	acta	PROPN
bptjm-15	319	2	pharmacol	pharmacol	PROPN
bptjm-15	319	3	.	.	PUNCT
bptjm-15	320	1	sin	sin	PROPN
bptjm-15	320	2	.	.	PUNCT
bptjm-15	321	1	34	34	NUM
bptjm-15	321	2	(	(	PUNCT
bptjm-15	321	3	2	2	NUM
bptjm-15	321	4	)	)	PUNCT
bptjm-15	321	5	,	,	PUNCT
bptjm-15	321	6	309–313	309–313	NUM
bptjm-15	321	7	.	.	PUNCT
bptjm-15	322	1	doi	doi	NOUN
bptjm-15	322	2	:	:	PUNCT
bptjm-15	322	3	10.1038	10.1038	NUM
bptjm-15	322	4	/	/	SYM
bptjm-15	322	5	aps.2012.125	aps.2012.125	PROPN
bptjm-15	322	6	13	13	NUM
bptjm-15	322	7	.	.	PUNCT
bptjm-15	323	1	dacic	dacic	NOUN
bptjm-15	323	2	,	,	PUNCT
bptjm-15	323	3	sanja	sanja	PROPN
bptjm-15	323	4	,	,	PUNCT
bptjm-15	323	5	hannelore	hannelore	NOUN
bptjm-15	323	6	kothmaier	kothmaier	PROPN
bptjm-15	323	7	,	,	PUNCT
bptjm-15	323	8	stephanie	stephanie	PROPN
bptjm-15	323	9	land	land	PROPN
bptjm-15	323	10	,	,	PUNCT
bptjm-15	323	11	yongli	yongli	PROPN
bptjm-15	323	12	shuai	shuai	PROPN
bptjm-15	323	13	,	,	PUNCT
bptjm-15	323	14	iris	iris	NOUN
bptjm-15	323	15	halbwedl	halbwedl	PROPN
bptjm-15	323	16	,	,	PUNCT
bptjm-15	323	17	patrizia	patrizia	PROPN
bptjm-15	323	18	morbini	morbini	PROPN
bptjm-15	323	19	,	,	PUNCT
bptjm-15	323	20	bruno	bruno	PROPN
bptjm-15	323	21	murer	murer	NOUN
bptjm-15	323	22	,	,	PUNCT
bptjm-15	323	23	et	et	PROPN
bptjm-15	323	24	al	al	PROPN
bptjm-15	323	25	.	.	PUNCT
bptjm-15	324	1	“	"	PUNCT
bptjm-15	324	2	prognostic	prognostic	ADJ
bptjm-15	324	3	signi	signi	PROPN
bptjm-15	324	4	�	�	PROPN
bptjm-15	324	5	cance	cance	NOUN
bptjm-15	324	6	of	of	ADP
bptjm-15	324	7	p16	p16	NOUN
bptjm-15	324	8	/	/	SYM
bptjm-15	324	9	cdkn2a	cdkn2a	NOUN
bptjm-15	324	10	loss	loss	NOUN
bptjm-15	324	11	in	in	ADP
bptjm-15	324	12	pleural	pleural	ADJ
bptjm-15	324	13	malignant	malignant	ADJ
bptjm-15	324	14	mesotheliomas	mesothelioma	NOUN
bptjm-15	324	15	.	.	PUNCT
bptjm-15	324	16	”	"	PUNCT
bptjm-15	324	17	virchows	virchow	VERB
bptjm-15	324	18	archiv	archiv	PROPN
bptjm-15	324	19	453	453	NUM
bptjm-15	324	20	,	,	PUNCT
bptjm-15	324	21	no	no	INTJ
bptjm-15	324	22	.	.	NOUN
bptjm-15	324	23	6	6	NUM
bptjm-15	324	24	(	(	PUNCT
bptjm-15	324	25	december	december	PROPN
bptjm-15	324	26	1	1	NUM
bptjm-15	324	27	,	,	PUNCT
bptjm-15	324	28	2008	2008	NUM
bptjm-15	324	29	):	):	PUNCT
bptjm-15	324	30	627–35	627–35	NUM
bptjm-15	324	31	.	.	PUNCT
bptjm-15	325	1	https://doi.org/10.1007/s00428-008-0689-3	https://doi.org/10.1007/s00428-008-0689-3	PROPN
bptjm-15	325	2	.	.	PUNCT
bptjm-15	326	1	14	14	NUM
bptjm-15	326	2	.	.	PUNCT
bptjm-15	327	1	dankner	dankner	NOUN
bptjm-15	327	2	,	,	PUNCT
bptjm-15	327	3	m.	m.	NOUN
bptjm-15	327	4	,	,	PUNCT
bptjm-15	327	5	rose	rise	VERB
bptjm-15	327	6	,	,	PUNCT
bptjm-15	327	7	a.	a.	NOUN
bptjm-15	327	8	,	,	PUNCT
bptjm-15	327	9	rajkumar	rajkumar	PROPN
bptjm-15	327	10	,	,	PUNCT
bptjm-15	327	11	s.	s.	PROPN
bptjm-15	327	12	,	,	PUNCT
bptjm-15	327	13	siegel	siegel	PROPN
bptjm-15	327	14	,	,	PUNCT
bptjm-15	327	15	p.	p.	NOUN
bptjm-15	327	16	m.	m.	NOUN
bptjm-15	327	17	,	,	PUNCT
bptjm-15	327	18	&	&	CCONJ
bptjm-15	327	19	watson	watson	PROPN
bptjm-15	327	20	,	,	PUNCT
bptjm-15	327	21	i.	i.	PROPN
bptjm-15	327	22	r.	r.	PROPN
bptjm-15	327	23	(	(	PUNCT
bptjm-15	327	24	2018	2018	NUM
bptjm-15	327	25	)	)	PUNCT
bptjm-15	327	26	.	.	PUNCT
bptjm-15	328	1	classifying	classify	VERB
bptjm-15	328	2	braf	braf	NOUN
bptjm-15	328	3	alterations	alteration	NOUN
bptjm-15	328	4	in	in	ADP
bptjm-15	328	5	cancer	cancer	NOUN
bptjm-15	328	6	:	:	PUNCT
bptjm-15	328	7	new	new	ADJ
bptjm-15	328	8	rational	rational	ADJ
bptjm-15	328	9	therapeutic	therapeutic	ADJ
bptjm-15	328	10	strategies	strategy	NOUN
bptjm-15	328	11	for	for	ADP
bptjm-15	328	12	actionable	actionable	ADJ
bptjm-15	328	13	mutations	mutation	NOUN
bptjm-15	328	14	.	.	PUNCT
bptjm-15	329	1	oncogene	oncogene	NOUN
bptjm-15	329	2	,	,	PUNCT
bptjm-15	329	3	37(24	37(24	NUM
bptjm-15	329	4	)	)	PUNCT
bptjm-15	329	5	,	,	PUNCT
bptjm-15	329	6	3183–3199	3183–3199	NUM
bptjm-15	329	7	.	.	PUNCT
bptjm-15	330	1	https://doi.org/10.1038/s41388-018-0171-x	https://doi.org/10.1038/s41388-018-0171-x	NOUN
bptjm-15	330	2	15	15	NUM
bptjm-15	330	3	.	.	PUNCT
bptjm-15	330	4	de	de	PROPN
bptjm-15	330	5	marco	marco	PROPN
bptjm-15	330	6	,	,	PUNCT
bptjm-15	330	7	c.	c.	PROPN
bptjm-15	330	8	,	,	PUNCT
bptjm-15	330	9	laudanna	laudanna	PROPN
bptjm-15	330	10	,	,	PUNCT
bptjm-15	330	11	c.	c.	PROPN
bptjm-15	330	12	,	,	PUNCT
bptjm-15	330	13	rinaldo	rinaldo	PROPN
bptjm-15	330	14	,	,	PUNCT
bptjm-15	330	15	n.	n.	PROPN
bptjm-15	330	16	,	,	PUNCT
bptjm-15	330	17	oliveira	oliveira	PROPN
bptjm-15	330	18	,	,	PUNCT
bptjm-15	330	19	d.	d.	PROPN
bptjm-15	330	20	m.	m.	PROPN
bptjm-15	330	21	,	,	PUNCT
bptjm-15	330	22	ravo	ravo	NOUN
bptjm-15	330	23	,	,	PUNCT
bptjm-15	330	24	m.	m.	NOUN
bptjm-15	330	25	,	,	PUNCT
bptjm-15	330	26	weisz	weisz	NOUN
bptjm-15	330	27	,	,	PUNCT
bptjm-15	330	28	a.	a.	PROPN
bptjm-15	330	29	,	,	PUNCT
bptjm-15	330	30	ceccarelli	ceccarelli	ADV
bptjm-15	330	31	,	,	PUNCT
bptjm-15	330	32	m.	m.	NOUN
bptjm-15	330	33	,	,	PUNCT
bptjm-15	330	34	caira	caira	PROPN
bptjm-15	330	35	,	,	PUNCT
bptjm-15	330	36	e.	e.	PROPN
bptjm-15	330	37	,	,	PUNCT
bptjm-15	330	38	rizzuto	rizzuto	PROPN
bptjm-15	330	39	,	,	PUNCT
bptjm-15	330	40	a.	a.	PROPN
bptjm-15	330	41	,	,	PUNCT
bptjm-15	330	42	zoppoli	zoppoli	PROPN
bptjm-15	330	43	,	,	PUNCT
bptjm-15	330	44	p.	p.	NOUN
bptjm-15	330	45	,	,	PUNCT
bptjm-15	330	46	malanga	malanga	PROPN
bptjm-15	330	47	,	,	PUNCT
bptjm-15	330	48	d.	d.	PROPN
bptjm-15	330	49	,	,	PUNCT
bptjm-15	330	50	&	&	CCONJ
bptjm-15	330	51	viglietto	viglietto	NOUN
bptjm-15	330	52	,	,	PUNCT
bptjm-15	330	53	g.	g.	PROPN
bptjm-15	330	54	(	(	PUNCT
bptjm-15	330	55	2017	2017	NUM
bptjm-15	330	56	)	)	PUNCT
bptjm-15	330	57	.	.	PUNCT
bptjm-15	331	1	speci	speci	PROPN
bptjm-15	331	2	�	�	PROPN
bptjm-15	331	3	c	c	PROPN
bptjm-15	331	4	gene	gene	NOUN
bptjm-15	331	5	expression	expression	NOUN
bptjm-15	331	6	signatures	signature	NOUN
bptjm-15	331	7	induced	induce	VERB
bptjm-15	331	8	by	by	ADP
bptjm-15	331	9	the	the	DET
bptjm-15	331	10	multiple	multiple	ADJ
bptjm-15	331	11	oncogenic	oncogenic	ADJ
bptjm-15	331	12	alterations	alteration	NOUN
bptjm-15	331	13	that	that	PRON
bptjm-15	331	14	occur	occur	VERB
bptjm-15	331	15	within	within	ADP
bptjm-15	331	16	the	the	DET
bptjm-15	331	17	pten	pten	NOUN
bptjm-15	331	18	/	/	SYM
bptjm-15	331	19	pi3k	pi3k	NOUN
bptjm-15	331	20	/	/	SYM
bptjm-15	331	21	akt	akt	PROPN
bptjm-15	331	22	pathway	pathway	NOUN
bptjm-15	331	23	in	in	ADP
bptjm-15	331	24	lung	lung	NOUN
bptjm-15	331	25	cancer	cancer	NOUN
bptjm-15	331	26	.	.	PUNCT
bptjm-15	332	1	plos	plos	PROPN
bptjm-15	332	2	one	one	NUM
bptjm-15	332	3	,	,	PUNCT
bptjm-15	332	4	12(6	12(6	NUM
bptjm-15	332	5	)	)	PUNCT
bptjm-15	332	6	,	,	PUNCT
bptjm-15	332	7	e0178865	e0178865	X
bptjm-15	332	8	.	.	PUNCT
bptjm-15	333	1	https://doi.org/10.1371/journal.pone.0178865	https://doi.org/10.1371/journal.pone.0178865	VERB
bptjm-15	333	2	16	16	NUM
bptjm-15	333	3	.	.	PUNCT
bptjm-15	334	1	delmonico	delmonico	PROPN
bptjm-15	334	2	,	,	PUNCT
bptjm-15	334	3	l.	l.	PROPN
bptjm-15	334	4	et	et	PROPN
bptjm-15	334	5	al	al	PROPN
bptjm-15	334	6	.	.	PROPN
bptjm-15	335	1	(	(	PUNCT
bptjm-15	335	2	2019	2019	NUM
bptjm-15	335	3	)	)	PUNCT
bptjm-15	335	4	.	.	PUNCT
bptjm-15	336	1	mutation	mutation	NOUN
bptjm-15	336	2	pro	pro	PROPN
bptjm-15	336	3	�	�	VERB
bptjm-15	336	4	ling	ling	NOUN
bptjm-15	336	5	in	in	ADP
bptjm-15	336	6	the	the	DET
bptjm-15	336	7	pik3ca	pik3ca	PROPN
bptjm-15	336	8	,	,	PUNCT
bptjm-15	336	9	tp53	tp53	PROPN
bptjm-15	336	10	,	,	PUNCT
bptjm-15	336	11	and	and	CCONJ
bptjm-15	336	12	cdkn2a	cdkn2a	PROPN
bptjm-15	336	13	genes	gene	NOUN
bptjm-15	336	14	in	in	ADP
bptjm-15	336	15	circulating	circulate	VERB
bptjm-15	336	16	free	free	ADJ
bptjm-15	336	17	dna	dna	NOUN
bptjm-15	336	18	and	and	CCONJ
bptjm-15	336	19	impalpable	impalpable	ADJ
bptjm-15	336	20	breast	breast	NOUN
bptjm-15	336	21	lesions	lesion	NOUN
bptjm-15	336	22	.	.	PUNCT
bptjm-15	337	1	annals	annal	NOUN
bptjm-15	337	2	of	of	ADP
bptjm-15	337	3	diagnostic	diagnostic	ADJ
bptjm-15	337	4	pathology	pathology	NOUN
bptjm-15	337	5	,	,	PUNCT
bptjm-15	337	6	39	39	NUM
bptjm-15	337	7	,	,	PUNCT
bptjm-15	337	8	30–35	30–35	NUM
bptjm-15	337	9	.	.	PUNCT
bptjm-15	338	1	https://doi.org/10.1016/j.anndiagpath.2018.12.008	https://doi.org/10.1016/j.anndiagpath.2018.12.008	NOUN
bptjm-15	338	2	.	.	PUNCT
bptjm-15	339	1	17	17	NUM
bptjm-15	339	2	.	.	PUNCT
bptjm-15	340	1	gagliato	gagliato	PROPN
bptjm-15	340	2	d.	d.	PROPN
bptjm-15	340	3	de	de	PROPN
bptjm-15	340	4	melo	melo	PROPN
bptjm-15	340	5	,	,	PUNCT
bptjm-15	340	6	jardim	jardim	PROPN
bptjm-15	340	7	d.	d.	PROPN
bptjm-15	340	8	leonardo	leonardo	PROPN
bptjm-15	340	9	fontes	fontes	PROPN
bptjm-15	340	10	,	,	PUNCT
bptjm-15	340	11	marchesi	marchesi	PROPN
bptjm-15	340	12	m.	m.	PROPN
bptjm-15	340	13	sergio	sergio	PROPN
bptjm-15	340	14	pereira	pereira	PROPN
bptjm-15	340	15	,	,	PUNCT
bptjm-15	340	16	hortobagyi	hortobagyi	PROPN
bptjm-15	340	17	g.	g.	PROPN
bptjm-15	340	18	n.	n.	PROPN
bptjm-15	340	19	(	(	PUNCT
bptjm-15	340	20	2016	2016	NUM
bptjm-15	340	21	)	)	PUNCT
bptjm-15	340	22	.	.	PUNCT
bptjm-15	341	1	mechanisms	mechanism	NOUN
bptjm-15	341	2	of	of	ADP
bptjm-15	341	3	resistance	resistance	NOUN
bptjm-15	341	4	and	and	CCONJ
bptjm-15	341	5	sensitivity	sensitivity	NOUN
bptjm-15	341	6	to	to	ADP
bptjm-15	341	7	anti	anti	ADJ
bptjm-15	341	8	-	-	ADJ
bptjm-15	341	9	her2	her2	ADJ
bptjm-15	341	10	therapies	therapy	NOUN
bptjm-15	341	11	in	in	ADP
bptjm-15	341	12	her2	her2	PROPN
bptjm-15	341	13	+	+	CCONJ
bptjm-15	341	14	breast	breast	NOUN
bptjm-15	341	15	cancer	cancer	NOUN
bptjm-15	341	16	.	.	PUNCT
bptjm-15	342	1	oncotarget	oncotarget	NOUN
bptjm-15	342	2	.	.	PUNCT
bptjm-15	343	1	7	7	NUM
bptjm-15	343	2	,	,	PUNCT
bptjm-15	343	3	64431	64431	NUM
bptjm-15	343	4	-	-	SYM
bptjm-15	343	5	64446	64446	NUM
bptjm-15	343	6	.	.	PUNCT
bptjm-15	344	1	retrieved	retrieve	VERB
bptjm-15	344	2	from	from	ADP
bptjm-15	344	3	https://www.oncotarget.com/article/7043/text/	https://www.oncotarget.com/article/7043/text/	PROPN
bptjm-15	344	4	18	18	NUM
bptjm-15	344	5	.	.	PUNCT
bptjm-15	345	1	dejima	dejima	PROPN
bptjm-15	345	2	,	,	PUNCT
bptjm-15	345	3	h.	h.	PROPN
bptjm-15	345	4	,	,	PUNCT
bptjm-15	345	5	iinuma	iinuma	PROPN
bptjm-15	345	6	,	,	PUNCT
bptjm-15	345	7	h.	h.	PROPN
bptjm-15	345	8	,	,	PUNCT
bptjm-15	345	9	kanaoka	kanaoka	PROPN
bptjm-15	345	10	,	,	PUNCT
bptjm-15	345	11	r.	r.	PROPN
bptjm-15	345	12	,	,	PUNCT
bptjm-15	345	13	matsutani	matsutani	PROPN
bptjm-15	345	14	,	,	PUNCT
bptjm-15	345	15	n.	n.	NOUN
bptjm-15	345	16	,	,	PUNCT
bptjm-15	345	17	&	&	CCONJ
bptjm-15	345	18	kawamura	kawamura	PROPN
bptjm-15	345	19	,	,	PUNCT
bptjm-15	345	20	m.	m.	NOUN
bptjm-15	345	21	(	(	PUNCT
bptjm-15	345	22	2017	2017	NUM
bptjm-15	345	23	)	)	PUNCT
bptjm-15	345	24	.	.	PUNCT
bptjm-15	346	1	exosomal	exosomal	PROPN
bptjm-15	346	2	microrna	microrna	PROPN
bptjm-15	346	3	in	in	ADP
bptjm-15	346	4	plasma	plasma	NOUN
bptjm-15	346	5	as	as	ADP
bptjm-15	346	6	a	a	DET
bptjm-15	346	7	non	non	ADJ
bptjm-15	346	8	-	-	ADJ
bptjm-15	346	9	invasive	invasive	ADJ
bptjm-15	346	10	biomarker	biomarker	NOUN
bptjm-15	346	11	for	for	ADP
bptjm-15	346	12	the	the	DET
bptjm-15	346	13	recurrence	recurrence	NOUN
bptjm-15	346	14	of	of	ADP
bptjm-15	346	15	non	non	ADJ
bptjm-15	346	16	-	-	ADJ
bptjm-15	346	17	small	small	ADJ
bptjm-15	346	18	cell	cell	NOUN
bptjm-15	346	19	lung	lung	NOUN
bptjm-15	346	20	cancer	cancer	NOUN
bptjm-15	346	21	.	.	PUNCT
bptjm-15	347	1	oncology	oncology	NOUN
bptjm-15	347	2	letters	letter	NOUN
bptjm-15	347	3	,	,	PUNCT
bptjm-15	347	4	13(3	13(3	NUM
bptjm-15	347	5	)	)	PUNCT
bptjm-15	347	6	,	,	PUNCT
bptjm-15	347	7	1256–1263	1256–1263	NUM
bptjm-15	347	8	.	.	PUNCT
bptjm-15	348	1	https://doi.org/10.3892/ol.2017.5569	https://doi.org/10.3892/ol.2017.5569	PROPN
bptjm-15	348	2	19	19	NUM
bptjm-15	348	3	.	.	PUNCT
bptjm-15	348	4	deng	deng	PROPN
bptjm-15	348	5	,	,	PUNCT
bptjm-15	348	6	l.	l.	PROPN
bptjm-15	348	7	,	,	PUNCT
bptjm-15	348	8	kiedrowski	kiedrowski	PROPN
bptjm-15	348	9	,	,	PUNCT
bptjm-15	348	10	l.	l.	PROPN
bptjm-15	348	11	a.	a.	PROPN
bptjm-15	348	12	,	,	PUNCT
bptjm-15	348	13	ravera	ravera	PROPN
bptjm-15	348	14	,	,	PUNCT
bptjm-15	348	15	e.	e.	PROPN
bptjm-15	348	16	,	,	PUNCT
bptjm-15	348	17	cheng	cheng	PROPN
bptjm-15	348	18	,	,	PUNCT
bptjm-15	348	19	h.	h.	PROPN
bptjm-15	348	20	,	,	PUNCT
bptjm-15	348	21	&	&	CCONJ
bptjm-15	348	22	halmos	halmos	PROPN
bptjm-15	348	23	,	,	PUNCT
bptjm-15	348	24	b.	b.	PROPN
bptjm-15	348	25	(	(	PUNCT
bptjm-15	348	26	2018	2018	NUM
bptjm-15	348	27	)	)	PUNCT
bptjm-15	348	28	.	.	PUNCT
bptjm-15	349	1	response	response	NOUN
bptjm-15	349	2	to	to	ADP
bptjm-15	349	3	dual	dual	ADJ
bptjm-15	349	4	crizotinib	crizotinib	NOUN
bptjm-15	349	5	and	and	CCONJ
bptjm-15	349	6	osimertinib	osimertinib	VERB
bptjm-15	349	7	treatment	treatment	NOUN
bptjm-15	349	8	in	in	ADP
bptjm-15	349	9	a	a	DET
bptjm-15	349	10	lung	lung	NOUN
bptjm-15	349	11	cancer	cancer	NOUN
bptjm-15	349	12	patient	patient	NOUN
bptjm-15	349	13	with	with	ADP
bptjm-15	349	14	met	meet	VERB
bptjm-15	349	15	ampli	ampli	NOUN
bptjm-15	349	16	�	�	NOUN
bptjm-15	349	17	cation	cation	NOUN
bptjm-15	349	18	detected	detect	VERB
bptjm-15	349	19	by	by	ADP
bptjm-15	349	20	liquid	liquid	ADJ
bptjm-15	349	21	biopsy	biopsy	NOUN
bptjm-15	349	22	who	who	PRON
bptjm-15	349	23	acquired	acquire	VERB
bptjm-15	349	24	secondary	secondary	ADJ
bptjm-15	349	25	resistance	resistance	NOUN
bptjm-15	349	26	to	to	ADP
bptjm-15	349	27	egfr	egfr	PROPN
bptjm-15	349	28	tyrosine	tyrosine	PROPN
bptjm-15	349	29	kinase	kinase	PROPN
bptjm-15	349	30	inhibition	inhibition	NOUN
bptjm-15	349	31	.	.	PUNCT
bptjm-15	350	1	journal	journal	NOUN
bptjm-15	350	2	of	of	ADP
bptjm-15	350	3	thoracic	thoracic	NOUN
bptjm-15	350	4	oncology	oncology	NOUN
bptjm-15	350	5	:	:	PUNCT
bptjm-15	350	6	official	official	ADJ
bptjm-15	350	7	publication	publication	NOUN
bptjm-15	350	8	of	of	ADP
bptjm-15	350	9	the	the	DET
bptjm-15	350	10	international	international	ADJ
bptjm-15	350	11	association	association	NOUN
bptjm-15	350	12	for	for	ADP
bptjm-15	350	13	the	the	DET
bptjm-15	350	14	study	study	NOUN
bptjm-15	350	15	of	of	ADP
bptjm-15	350	16	lung	lung	NOUN
bptjm-15	350	17	cancer	cancer	NOUN
bptjm-15	350	18	,	,	PUNCT
bptjm-15	350	19	13(9	13(9	NUM
bptjm-15	350	20	)	)	PUNCT
bptjm-15	350	21	,	,	PUNCT
bptjm-15	350	22	e169	e169	PROPN
bptjm-15	350	23	–	–	PUNCT
bptjm-15	350	24	e172	e172	NUM
bptjm-15	350	25	.	.	PUNCT
bptjm-15	351	1	https://doi.org/10.1016/j.jtho.2018.04.007	https://doi.org/10.1016/j.jtho.2018.04.007	PROPN
bptjm-15	351	2	20	20	NUM
bptjm-15	351	3	.	.	PUNCT
bptjm-15	352	1	donnem	donnem	PROPN
bptjm-15	352	2	,	,	PUNCT
bptjm-15	352	3	t.	t.	PROPN
bptjm-15	352	4	,	,	PUNCT
bptjm-15	352	5	eklo	eklo	PROPN
bptjm-15	352	6	,	,	PUNCT
bptjm-15	352	7	k.	k.	PROPN
bptjm-15	352	8	,	,	PUNCT
bptjm-15	352	9	berg	berg	PROPN
bptjm-15	352	10	,	,	PUNCT
bptjm-15	352	11	t.	t.	PROPN
bptjm-15	352	12	et	et	PROPN
bptjm-15	352	13	al	al	PROPN
bptjm-15	352	14	.	.	PROPN
bptjm-15	353	1	(	(	PUNCT
bptjm-15	353	2	2011	2011	NUM
bptjm-15	353	3	)	)	PUNCT
bptjm-15	353	4	.	.	PUNCT
bptjm-15	354	1	prognostic	prognostic	ADJ
bptjm-15	354	2	impact	impact	NOUN
bptjm-15	354	3	of	of	ADP
bptjm-15	354	4	mir-155	mir-155	NOUN
bptjm-15	354	5	in	in	ADP
bptjm-15	354	6	non	non	ADJ
bptjm-15	354	7	-	-	ADJ
bptjm-15	354	8	small	small	ADJ
bptjm-15	354	9	cell	cell	NOUN
bptjm-15	354	10	lung	lung	NOUN
bptjm-15	354	11	cancer	cancer	NOUN
bptjm-15	354	12	evaluated	evaluate	VERB
bptjm-15	354	13	by	by	ADP
bptjm-15	354	14	in	in	ADP
bptjm-15	354	15	situ	situ	ADJ
bptjm-15	354	16	hybridization	hybridization	NOUN
bptjm-15	354	17	.	.	PUNCT
bptjm-15	355	1	journal	journal	NOUN
bptjm-15	355	2	of	of	ADP
bptjm-15	355	3	translational	translational	ADJ
bptjm-15	355	4	medicine	medicine	NOUN
bptjm-15	355	5	,	,	PUNCT
bptjm-15	355	6	9(6	9(6	NUM
bptjm-15	355	7	)	)	PUNCT
bptjm-15	355	8	.	.	PUNCT
bptjm-15	356	1	https://doi.org/10.1186/1479-5876-9-6	https://doi.org/10.1186/1479-5876-9-6	PROPN
bptjm-15	356	2	.	.	PUNCT
bptjm-15	357	1	21	21	NUM
bptjm-15	357	2	.	.	PUNCT
bptjm-15	358	1	dou	dou	PROPN
bptjm-15	358	2	,	,	PUNCT
bptjm-15	358	3	h.	h.	PROPN
bptjm-15	358	4	,	,	PUNCT
bptjm-15	358	5	wang	wang	PROPN
bptjm-15	358	6	,	,	PUNCT
bptjm-15	358	7	y.	y.	PROPN
bptjm-15	358	8	,	,	PUNCT
bptjm-15	358	9	su	su	PROPN
bptjm-15	358	10	,	,	PUNCT
bptjm-15	358	11	g.	g.	PROPN
bptjm-15	358	12	,	,	PUNCT
bptjm-15	358	13	&	&	CCONJ
bptjm-15	358	14	zhao	zhao	PROPN
bptjm-15	358	15	,	,	PUNCT
bptjm-15	358	16	s.	s.	PROPN
bptjm-15	358	17	(	(	PUNCT
bptjm-15	358	18	2015	2015	NUM
bptjm-15	358	19	)	)	PUNCT
bptjm-15	358	20	.	.	PUNCT
bptjm-15	359	1	decreased	decrease	VERB
bptjm-15	359	2	plasma	plasma	NOUN
bptjm-15	359	3	let-7c	let-7c	PROPN
bptjm-15	359	4	and	and	CCONJ
bptjm-15	359	5	mir-152	mir-152	NOUN
bptjm-15	359	6	as	as	ADP
bptjm-15	359	7	noninvasive	noninvasive	ADJ
bptjm-15	359	8	biomarker	biomarker	NOUN
bptjm-15	359	9	for	for	ADP
bptjm-15	359	10	non	non	ADJ
bptjm-15	359	11	-	-	ADJ
bptjm-15	359	12	small	small	ADJ
bptjm-15	359	13	-	-	PUNCT
bptjm-15	359	14	cell	cell	NOUN
bptjm-15	359	15	lung	lung	NOUN
bptjm-15	359	16	cancer	cancer	NOUN
bptjm-15	359	17	.	.	PUNCT
bptjm-15	360	1	international	international	ADJ
bptjm-15	360	2	journal	journal	NOUN
bptjm-15	360	3	of	of	ADP
bptjm-15	360	4	clinical	clinical	ADJ
bptjm-15	360	5	and	and	CCONJ
bptjm-15	360	6	experimental	experimental	ADJ
bptjm-15	360	7	medicine	medicine	NOUN
bptjm-15	360	8	,	,	PUNCT
bptjm-15	360	9	8(6	8(6	NUM
bptjm-15	360	10	)	)	PUNCT
bptjm-15	360	11	,	,	PUNCT
bptjm-15	360	12	9291–9298	9291–9298	NUM
bptjm-15	360	13	.	.	PUNCT
bptjm-15	361	1	22	22	NUM
bptjm-15	361	2	.	.	PUNCT
bptjm-15	362	1	embl	embl	NOUN
bptjm-15	362	2	-	-	PUNCT
bptjm-15	362	3	ebi	ebi	PROPN
bptjm-15	362	4	.	.	PUNCT
bptjm-15	363	1	(	(	PUNCT
bptjm-15	363	2	n.d	n.d	PROPN
bptjm-15	363	3	.	.	PROPN
bptjm-15	363	4	)	)	PUNCT
bptjm-15	363	5	.	.	PUNCT
bptjm-15	364	1	what	what	PRON
bptjm-15	364	2	is	be	AUX
bptjm-15	364	3	next	next	ADJ
bptjm-15	364	4	generation	generation	NOUN
bptjm-15	364	5	dna	dna	NOUN
bptjm-15	364	6	sequencing	sequencing	NOUN
bptjm-15	364	7	?	?	PUNCT
bptjm-15	365	1	retrieved	retrieve	VERB
bptjm-15	365	2	december	december	PROPN
bptjm-15	365	3	08	08	NUM
bptjm-15	365	4	,	,	PUNCT
bptjm-15	365	5	2020	2020	NUM
bptjm-15	365	6	,	,	PUNCT
bptjm-15	365	7	from	from	ADP
bptjm-15	365	8	https://www.ebi.ac.uk/training-beta/online/courses/fu	https://www.ebi.ac.uk/training-beta/online/courses/fu	PROPN
bptjm-15	365	9	nctional	nctional	ADJ
bptjm-15	365	10	-	-	PUNCT
bptjm-15	365	11	genomics	genomics	NOUN
bptjm-15	365	12	-	-	PUNCT
bptjm-15	365	13	iicommon	iicommon	NOUN
bptjm-15	365	14	-	-	PUNCT
bptjm-15	365	15	technologies	technology	NOUN
bptjm-15	365	16	-	-	PUNCT
bptjm-15	365	17	and	and	CCONJ
bptjm-15	365	18	-	-	PUNCT
bptjm-15	365	19	data	data	NOUN
bptjm-15	365	20	-	-	PUNCT
bptjm-15	365	21	an	an	DET
bptjm-15	365	22	alysis	alysis	NOUN
bptjm-15	365	23	-	-	PUNCT
bptjm-15	365	24	methods	method	NOUN
bptjm-15	365	25	/	/	SYM
bptjm-15	365	26	next	next	ADJ
bptjm-15	365	27	-	-	PUNCT
bptjm-15	365	28	generation	generation	NOUN
bptjm-15	365	29	-	-	PUNCT
bptjm-15	365	30	sequencing/	sequencing/	NUM
bptjm-15	365	31	berkeley	berkeley	PROPN
bptjm-15	365	32	pharma	pharma	PROPN
bptjm-15	365	33	tech	tech	NOUN
bptjm-15	365	34	journal	journal	NOUN
bptjm-15	365	35	of	of	ADP
bptjm-15	365	36	medicine	medicine	NOUN
bptjm-15	365	37	|	|	ADV
bptjm-15	365	38	86	86	NUM
bptjm-15	365	39	https://doi.org/10.1371/journal.pone.0178865	https://doi.org/10.1371/journal.pone.0178865	VERB
bptjm-15	365	40	https://doi.org/10.1186/1479-5876-9-6	https://doi.org/10.1186/1479-5876-9-6	VERB
bptjm-15	365	41	http://www.ebi.ac.uk/training-beta/online/courses/functional-genomics-ii	http://www.ebi.ac.uk/training-beta/online/courses/functional-genomics-ii	PROPN
bptjm-15	365	42	http://www.ebi.ac.uk/training-beta/online/courses/functional-genomics-ii	http://www.ebi.ac.uk/training-beta/online/courses/functional-genomics-ii	PROPN
bptjm-15	365	43	http://www.ebi.ac.uk/training-beta/online/courses/functional-genomics-ii	http://www.ebi.ac.uk/training-beta/online/courses/functional-genomics-ii	PROPN
bptjm-15	365	44	23	23	NUM
bptjm-15	365	45	.	.	PUNCT
bptjm-15	366	1	farago	farago	PROPN
bptjm-15	366	2	,	,	PUNCT
bptjm-15	366	3	a.	a.	PROPN
bptjm-15	366	4	f.	f.	PROPN
bptjm-15	366	5	,	,	PUNCT
bptjm-15	366	6	le	le	PROPN
bptjm-15	366	7	,	,	PUNCT
bptjm-15	366	8	l.	l.	PROPN
bptjm-15	366	9	p.	p.	PROPN
bptjm-15	366	10	,	,	PUNCT
bptjm-15	366	11	zheng	zheng	PROPN
bptjm-15	366	12	,	,	PUNCT
bptjm-15	366	13	z.	z.	PROPN
bptjm-15	366	14	,	,	PUNCT
bptjm-15	366	15	muzikansky	muzikansky	PROPN
bptjm-15	366	16	,	,	PUNCT
bptjm-15	366	17	a.	a.	NOUN
bptjm-15	366	18	,	,	PUNCT
bptjm-15	366	19	drilon	drilon	NOUN
bptjm-15	366	20	,	,	PUNCT
bptjm-15	366	21	a.	a.	NOUN
bptjm-15	366	22	,	,	PUNCT
bptjm-15	366	23	patel	patel	PROPN
bptjm-15	366	24	,	,	PUNCT
bptjm-15	366	25	m.	m.	NOUN
bptjm-15	366	26	,	,	PUNCT
bptjm-15	366	27	bauer	bauer	PROPN
bptjm-15	366	28	,	,	PUNCT
bptjm-15	366	29	t.	t.	PROPN
bptjm-15	366	30	m.	m.	NOUN
bptjm-15	366	31	,	,	PUNCT
bptjm-15	366	32	liu	liu	PROPN
bptjm-15	366	33	,	,	PUNCT
bptjm-15	366	34	s.	s.	PROPN
bptjm-15	366	35	v.	v.	PROPN
bptjm-15	366	36	,	,	PUNCT
bptjm-15	366	37	ou	ou	PROPN
bptjm-15	366	38	,	,	PUNCT
bptjm-15	366	39	s.	s.	PROPN
bptjm-15	366	40	h.	h.	PROPN
bptjm-15	366	41	,	,	PUNCT
bptjm-15	366	42	jackman	jackman	PROPN
bptjm-15	366	43	,	,	PUNCT
bptjm-15	366	44	d.	d.	PROPN
bptjm-15	366	45	,	,	PUNCT
bptjm-15	366	46	costa	costa	PROPN
bptjm-15	366	47	,	,	PUNCT
bptjm-15	366	48	d.	d.	PROPN
bptjm-15	366	49	b.	b.	PROPN
bptjm-15	366	50	,	,	PUNCT
bptjm-15	366	51	multani	multani	PROPN
bptjm-15	366	52	,	,	PUNCT
bptjm-15	366	53	p.	p.	PROPN
bptjm-15	366	54	s.	s.	PROPN
bptjm-15	366	55	,	,	PUNCT
bptjm-15	366	56	li	li	PROPN
bptjm-15	366	57	,	,	PUNCT
bptjm-15	366	58	g.	g.	PROPN
bptjm-15	366	59	g.	g.	PROPN
bptjm-15	366	60	,	,	PUNCT
bptjm-15	366	61	hornby	hornby	PROPN
bptjm-15	366	62	,	,	PUNCT
bptjm-15	366	63	z.	z.	PROPN
bptjm-15	366	64	,	,	PUNCT
bptjm-15	366	65	chow	chow	NOUN
bptjm-15	366	66	-	-	PUNCT
bptjm-15	366	67	maneval	maneval	NOUN
bptjm-15	366	68	,	,	PUNCT
bptjm-15	366	69	e.	e.	PROPN
bptjm-15	366	70	,	,	PUNCT
bptjm-15	366	71	luo	luo	PROPN
bptjm-15	366	72	,	,	PUNCT
bptjm-15	366	73	d.	d.	PROPN
bptjm-15	366	74	,	,	PUNCT
bptjm-15	366	75	lim	lim	PROPN
bptjm-15	366	76	,	,	PUNCT
bptjm-15	366	77	j.	j.	PROPN
bptjm-15	366	78	e.	e.	PROPN
bptjm-15	366	79	,	,	PUNCT
bptjm-15	366	80	iafrate	iafrate	ADJ
bptjm-15	366	81	,	,	PUNCT
bptjm-15	366	82	a.	a.	PROPN
bptjm-15	366	83	j.	j.	PROPN
bptjm-15	366	84	,	,	PUNCT
bptjm-15	366	85	&	&	CCONJ
bptjm-15	366	86	shaw	shaw	PROPN
bptjm-15	366	87	,	,	PUNCT
bptjm-15	366	88	a.	a.	NOUN
bptjm-15	366	89	t.	t.	PROPN
bptjm-15	366	90	(	(	PUNCT
bptjm-15	366	91	2015	2015	NUM
bptjm-15	366	92	)	)	PUNCT
bptjm-15	366	93	.	.	PUNCT
bptjm-15	367	1	durable	durable	ADJ
bptjm-15	367	2	clinical	clinical	ADJ
bptjm-15	367	3	response	response	NOUN
bptjm-15	367	4	to	to	ADP
bptjm-15	367	5	entrectinib	entrectinib	VERB
bptjm-15	367	6	in	in	ADP
bptjm-15	367	7	ntrk1	ntrk1	NOUN
bptjm-15	367	8	-	-	PUNCT
bptjm-15	367	9	rearranged	rearrange	VERB
bptjm-15	367	10	non	non	ADJ
bptjm-15	367	11	-	-	ADJ
bptjm-15	367	12	small	small	ADJ
bptjm-15	367	13	cell	cell	NOUN
bptjm-15	367	14	lung	lung	NOUN
bptjm-15	367	15	cancer	cancer	NOUN
bptjm-15	367	16	.	.	PUNCT
bptjm-15	368	1	journal	journal	PROPN
bptjm-15	368	2	of	of	ADP
bptjm-15	368	3	thoracic	thoracic	NOUN
bptjm-15	368	4	oncology	oncology	NOUN
bptjm-15	368	5	:	:	PUNCT
bptjm-15	368	6	official	official	ADJ
bptjm-15	368	7	publication	publication	NOUN
bptjm-15	368	8	of	of	ADP
bptjm-15	368	9	the	the	DET
bptjm-15	368	10	international	international	ADJ
bptjm-15	368	11	association	association	NOUN
bptjm-15	368	12	for	for	ADP
bptjm-15	368	13	the	the	DET
bptjm-15	368	14	study	study	NOUN
bptjm-15	368	15	of	of	ADP
bptjm-15	368	16	lung	lung	NOUN
bptjm-15	368	17	cancer	cancer	NOUN
bptjm-15	368	18	,	,	PUNCT
bptjm-15	368	19	10(12	10(12	NUM
bptjm-15	368	20	)	)	PUNCT
bptjm-15	368	21	,	,	PUNCT
bptjm-15	368	22	1670–1674	1670–1674	NUM
bptjm-15	368	23	.	.	PUNCT
bptjm-15	369	1	https://doi.org/10.1097/01.jto	https://doi.org/10.1097/01.jto	NOUN
bptjm-15	369	2	.	.	PUNCT
bptjm-15	370	1	0000473485.38553.f0	0000473485.38553.f0	PROPN
bptjm-15	370	2	.	.	PUNCT
bptjm-15	371	1	24	24	NUM
bptjm-15	371	2	.	.	PUNCT
bptjm-15	372	1	feng	feng	PROPN
bptjm-15	372	2	,	,	PUNCT
bptjm-15	372	3	y.	y.	PROPN
bptjm-15	372	4	h.	h.	PROPN
bptjm-15	372	5	,	,	PUNCT
bptjm-15	372	6	&	&	CCONJ
bptjm-15	372	7	tsao	tsao	PROPN
bptjm-15	372	8	,	,	PUNCT
bptjm-15	372	9	c.	c.	PROPN
bptjm-15	372	10	j.	j.	PROPN
bptjm-15	372	11	(	(	PUNCT
bptjm-15	372	12	2016	2016	NUM
bptjm-15	372	13	)	)	PUNCT
bptjm-15	372	14	.	.	PUNCT
bptjm-15	373	1	emerging	emerge	VERB
bptjm-15	373	2	role	role	NOUN
bptjm-15	373	3	of	of	ADP
bptjm-15	373	4	microrna-21	microrna-21	PROPN
bptjm-15	373	5	in	in	ADP
bptjm-15	373	6	cancer	cancer	NOUN
bptjm-15	373	7	.	.	PUNCT
bptjm-15	374	1	biomedical	biomedical	ADJ
bptjm-15	374	2	reports	report	NOUN
bptjm-15	374	3	,	,	PUNCT
bptjm-15	374	4	5(4	5(4	NUM
bptjm-15	374	5	)	)	PUNCT
bptjm-15	374	6	,	,	PUNCT
bptjm-15	374	7	395–402	395–402	NUM
bptjm-15	374	8	.	.	PUNCT
bptjm-15	375	1	https://doi.org/10.3892/br.2016.747	https://doi.org/10.3892/br.2016.747	X
bptjm-15	376	1	25	25	NUM
bptjm-15	376	2	.	.	PUNCT
bptjm-15	377	1	fuchs	fuchs	PROPN
bptjm-15	377	2	,	,	PUNCT
bptjm-15	377	3	a.	a.	PROPN
bptjm-15	377	4	,	,	PUNCT
bptjm-15	377	5	könig	könig	PROPN
bptjm-15	377	6	,	,	PUNCT
bptjm-15	377	7	k.	k.	PROPN
bptjm-15	377	8	,	,	PUNCT
bptjm-15	377	9	heukamp	heukamp	PROPN
bptjm-15	377	10	,	,	PUNCT
bptjm-15	377	11	l.	l.	PROPN
bptjm-15	377	12	c.	c.	PROPN
bptjm-15	377	13	,	,	PUNCT
bptjm-15	377	14	fassunke	fassunke	NOUN
bptjm-15	377	15	,	,	PUNCT
bptjm-15	377	16	j.	j.	PROPN
bptjm-15	377	17	,	,	PUNCT
bptjm-15	377	18	kirfel	kirfel	PROPN
bptjm-15	377	19	,	,	PUNCT
bptjm-15	377	20	j.	j.	PROPN
bptjm-15	377	21	,	,	PUNCT
bptjm-15	377	22	huss	huss	PROPN
bptjm-15	377	23	,	,	PUNCT
bptjm-15	377	24	s.	s.	PROPN
bptjm-15	377	25	,	,	PUNCT
bptjm-15	377	26	becker	becker	PROPN
bptjm-15	377	27	,	,	PUNCT
bptjm-15	377	28	a.	a.	PROPN
bptjm-15	377	29	j.	j.	PROPN
bptjm-15	377	30	,	,	PUNCT
bptjm-15	377	31	büttner	büttner	PROPN
bptjm-15	377	32	,	,	PUNCT
bptjm-15	377	33	r.	r.	PROPN
bptjm-15	377	34	,	,	PUNCT
bptjm-15	377	35	&	&	CCONJ
bptjm-15	377	36	majores	majore	NOUN
bptjm-15	377	37	,	,	PUNCT
bptjm-15	377	38	m.	m.	NOUN
bptjm-15	377	39	(	(	PUNCT
bptjm-15	377	40	2014	2014	NUM
bptjm-15	377	41	)	)	PUNCT
bptjm-15	377	42	.	.	PUNCT
bptjm-15	378	1	tuberous	tuberous	ADJ
bptjm-15	378	2	-	-	PUNCT
bptjm-15	378	3	sclerosis	sclerosis	NOUN
bptjm-15	378	4	complex	complex	ADJ
bptjm-15	378	5	-	-	PUNCT
bptjm-15	378	6	related	relate	VERB
bptjm-15	378	7	cell	cell	NOUN
bptjm-15	378	8	signaling	signal	VERB
bptjm-15	378	9	in	in	ADP
bptjm-15	378	10	the	the	DET
bptjm-15	378	11	pathogenesis	pathogenesis	NOUN
bptjm-15	378	12	of	of	ADP
bptjm-15	378	13	lung	lung	NOUN
bptjm-15	378	14	cancer	cancer	NOUN
bptjm-15	378	15	.	.	PUNCT
bptjm-15	379	1	diagnostic	diagnostic	ADJ
bptjm-15	379	2	pathology	pathology	NOUN
bptjm-15	379	3	,	,	PUNCT
bptjm-15	379	4	9(48	9(48	NUM
bptjm-15	379	5	)	)	PUNCT
bptjm-15	379	6	.	.	PUNCT
bptjm-15	380	1	https://doi.org/10.1186/1746-1596-9-48	https://doi.org/10.1186/1746-1596-9-48	VERB
bptjm-15	380	2	26	26	NUM
bptjm-15	380	3	.	.	PUNCT
bptjm-15	381	1	friedmann	friedmann	NOUN
bptjm-15	381	2	-	-	PUNCT
bptjm-15	381	3	morvinski	morvinski	PROPN
bptjm-15	381	4	,	,	PUNCT
bptjm-15	381	5	d.	d.	PROPN
bptjm-15	381	6	,	,	PUNCT
bptjm-15	381	7	&	&	CCONJ
bptjm-15	381	8	verma	verma	PROPN
bptjm-15	381	9	,	,	PUNCT
bptjm-15	381	10	i.	i.	PROPN
bptjm-15	381	11	m.	m.	PROPN
bptjm-15	381	12	(	(	PUNCT
bptjm-15	381	13	2014	2014	NUM
bptjm-15	381	14	)	)	PUNCT
bptjm-15	381	15	.	.	PUNCT
bptjm-15	382	1	dedi	dedi	PROPN
bptjm-15	382	2	�	�	PROPN
bptjm-15	382	3	erentiation	erentiation	NOUN
bptjm-15	382	4	and	and	CCONJ
bptjm-15	382	5	reprogramming	reprogramme	VERB
bptjm-15	382	6	:	:	PUNCT
bptjm-15	382	7	origins	origin	NOUN
bptjm-15	382	8	of	of	ADP
bptjm-15	382	9	cancer	cancer	NOUN
bptjm-15	382	10	stem	stem	NOUN
bptjm-15	382	11	cells	cell	NOUN
bptjm-15	382	12	.	.	PUNCT
bptjm-15	383	1	embo	embo	PROPN
bptjm-15	383	2	reports	report	NOUN
bptjm-15	383	3	,	,	PUNCT
bptjm-15	383	4	15(3	15(3	NUM
bptjm-15	383	5	)	)	PUNCT
bptjm-15	383	6	,	,	PUNCT
bptjm-15	383	7	244–253	244–253	NUM
bptjm-15	383	8	.	.	PUNCT
bptjm-15	384	1	https://doi.org/10.1002/	https://doi.org/10.1002/	PROPN
bptjm-15	384	2	embr.201338254	embr.201338254	PROPN
bptjm-15	384	3	27	27	NUM
bptjm-15	384	4	.	.	PUNCT
bptjm-15	385	1	gao	gao	PROPN
bptjm-15	385	2	,	,	PUNCT
bptjm-15	385	3	w.	w.	PROPN
bptjm-15	385	4	,	,	PUNCT
bptjm-15	385	5	lu	lu	PROPN
bptjm-15	385	6	,	,	PUNCT
bptjm-15	385	7	x.	x.	PROPN
bptjm-15	385	8	,	,	PUNCT
bptjm-15	385	9	liu	liu	PROPN
bptjm-15	385	10	,	,	PUNCT
bptjm-15	385	11	l.	l.	PROPN
bptjm-15	385	12	,	,	PUNCT
bptjm-15	385	13	xu	xu	PROPN
bptjm-15	385	14	,	,	PUNCT
bptjm-15	385	15	j.	j.	PROPN
bptjm-15	385	16	,	,	PUNCT
bptjm-15	385	17	feng	feng	PROPN
bptjm-15	385	18	,	,	PUNCT
bptjm-15	385	19	d.	d.	PROPN
bptjm-15	385	20	,	,	PUNCT
bptjm-15	385	21	&	&	CCONJ
bptjm-15	385	22	shu	shu	PROPN
bptjm-15	385	23	,	,	PUNCT
bptjm-15	385	24	y.	y.	PROPN
bptjm-15	385	25	(	(	PUNCT
bptjm-15	385	26	2012	2012	NUM
bptjm-15	385	27	)	)	PUNCT
bptjm-15	385	28	.	.	PUNCT
bptjm-15	386	1	mirna-21	mirna-21	NOUN
bptjm-15	386	2	:	:	PUNCT
bptjm-15	386	3	a	a	DET
bptjm-15	386	4	biomarker	biomarker	NOUN
bptjm-15	386	5	predictive	predictive	NOUN
bptjm-15	386	6	for	for	ADP
bptjm-15	386	7	platinum	platinum	NOUN
bptjm-15	386	8	-	-	PUNCT
bptjm-15	386	9	based	base	VERB
bptjm-15	386	10	adjuvant	adjuvant	ADJ
bptjm-15	386	11	chemotherapy	chemotherapy	NOUN
bptjm-15	386	12	response	response	NOUN
bptjm-15	386	13	in	in	ADP
bptjm-15	386	14	patients	patient	NOUN
bptjm-15	386	15	with	with	ADP
bptjm-15	386	16	non	non	ADJ
bptjm-15	386	17	-	-	ADJ
bptjm-15	386	18	small	small	ADJ
bptjm-15	386	19	cell	cell	NOUN
bptjm-15	386	20	lung	lung	NOUN
bptjm-15	386	21	cancer	cancer	NOUN
bptjm-15	386	22	.	.	PUNCT
bptjm-15	387	1	cancer	cancer	NOUN
bptjm-15	387	2	biology	biology	NOUN
bptjm-15	387	3	&	&	CCONJ
bptjm-15	387	4	therapy	therapy	NOUN
bptjm-15	387	5	,	,	PUNCT
bptjm-15	387	6	13(5	13(5	NUM
bptjm-15	387	7	)	)	PUNCT
bptjm-15	387	8	,	,	PUNCT
bptjm-15	387	9	330–340	330–340	NUM
bptjm-15	387	10	.	.	PUNCT
bptjm-15	388	1	https://doi.org/10.4161/cbt.19073	https://doi.org/10.4161/cbt.19073	NOUN
bptjm-15	388	2	28	28	NUM
bptjm-15	388	3	.	.	PUNCT
bptjm-15	389	1	gao	gao	PROPN
bptjm-15	389	2	,	,	PUNCT
bptjm-15	389	3	z.j	z.j	PROPN
bptjm-15	389	4	.	.	PROPN
bptjm-15	389	5	,	,	PUNCT
bptjm-15	389	6	et	et	PROPN
bptjm-15	389	7	al	al	PROPN
bptjm-15	389	8	.	.	PROPN
bptjm-15	389	9	(	(	PUNCT
bptjm-15	389	10	2020	2020	NUM
bptjm-15	389	11	)	)	PUNCT
bptjm-15	389	12	.	.	PUNCT
bptjm-15	390	1	mir-486	mir-486	PROPN
bptjm-15	390	2	as	as	ADP
bptjm-15	390	3	an	an	DET
bptjm-15	390	4	unfavorable	unfavorable	ADJ
bptjm-15	390	5	prognostic	prognostic	ADJ
bptjm-15	390	6	biomarker	biomarker	NOUN
bptjm-15	390	7	for	for	ADP
bptjm-15	390	8	patients	patient	NOUN
bptjm-15	390	9	with	with	ADP
bptjm-15	390	10	non	non	ADJ
bptjm-15	390	11	-	-	ADJ
bptjm-15	390	12	small	small	ADJ
bptjm-15	390	13	cell	cell	NOUN
bptjm-15	390	14	lung	lung	NOUN
bptjm-15	390	15	cancer	cancer	NOUN
bptjm-15	390	16	.	.	PUNCT
bptjm-15	391	1	translational	translational	ADJ
bptjm-15	391	2	cancer	cancer	NOUN
bptjm-15	391	3	research	research	NOUN
bptjm-15	391	4	,	,	PUNCT
bptjm-15	391	5	9(1	9(1	NUM
bptjm-15	391	6	)	)	PUNCT
bptjm-15	391	7	,	,	PUNCT
bptjm-15	391	8	104–110	104–110	NUM
bptjm-15	391	9	.	.	NOUN
bptjm-15	391	10	,	,	PUNCT
bptjm-15	391	11	doi:10.21037	doi:10.21037	NOUN
bptjm-15	391	12	/	/	SYM
bptjm-15	391	13	tcr.2019.11.19	tcr.2019.11.19	NUM
bptjm-15	391	14	.	.	PROPN
bptjm-15	392	1	29	29	NUM
bptjm-15	392	2	.	.	PUNCT
bptjm-15	393	1	gilkes	gilke	NOUN
bptjm-15	393	2	,	,	PUNCT
bptjm-15	393	3	m.d	m.d	PROPN
bptjm-15	393	4	.	.	PROPN
bptjm-15	393	5	,	,	PUNCT
bptjm-15	393	6	gregg	gregg	PROPN
bptjm-15	393	7	s.l	s.l	PROPN
bptjm-15	393	8	.	.	PROPN
bptjm-15	393	9	,	,	PUNCT
bptjm-15	393	10	and	and	CCONJ
bptjm-15	393	11	denis	denis	PROPN
bptjm-15	393	12	w.	w.	PROPN
bptjm-15	393	13	(	(	PUNCT
bptjm-15	393	14	june	june	PROPN
bptjm-15	393	15	2014	2014	NUM
bptjm-15	393	16	)	)	PUNCT
bptjm-15	393	17	.	.	PUNCT
bptjm-15	393	18	hypoxia	hypoxia	NOUN
bptjm-15	393	19	and	and	CCONJ
bptjm-15	393	20	the	the	DET
bptjm-15	393	21	extracellular	extracellular	ADJ
bptjm-15	393	22	matrix	matrix	NOUN
bptjm-15	393	23	:	:	PUNCT
bptjm-15	393	24	drivers	driver	NOUN
bptjm-15	393	25	of	of	ADP
bptjm-15	393	26	tumour	tumour	NOUN
bptjm-15	393	27	metastasis	metastasis	NOUN
bptjm-15	393	28	.	.	PUNCT
bptjm-15	394	1	nature	nature	NOUN
bptjm-15	394	2	reviews	review	VERB
bptjm-15	394	3	cancer	cancer	NOUN
bptjm-15	394	4	,	,	PUNCT
bptjm-15	394	5	14(6	14(6	NOUN
bptjm-15	394	6	)	)	PUNCT
bptjm-15	394	7	,	,	PUNCT
bptjm-15	394	8	430–39	430–39	NUM
bptjm-15	394	9	.	.	PUNCT
bptjm-15	395	1	https://doi.org/10.1038/nrc3726	https://doi.org/10.1038/nrc3726	PROPN
bptjm-15	395	2	.	.	PUNCT
bptjm-15	396	1	30	30	NUM
bptjm-15	396	2	.	.	PUNCT
bptjm-15	397	1	hamilton	hamilton	PROPN
bptjm-15	397	2	,	,	PUNCT
bptjm-15	397	3	g.	g.	PROPN
bptjm-15	397	4	,	,	PUNCT
bptjm-15	397	5	&	&	CCONJ
bptjm-15	397	6	rath	rath	PROPN
bptjm-15	397	7	,	,	PUNCT
bptjm-15	397	8	b.	b.	PROPN
bptjm-15	397	9	(	(	PUNCT
bptjm-15	397	10	2018	2018	NUM
bptjm-15	397	11	)	)	PUNCT
bptjm-15	397	12	.	.	PUNCT
bptjm-15	398	1	pharmacogenetics	pharmacogenetic	NOUN
bptjm-15	398	2	of	of	ADP
bptjm-15	398	3	platinum	platinum	NOUN
bptjm-15	398	4	-	-	PUNCT
bptjm-15	398	5	based	base	VERB
bptjm-15	398	6	chemotherapy	chemotherapy	NOUN
bptjm-15	398	7	in	in	ADP
bptjm-15	398	8	non	non	ADJ
bptjm-15	398	9	-	-	ADJ
bptjm-15	398	10	small	small	ADJ
bptjm-15	398	11	cell	cell	NOUN
bptjm-15	398	12	lung	lung	NOUN
bptjm-15	398	13	cancer	cancer	NOUN
bptjm-15	398	14	:	:	PUNCT
bptjm-15	398	15	predictive	predictive	ADJ
bptjm-15	398	16	validity	validity	NOUN
bptjm-15	398	17	of	of	ADP
bptjm-15	398	18	polymorphisms	polymorphism	NOUN
bptjm-15	398	19	of	of	ADP
bptjm-15	398	20	ercc1	ercc1	PROPN
bptjm-15	398	21	.	.	PUNCT
bptjm-15	399	1	expert	expert	ADJ
bptjm-15	399	2	opinion	opinion	NOUN
bptjm-15	399	3	on	on	ADP
bptjm-15	399	4	drug	drug	NOUN
bptjm-15	399	5	metabolism	metabolism	NOUN
bptjm-15	399	6	&	&	CCONJ
bptjm-15	399	7	toxicology	toxicology	NOUN
bptjm-15	399	8	,	,	PUNCT
bptjm-15	399	9	14(1	14(1	NUM
bptjm-15	399	10	)	)	PUNCT
bptjm-15	399	11	,	,	PUNCT
bptjm-15	399	12	17–24	17–24	NUM
bptjm-15	399	13	.	.	PUNCT
bptjm-15	400	1	https://doi.org/	https://doi.org/	NOUN
bptjm-15	400	2	10.1080/17425255.2018.1416095	10.1080/17425255.2018.1416095	NUM
bptjm-15	400	3	.	.	PUNCT
bptjm-15	401	1	31	31	NUM
bptjm-15	401	2	.	.	PUNCT
bptjm-15	402	1	hana	hana	PROPN
bptjm-15	402	2	�	�	PROPN
bptjm-15	402	3	,	,	PUNCT
bptjm-15	402	4	a.	a.	PROPN
bptjm-15	402	5	r.	r.	PROPN
bptjm-15	402	6	,	,	PUNCT
bptjm-15	402	7	jayusman	jayusman	NOUN
bptjm-15	402	8	,	,	PUNCT
bptjm-15	402	9	a.	a.	NOUN
bptjm-15	402	10	m.	m.	NOUN
bptjm-15	402	11	,	,	PUNCT
bptjm-15	402	12	alfasunu	alfasunu	ADJ
bptjm-15	402	13	,	,	PUNCT
bptjm-15	402	14	s.	s.	PROPN
bptjm-15	402	15	,	,	PUNCT
bptjm-15	402	16	sadewa	sadewa	PROPN
bptjm-15	402	17	,	,	PUNCT
bptjm-15	402	18	a.	a.	PROPN
bptjm-15	402	19	h.	h.	PROPN
bptjm-15	402	20	,	,	PUNCT
bptjm-15	402	21	pramono	pramono	PROPN
bptjm-15	402	22	,	,	PUNCT
bptjm-15	402	23	d.	d.	PROPN
bptjm-15	402	24	,	,	PUNCT
bptjm-15	402	25	heriyanto	heriyanto	PROPN
bptjm-15	402	26	,	,	PUNCT
bptjm-15	402	27	d.	d.	PROPN
bptjm-15	402	28	s.	s.	PROPN
bptjm-15	402	29	,	,	PUNCT
bptjm-15	402	30	&	&	CCONJ
bptjm-15	402	31	haryana	haryana	PROPN
bptjm-15	402	32	,	,	PUNCT
bptjm-15	402	33	s.	s.	PROPN
bptjm-15	402	34	m.	m.	PROPN
bptjm-15	402	35	(	(	PUNCT
bptjm-15	402	36	2020	2020	NUM
bptjm-15	402	37	)	)	PUNCT
bptjm-15	402	38	.	.	PUNCT
bptjm-15	403	1	serum	serum	PROPN
bptjm-15	403	2	mirna	mirna	PROPN
bptjm-15	403	3	as	as	ADP
bptjm-15	403	4	predictive	predictive	ADJ
bptjm-15	403	5	and	and	CCONJ
bptjm-15	403	6	prognosis	prognosis	NOUN
bptjm-15	403	7	biomarker	biomarker	NOUN
bptjm-15	403	8	in	in	ADP
bptjm-15	403	9	advanced	advanced	ADJ
bptjm-15	403	10	stage	stage	NOUN
bptjm-15	403	11	non	non	ADJ
bptjm-15	403	12	-	-	ADJ
bptjm-15	403	13	small	small	ADJ
bptjm-15	403	14	cell	cell	NOUN
bptjm-15	403	15	lung	lung	NOUN
bptjm-15	403	16	cancer	cancer	NOUN
bptjm-15	403	17	in	in	ADP
bptjm-15	403	18	indonesia	indonesia	PROPN
bptjm-15	403	19	.	.	PUNCT
bptjm-15	404	1	zhongguo	zhongguo	PROPN
bptjm-15	404	2	fei	fei	PROPN
bptjm-15	404	3	ai	ai	VERB
bptjm-15	404	4	za	za	PROPN
bptjm-15	404	5	zhi	zhi	PROPN
bptjm-15	405	1	=	=	PROPN
bptjm-15	406	1	chinese	chinese	PROPN
bptjm-15	406	2	journal	journal	PROPN
bptjm-15	406	3	of	of	ADP
bptjm-15	406	4	lung	lung	NOUN
bptjm-15	406	5	cancer	cancer	NOUN
bptjm-15	406	6	,	,	PUNCT
bptjm-15	406	7	23(5	23(5	NUM
bptjm-15	406	8	)	)	PUNCT
bptjm-15	406	9	,	,	PUNCT
bptjm-15	406	10	321–332	321–332	NUM
bptjm-15	406	11	.	.	PUNCT
bptjm-15	407	1	https://doi.org/10.3779/j.issn	https://doi.org/10.3779/j.issn	X
bptjm-15	407	2	.	.	PUNCT
bptjm-15	408	1	1009	1009	NUM
bptjm-15	408	2	-	-	SYM
bptjm-15	408	3	3419.2020.104.02	3419.2020.104.02	NUM
bptjm-15	408	4	32	32	NUM
bptjm-15	408	5	.	.	PUNCT
bptjm-15	409	1	hojbjerg	hojbjerg	PROPN
bptjm-15	409	2	,	,	PUNCT
bptjm-15	409	3	j.	j.	PROPN
bptjm-15	409	4	a.	a.	PROPN
bptjm-15	409	5	,	,	PUNCT
bptjm-15	409	6	ebert	ebert	PROPN
bptjm-15	409	7	,	,	PUNCT
bptjm-15	409	8	e.	e.	PROPN
bptjm-15	409	9	b.	b.	PROPN
bptjm-15	409	10	f.	f.	PROPN
bptjm-15	409	11	,	,	PUNCT
bptjm-15	409	12	clement	clement	PROPN
bptjm-15	409	13	,	,	PUNCT
bptjm-15	409	14	m.	m.	PROPN
bptjm-15	409	15	s.	s.	PROPN
bptjm-15	409	16	,	,	PUNCT
bptjm-15	409	17	winther	winther	PROPN
bptjm-15	409	18	-	-	PUNCT
bptjm-15	409	19	larsen	larsen	PROPN
bptjm-15	409	20	,	,	PUNCT
bptjm-15	409	21	a.	a.	PROPN
bptjm-15	409	22	,	,	PUNCT
bptjm-15	409	23	meldgaard	meldgaard	NOUN
bptjm-15	409	24	,	,	PUNCT
bptjm-15	409	25	p.	p.	PROPN
bptjm-15	409	26	,	,	PUNCT
bptjm-15	409	27	&	&	CCONJ
bptjm-15	409	28	sorensen	sorensen	PROPN
bptjm-15	409	29	,	,	PUNCT
bptjm-15	409	30	b.	b.	PROPN
bptjm-15	409	31	(	(	PUNCT
bptjm-15	409	32	2019	2019	NUM
bptjm-15	409	33	)	)	PUNCT
bptjm-15	409	34	.	.	PUNCT
bptjm-15	410	1	circulating	circulate	VERB
bptjm-15	410	2	mir-30b	mir-30b	NUM
bptjm-15	410	3	and	and	CCONJ
bptjm-15	410	4	mir-30c	mir-30c	NOUN
bptjm-15	410	5	predict	predict	VERB
bptjm-15	410	6	erlotinib	erlotinib	NOUN
bptjm-15	410	7	response	response	NOUN
bptjm-15	410	8	in	in	ADP
bptjm-15	410	9	egfr	egfr	NOUN
bptjm-15	410	10	-	-	PUNCT
bptjm-15	410	11	mutated	mutate	VERB
bptjm-15	410	12	non	non	ADJ
bptjm-15	410	13	-	-	ADJ
bptjm-15	410	14	small	small	ADJ
bptjm-15	410	15	cell	cell	NOUN
bptjm-15	410	16	lung	lung	NOUN
bptjm-15	410	17	cancer	cancer	NOUN
bptjm-15	410	18	patients	patient	NOUN
bptjm-15	410	19	.	.	PUNCT
bptjm-15	411	1	lung	lung	NOUN
bptjm-15	411	2	cancer	cancer	NOUN
bptjm-15	411	3	,	,	PUNCT
bptjm-15	411	4	135	135	NUM
bptjm-15	411	5	,	,	PUNCT
bptjm-15	411	6	92–96	92–96	NUM
bptjm-15	411	7	.	.	PUNCT
bptjm-15	412	1	https://	https://	PROPN
bptjm-15	412	2	doi.org/10.1016/j.lungcan.2019.07.005	doi.org/10.1016/j.lungcan.2019.07.005	VERB
bptjm-15	412	3	33	33	NUM
bptjm-15	412	4	.	.	PUNCT
bptjm-15	413	1	howlader	howlader	PROPN
bptjm-15	413	2	,	,	PUNCT
bptjm-15	413	3	n.	n.	NOUN
bptjm-15	413	4	,	,	PUNCT
bptjm-15	413	5	noone	noone	NOUN
bptjm-15	413	6	,	,	PUNCT
bptjm-15	413	7	a.m.	a.m.	ADV
bptjm-15	413	8	,	,	PUNCT
bptjm-15	413	9	krapcho	krapcho	NOUN
bptjm-15	413	10	,	,	PUNCT
bptjm-15	413	11	m.	m.	NOUN
bptjm-15	413	12	,	,	PUNCT
bptjm-15	413	13	mille	mille	PROPN
bptjm-15	413	14	,	,	PUNCT
bptjm-15	413	15	r	r	PROPN
bptjm-15	413	16	d.	d.	PROPN
bptjm-15	413	17	,	,	PUNCT
bptjm-15	413	18	bresi	bresi	PROPN
bptjm-15	413	19	,	,	PUNCT
bptjm-15	413	20	a.	a.	PROPN
bptjm-15	413	21	,	,	PUNCT
bptjm-15	413	22	yu	yu	PROPN
bptjm-15	413	23	,	,	PUNCT
bptjm-15	413	24	m.	m.	NOUN
bptjm-15	413	25	,	,	PUNCT
bptjm-15	413	26	ruhl	ruhl	PROPN
bptjm-15	413	27	,	,	PUNCT
bptjm-15	413	28	j.	j.	PROPN
bptjm-15	413	29	,	,	PUNCT
bptjm-15	413	30	tatalovich	tatalovich	PROPN
bptjm-15	413	31	,	,	PUNCT
bptjm-15	413	32	z.	z.	PROPN
bptjm-15	413	33	,	,	PUNCT
bptjm-15	413	34	mariotto	mariotto	NOUN
bptjm-15	413	35	,	,	PUNCT
bptjm-15	413	36	a.	a.	NOUN
bptjm-15	413	37	,	,	PUNCT
bptjm-15	413	38	lewis	lewis	PROPN
bptjm-15	413	39	,	,	PUNCT
bptjm-15	413	40	d.r	d.r	PROPN
bptjm-15	413	41	.	.	PROPN
bptjm-15	413	42	,	,	PUNCT
bptjm-15	413	43	chen	chen	PROPN
bptjm-15	413	44	,	,	PUNCT
bptjm-15	413	45	h.s	h.s	PROPN
bptjm-15	413	46	.	.	PROPN
bptjm-15	413	47	,	,	PUNCT
bptjm-15	413	48	feuer	feuer	PROPN
bptjm-15	413	49	,	,	PUNCT
bptjm-15	413	50	e.j	e.j	PROPN
bptjm-15	413	51	.	.	PROPN
bptjm-15	413	52	,	,	PUNCT
bptjm-15	413	53	cronin	cronin	PROPN
bptjm-15	413	54	,	,	PUNCT
bptjm-15	413	55	k.a	k.a	PROPN
bptjm-15	413	56	.	.	PROPN
bptjm-15	413	57	(	(	PUNCT
bptjm-15	413	58	eds	ed	NOUN
bptjm-15	413	59	)	)	PUNCT
bptjm-15	413	60	.	.	PUNCT
bptjm-15	414	1	(	(	PUNCT
bptjm-15	414	2	2017	2017	NUM
bptjm-15	414	3	)	)	PUNCT
bptjm-15	414	4	.	.	PUNCT
bptjm-15	415	1	seer	seer	PROPN
bptjm-15	415	2	cancer	cancer	PROPN
bptjm-15	415	3	statistics	statistics	PROPN
bptjm-15	415	4	review	review	PROPN
bptjm-15	415	5	,	,	PUNCT
bptjm-15	415	6	1975	1975	NUM
bptjm-15	415	7	-	-	SYM
bptjm-15	415	8	2018	2018	NUM
bptjm-15	415	9	,	,	PUNCT
bptjm-15	415	10	national	national	PROPN
bptjm-15	415	11	cancer	cancer	PROPN
bptjm-15	415	12	institute	institute	PROPN
bptjm-15	415	13	.	.	PUNCT
bptjm-15	416	1	bethesda	bethesda	PROPN
bptjm-15	416	2	,	,	PUNCT
bptjm-15	416	3	md	md	PROPN
bptjm-15	416	4	,	,	PUNCT
bptjm-15	416	5	http://seer.cancer.gov/csr/	http://seer.cancer.gov/csr/	PROPN
bptjm-15	416	6	1975_2017	1975_2017	NUM
bptjm-15	416	7	,	,	PUNCT
bptjm-15	416	8	based	base	VERB
bptjm-15	416	9	on	on	ADP
bptjm-15	416	10	november	november	PROPN
bptjm-15	416	11	2019	2019	NUM
bptjm-15	416	12	seer	seer	NOUN
bptjm-15	416	13	data	datum	NOUN
bptjm-15	416	14	submission	submission	PROPN
bptjm-15	416	15	,	,	PUNCT
bptjm-15	416	16	posted	post	VERB
bptjm-15	416	17	to	to	ADP
bptjm-15	416	18	the	the	DET
bptjm-15	416	19	seer	seer	NOUN
bptjm-15	416	20	website	website	NOUN
bptjm-15	416	21	,	,	PUNCT
bptjm-15	416	22	april	april	PROPN
bptjm-15	416	23	2020	2020	NUM
bptjm-15	416	24	.	.	PUNCT
bptjm-15	417	1	34	34	NUM
bptjm-15	417	2	.	.	PUNCT
bptjm-15	417	3	hu	hu	PROPN
bptjm-15	417	4	,	,	PUNCT
bptjm-15	417	5	x.	x.	PROPN
bptjm-15	417	6	,	,	PUNCT
bptjm-15	417	7	dongyong	dongyong	PROPN
bptjm-15	417	8	,	,	PUNCT
bptjm-15	417	9	y.	y.	PROPN
bptjm-15	417	10	,	,	PUNCT
bptjm-15	417	11	yalun	yalun	NOUN
bptjm-15	417	12	,	,	PUNCT
bptjm-15	417	13	l.	l.	PROPN
bptjm-15	417	14	,	,	PUNCT
bptjm-15	417	15	li	li	PROPN
bptjm-15	417	16	,	,	PUNCT
bptjm-15	417	17	l.	l.	PROPN
bptjm-15	417	18	,	,	PUNCT
bptjm-15	417	19	yan	yan	PROPN
bptjm-15	417	20	,	,	PUNCT
bptjm-15	417	21	w.	w.	PROPN
bptjm-15	417	22	,	,	PUNCT
bptjm-15	417	23	peng	peng	PROPN
bptjm-15	417	24	,	,	PUNCT
bptjm-15	417	25	c.	c.	PROPN
bptjm-15	417	26	,	,	PUNCT
bptjm-15	417	27	song	song	NOUN
bptjm-15	417	28	,	,	PUNCT
bptjm-15	417	29	x.	x.	PROPN
bptjm-15	417	30	,	,	PUNCT
bptjm-15	417	31	et	et	PROPN
bptjm-15	417	32	al	al	PROPN
bptjm-15	417	33	.	.	PUNCT
bptjm-15	418	1	(	(	PUNCT
bptjm-15	418	2	august	august	PROPN
bptjm-15	418	3	2019	2019	NUM
bptjm-15	418	4	)	)	PUNCT
bptjm-15	418	5	.	.	PUNCT
bptjm-15	419	1	prevalence	prevalence	NOUN
bptjm-15	419	2	and	and	CCONJ
bptjm-15	419	3	clinical	clinical	ADJ
bptjm-15	419	4	signi	signi	PROPN
bptjm-15	419	5	�	�	PROPN
bptjm-15	419	6	cance	cance	NOUN
bptjm-15	419	7	of	of	ADP
bptjm-15	419	8	pathogenic	pathogenic	ADJ
bptjm-15	419	9	germline	germline	NOUN
bptjm-15	419	10	brca1/2	brca1/2	ADJ
bptjm-15	419	11	mutations	mutation	NOUN
bptjm-15	419	12	in	in	ADP
bptjm-15	419	13	chinese	chinese	ADJ
bptjm-15	419	14	non	non	ADJ
bptjm-15	419	15	-	-	ADJ
bptjm-15	419	16	small	small	ADJ
bptjm-15	419	17	cell	cell	NOUN
bptjm-15	419	18	lung	lung	NOUN
bptjm-15	419	19	cancer	cancer	NOUN
bptjm-15	419	20	patients	patient	NOUN
bptjm-15	419	21	.	.	PUNCT
bptjm-15	420	1	cancer	cancer	NOUN
bptjm-15	420	2	biology	biology	NOUN
bptjm-15	420	3	&	&	CCONJ
bptjm-15	420	4	medicine	medicine	PROPN
bptjm-15	420	5	16(3	16(3	PROPN
bptjm-15	420	6	)	)	PUNCT
bptjm-15	420	7	:	:	PUNCT
bptjm-15	421	1	556–64	556–64	NUM
bptjm-15	421	2	.	.	PUNCT
bptjm-15	421	3	https://doi.org/10.20892/j.issn.2095-3941.2018.0506	https://doi.org/10.20892/j.issn.2095-3941.2018.0506	PROPN
bptjm-15	421	4	.	.	PROPN
bptjm-15	421	5	35	35	NUM
bptjm-15	421	6	.	.	PUNCT
bptjm-15	421	7	hu	hu	PROPN
bptjm-15	421	8	,	,	PUNCT
bptjm-15	421	9	z.	z.	PROPN
bptjm-15	421	10	,	,	PUNCT
bptjm-15	421	11	chen	chen	PROPN
bptjm-15	421	12	,	,	PUNCT
bptjm-15	421	13	x.	x.	PROPN
bptjm-15	421	14	,	,	PUNCT
bptjm-15	421	15	zhao	zhao	PROPN
bptjm-15	421	16	,	,	PUNCT
bptjm-15	421	17	y.	y.	PROPN
bptjm-15	421	18	,	,	PUNCT
bptjm-15	421	19	tian	tian	ADJ
bptjm-15	421	20	,	,	PUNCT
bptjm-15	421	21	t.	t.	PROPN
bptjm-15	421	22	,	,	PUNCT
bptjm-15	421	23	jin	jin	PROPN
bptjm-15	421	24	,	,	PUNCT
bptjm-15	421	25	g.	g.	PROPN
bptjm-15	421	26	,	,	PUNCT
bptjm-15	421	27	shu	shu	PROPN
bptjm-15	421	28	,	,	PUNCT
bptjm-15	421	29	y.	y.	PROPN
bptjm-15	421	30	,	,	PUNCT
bptjm-15	421	31	berkeley	berkeley	PROPN
bptjm-15	421	32	pharma	pharma	PROPN
bptjm-15	421	33	tech	tech	NOUN
bptjm-15	421	34	journal	journal	NOUN
bptjm-15	421	35	of	of	ADP
bptjm-15	421	36	medicine	medicine	NOUN
bptjm-15	421	37	|	|	ADV
bptjm-15	421	38	87	87	NUM
bptjm-15	421	39	https://doi.org/10.1038/nrc3726	https://doi.org/10.1038/nrc3726	NOUN
bptjm-15	421	40	https://doi.org/	https://doi.org/	AUX
bptjm-15	421	41	http://seer.cancer.gov/csr/	http://seer.cancer.gov/csr/	PROPN
bptjm-15	421	42	http://seer.cancer.gov/csr/	http://seer.cancer.gov/csr/	PROPN
bptjm-15	421	43	chen	chen	PROPN
bptjm-15	421	44	,	,	PUNCT
bptjm-15	421	45	y.	y.	PROPN
bptjm-15	421	46	,	,	PUNCT
bptjm-15	421	47	xu	xu	PROPN
bptjm-15	421	48	,	,	PUNCT
bptjm-15	421	49	l.	l.	PROPN
bptjm-15	421	50	,	,	PUNCT
bptjm-15	421	51	zen	zen	PROPN
bptjm-15	421	52	,	,	PUNCT
bptjm-15	421	53	k.	k.	PROPN
bptjm-15	421	54	,	,	PUNCT
bptjm-15	421	55	zhang	zhang	PROPN
bptjm-15	421	56	,	,	PUNCT
bptjm-15	421	57	c.	c.	PROPN
bptjm-15	421	58	,	,	PUNCT
bptjm-15	421	59	shen	shen	PROPN
bptjm-15	421	60	,	,	PUNCT
bptjm-15	421	61	h.	h.	PROPN
bptjm-15	421	62	(	(	PUNCT
bptjm-15	421	63	april	april	PROPN
bptjm-15	421	64	1	1	NUM
bptjm-15	421	65	,	,	PUNCT
bptjm-15	421	66	2010	2010	NUM
bptjm-15	421	67	)	)	PUNCT
bptjm-15	421	68	.	.	PUNCT
bptjm-15	422	1	serum	serum	PROPN
bptjm-15	422	2	microrna	microrna	PROPN
bptjm-15	422	3	signatures	signatures	PROPN
bptjm-15	422	4	identi	identi	PROPN
bptjm-15	422	5	�	�	PROPN
bptjm-15	422	6	ed	ed	NOUN
bptjm-15	422	7	in	in	ADP
bptjm-15	422	8	a	a	DET
bptjm-15	422	9	genome	genome	NOUN
bptjm-15	422	10	-	-	PUNCT
bptjm-15	422	11	wide	wide	ADJ
bptjm-15	422	12	serum	serum	NOUN
bptjm-15	422	13	microrna	microrna	PROPN
bptjm-15	422	14	expression	expression	NOUN
bptjm-15	422	15	pro	pro	X
bptjm-15	422	16	�	�	PROPN
bptjm-15	422	17	ling	ling	NOUN
bptjm-15	422	18	predict	predict	VERB
bptjm-15	422	19	survival	survival	NOUN
bptjm-15	422	20	of	of	ADP
bptjm-15	422	21	non	non	ADJ
bptjm-15	422	22	-	-	ADJ
bptjm-15	422	23	small	small	ADJ
bptjm-15	422	24	-	-	PUNCT
bptjm-15	422	25	cell	cell	NOUN
bptjm-15	422	26	lung	lung	NOUN
bptjm-15	422	27	cancer	cancer	NOUN
bptjm-15	422	28	.	.	PUNCT
bptjm-15	423	1	journal	journal	NOUN
bptjm-15	423	2	of	of	ADP
bptjm-15	423	3	clinical	clinical	ADJ
bptjm-15	423	4	oncology	oncology	NOUN
bptjm-15	423	5	,	,	PUNCT
bptjm-15	423	6	28(10	28(10	NUM
bptjm-15	423	7	)	)	PUNCT
bptjm-15	423	8	,	,	PUNCT
bptjm-15	423	9	1721	1721	NUM
bptjm-15	423	10	-	-	SYM
bptjm-15	423	11	1726	1726	NUM
bptjm-15	423	12	.	.	PUNCT
bptjm-15	424	1	doi:10.1200	doi:10.1200	PROPN
bptjm-15	424	2	/	/	SYM
bptjm-15	424	3	jco.2009.24.9342	jco.2009.24.9342	PROPN
bptjm-15	424	4	.	.	PUNCT
bptjm-15	425	1	epub	epub	PROPN
bptjm-15	425	2	2010	2010	NUM
bptjm-15	425	3	mar	mar	PROPN
bptjm-15	425	4	1	1	NUM
bptjm-15	425	5	.	.	PUNCT
bptjm-15	426	1	pmid	pmid	NOUN
bptjm-15	426	2	:	:	PUNCT
bptjm-15	426	3	20194856	20194856	NUM
bptjm-15	426	4	.	.	PUNCT
bptjm-15	427	1	36	36	NUM
bptjm-15	427	2	.	.	PUNCT
bptjm-15	428	1	jeong	jeong	PROPN
bptjm-15	428	2	,	,	PUNCT
bptjm-15	428	3	e.	e.	PROPN
bptjm-15	428	4	h.	h.	PROPN
bptjm-15	428	5	,	,	PUNCT
bptjm-15	428	6	lee	lee	PROPN
bptjm-15	428	7	,	,	PUNCT
bptjm-15	428	8	t.	t.	PROPN
bptjm-15	428	9	g.	g.	PROPN
bptjm-15	428	10	,	,	PUNCT
bptjm-15	428	11	ko	ko	PROPN
bptjm-15	428	12	,	,	PUNCT
bptjm-15	428	13	y.	y.	PROPN
bptjm-15	428	14	j.	j.	PROPN
bptjm-15	428	15	,	,	PUNCT
bptjm-15	428	16	kim	kim	PROPN
bptjm-15	428	17	,	,	PUNCT
bptjm-15	428	18	s.	s.	PROPN
bptjm-15	428	19	y.	y.	PROPN
bptjm-15	428	20	,	,	PUNCT
bptjm-15	428	21	kim	kim	PROPN
bptjm-15	428	22	,	,	PUNCT
bptjm-15	428	23	h.	h.	PROPN
bptjm-15	428	24	r.	r.	PROPN
bptjm-15	428	25	,	,	PUNCT
bptjm-15	428	26	kim	kim	PROPN
bptjm-15	428	27	,	,	PUNCT
bptjm-15	428	28	h.	h.	PROPN
bptjm-15	428	29	,	,	PUNCT
bptjm-15	428	30	&	&	CCONJ
bptjm-15	428	31	kim	kim	PROPN
bptjm-15	428	32	,	,	PUNCT
bptjm-15	428	33	c.	c.	PROPN
bptjm-15	428	34	h.	h.	PROPN
bptjm-15	428	35	(	(	PUNCT
bptjm-15	428	36	2018	2018	NUM
bptjm-15	428	37	)	)	PUNCT
bptjm-15	428	38	.	.	PUNCT
bptjm-15	429	1	anti	anti	ADJ
bptjm-15	429	2	-	-	ADJ
bptjm-15	429	3	tumor	tumor	ADJ
bptjm-15	429	4	e	e	NOUN
bptjm-15	429	5	�	�	NOUN
bptjm-15	429	6	ect	ect	VERB
bptjm-15	429	7	of	of	ADP
bptjm-15	429	8	cdk	cdk	NOUN
bptjm-15	429	9	inhibitors	inhibitor	NOUN
bptjm-15	429	10	on	on	ADP
bptjm-15	429	11	cdkn2a	cdkn2a	ADJ
bptjm-15	429	12	-	-	PUNCT
bptjm-15	429	13	defective	defective	ADJ
bptjm-15	429	14	squamous	squamous	ADJ
bptjm-15	429	15	cell	cell	NOUN
bptjm-15	429	16	lung	lung	NOUN
bptjm-15	429	17	cancer	cancer	NOUN
bptjm-15	429	18	cells	cell	NOUN
bptjm-15	429	19	.	.	PUNCT
bptjm-15	430	1	cellular	cellular	ADJ
bptjm-15	430	2	oncology	oncology	NOUN
bptjm-15	430	3	(	(	PUNCT
bptjm-15	430	4	dordrecht	dordrecht	PROPN
bptjm-15	430	5	)	)	PUNCT
bptjm-15	430	6	,	,	PUNCT
bptjm-15	430	7	41(6	41(6	NOUN
bptjm-15	430	8	)	)	PUNCT
bptjm-15	430	9	,	,	PUNCT
bptjm-15	430	10	663–675	663–675	NUM
bptjm-15	430	11	.	.	PUNCT
bptjm-15	430	12	https://doi.org/10.1007/s13402-018-0404-6	https://doi.org/10.1007/s13402-018-0404-6	PROPN
bptjm-15	430	13	37	37	NUM
bptjm-15	430	14	.	.	PUNCT
bptjm-15	431	1	ji	ji	PROPN
bptjm-15	431	2	,	,	PUNCT
bptjm-15	431	3	w.	w.	PROPN
bptjm-15	431	4	,	,	PUNCT
bptjm-15	431	5	xiang	xiang	PROPN
bptjm-15	431	6	,	,	PUNCT
bptjm-15	431	7	w.	w.	PROPN
bptjm-15	431	8	,	,	PUNCT
bptjm-15	431	9	danhua	danhua	PROPN
bptjm-15	431	10	,	,	PUNCT
bptjm-15	431	11	x.	x.	NOUN
bptjm-15	431	12	,	,	PUNCT
bptjm-15	431	13	shufan	shufan	PROPN
bptjm-15	431	14	,	,	PUNCT
bptjm-15	431	15	c.	c.	PROPN
bptjm-15	431	16	,	,	PUNCT
bptjm-15	431	17	honggang	honggang	PROPN
bptjm-15	431	18	,	,	PUNCT
bptjm-15	431	19	l.	l.	PROPN
bptjm-15	431	20	,	,	PUNCT
bptjm-15	431	21	and	and	CCONJ
bptjm-15	431	22	ling	ling	PROPN
bptjm-15	431	23	,	,	PUNCT
bptjm-15	431	24	d.	d.	PROPN
bptjm-15	431	25	(	(	PUNCT
bptjm-15	431	26	january	january	PROPN
bptjm-15	431	27	29	29	NUM
bptjm-15	431	28	,	,	PUNCT
bptjm-15	431	29	2020	2020	NUM
bptjm-15	431	30	)	)	PUNCT
bptjm-15	431	31	.	.	PUNCT
bptjm-15	432	1	non	non	ADJ
bptjm-15	432	2	-	-	ADJ
bptjm-15	432	3	small	small	ADJ
bptjm-15	432	4	cell	cell	NOUN
bptjm-15	432	5	lung	lung	NOUN
bptjm-15	432	6	cancer	cancer	NOUN
bptjm-15	432	7	cells	cell	NOUN
bptjm-15	432	8	with	with	ADP
bptjm-15	432	9	de	de	PROPN
bptjm-15	432	10	�	�	NOUN
bptjm-15	432	11	ciencies	ciencie	NOUN
bptjm-15	432	12	in	in	ADP
bptjm-15	432	13	homologous	homologous	ADJ
bptjm-15	432	14	recombination	recombination	NOUN
bptjm-15	432	15	genes	gene	NOUN
bptjm-15	432	16	are	be	AUX
bptjm-15	432	17	sensitive	sensitive	ADJ
bptjm-15	432	18	to	to	ADP
bptjm-15	432	19	parp	parp	ADJ
bptjm-15	432	20	inhibitors	inhibitor	NOUN
bptjm-15	432	21	.	.	PUNCT
bptjm-15	433	1	biochemical	biochemical	ADJ
bptjm-15	433	2	and	and	CCONJ
bptjm-15	433	3	biophysical	biophysical	ADJ
bptjm-15	433	4	research	research	NOUN
bptjm-15	433	5	communications	communication	NOUN
bptjm-15	433	6	,	,	PUNCT
bptjm-15	433	7	522(1	522(1	NUM
bptjm-15	433	8	)	)	PUNCT
bptjm-15	433	9	,	,	PUNCT
bptjm-15	433	10	:	:	PUNCT
bptjm-15	434	1	121–26	121–26	NUM
bptjm-15	434	2	.	.	PUNCT
bptjm-15	435	1	https://doi.org/10.1016/j.bbrc	https://doi.org/10.1016/j.bbrc	NOUN
bptjm-15	435	2	.	.	NOUN
bptjm-15	436	1	2019.11.050	2019.11.050	NUM
bptjm-15	436	2	.	.	PUNCT
bptjm-15	437	1	38	38	NUM
bptjm-15	437	2	.	.	PUNCT
bptjm-15	438	1	jiang	jiang	PROPN
bptjm-15	438	2	,	,	PUNCT
bptjm-15	438	3	m.	m.	NOUN
bptjm-15	438	4	,	,	PUNCT
bptjm-15	438	5	li	li	PROPN
bptjm-15	438	6	,	,	PUNCT
bptjm-15	438	7	x.	x.	PROPN
bptjm-15	438	8	,	,	PUNCT
bptjm-15	438	9	quan	quan	PROPN
bptjm-15	438	10	,	,	PUNCT
bptjm-15	438	11	x.	x.	PROPN
bptjm-15	438	12	,	,	PUNCT
bptjm-15	438	13	et	et	PROPN
bptjm-15	438	14	al	al	PROPN
bptjm-15	438	15	.	.	PUNCT
bptjm-15	438	16	(	(	PUNCT
bptjm-15	438	17	2018	2018	NUM
bptjm-15	438	18	)	)	PUNCT
bptjm-15	438	19	.	.	PUNCT
bptjm-15	439	1	mir-486	mir-486	PROPN
bptjm-15	439	2	as	as	ADP
bptjm-15	439	3	an	an	DET
bptjm-15	439	4	e	e	NOUN
bptjm-15	439	5	�	�	NOUN
bptjm-15	439	6	ective	ective	ADJ
bptjm-15	439	7	biomarker	biomarker	NOUN
bptjm-15	439	8	in	in	ADP
bptjm-15	439	9	cancer	cancer	NOUN
bptjm-15	439	10	diagnosis	diagnosis	NOUN
bptjm-15	439	11	and	and	CCONJ
bptjm-15	439	12	prognosis	prognosis	NOUN
bptjm-15	439	13	:	:	PUNCT
bptjm-15	439	14	a	a	DET
bptjm-15	439	15	systematic	systematic	ADJ
bptjm-15	439	16	review	review	NOUN
bptjm-15	439	17	and	and	CCONJ
bptjm-15	439	18	meta	meta	ADJ
bptjm-15	439	19	-	-	PUNCT
bptjm-15	439	20	analysis	analysis	NOUN
bptjm-15	439	21	.	.	PUNCT
bptjm-15	440	1	oncotarget	oncotarget	NOUN
bptjm-15	440	2	,	,	PUNCT
bptjm-15	440	3	9(17	9(17	NUM
bptjm-15	440	4	)	)	PUNCT
bptjm-15	440	5	,	,	PUNCT
bptjm-15	440	6	13948	13948	NUM
bptjm-15	440	7	-	-	SYM
bptjm-15	440	8	13958	13958	NUM
bptjm-15	440	9	.	.	PUNCT
bptjm-15	441	1	published	publish	VERB
bptjm-15	441	2	2018	2018	NUM
bptjm-15	441	3	jan	jan	PROPN
bptjm-15	441	4	12	12	NUM
bptjm-15	441	5	.	.	PUNCT
bptjm-15	442	1	doi:10.18632	doi:10.18632	PROPN
bptjm-15	442	2	/	/	SYM
bptjm-15	442	3	oncotarget.24189	oncotarget.24189	PROPN
bptjm-15	442	4	39	39	NUM
bptjm-15	442	5	.	.	PUNCT
bptjm-15	443	1	joerger	joerger	NOUN
bptjm-15	443	2	,	,	PUNCT
bptjm-15	443	3	m.	m.	NOUN
bptjm-15	443	4	,	,	PUNCT
bptjm-15	443	5	d.	d.	PROPN
bptjm-15	443	6	dejong	dejong	PROPN
bptjm-15	443	7	,	,	PUNCT
bptjm-15	443	8	a.	a.	NOUN
bptjm-15	443	9	burylo	burylo	PROPN
bptjm-15	443	10	,	,	PUNCT
bptjm-15	443	11	j.	j.	PROPN
bptjm-15	443	12	a.	a.	PROPN
bptjm-15	443	13	burgers	burgers	PROPN
bptjm-15	443	14	,	,	PUNCT
bptjm-15	443	15	p.	p.	NOUN
bptjm-15	443	16	baas	baas	NOUN
bptjm-15	443	17	,	,	PUNCT
bptjm-15	443	18	a.	a.	PROPN
bptjm-15	443	19	d.	d.	PROPN
bptjm-15	443	20	r.	r.	PROPN
bptjm-15	443	21	huitema	huitema	PROPN
bptjm-15	443	22	,	,	PUNCT
bptjm-15	443	23	j.	j.	PROPN
bptjm-15	443	24	h.	h.	PROPN
bptjm-15	443	25	beijnen	beijnen	PROPN
bptjm-15	443	26	,	,	PUNCT
bptjm-15	443	27	and	and	CCONJ
bptjm-15	443	28	j.	j.	PROPN
bptjm-15	443	29	h.	h.	PROPN
bptjm-15	443	30	m.	m.	PROPN
bptjm-15	443	31	schellens	schellen	VERB
bptjm-15	443	32	.	.	PUNCT
bptjm-15	444	1	(	(	PUNCT
bptjm-15	444	2	november	november	PROPN
bptjm-15	444	3	1	1	NUM
bptjm-15	444	4	,	,	PUNCT
bptjm-15	444	5	2011	2011	NUM
bptjm-15	444	6	)	)	PUNCT
bptjm-15	444	7	.	.	PUNCT
bptjm-15	445	1	tubuline	tubuline	PROPN
bptjm-15	445	2	,	,	PUNCT
bptjm-15	445	3	brca1	brca1	PROPN
bptjm-15	445	4	,	,	PUNCT
bptjm-15	445	5	ercc1	ercc1	PROPN
bptjm-15	445	6	,	,	PUNCT
bptjm-15	445	7	abraxas	abraxas	PROPN
bptjm-15	445	8	,	,	PUNCT
bptjm-15	445	9	rap80	rap80	NOUN
bptjm-15	445	10	mrna	mrna	PROPN
bptjm-15	445	11	expression	expression	NOUN
bptjm-15	445	12	,	,	PUNCT
bptjm-15	445	13	p53	p53	NOUN
bptjm-15	445	14	/	/	SYM
bptjm-15	445	15	p21	p21	NOUN
bptjm-15	445	16	immunohistochemistry	immunohistochemistry	NOUN
bptjm-15	445	17	and	and	CCONJ
bptjm-15	445	18	clinical	clinical	ADJ
bptjm-15	445	19	outcome	outcome	NOUN
bptjm-15	445	20	in	in	ADP
bptjm-15	445	21	patients	patient	NOUN
bptjm-15	445	22	with	with	ADP
bptjm-15	445	23	advanced	advanced	ADJ
bptjm-15	445	24	non	non	ADJ
bptjm-15	445	25	small	small	ADJ
bptjm-15	445	26	-	-	PUNCT
bptjm-15	445	27	cell	cell	NOUN
bptjm-15	445	28	lung	lung	NOUN
bptjm-15	445	29	cancer	cancer	NOUN
bptjm-15	445	30	receiving	receive	VERB
bptjm-15	445	31	first	first	ADJ
bptjm-15	445	32	-	-	PUNCT
bptjm-15	445	33	line	line	NOUN
bptjm-15	445	34	platinum	platinum	NOUN
bptjm-15	445	35	–	–	PUNCT
bptjm-15	445	36	gemcitabine	gemcitabine	NOUN
bptjm-15	445	37	chemotherapy	chemotherapy	NOUN
bptjm-15	445	38	.	.	PUNCT
bptjm-15	446	1	lung	lung	NOUN
bptjm-15	446	2	cancer	cancer	NOUN
bptjm-15	446	3	,	,	PUNCT
bptjm-15	446	4	74(2	74(2	NUM
bptjm-15	446	5	)	)	PUNCT
bptjm-15	446	6	,	,	PUNCT
bptjm-15	446	7	310–17	310–17	NUM
bptjm-15	446	8	.	.	PUNCT
bptjm-15	447	1	https://doi.org/	https://doi.org/	VERB
bptjm-15	447	2	10.1016	10.1016	NUM
bptjm-15	447	3	/	/	SYM
bptjm-15	447	4	j.lungcan.2011.03.016	j.lungcan.2011.03.016	PROPN
bptjm-15	447	5	.	.	PROPN
bptjm-15	448	1	40	40	NUM
bptjm-15	448	2	.	.	PUNCT
bptjm-15	449	1	kato	kato	PROPN
bptjm-15	449	2	,	,	PUNCT
bptjm-15	449	3	shumei	shumei	PROPN
bptjm-15	449	4	,	,	PUNCT
bptjm-15	449	5	vivek	vivek	PROPN
bptjm-15	449	6	subbiah	subbiah	PROPN
bptjm-15	449	7	,	,	PUNCT
bptjm-15	449	8	erica	erica	PROPN
bptjm-15	449	9	marchlik	marchlik	PROPN
bptjm-15	449	10	,	,	PUNCT
bptjm-15	449	11	sheryl	sheryl	PROPN
bptjm-15	449	12	k.	k.	PROPN
bptjm-15	449	13	elkin	elkin	PROPN
bptjm-15	449	14	,	,	PUNCT
bptjm-15	449	15	jennifer	jennifer	PROPN
bptjm-15	449	16	l.	l.	PROPN
bptjm-15	449	17	carter	carter	PROPN
bptjm-15	449	18	,	,	PUNCT
bptjm-15	449	19	and	and	CCONJ
bptjm-15	449	20	razelle	razelle	NOUN
bptjm-15	449	21	kurzrock	kurzrock	NOUN
bptjm-15	449	22	.	.	PUNCT
bptjm-15	450	1	(	(	PUNCT
bptjm-15	450	2	april	april	PROPN
bptjm-15	450	3	15	15	NUM
bptjm-15	450	4	,	,	PUNCT
bptjm-15	450	5	2017	2017	NUM
bptjm-15	450	6	)	)	PUNCT
bptjm-15	450	7	.	.	PUNCT
bptjm-15	451	1	ret	ret	NOUN
bptjm-15	451	2	aberrations	aberration	NOUN
bptjm-15	451	3	in	in	ADP
bptjm-15	451	4	diverse	diverse	ADJ
bptjm-15	451	5	cancers	cancer	NOUN
bptjm-15	451	6	:	:	PUNCT
bptjm-15	451	7	next	next	ADJ
bptjm-15	451	8	-	-	PUNCT
bptjm-15	451	9	generation	generation	NOUN
bptjm-15	451	10	sequencing	sequencing	NOUN
bptjm-15	451	11	of	of	ADP
bptjm-15	451	12	4,871	4,871	NUM
bptjm-15	451	13	patients	patient	NOUN
bptjm-15	451	14	.	.	PUNCT
bptjm-15	452	1	clinical	clinical	ADJ
bptjm-15	452	2	cancer	cancer	NOUN
bptjm-15	452	3	research	research	NOUN
bptjm-15	452	4	,	,	PUNCT
bptjm-15	452	5	23(8	23(8	NOUN
bptjm-15	452	6	)	)	PUNCT
bptjm-15	452	7	,	,	PUNCT
bptjm-15	452	8	1988–97	1988–97	NUM
bptjm-15	452	9	.	.	PUNCT
bptjm-15	453	1	https://	https://	PROPN
bptjm-15	453	2	doi.org/10.1158/1078-0432.ccr-16-1679	doi.org/10.1158/1078-0432.ccr-16-1679	PROPN
bptjm-15	453	3	.	.	PUNCT
bptjm-15	454	1	41	41	NUM
bptjm-15	454	2	.	.	PUNCT
bptjm-15	455	1	kwak	kwak	PROPN
bptjm-15	455	2	,	,	PUNCT
bptjm-15	455	3	p.	p.	PROPN
bptjm-15	455	4	b.	b.	PROPN
bptjm-15	455	5	,	,	PUNCT
bptjm-15	455	6	iwasaki	iwasaki	PROPN
bptjm-15	455	7	,	,	PUNCT
bptjm-15	455	8	s.	s.	PROPN
bptjm-15	455	9	,	,	PUNCT
bptjm-15	455	10	&	&	CCONJ
bptjm-15	455	11	tomari	tomari	NOUN
bptjm-15	455	12	,	,	PUNCT
bptjm-15	455	13	y.	y.	PROPN
bptjm-15	455	14	(	(	PUNCT
bptjm-15	455	15	2010	2010	NUM
bptjm-15	455	16	)	)	PUNCT
bptjm-15	455	17	.	.	PUNCT
bptjm-15	456	1	the	the	DET
bptjm-15	456	2	microrna	microrna	PROPN
bptjm-15	456	3	pathway	pathway	NOUN
bptjm-15	456	4	and	and	CCONJ
bptjm-15	456	5	cancer	cancer	NOUN
bptjm-15	456	6	.	.	PUNCT
bptjm-15	457	1	cancer	cancer	NOUN
bptjm-15	457	2	science	science	NOUN
bptjm-15	457	3	,	,	PUNCT
bptjm-15	457	4	101(11	101(11	NUM
bptjm-15	457	5	)	)	PUNCT
bptjm-15	457	6	,	,	PUNCT
bptjm-15	457	7	2309–2315	2309–2315	NUM
bptjm-15	457	8	.	.	PUNCT
bptjm-15	458	1	https://doi.org/10.1111/j.1349-7006.2010.01683.x	https://doi.org/10.1111/j.1349-7006.2010.01683.x	NOUN
bptjm-15	458	2	42	42	NUM
bptjm-15	458	3	.	.	PUNCT
bptjm-15	459	1	kim	kim	PROPN
bptjm-15	459	2	,	,	PUNCT
bptjm-15	459	3	nayoung	nayoung	PROPN
bptjm-15	459	4	,	,	PUNCT
bptjm-15	459	5	mee	mee	PROPN
bptjm-15	459	6	song	song	NOUN
bptjm-15	459	7	,	,	PUNCT
bptjm-15	459	8	somin	somin	VERB
bptjm-15	459	9	kim	kim	PROPN
bptjm-15	459	10	,	,	PUNCT
bptjm-15	459	11	yujeong	yujeong	ADJ
bptjm-15	459	12	seo	seo	PROPN
bptjm-15	459	13	,	,	PUNCT
bptjm-15	459	14	yonghwan	yonghwan	PROPN
bptjm-15	459	15	kim	kim	PROPN
bptjm-15	459	16	,	,	PUNCT
bptjm-15	459	17	and	and	CCONJ
bptjm-15	459	18	sukjoon	sukjoon	PROPN
bptjm-15	459	19	yoon	yoon	PROPN
bptjm-15	459	20	.	.	PUNCT
bptjm-15	460	1	(	(	PUNCT
bptjm-15	460	2	november	november	PROPN
bptjm-15	460	3	20	20	NUM
bptjm-15	460	4	,	,	PUNCT
bptjm-15	460	5	2015	2015	NUM
bptjm-15	460	6	)	)	PUNCT
bptjm-15	460	7	.	.	PUNCT
bptjm-15	461	1	di	di	PROPN
bptjm-15	461	2	�	�	PROPN
bptjm-15	461	3	erential	erential	ADJ
bptjm-15	461	4	regulation	regulation	NOUN
bptjm-15	461	5	and	and	CCONJ
bptjm-15	461	6	synthetic	synthetic	ADJ
bptjm-15	461	7	lethality	lethality	NOUN
bptjm-15	461	8	of	of	ADP
bptjm-15	461	9	exclusive	exclusive	ADJ
bptjm-15	461	10	rb1	rb1	NOUN
bptjm-15	461	11	and	and	CCONJ
bptjm-15	461	12	cdkn2a	cdkn2a	PROPN
bptjm-15	461	13	mutations	mutation	NOUN
bptjm-15	461	14	in	in	ADP
bptjm-15	461	15	lung	lung	NOUN
bptjm-15	461	16	cancer	cancer	NOUN
bptjm-15	461	17	.	.	PUNCT
bptjm-15	462	1	international	international	ADJ
bptjm-15	462	2	journal	journal	PROPN
bptjm-15	462	3	of	of	ADP
bptjm-15	462	4	oncology	oncology	NOUN
bptjm-15	462	5	,	,	PUNCT
bptjm-15	462	6	48,(1	48,(1	PROPN
bptjm-15	462	7	)	)	PUNCT
bptjm-15	462	8	,	,	PUNCT
bptjm-15	462	9	367–75	367–75	NUM
bptjm-15	462	10	.	.	PUNCT
bptjm-15	463	1	https://doi.org/10.3892/ijo.2015.3262	https://doi.org/10.3892/ijo.2015.3262	NOUN
bptjm-15	463	2	.	.	PUNCT
bptjm-15	464	1	43	43	NUM
bptjm-15	464	2	.	.	PUNCT
bptjm-15	465	1	kishore	kishore	PROPN
bptjm-15	465	2	,	,	PUNCT
bptjm-15	465	3	j.	j.	PROPN
bptjm-15	465	4	,	,	PUNCT
bptjm-15	465	5	goel	goel	PROPN
bptjm-15	465	6	,	,	PUNCT
bptjm-15	465	7	m.	m.	PROPN
bptjm-15	465	8	k.	k.	PROPN
bptjm-15	465	9	,	,	PUNCT
bptjm-15	465	10	&	&	CCONJ
bptjm-15	465	11	khanna	khanna	PROPN
bptjm-15	465	12	,	,	PUNCT
bptjm-15	465	13	p.	p.	NOUN
bptjm-15	465	14	(	(	PUNCT
bptjm-15	465	15	2010	2010	NUM
bptjm-15	465	16	)	)	PUNCT
bptjm-15	465	17	.	.	PUNCT
bptjm-15	466	1	understanding	understand	VERB
bptjm-15	466	2	survival	survival	NOUN
bptjm-15	466	3	analysis	analysis	NOUN
bptjm-15	466	4	:	:	PUNCT
bptjm-15	466	5	kaplan	kaplan	PROPN
bptjm-15	466	6	meier	meier	PROPN
bptjm-15	466	7	estimate	estimate	PROPN
bptjm-15	466	8	.	.	PUNCT
bptjm-15	467	1	international	international	ADJ
bptjm-15	467	2	journal	journal	PROPN
bptjm-15	467	3	of	of	ADP
bptjm-15	467	4	ayurveda	ayurveda	PROPN
bptjm-15	467	5	research	research	NOUN
bptjm-15	467	6	,	,	PUNCT
bptjm-15	467	7	1(4	1(4	NUM
bptjm-15	467	8	)	)	PUNCT
bptjm-15	467	9	,	,	PUNCT
bptjm-15	467	10	274	274	NUM
bptjm-15	467	11	.	.	PUNCT
bptjm-15	467	12	https://doi.org/10.4103/0974-7788.76794	https://doi.org/10.4103/0974-7788.76794	PROPN
bptjm-15	467	13	44	44	NUM
bptjm-15	467	14	.	.	PUNCT
bptjm-15	468	1	krichevsky	krichevsky	PROPN
bptjm-15	468	2	,	,	PUNCT
bptjm-15	468	3	a.m.	a.m.	ADV
bptjm-15	468	4	,	,	PUNCT
bptjm-15	468	5	gabriely	gabriely	ADV
bptjm-15	468	6	,	,	PUNCT
bptjm-15	468	7	g.	g.	PROPN
bptjm-15	468	8	(	(	PUNCT
bptjm-15	468	9	2009	2009	NUM
bptjm-15	468	10	)	)	PUNCT
bptjm-15	468	11	.	.	PUNCT
bptjm-15	469	1	mir-21	mir-21	NOUN
bptjm-15	469	2	:	:	PUNCT
bptjm-15	469	3	a	a	DET
bptjm-15	469	4	small	small	ADJ
bptjm-15	469	5	multi	multi	ADJ
bptjm-15	469	6	-	-	ADJ
bptjm-15	469	7	faceted	faceted	ADJ
bptjm-15	469	8	rna	rna	PROPN
bptjm-15	469	9	.	.	PUNCT
bptjm-15	470	1	journal	journal	PROPN
bptjm-15	470	2	of	of	ADP
bptjm-15	470	3	cellular	cellular	ADJ
bptjm-15	470	4	and	and	CCONJ
bptjm-15	470	5	molecular	molecular	ADJ
bptjm-15	470	6	medicine	medicine	NOUN
bptjm-15	470	7	;	;	PUNCT
bptjm-15	470	8	13(1	13(1	X
bptjm-15	470	9	)	)	PUNCT
bptjm-15	470	10	,	,	PUNCT
bptjm-15	470	11	39	39	NUM
bptjm-15	470	12	-	-	SYM
bptjm-15	470	13	53	53	NUM
bptjm-15	470	14	.	.	PUNCT
bptjm-15	471	1	doi:10.1111	doi:10.1111	ADJ
bptjm-15	471	2	/	/	SYM
bptjm-15	471	3	j.1582	j.1582	NOUN
bptjm-15	471	4	-	-	PUNCT
bptjm-15	471	5	4934.2008.00556.x	4934.2008.00556.x	NUM
bptjm-15	471	6	45	45	NUM
bptjm-15	471	7	.	.	PUNCT
bptjm-15	472	1	kris	kris	PROPN
bptjm-15	472	2	,	,	PUNCT
bptjm-15	472	3	m.	m.	PROPN
bptjm-15	472	4	g.	g.	PROPN
bptjm-15	472	5	,	,	PUNCT
bptjm-15	472	6	d.	d.	PROPN
bptjm-15	472	7	r.	r.	PROPN
bptjm-15	472	8	camidge	camidge	PROPN
bptjm-15	472	9	,	,	PUNCT
bptjm-15	472	10	g.	g.	PROPN
bptjm-15	472	11	giaccone	giaccone	PROPN
bptjm-15	472	12	,	,	PUNCT
bptjm-15	472	13	t.	t.	PROPN
bptjm-15	472	14	hida	hida	PROPN
bptjm-15	472	15	,	,	PUNCT
bptjm-15	472	16	b.	b.	PROPN
bptjm-15	472	17	t.	t.	PROPN
bptjm-15	472	18	li	li	PROPN
bptjm-15	472	19	,	,	PUNCT
bptjm-15	472	20	j.	j.	PROPN
bptjm-15	472	21	o’connell	o’connell	PROPN
bptjm-15	472	22	,	,	PUNCT
bptjm-15	472	23	i.	i.	PROPN
bptjm-15	472	24	taylor	taylor	PROPN
bptjm-15	472	25	,	,	PUNCT
bptjm-15	472	26	et	et	PROPN
bptjm-15	472	27	al	al	PROPN
bptjm-15	472	28	.	.	PUNCT
bptjm-15	473	1	(	(	PUNCT
bptjm-15	473	2	july	july	PROPN
bptjm-15	473	3	1	1	NUM
bptjm-15	473	4	,	,	PUNCT
bptjm-15	473	5	2015	2015	NUM
bptjm-15	473	6	)	)	PUNCT
bptjm-15	473	7	.	.	PUNCT
bptjm-15	474	1	targeting	target	VERB
bptjm-15	474	2	her2	her2	NOUN
bptjm-15	474	3	aberrations	aberration	NOUN
bptjm-15	474	4	as	as	ADP
bptjm-15	474	5	actionable	actionable	ADJ
bptjm-15	474	6	drivers	driver	NOUN
bptjm-15	474	7	in	in	ADP
bptjm-15	474	8	lung	lung	NOUN
bptjm-15	474	9	cancers	cancer	NOUN
bptjm-15	474	10	:	:	PUNCT
bptjm-15	474	11	phase	phase	NOUN
bptjm-15	474	12	ii	ii	NOUN
bptjm-15	474	13	trial	trial	NOUN
bptjm-15	474	14	of	of	ADP
bptjm-15	474	15	the	the	DET
bptjm-15	474	16	pan	pan	NOUN
bptjm-15	474	17	-	-	ADJ
bptjm-15	474	18	her	her	PRON
bptjm-15	474	19	tyrosine	tyrosine	NOUN
bptjm-15	474	20	kinase	kinase	PROPN
bptjm-15	474	21	inhibitor	inhibitor	PROPN
bptjm-15	474	22	dacomitinib	dacomitinib	PROPN
bptjm-15	474	23	in	in	ADP
bptjm-15	474	24	patients	patient	NOUN
bptjm-15	474	25	with	with	ADP
bptjm-15	474	26	her2	her2	NOUN
bptjm-15	474	27	-	-	PUNCT
bptjm-15	474	28	mutant	mutant	ADJ
bptjm-15	474	29	or	or	CCONJ
bptjm-15	474	30	ampli	ampli	VERB
bptjm-15	474	31	�	�	NOUN
bptjm-15	474	32	ed	ed	NOUN
bptjm-15	474	33	tumors	tumor	NOUN
bptjm-15	474	34	.	.	PUNCT
bptjm-15	475	1	annals	annal	NOUN
bptjm-15	475	2	of	of	ADP
bptjm-15	475	3	oncology	oncology	NOUN
bptjm-15	475	4	,	,	PUNCT
bptjm-15	475	5	26(7	26(7	NOUN
bptjm-15	475	6	)	)	PUNCT
bptjm-15	475	7	,	,	PUNCT
bptjm-15	475	8	1421–27	1421–27	NUM
bptjm-15	475	9	.	.	PUNCT
bptjm-15	476	1	https://	https://	PROPN
bptjm-15	476	2	doi.org/10.1093/annonc/mdv186	doi.org/10.1093/annonc/mdv186	PROPN
bptjm-15	476	3	.	.	PUNCT
bptjm-15	476	4	46	46	NUM
bptjm-15	476	5	.	.	PUNCT
bptjm-15	477	1	kodama	kodama	PROPN
bptjm-15	477	2	,	,	PUNCT
bptjm-15	477	3	tatsushi	tatsushi	PROPN
bptjm-15	477	4	,	,	PUNCT
bptjm-15	477	5	toshiyuki	toshiyuki	PROPN
bptjm-15	477	6	tsukaguchi	tsukaguchi	NOUN
bptjm-15	477	7	,	,	PUNCT
bptjm-15	477	8	yasuko	yasuko	PROPN
bptjm-15	477	9	satoh	satoh	PROPN
bptjm-15	477	10	,	,	PUNCT
bptjm-15	477	11	miyuki	miyuki	PROPN
bptjm-15	477	12	yoshida	yoshida	PROPN
bptjm-15	477	13	,	,	PUNCT
bptjm-15	477	14	yoshiaki	yoshiaki	PROPN
bptjm-15	477	15	watanabe	watanabe	PROPN
bptjm-15	477	16	,	,	PUNCT
bptjm-15	477	17	osamu	osamu	PROPN
bptjm-15	477	18	kondoh	kondoh	PROPN
bptjm-15	477	19	,	,	PUNCT
bptjm-15	477	20	and	and	CCONJ
bptjm-15	477	21	hiroshi	hiroshi	PROPN
bptjm-15	477	22	sakamoto	sakamoto	PROPN
bptjm-15	477	23	.	.	PUNCT
bptjm-15	478	1	(	(	PUNCT
bptjm-15	478	2	december	december	PROPN
bptjm-15	478	3	1	1	NUM
bptjm-15	478	4	,	,	PUNCT
bptjm-15	478	5	2014	2014	NUM
bptjm-15	478	6	)	)	PUNCT
bptjm-15	478	7	.	.	PUNCT
bptjm-15	479	1	alectinib	alectinib	PROPN
bptjm-15	479	2	shows	show	VERB
bptjm-15	479	3	potent	potent	ADJ
bptjm-15	479	4	antitumor	antitumor	PROPN
bptjm-15	479	5	activity	activity	NOUN
bptjm-15	479	6	against	against	ADP
bptjm-15	479	7	ret	ret	NOUN
bptjm-15	479	8	-	-	PUNCT
bptjm-15	479	9	rearranged	rearrange	VERB
bptjm-15	479	10	non	non	ADJ
bptjm-15	479	11	–	–	ADJ
bptjm-15	479	12	small	small	ADJ
bptjm-15	479	13	cell	cell	NOUN
bptjm-15	479	14	lung	lung	NOUN
bptjm-15	479	15	cancer	cancer	NOUN
bptjm-15	479	16	.	.	PUNCT
bptjm-15	480	1	molecular	molecular	ADJ
bptjm-15	480	2	cancer	cancer	NOUN
bptjm-15	480	3	therapeutics	therapeutic	NOUN
bptjm-15	480	4	,	,	PUNCT
bptjm-15	480	5	13(12	13(12	NUM
bptjm-15	480	6	)	)	PUNCT
bptjm-15	480	7	:	:	PUNCT
bptjm-15	481	1	2910–18	2910–18	X
bptjm-15	481	2	.	.	PUNCT
bptjm-15	481	3	https://doi.org/	https://doi.org/	VERB
bptjm-15	481	4	10.1158/1535	10.1158/1535	NUM
bptjm-15	481	5	-	-	PUNCT
bptjm-15	481	6	7163.mct-14	7163.mct-14	NUM
bptjm-15	481	7	-	-	PUNCT
bptjm-15	481	8	0274	0274	NUM
bptjm-15	481	9	.	.	PUNCT
bptjm-15	482	1	berkeley	berkeley	PROPN
bptjm-15	482	2	pharma	pharma	PROPN
bptjm-15	482	3	tech	tech	PROPN
bptjm-15	482	4	journal	journal	NOUN
bptjm-15	482	5	of	of	ADP
bptjm-15	482	6	medicine	medicine	NOUN
bptjm-15	482	7	|	|	ADV
bptjm-15	482	8	88	88	NUM
bptjm-15	482	9	47	47	NUM
bptjm-15	482	10	.	.	PUNCT
bptjm-15	483	1	kohno	kohno	PROPN
bptjm-15	483	2	,	,	PUNCT
bptjm-15	483	3	takashi	takashi	PROPN
bptjm-15	483	4	,	,	PUNCT
bptjm-15	483	5	koji	koji	PROPN
bptjm-15	483	6	tsuta	tsuta	PROPN
bptjm-15	483	7	,	,	PUNCT
bptjm-15	483	8	katsuya	katsuya	PROPN
bptjm-15	483	9	tsuchihara	tsuchihara	PROPN
bptjm-15	483	10	,	,	PUNCT
bptjm-15	483	11	takashi	takashi	PROPN
bptjm-15	483	12	nakaoku	nakaoku	PROPN
bptjm-15	483	13	,	,	PUNCT
bptjm-15	483	14	kiyotaka	kiyotaka	PROPN
bptjm-15	483	15	yoh	yoh	PROPN
bptjm-15	483	16	,	,	PUNCT
bptjm-15	483	17	and	and	CCONJ
bptjm-15	483	18	koichi	koichi	PROPN
bptjm-15	483	19	goto	goto	NOUN
bptjm-15	483	20	.	.	PUNCT
bptjm-15	484	1	(	(	PUNCT
bptjm-15	484	2	2013	2013	NUM
bptjm-15	484	3	)	)	PUNCT
bptjm-15	484	4	.	.	PUNCT
bptjm-15	485	1	ret	ret	NOUN
bptjm-15	485	2	fusion	fusion	NOUN
bptjm-15	485	3	gene	gene	NOUN
bptjm-15	485	4	:	:	PUNCT
bptjm-15	485	5	translation	translation	NOUN
bptjm-15	485	6	to	to	ADP
bptjm-15	485	7	personalized	personalize	VERB
bptjm-15	485	8	lung	lung	NOUN
bptjm-15	485	9	cancer	cancer	NOUN
bptjm-15	485	10	therapy	therapy	NOUN
bptjm-15	485	11	.	.	PUNCT
bptjm-15	486	1	cancer	cancer	NOUN
bptjm-15	486	2	science	science	PROPN
bptjm-15	486	3	,	,	PUNCT
bptjm-15	486	4	104(11	104(11	NUM
bptjm-15	486	5	)	)	PUNCT
bptjm-15	486	6	:	:	PUNCT
bptjm-15	486	7	1396–1400	1396–1400	X
bptjm-15	486	8	.	.	PUNCT
bptjm-15	487	1	https://doi.org/10.1111/cas.12275	https://doi.org/10.1111/cas.12275	PROPN
bptjm-15	487	2	.	.	PROPN
bptjm-15	487	3	48	48	NUM
bptjm-15	487	4	.	.	PUNCT
bptjm-15	488	1	labbé	labbé	PROPN
bptjm-15	488	2	,	,	PUNCT
bptjm-15	488	3	c.	c.	NOUN
bptjm-15	488	4	,	,	PUNCT
bptjm-15	488	5	cabanero	cabanero	NOUN
bptjm-15	488	6	,	,	PUNCT
bptjm-15	488	7	m.	m.	NOUN
bptjm-15	488	8	,	,	PUNCT
bptjm-15	488	9	korpanty	korpanty	NOUN
bptjm-15	488	10	,	,	PUNCT
bptjm-15	488	11	g.	g.	PROPN
bptjm-15	488	12	j.	j.	PROPN
bptjm-15	488	13	,	,	PUNCT
bptjm-15	488	14	tomasini	tomasini	PROPN
bptjm-15	488	15	,	,	PUNCT
bptjm-15	488	16	p.	p.	PROPN
bptjm-15	488	17	,	,	PUNCT
bptjm-15	488	18	doherty	doherty	PROPN
bptjm-15	488	19	,	,	PUNCT
bptjm-15	488	20	m.	m.	PROPN
bptjm-15	488	21	k.	k.	PROPN
bptjm-15	488	22	,	,	PUNCT
bptjm-15	488	23	mascaux	mascaux	PROPN
bptjm-15	488	24	,	,	PUNCT
bptjm-15	488	25	c.	c.	PROPN
bptjm-15	488	26	,	,	PUNCT
bptjm-15	488	27	jao	jao	PROPN
bptjm-15	488	28	,	,	PUNCT
bptjm-15	488	29	k.	k.	PROPN
bptjm-15	488	30	,	,	PUNCT
bptjm-15	488	31	pitcher	pitcher	PROPN
bptjm-15	488	32	,	,	PUNCT
bptjm-15	488	33	b.	b.	PROPN
bptjm-15	488	34	,	,	PUNCT
bptjm-15	488	35	wang	wang	PROPN
bptjm-15	488	36	,	,	PUNCT
bptjm-15	488	37	r.	r.	PROPN
bptjm-15	488	38	,	,	PUNCT
bptjm-15	488	39	pintilie	pintilie	NOUN
bptjm-15	488	40	,	,	PUNCT
bptjm-15	488	41	m.	m.	NOUN
bptjm-15	488	42	,	,	PUNCT
bptjm-15	488	43	leighl	leighl	NOUN
bptjm-15	488	44	,	,	PUNCT
bptjm-15	488	45	n.	n.	PROPN
bptjm-15	488	46	b.	b.	PROPN
bptjm-15	488	47	,	,	PUNCT
bptjm-15	488	48	feld	feld	PROPN
bptjm-15	488	49	,	,	PUNCT
bptjm-15	488	50	r.	r.	PROPN
bptjm-15	488	51	,	,	PUNCT
bptjm-15	488	52	liu	liu	PROPN
bptjm-15	488	53	,	,	PUNCT
bptjm-15	488	54	g.	g.	PROPN
bptjm-15	488	55	,	,	PUNCT
bptjm-15	488	56	bradbury	bradbury	PROPN
bptjm-15	488	57	,	,	PUNCT
bptjm-15	488	58	p.	p.	PROPN
bptjm-15	488	59	a.	a.	PROPN
bptjm-15	488	60	,	,	PUNCT
bptjm-15	488	61	kamel	kamel	PROPN
bptjm-15	488	62	-	-	PUNCT
bptjm-15	488	63	reid	reid	PROPN
bptjm-15	488	64	,	,	PUNCT
bptjm-15	488	65	s.	s.	PROPN
bptjm-15	488	66	,	,	PUNCT
bptjm-15	488	67	tsao	tsao	PROPN
bptjm-15	488	68	,	,	PUNCT
bptjm-15	488	69	m.	m.	NOUN
bptjm-15	488	70	s.	s.	PROPN
bptjm-15	488	71	,	,	PUNCT
bptjm-15	488	72	&	&	CCONJ
bptjm-15	488	73	shepherd	shepherd	PROPN
bptjm-15	488	74	,	,	PUNCT
bptjm-15	488	75	f.	f.	PROPN
bptjm-15	488	76	a.	a.	PROPN
bptjm-15	488	77	(	(	PUNCT
bptjm-15	488	78	2017	2017	NUM
bptjm-15	488	79	)	)	PUNCT
bptjm-15	488	80	.	.	PUNCT
bptjm-15	489	1	prognostic	prognostic	ADJ
bptjm-15	489	2	and	and	CCONJ
bptjm-15	489	3	predictive	predictive	ADJ
bptjm-15	489	4	e	e	NOUN
bptjm-15	489	5	�	�	NOUN
bptjm-15	489	6	ects	ect	NOUN
bptjm-15	489	7	of	of	ADP
bptjm-15	489	8	tp53	tp53	PROPN
bptjm-15	489	9	co	co	NOUN
bptjm-15	489	10	-	-	NOUN
bptjm-15	489	11	mutation	mutation	NOUN
bptjm-15	489	12	in	in	ADP
bptjm-15	489	13	patients	patient	NOUN
bptjm-15	489	14	with	with	ADP
bptjm-15	489	15	egfr	egfr	NOUN
bptjm-15	489	16	-	-	PUNCT
bptjm-15	489	17	mutated	mutate	VERB
bptjm-15	489	18	non	non	ADJ
bptjm-15	489	19	-	-	ADJ
bptjm-15	489	20	small	small	ADJ
bptjm-15	489	21	cell	cell	NOUN
bptjm-15	489	22	lung	lung	NOUN
bptjm-15	489	23	cancer	cancer	NOUN
bptjm-15	489	24	(	(	PUNCT
bptjm-15	489	25	nsclc	nsclc	NOUN
bptjm-15	489	26	)	)	PUNCT
bptjm-15	489	27	.	.	PUNCT
bptjm-15	490	1	lung	lung	NOUN
bptjm-15	490	2	cancer	cancer	NOUN
bptjm-15	490	3	(	(	PUNCT
bptjm-15	490	4	amsterdam	amsterdam	PROPN
bptjm-15	490	5	,	,	PUNCT
bptjm-15	490	6	netherlands	netherlands	PROPN
bptjm-15	490	7	)	)	PUNCT
bptjm-15	490	8	,	,	PUNCT
bptjm-15	490	9	111	111	NUM
bptjm-15	490	10	,	,	PUNCT
bptjm-15	490	11	23–29	23–29	NUM
bptjm-15	490	12	.	.	PUNCT
bptjm-15	491	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
bptjm-15	491	2	j.lungcan.2017.06.014	j.lungcan.2017.06.014	PROPN
bptjm-15	491	3	.	.	PROPN
bptjm-15	492	1	49	49	NUM
bptjm-15	492	2	.	.	PUNCT
bptjm-15	493	1	le	le	PROPN
bptjm-15	493	2	,	,	PUNCT
bptjm-15	493	3	h.	h.	PROPN
bptjm-15	493	4	b.	b.	PROPN
bptjm-15	493	5	,	,	PUNCT
bptjm-15	493	6	zhu	zhu	PROPN
bptjm-15	493	7	,	,	PUNCT
bptjm-15	493	8	w.	w.	PROPN
bptjm-15	493	9	y.	y.	PROPN
bptjm-15	493	10	,	,	PUNCT
bptjm-15	493	11	chen	chen	PROPN
bptjm-15	493	12	,	,	PUNCT
bptjm-15	493	13	d.	d.	PROPN
bptjm-15	493	14	d.	d.	PROPN
bptjm-15	493	15	,	,	PUNCT
bptjm-15	493	16	he	he	PRON
bptjm-15	493	17	,	,	PUNCT
bptjm-15	493	18	j.	j.	PROPN
bptjm-15	493	19	y.	y.	PROPN
bptjm-15	493	20	,	,	PUNCT
bptjm-15	493	21	huang	huang	PROPN
bptjm-15	493	22	,	,	PUNCT
bptjm-15	493	23	y.	y.	PROPN
bptjm-15	493	24	y.	y.	PROPN
bptjm-15	493	25	,	,	PUNCT
bptjm-15	493	26	liu	liu	PROPN
bptjm-15	493	27	,	,	PUNCT
bptjm-15	493	28	x.	x.	PROPN
bptjm-15	493	29	g.	g.	PROPN
bptjm-15	493	30	,	,	PUNCT
bptjm-15	493	31	&	&	CCONJ
bptjm-15	493	32	zhang	zhang	PROPN
bptjm-15	493	33	,	,	PUNCT
bptjm-15	493	34	y.	y.	PROPN
bptjm-15	493	35	k.	k.	PROPN
bptjm-15	493	36	(	(	PUNCT
bptjm-15	493	37	2012	2012	NUM
bptjm-15	493	38	)	)	PUNCT
bptjm-15	493	39	.	.	PUNCT
bptjm-15	494	1	evaluation	evaluation	NOUN
bptjm-15	494	2	of	of	ADP
bptjm-15	494	3	dynamic	dynamic	ADJ
bptjm-15	494	4	change	change	NOUN
bptjm-15	494	5	of	of	ADP
bptjm-15	494	6	serum	serum	PROPN
bptjm-15	494	7	mir-21	mir-21	PROPN
bptjm-15	494	8	and	and	CCONJ
bptjm-15	494	9	mir-24	mir-24	NOUN
bptjm-15	494	10	in	in	ADP
bptjm-15	494	11	preand	preand	NOUN
bptjm-15	494	12	post	post	ADJ
bptjm-15	494	13	-	-	ADJ
bptjm-15	494	14	operative	operative	ADJ
bptjm-15	494	15	lung	lung	NOUN
bptjm-15	494	16	carcinoma	carcinoma	NOUN
bptjm-15	494	17	patients	patient	NOUN
bptjm-15	494	18	.	.	PUNCT
bptjm-15	495	1	medical	medical	ADJ
bptjm-15	495	2	oncology	oncology	NOUN
bptjm-15	495	3	(	(	PUNCT
bptjm-15	495	4	northwood	northwood	PROPN
bptjm-15	495	5	,	,	PUNCT
bptjm-15	495	6	london	london	PROPN
bptjm-15	495	7	,	,	PUNCT
bptjm-15	495	8	england	england	PROPN
bptjm-15	495	9	)	)	PUNCT
bptjm-15	495	10	,	,	PUNCT
bptjm-15	495	11	29(5	29(5	NUM
bptjm-15	495	12	)	)	PUNCT
bptjm-15	495	13	,	,	PUNCT
bptjm-15	495	14	3190–3197	3190–3197	NUM
bptjm-15	495	15	.	.	PUNCT
bptjm-15	496	1	https://doi.org/10.1007/s12032-012-0303-z	https://doi.org/10.1007/s12032-012-0303-z	PROPN
bptjm-15	496	2	50	50	NUM
bptjm-15	496	3	.	.	PUNCT
bptjm-15	497	1	li	li	PROPN
bptjm-15	497	2	,	,	PUNCT
bptjm-15	497	3	m.	m.	NOUN
bptjm-15	497	4	x.	x.	PROPN
bptjm-15	497	5	,	,	PUNCT
bptjm-15	497	6	bi	bi	PROPN
bptjm-15	497	7	,	,	PUNCT
bptjm-15	497	8	x.	x.	NOUN
bptjm-15	497	9	y.	y.	PROPN
bptjm-15	497	10	,	,	PUNCT
bptjm-15	497	11	zhao	zhao	PROPN
bptjm-15	497	12	,	,	PUNCT
bptjm-15	497	13	h.	h.	PROPN
bptjm-15	497	14	,	,	PUNCT
bptjm-15	497	15	huang	huang	PROPN
bptjm-15	497	16	,	,	PUNCT
bptjm-15	497	17	z.	z.	PROPN
bptjm-15	497	18	,	,	PUNCT
bptjm-15	497	19	han	han	PROPN
bptjm-15	497	20	,	,	PUNCT
bptjm-15	497	21	y.	y.	PROPN
bptjm-15	497	22	,	,	PUNCT
bptjm-15	497	23	zhao	zhao	PROPN
bptjm-15	497	24	,	,	PUNCT
bptjm-15	497	25	d.	d.	PROPN
bptjm-15	497	26	b.	b.	PROPN
bptjm-15	497	27	,	,	PUNCT
bptjm-15	497	28	zhao	zhao	PROPN
bptjm-15	497	29	,	,	PUNCT
bptjm-15	497	30	j.	j.	PROPN
bptjm-15	497	31	j.	j.	PROPN
bptjm-15	497	32	,	,	PUNCT
bptjm-15	497	33	&	&	CCONJ
bptjm-15	497	34	cai	cai	PROPN
bptjm-15	497	35	,	,	PUNCT
bptjm-15	497	36	j.	j.	PROPN
bptjm-15	497	37	q.	q.	PROPN
bptjm-15	497	38	(	(	PUNCT
bptjm-15	497	39	2016	2016	NUM
bptjm-15	497	40	)	)	PUNCT
bptjm-15	497	41	.	.	PUNCT
bptjm-15	498	1	excision	excision	NOUN
bptjm-15	498	2	repair	repair	NOUN
bptjm-15	498	3	cross	cross	ADJ
bptjm-15	498	4	-	-	ADJ
bptjm-15	498	5	complementation	complementation	ADJ
bptjm-15	498	6	group	group	NOUN
bptjm-15	498	7	1	1	NUM
bptjm-15	498	8	is	be	AUX
bptjm-15	498	9	a	a	DET
bptjm-15	498	10	prognostic	prognostic	ADJ
bptjm-15	498	11	biomarker	biomarker	NOUN
bptjm-15	498	12	in	in	ADP
bptjm-15	498	13	patients	patient	NOUN
bptjm-15	498	14	with	with	ADP
bptjm-15	498	15	colorectal	colorectal	ADJ
bptjm-15	498	16	cancer	cancer	NOUN
bptjm-15	498	17	receiving	receive	VERB
bptjm-15	498	18	chemotherapy	chemotherapy	NOUN
bptjm-15	498	19	.	.	PUNCT
bptjm-15	499	1	chinese	chinese	ADJ
bptjm-15	499	2	medical	medical	ADJ
bptjm-15	499	3	journal	journal	NOUN
bptjm-15	499	4	,	,	PUNCT
bptjm-15	499	5	129(5	129(5	NUM
bptjm-15	499	6	)	)	PUNCT
bptjm-15	499	7	,	,	PUNCT
bptjm-15	499	8	586–593	586–593	NUM
bptjm-15	499	9	.	.	PUNCT
bptjm-15	500	1	https://doi.org/10.4103/0366-6999.176993	https://doi.org/10.4103/0366-6999.176993	NOUN
bptjm-15	500	2	.	.	PUNCT
bptjm-15	501	1	51	51	NUM
bptjm-15	501	2	.	.	PUNCT
bptjm-15	502	1	li	li	PROPN
bptjm-15	502	2	,	,	PUNCT
bptjm-15	502	3	w.	w.	PROPN
bptjm-15	502	4	,	,	PUNCT
bptjm-15	502	5	wang	wang	PROPN
bptjm-15	502	6	,	,	PUNCT
bptjm-15	502	7	y.	y.	PROPN
bptjm-15	502	8	,	,	PUNCT
bptjm-15	502	9	zhang	zhang	PROPN
bptjm-15	502	10	,	,	PUNCT
bptjm-15	502	11	q.	q.	PROPN
bptjm-15	502	12	,	,	PUNCT
bptjm-15	502	13	tang	tang	PROPN
bptjm-15	502	14	,	,	PUNCT
bptjm-15	502	15	l.	l.	PROPN
bptjm-15	502	16	,	,	PUNCT
bptjm-15	502	17	liu	liu	PROPN
bptjm-15	502	18	,	,	PUNCT
bptjm-15	502	19	x.	x.	PROPN
bptjm-15	502	20	,	,	PUNCT
bptjm-15	502	21	dai	dai	PROPN
bptjm-15	502	22	,	,	PUNCT
bptjm-15	502	23	y.	y.	PROPN
bptjm-15	502	24	,	,	PUNCT
bptjm-15	502	25	et	et	PROPN
bptjm-15	502	26	al	al	PROPN
bptjm-15	502	27	.	.	PROPN
bptjm-15	502	28	(	(	PUNCT
bptjm-15	502	29	2015	2015	NUM
bptjm-15	502	30	)	)	PUNCT
bptjm-15	502	31	microrna-486	microrna-486	ADJ
bptjm-15	502	32	as	as	ADP
bptjm-15	502	33	a	a	DET
bptjm-15	502	34	biomarker	biomarker	NOUN
bptjm-15	502	35	for	for	ADP
bptjm-15	502	36	early	early	ADJ
bptjm-15	502	37	diagnosis	diagnosis	NOUN
bptjm-15	502	38	and	and	CCONJ
bptjm-15	502	39	recurrence	recurrence	NOUN
bptjm-15	502	40	of	of	ADP
bptjm-15	502	41	non	non	ADJ
bptjm-15	502	42	-	-	ADJ
bptjm-15	502	43	small	small	ADJ
bptjm-15	502	44	cell	cell	NOUN
bptjm-15	502	45	lung	lung	NOUN
bptjm-15	502	46	cancer	cancer	NOUN
bptjm-15	502	47	.	.	PUNCT
bptjm-15	503	1	plos	plos	PROPN
bptjm-15	503	2	one	one	NUM
bptjm-15	503	3	,	,	PUNCT
bptjm-15	503	4	10(8	10(8	NUM
bptjm-15	503	5	):	):	PUNCT
bptjm-15	503	6	e0134220	e0134220	NOUN
bptjm-15	503	7	.	.	PROPN
bptjm-15	503	8	https://doi.org/10.1371/journal.pone.0134220	https://doi.org/10.1371/journal.pone.0134220	PROPN
bptjm-15	503	9	52	52	NUM
bptjm-15	503	10	.	.	PUNCT
bptjm-15	504	1	liang	liang	PROPN
bptjm-15	504	2	,	,	PUNCT
bptjm-15	504	3	l.	l.	PROPN
bptjm-15	504	4	,	,	PUNCT
bptjm-15	504	5	zhu	zhu	PROPN
bptjm-15	504	6	,	,	PUNCT
bptjm-15	504	7	w.	w.	PROPN
bptjm-15	504	8	,	,	PUNCT
bptjm-15	504	9	chen	chen	PROPN
bptjm-15	504	10	,	,	PUNCT
bptjm-15	504	11	x.	x.	PROPN
bptjm-15	504	12	,	,	PUNCT
bptjm-15	504	13	&	&	CCONJ
bptjm-15	504	14	amp	amp	PROPN
bptjm-15	504	15	;	;	PUNCT
bptjm-15	504	16	luo	luo	PROPN
bptjm-15	504	17	,	,	PUNCT
bptjm-15	504	18	f.	f.	PROPN
bptjm-15	504	19	(	(	PUNCT
bptjm-15	504	20	2019	2019	NUM
bptjm-15	504	21	)	)	PUNCT
bptjm-15	504	22	.	.	PUNCT
bptjm-15	505	1	plasma	plasma	PROPN
bptjm-15	505	2	mir-30a-5p	mir-30a-5p	PROPN
bptjm-15	505	3	as	as	ADP
bptjm-15	505	4	an	an	DET
bptjm-15	505	5	early	early	ADJ
bptjm-15	505	6	novel	novel	NOUN
bptjm-15	505	7	noninvasive	noninvasive	ADJ
bptjm-15	505	8	diagnostic	diagnostic	ADJ
bptjm-15	505	9	and	and	CCONJ
bptjm-15	505	10	prognostic	prognostic	ADJ
bptjm-15	505	11	biomarker	biomarker	NOUN
bptjm-15	505	12	for	for	ADP
bptjm-15	505	13	lung	lung	NOUN
bptjm-15	505	14	cancer	cancer	NOUN
bptjm-15	505	15	.	.	PUNCT
bptjm-15	506	1	future	future	ADJ
bptjm-15	506	2	oncology	oncology	NOUN
bptjm-15	506	3	,	,	PUNCT
bptjm-15	506	4	15(32	15(32	NUM
bptjm-15	506	5	)	)	PUNCT
bptjm-15	506	6	,	,	PUNCT
bptjm-15	506	7	3711	3711	NUM
bptjm-15	506	8	-	-	SYM
bptjm-15	506	9	3721	3721	NUM
bptjm-15	506	10	.	.	PUNCT
bptjm-15	507	1	doi:10.2217	doi:10.2217	NOUN
bptjm-15	507	2	/	/	SYM
bptjm-15	507	3	fon-2019	fon-2019	NOUN
bptjm-15	507	4	-	-	PUNCT
bptjm-15	507	5	0393	0393	NUM
bptjm-15	507	6	53	53	NUM
bptjm-15	507	7	.	.	PUNCT
bptjm-15	508	1	lin	lin	PROPN
bptjm-15	508	2	,	,	PUNCT
bptjm-15	508	3	q.	q.	PROPN
bptjm-15	508	4	,	,	PUNCT
bptjm-15	508	5	zhang	zhang	PROPN
bptjm-15	508	6	,	,	PUNCT
bptjm-15	508	7	h.	h.	PROPN
bptjm-15	508	8	,	,	PUNCT
bptjm-15	508	9	ding	ding	PROPN
bptjm-15	508	10	,	,	PUNCT
bptjm-15	508	11	h.	h.	PROPN
bptjm-15	508	12	,	,	PUNCT
bptjm-15	508	13	qian	qian	PROPN
bptjm-15	508	14	,	,	PUNCT
bptjm-15	508	15	j.	j.	PROPN
bptjm-15	508	16	,	,	PUNCT
bptjm-15	508	17	lizaso	lizaso	PROPN
bptjm-15	508	18	,	,	PUNCT
bptjm-15	508	19	a.	a.	PROPN
bptjm-15	508	20	,	,	PUNCT
bptjm-15	508	21	lin	lin	PROPN
bptjm-15	508	22	,	,	PUNCT
bptjm-15	508	23	j.	j.	PROPN
bptjm-15	508	24	,	,	PUNCT
bptjm-15	508	25	han	han	PROPN
bptjm-15	508	26	-	-	PUNCT
bptjm-15	508	27	zhang	zhang	PROPN
bptjm-15	508	28	,	,	PUNCT
bptjm-15	508	29	h.	h.	PROPN
bptjm-15	508	30	,	,	PUNCT
bptjm-15	508	31	xiang	xiang	PROPN
bptjm-15	508	32	,	,	PUNCT
bptjm-15	508	33	j.	j.	PROPN
bptjm-15	508	34	,	,	PUNCT
bptjm-15	508	35	li	li	PROPN
bptjm-15	508	36	,	,	PUNCT
bptjm-15	508	37	y.	y.	PROPN
bptjm-15	508	38	,	,	PUNCT
bptjm-15	508	39	&	&	CCONJ
bptjm-15	508	40	zhu	zhu	PROPN
bptjm-15	508	41	,	,	PUNCT
bptjm-15	508	42	h.	h.	PROPN
bptjm-15	508	43	(	(	PUNCT
bptjm-15	508	44	2019	2019	NUM
bptjm-15	508	45	)	)	PUNCT
bptjm-15	508	46	.	.	PUNCT
bptjm-15	509	1	the	the	DET
bptjm-15	509	2	association	association	NOUN
bptjm-15	509	3	between	between	ADP
bptjm-15	509	4	braf	braf	NOUN
bptjm-15	509	5	mutation	mutation	NOUN
bptjm-15	509	6	class	class	NOUN
bptjm-15	509	7	and	and	CCONJ
bptjm-15	509	8	clinical	clinical	ADJ
bptjm-15	509	9	features	feature	NOUN
bptjm-15	509	10	in	in	ADP
bptjm-15	509	11	braf	braf	NOUN
bptjm-15	509	12	-	-	PUNCT
bptjm-15	509	13	mutant	mutant	ADJ
bptjm-15	509	14	chinese	chinese	ADJ
bptjm-15	509	15	non	non	ADJ
bptjm-15	509	16	-	-	ADJ
bptjm-15	509	17	small	small	ADJ
bptjm-15	509	18	cell	cell	NOUN
bptjm-15	509	19	lung	lung	NOUN
bptjm-15	509	20	cancer	cancer	NOUN
bptjm-15	509	21	patients	patient	NOUN
bptjm-15	509	22	.	.	PUNCT
bptjm-15	510	1	journal	journal	NOUN
bptjm-15	510	2	of	of	ADP
bptjm-15	510	3	translational	translational	ADJ
bptjm-15	510	4	medicine	medicine	NOUN
bptjm-15	510	5	,	,	PUNCT
bptjm-15	510	6	17(1	17(1	NUM
bptjm-15	510	7	)	)	PUNCT
bptjm-15	510	8	,	,	PUNCT
bptjm-15	510	9	298	298	NUM
bptjm-15	510	10	.	.	PUNCT
bptjm-15	511	1	https://doi.org/10.1186/s12967-019-2036-7	https://doi.org/10.1186/s12967-019-2036-7	PROPN
bptjm-15	511	2	54	54	NUM
bptjm-15	511	3	.	.	PUNCT
bptjm-15	512	1	liu	liu	PROPN
bptjm-15	512	2	,	,	PUNCT
bptjm-15	512	3	w.	w.	PROPN
bptjm-15	512	4	,	,	PUNCT
bptjm-15	512	5	zhuang	zhuang	PROPN
bptjm-15	512	6	,	,	PUNCT
bptjm-15	512	7	c.	c.	PROPN
bptjm-15	512	8	,	,	PUNCT
bptjm-15	512	9	huang	huang	PROPN
bptjm-15	512	10	,	,	PUNCT
bptjm-15	512	11	t.	t.	PROPN
bptjm-15	512	12	,	,	PUNCT
bptjm-15	512	13	yang	yang	PROPN
bptjm-15	512	14	,	,	PUNCT
bptjm-15	512	15	s.	s.	PROPN
bptjm-15	512	16	,	,	PUNCT
bptjm-15	512	17	zhang	zhang	PROPN
bptjm-15	512	18	,	,	PUNCT
bptjm-15	512	19	m.	m.	NOUN
bptjm-15	512	20	,	,	PUNCT
bptjm-15	512	21	lin	lin	PROPN
bptjm-15	512	22	,	,	PUNCT
bptjm-15	512	23	b.	b.	PROPN
bptjm-15	512	24	and	and	CCONJ
bptjm-15	512	25	jiang	jiang	PROPN
bptjm-15	512	26	,	,	PUNCT
bptjm-15	512	27	y.	y.	PROPN
bptjm-15	512	28	(	(	PUNCT
bptjm-15	512	29	2020	2020	NUM
bptjm-15	512	30	)	)	PUNCT
bptjm-15	512	31	,	,	PUNCT
bptjm-15	512	32	loss	loss	NOUN
bptjm-15	512	33	of	of	ADP
bptjm-15	512	34	cdkn2a	cdkn2a	PROPN
bptjm-15	512	35	at	at	ADP
bptjm-15	512	36	chromosome	chromosome	NOUN
bptjm-15	512	37	9	9	NUM
bptjm-15	512	38	has	have	VERB
bptjm-15	512	39	a	a	DET
bptjm-15	512	40	poor	poor	ADJ
bptjm-15	512	41	clinical	clinical	ADJ
bptjm-15	512	42	prognosis	prognosis	NOUN
bptjm-15	512	43	and	and	CCONJ
bptjm-15	512	44	promotes	promote	VERB
bptjm-15	512	45	lung	lung	NOUN
bptjm-15	512	46	cancer	cancer	NOUN
bptjm-15	512	47	progression	progression	NOUN
bptjm-15	512	48	.	.	PUNCT
bptjm-15	513	1	mol	mol	ADP
bptjm-15	513	2	genet	genet	PROPN
bptjm-15	513	3	genomic	genomic	NOUN
bptjm-15	513	4	med	me	VERB
bptjm-15	513	5	,	,	PUNCT
bptjm-15	513	6	8(1521	8(1521	NOUN
bptjm-15	513	7	)	)	PUNCT
bptjm-15	513	8	.	.	PUNCT
bptjm-15	514	1	https://doi.org/10.1002/mgg3.1521	https://doi.org/10.1002/mgg3.1521	PROPN
bptjm-15	514	2	.	.	PROPN
bptjm-15	515	1	55	55	NUM
bptjm-15	515	2	.	.	PUNCT
bptjm-15	516	1	liu	liu	PROPN
bptjm-15	516	2	,	,	PUNCT
bptjm-15	516	3	heng	heng	PROPN
bptjm-15	516	4	-	-	PUNCT
bptjm-15	516	5	jia	jia	PROPN
bptjm-15	516	6	&	&	CCONJ
bptjm-15	516	7	lizotte	lizotte	PROPN
bptjm-15	516	8	,	,	PUNCT
bptjm-15	516	9	patrick	patrick	PROPN
bptjm-15	516	10	&	&	CCONJ
bptjm-15	516	11	du	du	PROPN
bptjm-15	516	12	,	,	PUNCT
bptjm-15	516	13	heng	heng	PROPN
bptjm-15	516	14	&	&	CCONJ
bptjm-15	516	15	speranza	speranza	PROPN
bptjm-15	516	16	,	,	PUNCT
bptjm-15	516	17	maria	maria	PROPN
bptjm-15	516	18	&	&	CCONJ
bptjm-15	516	19	vaughan	vaughan	PROPN
bptjm-15	516	20	,	,	PUNCT
bptjm-15	516	21	spencer	spencer	PROPN
bptjm-15	516	22	&	&	CCONJ
bptjm-15	516	23	alesi	alesi	PROPN
bptjm-15	516	24	,	,	PUNCT
bptjm-15	516	25	nicola	nicola	PROPN
bptjm-15	516	26	&	&	CCONJ
bptjm-15	516	27	wong	wong	PROPN
bptjm-15	516	28	,	,	PUNCT
bptjm-15	516	29	kwok	kwok	PROPN
bptjm-15	516	30	-	-	PUNCT
bptjm-15	516	31	kin	kin	PROPN
bptjm-15	516	32	&	&	CCONJ
bptjm-15	516	33	freeman	freeman	PROPN
bptjm-15	516	34	,	,	PUNCT
bptjm-15	516	35	gordon	gordon	PROPN
bptjm-15	516	36	&	&	CCONJ
bptjm-15	516	37	sharpe	sharpe	PROPN
bptjm-15	516	38	,	,	PUNCT
bptjm-15	516	39	arlene	arlene	PROPN
bptjm-15	516	40	&	&	CCONJ
bptjm-15	516	41	henske	henske	PROPN
bptjm-15	516	42	,	,	PUNCT
bptjm-15	516	43	elizabeth	elizabeth	PROPN
bptjm-15	516	44	.	.	PUNCT
bptjm-15	516	45	(	(	PUNCT
bptjm-15	516	46	2018	2018	NUM
bptjm-15	516	47	)	)	PUNCT
bptjm-15	516	48	.	.	PUNCT
bptjm-15	517	1	abstract	abstract	ADJ
bptjm-15	517	2	1686	1686	NUM
bptjm-15	517	3	:	:	PUNCT
bptjm-15	517	4	tsc2	tsc2	NOUN
bptjm-15	517	5	enhances	enhance	VERB
bptjm-15	517	6	antitumor	antitumor	PROPN
bptjm-15	517	7	immunity	immunity	NOUN
bptjm-15	517	8	and	and	CCONJ
bptjm-15	517	9	potentiates	potentiate	NOUN
bptjm-15	517	10	pd-1	pd-1	ADP
bptjm-15	517	11	and	and	CCONJ
bptjm-15	517	12	ctla-4	ctla-4	NOUN
bptjm-15	517	13	blockade	blockade	NOUN
bptjm-15	517	14	.	.	PUNCT
bptjm-15	518	1	cancer	cancer	NOUN
bptjm-15	518	2	research	research	NOUN
bptjm-15	518	3	.	.	PUNCT
bptjm-15	519	1	78	78	NUM
bptjm-15	519	2	,	,	PUNCT
bptjm-15	519	3	1686	1686	NUM
bptjm-15	519	4	-	-	SYM
bptjm-15	519	5	1686	1686	NUM
bptjm-15	519	6	.	.	PUNCT
bptjm-15	520	1	56	56	NUM
bptjm-15	520	2	.	.	PUNCT
bptjm-15	521	1	liu	liu	PROPN
bptjm-15	521	2	,	,	PUNCT
bptjm-15	521	3	k.	k.	PROPN
bptjm-15	521	4	,	,	PUNCT
bptjm-15	521	5	chen	chen	PROPN
bptjm-15	521	6	,	,	PUNCT
bptjm-15	521	7	h.	h.	PROPN
bptjm-15	521	8	,	,	PUNCT
bptjm-15	521	9	you	you	PRON
bptjm-15	521	10	,	,	PUNCT
bptjm-15	521	11	q.	q.	PROPN
bptjm-15	521	12	,	,	PUNCT
bptjm-15	521	13	ye	ye	PROPN
bptjm-15	521	14	,	,	PUNCT
bptjm-15	521	15	q.	q.	PROPN
bptjm-15	521	16	,	,	PUNCT
bptjm-15	521	17	wang	wang	PROPN
bptjm-15	521	18	,	,	PUNCT
bptjm-15	521	19	f.	f.	PROPN
bptjm-15	521	20	,	,	PUNCT
bptjm-15	521	21	wang	wang	PROPN
bptjm-15	521	22	,	,	PUNCT
bptjm-15	521	23	s.	s.	PROPN
bptjm-15	521	24	,	,	PUNCT
bptjm-15	521	25	zhang	zhang	PROPN
bptjm-15	521	26	,	,	PUNCT
bptjm-15	521	27	s.	s.	PROPN
bptjm-15	521	28	,	,	PUNCT
bptjm-15	521	29	yu	yu	PROPN
bptjm-15	521	30	,	,	PUNCT
bptjm-15	521	31	k.	k.	PROPN
bptjm-15	521	32	,	,	PUNCT
bptjm-15	521	33	li	li	PROPN
bptjm-15	521	34	,	,	PUNCT
bptjm-15	521	35	w.	w.	PROPN
bptjm-15	521	36	,	,	PUNCT
bptjm-15	521	37	gu	gu	PROPN
bptjm-15	521	38	,	,	PUNCT
bptjm-15	521	39	m.	m.	NOUN
bptjm-15	521	40	(	(	PUNCT
bptjm-15	521	41	2018	2018	NUM
bptjm-15	521	42	)	)	PUNCT
bptjm-15	521	43	.	.	PUNCT
bptjm-15	522	1	mir-145	mir-145	PROPN
bptjm-15	522	2	inhibits	inhibit	VERB
bptjm-15	522	3	human	human	ADJ
bptjm-15	522	4	non	non	ADJ
bptjm-15	522	5	-	-	ADJ
bptjm-15	522	6	small	small	ADJ
bptjm-15	522	7	-	-	PUNCT
bptjm-15	522	8	cell	cell	NOUN
bptjm-15	522	9	lung	lung	NOUN
bptjm-15	522	10	cancer	cancer	NOUN
bptjm-15	522	11	growth	growth	NOUN
bptjm-15	522	12	by	by	ADP
bptjm-15	522	13	dual	dual	ADV
bptjm-15	522	14	-	-	PUNCT
bptjm-15	522	15	targeting	target	VERB
bptjm-15	522	16	riok2	riok2	NOUN
bptjm-15	522	17	and	and	CCONJ
bptjm-15	522	18	nob1	nob1	PROPN
bptjm-15	522	19	.	.	PUNCT
bptjm-15	523	1	international	international	ADJ
bptjm-15	523	2	journal	journal	PROPN
bptjm-15	523	3	of	of	ADP
bptjm-15	523	4	oncology	oncology	NOUN
bptjm-15	523	5	,	,	PUNCT
bptjm-15	523	6	53(1	53(1	NUM
bptjm-15	523	7	)	)	PUNCT
bptjm-15	523	8	,	,	PUNCT
bptjm-15	523	9	257	257	NUM
bptjm-15	523	10	-	-	SYM
bptjm-15	523	11	265	265	NUM
bptjm-15	523	12	.	.	PUNCT
bptjm-15	524	1	57	57	NUM
bptjm-15	524	2	.	.	PUNCT
bptjm-15	525	1	liu	liu	PROPN
bptjm-15	525	2	xg	xg	PROPN
bptjm-15	525	3	,	,	PUNCT
bptjm-15	525	4	zhu	zhu	PROPN
bptjm-15	525	5	wy	wy	PROPN
bptjm-15	525	6	,	,	PUNCT
bptjm-15	525	7	huang	huang	PROPN
bptjm-15	525	8	yy	yy	PROPN
bptjm-15	525	9	,	,	PUNCT
bptjm-15	525	10	ma	ma	PROPN
bptjm-15	525	11	ln	ln	PROPN
bptjm-15	525	12	,	,	PUNCT
bptjm-15	525	13	zhou	zhou	PROPN
bptjm-15	525	14	sq	sq	PROPN
bptjm-15	525	15	,	,	PUNCT
bptjm-15	525	16	et	et	PROPN
bptjm-15	525	17	al	al	PROPN
bptjm-15	525	18	.	.	PROPN
bptjm-15	525	19	high	high	ADJ
bptjm-15	525	20	expression	expression	NOUN
bptjm-15	525	21	of	of	ADP
bptjm-15	525	22	serum	serum	PROPN
bptjm-15	525	23	mir-21	mir-21	PROPN
bptjm-15	525	24	and	and	CCONJ
bptjm-15	525	25	tumor	tumor	NOUN
bptjm-15	525	26	mir-200c	mir-200c	NOUN
bptjm-15	525	27	associated	associate	VERB
bptjm-15	525	28	with	with	ADP
bptjm-15	525	29	poor	poor	ADJ
bptjm-15	525	30	prognosis	prognosis	NOUN
bptjm-15	525	31	in	in	ADP
bptjm-15	525	32	patients	patient	NOUN
bptjm-15	525	33	with	with	ADP
bptjm-15	525	34	lung	lung	NOUN
bptjm-15	525	35	cancer	cancer	NOUN
bptjm-15	525	36	,	,	PUNCT
bptjm-15	525	37	med	med	PROPN
bptjm-15	525	38	oncol	oncol	ADJ
bptjm-15	525	39	,	,	PUNCT
bptjm-15	525	40	2012	2012	NUM
bptjm-15	525	41	,	,	PUNCT
bptjm-15	525	42	vol	vol	NOUN
bptjm-15	525	43	.	.	PROPN
bptjm-15	525	44	29	29	NUM
bptjm-15	525	45	(	(	PUNCT
bptjm-15	525	46	pg	pg	INTJ
bptjm-15	525	47	.	.	PUNCT
bptjm-15	525	48	618	618	NUM
bptjm-15	525	49	-	-	SYM
bptjm-15	525	50	26	26	NUM
bptjm-15	525	51	)	)	PUNCT
bptjm-15	525	52	58	58	NUM
bptjm-15	525	53	.	.	PUNCT
bptjm-15	526	1	luk	luk	PROPN
bptjm-15	526	2	,	,	PUNCT
bptjm-15	526	3	p.	p.	PROPN
bptjm-15	526	4	p.	p.	PROPN
bptjm-15	526	5	,	,	PUNCT
bptjm-15	526	6	selinger	selinger	NOUN
bptjm-15	526	7	,	,	PUNCT
bptjm-15	526	8	c.	c.	PROPN
bptjm-15	526	9	i.	i.	PROPN
bptjm-15	526	10	,	,	PUNCT
bptjm-15	526	11	mahar	mahar	PROPN
bptjm-15	526	12	,	,	PUNCT
bptjm-15	526	13	a.	a.	PROPN
bptjm-15	526	14	,	,	PUNCT
bptjm-15	526	15	&	&	CCONJ
bptjm-15	526	16	cooper	cooper	PROPN
bptjm-15	526	17	,	,	PUNCT
bptjm-15	526	18	w.	w.	PROPN
bptjm-15	526	19	a.	a.	PROPN
bptjm-15	526	20	(	(	PUNCT
bptjm-15	526	21	2018	2018	NUM
bptjm-15	526	22	)	)	PUNCT
bptjm-15	526	23	.	.	PUNCT
bptjm-15	527	1	biomarkers	biomarker	NOUN
bptjm-15	527	2	for	for	ADP
bptjm-15	527	3	alk	alk	PROPN
bptjm-15	527	4	and	and	CCONJ
bptjm-15	527	5	ros1	ros1	VERB
bptjm-15	527	6	in	in	ADP
bptjm-15	527	7	lung	lung	NOUN
bptjm-15	527	8	cancer	cancer	NOUN
bptjm-15	527	9	:	:	PUNCT
bptjm-15	527	10	immunohistochemistry	immunohistochemistry	NOUN
bptjm-15	527	11	and	and	CCONJ
bptjm-15	527	12	fluorescent	fluorescent	NOUN
bptjm-15	527	13	in	in	ADP
bptjm-15	527	14	situ	situ	ADJ
bptjm-15	527	15	hybridization	hybridization	NOUN
bptjm-15	527	16	.	.	PUNCT
bptjm-15	528	1	archives	archive	NOUN
bptjm-15	528	2	of	of	ADP
bptjm-15	528	3	pathology	pathology	PROPN
bptjm-15	528	4	&	&	CCONJ
bptjm-15	528	5	laboratory	laboratory	PROPN
bptjm-15	528	6	medicine	medicine	NOUN
bptjm-15	528	7	,	,	PUNCT
bptjm-15	528	8	142(8	142(8	NUM
bptjm-15	528	9	)	)	PUNCT
bptjm-15	528	10	,	,	PUNCT
bptjm-15	528	11	922–928	922–928	NUM
bptjm-15	528	12	.	.	PUNCT
bptjm-15	529	1	https://doi.org/10.5858/	https://doi.org/10.5858/	PROPN
bptjm-15	529	2	arpa.2017	arpa.2017	PROPN
bptjm-15	529	3	-	-	PUNCT
bptjm-15	529	4	0502	0502	NUM
bptjm-15	529	5	-	-	PUNCT
bptjm-15	529	6	ra	ra	PROPN
bptjm-15	529	7	59	59	NUM
bptjm-15	529	8	.	.	PUNCT
bptjm-15	530	1	mader	mader	NOUN
bptjm-15	530	2	,	,	PUNCT
bptjm-15	530	3	s.	s.	PROPN
bptjm-15	530	4	,	,	PUNCT
bptjm-15	530	5	&	&	CCONJ
bptjm-15	530	6	pantel	pantel	PROPN
bptjm-15	530	7	,	,	PUNCT
bptjm-15	530	8	k.	k.	PROPN
bptjm-15	530	9	(	(	PUNCT
bptjm-15	530	10	2017	2017	NUM
bptjm-15	530	11	)	)	PUNCT
bptjm-15	530	12	.	.	PUNCT
bptjm-15	531	1	liquid	liquid	ADJ
bptjm-15	531	2	biopsy	biopsy	NOUN
bptjm-15	531	3	:	:	PUNCT
bptjm-15	531	4	berkeley	berkeley	PROPN
bptjm-15	531	5	pharma	pharma	PROPN
bptjm-15	531	6	tech	tech	NOUN
bptjm-15	531	7	journal	journal	NOUN
bptjm-15	531	8	of	of	ADP
bptjm-15	531	9	medicine	medicine	NOUN
bptjm-15	531	10	|	|	ADV
bptjm-15	531	11	89	89	NUM
bptjm-15	531	12	current	current	ADJ
bptjm-15	531	13	status	status	NOUN
bptjm-15	531	14	and	and	CCONJ
bptjm-15	531	15	future	future	ADJ
bptjm-15	531	16	perspectives.oncology	perspectives.oncology	NOUN
bptjm-15	531	17	research	research	NOUN
bptjm-15	531	18	and	and	CCONJ
bptjm-15	531	19	treatment	treatment	NOUN
bptjm-15	531	20	,	,	PUNCT
bptjm-15	531	21	40(7	40(7	NOUN
bptjm-15	531	22	-	-	SYM
bptjm-15	531	23	8)	8)	NUM
bptjm-15	531	24	,	,	PUNCT
bptjm-15	531	25	404–408	404–408	NUM
bptjm-15	531	26	.	.	PUNCT
bptjm-15	532	1	https://doi.org/10.1159/000478018	https://doi.org/10.1159/000478018	ADV
bptjm-15	532	2	60	60	NUM
bptjm-15	532	3	.	.	PUNCT
bptjm-15	533	1	madsen	madsen	PROPN
bptjm-15	533	2	,	,	PUNCT
bptjm-15	533	3	a.	a.	NOUN
bptjm-15	533	4	t.	t.	PROPN
bptjm-15	533	5	,	,	PUNCT
bptjm-15	533	6	winther	winther	PROPN
bptjm-15	533	7	-	-	PUNCT
bptjm-15	533	8	larsen	larsen	PROPN
bptjm-15	533	9	,	,	PUNCT
bptjm-15	533	10	a.	a.	PROPN
bptjm-15	533	11	,	,	PUNCT
bptjm-15	533	12	mcculloch	mcculloch	PROPN
bptjm-15	533	13	,	,	PUNCT
bptjm-15	533	14	t.	t.	PROPN
bptjm-15	533	15	,	,	PUNCT
bptjm-15	533	16	meldgaard	meldgaard	NOUN
bptjm-15	533	17	,	,	PUNCT
bptjm-15	533	18	p.	p.	PROPN
bptjm-15	533	19	,	,	PUNCT
bptjm-15	533	20	&	&	CCONJ
bptjm-15	533	21	sorensen	sorensen	PROPN
bptjm-15	533	22	,	,	PUNCT
bptjm-15	533	23	b.	b.	PROPN
bptjm-15	533	24	s.	s.	PROPN
bptjm-15	533	25	(	(	PUNCT
bptjm-15	533	26	2020	2020	NUM
bptjm-15	533	27	)	)	PUNCT
bptjm-15	533	28	.	.	PUNCT
bptjm-15	534	1	genomic	genomic	ADJ
bptjm-15	534	2	pro	pro	ADJ
bptjm-15	534	3	�	�	PROPN
bptjm-15	534	4	ling	ling	NOUN
bptjm-15	534	5	of	of	ADP
bptjm-15	534	6	circulating	circulate	VERB
bptjm-15	534	7	tumor	tumor	NOUN
bptjm-15	534	8	dna	dna	PROPN
bptjm-15	534	9	predicts	predict	NOUN
bptjm-15	534	10	outcome	outcome	VERB
bptjm-15	534	11	and	and	CCONJ
bptjm-15	534	12	demonstrates	demonstrate	VERB
bptjm-15	534	13	tumor	tumor	NOUN
bptjm-15	534	14	evolution	evolution	NOUN
bptjm-15	534	15	in	in	ADP
bptjm-15	534	16	alk	alk	NOUN
bptjm-15	534	17	-	-	PUNCT
bptjm-15	534	18	positive	positive	ADJ
bptjm-15	534	19	non	non	ADJ
bptjm-15	534	20	-	-	ADJ
bptjm-15	534	21	small	small	ADJ
bptjm-15	534	22	cell	cell	NOUN
bptjm-15	534	23	lung	lung	NOUN
bptjm-15	534	24	cancer	cancer	NOUN
bptjm-15	534	25	patients	patient	NOUN
bptjm-15	534	26	.	.	PUNCT
bptjm-15	535	1	cancers	cancer	NOUN
bptjm-15	535	2	,	,	PUNCT
bptjm-15	535	3	12(4	12(4	NUM
bptjm-15	535	4	)	)	PUNCT
bptjm-15	535	5	,	,	PUNCT
bptjm-15	535	6	947	947	NUM
bptjm-15	535	7	.	.	PUNCT
bptjm-15	536	1	https://doi.org/10.3390/cancers12040947	https://doi.org/10.3390/cancers12040947	PROPN
bptjm-15	536	2	61	61	NUM
bptjm-15	536	3	.	.	PUNCT
bptjm-15	536	4	mao	mao	PROPN
bptjm-15	536	5	,	,	PUNCT
bptjm-15	536	6	l.	l.	PROPN
bptjm-15	536	7	,	,	PUNCT
bptjm-15	536	8	liu	liu	PROPN
bptjm-15	536	9	,	,	PUNCT
bptjm-15	536	10	s.	s.	PROPN
bptjm-15	536	11	,	,	PUNCT
bptjm-15	536	12	hu	hu	PROPN
bptjm-15	536	13	,	,	PUNCT
bptjm-15	536	14	l.	l.	PROPN
bptjm-15	536	15	,	,	PUNCT
bptjm-15	536	16	jia	jia	PROPN
bptjm-15	536	17	,	,	PUNCT
bptjm-15	536	18	l.	l.	PROPN
bptjm-15	536	19	,	,	PUNCT
bptjm-15	536	20	wang	wang	PROPN
bptjm-15	536	21	,	,	PUNCT
bptjm-15	536	22	h.	h.	PROPN
bptjm-15	536	23	,	,	PUNCT
bptjm-15	536	24	guo	guo	PROPN
bptjm-15	536	25	,	,	PUNCT
bptjm-15	536	26	m.	m.	NOUN
bptjm-15	536	27	,	,	PUNCT
bptjm-15	536	28	…	…	PUNCT
bptjm-15	536	29	xu	xu	INTJ
bptjm-15	536	30	,	,	PUNCT
bptjm-15	536	31	l.	l.	PROPN
bptjm-15	536	32	(	(	PUNCT
bptjm-15	536	33	2018	2018	NUM
bptjm-15	536	34	)	)	PUNCT
bptjm-15	536	35	.	.	PUNCT
bptjm-15	537	1	mir-30	mir-30	NUM
bptjm-15	537	2	family	family	NOUN
bptjm-15	537	3	:	:	PUNCT
bptjm-15	537	4	a	a	DET
bptjm-15	537	5	promising	promising	ADJ
bptjm-15	537	6	regulator	regulator	NOUN
bptjm-15	537	7	in	in	ADP
bptjm-15	537	8	development	development	NOUN
bptjm-15	537	9	and	and	CCONJ
bptjm-15	537	10	disease	disease	NOUN
bptjm-15	537	11	.	.	PUNCT
bptjm-15	537	12	biomed	biome	VERB
bptjm-15	537	13	research	research	NOUN
bptjm-15	537	14	international	international	PROPN
bptjm-15	537	15	,	,	PUNCT
bptjm-15	537	16	2018	2018	NUM
bptjm-15	537	17	,	,	PUNCT
bptjm-15	537	18	1–8	1–8	X
bptjm-15	537	19	.	.	PUNCT
bptjm-15	538	1	https://doi.org/10.1155/2018/9623412	https://doi.org/10.1155/2018/9623412	PROPN
bptjm-15	538	2	62	62	NUM
bptjm-15	538	3	.	.	PUNCT
bptjm-15	538	4	mao	mao	PROPN
bptjm-15	538	5	,	,	PUNCT
bptjm-15	538	6	xiaowei	xiaowei	PROPN
bptjm-15	538	7	,	,	PUNCT
bptjm-15	538	8	zhou	zhou	PROPN
bptjm-15	538	9	zhang	zhang	PROPN
bptjm-15	538	10	,	,	PUNCT
bptjm-15	538	11	xiaoxuan	xiaoxuan	PROPN
bptjm-15	538	12	zheng	zheng	PROPN
bptjm-15	538	13	,	,	PUNCT
bptjm-15	538	14	fangfang	fangfang	PROPN
bptjm-15	538	15	xie	xie	PROPN
bptjm-15	538	16	,	,	PUNCT
bptjm-15	538	17	feidie	feidie	PROPN
bptjm-15	538	18	duan	duan	PROPN
bptjm-15	538	19	,	,	PUNCT
bptjm-15	538	20	liyan	liyan	VERB
bptjm-15	538	21	jiang	jiang	PROPN
bptjm-15	538	22	,	,	PUNCT
bptjm-15	538	23	shannon	shannon	PROPN
bptjm-15	538	24	chuai	chuai	PROPN
bptjm-15	538	25	,	,	PUNCT
bptjm-15	538	26	han	han	PROPN
bptjm-15	538	27	han	han	PROPN
bptjm-15	538	28	-	-	PUNCT
bptjm-15	538	29	zhang	zhang	PROPN
bptjm-15	538	30	,	,	PUNCT
bptjm-15	538	31	baohui	baohui	PROPN
bptjm-15	538	32	han	han	PROPN
bptjm-15	538	33	,	,	PUNCT
bptjm-15	538	34	and	and	CCONJ
bptjm-15	538	35	jiayuan	jiayuan	PROPN
bptjm-15	538	36	sun	sun	PROPN
bptjm-15	538	37	.	.	PUNCT
bptjm-15	539	1	(	(	PUNCT
bptjm-15	539	2	april	april	PROPN
bptjm-15	539	3	1	1	NUM
bptjm-15	539	4	,	,	PUNCT
bptjm-15	539	5	2017	2017	NUM
bptjm-15	539	6	)	)	PUNCT
bptjm-15	539	7	.	.	PUNCT
bptjm-15	540	1	capture	capture	NOUN
bptjm-15	540	2	-	-	PUNCT
bptjm-15	540	3	based	base	VERB
bptjm-15	540	4	targeted	target	VERB
bptjm-15	540	5	ultradeep	ultradeep	ADJ
bptjm-15	540	6	sequencing	sequence	VERB
bptjm-15	540	7	in	in	ADP
bptjm-15	540	8	paired	pair	VERB
bptjm-15	540	9	tissue	tissue	NOUN
bptjm-15	540	10	and	and	CCONJ
bptjm-15	540	11	plasma	plasma	NOUN
bptjm-15	540	12	samples	sample	NOUN
bptjm-15	540	13	demonstrates	demonstrate	VERB
bptjm-15	540	14	di	di	PROPN
bptjm-15	540	15	�	�	PROPN
bptjm-15	540	16	erential	erential	ADJ
bptjm-15	540	17	subclonal	subclonal	ADJ
bptjm-15	540	18	ctdna	ctdna	NOUN
bptjm-15	540	19	-	-	PUNCT
bptjm-15	540	20	releasing	release	VERB
bptjm-15	540	21	capability	capability	NOUN
bptjm-15	540	22	in	in	ADP
bptjm-15	540	23	advanced	advanced	ADJ
bptjm-15	540	24	lung	lung	NOUN
bptjm-15	540	25	cancer	cancer	NOUN
bptjm-15	540	26	.	.	PUNCT
bptjm-15	541	1	journal	journal	PROPN
bptjm-15	541	2	of	of	ADP
bptjm-15	541	3	thoracic	thoracic	NOUN
bptjm-15	541	4	oncology	oncology	NOUN
bptjm-15	541	5	,	,	PUNCT
bptjm-15	541	6	12(4	12(4	NUM
bptjm-15	541	7	)	)	PUNCT
bptjm-15	541	8	,	,	PUNCT
bptjm-15	541	9	663–72	663–72	NUM
bptjm-15	541	10	.	.	PUNCT
bptjm-15	542	1	https://doi.org/10.1016/j.jtho	https://doi.org/10.1016/j.jtho	NOUN
bptjm-15	542	2	.	.	PUNCT
bptjm-15	543	1	2016.11.2235	2016.11.2235	NUM
bptjm-15	543	2	.	.	NOUN
bptjm-15	543	3	63	63	NUM
bptjm-15	543	4	.	.	PUNCT
bptjm-15	544	1	mlak	mlak	PROPN
bptjm-15	544	2	,	,	PUNCT
bptjm-15	544	3	r.	r.	PROPN
bptjm-15	544	4	,	,	PUNCT
bptjm-15	544	5	powrózek	powrózek	NOUN
bptjm-15	544	6	,	,	PUNCT
bptjm-15	544	7	t.	t.	PROPN
bptjm-15	544	8	,	,	PUNCT
bptjm-15	544	9	brzozowska	brzozowska	PROPN
bptjm-15	544	10	,	,	PUNCT
bptjm-15	544	11	a.	a.	NOUN
bptjm-15	544	12	,	,	PUNCT
bptjm-15	544	13	homa	homa	NOUN
bptjm-15	544	14	-	-	PUNCT
bptjm-15	544	15	mlak	mlak	ADJ
bptjm-15	544	16	,	,	PUNCT
bptjm-15	544	17	i.	i.	NOUN
bptjm-15	544	18	,	,	PUNCT
bptjm-15	544	19	mazurek	mazurek	PROPN
bptjm-15	544	20	,	,	PUNCT
bptjm-15	544	21	m.	m.	NOUN
bptjm-15	544	22	,	,	PUNCT
bptjm-15	544	23	&	&	CCONJ
bptjm-15	544	24	małecka	małecka	PROPN
bptjm-15	544	25	massalska	massalska	PROPN
bptjm-15	544	26	,	,	PUNCT
bptjm-15	544	27	t.	t.	PROPN
bptjm-15	544	28	(	(	PUNCT
bptjm-15	544	29	2018	2018	NUM
bptjm-15	544	30	)	)	PUNCT
bptjm-15	544	31	.	.	PUNCT
bptjm-15	545	1	rrm1	rrm1	NOUN
bptjm-15	545	2	gene	gene	NOUN
bptjm-15	545	3	expression	expression	NOUN
bptjm-15	545	4	evaluated	evaluate	VERB
bptjm-15	545	5	in	in	ADP
bptjm-15	545	6	the	the	DET
bptjm-15	545	7	liquid	liquid	ADJ
bptjm-15	545	8	biopsy	biopsy	NOUN
bptjm-15	545	9	(	(	PUNCT
bptjm-15	545	10	blood	blood	NOUN
bptjm-15	545	11	cfrna	cfrna	NOUN
bptjm-15	545	12	)	)	PUNCT
bptjm-15	545	13	as	as	ADP
bptjm-15	545	14	a	a	DET
bptjm-15	545	15	non	non	ADJ
bptjm-15	545	16	-	-	ADJ
bptjm-15	545	17	invasive	invasive	ADJ
bptjm-15	545	18	,	,	PUNCT
bptjm-15	545	19	predictive	predictive	ADJ
bptjm-15	545	20	factor	factor	NOUN
bptjm-15	545	21	for	for	ADP
bptjm-15	545	22	radiotherapy	radiotherapy	NOUN
bptjm-15	545	23	-	-	PUNCT
bptjm-15	545	24	induced	induce	VERB
bptjm-15	545	25	oral	oral	ADJ
bptjm-15	545	26	mucositis	mucositis	NOUN
bptjm-15	545	27	and	and	CCONJ
bptjm-15	545	28	potential	potential	ADJ
bptjm-15	545	29	prognostic	prognostic	ADJ
bptjm-15	545	30	biomarker	biomarker	NOUN
bptjm-15	545	31	in	in	ADP
bptjm-15	545	32	head	head	NOUN
bptjm-15	545	33	and	and	CCONJ
bptjm-15	545	34	neck	neck	NOUN
bptjm-15	545	35	cancer	cancer	NOUN
bptjm-15	545	36	patients	patient	NOUN
bptjm-15	545	37	.	.	PUNCT
bptjm-15	546	1	cancer	cancer	NOUN
bptjm-15	546	2	biomarkers	biomarker	NOUN
bptjm-15	546	3	:	:	PUNCT
bptjm-15	546	4	section	section	NOUN
bptjm-15	546	5	a	a	PRON
bptjm-15	546	6	of	of	ADP
bptjm-15	546	7	disease	disease	NOUN
bptjm-15	546	8	markers	marker	NOUN
bptjm-15	546	9	,	,	PUNCT
bptjm-15	546	10	22(4	22(4	NUM
bptjm-15	546	11	)	)	PUNCT
bptjm-15	546	12	,	,	PUNCT
bptjm-15	546	13	657–667	657–667	NUM
bptjm-15	546	14	.	.	PUNCT
bptjm-15	546	15	https://doi.org/10.3233/cbm-171082	https://doi.org/10.3233/cbm-171082	ADP
bptjm-15	546	16	64	64	NUM
bptjm-15	546	17	.	.	PUNCT
bptjm-15	547	1	mo	mo	PROPN
bptjm-15	547	2	,	,	PUNCT
bptjm-15	547	3	h.	h.	PROPN
bptjm-15	547	4	n.	n.	PROPN
bptjm-15	547	5	,	,	PUNCT
bptjm-15	547	6	&	&	CCONJ
bptjm-15	547	7	liu	liu	PROPN
bptjm-15	547	8	,	,	PUNCT
bptjm-15	547	9	p.	p.	NOUN
bptjm-15	547	10	(	(	PUNCT
bptjm-15	547	11	2017	2017	NUM
bptjm-15	547	12	)	)	PUNCT
bptjm-15	547	13	.	.	PUNCT
bptjm-15	548	1	targeting	target	VERB
bptjm-15	548	2	met	meet	VERB
bptjm-15	548	3	in	in	ADP
bptjm-15	548	4	cancer	cancer	NOUN
bptjm-15	548	5	therapy	therapy	NOUN
bptjm-15	548	6	.	.	PUNCT
bptjm-15	549	1	chronic	chronic	ADJ
bptjm-15	549	2	diseases	disease	NOUN
bptjm-15	549	3	and	and	CCONJ
bptjm-15	549	4	translational	translational	ADJ
bptjm-15	549	5	medicine	medicine	NOUN
bptjm-15	549	6	,	,	PUNCT
bptjm-15	549	7	3(3	3(3	NUM
bptjm-15	549	8	)	)	PUNCT
bptjm-15	549	9	,	,	PUNCT
bptjm-15	549	10	148–153	148–153	NUM
bptjm-15	549	11	.	.	PUNCT
bptjm-15	550	1	https://doi.org/10.1016/j.cdtm.2017.06.002	https://doi.org/10.1016/j.cdtm.2017.06.002	NUM
bptjm-15	550	2	65	65	NUM
bptjm-15	550	3	.	.	PUNCT
bptjm-15	551	1	munagala	munagala	PROPN
bptjm-15	551	2	r	r	PROPN
bptjm-15	551	3	,	,	PUNCT
bptjm-15	551	4	aqil	aqil	PROPN
bptjm-15	551	5	f	f	PROPN
bptjm-15	551	6	,	,	PUNCT
bptjm-15	551	7	gupta	gupta	PROPN
bptjm-15	551	8	rc	rc	PROPN
bptjm-15	551	9	.	.	PUNCT
bptjm-15	551	10	(	(	PUNCT
bptjm-15	551	11	august	august	PROPN
bptjm-15	551	12	2016	2016	NUM
bptjm-15	551	13	)	)	PUNCT
bptjm-15	551	14	.	.	PUNCT
bptjm-15	552	1	exosomal	exosomal	ADJ
bptjm-15	552	2	mirnas	mirna	NOUN
bptjm-15	552	3	as	as	ADP
bptjm-15	552	4	biomarkers	biomarker	NOUN
bptjm-15	552	5	of	of	ADP
bptjm-15	552	6	recurrent	recurrent	ADJ
bptjm-15	552	7	lung	lung	NOUN
bptjm-15	552	8	cancer	cancer	NOUN
bptjm-15	552	9	.	.	PUNCT
bptjm-15	553	1	tumour	tumour	PROPN
bptjm-15	553	2	biol	biol	PROPN
bptjm-15	553	3	.	.	PUNCT
bptjm-15	553	4	,	,	PUNCT
bptjm-15	553	5	37(8	37(8	NUM
bptjm-15	553	6	)	)	PUNCT
bptjm-15	553	7	,	,	PUNCT
bptjm-15	553	8	10703	10703	NUM
bptjm-15	553	9	-	-	SYM
bptjm-15	553	10	14	14	NUM
bptjm-15	553	11	.	.	PUNCT
bptjm-15	554	1	doi	doi	NOUN
bptjm-15	554	2	:	:	PUNCT
bptjm-15	554	3	10.1007	10.1007	NUM
bptjm-15	554	4	/	/	SYM
bptjm-15	554	5	s13277	s13277	NOUN
bptjm-15	554	6	-	-	PUNCT
bptjm-15	554	7	016	016	NUM
bptjm-15	554	8	-	-	PUNCT
bptjm-15	554	9	4939	4939	NUM
bptjm-15	554	10	-	-	SYM
bptjm-15	554	11	8	8	NUM
bptjm-15	554	12	.	.	PUNCT
bptjm-15	555	1	epub	epub	PROPN
bptjm-15	555	2	2016	2016	NUM
bptjm-15	555	3	feb	feb	PROPN
bptjm-15	555	4	11	11	NUM
bptjm-15	555	5	.	.	PUNCT
bptjm-15	556	1	pmid	pmid	NOUN
bptjm-15	556	2	:	:	PUNCT
bptjm-15	556	3	26867772	26867772	NUM
bptjm-15	556	4	.	.	PUNCT
bptjm-15	557	1	66	66	NUM
bptjm-15	557	2	.	.	PUNCT
bptjm-15	557	3	reis	reis	NOUN
bptjm-15	557	4	,	,	PUNCT
bptjm-15	557	5	gerald	gerald	PROPN
bptjm-15	557	6	f.	f.	PROPN
bptjm-15	557	7	,	,	PUNCT
bptjm-15	557	8	melike	melike	ADJ
bptjm-15	557	9	pekmezci	pekmezci	NOUN
bptjm-15	557	10	,	,	PUNCT
bptjm-15	557	11	helen	helen	PROPN
bptjm-15	557	12	m.	m.	PROPN
bptjm-15	557	13	hansen	hansen	PROPN
bptjm-15	557	14	,	,	PUNCT
bptjm-15	557	15	terri	terri	PROPN
bptjm-15	557	16	rice	rice	PROPN
bptjm-15	557	17	,	,	PUNCT
bptjm-15	557	18	roxanne	roxanne	PROPN
bptjm-15	557	19	e.	e.	PROPN
bptjm-15	557	20	marshall	marshall	PROPN
bptjm-15	557	21	,	,	PUNCT
bptjm-15	557	22	annette	annette	PROPN
bptjm-15	557	23	m.	m.	PROPN
bptjm-15	557	24	molinaro	molinaro	PROPN
bptjm-15	557	25	,	,	PUNCT
bptjm-15	557	26	joanna	joanna	PROPN
bptjm-15	557	27	j.	j.	PROPN
bptjm-15	557	28	phillips	phillips	PROPN
bptjm-15	557	29	,	,	PUNCT
bptjm-15	557	30	et	et	PROPN
bptjm-15	557	31	al	al	PROPN
bptjm-15	557	32	.	.	PUNCT
bptjm-15	558	1	(	(	PUNCT
bptjm-15	558	2	may	may	PROPN
bptjm-15	558	3	1	1	NUM
bptjm-15	558	4	,	,	PUNCT
bptjm-15	558	5	2015	2015	NUM
bptjm-15	558	6	)	)	PUNCT
bptjm-15	558	7	.	.	PUNCT
bptjm-15	559	1	cdkn2a	cdkn2a	PROPN
bptjm-15	559	2	loss	loss	NOUN
bptjm-15	559	3	is	be	AUX
bptjm-15	559	4	associated	associate	VERB
bptjm-15	559	5	with	with	ADP
bptjm-15	559	6	shortened	shorten	VERB
bptjm-15	559	7	overall	overall	ADJ
bptjm-15	559	8	survival	survival	NOUN
bptjm-15	559	9	in	in	ADP
bptjm-15	559	10	lower	low	ADJ
bptjm-15	559	11	-	-	PUNCT
bptjm-15	559	12	grade	grade	NOUN
bptjm-15	559	13	(	(	PUNCT
bptjm-15	559	14	world	world	NOUN
bptjm-15	559	15	health	health	NOUN
bptjm-15	559	16	organization	organization	PROPN
bptjm-15	559	17	grades	grades	PROPN
bptjm-15	559	18	ii	ii	PROPN
bptjm-15	559	19	–	–	PUNCT
bptjm-15	559	20	iii	iii	NOUN
bptjm-15	559	21	)	)	PUNCT
bptjm-15	559	22	astrocytomas	astrocytoma	NOUN
bptjm-15	559	23	.	.	PUNCT
bptjm-15	560	1	journal	journal	PROPN
bptjm-15	560	2	of	of	ADP
bptjm-15	560	3	neuropathology	neuropathology	NOUN
bptjm-15	560	4	&	&	CCONJ
bptjm-15	560	5	experimental	experimental	ADJ
bptjm-15	560	6	neurology	neurology	NOUN
bptjm-15	560	7	,	,	PUNCT
bptjm-15	560	8	74(5	74(5	NOUN
bptjm-15	560	9	)	)	PUNCT
bptjm-15	560	10	,	,	PUNCT
bptjm-15	560	11	442–52	442–52	PROPN
bptjm-15	560	12	.	.	PUNCT
bptjm-15	561	1	https://doi.org/10.1097/nen.0000000000000188	https://doi.org/10.1097/nen.0000000000000188	PROPN
bptjm-15	561	2	.	.	PROPN
bptjm-15	562	1	67	67	NUM
bptjm-15	562	2	.	.	PUNCT
bptjm-15	563	1	remon	remon	PROPN
bptjm-15	563	2	,	,	PUNCT
bptjm-15	563	3	jordi	jordi	PROPN
bptjm-15	563	4	,	,	PUNCT
bptjm-15	563	5	benjamin	benjamin	PROPN
bptjm-15	563	6	besse	besse	PROPN
bptjm-15	563	7	,	,	PUNCT
bptjm-15	563	8	alexandra	alexandra	PROPN
bptjm-15	563	9	leary	leary	PROPN
bptjm-15	563	10	,	,	PUNCT
bptjm-15	563	11	ivan	ivan	PROPN
bptjm-15	563	12	bièche	bièche	PROPN
bptjm-15	563	13	,	,	PUNCT
bptjm-15	563	14	bastien	bastien	PROPN
bptjm-15	563	15	job	job	PROPN
bptjm-15	563	16	,	,	PUNCT
bptjm-15	563	17	ludovic	ludovic	PROPN
bptjm-15	563	18	lacroix	lacroix	PROPN
bptjm-15	563	19	,	,	PUNCT
bptjm-15	563	20	aurélie	aurélie	NOUN
bptjm-15	563	21	auguste	auguste	PROPN
bptjm-15	563	22	,	,	PUNCT
bptjm-15	563	23	et	et	PROPN
bptjm-15	563	24	al	al	PROPN
bptjm-15	563	25	.	.	PUNCT
bptjm-15	564	1	(	(	PUNCT
bptjm-15	564	2	september	september	PROPN
bptjm-15	564	3	1	1	NUM
bptjm-15	564	4	,	,	PUNCT
bptjm-15	564	5	2020	2020	NUM
bptjm-15	564	6	)	)	PUNCT
bptjm-15	564	7	.	.	PUNCT
bptjm-15	565	1	somatic	somatic	ADJ
bptjm-15	565	2	and	and	CCONJ
bptjm-15	565	3	germline	germline	NOUN
bptjm-15	565	4	brca	brca	PROPN
bptjm-15	565	5	1	1	NUM
bptjm-15	565	6	and	and	CCONJ
bptjm-15	565	7	2	2	NUM
bptjm-15	565	8	mutations	mutation	NOUN
bptjm-15	565	9	in	in	ADP
bptjm-15	565	10	advanced	advanced	ADJ
bptjm-15	565	11	nsclc	nsclc	NOUN
bptjm-15	565	12	from	from	ADP
bptjm-15	565	13	the	the	DET
bptjm-15	565	14	safir02	safir02	NOUN
bptjm-15	565	15	-	-	PUNCT
bptjm-15	565	16	lung	lung	NOUN
bptjm-15	565	17	trial	trial	NOUN
bptjm-15	565	18	.	.	PUNCT
bptjm-15	566	1	jto	jto	PROPN
bptjm-15	566	2	clinical	clinical	ADJ
bptjm-15	566	3	and	and	CCONJ
bptjm-15	566	4	research	research	NOUN
bptjm-15	566	5	reports	report	NOUN
bptjm-15	566	6	,	,	PUNCT
bptjm-15	566	7	1(3	1(3	NUM
bptjm-15	566	8	)	)	PUNCT
bptjm-15	566	9	,	,	PUNCT
bptjm-15	566	10	100068	100068	NUM
bptjm-15	566	11	.	.	PUNCT
bptjm-15	567	1	https://doi.org/10.1016/j.jtocrr.2020.100068	https://doi.org/10.1016/j.jtocrr.2020.100068	PROPN
bptjm-15	567	2	.	.	PUNCT
bptjm-15	568	1	68	68	NUM
bptjm-15	568	2	.	.	PUNCT
bptjm-15	569	1	ricciuti	ricciuti	PROPN
bptjm-15	569	2	,	,	PUNCT
bptjm-15	569	3	b.	b.	PROPN
bptjm-15	569	4	,	,	PUNCT
bptjm-15	569	5	brambilla	brambilla	NOUN
bptjm-15	569	6	,	,	PUNCT
bptjm-15	569	7	m.	m.	NOUN
bptjm-15	569	8	,	,	PUNCT
bptjm-15	569	9	metro	metro	PROPN
bptjm-15	569	10	,	,	PUNCT
bptjm-15	569	11	g.	g.	PROPN
bptjm-15	569	12	,	,	PUNCT
bptjm-15	569	13	baglivo	baglivo	PROPN
bptjm-15	569	14	,	,	PUNCT
bptjm-15	569	15	s.	s.	PROPN
bptjm-15	569	16	,	,	PUNCT
bptjm-15	569	17	matocci	matocci	PROPN
bptjm-15	569	18	,	,	PUNCT
bptjm-15	569	19	r.	r.	PROPN
bptjm-15	569	20	,	,	PUNCT
bptjm-15	569	21	pirro	pirro	NOUN
bptjm-15	569	22	,	,	PUNCT
bptjm-15	569	23	m.	m.	NOUN
bptjm-15	569	24	,	,	PUNCT
bptjm-15	569	25	&	&	CCONJ
bptjm-15	569	26	chiari	chiari	PROPN
bptjm-15	569	27	,	,	PUNCT
bptjm-15	569	28	r.	r.	PROPN
bptjm-15	569	29	(	(	PUNCT
bptjm-15	569	30	2017	2017	NUM
bptjm-15	569	31	)	)	PUNCT
bptjm-15	569	32	.	.	PUNCT
bptjm-15	570	1	targeting	target	VERB
bptjm-15	570	2	ntrk	ntrk	NOUN
bptjm-15	570	3	fusion	fusion	NOUN
bptjm-15	570	4	in	in	ADP
bptjm-15	570	5	non	non	ADJ
bptjm-15	570	6	-	-	ADJ
bptjm-15	570	7	small	small	ADJ
bptjm-15	570	8	cell	cell	NOUN
bptjm-15	570	9	lung	lung	NOUN
bptjm-15	570	10	cancer	cancer	NOUN
bptjm-15	570	11	:	:	PUNCT
bptjm-15	570	12	rationale	rationale	NOUN
bptjm-15	570	13	and	and	CCONJ
bptjm-15	570	14	clinical	clinical	ADJ
bptjm-15	570	15	evidence	evidence	NOUN
bptjm-15	570	16	.	.	PUNCT
bptjm-15	571	1	medical	medical	ADJ
bptjm-15	571	2	oncology	oncology	NOUN
bptjm-15	571	3	(	(	PUNCT
bptjm-15	571	4	northwood	northwood	PROPN
bptjm-15	571	5	,	,	PUNCT
bptjm-15	571	6	london	london	PROPN
bptjm-15	571	7	,	,	PUNCT
bptjm-15	571	8	england	england	PROPN
bptjm-15	571	9	)	)	PUNCT
bptjm-15	571	10	,	,	PUNCT
bptjm-15	571	11	34(6	34(6	NOUN
bptjm-15	571	12	)	)	PUNCT
bptjm-15	571	13	,	,	PUNCT
bptjm-15	571	14	105	105	NUM
bptjm-15	571	15	.	.	PUNCT
bptjm-15	571	16	https://doi.org/10.1007/s12032-017-0967-5	https://doi.org/10.1007/s12032-017-0967-5	PROPN
bptjm-15	571	17	.	.	PUNCT
bptjm-15	572	1	69	69	NUM
bptjm-15	572	2	.	.	PUNCT
bptjm-15	572	3	rijavec	rijavec	PROPN
bptjm-15	572	4	,	,	PUNCT
bptjm-15	572	5	e.	e.	PROPN
bptjm-15	572	6	,	,	PUNCT
bptjm-15	572	7	coco	coco	PROPN
bptjm-15	572	8	,	,	PUNCT
bptjm-15	572	9	s.	s.	PROPN
bptjm-15	572	10	,	,	PUNCT
bptjm-15	572	11	genova	genova	PROPN
bptjm-15	572	12	,	,	PUNCT
bptjm-15	572	13	c.	c.	PROPN
bptjm-15	572	14	,	,	PUNCT
bptjm-15	572	15	rossi	rossi	PROPN
bptjm-15	572	16	,	,	PUNCT
bptjm-15	572	17	g.	g.	PROPN
bptjm-15	572	18	,	,	PUNCT
bptjm-15	572	19	longo	longo	PROPN
bptjm-15	572	20	,	,	PUNCT
bptjm-15	572	21	l.	l.	PROPN
bptjm-15	572	22	,	,	PUNCT
bptjm-15	572	23	&	&	CCONJ
bptjm-15	572	24	grossi	grossi	PROPN
bptjm-15	572	25	,	,	PUNCT
bptjm-15	572	26	f.	f.	PROPN
bptjm-15	572	27	(	(	PUNCT
bptjm-15	572	28	2019	2019	NUM
bptjm-15	572	29	)	)	PUNCT
bptjm-15	572	30	.	.	PUNCT
bptjm-15	573	1	liquid	liquid	ADJ
bptjm-15	573	2	biopsy	biopsy	NOUN
bptjm-15	573	3	in	in	ADP
bptjm-15	573	4	non	non	ADJ
bptjm-15	573	5	-	-	ADJ
bptjm-15	573	6	small	small	ADJ
bptjm-15	573	7	cell	cell	NOUN
bptjm-15	573	8	lung	lung	NOUN
bptjm-15	573	9	cancer	cancer	NOUN
bptjm-15	573	10	:	:	PUNCT
bptjm-15	573	11	highlights	highlight	NOUN
bptjm-15	573	12	and	and	CCONJ
bptjm-15	573	13	challenges	challenge	NOUN
bptjm-15	573	14	.	.	PUNCT
bptjm-15	574	1	cancers	cancer	NOUN
bptjm-15	574	2	,	,	PUNCT
bptjm-15	574	3	12(1	12(1	NUM
bptjm-15	574	4	)	)	PUNCT
bptjm-15	574	5	,	,	PUNCT
bptjm-15	574	6	17	17	NUM
bptjm-15	574	7	.	.	PUNCT
bptjm-15	574	8	https://doi.org/10.3390/cancers12010017	https://doi.org/10.3390/cancers12010017	PROPN
bptjm-15	574	9	70	70	NUM
bptjm-15	574	10	.	.	PUNCT
bptjm-15	575	1	rinaldi	rinaldi	PROPN
bptjm-15	575	2	a.	a.	PROPN
bptjm-15	575	3	(	(	PUNCT
bptjm-15	575	4	2011	2011	NUM
bptjm-15	575	5	)	)	PUNCT
bptjm-15	575	6	.	.	PUNCT
bptjm-15	576	1	teaming	team	VERB
bptjm-15	576	2	up	up	ADP
bptjm-15	576	3	for	for	ADP
bptjm-15	576	4	biomarker	biomarker	NOUN
bptjm-15	576	5	future	future	NOUN
bptjm-15	576	6	.	.	PUNCT
bptjm-15	577	1	many	many	ADJ
bptjm-15	577	2	problems	problem	NOUN
bptjm-15	577	3	still	still	ADV
bptjm-15	577	4	hinder	hinder	VERB
bptjm-15	577	5	the	the	DET
bptjm-15	577	6	use	use	NOUN
bptjm-15	577	7	of	of	ADP
bptjm-15	577	8	biomarkers	biomarker	NOUN
bptjm-15	577	9	in	in	ADP
bptjm-15	577	10	clinical	clinical	ADJ
bptjm-15	577	11	practice	practice	NOUN
bptjm-15	577	12	,	,	PUNCT
bptjm-15	577	13	but	but	CCONJ
bptjm-15	577	14	new	new	ADJ
bptjm-15	577	15	public	public	ADJ
bptjm-15	577	16	-	-	PUNCT
bptjm-15	577	17	private	private	ADJ
bptjm-15	577	18	partnerships	partnership	NOUN
bptjm-15	577	19	could	could	AUX
bptjm-15	577	20	improve	improve	VERB
bptjm-15	577	21	the	the	DET
bptjm-15	577	22	situation	situation	NOUN
bptjm-15	577	23	.	.	PUNCT
bptjm-15	578	1	embo	embo	PROPN
bptjm-15	578	2	reports	report	NOUN
bptjm-15	578	3	,	,	PUNCT
bptjm-15	578	4	12(6	12(6	NUM
bptjm-15	578	5	)	)	PUNCT
bptjm-15	578	6	,	,	PUNCT
bptjm-15	578	7	500–504	500–504	NUM
bptjm-15	578	8	.	.	PUNCT
bptjm-15	579	1	https://doi.org/10.1038/embor.2011.90	https://doi.org/10.1038/embor.2011.90	PROPN
bptjm-15	579	2	berkeley	berkeley	PROPN
bptjm-15	579	3	pharma	pharma	PROPN
bptjm-15	579	4	tech	tech	NOUN
bptjm-15	579	5	journal	journal	NOUN
bptjm-15	579	6	of	of	ADP
bptjm-15	579	7	medicine	medicine	NOUN
bptjm-15	579	8	|	|	ADV
bptjm-15	579	9	90	90	NUM
bptjm-15	579	10	71	71	NUM
bptjm-15	579	11	.	.	PUNCT
bptjm-15	580	1	rulli	rulli	PROPN
bptjm-15	580	2	,	,	PUNCT
bptjm-15	580	3	antonio	antonio	PROPN
bptjm-15	580	4	&	&	CCONJ
bptjm-15	580	5	antognelli	antognelli	PROPN
bptjm-15	580	6	,	,	PUNCT
bptjm-15	580	7	cinzia	cinzia	PROPN
bptjm-15	580	8	&	&	CCONJ
bptjm-15	580	9	covarelli	covarelli	PROPN
bptjm-15	580	10	,	,	PUNCT
bptjm-15	580	11	piero	piero	PROPN
bptjm-15	580	12	&	&	CCONJ
bptjm-15	580	13	izzo	izzo	PROPN
bptjm-15	580	14	,	,	PUNCT
bptjm-15	580	15	luciano	luciano	PROPN
bptjm-15	580	16	&	&	CCONJ
bptjm-15	580	17	vienna	vienna	PROPN
bptjm-15	580	18	,	,	PUNCT
bptjm-15	580	19	ludovini	ludovini	PROPN
bptjm-15	580	20	&	&	CCONJ
bptjm-15	580	21	annamaria	annamaria	PROPN
bptjm-15	580	22	,	,	PUNCT
bptjm-15	580	23	siggillino	siggillino	PROPN
bptjm-15	580	24	&	&	CCONJ
bptjm-15	580	25	nicola	nicola	PROPN
bptjm-15	580	26	,	,	PUNCT
bptjm-15	580	27	talesa	talesa	PROPN
bptjm-15	580	28	&	&	CCONJ
bptjm-15	580	29	svitlana	svitlana	PROPN
bptjm-15	580	30	,	,	PUNCT
bptjm-15	580	31	zayik	zayik	PROPN
bptjm-15	580	32	.	.	PUNCT
bptjm-15	580	33	(	(	PUNCT
bptjm-15	580	34	2020	2020	NUM
bptjm-15	580	35	)	)	PUNCT
bptjm-15	580	36	.	.	PUNCT
bptjm-15	581	1	liquid	liquid	ADJ
bptjm-15	581	2	biopsy	biopsy	NOUN
bptjm-15	581	3	in	in	ADP
bptjm-15	581	4	early	early	ADJ
bptjm-15	581	5	breast	breast	NOUN
bptjm-15	581	6	cancer	cancer	NOUN
bptjm-15	581	7	:	:	PUNCT
bptjm-15	581	8	a	a	DET
bptjm-15	581	9	preliminary	preliminary	ADJ
bptjm-15	581	10	report	report	NOUN
bptjm-15	581	11	.	.	PUNCT
bptjm-15	582	1	annals	annal	NOUN
bptjm-15	582	2	of	of	ADP
bptjm-15	582	3	clinical	clinical	ADJ
bptjm-15	582	4	oncology	oncology	NOUN
bptjm-15	582	5	.	.	PUNCT
bptjm-15	583	1	1	1	NUM
bptjm-15	583	2	-	-	SYM
bptjm-15	583	3	8	8	NUM
bptjm-15	583	4	.	.	NOUN
bptjm-15	583	5	10.31487	10.31487	NUM
bptjm-15	583	6	/	/	SYM
bptjm-15	583	7	j.aco.2020.01.01	j.aco.2020.01.01	PROPN
bptjm-15	583	8	.	.	PUNCT
bptjm-15	584	1	72	72	NUM
bptjm-15	584	2	.	.	PUNCT
bptjm-15	585	1	saito	saito	PROPN
bptjm-15	585	2	,	,	PUNCT
bptjm-15	585	3	m.	m.	NOUN
bptjm-15	585	4	,	,	PUNCT
bptjm-15	585	5	schetter	schetter	NOUN
bptjm-15	585	6	,	,	PUNCT
bptjm-15	585	7	a.	a.	PROPN
bptjm-15	585	8	j.	j.	PROPN
bptjm-15	585	9	,	,	PUNCT
bptjm-15	585	10	mollerup	mollerup	NOUN
bptjm-15	585	11	,	,	PUNCT
bptjm-15	585	12	s.	s.	PROPN
bptjm-15	585	13	,	,	PUNCT
bptjm-15	585	14	kohno	kohno	NOUN
bptjm-15	585	15	,	,	PUNCT
bptjm-15	585	16	t.	t.	PROPN
bptjm-15	585	17	,	,	PUNCT
bptjm-15	585	18	skaug	skaug	PROPN
bptjm-15	585	19	,	,	PUNCT
bptjm-15	585	20	v.	v.	PROPN
bptjm-15	585	21	,	,	PUNCT
bptjm-15	585	22	bowman	bowman	PROPN
bptjm-15	585	23	,	,	PUNCT
bptjm-15	585	24	e.	e.	PROPN
bptjm-15	585	25	d.	d.	PROPN
bptjm-15	585	26	,	,	PUNCT
bptjm-15	585	27	mathé	mathé	PROPN
bptjm-15	585	28	,	,	PUNCT
bptjm-15	585	29	e.	e.	PROPN
bptjm-15	585	30	a.	a.	PROPN
bptjm-15	585	31	,	,	PUNCT
bptjm-15	585	32	takenoshita	takenoshita	PROPN
bptjm-15	585	33	,	,	PUNCT
bptjm-15	585	34	s.	s.	PROPN
bptjm-15	585	35	,	,	PUNCT
bptjm-15	585	36	yokota	yokota	PROPN
bptjm-15	585	37	,	,	PUNCT
bptjm-15	585	38	j.	j.	PROPN
bptjm-15	585	39	,	,	PUNCT
bptjm-15	585	40	haugen	haugen	PROPN
bptjm-15	585	41	,	,	PUNCT
bptjm-15	585	42	a.	a.	PROPN
bptjm-15	585	43	,	,	PUNCT
bptjm-15	585	44	&	&	CCONJ
bptjm-15	585	45	harris	harris	PROPN
bptjm-15	585	46	,	,	PUNCT
bptjm-15	585	47	c.	c.	PROPN
bptjm-15	585	48	c.	c.	PROPN
bptjm-15	585	49	(	(	PUNCT
bptjm-15	585	50	2011	2011	NUM
bptjm-15	585	51	)	)	PUNCT
bptjm-15	585	52	.	.	PUNCT
bptjm-15	586	1	the	the	DET
bptjm-15	586	2	association	association	PROPN
bptjm-15	586	3	of	of	ADP
bptjm-15	586	4	microrna	microrna	PROPN
bptjm-15	586	5	expression	expression	NOUN
bptjm-15	586	6	with	with	ADP
bptjm-15	586	7	prognosis	prognosis	NOUN
bptjm-15	586	8	and	and	CCONJ
bptjm-15	586	9	progression	progression	NOUN
bptjm-15	586	10	in	in	ADP
bptjm-15	586	11	early	early	ADJ
bptjm-15	586	12	-	-	PUNCT
bptjm-15	586	13	stage	stage	NOUN
bptjm-15	586	14	,	,	PUNCT
bptjm-15	586	15	non	non	ADJ
bptjm-15	586	16	-	-	ADJ
bptjm-15	586	17	small	small	ADJ
bptjm-15	586	18	cell	cell	NOUN
bptjm-15	586	19	lung	lung	NOUN
bptjm-15	586	20	adenocarcinoma	adenocarcinoma	NOUN
bptjm-15	586	21	:	:	PUNCT
bptjm-15	586	22	a	a	DET
bptjm-15	586	23	retrospective	retrospective	ADJ
bptjm-15	586	24	analysis	analysis	NOUN
bptjm-15	586	25	of	of	ADP
bptjm-15	586	26	three	three	NUM
bptjm-15	586	27	cohorts	cohort	NOUN
bptjm-15	586	28	.	.	PUNCT
bptjm-15	587	1	clinical	clinical	ADJ
bptjm-15	587	2	cancer	cancer	NOUN
bptjm-15	587	3	research	research	NOUN
bptjm-15	587	4	:	:	PUNCT
bptjm-15	587	5	an	an	DET
bptjm-15	587	6	official	official	ADJ
bptjm-15	587	7	journal	journal	NOUN
bptjm-15	587	8	of	of	ADP
bptjm-15	587	9	the	the	DET
bptjm-15	587	10	american	american	PROPN
bptjm-15	587	11	association	association	PROPN
bptjm-15	587	12	for	for	ADP
bptjm-15	587	13	cancer	cancer	NOUN
bptjm-15	587	14	research	research	NOUN
bptjm-15	587	15	,	,	PUNCT
bptjm-15	587	16	17(7	17(7	NUM
bptjm-15	587	17	)	)	PUNCT
bptjm-15	587	18	,	,	PUNCT
bptjm-15	587	19	1875–1882	1875–1882	NUM
bptjm-15	587	20	.	.	PUNCT
bptjm-15	588	1	https://doi.org/10.1158/1078-0432.ccr-10-2961	https://doi.org/10.1158/1078-0432.ccr-10-2961	PROPN
bptjm-15	588	2	73	73	NUM
bptjm-15	588	3	.	.	PUNCT
bptjm-15	589	1	san	san	PROPN
bptjm-15	589	2	�	�	PROPN
bptjm-15	589	3	orenzo	orenzo	PROPN
bptjm-15	589	4	,	,	PUNCT
bptjm-15	589	5	c.	c.	PROPN
bptjm-15	589	6	,	,	PUNCT
bptjm-15	589	7	ilie	ilie	PROPN
bptjm-15	589	8	,	,	PUNCT
bptjm-15	589	9	m.	m.	NOUN
bptjm-15	589	10	i.	i.	PROPN
bptjm-15	589	11	,	,	PUNCT
bptjm-15	589	12	belaid	belaid	PROPN
bptjm-15	589	13	,	,	PUNCT
bptjm-15	589	14	a.	a.	PROPN
bptjm-15	589	15	,	,	PUNCT
bptjm-15	589	16	barlési	barlési	PROPN
bptjm-15	589	17	,	,	PUNCT
bptjm-15	589	18	f.	f.	PROPN
bptjm-15	589	19	,	,	PUNCT
bptjm-15	589	20	mouroux	mouroux	NOUN
bptjm-15	589	21	,	,	PUNCT
bptjm-15	589	22	j.	j.	PROPN
bptjm-15	589	23	,	,	PUNCT
bptjm-15	589	24	marquette	marquette	PROPN
bptjm-15	589	25	,	,	PUNCT
bptjm-15	589	26	c.	c.	PROPN
bptjm-15	589	27	h.	h.	PROPN
bptjm-15	589	28	,	,	PUNCT
bptjm-15	589	29	brest	brest	NOUN
bptjm-15	589	30	,	,	PUNCT
bptjm-15	589	31	p.	p.	NOUN
bptjm-15	589	32	,	,	PUNCT
bptjm-15	589	33	&	&	CCONJ
bptjm-15	589	34	hofman	hofman	PROPN
bptjm-15	589	35	,	,	PUNCT
bptjm-15	589	36	p.	p.	NOUN
bptjm-15	589	37	(	(	PUNCT
bptjm-15	589	38	2013	2013	NUM
bptjm-15	589	39	)	)	PUNCT
bptjm-15	589	40	.	.	PUNCT
bptjm-15	590	1	two	two	NUM
bptjm-15	590	2	panels	panel	NOUN
bptjm-15	590	3	of	of	ADP
bptjm-15	590	4	plasma	plasma	NOUN
bptjm-15	590	5	micrornas	microrna	NOUN
bptjm-15	590	6	as	as	ADP
bptjm-15	590	7	non	non	ADJ
bptjm-15	590	8	-	-	ADJ
bptjm-15	590	9	invasive	invasive	ADJ
bptjm-15	590	10	biomarkers	biomarker	NOUN
bptjm-15	590	11	for	for	ADP
bptjm-15	590	12	prediction	prediction	NOUN
bptjm-15	590	13	of	of	ADP
bptjm-15	590	14	recurrence	recurrence	NOUN
bptjm-15	590	15	in	in	ADP
bptjm-15	590	16	resectable	resectable	ADJ
bptjm-15	590	17	nsclc	nsclc	NOUN
bptjm-15	590	18	.	.	PUNCT
bptjm-15	591	1	plos	plos	PROPN
bptjm-15	591	2	one	one	NUM
bptjm-15	591	3	,	,	PUNCT
bptjm-15	591	4	8(1	8(1	NOUN
bptjm-15	591	5	)	)	PUNCT
bptjm-15	591	6	,	,	PUNCT
bptjm-15	591	7	e54596	e54596	NOUN
bptjm-15	591	8	.	.	PUNCT
bptjm-15	592	1	https://doi.org/	https://doi.org/	PROPN
bptjm-15	592	2	10.1371	10.1371	NUM
bptjm-15	592	3	/	/	SYM
bptjm-15	592	4	journal.pone.0054596	journal.pone.0054596	PROPN
bptjm-15	592	5	74	74	NUM
bptjm-15	592	6	.	.	PUNCT
bptjm-15	593	1	santiago	santiago	PROPN
bptjm-15	593	2	-	-	PUNCT
bptjm-15	593	3	walker	walker	PROPN
bptjm-15	593	4	,	,	PUNCT
bptjm-15	593	5	ademi	ademi	PROPN
bptjm-15	593	6	&	&	CCONJ
bptjm-15	593	7	moy	moy	PROPN
bptjm-15	593	8	,	,	PUNCT
bptjm-15	593	9	christopher	christopher	PROPN
bptjm-15	593	10	&	&	CCONJ
bptjm-15	593	11	cherkas	cherkas	PROPN
bptjm-15	593	12	,	,	PUNCT
bptjm-15	593	13	yauheniya	yauheniya	NOUN
bptjm-15	593	14	&	&	CCONJ
bptjm-15	593	15	loriot	loriot	PROPN
bptjm-15	593	16	,	,	PUNCT
bptjm-15	593	17	yohann	yohann	PROPN
bptjm-15	593	18	&	&	CCONJ
bptjm-15	593	19	siefker	siefker	NOUN
bptjm-15	593	20	-	-	PUNCT
bptjm-15	593	21	radtke	radtke	NOUN
bptjm-15	593	22	,	,	PUNCT
bptjm-15	593	23	arlene	arlene	PROPN
bptjm-15	593	24	&	&	CCONJ
bptjm-15	593	25	motley	motley	PROPN
bptjm-15	593	26	,	,	PUNCT
bptjm-15	593	27	cli	cli	PROPN
bptjm-15	593	28	�	�	PROPN
bptjm-15	593	29	ord	ord	PROPN
bptjm-15	593	30	&	&	CCONJ
bptjm-15	593	31	avadhani	avadhani	PROPN
bptjm-15	593	32	,	,	PUNCT
bptjm-15	593	33	anjali	anjali	PROPN
bptjm-15	593	34	&	&	CCONJ
bptjm-15	593	35	ohagan	ohagan	PROPN
bptjm-15	593	36	,	,	PUNCT
bptjm-15	593	37	anne	anne	PROPN
bptjm-15	593	38	&	&	CCONJ
bptjm-15	593	39	porre	porre	PROPN
bptjm-15	593	40	,	,	PUNCT
bptjm-15	593	41	peter	peter	PROPN
bptjm-15	593	42	&	&	CCONJ
bptjm-15	593	43	lorenzi	lorenzi	PROPN
bptjm-15	593	44	,	,	PUNCT
bptjm-15	593	45	matthew	matthew	PROPN
bptjm-15	593	46	&	&	CCONJ
bptjm-15	593	47	mcca	mcca	PROPN
bptjm-15	593	48	�	�	PROPN
bptjm-15	593	49	ery	ery	PROPN
bptjm-15	593	50	,	,	PUNCT
bptjm-15	593	51	ian	ian	PROPN
bptjm-15	593	52	.	.	PUNCT
bptjm-15	593	53	(	(	PUNCT
bptjm-15	593	54	2019	2019	NUM
bptjm-15	593	55	)	)	PUNCT
bptjm-15	593	56	.	.	PUNCT
bptjm-15	594	1	analysis	analysis	NOUN
bptjm-15	594	2	of	of	ADP
bptjm-15	594	3	fgfr	fgfr	ADJ
bptjm-15	594	4	alterations	alteration	NOUN
bptjm-15	594	5	from	from	ADP
bptjm-15	594	6	circulating	circulate	VERB
bptjm-15	594	7	tumor	tumor	NOUN
bptjm-15	594	8	dna	dna	NOUN
bptjm-15	594	9	(	(	PUNCT
bptjm-15	594	10	ctdna	ctdna	NOUN
bptjm-15	594	11	)	)	PUNCT
bptjm-15	594	12	and	and	CCONJ
bptjm-15	594	13	tissue	tissue	NOUN
bptjm-15	594	14	in	in	ADP
bptjm-15	594	15	a	a	DET
bptjm-15	594	16	phase	phase	NOUN
bptjm-15	594	17	ii	ii	NOUN
bptjm-15	594	18	trial	trial	NOUN
bptjm-15	594	19	of	of	ADP
bptjm-15	594	20	erda	erda	PROPN
bptjm-15	594	21	�	�	NOUN
bptjm-15	594	22	tinib	tinib	NOUN
bptjm-15	594	23	in	in	ADP
bptjm-15	594	24	urothelial	urothelial	ADJ
bptjm-15	594	25	carcinoma	carcinoma	NOUN
bptjm-15	594	26	(	(	PUNCT
bptjm-15	594	27	uc	uc	PROPN
bptjm-15	594	28	)	)	PUNCT
bptjm-15	594	29	..	..	PUNCT
bptjm-15	594	30	journal	journal	NOUN
bptjm-15	594	31	of	of	ADP
bptjm-15	594	32	clinical	clinical	ADJ
bptjm-15	594	33	oncology	oncology	NOUN
bptjm-15	594	34	.	.	PUNCT
bptjm-15	595	1	37	37	NUM
bptjm-15	595	2	.	.	X
bptjm-15	595	3	420	420	NUM
bptjm-15	595	4	-	-	SYM
bptjm-15	595	5	420	420	NUM
bptjm-15	595	6	.	.	PUNCT
bptjm-15	596	1	10.1200	10.1200	NUM
bptjm-15	596	2	/	/	SYM
bptjm-15	596	3	jco	jco	PROPN
bptjm-15	596	4	.	.	PUNCT
bptjm-15	597	1	2019.37.7_suppl.420	2019.37.7_suppl.420	NUM
bptjm-15	597	2	.	.	PUNCT
bptjm-15	598	1	75	75	NUM
bptjm-15	598	2	.	.	PUNCT
bptjm-15	598	3	satoh	satoh	NOUN
bptjm-15	598	4	,	,	PUNCT
bptjm-15	598	5	n.	n.	NOUN
bptjm-15	598	6	,	,	PUNCT
bptjm-15	598	7	maniwa	maniwa	PROPN
bptjm-15	598	8	,	,	PUNCT
bptjm-15	598	9	y.	y.	PROPN
bptjm-15	598	10	,	,	PUNCT
bptjm-15	598	11	bermudez	bermudez	PROPN
bptjm-15	598	12	,	,	PUNCT
bptjm-15	598	13	v.	v.	PROPN
bptjm-15	598	14	p.	p.	PROPN
bptjm-15	598	15	,	,	PUNCT
bptjm-15	598	16	nishimura	nishimura	PROPN
bptjm-15	598	17	,	,	PUNCT
bptjm-15	598	18	k.	k.	PROPN
bptjm-15	598	19	,	,	PUNCT
bptjm-15	598	20	nishio	nishio	PROPN
bptjm-15	598	21	,	,	PUNCT
bptjm-15	598	22	w.	w.	PROPN
bptjm-15	598	23	,	,	PUNCT
bptjm-15	598	24	yoshimura	yoshimura	NOUN
bptjm-15	598	25	,	,	PUNCT
bptjm-15	598	26	m.	m.	NOUN
bptjm-15	598	27	,	,	PUNCT
bptjm-15	598	28	okita	okita	PROPN
bptjm-15	598	29	,	,	PUNCT
bptjm-15	598	30	y.	y.	PROPN
bptjm-15	598	31	,	,	PUNCT
bptjm-15	598	32	ohbayashi	ohbayashi	ADJ
bptjm-15	598	33	,	,	PUNCT
bptjm-15	598	34	c.	c.	PROPN
bptjm-15	598	35	,	,	PUNCT
bptjm-15	598	36	hurwitz	hurwitz	PROPN
bptjm-15	598	37	,	,	PUNCT
bptjm-15	598	38	j.	j.	PROPN
bptjm-15	598	39	,	,	PUNCT
bptjm-15	598	40	&	&	CCONJ
bptjm-15	598	41	hayashi	hayashi	PROPN
bptjm-15	598	42	,	,	PUNCT
bptjm-15	598	43	y.	y.	PROPN
bptjm-15	598	44	(	(	PUNCT
bptjm-15	598	45	2011	2011	NUM
bptjm-15	598	46	)	)	PUNCT
bptjm-15	598	47	.	.	PUNCT
bptjm-15	599	1	oncogenic	oncogenic	ADJ
bptjm-15	599	2	phosphatase	phosphatase	NOUN
bptjm-15	599	3	wip1	wip1	PROPN
bptjm-15	599	4	is	be	AUX
bptjm-15	599	5	a	a	DET
bptjm-15	599	6	novel	novel	ADJ
bptjm-15	599	7	prognostic	prognostic	ADJ
bptjm-15	599	8	marker	marker	NOUN
bptjm-15	599	9	for	for	ADP
bptjm-15	599	10	lung	lung	NOUN
bptjm-15	599	11	adenocarcinoma	adenocarcinoma	PROPN
bptjm-15	599	12	patient	patient	NOUN
bptjm-15	599	13	survival	survival	NOUN
bptjm-15	599	14	.	.	PUNCT
bptjm-15	600	1	cancer	cancer	NOUN
bptjm-15	600	2	science	science	NOUN
bptjm-15	600	3	,	,	PUNCT
bptjm-15	600	4	102(5	102(5	NUM
bptjm-15	600	5	)	)	PUNCT
bptjm-15	600	6	,	,	PUNCT
bptjm-15	600	7	1101–1106	1101–1106	NUM
bptjm-15	600	8	.	.	PUNCT
bptjm-15	601	1	https://doi.org/10.1111/j.1349-7006.2011.01898.x	https://doi.org/10.1111/j.1349-7006.2011.01898.x	ADJ
bptjm-15	601	2	.	.	PUNCT
bptjm-15	602	1	76	76	NUM
bptjm-15	602	2	.	.	PUNCT
bptjm-15	603	1	sequist	sequist	PROPN
bptjm-15	603	2	,	,	PUNCT
bptjm-15	603	3	l.	l.	PROPN
bptjm-15	603	4	v.	v.	PROPN
bptjm-15	603	5	,	,	PUNCT
bptjm-15	603	6	von	von	PROPN
bptjm-15	603	7	pawel	pawel	PROPN
bptjm-15	603	8	,	,	PUNCT
bptjm-15	603	9	j.	j.	PROPN
bptjm-15	603	10	,	,	PUNCT
bptjm-15	603	11	garmey	garmey	NOUN
bptjm-15	603	12	,	,	PUNCT
bptjm-15	603	13	e.	e.	PROPN
bptjm-15	603	14	g.	g.	PROPN
bptjm-15	603	15	,	,	PUNCT
bptjm-15	603	16	akerley	akerley	PROPN
bptjm-15	603	17	,	,	PUNCT
bptjm-15	603	18	w.	w.	PROPN
bptjm-15	603	19	l.	l.	PROPN
bptjm-15	603	20	,	,	PUNCT
bptjm-15	603	21	brugger	brugger	PROPN
bptjm-15	603	22	,	,	PUNCT
bptjm-15	603	23	w.	w.	PROPN
bptjm-15	603	24	,	,	PUNCT
bptjm-15	603	25	ferrari	ferrari	PROPN
bptjm-15	603	26	,	,	PUNCT
bptjm-15	603	27	d.	d.	PROPN
bptjm-15	603	28	,	,	PUNCT
bptjm-15	603	29	chen	chen	PROPN
bptjm-15	603	30	,	,	PUNCT
bptjm-15	603	31	y.	y.	PROPN
bptjm-15	603	32	,	,	PUNCT
bptjm-15	603	33	costa	costa	PROPN
bptjm-15	603	34	,	,	PUNCT
bptjm-15	603	35	d.	d.	PROPN
bptjm-15	603	36	b.	b.	PROPN
bptjm-15	603	37	,	,	PUNCT
bptjm-15	603	38	gerber	gerber	PROPN
bptjm-15	603	39	,	,	PUNCT
bptjm-15	603	40	d.	d.	PROPN
bptjm-15	603	41	e.	e.	PROPN
bptjm-15	603	42	,	,	PUNCT
bptjm-15	603	43	orlov	orlov	PROPN
bptjm-15	603	44	,	,	PUNCT
bptjm-15	603	45	s.	s.	PROPN
bptjm-15	603	46	,	,	PUNCT
bptjm-15	603	47	ramlau	ramlau	PROPN
bptjm-15	603	48	,	,	PUNCT
bptjm-15	603	49	r.	r.	PROPN
bptjm-15	603	50	,	,	PUNCT
bptjm-15	603	51	arthur	arthur	PROPN
bptjm-15	603	52	,	,	PUNCT
bptjm-15	603	53	s.	s.	PROPN
bptjm-15	603	54	,	,	PUNCT
bptjm-15	603	55	gorbachevsky	gorbachevsky	PROPN
bptjm-15	603	56	,	,	PUNCT
bptjm-15	603	57	i.	i.	PROPN
bptjm-15	603	58	,	,	PUNCT
bptjm-15	603	59	schwartz	schwartz	PROPN
bptjm-15	603	60	,	,	PUNCT
bptjm-15	603	61	b.	b.	PROPN
bptjm-15	603	62	,	,	PUNCT
bptjm-15	603	63	&	&	CCONJ
bptjm-15	603	64	schiller	schiller	PROPN
bptjm-15	603	65	,	,	PUNCT
bptjm-15	603	66	j.	j.	PROPN
bptjm-15	603	67	h.	h.	PROPN
bptjm-15	603	68	(	(	PUNCT
bptjm-15	603	69	2011	2011	NUM
bptjm-15	603	70	)	)	PUNCT
bptjm-15	603	71	.	.	PUNCT
bptjm-15	604	1	randomized	randomize	VERB
bptjm-15	604	2	phase	phase	NOUN
bptjm-15	604	3	ii	ii	PROPN
bptjm-15	604	4	study	study	NOUN
bptjm-15	604	5	of	of	ADP
bptjm-15	604	6	erlotinib	erlotinib	NOUN
bptjm-15	604	7	plus	plus	CCONJ
bptjm-15	604	8	tivantinib	tivantinib	NOUN
bptjm-15	604	9	versus	versus	ADP
bptjm-15	604	10	erlotinib	erlotinib	NOUN
bptjm-15	604	11	plus	plus	CCONJ
bptjm-15	604	12	placebo	placebo	NOUN
bptjm-15	604	13	in	in	ADP
bptjm-15	604	14	previously	previously	ADV
bptjm-15	604	15	treated	treat	VERB
bptjm-15	604	16	non	non	ADJ
bptjm-15	604	17	-	-	ADJ
bptjm-15	604	18	small	small	ADJ
bptjm-15	604	19	-	-	PUNCT
bptjm-15	604	20	cell	cell	NOUN
bptjm-15	604	21	lung	lung	NOUN
bptjm-15	604	22	cancer	cancer	NOUN
bptjm-15	604	23	.	.	PUNCT
bptjm-15	605	1	journal	journal	NOUN
bptjm-15	605	2	of	of	ADP
bptjm-15	605	3	clinical	clinical	ADJ
bptjm-15	605	4	oncology	oncology	NOUN
bptjm-15	605	5	:	:	PUNCT
bptjm-15	605	6	official	official	ADJ
bptjm-15	605	7	journal	journal	NOUN
bptjm-15	605	8	of	of	ADP
bptjm-15	605	9	the	the	DET
bptjm-15	605	10	american	american	ADJ
bptjm-15	605	11	society	society	NOUN
bptjm-15	605	12	of	of	ADP
bptjm-15	605	13	clinical	clinical	ADJ
bptjm-15	605	14	oncology	oncology	NOUN
bptjm-15	605	15	,	,	PUNCT
bptjm-15	605	16	29(24	29(24	NUM
bptjm-15	605	17	)	)	PUNCT
bptjm-15	605	18	,	,	PUNCT
bptjm-15	605	19	3307–3315	3307–3315	NUM
bptjm-15	605	20	.	.	PUNCT
bptjm-15	606	1	https://doi.org/10.1200/jco.2010.34.0570	https://doi.org/10.1200/jco.2010.34.0570	NOUN
bptjm-15	606	2	.	.	PUNCT
bptjm-15	607	1	77	77	NUM
bptjm-15	607	2	.	.	PUNCT
bptjm-15	608	1	schildhaus	schildhaus	PROPN
bptjm-15	608	2	h.	h.	PROPN
bptjm-15	608	3	u.	u.	PROPN
bptjm-15	608	4	(	(	PUNCT
bptjm-15	608	5	2020	2020	NUM
bptjm-15	608	6	)	)	PUNCT
bptjm-15	608	7	.	.	PUNCT
bptjm-15	609	1	immunhistochemiebasierte	immunhistochemiebasierte	PROPN
bptjm-15	609	2	prädiktive	prädiktive	ADJ
bptjm-15	609	3	biomarker	biomarker	NOUN
bptjm-15	609	4	bei	bei	VERB
bptjm-15	609	5	lungenkarzinomen	lungenkarzinoman	NOUN
bptjm-15	609	6	[	[	X
bptjm-15	609	7	immunohistochemistry	immunohistochemistry	NOUN
bptjm-15	609	8	-	-	PUNCT
bptjm-15	609	9	based	base	VERB
bptjm-15	609	10	predictive	predictive	ADJ
bptjm-15	609	11	biomarkers	biomarker	NOUN
bptjm-15	609	12	for	for	ADP
bptjm-15	609	13	lung	lung	NOUN
bptjm-15	609	14	cancer	cancer	NOUN
bptjm-15	609	15	]	]	PUNCT
bptjm-15	609	16	.	.	PUNCT
bptjm-15	610	1	der	der	ADJ
bptjm-15	610	2	pathologe	pathologe	NOUN
bptjm-15	610	3	,	,	PUNCT
bptjm-15	610	4	41(1	41(1	NUM
bptjm-15	610	5	)	)	PUNCT
bptjm-15	610	6	,	,	PUNCT
bptjm-15	610	7	21–31	21–31	NUM
bptjm-15	610	8	.	.	PUNCT
bptjm-15	611	1	https://doi.org/10.1007/s00292-020-00750-7	https://doi.org/10.1007/s00292-020-00750-7	NUM
bptjm-15	611	2	78	78	NUM
bptjm-15	611	3	.	.	PUNCT
bptjm-15	612	1	shaw	shaw	PROPN
bptjm-15	612	2	,	,	PUNCT
bptjm-15	612	3	a.	a.	NOUN
bptjm-15	612	4	t.	t.	PROPN
bptjm-15	612	5	,	,	PUNCT
bptjm-15	612	6	yeap	yeap	PROPN
bptjm-15	612	7	,	,	PUNCT
bptjm-15	612	8	b.	b.	PROPN
bptjm-15	612	9	y.	y.	PROPN
bptjm-15	612	10	,	,	PUNCT
bptjm-15	612	11	solomon	solomon	PROPN
bptjm-15	612	12	,	,	PUNCT
bptjm-15	612	13	b.	b.	PROPN
bptjm-15	612	14	j.	j.	PROPN
bptjm-15	612	15	,	,	PUNCT
bptjm-15	612	16	riely	riely	PROPN
bptjm-15	612	17	,	,	PUNCT
bptjm-15	612	18	g.	g.	PROPN
bptjm-15	612	19	j.	j.	PROPN
bptjm-15	612	20	,	,	PUNCT
bptjm-15	612	21	gainor	gainor	PROPN
bptjm-15	612	22	,	,	PUNCT
bptjm-15	612	23	j.	j.	PROPN
bptjm-15	612	24	,	,	PUNCT
bptjm-15	612	25	engelman	engelman	PROPN
bptjm-15	612	26	,	,	PUNCT
bptjm-15	612	27	j.	j.	PROPN
bptjm-15	612	28	a.	a.	PROPN
bptjm-15	612	29	,	,	PUNCT
bptjm-15	612	30	shapiro	shapiro	PROPN
bptjm-15	612	31	,	,	PUNCT
bptjm-15	612	32	g.	g.	PROPN
bptjm-15	612	33	i.	i.	PROPN
bptjm-15	612	34	,	,	PUNCT
bptjm-15	612	35	costa	costa	PROPN
bptjm-15	612	36	,	,	PUNCT
bptjm-15	612	37	d.	d.	PROPN
bptjm-15	612	38	b.	b.	PROPN
bptjm-15	612	39	,	,	PUNCT
bptjm-15	612	40	ou	ou	PROPN
bptjm-15	612	41	,	,	PUNCT
bptjm-15	612	42	s.	s.	PROPN
bptjm-15	612	43	h.	h.	PROPN
bptjm-15	612	44	,	,	PUNCT
bptjm-15	612	45	butaney	butaney	NOUN
bptjm-15	612	46	,	,	PUNCT
bptjm-15	612	47	m.	m.	NOUN
bptjm-15	612	48	,	,	PUNCT
bptjm-15	612	49	salgia	salgia	NOUN
bptjm-15	612	50	,	,	PUNCT
bptjm-15	612	51	r.	r.	PROPN
bptjm-15	612	52	,	,	PUNCT
bptjm-15	612	53	maki	maki	PROPN
bptjm-15	612	54	,	,	PUNCT
bptjm-15	612	55	r.	r.	PROPN
bptjm-15	612	56	g.	g.	PROPN
bptjm-15	612	57	,	,	PUNCT
bptjm-15	612	58	varella	varella	NOUN
bptjm-15	612	59	garcia	garcia	PROPN
bptjm-15	612	60	,	,	PUNCT
bptjm-15	612	61	m.	m.	NOUN
bptjm-15	612	62	,	,	PUNCT
bptjm-15	612	63	doebele	doebele	PROPN
bptjm-15	612	64	,	,	PUNCT
bptjm-15	612	65	r.	r.	PROPN
bptjm-15	612	66	c.	c.	PROPN
bptjm-15	612	67	,	,	PUNCT
bptjm-15	612	68	bang	bang	PROPN
bptjm-15	612	69	,	,	PUNCT
bptjm-15	612	70	y.	y.	PROPN
bptjm-15	612	71	j.	j.	PROPN
bptjm-15	612	72	,	,	PUNCT
bptjm-15	612	73	kulig	kulig	PROPN
bptjm-15	612	74	,	,	PUNCT
bptjm-15	612	75	k.	k.	PROPN
bptjm-15	612	76	,	,	PUNCT
bptjm-15	612	77	selaru	selaru	PROPN
bptjm-15	612	78	,	,	PUNCT
bptjm-15	612	79	p.	p.	PROPN
bptjm-15	612	80	,	,	PUNCT
bptjm-15	612	81	tang	tang	PROPN
bptjm-15	612	82	,	,	PUNCT
bptjm-15	612	83	y.	y.	PROPN
bptjm-15	612	84	,	,	PUNCT
bptjm-15	612	85	wilner	wilner	PROPN
bptjm-15	612	86	,	,	PUNCT
bptjm-15	612	87	k.	k.	PROPN
bptjm-15	612	88	d.	d.	PROPN
bptjm-15	612	89	,	,	PUNCT
bptjm-15	612	90	kwak	kwak	PROPN
bptjm-15	612	91	,	,	PUNCT
bptjm-15	612	92	e.	e.	PROPN
bptjm-15	612	93	l.	l.	PROPN
bptjm-15	612	94	,	,	PUNCT
bptjm-15	612	95	…	…	PUNCT
bptjm-15	612	96	camidge	camidge	NOUN
bptjm-15	612	97	,	,	PUNCT
bptjm-15	612	98	d.	d.	PROPN
bptjm-15	612	99	r.	r.	PROPN
bptjm-15	612	100	(	(	PUNCT
bptjm-15	612	101	2011	2011	NUM
bptjm-15	612	102	)	)	PUNCT
bptjm-15	612	103	.	.	PUNCT
bptjm-15	613	1	e	e	X
bptjm-15	613	2	�	�	NOUN
bptjm-15	613	3	ect	ect	VERB
bptjm-15	613	4	of	of	ADP
bptjm-15	613	5	crizotinib	crizotinib	NOUN
bptjm-15	613	6	on	on	ADP
bptjm-15	613	7	overall	overall	ADJ
bptjm-15	613	8	survival	survival	NOUN
bptjm-15	613	9	in	in	ADP
bptjm-15	613	10	patients	patient	NOUN
bptjm-15	613	11	with	with	ADP
bptjm-15	613	12	advanced	advanced	ADJ
bptjm-15	613	13	non	non	ADJ
bptjm-15	613	14	-	-	ADJ
bptjm-15	613	15	small	small	ADJ
bptjm-15	613	16	-	-	PUNCT
bptjm-15	613	17	cell	cell	NOUN
bptjm-15	613	18	lung	lung	NOUN
bptjm-15	613	19	cancer	cancer	NOUN
bptjm-15	613	20	harbouring	harbouring	NOUN
bptjm-15	613	21	alk	alk	PROPN
bptjm-15	613	22	gene	gene	NOUN
bptjm-15	613	23	rearrangement	rearrangement	NOUN
bptjm-15	613	24	:	:	PUNCT
bptjm-15	613	25	a	a	DET
bptjm-15	613	26	retrospective	retrospective	ADJ
bptjm-15	613	27	analysis	analysis	NOUN
bptjm-15	613	28	.	.	PUNCT
bptjm-15	614	1	the	the	DET
bptjm-15	614	2	lancet	lancet	PROPN
bptjm-15	614	3	.	.	PUNCT
bptjm-15	615	1	oncology	oncology	NOUN
bptjm-15	615	2	,	,	PUNCT
bptjm-15	615	3	12(11	12(11	NUM
bptjm-15	615	4	)	)	PUNCT
bptjm-15	615	5	,	,	PUNCT
bptjm-15	615	6	1004–1012	1004–1012	NUM
bptjm-15	615	7	.	.	PUNCT
bptjm-15	615	8	https://doi.org/	https://doi.org/	VERB
bptjm-15	615	9	10.1016	10.1016	NUM
bptjm-15	615	10	/	/	SYM
bptjm-15	615	11	s1470	s1470	PROPN
bptjm-15	615	12	-	-	PUNCT
bptjm-15	615	13	2045(11)70232	2045(11)70232	NOUN
bptjm-15	615	14	-	-	PUNCT
bptjm-15	615	15	7	7	NUM
bptjm-15	615	16	79	79	NUM
bptjm-15	615	17	.	.	PUNCT
bptjm-15	616	1	shi	shi	PROPN
bptjm-15	616	2	gl	gl	PROPN
bptjm-15	616	3	,	,	PUNCT
bptjm-15	616	4	zhang	zhang	PROPN
bptjm-15	616	5	xy	xy	PROPN
bptjm-15	616	6	,	,	PUNCT
bptjm-15	616	7	chen	chen	PROPN
bptjm-15	616	8	y	y	PROPN
bptjm-15	616	9	,	,	PUNCT
bptjm-15	616	10	ma	ma	PROPN
bptjm-15	616	11	s	s	PROPN
bptjm-15	616	12	,	,	PUNCT
bptjm-15	616	13	bai	bai	PROPN
bptjm-15	616	14	wq	wq	PROPN
bptjm-15	616	15	,	,	PUNCT
bptjm-15	616	16	yin	yin	PROPN
bptjm-15	616	17	yj	yj	PROPN
bptjm-15	616	18	.	.	PROPN
bptjm-15	616	19	(	(	PUNCT
bptjm-15	616	20	june	june	PROPN
bptjm-15	616	21	1	1	NUM
bptjm-15	616	22	,	,	PUNCT
bptjm-15	616	23	2020	2020	NUM
bptjm-15	616	24	)	)	PUNCT
bptjm-15	616	25	.	.	PUNCT
bptjm-15	617	1	prognostic	prognostic	ADJ
bptjm-15	617	2	signi	signi	PROPN
bptjm-15	617	3	�	�	PROPN
bptjm-15	617	4	cance	cance	NOUN
bptjm-15	617	5	of	of	ADP
bptjm-15	617	6	serum	serum	NOUN
bptjm-15	617	7	mir-22	mir-22	NOUN
bptjm-15	617	8	,	,	PUNCT
bptjm-15	617	9	mir-125b	mir-125b	NOUN
bptjm-15	617	10	,	,	PUNCT
bptjm-15	617	11	and	and	CCONJ
bptjm-15	617	12	mir-15b	mir-15b	NOUN
bptjm-15	617	13	in	in	ADP
bptjm-15	617	14	non	non	ADJ
bptjm-15	617	15	-	-	ADJ
bptjm-15	617	16	small	small	ADJ
bptjm-15	617	17	cell	cell	NOUN
bptjm-15	617	18	lung	lung	NOUN
bptjm-15	617	19	cancer	cancer	NOUN
bptjm-15	617	20	patients	patient	NOUN
bptjm-15	617	21	.	.	PUNCT
bptjm-15	618	1	clin	clin	PROPN
bptjm-15	618	2	lab	lab	PROPN
bptjm-15	618	3	.	.	PUNCT
bptjm-15	618	4	,	,	PUNCT
bptjm-15	618	5	66(6	66(6	NUM
bptjm-15	618	6	)	)	PUNCT
bptjm-15	618	7	.	.	PUNCT
bptjm-15	619	1	doi	doi	NOUN
bptjm-15	619	2	:	:	PUNCT
bptjm-15	619	3	10.7754	10.7754	NUM
bptjm-15	619	4	/	/	SYM
bptjm-15	619	5	clin.lab.2019.191129	clin.lab.2019.191129	PROPN
bptjm-15	619	6	.	.	PUNCT
bptjm-15	620	1	pmid	pmid	NOUN
bptjm-15	620	2	:	:	PUNCT
bptjm-15	620	3	32538046	32538046	NUM
bptjm-15	620	4	.	.	PUNCT
bptjm-15	621	1	80	80	NUM
bptjm-15	621	2	.	.	PUNCT
bptjm-15	621	3	siravegna	siravegna	PROPN
bptjm-15	621	4	,	,	PUNCT
bptjm-15	621	5	giulia	giulia	PROPN
bptjm-15	621	6	,	,	PUNCT
bptjm-15	621	7	andrea	andrea	PROPN
bptjm-15	621	8	sartore	sartore	NOUN
bptjm-15	621	9	-	-	PUNCT
bptjm-15	621	10	bianchi	bianchi	NOUN
bptjm-15	621	11	,	,	PUNCT
bptjm-15	621	12	rebecca	rebecca	PROPN
bptjm-15	621	13	j.	j.	PROPN
bptjm-15	621	14	nagy	nagy	PROPN
bptjm-15	621	15	,	,	PUNCT
bptjm-15	621	16	kanwal	kanwal	PROPN
bptjm-15	621	17	raghav	raghav	PROPN
bptjm-15	621	18	,	,	PUNCT
bptjm-15	621	19	justin	justin	PROPN
bptjm-15	621	20	i.	i.	PROPN
bptjm-15	621	21	odegaard	odegaard	PROPN
bptjm-15	621	22	,	,	PUNCT
bptjm-15	621	23	richard	richard	PROPN
bptjm-15	621	24	b.	b.	PROPN
bptjm-15	621	25	lanman	lanman	PROPN
bptjm-15	621	26	,	,	PUNCT
bptjm-15	621	27	livio	livio	PROPN
bptjm-15	621	28	trusolino	trusolino	PROPN
bptjm-15	621	29	,	,	PUNCT
bptjm-15	621	30	silvia	silvia	PROPN
bptjm-15	621	31	marsoni	marsoni	PROPN
bptjm-15	621	32	,	,	PUNCT
bptjm-15	621	33	salvatore	salvatore	PROPN
bptjm-15	621	34	siena	siena	PROPN
bptjm-15	621	35	,	,	PUNCT
bptjm-15	621	36	and	and	CCONJ
bptjm-15	621	37	alberto	alberto	PROPN
bptjm-15	621	38	bardelli	bardelli	NOUN
bptjm-15	621	39	.	.	PUNCT
bptjm-15	622	1	(	(	PUNCT
bptjm-15	622	2	may	may	PROPN
bptjm-15	622	3	15	15	NUM
bptjm-15	622	4	,	,	PUNCT
bptjm-15	622	5	2019	2019	NUM
bptjm-15	622	6	)	)	PUNCT
bptjm-15	622	7	.	.	PUNCT
bptjm-15	623	1	plasma	plasma	NOUN
bptjm-15	623	2	her2	her2	PROPN
bptjm-15	623	3	(	(	PUNCT
bptjm-15	623	4	erbb2	erbb2	ADJ
bptjm-15	623	5	)	)	PUNCT
bptjm-15	623	6	copy	copy	NOUN
bptjm-15	623	7	number	number	NOUN
bptjm-15	623	8	predicts	predict	VERB
bptjm-15	623	9	response	response	NOUN
bptjm-15	623	10	to	to	ADP
bptjm-15	623	11	her2	her2	VERB
bptjm-15	623	12	-	-	PUNCT
bptjm-15	623	13	targeted	target	VERB
bptjm-15	623	14	therapy	therapy	NOUN
bptjm-15	623	15	in	in	ADP
bptjm-15	623	16	metastatic	metastatic	ADJ
bptjm-15	623	17	colorectal	colorectal	ADJ
bptjm-15	623	18	cancer	cancer	NOUN
bptjm-15	623	19	.	.	PUNCT
bptjm-15	624	1	clinical	clinical	ADJ
bptjm-15	624	2	cancer	cancer	NOUN
bptjm-15	624	3	research	research	NOUN
bptjm-15	624	4	,	,	PUNCT
bptjm-15	624	5	25(10	25(10	NOUN
bptjm-15	624	6	)	)	PUNCT
bptjm-15	624	7	,	,	PUNCT
bptjm-15	624	8	3046–53	3046–53	NOUN
bptjm-15	624	9	.	.	PUNCT
bptjm-15	625	1	https://doi.org/10.1158/1078-0432.ccr-18-3389	https://doi.org/10.1158/1078-0432.ccr-18-3389	PROPN
bptjm-15	625	2	.	.	PUNCT
bptjm-15	626	1	berkeley	berkeley	PROPN
bptjm-15	626	2	pharma	pharma	PROPN
bptjm-15	626	3	tech	tech	PROPN
bptjm-15	626	4	journal	journal	NOUN
bptjm-15	626	5	of	of	ADP
bptjm-15	626	6	medicine	medicine	NOUN
bptjm-15	626	7	|	|	ADV
bptjm-15	626	8	91	91	NUM
bptjm-15	626	9	81	81	NUM
bptjm-15	626	10	.	.	PUNCT
bptjm-15	627	1	sromek	sromek	PROPN
bptjm-15	627	2	m	m	PROPN
bptjm-15	627	3	,	,	PUNCT
bptjm-15	627	4	glogowski	glogowski	PROPN
bptjm-15	627	5	m	m	PROPN
bptjm-15	627	6	,	,	PUNCT
bptjm-15	627	7	chechlinska	chechlinska	PROPN
bptjm-15	627	8	m	m	PROPN
bptjm-15	627	9	,	,	PUNCT
bptjm-15	627	10	kulinczak	kulinczak	PROPN
bptjm-15	627	11	m	m	PROPN
bptjm-15	627	12	,	,	PUNCT
bptjm-15	627	13	szafron	szafron	NOUN
bptjm-15	627	14	l	l	NOUN
bptjm-15	627	15	,	,	PUNCT
bptjm-15	627	16	zakrzewska	zakrzewska	PROPN
bptjm-15	627	17	k	k	PROPN
bptjm-15	627	18	,	,	PUNCT
bptjm-15	627	19	owczarek	owczarek	PROPN
bptjm-15	627	20	j	j	PROPN
bptjm-15	627	21	,	,	PUNCT
bptjm-15	627	22	wisniewski	wisniewski	PROPN
bptjm-15	627	23	p	p	PROPN
bptjm-15	627	24	,	,	PUNCT
bptjm-15	627	25	wlodarczyk	wlodarczyk	VERB
bptjm-15	627	26	r	r	NOUN
bptjm-15	627	27	,	,	PUNCT
bptjm-15	627	28	talarek	talarek	NOUN
bptjm-15	627	29	l	l	NOUN
bptjm-15	627	30	,	,	PUNCT
bptjm-15	627	31	turski	turski	PROPN
bptjm-15	627	32	m	m	PROPN
bptjm-15	627	33	,	,	PUNCT
bptjm-15	627	34	siwicki	siwicki	PROPN
bptjm-15	627	35	jk	jk	PROPN
bptjm-15	627	36	.	.	PUNCT
bptjm-15	628	1	(	(	PUNCT
bptjm-15	628	2	october	october	PROPN
bptjm-15	628	3	2017	2017	NUM
bptjm-15	628	4	)	)	PUNCT
bptjm-15	628	5	.	.	PUNCT
bptjm-15	629	1	changes	change	NOUN
bptjm-15	629	2	in	in	ADP
bptjm-15	629	3	plasma	plasma	NOUN
bptjm-15	629	4	mir-9	mir-9	NOUN
bptjm-15	629	5	,	,	PUNCT
bptjm-15	629	6	mir-16	mir-16	NOUN
bptjm-15	629	7	,	,	PUNCT
bptjm-15	629	8	mir-205	mir-205	NOUN
bptjm-15	629	9	and	and	CCONJ
bptjm-15	629	10	mir-486	mir-486	ADJ
bptjm-15	629	11	levels	level	NOUN
bptjm-15	629	12	after	after	ADP
bptjm-15	629	13	non	non	ADJ
bptjm-15	629	14	-	-	ADJ
bptjm-15	629	15	small	small	ADJ
bptjm-15	629	16	cell	cell	NOUN
bptjm-15	629	17	lung	lung	NOUN
bptjm-15	629	18	cancer	cancer	NOUN
bptjm-15	629	19	resection	resection	NOUN
bptjm-15	629	20	.	.	PUNCT
bptjm-15	630	1	cell	cell	NOUN
bptjm-15	630	2	oncol	oncol	ADJ
bptjm-15	630	3	(	(	PUNCT
bptjm-15	630	4	dordr).;40(5):529	dordr).;40(5):529	NOUN
bptjm-15	630	5	-	-	PUNCT
bptjm-15	630	6	536	536	NUM
bptjm-15	630	7	.	.	PUNCT
bptjm-15	631	1	doi	doi	NOUN
bptjm-15	631	2	:	:	PUNCT
bptjm-15	631	3	10.1007	10.1007	NUM
bptjm-15	631	4	/	/	SYM
bptjm-15	631	5	s13402	s13402	PROPN
bptjm-15	631	6	-	-	PUNCT
bptjm-15	631	7	017	017	NUM
bptjm-15	631	8	-	-	PUNCT
bptjm-15	631	9	0334	0334	NUM
bptjm-15	631	10	-	-	PUNCT
bptjm-15	631	11	8	8	NUM
bptjm-15	631	12	.	.	PUNCT
bptjm-15	632	1	epub	epub	PROPN
bptjm-15	632	2	2017	2017	NUM
bptjm-15	632	3	jun	jun	PROPN
bptjm-15	632	4	20	20	NUM
bptjm-15	632	5	.	.	PUNCT
bptjm-15	633	1	pmid	pmid	NOUN
bptjm-15	633	2	:	:	PUNCT
bptjm-15	633	3	28634901	28634901	NUM
bptjm-15	633	4	.	.	PUNCT
bptjm-15	634	1	82	82	NUM
bptjm-15	634	2	.	.	PUNCT
bptjm-15	634	3	subbiah	subbiah	PROPN
bptjm-15	634	4	,	,	PUNCT
bptjm-15	634	5	vivek	vivek	PROPN
bptjm-15	634	6	,	,	PUNCT
bptjm-15	634	7	jenny	jenny	PROPN
bptjm-15	634	8	berry	berry	PROPN
bptjm-15	634	9	,	,	PUNCT
bptjm-15	634	10	michael	michael	PROPN
bptjm-15	634	11	roxas	roxas	PROPN
bptjm-15	634	12	,	,	PUNCT
bptjm-15	634	13	nandita	nandita	PROPN
bptjm-15	634	14	guha	guha	PROPN
bptjm-15	634	15	-	-	PUNCT
bptjm-15	634	16	thakurta	thakurta	PROPN
bptjm-15	634	17	,	,	PUNCT
bptjm-15	634	18	ishwaria	ishwaria	PROPN
bptjm-15	634	19	mohan	mohan	PROPN
bptjm-15	634	20	subbiah	subbiah	PROPN
bptjm-15	634	21	,	,	PUNCT
bptjm-15	634	22	siraj	siraj	PROPN
bptjm-15	634	23	m.	m.	PROPN
bptjm-15	634	24	ali	ali	PROPN
bptjm-15	634	25	,	,	PUNCT
bptjm-15	634	26	caitlin	caitlin	PROPN
bptjm-15	634	27	mcmahon	mcmahon	PROPN
bptjm-15	634	28	,	,	PUNCT
bptjm-15	634	29	et	et	PROPN
bptjm-15	634	30	al	al	PROPN
bptjm-15	634	31	.	.	PUNCT
bptjm-15	635	1	(	(	PUNCT
bptjm-15	635	2	july	july	PROPN
bptjm-15	635	3	1	1	NUM
bptjm-15	635	4	,	,	PUNCT
bptjm-15	635	5	2015	2015	NUM
bptjm-15	635	6	)	)	PUNCT
bptjm-15	635	7	.	.	PUNCT
bptjm-15	636	1	systemic	systemic	ADJ
bptjm-15	636	2	and	and	CCONJ
bptjm-15	636	3	cns	cns	NOUN
bptjm-15	636	4	activity	activity	NOUN
bptjm-15	636	5	of	of	ADP
bptjm-15	636	6	the	the	DET
bptjm-15	636	7	ret	ret	PROPN
bptjm-15	636	8	inhibitor	inhibitor	NOUN
bptjm-15	636	9	vandetanib	vandetanib	NOUN
bptjm-15	636	10	combined	combine	VERB
bptjm-15	636	11	with	with	ADP
bptjm-15	636	12	the	the	DET
bptjm-15	636	13	mtor	mtor	PROPN
bptjm-15	636	14	inhibitor	inhibitor	NOUN
bptjm-15	636	15	everolimus	everolimus	NOUN
bptjm-15	636	16	in	in	ADP
bptjm-15	636	17	kif5b	kif5b	PROPN
bptjm-15	636	18	-	-	PUNCT
bptjm-15	636	19	ret	ret	PROPN
bptjm-15	636	20	re	re	PROPN
bptjm-15	636	21	arranged	arrange	VERB
bptjm-15	636	22	non	non	ADJ
bptjm-15	636	23	-	-	ADJ
bptjm-15	636	24	small	small	ADJ
bptjm-15	636	25	cell	cell	NOUN
bptjm-15	636	26	lung	lung	NOUN
bptjm-15	636	27	cancer	cancer	NOUN
bptjm-15	636	28	with	with	ADP
bptjm-15	636	29	brain	brain	NOUN
bptjm-15	636	30	metastases	metastasis	NOUN
bptjm-15	636	31	.	.	PUNCT
bptjm-15	637	1	lung	lung	NOUN
bptjm-15	637	2	cancer	cancer	NOUN
bptjm-15	637	3	,	,	PUNCT
bptjm-15	637	4	89(1	89(1	NOUN
bptjm-15	637	5	)	)	PUNCT
bptjm-15	637	6	,	,	PUNCT
bptjm-15	637	7	76–79	76–79	ADV
bptjm-15	637	8	.	.	PUNCT
bptjm-15	638	1	https://doi.org/10.1016/j.lungcan.2015.04.004	https://doi.org/10.1016/j.lungcan.2015.04.004	NOUN
bptjm-15	638	2	.	.	PUNCT
bptjm-15	639	1	83	83	NUM
bptjm-15	639	2	.	.	PUNCT
bptjm-15	640	1	peter	peter	PROPN
bptjm-15	640	2	stein	stein	PROPN
bptjm-15	640	3	.	.	PUNCT
bptjm-15	641	1	(	(	PUNCT
bptjm-15	641	2	n.d	n.d	PROPN
bptjm-15	641	3	.	.	PROPN
bptjm-15	641	4	)	)	PUNCT
bptjm-15	641	5	.	.	PUNCT
bptjm-15	642	1	brief	brief	ADJ
bptjm-15	642	2	overview	overview	NOUN
bptjm-15	642	3	of	of	ADP
bptjm-15	642	4	biomarkers	biomarker	NOUN
bptjm-15	642	5	:	:	PUNCT
bptjm-15	642	6	value	value	NOUN
bptjm-15	642	7	,	,	PUNCT
bptjm-15	642	8	limitations	limitation	NOUN
bptjm-15	642	9	,	,	PUNCT
bptjm-15	642	10	and	and	CCONJ
bptjm-15	642	11	the	the	DET
bptjm-15	642	12	biomarker	biomarker	NOUN
bptjm-15	642	13	quali	quali	PROPN
bptjm-15	642	14	�	�	PROPN
bptjm-15	642	15	cation	cation	NOUN
bptjm-15	642	16	program	program	NOUN
bptjm-15	642	17	(	(	PUNCT
bptjm-15	642	18	bqp	bqp	PROPN
bptjm-15	642	19	)	)	PUNCT
bptjm-15	643	1	[	[	X
bptjm-15	643	2	brochure	brochure	NOUN
bptjm-15	643	3	]	]	X
bptjm-15	643	4	.	.	PUNCT
bptjm-15	644	1	u.s	u.s	PROPN
bptjm-15	644	2	.	.	PROPN
bptjm-15	644	3	food	food	PROPN
bptjm-15	644	4	and	and	CCONJ
bptjm-15	644	5	drug	drug	NOUN
bptjm-15	644	6	administration	administration	NOUN
bptjm-15	644	7	:	:	PUNCT
bptjm-15	644	8	author	author	NOUN
bptjm-15	644	9	.	.	PUNCT
bptjm-15	645	1	retrieved	retrieve	VERB
bptjm-15	645	2	from	from	ADP
bptjm-15	645	3	https://fnih.org/sites/default/�les/�nal/pdf/2-stein-bio	https://fnih.org/sites/default/�les/�nal/pdf/2-stein-bio	PROPN
bptjm-15	645	4	markers%20introduction.pdf	markers%20introduction.pdf	ADJ
bptjm-15	645	5	84	84	NUM
bptjm-15	645	6	.	.	PUNCT
bptjm-15	646	1	tao	tao	PROPN
bptjm-15	646	2	,	,	PUNCT
bptjm-15	646	3	j.	j.	PROPN
bptjm-15	646	4	,	,	PUNCT
bptjm-15	646	5	sun	sun	PROPN
bptjm-15	646	6	,	,	PUNCT
bptjm-15	646	7	d.	d.	PROPN
bptjm-15	646	8	,	,	PUNCT
bptjm-15	646	9	dong	dong	PROPN
bptjm-15	646	10	,	,	PUNCT
bptjm-15	646	11	l.	l.	PROPN
bptjm-15	646	12	,	,	PUNCT
bptjm-15	646	13	zhu	zhu	PROPN
bptjm-15	646	14	,	,	PUNCT
bptjm-15	646	15	h.	h.	PROPN
bptjm-15	646	16	,	,	PUNCT
bptjm-15	646	17	&	&	CCONJ
bptjm-15	646	18	hou	hou	PROPN
bptjm-15	646	19	,	,	PUNCT
bptjm-15	646	20	h.	h.	PROPN
bptjm-15	646	21	(	(	PUNCT
bptjm-15	646	22	2020	2020	NUM
bptjm-15	646	23	)	)	PUNCT
bptjm-15	646	24	.	.	PUNCT
bptjm-15	647	1	advancement	advancement	NOUN
bptjm-15	647	2	in	in	ADP
bptjm-15	647	3	research	research	NOUN
bptjm-15	647	4	and	and	CCONJ
bptjm-15	647	5	therapy	therapy	NOUN
bptjm-15	647	6	of	of	ADP
bptjm-15	647	7	nf1	nf1	NOUN
bptjm-15	647	8	mutant	mutant	ADJ
bptjm-15	647	9	malignant	malignant	ADJ
bptjm-15	647	10	tumors	tumor	NOUN
bptjm-15	647	11	.	.	PUNCT
bptjm-15	648	1	cancer	cancer	NOUN
bptjm-15	648	2	cell	cell	NOUN
bptjm-15	648	3	international	international	NOUN
bptjm-15	648	4	,	,	PUNCT
bptjm-15	648	5	20	20	NUM
bptjm-15	648	6	,	,	PUNCT
bptjm-15	648	7	492	492	NUM
bptjm-15	648	8	.	.	PUNCT
bptjm-15	649	1	https://	https://	PROPN
bptjm-15	649	2	doi.org/10.1186/s12935-020-01570-8	doi.org/10.1186/s12935-020-01570-8	PROPN
bptjm-15	649	3	85	85	NUM
bptjm-15	649	4	.	.	PUNCT
bptjm-15	650	1	teresi	teresi	PROPN
bptjm-15	650	2	,	,	PUNCT
bptjm-15	650	3	rosemary	rosemary	PROPN
bptjm-15	650	4	e.	e.	PROPN
bptjm-15	650	5	,	,	PUNCT
bptjm-15	650	6	chung	chung	PROPN
bptjm-15	650	7	-	-	PUNCT
bptjm-15	650	8	wai	wai	PROPN
bptjm-15	650	9	shaiu	shaiu	PROPN
bptjm-15	650	10	,	,	PUNCT
bptjm-15	650	11	ching	ching	PROPN
bptjm-15	650	12	-	-	PUNCT
bptjm-15	650	13	shih	shih	PROPN
bptjm-15	650	14	chen	chen	PROPN
bptjm-15	650	15	,	,	PUNCT
bptjm-15	650	16	v.	v.	ADP
bptjm-15	650	17	krishna	krishna	PROPN
bptjm-15	650	18	chatterjee	chatterjee	PROPN
bptjm-15	650	19	,	,	PUNCT
bptjm-15	650	20	kristin	kristin	PROPN
bptjm-15	650	21	a.	a.	PROPN
bptjm-15	650	22	waite	waite	PROPN
bptjm-15	650	23	,	,	PUNCT
bptjm-15	650	24	and	and	CCONJ
bptjm-15	650	25	charis	charis	PROPN
bptjm-15	650	26	eng	eng	PROPN
bptjm-15	650	27	.	.	PUNCT
bptjm-15	651	1	(	(	PUNCT
bptjm-15	651	2	2006	2006	NUM
bptjm-15	651	3	)	)	PUNCT
bptjm-15	651	4	.	.	PUNCT
bptjm-15	652	1	increased	increase	VERB
bptjm-15	652	2	pten	pten	NOUN
bptjm-15	652	3	expression	expression	NOUN
bptjm-15	652	4	due	due	ADP
bptjm-15	652	5	to	to	ADP
bptjm-15	652	6	transcriptional	transcriptional	ADJ
bptjm-15	652	7	activation	activation	NOUN
bptjm-15	652	8	of	of	ADP
bptjm-15	652	9	pparγ	pparγ	NOUN
bptjm-15	652	10	by	by	ADP
bptjm-15	652	11	lovastatin	lovastatin	NOUN
bptjm-15	652	12	and	and	CCONJ
bptjm-15	652	13	rosiglitazone	rosiglitazone	NOUN
bptjm-15	652	14	.	.	PUNCT
bptjm-15	653	1	international	international	ADJ
bptjm-15	653	2	journal	journal	PROPN
bptjm-15	653	3	of	of	ADP
bptjm-15	653	4	cancer	cancer	NOUN
bptjm-15	653	5	,	,	PUNCT
bptjm-15	653	6	118(10	118(10	NUM
bptjm-15	653	7	)	)	PUNCT
bptjm-15	653	8	,	,	PUNCT
bptjm-15	653	9	2390–98	2390–98	NUM
bptjm-15	653	10	.	.	PUNCT
bptjm-15	654	1	https://doi.org/10.1002/ijc.21799	https://doi.org/10.1002/ijc.21799	NOUN
bptjm-15	654	2	.	.	PUNCT
bptjm-15	655	1	86	86	NUM
bptjm-15	655	2	.	.	PUNCT
bptjm-15	656	1	thompson	thompson	PROPN
bptjm-15	656	2	,	,	PUNCT
bptjm-15	656	3	je	je	PROPN
bptjm-15	656	4	�	�	PROPN
bptjm-15	656	5	rey	rey	PROPN
bptjm-15	656	6	c.	c.	PROPN
bptjm-15	656	7	,	,	PUNCT
bptjm-15	656	8	stephanie	stephanie	PROPN
bptjm-15	656	9	s.	s.	PROPN
bptjm-15	656	10	yee	yee	PROPN
bptjm-15	656	11	,	,	PUNCT
bptjm-15	656	12	andrea	andrea	PROPN
bptjm-15	656	13	b.	b.	PROPN
bptjm-15	656	14	troxel	troxel	PROPN
bptjm-15	656	15	,	,	PUNCT
bptjm-15	656	16	samantha	samantha	PROPN
bptjm-15	656	17	l.	l.	PROPN
bptjm-15	656	18	savitch	savitch	PROPN
bptjm-15	656	19	,	,	PUNCT
bptjm-15	656	20	ryan	ryan	PROPN
bptjm-15	656	21	fan	fan	PROPN
bptjm-15	656	22	,	,	PUNCT
bptjm-15	656	23	david	david	PROPN
bptjm-15	656	24	balli	balli	PROPN
bptjm-15	656	25	,	,	PUNCT
bptjm-15	656	26	david	david	PROPN
bptjm-15	656	27	b.	b.	PROPN
bptjm-15	656	28	lieberman	lieberman	PROPN
bptjm-15	656	29	,	,	PUNCT
bptjm-15	656	30	et	et	PROPN
bptjm-15	656	31	al	al	PROPN
bptjm-15	656	32	.	.	PUNCT
bptjm-15	657	1	(	(	PUNCT
bptjm-15	657	2	december	december	PROPN
bptjm-15	657	3	1	1	NUM
bptjm-15	657	4	,	,	PUNCT
bptjm-15	657	5	2016	2016	NUM
bptjm-15	657	6	)	)	PUNCT
bptjm-15	657	7	.	.	PUNCT
bptjm-15	658	1	detection	detection	NOUN
bptjm-15	658	2	of	of	ADP
bptjm-15	658	3	therapeutically	therapeutically	ADV
bptjm-15	658	4	targetable	targetable	ADJ
bptjm-15	658	5	driver	driver	NOUN
bptjm-15	658	6	and	and	CCONJ
bptjm-15	658	7	resistance	resistance	NOUN
bptjm-15	658	8	mutations	mutation	NOUN
bptjm-15	658	9	in	in	ADP
bptjm-15	658	10	lung	lung	NOUN
bptjm-15	658	11	cancer	cancer	NOUN
bptjm-15	658	12	patients	patient	NOUN
bptjm-15	658	13	by	by	ADP
bptjm-15	658	14	next	next	ADJ
bptjm-15	658	15	-	-	PUNCT
bptjm-15	658	16	generation	generation	NOUN
bptjm-15	658	17	sequencing	sequencing	NOUN
bptjm-15	658	18	of	of	ADP
bptjm-15	658	19	cell	cell	NOUN
bptjm-15	658	20	-	-	PUNCT
bptjm-15	658	21	free	free	ADJ
bptjm-15	658	22	circulating	circulate	VERB
bptjm-15	658	23	tumor	tumor	NOUN
bptjm-15	658	24	dna	dna	PROPN
bptjm-15	658	25	.	.	PUNCT
bptjm-15	659	1	clinical	clinical	ADJ
bptjm-15	659	2	cancer	cancer	NOUN
bptjm-15	659	3	research	research	NOUN
bptjm-15	659	4	:	:	PUNCT
bptjm-15	659	5	an	an	DET
bptjm-15	659	6	official	official	ADJ
bptjm-15	659	7	journal	journal	NOUN
bptjm-15	659	8	of	of	ADP
bptjm-15	659	9	the	the	DET
bptjm-15	659	10	american	american	PROPN
bptjm-15	659	11	association	association	PROPN
bptjm-15	659	12	for	for	ADP
bptjm-15	659	13	cancer	cancer	NOUN
bptjm-15	659	14	research	research	NOUN
bptjm-15	659	15	,	,	PUNCT
bptjm-15	659	16	22(23	22(23	NOUN
bptjm-15	659	17	)	)	PUNCT
bptjm-15	659	18	,	,	PUNCT
bptjm-15	659	19	:	:	PUNCT
bptjm-15	659	20	5772–82	5772–82	NUM
bptjm-15	659	21	.	.	PUNCT
bptjm-15	660	1	https://doi.org/10.1158/1078-0432.ccr-16-1231	https://doi.org/10.1158/1078-0432.ccr-16-1231	X
bptjm-15	660	2	.	.	X
bptjm-15	661	1	87	87	NUM
bptjm-15	661	2	.	.	PUNCT
bptjm-15	662	1	tian	tian	PROPN
bptjm-15	662	2	f	f	PROPN
bptjm-15	662	3	,	,	PUNCT
bptjm-15	662	4	wang	wang	PROPN
bptjm-15	662	5	j	j	PROPN
bptjm-15	662	6	,	,	PUNCT
bptjm-15	662	7	ouyang	ouyang	PROPN
bptjm-15	662	8	t	t	PROPN
bptjm-15	662	9	,	,	PUNCT
bptjm-15	662	10	et	et	PROPN
bptjm-15	662	11	al	al	PROPN
bptjm-15	662	12	.	.	PROPN
bptjm-15	662	13	(	(	PUNCT
bptjm-15	662	14	2019	2019	NUM
bptjm-15	662	15	)	)	PUNCT
bptjm-15	662	16	.	.	PUNCT
bptjm-15	663	1	mir-486	mir-486	VERB
bptjm-15	663	2	-	-	PUNCT
bptjm-15	663	3	5p	5p	PROPN
bptjm-15	663	4	serves	serve	VERB
bptjm-15	663	5	as	as	ADP
bptjm-15	663	6	a	a	DET
bptjm-15	663	7	good	good	ADJ
bptjm-15	663	8	biomarker	biomarker	NOUN
bptjm-15	663	9	in	in	ADP
bptjm-15	663	10	non	non	ADJ
bptjm-15	663	11	small	small	ADJ
bptjm-15	663	12	cell	cell	NOUN
bptjm-15	663	13	lung	lung	NOUN
bptjm-15	663	14	cancer	cancer	NOUN
bptjm-15	663	15	and	and	CCONJ
bptjm-15	663	16	suppresses	suppress	VERB
bptjm-15	663	17	cell	cell	NOUN
bptjm-15	663	18	growth	growth	NOUN
bptjm-15	663	19	with	with	ADP
bptjm-15	663	20	the	the	DET
bptjm-15	663	21	involvement	involvement	NOUN
bptjm-15	663	22	of	of	ADP
bptjm-15	663	23	a	a	DET
bptjm-15	663	24	target	target	NOUN
bptjm-15	663	25	pik3r1	pik3r1	NOUN
bptjm-15	663	26	.	.	PUNCT
bptjm-15	664	1	front	front	ADJ
bptjm-15	664	2	genet	genet	PROPN
bptjm-15	664	3	.	.	PUNCT
bptjm-15	664	4	,	,	PUNCT
bptjm-15	664	5	10(688	10(688	NUM
bptjm-15	664	6	)	)	PUNCT
bptjm-15	664	7	.	.	PUNCT
bptjm-15	665	1	published	publish	VERB
bptjm-15	665	2	2019	2019	NUM
bptjm-15	665	3	jul	jul	PROPN
bptjm-15	665	4	26	26	NUM
bptjm-15	665	5	.	.	PUNCT
bptjm-15	666	1	doi:10.3389	doi:10.3389	PROPN
bptjm-15	666	2	/	/	SYM
bptjm-15	666	3	fgene.2019.00688	fgene.2019.00688	PROPN
bptjm-15	666	4	88	88	NUM
bptjm-15	666	5	.	.	PUNCT
bptjm-15	667	1	to	to	ADP
bptjm-15	667	2	,	,	PUNCT
bptjm-15	667	3	kenneth	kenneth	PROPN
bptjm-15	667	4	k.	k.	PROPN
bptjm-15	667	5	w.	w.	PROPN
bptjm-15	667	6	,	,	PUNCT
bptjm-15	667	7	william	william	PROPN
bptjm-15	667	8	k.	k.	PROPN
bptjm-15	667	9	k.	k.	PROPN
bptjm-15	667	10	wu	wu	PROPN
bptjm-15	667	11	,	,	PUNCT
bptjm-15	667	12	and	and	CCONJ
bptjm-15	667	13	herbert	herbert	PROPN
bptjm-15	667	14	h.	h.	PROPN
bptjm-15	667	15	f.	f.	PROPN
bptjm-15	667	16	loong	loong	PROPN
bptjm-15	667	17	.	.	PUNCT
bptjm-15	668	1	(	(	PUNCT
bptjm-15	668	2	march	march	PROPN
bptjm-15	668	3	15	15	NUM
bptjm-15	668	4	,	,	PUNCT
bptjm-15	668	5	2018	2018	NUM
bptjm-15	668	6	)	)	PUNCT
bptjm-15	668	7	.	.	PUNCT
bptjm-15	669	1	ppargamma	ppargamma	PROPN
bptjm-15	669	2	agonists	agonist	NOUN
bptjm-15	669	3	sensitize	sensitize	VERB
bptjm-15	669	4	pten	pten	NOUN
bptjm-15	669	5	-	-	PUNCT
bptjm-15	669	6	de	de	X
bptjm-15	669	7	�	�	NOUN
bptjm-15	669	8	cient	cient	NOUN
bptjm-15	669	9	resistant	resistant	ADJ
bptjm-15	669	10	lung	lung	NOUN
bptjm-15	669	11	cancer	cancer	NOUN
bptjm-15	669	12	cells	cell	NOUN
bptjm-15	669	13	to	to	PART
bptjm-15	669	14	egfr	egfr	VERB
bptjm-15	669	15	tyrosine	tyrosine	PROPN
bptjm-15	669	16	kinase	kinase	PROPN
bptjm-15	669	17	inhibitors	inhibitor	NOUN
bptjm-15	669	18	by	by	ADP
bptjm-15	669	19	inducing	induce	VERB
bptjm-15	669	20	autophagy	autophagy	NOUN
bptjm-15	669	21	.	.	PUNCT
bptjm-15	670	1	european	european	ADJ
bptjm-15	670	2	journal	journal	PROPN
bptjm-15	670	3	of	of	ADP
bptjm-15	670	4	pharmacology	pharmacology	NOUN
bptjm-15	670	5	,	,	PUNCT
bptjm-15	670	6	823	823	NUM
bptjm-15	670	7	,	,	PUNCT
bptjm-15	670	8	19–26	19–26	NUM
bptjm-15	670	9	.	.	PUNCT
bptjm-15	671	1	https://doi.org/10.1016/j.ejphar.2018.01.036	https://doi.org/10.1016/j.ejphar.2018.01.036	PROPN
bptjm-15	671	2	.	.	PROPN
bptjm-15	671	3	89	89	NUM
bptjm-15	671	4	.	.	PUNCT
bptjm-15	672	1	veldore	veldore	NOUN
bptjm-15	672	2	,	,	PUNCT
bptjm-15	672	3	vidya	vidya	PROPN
bptjm-15	672	4	h	h	PROPN
bptjm-15	672	5	,	,	PUNCT
bptjm-15	672	6	anuradha	anuradha	PROPN
bptjm-15	672	7	choughule	choughule	NOUN
bptjm-15	672	8	,	,	PUNCT
bptjm-15	672	9	tejaswi	tejaswi	PROPN
bptjm-15	672	10	routhu	routhu	PROPN
bptjm-15	672	11	,	,	PUNCT
bptjm-15	672	12	nitin	nitin	PROPN
bptjm-15	672	13	mandloi	mandloi	PROPN
bptjm-15	672	14	,	,	PUNCT
bptjm-15	672	15	vanita	vanita	PROPN
bptjm-15	672	16	noronha	noronha	NOUN
bptjm-15	672	17	,	,	PUNCT
bptjm-15	672	18	amit	amit	PROPN
bptjm-15	672	19	joshi	joshi	PROPN
bptjm-15	672	20	,	,	PUNCT
bptjm-15	672	21	amit	amit	PROPN
bptjm-15	672	22	dutt	dutt	PROPN
bptjm-15	672	23	,	,	PUNCT
bptjm-15	672	24	ravi	ravi	NOUN
bptjm-15	672	25	gupta	gupta	PROPN
bptjm-15	672	26	,	,	PUNCT
bptjm-15	672	27	ramprasad	ramprasad	ADJ
bptjm-15	672	28	vedam	vedam	NOUN
bptjm-15	672	29	,	,	PUNCT
bptjm-15	672	30	and	and	CCONJ
bptjm-15	672	31	kumar	kumar	PROPN
bptjm-15	672	32	prabhash	prabhash	PROPN
bptjm-15	672	33	.	.	PUNCT
bptjm-15	673	1	(	(	PUNCT
bptjm-15	673	2	january	january	PROPN
bptjm-15	673	3	3	3	NUM
bptjm-15	673	4	,	,	PUNCT
bptjm-15	673	5	2018	2018	NUM
bptjm-15	673	6	)	)	PUNCT
bptjm-15	673	7	.	.	PUNCT
bptjm-15	674	1	validation	validation	NOUN
bptjm-15	674	2	of	of	ADP
bptjm-15	674	3	liquid	liquid	ADJ
bptjm-15	674	4	biopsy	biopsy	NOUN
bptjm-15	674	5	:	:	PUNCT
bptjm-15	674	6	plasma	plasma	NOUN
bptjm-15	674	7	cell	cell	NOUN
bptjm-15	674	8	-	-	PUNCT
bptjm-15	674	9	free	free	ADJ
bptjm-15	674	10	dna	dna	NOUN
bptjm-15	674	11	testing	testing	NOUN
bptjm-15	674	12	in	in	ADP
bptjm-15	674	13	clinical	clinical	ADJ
bptjm-15	674	14	management	management	NOUN
bptjm-15	674	15	of	of	ADP
bptjm-15	674	16	advanced	advanced	ADJ
bptjm-15	674	17	non	non	ADJ
bptjm-15	674	18	-	-	ADJ
bptjm-15	674	19	small	small	ADJ
bptjm-15	674	20	cell	cell	NOUN
bptjm-15	674	21	lung	lung	NOUN
bptjm-15	674	22	cancer	cancer	NOUN
bptjm-15	674	23	.	.	PUNCT
bptjm-15	675	1	lung	lung	NOUN
bptjm-15	675	2	cancer	cancer	NOUN
bptjm-15	675	3	:	:	PUNCT
bptjm-15	675	4	targets	target	NOUN
bptjm-15	675	5	and	and	CCONJ
bptjm-15	675	6	therapy	therapy	NOUN
bptjm-15	675	7	,	,	PUNCT
bptjm-15	675	8	9	9	NUM
bptjm-15	675	9	,	,	PUNCT
bptjm-15	675	10	1–11	1–11	PROPN
bptjm-15	675	11	.	.	PUNCT
bptjm-15	676	1	https://doi.org/10.2147/lctt.s147841	https://doi.org/10.2147/lctt.s147841	PROPN
bptjm-15	676	2	.	.	PUNCT
bptjm-15	677	1	90	90	NUM
bptjm-15	677	2	.	.	PUNCT
bptjm-15	678	1	vincent	vincent	PROPN
bptjm-15	678	2	,	,	PUNCT
bptjm-15	678	3	m.	m.	PROPN
bptjm-15	678	4	d.	d.	PROPN
bptjm-15	678	5	,	,	PUNCT
bptjm-15	678	6	kuruvilla	kuruvilla	PROPN
bptjm-15	678	7	,	,	PUNCT
bptjm-15	678	8	m.	m.	NOUN
bptjm-15	678	9	s.	s.	PROPN
bptjm-15	678	10	,	,	PUNCT
bptjm-15	678	11	leighl	leighl	NOUN
bptjm-15	678	12	,	,	PUNCT
bptjm-15	678	13	n.	n.	PROPN
bptjm-15	678	14	b.	b.	PROPN
bptjm-15	678	15	,	,	PUNCT
bptjm-15	678	16	&	&	CCONJ
bptjm-15	678	17	kamel	kamel	PROPN
bptjm-15	678	18	-	-	PUNCT
bptjm-15	678	19	reid	reid	PROPN
bptjm-15	678	20	,	,	PUNCT
bptjm-15	678	21	s.	s.	PROPN
bptjm-15	678	22	(	(	PUNCT
bptjm-15	678	23	2012	2012	NUM
bptjm-15	678	24	)	)	PUNCT
bptjm-15	678	25	.	.	PUNCT
bptjm-15	679	1	biomarkers	biomarker	NOUN
bptjm-15	679	2	that	that	SCONJ
bptjm-15	679	3	currently	currently	ADV
bptjm-15	679	4	a	a	DET
bptjm-15	679	5	�	�	NOUN
bptjm-15	679	6	ect	ect	VERB
bptjm-15	679	7	clinical	clinical	ADJ
bptjm-15	679	8	practice	practice	NOUN
bptjm-15	679	9	:	:	PUNCT
bptjm-15	679	10	egfr	egfr	X
bptjm-15	679	11	,	,	PUNCT
bptjm-15	679	12	alk	alk	PROPN
bptjm-15	679	13	,	,	PUNCT
bptjm-15	679	14	met	meet	VERB
bptjm-15	679	15	,	,	PUNCT
bptjm-15	679	16	kras	kras	PROPN
bptjm-15	679	17	.	.	PUNCT
bptjm-15	680	1	current	current	ADJ
bptjm-15	680	2	oncology	oncology	NOUN
bptjm-15	680	3	(	(	PUNCT
bptjm-15	680	4	toronto	toronto	PROPN
bptjm-15	680	5	,	,	PUNCT
bptjm-15	680	6	ont	ont	PROPN
bptjm-15	680	7	.	.	PUNCT
bptjm-15	680	8	)	)	PUNCT
bptjm-15	680	9	,	,	PUNCT
bptjm-15	680	10	19(suppl	19(suppl	NUM
bptjm-15	680	11	1	1	NUM
bptjm-15	680	12	)	)	PUNCT
bptjm-15	680	13	,	,	PUNCT
bptjm-15	680	14	s33	s33	NOUN
bptjm-15	680	15	–	–	PUNCT
bptjm-15	680	16	s44	s44	ADJ
bptjm-15	680	17	.	.	PUNCT
bptjm-15	681	1	https://doi.org/10.3747/co.19.1149	https://doi.org/10.3747/co.19.1149	VERB
bptjm-15	682	1	91	91	NUM
bptjm-15	682	2	.	.	PUNCT
bptjm-15	683	1	wang	wang	PROPN
bptjm-15	683	2	,	,	PUNCT
bptjm-15	683	3	l.	l.	PROPN
bptjm-15	683	4	,	,	PUNCT
bptjm-15	683	5	hu	hu	PROPN
bptjm-15	683	6	,	,	PUNCT
bptjm-15	683	7	y.	y.	PROPN
bptjm-15	683	8	,	,	PUNCT
bptjm-15	683	9	wang	wang	PROPN
bptjm-15	683	10	,	,	PUNCT
bptjm-15	683	11	s.	s.	PROPN
bptjm-15	683	12	,	,	PUNCT
bptjm-15	683	13	shen	shen	PROPN
bptjm-15	683	14	,	,	PUNCT
bptjm-15	683	15	j.	j.	PROPN
bptjm-15	683	16	,	,	PUNCT
bptjm-15	683	17	&	&	CCONJ
bptjm-15	683	18	wang	wang	PROPN
bptjm-15	683	19	,	,	PUNCT
bptjm-15	683	20	x.	x.	NOUN
bptjm-15	683	21	(	(	PUNCT
bptjm-15	683	22	2020	2020	NUM
bptjm-15	683	23	)	)	PUNCT
bptjm-15	683	24	.	.	PUNCT
bptjm-15	684	1	biomarkers	biomarker	NOUN
bptjm-15	684	2	of	of	ADP
bptjm-15	684	3	immunotherapy	immunotherapy	NOUN
bptjm-15	684	4	in	in	ADP
bptjm-15	684	5	non	non	ADJ
bptjm-15	684	6	-	-	ADJ
bptjm-15	684	7	small	small	ADJ
bptjm-15	684	8	cell	cell	NOUN
bptjm-15	684	9	lung	lung	NOUN
bptjm-15	684	10	cancer	cancer	NOUN
bptjm-15	684	11	.	.	PUNCT
bptjm-15	685	1	oncology	oncology	NOUN
bptjm-15	685	2	letters	letter	NOUN
bptjm-15	685	3	,	,	PUNCT
bptjm-15	685	4	20(5	20(5	NUM
bptjm-15	685	5	)	)	PUNCT
bptjm-15	685	6	,	,	PUNCT
bptjm-15	685	7	139	139	NUM
bptjm-15	685	8	.	.	PUNCT
bptjm-15	686	1	https://doi.org/10.3892/ol	https://doi.org/10.3892/ol	NOUN
bptjm-15	686	2	.	.	PUNCT
bptjm-15	687	1	2020.11999	2020.11999	NUM
bptjm-15	687	2	92	92	NUM
bptjm-15	687	3	.	.	PUNCT
bptjm-15	688	1	wang	wang	PROPN
bptjm-15	688	2	,	,	PUNCT
bptjm-15	688	3	h.	h.	PROPN
bptjm-15	688	4	,	,	PUNCT
bptjm-15	688	5	peng	peng	PROPN
bptjm-15	688	6	,	,	PUNCT
bptjm-15	688	7	r.	r.	PROPN
bptjm-15	688	8	,	,	PUNCT
bptjm-15	688	9	wang	wang	PROPN
bptjm-15	688	10	,	,	PUNCT
bptjm-15	688	11	j.	j.	PROPN
bptjm-15	688	12	,	,	PUNCT
bptjm-15	688	13	qin	qin	PROPN
bptjm-15	688	14	,	,	PUNCT
bptjm-15	688	15	z.	z.	PROPN
bptjm-15	688	16	,	,	PUNCT
bptjm-15	688	17	&	&	CCONJ
bptjm-15	688	18	xue	xue	PROPN
bptjm-15	688	19	,	,	PUNCT
bptjm-15	688	20	l.	l.	PROPN
bptjm-15	688	21	(	(	PUNCT
bptjm-15	688	22	2018	2018	NUM
bptjm-15	688	23	)	)	PUNCT
bptjm-15	688	24	.	.	PUNCT
bptjm-15	689	1	circulating	circulate	VERB
bptjm-15	689	2	micrornas	microrna	NOUN
bptjm-15	689	3	as	as	ADP
bptjm-15	689	4	potential	potential	ADJ
bptjm-15	689	5	cancer	cancer	NOUN
bptjm-15	689	6	biomarkers	biomarker	NOUN
bptjm-15	689	7	:	:	PUNCT
bptjm-15	689	8	the	the	DET
bptjm-15	689	9	advantage	advantage	NOUN
bptjm-15	689	10	and	and	CCONJ
bptjm-15	689	11	disadvantage	disadvantage	NOUN
bptjm-15	689	12	.	.	PUNCT
bptjm-15	690	1	clinical	clinical	ADJ
bptjm-15	690	2	berkeley	berkeley	PROPN
bptjm-15	690	3	pharma	pharma	PROPN
bptjm-15	690	4	tech	tech	NOUN
bptjm-15	690	5	journal	journal	NOUN
bptjm-15	690	6	of	of	ADP
bptjm-15	690	7	medicine	medicine	NOUN
bptjm-15	690	8	|	|	ADV
bptjm-15	690	9	92	92	NUM
bptjm-15	690	10	epigenetics	epigenetic	NOUN
bptjm-15	690	11	,	,	PUNCT
bptjm-15	690	12	10	10	NUM
bptjm-15	690	13	,	,	PUNCT
bptjm-15	690	14	59	59	NUM
bptjm-15	690	15	.	.	PUNCT
bptjm-15	691	1	https://doi.org/10.1186/s13148-018-0492-1	https://doi.org/10.1186/s13148-018-0492-1	PROPN
bptjm-15	691	2	93	93	NUM
bptjm-15	691	3	.	.	PUNCT
bptjm-15	692	1	wang	wang	PROPN
bptjm-15	692	2	,	,	PUNCT
bptjm-15	692	3	j.	j.	PROPN
bptjm-15	692	4	,	,	PUNCT
bptjm-15	692	5	tian	tian	PROPN
bptjm-15	692	6	,	,	PUNCT
bptjm-15	692	7	x.	x.	PROPN
bptjm-15	692	8	,	,	PUNCT
bptjm-15	692	9	han	han	PROPN
bptjm-15	692	10	,	,	PUNCT
bptjm-15	692	11	r.	r.	PROPN
bptjm-15	692	12	et	et	PROPN
bptjm-15	692	13	al	al	PROPN
bptjm-15	692	14	.	.	PROPN
bptjm-15	692	15	(	(	PUNCT
bptjm-15	692	16	2014	2014	NUM
bptjm-15	692	17	)	)	PUNCT
bptjm-15	692	18	.	.	PUNCT
bptjm-15	693	1	downregulation	downregulation	NOUN
bptjm-15	693	2	of	of	ADP
bptjm-15	693	3	mir-486	mir-486	ADJ
bptjm-15	693	4	-	-	PUNCT
bptjm-15	693	5	5p	5p	NUM
bptjm-15	693	6	contributes	contribute	VERB
bptjm-15	693	7	to	to	ADP
bptjm-15	693	8	tumor	tumor	NOUN
bptjm-15	693	9	progression	progression	NOUN
bptjm-15	693	10	and	and	CCONJ
bptjm-15	693	11	metastasis	metastasis	NOUN
bptjm-15	693	12	by	by	ADP
bptjm-15	693	13	targeting	target	VERB
bptjm-15	693	14	protumorigenic	protumorigenic	NOUN
bptjm-15	693	15	arhgap5	arhgap5	VERB
bptjm-15	693	16	in	in	ADP
bptjm-15	693	17	lung	lung	NOUN
bptjm-15	693	18	cancer	cancer	NOUN
bptjm-15	693	19	.	.	PUNCT
bptjm-15	694	1	oncogene	oncogene	NOUN
bptjm-15	694	2	,	,	PUNCT
bptjm-15	694	3	33	33	NUM
bptjm-15	694	4	,	,	PUNCT
bptjm-15	694	5	1181–1189	1181–1189	NUM
bptjm-15	694	6	.	.	PUNCT
bptjm-15	695	1	https://doi.org/10.1038/onc.2013.42	https://doi.org/10.1038/onc.2013.42	NOUN
bptjm-15	695	2	94	94	NUM
bptjm-15	695	3	.	.	PUNCT
bptjm-15	696	1	wang	wang	PROPN
bptjm-15	696	2	y	y	PROPN
bptjm-15	696	3	,	,	PUNCT
bptjm-15	696	4	zeng	zeng	PROPN
bptjm-15	696	5	g	g	PROPN
bptjm-15	696	6	,	,	PUNCT
bptjm-15	696	7	jiang	jiang	PROPN
bptjm-15	696	8	y.	y.	PROPN
bptjm-15	696	9	(	(	PUNCT
bptjm-15	696	10	2020	2020	NUM
bptjm-15	696	11	)	)	PUNCT
bptjm-15	696	12	.	.	PUNCT
bptjm-15	697	1	the	the	DET
bptjm-15	697	2	emerging	emerge	VERB
bptjm-15	697	3	roles	role	NOUN
bptjm-15	697	4	of	of	ADP
bptjm-15	697	5	mir-125b	mir-125b	NOUN
bptjm-15	697	6	in	in	ADP
bptjm-15	697	7	cancers	cancer	NOUN
bptjm-15	697	8	.	.	PUNCT
bptjm-15	698	1	cancer	cancer	NOUN
bptjm-15	698	2	manag	manag	PROPN
bptjm-15	698	3	res	re	NOUN
bptjm-15	698	4	.	.	PROPN
bptjm-15	698	5	,	,	PUNCT
bptjm-15	698	6	12	12	NUM
bptjm-15	698	7	,	,	PUNCT
bptjm-15	698	8	1079	1079	NUM
bptjm-15	698	9	-	-	SYM
bptjm-15	698	10	1088	1088	NUM
bptjm-15	698	11	.	.	PUNCT
bptjm-15	699	1	published	publish	VERB
bptjm-15	699	2	2020	2020	NUM
bptjm-15	699	3	feb	feb	PROPN
bptjm-15	699	4	12	12	NUM
bptjm-15	699	5	.	.	PUNCT
bptjm-15	699	6	doi:10.2147	doi:10.2147	NOUN
bptjm-15	699	7	/	/	SYM
bptjm-15	699	8	cmar.s232388	cmar.s232388	X
bptjm-15	699	9	95	95	NUM
bptjm-15	699	10	.	.	PUNCT
bptjm-15	700	1	wang	wang	PROPN
bptjm-15	700	2	,	,	PUNCT
bptjm-15	700	3	y.	y.	PROPN
bptjm-15	700	4	,	,	PUNCT
bptjm-15	700	5	wang	wang	PROPN
bptjm-15	700	6	,	,	PUNCT
bptjm-15	700	7	y.	y.	PROPN
bptjm-15	700	8	,	,	PUNCT
bptjm-15	700	9	li	li	PROPN
bptjm-15	700	10	,	,	PUNCT
bptjm-15	700	11	j.	j.	PROPN
bptjm-15	700	12	,	,	PUNCT
bptjm-15	700	13	li	li	PROPN
bptjm-15	700	14	,	,	PUNCT
bptjm-15	700	15	j.	j.	PROPN
bptjm-15	700	16	,	,	PUNCT
bptjm-15	700	17	&	&	CCONJ
bptjm-15	700	18	che	che	PROPN
bptjm-15	700	19	,	,	PUNCT
bptjm-15	700	20	g.	g.	PROPN
bptjm-15	700	21	(	(	PUNCT
bptjm-15	700	22	2020	2020	NUM
bptjm-15	700	23	)	)	PUNCT
bptjm-15	700	24	.	.	PUNCT
bptjm-15	701	1	clinical	clinical	ADJ
bptjm-15	701	2	signi	signi	PROPN
bptjm-15	701	3	�	�	PROPN
bptjm-15	701	4	cance	cance	NOUN
bptjm-15	701	5	of	of	ADP
bptjm-15	701	6	pik3ca	pik3ca	PROPN
bptjm-15	701	7	gene	gene	NOUN
bptjm-15	701	8	in	in	ADP
bptjm-15	701	9	non	non	ADJ
bptjm-15	701	10	-	-	ADJ
bptjm-15	701	11	small	small	ADJ
bptjm-15	701	12	-	-	PUNCT
bptjm-15	701	13	cell	cell	NOUN
bptjm-15	701	14	lung	lung	NOUN
bptjm-15	701	15	cancer	cancer	NOUN
bptjm-15	701	16	:	:	PUNCT
bptjm-15	701	17	a	a	DET
bptjm-15	701	18	systematic	systematic	ADJ
bptjm-15	701	19	review	review	NOUN
bptjm-15	701	20	and	and	CCONJ
bptjm-15	701	21	meta	meta	ADJ
bptjm-15	701	22	-	-	PUNCT
bptjm-15	701	23	analysis	analysis	NOUN
bptjm-15	701	24	.	.	PUNCT
bptjm-15	701	25	biomed	biome	VERB
bptjm-15	701	26	research	research	NOUN
bptjm-15	701	27	international	international	PROPN
bptjm-15	701	28	,	,	PUNCT
bptjm-15	701	29	2020	2020	NUM
bptjm-15	701	30	,	,	PUNCT
bptjm-15	701	31	3608241	3608241	NUM
bptjm-15	701	32	.	.	PUNCT
bptjm-15	702	1	https://doi.org/10.1155/2020/3608241	https://doi.org/10.1155/2020/3608241	NOUN
bptjm-15	702	2	96	96	NUM
bptjm-15	702	3	.	.	PUNCT
bptjm-15	703	1	wang	wang	PROPN
bptjm-15	703	2	zx	zx	PROPN
bptjm-15	703	3	,	,	PUNCT
bptjm-15	703	4	bian	bian	PROPN
bptjm-15	703	5	hb	hb	PROPN
bptjm-15	703	6	,	,	PUNCT
bptjm-15	703	7	wang	wang	PROPN
bptjm-15	703	8	jr	jr	PROPN
bptjm-15	703	9	,	,	PUNCT
bptjm-15	703	10	cheng	cheng	PROPN
bptjm-15	703	11	zx	zx	PROPN
bptjm-15	703	12	,	,	PUNCT
bptjm-15	703	13	wang	wang	PROPN
bptjm-15	703	14	km	km	PROPN
bptjm-15	703	15	,	,	PUNCT
bptjm-15	703	16	de	de	PROPN
bptjm-15	703	17	w.	w.	PROPN
bptjm-15	703	18	(	(	PUNCT
bptjm-15	703	19	december	december	PROPN
bptjm-15	703	20	2011	2011	NUM
bptjm-15	703	21	)	)	PUNCT
bptjm-15	703	22	.	.	PUNCT
bptjm-15	704	1	prognostic	prognostic	ADJ
bptjm-15	704	2	signi	signi	PROPN
bptjm-15	704	3	�	�	PROPN
bptjm-15	704	4	cance	cance	NOUN
bptjm-15	704	5	of	of	ADP
bptjm-15	704	6	serum	serum	NOUN
bptjm-15	704	7	mirna-21	mirna-21	ADJ
bptjm-15	704	8	expression	expression	NOUN
bptjm-15	704	9	in	in	ADP
bptjm-15	704	10	human	human	ADJ
bptjm-15	704	11	non	non	ADJ
bptjm-15	704	12	-	-	ADJ
bptjm-15	704	13	small	small	ADJ
bptjm-15	704	14	cell	cell	NOUN
bptjm-15	704	15	lung	lung	NOUN
bptjm-15	704	16	cancer	cancer	NOUN
bptjm-15	704	17	.	.	PUNCT
bptjm-15	705	1	j	j	PROPN
bptjm-15	705	2	surg	surg	PROPN
bptjm-15	705	3	oncol	oncol	PROPN
bptjm-15	705	4	.	.	PUNCT
bptjm-15	705	5	,	,	PUNCT
bptjm-15	705	6	104(7):847	104(7):847	NUM
bptjm-15	705	7	-	-	SYM
bptjm-15	705	8	51	51	NUM
bptjm-15	705	9	.	.	PUNCT
bptjm-15	706	1	doi	doi	NOUN
bptjm-15	706	2	:	:	PUNCT
bptjm-15	706	3	10.1002	10.1002	NUM
bptjm-15	706	4	/	/	SYM
bptjm-15	706	5	jso.22008	jso.22008	NOUN
bptjm-15	706	6	.	.	PUNCT
bptjm-15	707	1	epub	epub	PROPN
bptjm-15	707	2	2011	2011	NUM
bptjm-15	707	3	jun	jun	PROPN
bptjm-15	707	4	30	30	NUM
bptjm-15	707	5	.	.	PUNCT
bptjm-15	708	1	pmid	pmid	NOUN
bptjm-15	708	2	:	:	PUNCT
bptjm-15	708	3	2172101	2172101	NUM
bptjm-15	708	4	97	97	NUM
bptjm-15	708	5	.	.	PUNCT
bptjm-15	709	1	wang	wang	PROPN
bptjm-15	709	2	,	,	PUNCT
bptjm-15	709	3	yanye	yanye	PROPN
bptjm-15	709	4	et	et	PROPN
bptjm-15	709	5	al	al	PROPN
bptjm-15	709	6	.	.	PROPN
bptjm-15	709	7	(	(	PUNCT
bptjm-15	709	8	2020	2020	NUM
bptjm-15	709	9	)	)	PUNCT
bptjm-15	709	10	.	.	PUNCT
bptjm-15	710	1	clinical	clinical	ADJ
bptjm-15	710	2	and	and	CCONJ
bptjm-15	710	3	molecular	molecular	ADJ
bptjm-15	710	4	characteristics	characteristic	NOUN
bptjm-15	710	5	of	of	ADP
bptjm-15	710	6	tsc1/2	tsc1/2	PROPN
bptjm-15	710	7	mutant	mutant	ADJ
bptjm-15	710	8	lung	lung	NOUN
bptjm-15	710	9	cancer	cancer	NOUN
bptjm-15	710	10	.	.	PUNCT
bptjm-15	711	1	journal	journal	NOUN
bptjm-15	711	2	of	of	ADP
bptjm-15	711	3	clinical	clinical	ADJ
bptjm-15	711	4	oncology	oncology	NOUN
bptjm-15	711	5	,	,	PUNCT
bptjm-15	711	6	38(15	38(15	NUM
bptjm-15	711	7	)	)	PUNCT
bptjm-15	711	8	.	.	PUNCT
bptjm-15	712	1	doi:10.1200	doi:10.1200	PROPN
bptjm-15	712	2	/	/	SYM
bptjm-15	712	3	jco.2020.38.15_suppl.e21647	jco.2020.38.15_suppl.e21647	PROPN
bptjm-15	712	4	.	.	PROPN
bptjm-15	712	5	98	98	NUM
bptjm-15	712	6	.	.	PUNCT
bptjm-15	713	1	wachters	wachter	NOUN
bptjm-15	713	2	,	,	PUNCT
bptjm-15	713	3	f.	f.	PROPN
bptjm-15	713	4	m.	m.	PROPN
bptjm-15	713	5	,	,	PUNCT
bptjm-15	713	6	l.	l.	PROPN
bptjm-15	713	7	s.	s.	PROPN
bptjm-15	713	8	m.	m.	PROPN
bptjm-15	713	9	wong	wong	PROPN
bptjm-15	713	10	,	,	PUNCT
bptjm-15	713	11	w.	w.	PROPN
bptjm-15	713	12	timens	timens	PROPN
bptjm-15	713	13	,	,	PUNCT
bptjm-15	713	14	h.	h.	PROPN
bptjm-15	713	15	h.	h.	PROPN
bptjm-15	713	16	kampinga	kampinga	PROPN
bptjm-15	713	17	,	,	PUNCT
bptjm-15	713	18	and	and	CCONJ
bptjm-15	713	19	h.	h.	PROPN
bptjm-15	713	20	j.	j.	PROPN
bptjm-15	713	21	m.	m.	PROPN
bptjm-15	713	22	groen	groen	PROPN
bptjm-15	713	23	.	.	PUNCT
bptjm-15	714	1	(	(	PUNCT
bptjm-15	714	2	november	november	PROPN
bptjm-15	714	3	2005	2005	NUM
bptjm-15	714	4	)	)	PUNCT
bptjm-15	714	5	.	.	PUNCT
bptjm-15	715	1	ercc1	ercc1	PROPN
bptjm-15	715	2	,	,	PUNCT
bptjm-15	715	3	hrad51	hrad51	NOUN
bptjm-15	715	4	,	,	PUNCT
bptjm-15	715	5	and	and	CCONJ
bptjm-15	715	6	brca1	brca1	NOUN
bptjm-15	715	7	protein	protein	NOUN
bptjm-15	715	8	expression	expression	NOUN
bptjm-15	715	9	in	in	ADP
bptjm-15	715	10	relation	relation	NOUN
bptjm-15	715	11	to	to	ADP
bptjm-15	715	12	tumour	tumour	NOUN
bptjm-15	715	13	response	response	NOUN
bptjm-15	715	14	and	and	CCONJ
bptjm-15	715	15	survival	survival	NOUN
bptjm-15	715	16	of	of	ADP
bptjm-15	715	17	stage	stage	NOUN
bptjm-15	715	18	iii	iii	SYM
bptjm-15	715	19	/	/	SYM
bptjm-15	715	20	iv	iv	NUM
bptjm-15	715	21	nsclc	nsclc	NOUN
bptjm-15	715	22	patients	patient	NOUN
bptjm-15	715	23	treated	treat	VERB
bptjm-15	715	24	with	with	ADP
bptjm-15	715	25	chemotherapy	chemotherapy	NOUN
bptjm-15	715	26	.	.	PUNCT
bptjm-15	716	1	lung	lung	NOUN
bptjm-15	716	2	cancer	cancer	NOUN
bptjm-15	716	3	(	(	PUNCT
bptjm-15	716	4	amsterdam	amsterdam	PROPN
bptjm-15	716	5	,	,	PUNCT
bptjm-15	716	6	netherlands	netherlands	PROPN
bptjm-15	716	7	)	)	PUNCT
bptjm-15	716	8	50(2	50(2	NUM
bptjm-15	716	9	)	)	PUNCT
bptjm-15	716	10	,	,	PUNCT
bptjm-15	716	11	211–19	211–19	NUM
bptjm-15	716	12	.	.	PUNCT
bptjm-15	717	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
bptjm-15	717	2	j.lungcan.2005.06.013	j.lungcan.2005.06.013	NOUN
bptjm-15	717	3	.	.	PROPN
bptjm-15	718	1	99	99	NUM
bptjm-15	718	2	.	.	PUNCT
bptjm-15	719	1	waters	water	NOUN
bptjm-15	719	2	,	,	PUNCT
bptjm-15	719	3	d.	d.	PROPN
bptjm-15	719	4	l.	l.	PROPN
bptjm-15	719	5	,	,	PUNCT
bptjm-15	719	6	&	&	CCONJ
bptjm-15	719	7	shapter	shapter	PROPN
bptjm-15	719	8	,	,	PUNCT
bptjm-15	719	9	f.	f.	PROPN
bptjm-15	719	10	m.	m.	PROPN
bptjm-15	719	11	(	(	PUNCT
bptjm-15	719	12	2014	2014	NUM
bptjm-15	719	13	)	)	PUNCT
bptjm-15	719	14	.	.	PUNCT
bptjm-15	720	1	the	the	DET
bptjm-15	720	2	polymerase	polymerase	NOUN
bptjm-15	720	3	chain	chain	NOUN
bptjm-15	720	4	reaction	reaction	NOUN
bptjm-15	720	5	(	(	PUNCT
bptjm-15	720	6	pcr	pcr	PROPN
bptjm-15	720	7	):	):	PUNCT
bptjm-15	720	8	general	general	ADJ
bptjm-15	720	9	methods	method	NOUN
bptjm-15	720	10	.	.	PUNCT
bptjm-15	721	1	methods	method	NOUN
bptjm-15	721	2	in	in	ADP
bptjm-15	721	3	molecular	molecular	ADJ
bptjm-15	721	4	biology	biology	NOUN
bptjm-15	721	5	(	(	PUNCT
bptjm-15	721	6	clifton	clifton	PROPN
bptjm-15	721	7	,	,	PUNCT
bptjm-15	721	8	n.j	n.j	PROPN
bptjm-15	721	9	.	.	PROPN
bptjm-15	721	10	)	)	PUNCT
bptjm-15	721	11	,	,	PUNCT
bptjm-15	721	12	1099	1099	NUM
bptjm-15	721	13	,	,	PUNCT
bptjm-15	721	14	65–75	65–75	NUM
bptjm-15	721	15	.	.	PUNCT
bptjm-15	721	16	https://doi.org/	https://doi.org/	VERB
bptjm-15	721	17	10.1007/978	10.1007/978	NUM
bptjm-15	721	18	-	-	SYM
bptjm-15	721	19	1	1	NUM
bptjm-15	721	20	-	-	PUNCT
bptjm-15	721	21	62703	62703	NUM
bptjm-15	721	22	-	-	PUNCT
bptjm-15	721	23	715	715	NUM
bptjm-15	721	24	-	-	PUNCT
bptjm-15	721	25	0_7	0_7	NUM
bptjm-15	721	26	wei	wei	PROPN
bptjm-15	721	27	j	j	PROPN
bptjm-15	721	28	,	,	PUNCT
bptjm-15	721	29	gao	gao	PROPN
bptjm-15	721	30	w	w	PROPN
bptjm-15	721	31	,	,	PUNCT
bptjm-15	721	32	zhu	zhu	PROPN
bptjm-15	721	33	cj	cj	PROPN
bptjm-15	721	34	,	,	PUNCT
bptjm-15	721	35	liu	liu	PROPN
bptjm-15	721	36	yq	yq	PROPN
bptjm-15	721	37	,	,	PUNCT
bptjm-15	721	38	mei	mei	PROPN
bptjm-15	721	39	z	z	PROPN
bptjm-15	721	40	,	,	PUNCT
bptjm-15	721	41	cheng	cheng	PROPN
bptjm-15	721	42	t	t	PROPN
bptjm-15	721	43	,	,	PUNCT
bptjm-15	721	44	shu	shu	PROPN
bptjm-15	721	45	yq	yq	PROPN
bptjm-15	721	46	.	.	PUNCT
bptjm-15	722	1	(	(	PUNCT
bptjm-15	722	2	june	june	PROPN
bptjm-15	722	3	2011	2011	NUM
bptjm-15	722	4	)	)	PUNCT
bptjm-15	722	5	.	.	PUNCT
bptjm-15	723	1	identi	identi	PROPN
bptjm-15	723	2	�	�	PROPN
bptjm-15	723	3	cation	cation	NOUN
bptjm-15	723	4	of	of	ADP
bptjm-15	723	5	plasma	plasma	NOUN
bptjm-15	723	6	microrna-21	microrna-21	PROPN
bptjm-15	723	7	as	as	ADP
bptjm-15	723	8	a	a	DET
bptjm-15	723	9	biomarker	biomarker	NOUN
bptjm-15	723	10	for	for	ADP
bptjm-15	723	11	early	early	ADJ
bptjm-15	723	12	detection	detection	NOUN
bptjm-15	723	13	and	and	CCONJ
bptjm-15	723	14	chemosensitivity	chemosensitivity	NOUN
bptjm-15	723	15	of	of	ADP
bptjm-15	723	16	non	non	ADJ
bptjm-15	723	17	-	-	ADJ
bptjm-15	723	18	small	small	ADJ
bptjm-15	723	19	cell	cell	NOUN
bptjm-15	723	20	lung	lung	NOUN
bptjm-15	723	21	cancer	cancer	NOUN
bptjm-15	723	22	.	.	PUNCT
bptjm-15	724	1	chin	chin	PROPN
bptjm-15	724	2	j	j	PROPN
bptjm-15	724	3	cancer	cancer	PROPN
bptjm-15	724	4	,	,	PUNCT
bptjm-15	724	5	30(6	30(6	NUM
bptjm-15	724	6	)	)	PUNCT
bptjm-15	724	7	,	,	PUNCT
bptjm-15	724	8	407	407	NUM
bptjm-15	724	9	-	-	SYM
bptjm-15	724	10	14	14	NUM
bptjm-15	724	11	.	.	PUNCT
bptjm-15	725	1	doi	doi	NOUN
bptjm-15	725	2	:	:	PUNCT
bptjm-15	725	3	10.5732	10.5732	NUM
bptjm-15	725	4	/	/	SYM
bptjm-15	726	1	cjc.010.10522	cjc.010.10522	NOUN
bptjm-15	726	2	.	.	PUNCT
bptjm-15	727	1	pmid	pmid	NOUN
bptjm-15	727	2	:	:	PUNCT
bptjm-15	727	3	21627863	21627863	NUM
bptjm-15	727	4	;	;	PUNCT
bptjm-15	727	5	pmcid	pmcid	ADJ
bptjm-15	727	6	:	:	PUNCT
bptjm-15	727	7	pmc4013415	pmc4013415	NOUN
bptjm-15	727	8	.	.	PUNCT
bptjm-15	728	1	100	100	NUM
bptjm-15	728	2	.	.	X
bptjm-15	729	1	wen	wen	PROPN
bptjm-15	729	2	,	,	PUNCT
bptjm-15	729	3	shiwang	shiwang	PROPN
bptjm-15	729	4	,	,	PUNCT
bptjm-15	729	5	lei	lei	PROPN
bptjm-15	729	6	dai	dai	PROPN
bptjm-15	729	7	,	,	PUNCT
bptjm-15	729	8	lei	lei	PROPN
bptjm-15	729	9	wang	wang	PROPN
bptjm-15	729	10	,	,	PUNCT
bptjm-15	729	11	wenjian	wenjian	PROPN
bptjm-15	729	12	wang	wang	PROPN
bptjm-15	729	13	,	,	PUNCT
bptjm-15	729	14	duoguang	duoguang	PROPN
bptjm-15	729	15	wu	wu	PROPN
bptjm-15	729	16	,	,	PUNCT
bptjm-15	729	17	kefeng	kefeng	PROPN
bptjm-15	729	18	wang	wang	PROPN
bptjm-15	729	19	,	,	PUNCT
bptjm-15	729	20	zhanghai	zhanghai	VERB
bptjm-15	730	1	he	he	PRON
bptjm-15	730	2	,	,	PUNCT
bptjm-15	730	3	et	et	PROPN
bptjm-15	730	4	al	al	PROPN
bptjm-15	730	5	.	.	PUNCT
bptjm-15	730	6	(	(	PUNCT
bptjm-15	730	7	november	november	PROPN
bptjm-15	730	8	2019	2019	NUM
bptjm-15	730	9	)	)	PUNCT
bptjm-15	730	10	.	.	PUNCT
bptjm-15	731	1	genomic	genomic	ADJ
bptjm-15	731	2	signature	signature	NOUN
bptjm-15	731	3	of	of	ADP
bptjm-15	731	4	driver	driver	NOUN
bptjm-15	731	5	genes	gene	NOUN
bptjm-15	731	6	identi	identi	NOUN
bptjm-15	731	7	�	�	PROPN
bptjm-15	731	8	ed	ed	NOUN
bptjm-15	731	9	by	by	ADP
bptjm-15	731	10	target	target	NOUN
bptjm-15	731	11	next	next	ADJ
bptjm-15	731	12	generation	generation	NOUN
bptjm-15	731	13	sequencing	sequence	VERB
bptjm-15	731	14	in	in	ADP
bptjm-15	731	15	chinese	chinese	ADJ
bptjm-15	731	16	non	non	ADJ
bptjm-15	731	17	-	-	ADJ
bptjm-15	731	18	small	small	ADJ
bptjm-15	731	19	cell	cell	NOUN
bptjm-15	731	20	lung	lung	NOUN
bptjm-15	731	21	cancer	cancer	NOUN
bptjm-15	731	22	.	.	PUNCT
bptjm-15	732	1	the	the	DET
bptjm-15	732	2	oncologist	oncologist	NOUN
bptjm-15	732	3	,	,	PUNCT
bptjm-15	732	4	24(11	24(11	NUM
bptjm-15	732	5	)	)	PUNCT
bptjm-15	732	6	,	,	PUNCT
bptjm-15	732	7	e1070–81	e1070–81	NUM
bptjm-15	732	8	.	.	PUNCT
bptjm-15	732	9	https://doi.org/10.1634/theoncologist.2018-0572	https://doi.org/10.1634/theoncologist.2018-0572	NOUN
bptjm-15	732	10	.	.	PUNCT
bptjm-15	733	1	101	101	NUM
bptjm-15	733	2	.	.	PUNCT
bptjm-15	734	1	xie	xie	PROPN
bptjm-15	734	2	,	,	PUNCT
bptjm-15	734	3	p.	p.	PROPN
bptjm-15	734	4	,	,	PUNCT
bptjm-15	734	5	li	li	PROPN
bptjm-15	734	6	,	,	PUNCT
bptjm-15	734	7	x.	x.	PROPN
bptjm-15	734	8	,	,	PUNCT
bptjm-15	734	9	tan	tan	PROPN
bptjm-15	734	10	,	,	PUNCT
bptjm-15	734	11	x.	x.	NOUN
bptjm-15	734	12	,	,	PUNCT
bptjm-15	734	13	sun	sun	PROPN
bptjm-15	734	14	,	,	PUNCT
bptjm-15	734	15	x.	x.	PROPN
bptjm-15	734	16	,	,	PUNCT
bptjm-15	734	17	wang	wang	PROPN
bptjm-15	734	18	,	,	PUNCT
bptjm-15	734	19	c.	c.	PROPN
bptjm-15	734	20	,	,	PUNCT
bptjm-15	734	21	yu	yu	PROPN
bptjm-15	734	22	,	,	PUNCT
bptjm-15	734	23	j.	j.	PROPN
bptjm-15	734	24	(	(	PUNCT
bptjm-15	734	25	2016	2016	NUM
bptjm-15	734	26	)	)	PUNCT
bptjm-15	734	27	.	.	PUNCT
bptjm-15	735	1	sequential	sequential	ADJ
bptjm-15	735	2	serum	serum	NOUN
bptjm-15	735	3	let-7	let-7	PUNCT
bptjm-15	735	4	is	be	AUX
bptjm-15	735	5	a	a	DET
bptjm-15	735	6	novel	novel	ADJ
bptjm-15	735	7	biomarker	biomarker	NOUN
bptjm-15	735	8	to	to	PART
bptjm-15	735	9	predict	predict	VERB
bptjm-15	735	10	accelerated	accelerate	VERB
bptjm-15	735	11	reproliferation	reproliferation	NOUN
bptjm-15	735	12	during	during	ADP
bptjm-15	735	13	fractional	fractional	ADJ
bptjm-15	735	14	radiotherapy	radiotherapy	NOUN
bptjm-15	735	15	in	in	ADP
bptjm-15	735	16	lung	lung	NOUN
bptjm-15	735	17	cancer	cancer	NOUN
bptjm-15	735	18	.	.	PUNCT
bptjm-15	736	1	clinical	clinical	ADJ
bptjm-15	736	2	lung	lung	NOUN
bptjm-15	736	3	cancer	cancer	NOUN
bptjm-15	736	4	,	,	PUNCT
bptjm-15	736	5	17(5	17(5	NUM
bptjm-15	736	6	)	)	PUNCT
bptjm-15	736	7	.	.	PUNCT
bptjm-15	737	1	https://doi.org/10.1016/j.cllc	https://doi.org/10.1016/j.cllc	NOUN
bptjm-15	737	2	.	.	PUNCT
bptjm-15	738	1	2016.03.010	2016.03.010	NUM
bptjm-15	738	2	102	102	NUM
bptjm-15	738	3	.	.	PUNCT
bptjm-15	739	1	xu	xu	PROPN
bptjm-15	739	2	,	,	PUNCT
bptjm-15	739	3	s.	s.	PROPN
bptjm-15	739	4	,	,	PUNCT
bptjm-15	739	5	&	&	CCONJ
bptjm-15	739	6	xu	xu	PROPN
bptjm-15	739	7	,	,	PUNCT
bptjm-15	739	8	s.	s.	PROPN
bptjm-15	739	9	(	(	PUNCT
bptjm-15	739	10	2019	2019	NUM
bptjm-15	739	11	)	)	PUNCT
bptjm-15	739	12	.	.	PUNCT
bptjm-15	740	1	high	high	ADJ
bptjm-15	740	2	expression	expression	NOUN
bptjm-15	740	3	of	of	ADP
bptjm-15	740	4	mir-155	mir-155	NOUN
bptjm-15	740	5	and	and	CCONJ
bptjm-15	740	6	mir-21	mir-21	PROPN
bptjm-15	740	7	in	in	ADP
bptjm-15	740	8	the	the	DET
bptjm-15	740	9	recurrence	recurrence	NOUN
bptjm-15	740	10	or	or	CCONJ
bptjm-15	740	11	metastasis	metastasis	NOUN
bptjm-15	740	12	of	of	ADP
bptjm-15	740	13	non	non	ADJ
bptjm-15	740	14	-	-	ADJ
bptjm-15	740	15	small	small	ADJ
bptjm-15	740	16	cell	cell	NOUN
bptjm-15	740	17	lung	lung	NOUN
bptjm-15	740	18	cancer	cancer	NOUN
bptjm-15	740	19	.	.	PUNCT
bptjm-15	741	1	oncology	oncology	NOUN
bptjm-15	741	2	letters	letter	NOUN
bptjm-15	741	3	,	,	PUNCT
bptjm-15	741	4	18	18	NUM
bptjm-15	741	5	,	,	PUNCT
bptjm-15	741	6	758	758	NUM
bptjm-15	741	7	-	-	SYM
bptjm-15	741	8	763	763	NUM
bptjm-15	741	9	.	.	PUNCT
bptjm-15	742	1	https://doi.org/	https://doi.org/	VERB
bptjm-15	742	2	10.3892	10.3892	NUM
bptjm-15	742	3	/	/	SYM
bptjm-15	742	4	ol.2019.10337	ol.2019.10337	NOUN
bptjm-15	742	5	.	.	PUNCT
bptjm-15	743	1	103	103	NUM
bptjm-15	743	2	.	.	X
bptjm-15	744	1	yang	yang	PROPN
bptjm-15	744	2	,	,	PUNCT
bptjm-15	744	3	nong	nong	PROPN
bptjm-15	744	4	,	,	PUNCT
bptjm-15	744	5	yi	yi	PROPN
bptjm-15	744	6	li	li	PROPN
bptjm-15	744	7	,	,	PUNCT
bptjm-15	744	8	zhidong	zhidong	PROPN
bptjm-15	744	9	liu	liu	PROPN
bptjm-15	744	10	,	,	PUNCT
bptjm-15	744	11	hao	hao	PROPN
bptjm-15	744	12	qin	qin	PROPN
bptjm-15	744	13	,	,	PUNCT
bptjm-15	744	14	duanming	duanme	VERB
bptjm-15	744	15	du	du	PROPN
bptjm-15	744	16	,	,	PUNCT
bptjm-15	744	17	xinkai	xinkai	PROPN
bptjm-15	744	18	cao	cao	PROPN
bptjm-15	744	19	,	,	PUNCT
bptjm-15	744	20	xiaoqing	xiaoqing	PROPN
bptjm-15	744	21	cao	cao	PROPN
bptjm-15	744	22	,	,	PUNCT
bptjm-15	744	23	et	et	PROPN
bptjm-15	744	24	al	al	PROPN
bptjm-15	744	25	.	.	PUNCT
bptjm-15	745	1	(	(	PUNCT
bptjm-15	745	2	march	march	PROPN
bptjm-15	745	3	23	23	NUM
bptjm-15	745	4	,	,	PUNCT
bptjm-15	745	5	2018	2018	NUM
bptjm-15	745	6	)	)	PUNCT
bptjm-15	745	7	.	.	PUNCT
bptjm-15	746	1	the	the	DET
bptjm-15	746	2	characteristics	characteristic	NOUN
bptjm-15	746	3	of	of	ADP
bptjm-15	746	4	ctdna	ctdna	NOUN
bptjm-15	746	5	reveal	reveal	VERB
bptjm-15	746	6	the	the	DET
bptjm-15	746	7	high	high	ADJ
bptjm-15	746	8	complexity	complexity	NOUN
bptjm-15	746	9	in	in	ADP
bptjm-15	746	10	matching	match	VERB
bptjm-15	746	11	the	the	DET
bptjm-15	746	12	corresponding	correspond	VERB
bptjm-15	746	13	tumor	tumor	NOUN
bptjm-15	746	14	tissues	tissue	NOUN
bptjm-15	746	15	.	.	PUNCT
bptjm-15	747	1	bmc	bmc	ADJ
bptjm-15	747	2	cancer	cancer	NOUN
bptjm-15	747	3	18(1	18(1	NOUN
bptjm-15	747	4	)	)	PUNCT
bptjm-15	747	5	,	,	PUNCT
bptjm-15	747	6	319	319	NUM
bptjm-15	747	7	.	.	PUNCT
bptjm-15	747	8	https://doi.org/10.1186/s12885-018-4199-7	https://doi.org/10.1186/s12885-018-4199-7	NUM
bptjm-15	747	9	.	.	PUNCT
bptjm-15	748	1	104	104	NUM
bptjm-15	748	2	.	.	PUNCT
bptjm-15	749	1	yarlagadda	yarlagadda	NOUN
bptjm-15	749	2	,	,	PUNCT
bptjm-15	749	3	bhavya	bhavya	NOUN
bptjm-15	749	4	,	,	PUNCT
bptjm-15	749	5	vaishnavi	vaishnavi	PROPN
bptjm-15	749	6	kamatham	kamatham	PROPN
bptjm-15	749	7	,	,	PUNCT
bptjm-15	749	8	ashton	ashton	PROPN
bptjm-15	749	9	ritter	ritter	PROPN
bptjm-15	749	10	,	,	PUNCT
bptjm-15	749	11	faisal	faisal	ADJ
bptjm-15	749	12	shahjehan	shahjehan	PROPN
bptjm-15	749	13	,	,	PUNCT
bptjm-15	749	14	and	and	CCONJ
bptjm-15	749	15	pashtoon	pashtoon	PROPN
bptjm-15	749	16	m.	m.	PROPN
bptjm-15	749	17	kasi	kasi	PROPN
bptjm-15	749	18	.	.	PUNCT
bptjm-15	750	1	(	(	PUNCT
bptjm-15	750	2	august	august	PROPN
bptjm-15	750	3	19	19	NUM
bptjm-15	750	4	,	,	PUNCT
bptjm-15	750	5	2019	2019	NUM
bptjm-15	750	6	)	)	PUNCT
bptjm-15	750	7	.	.	PUNCT
bptjm-15	751	1	trastuzumab	trastuzumab	NOUN
bptjm-15	751	2	and	and	CCONJ
bptjm-15	751	3	pertuzumab	pertuzumab	NOUN
bptjm-15	751	4	in	in	ADP
bptjm-15	751	5	circulating	circulate	VERB
bptjm-15	751	6	tumor	tumor	NOUN
bptjm-15	751	7	dna	dna	PROPN
bptjm-15	751	8	erbb2ampli	erbb2ampli	PROPN
bptjm-15	751	9	�	�	PROPN
bptjm-15	751	10	ed	ed	PROPN
bptjm-15	751	11	her2	her2	PROPN
bptjm-15	751	12	-	-	PUNCT
bptjm-15	751	13	positive	positive	ADJ
bptjm-15	751	14	refractory	refractory	NOUN
bptjm-15	751	15	cholangiocarcinoma	cholangiocarcinoma	NOUN
bptjm-15	751	16	.	.	PUNCT
bptjm-15	752	1	npj	npj	PROPN
bptjm-15	752	2	precision	precision	PROPN
bptjm-15	752	3	oncology	oncology	NOUN
bptjm-15	752	4	,	,	PUNCT
bptjm-15	752	5	3(1	3(1	NUM
bptjm-15	752	6	)	)	PUNCT
bptjm-15	752	7	,	,	PUNCT
bptjm-15	752	8	1–5	1–5	PROPN
bptjm-15	752	9	.	.	NOUN
bptjm-15	752	10	https://doi.org/10.1038/s41698-019-0091-4	https://doi.org/10.1038/s41698-019-0091-4	NUM
bptjm-15	752	11	.	.	PUNCT
bptjm-15	753	1	105	105	NUM
bptjm-15	753	2	.	.	PUNCT
bptjm-15	754	1	yuxia	yuxia	PROPN
bptjm-15	754	2	m	m	PROPN
bptjm-15	754	3	,	,	PUNCT
bptjm-15	754	4	zhennan	zhennan	PROPN
bptjm-15	754	5	t	t	PROPN
bptjm-15	754	6	,	,	PUNCT
bptjm-15	754	7	wei	wei	PROPN
bptjm-15	754	8	z.	z.	PROPN
bptjm-15	754	9	(	(	PUNCT
bptjm-15	754	10	december	december	PROPN
bptjm-15	754	11	2012	2012	NUM
bptjm-15	754	12	)	)	PUNCT
bptjm-15	754	13	.	.	PUNCT
bptjm-15	755	1	circulating	circulate	VERB
bptjm-15	755	2	mir-125b	mir-125b	PROPN
bptjm-15	755	3	is	be	AUX
bptjm-15	755	4	a	a	DET
bptjm-15	755	5	novel	novel	ADJ
bptjm-15	755	6	biomarker	biomarker	NOUN
bptjm-15	755	7	for	for	ADP
bptjm-15	755	8	screening	screen	VERB
bptjm-15	755	9	berkeley	berkeley	PROPN
bptjm-15	755	10	pharma	pharma	PROPN
bptjm-15	755	11	tech	tech	NOUN
bptjm-15	755	12	journal	journal	NOUN
bptjm-15	755	13	of	of	ADP
bptjm-15	755	14	medicine	medicine	NOUN
bptjm-15	755	15	|	|	ADV
bptjm-15	755	16	93	93	NUM
bptjm-15	755	17	non	non	ADJ
bptjm-15	755	18	-	-	ADJ
bptjm-15	755	19	small	small	ADJ
bptjm-15	755	20	-	-	PUNCT
bptjm-15	755	21	cell	cell	NOUN
bptjm-15	755	22	lung	lung	NOUN
bptjm-15	755	23	cancer	cancer	NOUN
bptjm-15	755	24	and	and	CCONJ
bptjm-15	755	25	predicts	predict	VERB
bptjm-15	755	26	poor	poor	ADJ
bptjm-15	755	27	prognosis	prognosis	NOUN
bptjm-15	755	28	.	.	PUNCT
bptjm-15	756	1	j	j	PROPN
bptjm-15	756	2	cancer	cancer	NOUN
bptjm-15	756	3	res	re	VERB
bptjm-15	756	4	clin	clin	PROPN
bptjm-15	756	5	oncol	oncol	PROPN
bptjm-15	756	6	.	.	PUNCT
bptjm-15	756	7	,	,	PUNCT
bptjm-15	756	8	138(12):2045	138(12):2045	NUM
bptjm-15	756	9	-	-	SYM
bptjm-15	756	10	50	50	NUM
bptjm-15	756	11	.	.	PUNCT
bptjm-15	757	1	doi:10.1007	doi:10.1007	VERB
bptjm-15	757	2	/	/	SYM
bptjm-15	757	3	s00432	s00432	PROPN
bptjm-15	757	4	-	-	PUNCT
bptjm-15	757	5	012	012	NUM
bptjm-15	757	6	-	-	PUNCT
bptjm-15	757	7	1285	1285	NUM
bptjm-15	757	8	-	-	SYM
bptjm-15	757	9	0	0	NUM
bptjm-15	757	10	.	.	PUNCT
bptjm-15	758	1	epub	epub	PROPN
bptjm-15	758	2	2012	2012	NUM
bptjm-15	758	3	jul	jul	PROPN
bptjm-15	758	4	18	18	NUM
bptjm-15	758	5	.	.	PUNCT
bptjm-15	759	1	pmid	pmid	NOUN
bptjm-15	759	2	:	:	PUNCT
bptjm-15	759	3	22806310	22806310	NUM
bptjm-15	759	4	.	.	PUNCT
bptjm-15	760	1	106	106	NUM
bptjm-15	760	2	.	.	PUNCT
bptjm-15	761	1	zeng	zeng	PROPN
bptjm-15	761	2	,	,	PUNCT
bptjm-15	761	3	hanlin	hanlin	PROPN
bptjm-15	761	4	,	,	PUNCT
bptjm-15	761	5	aparna	aparna	PROPN
bptjm-15	761	6	jorapur	jorapur	PROPN
bptjm-15	761	7	,	,	PUNCT
bptjm-15	761	8	a.	a.	NOUN
bptjm-15	761	9	hunter	hunter	PROPN
bptjm-15	761	10	shain	shain	PROPN
bptjm-15	761	11	,	,	PUNCT
bptjm-15	761	12	ursula	ursula	PROPN
bptjm-15	761	13	e.	e.	PROPN
bptjm-15	761	14	lang	lang	PROPN
bptjm-15	761	15	,	,	PUNCT
bptjm-15	761	16	rodrigo	rodrigo	PROPN
bptjm-15	761	17	torres	torres	PROPN
bptjm-15	761	18	,	,	PUNCT
bptjm-15	761	19	yuntian	yuntian	PROPN
bptjm-15	761	20	zhang	zhang	PROPN
bptjm-15	761	21	,	,	PUNCT
bptjm-15	761	22	andrew	andrew	PROPN
bptjm-15	761	23	s.	s.	PROPN
bptjm-15	761	24	mcneal	mcneal	PROPN
bptjm-15	761	25	,	,	PUNCT
bptjm-15	761	26	et	et	PROPN
bptjm-15	761	27	al	al	PROPN
bptjm-15	761	28	.	.	PUNCT
bptjm-15	761	29	(	(	PUNCT
bptjm-15	761	30	july	july	PROPN
bptjm-15	761	31	9	9	NUM
bptjm-15	761	32	,	,	PUNCT
bptjm-15	761	33	2018	2018	NUM
bptjm-15	761	34	)	)	PUNCT
bptjm-15	761	35	.	.	PUNCT
bptjm-15	762	1	bi	bi	ADJ
bptjm-15	762	2	-	-	ADJ
bptjm-15	762	3	allelic	allelic	ADJ
bptjm-15	762	4	loss	loss	NOUN
bptjm-15	762	5	of	of	ADP
bptjm-15	762	6	cdkn2a	cdkn2a	PROPN
bptjm-15	762	7	initiates	initiate	VERB
bptjm-15	762	8	melanoma	melanoma	NOUN
bptjm-15	762	9	invasion	invasion	NOUN
bptjm-15	762	10	via	via	ADP
bptjm-15	762	11	brn2	brn2	NOUN
bptjm-15	762	12	activation	activation	NOUN
bptjm-15	762	13	.	.	PUNCT
bptjm-15	763	1	cancer	cancer	NOUN
bptjm-15	763	2	cell	cell	NOUN
bptjm-15	763	3	,	,	PUNCT
bptjm-15	763	4	34(1	34(1	NUM
bptjm-15	763	5	)	)	PUNCT
bptjm-15	763	6	:	:	PUNCT
bptjm-15	763	7	56	56	NUM
bptjm-15	763	8	-	-	SYM
bptjm-15	763	9	68.e9	68.e9	NOUN
bptjm-15	763	10	.	.	PUNCT
bptjm-15	764	1	https://doi.org/10.1016/j.ccell.2018.05.014	https://doi.org/10.1016/j.ccell.2018.05.014	PROPN
bptjm-15	764	2	.	.	PUNCT
bptjm-15	764	3	107	107	NUM
bptjm-15	764	4	.	.	PUNCT
bptjm-15	765	1	zhang	zhang	PROPN
bptjm-15	765	2	,	,	PUNCT
bptjm-15	765	3	g.	g.	PROPN
bptjm-15	765	4	b.	b.	PROPN
bptjm-15	765	5	,	,	PUNCT
bptjm-15	765	6	chen	chen	PROPN
bptjm-15	765	7	,	,	PUNCT
bptjm-15	765	8	j.	j.	PROPN
bptjm-15	765	9	,	,	PUNCT
bptjm-15	765	10	wang	wang	PROPN
bptjm-15	765	11	,	,	PUNCT
bptjm-15	765	12	l.	l.	PROPN
bptjm-15	765	13	r.	r.	PROPN
bptjm-15	765	14	,	,	PUNCT
bptjm-15	765	15	li	li	PROPN
bptjm-15	765	16	,	,	PUNCT
bptjm-15	765	17	j.	j.	PROPN
bptjm-15	765	18	,	,	PUNCT
bptjm-15	765	19	li	li	PROPN
bptjm-15	765	20	,	,	PUNCT
bptjm-15	765	21	m.	m.	PROPN
bptjm-15	765	22	w.	w.	PROPN
bptjm-15	765	23	,	,	PUNCT
bptjm-15	765	24	xu	xu	PROPN
bptjm-15	765	25	,	,	PUNCT
bptjm-15	765	26	n.	n.	PROPN
bptjm-15	765	27	,	,	PUNCT
bptjm-15	765	28	wang	wang	PROPN
bptjm-15	765	29	,	,	PUNCT
bptjm-15	765	30	y.	y.	PROPN
bptjm-15	765	31	,	,	PUNCT
bptjm-15	765	32	&	&	CCONJ
bptjm-15	765	33	shentu	shentu	PROPN
bptjm-15	765	34	,	,	PUNCT
bptjm-15	765	35	j.	j.	PROPN
bptjm-15	765	36	z.	z.	PROPN
bptjm-15	765	37	(	(	PUNCT
bptjm-15	765	38	2012	2012	NUM
bptjm-15	765	39	)	)	PUNCT
bptjm-15	765	40	.	.	PUNCT
bptjm-15	766	1	rrm1	rrm1	NOUN
bptjm-15	766	2	and	and	CCONJ
bptjm-15	766	3	ercc1	ercc1	NOUN
bptjm-15	766	4	expression	expression	NOUN
bptjm-15	766	5	in	in	ADP
bptjm-15	766	6	peripheral	peripheral	ADJ
bptjm-15	766	7	blood	blood	NOUN
bptjm-15	766	8	versus	versus	ADP
bptjm-15	766	9	tumor	tumor	NOUN
bptjm-15	766	10	tissue	tissue	NOUN
bptjm-15	766	11	in	in	ADP
bptjm-15	766	12	gemcitabine	gemcitabine	NOUN
bptjm-15	766	13	/	/	SYM
bptjm-15	766	14	carboplatin	carboplatin	NOUN
bptjm-15	766	15	-	-	PUNCT
bptjm-15	766	16	treated	treat	VERB
bptjm-15	766	17	advanced	advanced	ADJ
bptjm-15	766	18	non	non	ADJ
bptjm-15	766	19	-	-	ADJ
bptjm-15	766	20	small	small	ADJ
bptjm-15	766	21	cell	cell	NOUN
bptjm-15	766	22	lung	lung	NOUN
bptjm-15	766	23	cancer	cancer	NOUN
bptjm-15	766	24	.	.	PUNCT
bptjm-15	767	1	cancer	cancer	NOUN
bptjm-15	767	2	chemotherapy	chemotherapy	NOUN
bptjm-15	767	3	and	and	CCONJ
bptjm-15	767	4	pharmacology	pharmacology	NOUN
bptjm-15	767	5	,	,	PUNCT
bptjm-15	767	6	69(5	69(5	NUM
bptjm-15	767	7	)	)	PUNCT
bptjm-15	767	8	,	,	PUNCT
bptjm-15	767	9	1277–1287	1277–1287	NUM
bptjm-15	767	10	.	.	PUNCT
bptjm-15	768	1	https://doi.org/10.1007/	https://doi.org/10.1007/	PROPN
bptjm-15	768	2	s00280	s00280	PROPN
bptjm-15	768	3	-	-	PUNCT
bptjm-15	768	4	012	012	NUM
bptjm-15	768	5	-	-	PUNCT
bptjm-15	768	6	1834	1834	NUM
bptjm-15	768	7	-	-	PUNCT
bptjm-15	768	8	x	x	SYM
bptjm-15	768	9	108	108	NUM
bptjm-15	768	10	.	.	PUNCT
bptjm-15	769	1	zhang	zhang	PROPN
bptjm-15	769	2	,	,	PUNCT
bptjm-15	769	3	y.	y.	PROPN
bptjm-15	769	4	,	,	PUNCT
bptjm-15	769	5	roth	roth	PROPN
bptjm-15	769	6	,	,	PUNCT
bptjm-15	769	7	j.	j.	PROPN
bptjm-15	769	8	a.	a.	PROPN
bptjm-15	769	9	,	,	PUNCT
bptjm-15	769	10	yu	yu	PROPN
bptjm-15	769	11	,	,	PUNCT
bptjm-15	769	12	h.	h.	PROPN
bptjm-15	769	13	,	,	PUNCT
bptjm-15	769	14	ye	ye	PROPN
bptjm-15	769	15	,	,	PUNCT
bptjm-15	769	16	y.	y.	PROPN
bptjm-15	769	17	,	,	PUNCT
bptjm-15	769	18	xie	xie	PROPN
bptjm-15	769	19	,	,	PUNCT
bptjm-15	769	20	k.	k.	PROPN
bptjm-15	769	21	,	,	PUNCT
bptjm-15	769	22	zhao	zhao	PROPN
bptjm-15	769	23	,	,	PUNCT
bptjm-15	769	24	h.	h.	PROPN
bptjm-15	769	25	,	,	PUNCT
bptjm-15	769	26	chang	chang	PROPN
bptjm-15	769	27	,	,	PUNCT
bptjm-15	769	28	d.	d.	PROPN
bptjm-15	769	29	w.	w.	PROPN
bptjm-15	769	30	,	,	PUNCT
bptjm-15	769	31	huang	huang	PROPN
bptjm-15	769	32	,	,	PUNCT
bptjm-15	769	33	m.	m.	NOUN
bptjm-15	769	34	,	,	PUNCT
bptjm-15	769	35	li	li	PROPN
bptjm-15	769	36	,	,	PUNCT
bptjm-15	769	37	h.	h.	PROPN
bptjm-15	769	38	,	,	PUNCT
bptjm-15	769	39	qu	qu	PROPN
bptjm-15	769	40	,	,	PUNCT
bptjm-15	769	41	j.	j.	PROPN
bptjm-15	769	42	,	,	PUNCT
bptjm-15	769	43	&	&	CCONJ
bptjm-15	769	44	wu	wu	PROPN
bptjm-15	769	45	,	,	PUNCT
bptjm-15	769	46	x.	x.	NOUN
bptjm-15	769	47	(	(	PUNCT
bptjm-15	769	48	2019	2019	NUM
bptjm-15	769	49	)	)	PUNCT
bptjm-15	769	50	.	.	PUNCT
bptjm-15	770	1	a	a	DET
bptjm-15	770	2	5	5	NUM
bptjm-15	770	3	-	-	PUNCT
bptjm-15	770	4	microrna	microrna	PROPN
bptjm-15	770	5	signature	signature	NOUN
bptjm-15	770	6	identi	identi	PROPN
bptjm-15	770	7	�	�	PROPN
bptjm-15	770	8	ed	ed	PROPN
bptjm-15	770	9	from	from	ADP
bptjm-15	770	10	serum	serum	PROPN
bptjm-15	770	11	microrna	microrna	PROPN
bptjm-15	770	12	pro	pro	PROPN
bptjm-15	770	13	�	�	PROPN
bptjm-15	770	14	ling	ling	NOUN
bptjm-15	770	15	predicts	predict	NOUN
bptjm-15	770	16	survival	survival	NOUN
bptjm-15	770	17	in	in	ADP
bptjm-15	770	18	patients	patient	NOUN
bptjm-15	770	19	with	with	ADP
bptjm-15	770	20	advanced	advanced	ADJ
bptjm-15	770	21	stage	stage	NOUN
bptjm-15	770	22	non	non	ADJ
bptjm-15	770	23	-	-	ADJ
bptjm-15	770	24	small	small	ADJ
bptjm-15	770	25	cell	cell	NOUN
bptjm-15	770	26	lung	lung	NOUN
bptjm-15	770	27	cancer	cancer	NOUN
bptjm-15	770	28	.	.	PUNCT
bptjm-15	771	1	carcinogenesis	carcinogenesis	NOUN
bptjm-15	771	2	,	,	PUNCT
bptjm-15	771	3	40(5	40(5	NOUN
bptjm-15	771	4	)	)	PUNCT
bptjm-15	771	5	,	,	PUNCT
bptjm-15	771	6	643–650	643–650	NUM
bptjm-15	771	7	.	.	PUNCT
bptjm-15	772	1	https://doi.org/10.1093/carcin/bgy132	https://doi.org/10.1093/carcin/bgy132	PROPN
bptjm-15	772	2	109	109	NUM
bptjm-15	772	3	.	.	PUNCT
bptjm-15	773	1	zhao	zhao	PROPN
bptjm-15	773	2	,	,	PUNCT
bptjm-15	773	3	m.	m.	NOUN
bptjm-15	773	4	,	,	PUNCT
bptjm-15	773	5	zhang	zhang	PROPN
bptjm-15	773	6	,	,	PUNCT
bptjm-15	773	7	h.	h.	PROPN
bptjm-15	773	8	,	,	PUNCT
bptjm-15	773	9	zhu	zhu	PROPN
bptjm-15	773	10	,	,	PUNCT
bptjm-15	773	11	g.	g.	PROPN
bptjm-15	773	12	,	,	PUNCT
bptjm-15	773	13	liang	liang	PROPN
bptjm-15	773	14	,	,	PUNCT
bptjm-15	773	15	j.	j.	PROPN
bptjm-15	773	16	,	,	PUNCT
bptjm-15	773	17	chen	chen	PROPN
bptjm-15	773	18	,	,	PUNCT
bptjm-15	773	19	n.	n.	PROPN
bptjm-15	773	20	,	,	PUNCT
bptjm-15	773	21	yang	yang	PROPN
bptjm-15	773	22	,	,	PUNCT
bptjm-15	773	23	y.	y.	PROPN
bptjm-15	773	24	,	,	PUNCT
bptjm-15	773	25	liang	liang	PROPN
bptjm-15	773	26	,	,	PUNCT
bptjm-15	773	27	x.	x.	PROPN
bptjm-15	773	28	,	,	PUNCT
bptjm-15	773	29	cai	cai	PROPN
bptjm-15	773	30	,	,	PUNCT
bptjm-15	773	31	h.	h.	PROPN
bptjm-15	773	32	,	,	PUNCT
bptjm-15	773	33	&	&	CCONJ
bptjm-15	773	34	liu	liu	PROPN
bptjm-15	773	35	,	,	PUNCT
bptjm-15	773	36	w.	w.	PROPN
bptjm-15	773	37	(	(	PUNCT
bptjm-15	773	38	2016	2016	NUM
bptjm-15	773	39	)	)	PUNCT
bptjm-15	773	40	.	.	PUNCT
bptjm-15	774	1	association	association	NOUN
bptjm-15	774	2	between	between	ADP
bptjm-15	774	3	overexpression	overexpression	NOUN
bptjm-15	774	4	of	of	ADP
bptjm-15	774	5	wip1	wip1	NOUN
bptjm-15	774	6	and	and	CCONJ
bptjm-15	774	7	prognosis	prognosis	NOUN
bptjm-15	774	8	of	of	ADP
bptjm-15	774	9	patients	patient	NOUN
bptjm-15	774	10	with	with	ADP
bptjm-15	774	11	non	non	PRON
bptjm-15	774	12	small	small	ADJ
bptjm-15	774	13	cell	cell	NOUN
bptjm-15	774	14	lung	lung	NOUN
bptjm-15	774	15	cancer	cancer	NOUN
bptjm-15	774	16	.	.	PUNCT
bptjm-15	775	1	oncology	oncology	NOUN
bptjm-15	775	2	letters	letter	NOUN
bptjm-15	775	3	,	,	PUNCT
bptjm-15	775	4	11(4	11(4	NUM
bptjm-15	775	5	)	)	PUNCT
bptjm-15	775	6	,	,	PUNCT
bptjm-15	775	7	2365–2370	2365–2370	NUM
bptjm-15	775	8	.	.	PUNCT
bptjm-15	776	1	https://doi.org/10.3892/ol	https://doi.org/10.3892/ol	NOUN
bptjm-15	776	2	.	.	PUNCT
bptjm-15	777	1	2016.4245	2016.4245	NUM
bptjm-15	777	2	.	.	PUNCT
bptjm-15	778	1	110	110	NUM
bptjm-15	778	2	.	.	PUNCT
bptjm-15	779	1	zhao	zhao	PROPN
bptjm-15	779	2	w	w	PROPN
bptjm-15	779	3	,	,	PUNCT
bptjm-15	779	4	zhao	zhao	PROPN
bptjm-15	779	5	jj	jj	PROPN
bptjm-15	779	6	,	,	PUNCT
bptjm-15	779	7	zhang	zhang	PROPN
bptjm-15	779	8	l	l	PROPN
bptjm-15	779	9	,	,	PUNCT
bptjm-15	779	10	xu	xu	PROPN
bptjm-15	779	11	qf	qf	PROPN
bptjm-15	779	12	,	,	PUNCT
bptjm-15	779	13	zhao	zhao	PROPN
bptjm-15	779	14	ym	ym	PROPN
bptjm-15	779	15	,	,	PUNCT
bptjm-15	779	16	shi	shi	PROPN
bptjm-15	779	17	xy	xy	PROPN
bptjm-15	779	18	and	and	CCONJ
bptjm-15	779	19	xu	xu	PROPN
bptjm-15	779	20	ag	ag	PROPN
bptjm-15	779	21	.	.	PUNCT
bptjm-15	779	22	(	(	PUNCT
bptjm-15	779	23	2015	2015	NUM
bptjm-15	779	24	)	)	PUNCT
bptjm-15	779	25	.	.	PUNCT
bptjm-15	780	1	serum	serum	PROPN
bptjm-15	780	2	mir-21	mir-21	PROPN
bptjm-15	780	3	level	level	NOUN
bptjm-15	780	4	:	:	PUNCT
bptjm-15	780	5	a	a	DET
bptjm-15	780	6	potential	potential	ADJ
bptjm-15	780	7	diagnostic	diagnostic	ADJ
bptjm-15	780	8	and	and	CCONJ
bptjm-15	780	9	prognostic	prognostic	ADJ
bptjm-15	780	10	biomarker	biomarker	NOUN
bptjm-15	780	11	for	for	ADP
bptjm-15	780	12	non	non	ADJ
bptjm-15	780	13	-	-	ADJ
bptjm-15	780	14	small	small	ADJ
bptjm-15	780	15	cell	cell	NOUN
bptjm-15	780	16	lung	lung	NOUN
bptjm-15	780	17	cancer	cancer	NOUN
bptjm-15	780	18	.	.	PUNCT
bptjm-15	781	1	int	int	PROPN
bptjm-15	782	1	j	j	PROPN
bptjm-15	782	2	clin	clin	PROPN
bptjm-15	782	3	exp	exp	PROPN
bptjm-15	782	4	med	med	PROPN
bptjm-15	782	5	.	.	PROPN
bptjm-15	782	6	,	,	PUNCT
bptjm-15	782	7	8:14759–14763	8:14759–14763	NUM
bptjm-15	782	8	.	.	PUNCT
bptjm-15	782	9	2015	2015	NUM
bptjm-15	782	10	111	111	NUM
bptjm-15	782	11	.	.	PUNCT
bptjm-15	783	1	zhu	zhu	PROPN
bptjm-15	783	2	,	,	PUNCT
bptjm-15	783	3	w.	w.	PROPN
bptjm-15	783	4	,	,	PUNCT
bptjm-15	783	5	luo	luo	PROPN
bptjm-15	783	6	,	,	PUNCT
bptjm-15	783	7	b.	b.	PROPN
bptjm-15	783	8	,	,	PUNCT
bptjm-15	783	9	an	an	PRON
bptjm-15	783	10	,	,	PUNCT
bptjm-15	783	11	j.	j.	PROPN
bptjm-15	783	12	,	,	PUNCT
bptjm-15	783	13	he	he	PRON
bptjm-15	783	14	,	,	PUNCT
bptjm-15	783	15	j.	j.	PROPN
bptjm-15	783	16	,	,	PUNCT
bptjm-15	783	17	chen	chen	PROPN
bptjm-15	783	18	,	,	PUNCT
bptjm-15	783	19	d.	d.	PROPN
bptjm-15	783	20	,	,	PUNCT
bptjm-15	783	21	xu	xu	PROPN
bptjm-15	783	22	,	,	PUNCT
bptjm-15	783	23	l.	l.	PROPN
bptjm-15	783	24	,	,	PUNCT
bptjm-15	783	25	…	…	PUNCT
bptjm-15	783	26	zhang	zhang	PROPN
bptjm-15	783	27	,	,	PUNCT
bptjm-15	783	28	y.	y.	PROPN
bptjm-15	783	29	(	(	PUNCT
bptjm-15	783	30	2014	2014	NUM
bptjm-15	783	31	)	)	PUNCT
bptjm-15	783	32	.	.	PUNCT
bptjm-15	784	1	di	di	PROPN
bptjm-15	784	2	�	�	PROPN
bptjm-15	784	3	erential	erential	ADJ
bptjm-15	784	4	expression	expression	NOUN
bptjm-15	784	5	of	of	ADP
bptjm-15	784	6	mir-125a-5p	mir-125a-5p	PROPN
bptjm-15	784	7	and	and	CCONJ
bptjm-15	784	8	let-7e	let-7e	PROPN
bptjm-15	784	9	predicts	predict	VERB
bptjm-15	784	10	the	the	DET
bptjm-15	784	11	progression	progression	NOUN
bptjm-15	784	12	and	and	CCONJ
bptjm-15	784	13	prognosis	prognosis	NOUN
bptjm-15	784	14	of	of	ADP
bptjm-15	784	15	non	non	ADJ
bptjm-15	784	16	small	small	ADJ
bptjm-15	784	17	cell	cell	NOUN
bptjm-15	784	18	lung	lung	NOUN
bptjm-15	784	19	cancer	cancer	NOUN
bptjm-15	784	20	.	.	PUNCT
bptjm-15	785	1	cancer	cancer	NOUN
bptjm-15	785	2	investigation	investigation	NOUN
bptjm-15	785	3	,	,	PUNCT
bptjm-15	785	4	32(8	32(8	NUM
bptjm-15	785	5	)	)	PUNCT
bptjm-15	785	6	,	,	PUNCT
bptjm-15	785	7	394	394	NUM
bptjm-15	785	8	-	-	SYM
bptjm-15	785	9	401	401	NUM
bptjm-15	785	10	.	.	PUNCT
bptjm-15	786	1	doi:10.3109/07357907.2014.922569	doi:10.3109/07357907.2014.922569	PROPN
bptjm-15	786	2	berkeley	berkeley	PROPN
bptjm-15	786	3	pharma	pharma	PROPN
bptjm-15	786	4	tech	tech	NOUN
bptjm-15	786	5	journal	journal	NOUN
bptjm-15	786	6	of	of	ADP
bptjm-15	786	7	medicine	medicine	NOUN
bptjm-15	786	8	|	|	ADV
bptjm-15	786	9	94	94	NUM
bptjm-15	786	10	artlcle	artlcle	NOUN
bptjm-15	786	11	3_ms	3_ms	NOUN
bptjm-15	786	12	gut	gut	NOUN
bptjm-15	786	13	microbiome_publish_20211217.pdf	microbiome_publish_20211217.pdf	ADJ
bptjm-15	786	14	front	front	ADJ
bptjm-15	786	15	page	page	NOUN
bptjm-15	786	16	the	the	DET
bptjm-15	786	17	role	role	NOUN
bptjm-15	786	18	of	of	ADP
bptjm-15	786	19	the	the	DET
bptjm-15	786	20	gut	gut	NOUN
bptjm-15	786	21	microbiome	microbiome	NOUN
bptjm-15	786	22	in	in	ADP
bptjm-15	786	23	neuromodulation	neuromodulation	NOUN
bptjm-15	786	24	therapies	therapy	NOUN
bptjm-15	786	25	as	as	ADP
bptjm-15	786	26	a	a	DET
bptjm-15	786	27	potential	potential	ADJ
bptjm-15	786	28	treatment	treatment	NOUN
bptjm-15	786	29	adjunct	adjunct	ADJ
bptjm-15	786	30	for	for	ADP
bptjm-15	786	31	multiple	multiple	ADJ
bptjm-15	786	32	sclerosis.pdf	sclerosis.pdf	NOUN
bptjm-15	786	33	3	3	NUM
bptjm-15	786	34	.	.	PUNCT
bptjm-15	786	35	body	body	VERB
bptjm-15	786	36	the	the	DET
bptjm-15	786	37	role	role	NOUN
bptjm-15	786	38	of	of	ADP
bptjm-15	786	39	the	the	DET
bptjm-15	786	40	gut	gut	NOUN
bptjm-15	786	41	microbiome	microbiome	NOUN
bptjm-15	786	42	in	in	ADP
bptjm-15	786	43	neuromodulation	neuromodulation	NOUN
bptjm-15	786	44	therapies	therapy	NOUN
bptjm-15	786	45	as	as	ADP
bptjm-15	786	46	a	a	DET
bptjm-15	786	47	potential	potential	ADJ
bptjm-15	786	48	treatment	treatment	NOUN
bptjm-15	786	49	adjunct	adjunct	ADJ
bptjm-15	786	50	for	for	ADP
bptjm-15	786	51	multiple	multiple	ADJ
bptjm-15	786	52	sclerosis.pdf	sclerosis.pdf	NOUN
bptjm-15	786	53	the	the	DET
bptjm-15	786	54	role	role	NOUN
bptjm-15	786	55	of	of	ADP
bptjm-15	786	56	the	the	DET
bptjm-15	786	57	gut	gut	NOUN
bptjm-15	786	58	microbiome	microbiome	NOUN
bptjm-15	786	59	in	in	ADP
bptjm-15	786	60	neuromodulation	neuromodulation	NOUN
bptjm-15	786	61	therapies	therapy	NOUN
bptjm-15	786	62	as	as	ADP
bptjm-15	786	63	a	a	DET
bptjm-15	786	64	potential	potential	ADJ
bptjm-15	786	65	treatment	treatment	NOUN
bptjm-15	786	66	adjunct	adjunct	ADJ
bptjm-15	786	67	for	for	ADP
bptjm-15	786	68	multiple	multiple	ADJ
bptjm-15	786	69	sclerosis	sclerosis	NOUN
bptjm-15	786	70	(	(	PUNCT
bptjm-15	786	71	reference	reference	NOUN
bptjm-15	786	72	page	page	NOUN
bptjm-15	786	73	template).pdf	template).pdf	NOUN